data_2knf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2knf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.475 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.624 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 9.8 ptt? -96.64 156.64 16.26 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.602 ' HD2' ' HB3' ' A' ' 81' ' ' ALA . 81.4 m-85 -113.35 97.82 6.72 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.85 -114.26 3.86 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.416 ' OD1' ' HA ' ' A' ' 58' ' ' VAL . 91.8 m-20 -79.35 -24.68 42.54 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.573 0.808 . . . . 0.0 110.58 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.562 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.46 17.65 11.12 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.733 -1.222 . . . . 0.0 111.632 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -65.46 -43.95 88.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.174 0.511 . . . . 0.0 109.822 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -103.68 25.09 27.79 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.739 ' CE1' HG22 ' A' ' 77' ' ' VAL . 3.2 t80 -67.3 103.38 1.25 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 171.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -108.27 45.18 1.04 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.205 0.526 . . . . 0.0 109.677 -176.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.647 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -95.56 -155.37 31.16 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.93 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 7.1 ptmt -148.87 20.06 1.0 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.802 0.334 . . . . 0.0 111.012 -170.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.831 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.1 mmt180 -66.86 139.07 57.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 171.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.64 38.4 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.676 0.75 . . . . 0.0 110.742 -171.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.464 ' HB ' ' HA2' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -151.4 147.94 27.5 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.345 -175.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.0 p -74.32 -172.85 1.54 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.529 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 m -65.22 -16.75 20.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.393 0.616 . . . . 0.0 111.371 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -94.19 -13.75 26.33 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.037 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.464 ' HA2' ' HB ' ' A' ' 15' ' ' THR . . . 87.02 14.84 63.85 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.598 -170.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.952 HG22 ' HB2' ' A' ' 67' ' ' ASN . 86.4 m -75.78 119.52 77.5 Favored Pre-proline 0 N--CA 1.448 -0.564 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 171.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -48.12 129.22 18.23 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.999 2.466 . . . . 0.0 113.564 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.7 m -70.04 134.77 48.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.073 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 24.0 tt0 -67.95 166.36 15.89 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.663 174.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.512 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 3.2 m-20 -76.07 125.99 30.17 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.682 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 39.1 m95 -54.76 -31.07 58.12 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 173.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.2 -21.0 56.97 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.938 -1.483 . . . . 0.0 113.267 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.512 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -103.08 150.64 23.41 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 119.168 0.895 . . . . 0.0 109.061 -172.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.732 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 27.7 mm-40 -103.2 35.31 2.59 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 37.3 mt-10 -145.29 119.64 5.59 Favored Pre-proline 0 N--CA 1.432 -1.327 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -156.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 93.8 Cg_endo -89.43 32.1 9.0 Favored 'Cis proline' 0 C--N 1.346 0.42 0 C-N-CA 123.424 -1.49 . . . . 0.0 112.979 0.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.527 ' HB3' HD12 ' A' ' 71' ' ' LEU . 53.4 m80 -130.91 108.01 9.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.732 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.0 123.07 22.77 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.4 p80 -151.71 94.57 2.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.108 0.956 . . . . 0.0 110.142 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.9 m -75.23 29.63 0.1 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.398 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.526 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.4 pt -141.6 151.0 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.516 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 39.9 m-85 51.74 47.13 25.38 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 122.032 0.92 . . . . 0.0 111.274 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.7 p -99.28 170.88 6.27 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 114.266 -1.334 . . . . 0.0 108.124 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.14 -17.26 59.3 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.704 1.602 . . . . 0.0 111.804 172.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.84 -20.48 14.28 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.37 -171.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.414 ' C ' ' HD3' ' A' ' 42' ' ' PRO . 42.6 p -98.47 -15.48 19.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.196 0.522 . . . . 0.0 110.241 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.57 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 12.8 m120 -135.8 55.12 11.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.064 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 10.1 Cg_exo -71.16 36.61 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.071 2.514 . . . . 0.0 112.842 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -134.77 -9.95 2.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.319 178.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.665 ' HB2' HD11 ' A' ' 46' ' ' LEU . . . -110.58 12.6 22.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.412 . . . . 0.0 111.266 -176.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.15 44.01 97.79 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-N 115.27 -0.877 . . . . 0.0 113.37 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.665 HD11 ' HB2' ' A' ' 44' ' ' ALA . 5.1 mp -80.46 111.78 17.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.056 0.455 . . . . 0.0 110.52 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.643 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 2.0 pt-20 -124.47 134.59 53.0 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.662 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 48' ' ' LYS . 61.0 mmtt 50.75 -107.57 0.3 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -137.11 13.97 3.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.059 0.456 . . . . 0.0 110.19 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.643 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 22.2 m-85 -67.36 131.03 44.91 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.507 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 79.1 m -54.04 149.74 8.92 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.247 0.342 . . . . 0.0 111.571 -173.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.494 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 33.6 mmt-85 -153.94 165.94 34.53 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.438 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -127.88 79.46 73.65 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.238 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.665 ' HG3' HD22 ' A' ' 46' ' ' LEU . 37.6 Cg_exo -58.96 -35.83 97.9 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.556 2.17 . . . . 0.0 112.281 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -91.54 -17.28 25.89 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.252 0.549 . . . . 0.0 110.644 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.65 47.77 86.65 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.313 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 59' ' ' GLY . 9.3 t70 -50.12 131.97 23.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.416 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 3.3 t -74.38 8.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.565 0.698 . . . . 0.0 110.556 -175.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -100.58 -18.95 19.46 Favored Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 177.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.22 179.58 16.15 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.772 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.624 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 90.6 Cg_endo -73.86 156.78 48.07 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.502 2.134 . . . . 0.0 111.277 -175.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.558 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.5 p-90 -144.89 -172.76 3.9 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.292 -171.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.682 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.8 p -168.65 -179.03 3.65 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.034 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.465 ' CD1' ' HG ' ' A' ' 71' ' ' LEU . 39.7 m-85 -100.75 144.77 29.32 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 171.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.5 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.6 p -102.95 146.23 28.65 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.442 -170.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 p -81.87 27.73 0.45 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.482 0.658 . . . . 0.0 109.779 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.952 ' HB2' HG22 ' A' ' 20' ' ' THR . 58.4 t-20 -102.1 120.58 53.28 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.785 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.75 0.04 3.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.246 2.631 . . . . 0.0 113.557 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -84.17 -53.41 5.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.78 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.59 149.78 52.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.36 0.6 . . . . 0.0 111.056 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 31' ' ' HIS . 36.2 tp -69.92 -45.77 66.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.117 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 11.3 p90 -142.66 162.34 35.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -156.88 -177.96 7.01 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -97.97 155.74 16.95 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 93.5 m -103.75 173.74 6.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.098 0.475 . . . . 0.0 111.029 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -119.69 71.47 0.88 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.536 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.831 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.7 p -108.54 130.03 23.26 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.654 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.83 153.91 47.32 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 123.824 3.016 . . . . 0.0 113.68 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.59 112.61 12.12 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.326 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.475 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.45 -40.75 57.12 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.436 178.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.602 ' HB3' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.186 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.529 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.441 -0.9 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.753 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.4 ptt? -96.63 149.57 21.64 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.656 ' HD2' ' HB3' ' A' ' 81' ' ' ALA . 80.8 m-85 -107.07 102.34 11.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.43 -111.65 3.31 Favored Glycine 0 N--CA 1.425 -2.068 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.498 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.562 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 81.4 m-20 -78.87 -27.46 44.02 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.551 0.795 . . . . 0.0 110.555 -176.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.631 ' HA2' ' HB2' ' A' ' 2' ' ' MET . . . 111.61 17.33 8.69 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.562 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 43.1 mtmt -65.46 -47.93 74.42 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.41 -0.895 . . . . 0.0 109.711 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.21 23.32 36.8 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.473 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.661 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.0 t80 -65.42 98.49 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.072 0.463 . . . . 0.0 109.962 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.96 44.47 1.01 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.599 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -95.55 -155.27 31.12 Favored Glycine 0 N--CA 1.454 -0.104 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.741 -175.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -144.35 15.6 1.66 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.873 0.337 . . . . 0.0 110.696 -174.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.683 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 12.8 mmt180 -66.08 133.26 50.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.63 37.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.532 0.682 . . . . 0.0 111.174 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.24 147.7 27.99 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.168 -177.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.514 ' HB ' ' OD2' ' A' ' 73' ' ' ASP . 66.4 p -75.53 -174.17 2.39 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.028 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 m -65.63 -17.53 22.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.58 0.705 . . . . 0.0 110.878 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 50.6 p -93.57 -14.69 26.24 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.903 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.28 11.95 63.9 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.517 -172.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.696 HG22 ' HB2' ' A' ' 67' ' ' ASN . 98.4 m -75.95 119.43 77.18 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 173.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -49.68 127.85 19.71 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.868 2.379 . . . . 0.0 113.244 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.5 m -68.48 138.59 55.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.875 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -69.06 165.65 19.79 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.528 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.21 129.08 35.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.674 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 59.5 m95 -58.73 -31.53 68.38 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.33 -15.08 59.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.492 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.21 148.49 26.26 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -175.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.752 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.6 mm-40 -102.28 33.71 3.01 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 41.7 mt-10 -145.22 120.72 5.83 Favored Pre-proline 0 N--CA 1.429 -1.495 0 CA-C-N 114.61 -1.177 . . . . 0.0 114.046 -157.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 97.1 Cg_endo -90.41 37.05 5.16 Favored 'Cis proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.258 -1.559 . . . . 0.0 113.641 0.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.412 ' HB3' HD11 ' A' ' 71' ' ' LEU . 53.3 m80 -133.56 112.56 11.59 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.752 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 23.1 mmm180 -73.35 114.48 11.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -176.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.507 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.8 p80 -146.98 91.11 1.97 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.345 1.069 . . . . 0.0 110.395 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.8 t -77.29 35.46 0.17 Allowed 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.263 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.507 ' H ' ' C ' ' A' ' 33' ' ' HIS . 19.4 pt -143.95 141.42 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.604 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 42.1 m-85 55.85 47.09 20.93 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.062 0.934 . . . . 0.0 111.04 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 18.8 p -99.58 175.23 2.53 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.649 168.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 36.5 Cg_exo -60.91 -22.22 73.5 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 121.713 1.609 . . . . 0.0 112.001 172.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.71 -28.73 13.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.464 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.9 p -88.04 -17.03 32.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.068 0.461 . . . . 0.0 110.241 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.604 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.0 m120 -137.77 55.0 8.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.531 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 8.7 Cg_exo -71.04 35.39 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.807 2.338 . . . . 0.0 112.971 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -131.33 -11.03 3.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.035 177.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HB1' HD12 ' A' ' 46' ' ' LEU . . . -110.56 13.27 22.65 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.997 0.427 . . . . 0.0 110.859 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.39 43.98 95.47 Favored Glycine 0 C--O 1.224 -0.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.861 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.628 HD12 ' HB1' ' A' ' 44' ' ' ALA . 5.1 mp -80.16 100.75 8.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.0 0.4 . . . . 0.0 111.161 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.5 pt-20 -121.72 149.88 42.61 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.762 172.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.414 ' O ' ' HD1' ' A' ' 25' ' ' TRP . 42.0 mmtm 50.65 -124.96 2.24 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.22 0.95 . . . . 0.0 111.022 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -128.49 19.39 6.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.039 0.447 . . . . 0.0 110.486 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.456 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 24.1 m-85 -66.87 127.1 31.21 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 175.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.564 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 78.8 m -52.61 150.75 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 111.543 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 51' ' ' CYS . 1.2 mmt85 -154.76 159.59 40.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -123.28 78.01 53.05 Favored Pre-proline 0 C--N 1.317 -0.819 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.045 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.612 ' HG3' HD23 ' A' ' 46' ' ' LEU . 18.0 Cg_endo -70.37 -11.47 30.1 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.472 2.115 . . . . 0.0 112.971 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -99.07 -22.79 15.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.427 0.632 . . . . 0.0 109.816 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.89 51.02 60.04 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.878 -170.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -53.42 128.58 29.14 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 171.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.3 7.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.427 0.632 . . . . 0.0 110.361 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.86 -15.1 27.46 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 111.221 -0.751 . . . . 0.0 111.221 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.33 178.73 15.58 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 119.705 -1.236 . . . . 0.0 111.87 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.753 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 91.9 Cg_endo -77.45 163.58 29.6 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.686 2.257 . . . . 0.0 111.867 -175.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.522 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.4 p-90 -148.5 -171.28 3.81 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.053 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.674 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.8 p -168.47 -178.25 3.46 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.029 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -100.75 144.59 29.54 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.41 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.1 p -99.91 143.99 29.49 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.239 -172.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 p -78.55 14.24 1.34 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.542 170.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.696 ' HB2' HG22 ' A' ' 20' ' ' THR . 59.8 t-20 -86.86 119.97 71.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -65.02 0.21 2.77 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.728 2.285 . . . . 0.0 113.102 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -85.33 -55.26 4.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.174 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 12.3 ptmt -120.32 160.16 23.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.315 0.579 . . . . 0.0 111.025 -174.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 31' ' ' HIS . 55.0 tp -87.62 -46.76 9.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.452 -176.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -143.79 164.23 31.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.989 0.423 . . . . 0.0 110.461 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.514 ' OD2' ' HB ' ' A' ' 16' ' ' THR . 32.2 t0 -160.47 173.56 15.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.673 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 69.5 m-85 -92.85 156.23 17.11 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.9 m -105.11 170.31 7.94 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.044 0.449 . . . . 0.0 111.154 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -114.57 73.82 0.84 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.338 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.683 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.1 p -114.2 128.04 26.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.491 0.662 . . . . 0.0 111.037 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 17.3 Cg_endo -57.47 158.75 18.26 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 124.489 3.459 . . . . 0.0 114.226 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.0 111.41 10.18 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.451 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.501 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.36 -41.41 56.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.241 178.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.656 ' HB3' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.948 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.575 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.441 -0.88 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.418 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.8 ptt? -94.86 155.41 16.8 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.553 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 91.2 m-85 -113.53 95.43 5.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.81 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.44 -106.53 2.07 Favored Glycine 0 N--CA 1.426 -1.991 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -172.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.41 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 8.0 m-20 -77.7 -35.89 51.63 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.856 0.974 . . . . 0.0 110.517 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . 112.06 17.89 8.1 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.104 -1.046 . . . . 0.0 110.945 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 46.7 mtmt -70.9 -35.02 72.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.062 -0.569 . . . . 0.0 109.656 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -104.25 19.91 41.69 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.702 171.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.707 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -67.06 109.99 3.23 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 171.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -114.98 48.06 1.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.082 0.467 . . . . 0.0 110.026 -176.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.622 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -99.64 -156.97 28.6 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.815 -0.629 . . . . 0.0 113.565 -172.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 11.4 ptmm? -141.73 13.89 2.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.453 0.168 . . . . 0.0 111.198 -169.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.676 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 32.8 mmt180 -66.05 137.48 57.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.43 36.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.286 0.565 . . . . 0.0 111.997 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.27 146.44 26.79 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.451 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 58.7 p -74.52 -174.06 1.95 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.681 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -66.49 -17.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.414 0.626 . . . . 0.0 110.752 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.4 p -92.77 -14.62 27.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.444 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.74 11.1 64.23 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.302 -173.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.957 HG23 ' HB2' ' A' ' 67' ' ' ASN . 84.6 m -75.85 119.43 77.13 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -45.85 124.13 6.79 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 123.119 2.546 . . . . 0.0 113.532 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 63' ' ' CYS . 80.8 m -65.94 136.12 55.66 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.151 173.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -68.29 164.92 19.62 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.715 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -77.68 127.11 31.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.759 ' CE3' HD22 ' A' ' 46' ' ' LEU . 71.6 m95 -57.24 -31.0 65.09 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.613 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.66 -18.13 54.9 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.615 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.68 151.24 20.32 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.666 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.8 mm-40 -104.41 33.44 3.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 48.3 mt-10 -144.94 120.53 5.92 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -156.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 83.8 Cg_endo -87.91 27.96 12.76 Favored 'Cis proline' 0 C--N 1.344 0.339 0 C-N-CA 123.206 -1.581 . . . . 0.0 112.807 0.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.406 ' HB3' HD13 ' A' ' 71' ' ' LEU . 39.7 m80 -127.87 109.23 11.4 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.666 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.55 118.31 16.36 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.348 -177.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.439 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.0 p80 -149.19 100.12 3.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.255 1.026 . . . . 0.0 110.269 -177.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 m -81.74 30.49 0.37 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.056 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.439 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.7 pt -141.4 147.57 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.624 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 37.0 m-85 52.68 47.65 24.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.886 0.85 . . . . 0.0 111.093 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.4 p -100.19 175.42 2.4 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.314 170.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.448 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 19.0 Cg_exo -65.45 -17.6 57.95 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.371 1.381 . . . . 0.0 111.138 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -87.98 -38.37 15.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.178 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 p -90.32 -22.82 21.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.313 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.624 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.3 m120 -132.7 67.87 78.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.079 0.466 . . . . 0.0 111.021 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.96 5.98 2.32 Favored 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.344 2.029 . . . . 0.0 112.698 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -97.4 -26.99 14.67 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.401 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -99.49 4.85 46.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.406 0.622 . . . . 0.0 111.126 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.92 46.33 94.77 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.176 174.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.759 HD22 ' CE3' ' A' ' 25' ' ' TRP . 5.6 mp -71.18 86.94 0.78 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.385 0.612 . . . . 0.0 109.939 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.947 ' HG2' ' HD3' ' A' ' 48' ' ' LYS . 20.1 tt0 -102.45 145.84 28.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.858 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.947 ' HD3' ' HG2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER 44.12 -106.46 0.1 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.384 1.053 . . . . 0.0 110.949 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -138.68 22.11 2.69 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.984 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.584 ' HD2' ' HB3' ' A' ' 47' ' ' GLU . 28.6 m-85 -69.39 128.35 36.23 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.38 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 77.6 m -51.54 148.22 5.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.446 0.466 . . . . 0.0 111.417 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 36.7 mmt-85 -154.09 164.24 38.8 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.481 -176.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -126.23 77.04 72.35 Favored Pre-proline 0 C--N 1.321 -0.664 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.132 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.541 ' HG3' HD21 ' A' ' 46' ' ' LEU . 27.7 Cg_endo -70.63 -16.9 33.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.207 1.938 . . . . 0.0 112.746 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -90.18 -27.65 19.43 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.671 0.748 . . . . 0.0 109.503 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.75 46.63 91.44 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.621 -169.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.505 ' C ' ' H ' ' A' ' 59' ' ' GLY . 6.8 t70 -54.4 135.79 44.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.4 16.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.918 0.866 . . . . 0.0 109.978 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -104.49 -20.96 9.63 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 175.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.83 176.0 14.6 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.177 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.418 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 57.1 Cg_endo -70.13 159.92 51.43 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.319 2.013 . . . . 0.0 111.613 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.535 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.9 p-90 -149.61 -168.14 3.02 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.954 -169.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.728 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.7 p -168.2 -178.99 3.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.586 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.419 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 39.2 m-85 -100.17 146.48 26.8 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 172.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.44 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.3 p -103.54 144.4 31.47 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.009 -1.076 . . . . 0.0 109.662 -171.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.2 p -79.81 17.37 0.95 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.213 169.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.957 ' HB2' HG23 ' A' ' 20' ' ' THR . 56.4 t-20 -94.48 124.94 53.75 Favored Pre-proline 0 C--O 1.229 -0.026 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.343 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.1 4.62 1.81 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.688 2.259 . . . . 0.0 113.309 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -85.01 -58.26 2.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -122.14 161.05 23.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.732 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.419 ' O ' ' HD1' ' A' ' 64' ' ' TYR . 57.4 tp -86.21 -45.33 11.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.604 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 4.2 p90 -143.34 159.4 42.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.703 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.451 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 47.4 t0 -154.5 172.43 17.8 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.8 155.5 17.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 71.2 m -105.41 171.76 7.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.947 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -115.7 60.99 0.7 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.378 0.609 . . . . 0.0 110.337 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.707 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.4 p -97.87 129.43 31.22 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.427 0.632 . . . . 0.0 110.398 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.496 ' HD2' HG22 ' A' ' 77' ' ' VAL . 36.2 Cg_endo -63.01 160.2 35.01 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 123.986 3.124 . . . . 0.0 113.49 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.34 111.9 11.08 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.028 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.501 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.09 -41.99 57.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.846 178.131 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.445 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.583 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.428 ' SD ' ' NE2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -98.07 146.74 25.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.619 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 67.9 m-85 -104.27 103.58 13.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.3 -107.78 2.3 Favored Glycine 0 N--CA 1.422 -2.239 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.336 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 86.3 m-20 -80.73 -32.46 35.72 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 124.819 0.952 . . . . 0.0 110.415 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 110.59 20.22 7.45 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.079 -1.057 . . . . 0.0 110.97 -174.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.49 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 47.4 mtmt -66.02 -45.14 82.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.89 -0.655 . . . . 0.0 109.812 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.14 27.25 20.16 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.645 ' CE1' ' HA3' ' A' ' 11' ' ' GLY . 2.9 t80 -65.19 101.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HE ' ' C ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -102.24 51.26 0.82 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.013 0.435 . . . . 0.0 110.69 -177.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.645 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -108.42 -163.86 20.89 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.71 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -142.21 16.79 2.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.721 0.26 . . . . 0.0 110.926 -170.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.821 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 19.5 mmt180 -64.42 136.61 57.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.0 m -138.59 40.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.857 0.837 . . . . 0.0 110.422 -172.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.97 HG22 ' HA2' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -150.81 135.08 16.94 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.158 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.543 HG22 ' HB3' ' A' ' 73' ' ' ASP . 54.5 p -74.03 -170.57 0.95 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.026 0.441 . . . . 0.0 112.035 -175.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.2 -18.89 24.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.427 0.632 . . . . 0.0 110.875 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.4 p -93.45 -13.09 28.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.995 0.902 . . . . 0.0 109.063 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.97 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 81.02 20.56 64.86 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.904 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.956 HG21 ' HB2' ' A' ' 67' ' ' ASN . 60.0 m -75.69 123.27 88.32 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 169.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 78.1 Cg_exo -50.28 135.4 38.74 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.497 2.131 . . . . 0.0 113.128 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.0 m -75.49 141.41 43.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.533 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -71.45 163.32 27.92 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.88 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 6.3 m-20 -76.7 125.16 28.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.729 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 38.6 m95 -53.34 -30.56 40.0 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.49 -14.04 59.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.013 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.89 148.52 27.51 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.655 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 36.1 mm-40 -103.39 29.71 5.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 3.1 mt-10 -146.74 127.06 6.91 Favored Pre-proline 0 N--CA 1.426 -1.644 0 CA-C-N 113.581 -1.645 . . . . 0.0 114.104 -159.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 2.9 Cg_endo -85.61 26.32 11.67 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 123.853 -1.311 . . . . 0.0 112.59 1.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.666 ' HB3' HD11 ' A' ' 71' ' ' LEU . 68.3 m80 -129.17 104.01 7.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.655 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -74.61 118.2 17.3 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -176.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.49 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.7 p80 -144.8 92.73 2.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.75 0.786 . . . . 0.0 110.509 -173.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 m -74.1 31.42 0.08 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.705 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.49 ' H ' ' C ' ' A' ' 33' ' ' HIS . 25.7 pt -142.79 143.86 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.596 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 72.2 m-85 49.53 50.81 17.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.92 0.867 . . . . 0.0 111.185 -173.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 60.5 p -103.03 176.48 1.8 Allowed Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.468 171.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 24.2 Cg_exo -66.44 -11.49 31.79 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.98 1.787 . . . . 0.0 111.466 169.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -89.47 -40.72 12.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.09 0.471 . . . . 0.0 110.171 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.5 p -90.56 -22.55 21.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.251 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.624 ' O ' HD13 ' A' ' 46' ' ' LEU . 15.2 m120 -137.15 60.82 30.24 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.368 . . . . 0.0 111.514 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.53 20.33 0.69 Allowed 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 122.026 1.817 . . . . 0.0 112.396 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.58 -8.86 7.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.685 ' HB1' HD12 ' A' ' 46' ' ' LEU . . . -105.19 10.93 33.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.26 0.553 . . . . 0.0 110.324 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.76 41.68 73.19 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.163 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.8 HD22 ' HG3' ' A' ' 54' ' ' PRO . 5.5 mp -80.41 79.12 7.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.71 0.767 . . . . 0.0 110.368 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.809 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 7.2 pt-20 -101.78 136.48 41.54 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.818 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 11.0 mtpp 48.63 -105.98 0.17 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -141.67 11.62 2.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.646 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.809 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 23.2 m-85 -65.53 131.41 46.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.53 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 70.7 m -52.35 144.66 12.53 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.246 0.341 . . . . 0.0 111.028 -176.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.53 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 35.6 mmt-85 -149.32 168.78 22.42 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.268 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -129.49 77.86 76.59 Favored Pre-proline 0 C--N 1.313 -0.981 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.969 171.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.8 ' HG3' HD22 ' A' ' 46' ' ' LEU . 39.5 Cg_endo -72.93 -10.17 24.44 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.082 1.855 . . . . 0.0 111.801 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -90.98 -32.62 15.87 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 172.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.93 36.45 93.3 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.3 -165.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -46.84 134.05 10.36 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.942 -0.629 . . . . 0.0 109.877 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 t -70.09 0.31 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.563 0.697 . . . . 0.0 110.579 -178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.56 -19.95 39.37 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.46 -179.64 16.13 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.757 -1.211 . . . . 0.0 111.41 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -73.44 158.48 47.96 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.194 1.929 . . . . 0.0 111.859 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.487 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 19.2 p-90 -150.72 -169.24 3.33 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.867 -170.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.729 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.3 p -168.53 -176.62 2.87 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.5 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.443 ' OH ' ' HD2' ' A' ' 36' ' ' PHE . 84.1 m-85 -100.4 147.23 26.07 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 169.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.452 ' C ' ' H ' ' A' ' 67' ' ' ASN . 2.7 p -100.62 149.7 23.48 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.741 -169.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.5 p -82.47 24.56 0.69 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.424 0.631 . . . . 0.0 109.89 167.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.956 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.7 t-20 -108.0 118.27 53.14 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.889 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.66 5.95 1.14 Allowed 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.92 2.414 . . . . 0.0 113.585 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 -85.33 -49.13 8.4 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 149.04 52.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.163 0.506 . . . . 0.0 110.595 -175.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.666 HD11 ' HB3' ' A' ' 31' ' ' HIS . 39.4 tp -76.37 -43.75 39.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.999 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.96 153.47 43.06 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.501 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.543 ' HB3' HG22 ' A' ' 16' ' ' THR . 18.9 t0 -152.98 164.85 37.2 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -175.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -92.48 156.56 17.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.59 171.76 7.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.827 0.346 . . . . 0.0 110.67 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -118.76 60.71 0.8 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.389 0.614 . . . . 0.0 109.99 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.821 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.5 p -102.28 130.44 24.18 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.396 0.617 . . . . 0.0 110.512 176.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.41 ' HD2' HG23 ' A' ' 77' ' ' VAL . 21.0 Cg_endo -60.12 160.9 20.96 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 124.691 3.594 . . . . 0.0 114.231 -176.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.428 ' NE2' ' SD ' ' A' ' 2' ' ' MET . 8.8 tp-100 -75.63 112.01 11.55 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.941 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.583 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.96 -41.61 50.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.724 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.619 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.252 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.581 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.596 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 16.2 ptt? -96.52 146.23 24.99 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.584 ' HD2' ' HB3' ' A' ' 81' ' ' ALA . 90.5 m-85 -105.47 99.47 9.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.25 -119.77 4.96 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.892 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -79.74 -18.12 51.91 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 124.481 0.753 . . . . 0.0 110.585 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.589 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.31 13.45 21.0 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.917 -174.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -64.5 -39.49 93.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.199 -0.501 . . . . 0.0 109.687 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.582 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -107.06 23.05 28.34 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 172.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.703 ' CE1' HG22 ' A' ' 77' ' ' VAL . 2.8 t80 -67.59 105.15 1.78 Allowed 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 172.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.52 39.06 2.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.17 0.509 . . . . 0.0 110.214 -175.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.472 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -94.72 -158.88 33.39 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.978 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.49 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 9.1 ptmm? -140.48 19.04 2.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.88 0.371 . . . . 0.0 110.33 -168.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.629 ' HB2' ' OH ' ' A' ' 9' ' ' TYR . 2.5 mpt_? -67.98 137.59 55.25 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 m -140.29 33.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.939 0.876 . . . . 0.0 110.322 -170.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.467 HG21 ' HA2' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -150.58 139.11 20.54 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -172.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.59 ' HB ' ' OD2' ' A' ' 73' ' ' ASP . 72.3 p -74.84 -176.22 2.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.647 0.261 . . . . 0.0 111.39 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.411 HG22 ' OD2' ' A' ' 73' ' ' ASP . 15.4 m -65.87 -20.41 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.647 0.737 . . . . 0.0 110.187 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 p -91.99 -14.23 29.77 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.529 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.467 ' HA2' HG21 ' A' ' 15' ' ' THR . . . 89.94 11.97 62.71 Favored Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.846 -174.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.743 HG22 ' HB2' ' A' ' 67' ' ' ASN . 78.4 m -76.58 120.82 83.3 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 120.426 -0.509 . . . . 0.0 109.84 170.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -50.55 125.82 16.45 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.837 2.358 . . . . 0.0 113.198 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.4 m -64.44 137.87 58.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.499 0.666 . . . . 0.0 110.627 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 25.5 tt0 -71.22 166.12 22.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.925 174.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 1.0 OUTLIER -75.98 125.11 28.49 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.726 ' CE3' HD21 ' A' ' 46' ' ' LEU . 45.9 m95 -54.8 -29.25 54.02 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.611 0.719 . . . . 0.0 109.122 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.87 -21.35 55.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.556 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.69 150.38 22.8 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -172.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.736 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.5 mm-40 -103.5 33.0 3.53 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 43.4 mt-10 -143.17 119.58 6.66 Favored Pre-proline 0 N--CA 1.43 -1.474 0 CA-C-N 114.205 -1.361 . . . . 0.0 114.209 -157.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 88.9 Cg_endo -90.04 31.98 9.58 Favored 'Cis proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.298 -1.542 . . . . 0.0 113.456 1.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.497 ' HB3' HD11 ' A' ' 71' ' ' LEU . 61.5 m80 -131.63 113.02 13.1 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.736 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.72 116.55 14.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.823 -176.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.495 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.8 p80 -148.57 89.71 1.72 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.449 1.119 . . . . 0.0 110.543 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.1 m -78.19 35.84 0.22 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.996 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.495 ' H ' ' C ' ' A' ' 33' ' ' HIS . 20.1 pt -143.19 146.63 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.574 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 31.0 m-85 53.97 46.51 25.43 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.343 1.068 . . . . 0.0 110.629 -174.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.548 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 42.6 p -99.8 176.77 1.78 Allowed Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.145 170.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 30.3 Cg_exo -61.99 -21.58 72.64 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 121.959 1.773 . . . . 0.0 111.95 169.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -87.49 -34.71 18.56 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.981 0.419 . . . . 0.0 111.122 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.3 p -89.08 -24.03 22.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.973 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.574 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.0 m120 -136.03 59.28 27.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 21.1 Cg_exo -64.48 4.15 0.68 Allowed 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.476 2.117 . . . . 0.0 112.787 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.438 ' H ' ' C ' ' A' ' 41' ' ' ASN . 23.2 ptt180 -95.06 -19.36 20.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.588 0.233 . . . . 0.0 111.376 -173.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.662 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -109.09 2.74 21.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.595 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.05 47.48 85.04 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.262 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.871 HD23 ' HG3' ' A' ' 54' ' ' PRO . 5.6 mp -75.14 74.28 2.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.967 0.413 . . . . 0.0 111.5 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.527 ' HG3' ' CD2' ' A' ' 50' ' ' TYR . 3.0 pt-20 -98.94 152.83 19.35 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.669 176.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 48.0 mttp 49.96 -113.65 0.66 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.418 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -140.69 19.63 2.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.176 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.527 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 30.2 m-85 -61.92 128.83 38.06 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.644 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 80.5 m -53.76 145.23 16.19 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 38.8 mmt-85 -152.5 164.62 37.23 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.225 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -125.57 81.45 64.7 Favored Pre-proline 0 C--N 1.318 -0.762 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.719 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.871 ' HG3' HD23 ' A' ' 46' ' ' LEU . 39.1 Cg_exo -59.17 -31.89 96.15 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.727 2.285 . . . . 0.0 112.458 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -89.76 -20.0 24.07 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.525 0.679 . . . . 0.0 109.97 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.96 44.09 97.5 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.539 -168.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 59' ' ' GLY . 4.9 t70 -48.03 135.09 13.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.414 -0.893 . . . . 0.0 109.443 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 58' ' ' VAL . 11.4 t -71.67 6.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 123.893 0.746 . . . . 0.0 110.868 -173.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -105.42 -17.82 13.0 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.88 -178.15 16.5 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 119.89 -1.148 . . . . 0.0 111.234 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.596 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 74.2 Cg_endo -73.5 157.92 48.43 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.091 1.861 . . . . 0.0 111.815 -174.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.535 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 32.2 p-90 -145.61 -172.09 3.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.717 -172.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.698 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.0 p -168.52 -179.82 4.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.122 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.44 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 43.7 m-85 -100.16 145.61 27.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.3 p -102.84 147.02 27.41 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.664 -170.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.7 p -80.99 23.57 0.55 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.383 0.611 . . . . 0.0 110.517 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.743 ' HB2' HG22 ' A' ' 20' ' ' THR . 57.1 t-20 -103.98 121.76 46.73 Favored Pre-proline 0 CA--C 1.528 0.115 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.086 -177.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 16.5 Cg_exo -67.23 -0.33 4.81 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.888 2.392 . . . . 0.0 113.703 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -84.66 -44.98 12.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.836 0.35 . . . . 0.0 111.619 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -133.13 145.57 50.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.468 0.651 . . . . 0.0 111.048 -175.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 31' ' ' HIS . 41.8 tp -71.28 -43.04 67.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.621 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -143.29 164.29 30.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.089 0.471 . . . . 0.0 110.338 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.59 ' OD2' ' HB ' ' A' ' 16' ' ' THR . 33.0 t70 -157.94 173.89 16.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -93.63 158.67 15.58 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 86.6 m -106.37 171.24 7.46 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -122.64 69.25 0.97 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.3 0.571 . . . . 0.0 109.99 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.703 HG22 ' CE1' ' A' ' 9' ' ' TYR . 2.6 p -105.29 132.72 20.63 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.854 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.5 ' HD2' HG23 ' A' ' 77' ' ' VAL . 51.8 Cg_endo -65.76 162.24 35.51 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 123.631 2.887 . . . . 0.0 113.378 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.413 ' OE1' ' HB2' ' A' ' 81' ' ' ALA . 9.3 tp-100 -75.6 108.96 8.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.231 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.493 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -73.3 -37.94 66.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.306 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.584 ' HB3' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.194 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.512 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.612 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.8 ptt? -97.29 150.74 20.61 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 121.358 0.599 . . . . 0.0 112.514 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.72 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 71.8 m-85 -109.7 102.07 10.91 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.38 -115.48 4.19 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 119.997 -1.097 . . . . 0.0 111.033 -175.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.18 -23.93 40.69 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 124.531 0.783 . . . . 0.0 109.576 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.507 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.31 17.41 10.75 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.313 -0.946 . . . . 0.0 110.969 -174.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -66.48 -39.9 89.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.103 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.569 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -105.61 20.69 36.33 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.643 ' CE1' HG22 ' A' ' 77' ' ' VAL . 4.0 t80 -65.31 105.19 1.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -113.08 35.78 3.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.233 0.54 . . . . 0.0 109.551 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.497 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -88.25 -154.04 27.17 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.995 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 4.7 ptmt -150.29 22.07 0.84 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.912 0.387 . . . . 0.0 110.687 -168.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.692 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 22.5 mmt180 -68.5 137.86 54.74 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 171.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.79 38.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.486 0.66 . . . . 0.0 111.655 -171.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.06 145.31 25.42 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.957 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 73' ' ' ASP . 69.4 p -74.36 -174.05 1.89 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.042 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -63.71 -20.45 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.489 0.661 . . . . 0.0 110.818 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.4 p -92.87 -12.71 30.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.499 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.43 11.41 69.03 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.42 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.96 HG23 ' HB2' ' A' ' 67' ' ' ASN . 95.4 m -76.69 119.15 76.2 Favored Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.329 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -47.25 124.7 9.45 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 123.098 2.532 . . . . 0.0 113.689 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.8 m -63.5 139.48 58.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.425 0.631 . . . . 0.0 110.884 172.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 23.1 tt0 -71.16 164.81 24.9 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.021 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 5.3 m-20 -76.95 125.56 29.51 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.679 ' CE3' HD23 ' A' ' 46' ' ' LEU . 37.7 m95 -54.06 -31.79 52.62 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.59 -17.08 58.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.749 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' A' ' 24' ' ' ASP . . . -106.82 150.41 26.38 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -174.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.857 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.3 mm-40 -102.61 29.52 5.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 4.0 mm-40 -133.78 119.47 14.92 Favored Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -159.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 88.7 Cg_endo -94.24 35.65 7.57 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.079 -1.634 . . . . 0.0 112.783 -0.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.446 ' HB3' HD13 ' A' ' 71' ' ' LEU . 58.2 m80 -126.81 107.48 10.16 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.857 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.0 OUTLIER -76.59 113.02 13.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.068 -175.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 5.0 p80 -143.53 92.53 2.37 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.997 0.903 . . . . 0.0 110.422 -172.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.4 m -77.47 39.11 0.25 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.47 0.653 . . . . 0.0 109.534 172.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.4 pt -143.37 135.86 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -173.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.558 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 45.6 m-85 53.58 48.2 22.2 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 122.265 1.031 . . . . 0.0 111.275 -175.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 46.9 p -99.84 175.54 2.36 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.101 170.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.499 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 22.6 Cg_exo -64.79 -18.52 62.72 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.798 1.666 . . . . 0.0 111.257 168.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -83.17 -38.94 21.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.314 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.3 p -92.04 -25.23 18.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.085 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.558 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.0 m120 -132.41 68.25 79.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.346 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.22 12.37 1.81 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.453 2.102 . . . . 0.0 112.159 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -100.12 -27.7 13.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 -174.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.578 ' HB1' HD12 ' A' ' 46' ' ' LEU . . . -105.41 6.9 32.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 111.689 -172.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.36 46.29 93.09 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.368 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.679 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.6 mp -75.4 78.46 2.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.201 0.524 . . . . 0.0 110.507 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.732 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.6 pt-20 -97.64 139.89 32.86 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.675 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 48' ' ' LYS . 29.4 mmtp 51.82 -111.47 0.57 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.865 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -137.22 14.16 3.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.831 0.348 . . . . 0.0 110.853 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.732 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 18.8 m-85 -66.92 129.5 40.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.5 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 84.1 m -52.88 153.1 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.265 0.353 . . . . 0.0 111.718 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 39.0 mmt-85 -156.26 166.91 32.06 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.17 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -128.32 78.72 75.21 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.941 171.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.673 ' HG3' HD22 ' A' ' 46' ' ' LEU . 28.3 Cg_endo -70.62 -14.08 33.07 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.328 2.019 . . . . 0.0 112.807 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.45 -21.59 20.09 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.468 0.651 . . . . 0.0 109.412 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.74 43.92 86.71 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.51 -167.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 59' ' ' GLY . 7.8 t70 -56.89 140.44 48.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.35 -0.925 . . . . 0.0 109.504 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 58' ' ' VAL . 9.2 t -75.11 13.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 122.045 0.926 . . . . 0.0 110.102 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -103.7 -18.61 13.73 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.28 -177.81 16.61 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.872 -1.156 . . . . 0.0 111.358 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.612 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 86.8 Cg_endo -77.22 153.51 31.76 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.36 2.04 . . . . 0.0 111.304 -175.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.531 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 19.3 p-90 -145.53 -169.23 3.17 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.893 -170.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.675 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.8 p -168.74 -178.11 3.29 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.812 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -101.06 145.36 28.84 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.53 HG23 ' HE3' ' A' ' 70' ' ' LYS . 3.1 p -99.4 149.27 23.34 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.119 -1.033 . . . . 0.0 109.729 -170.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.9 p -83.86 33.54 0.48 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.523 0.678 . . . . 0.0 109.738 166.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.96 ' HB2' HG23 ' A' ' 20' ' ' THR . 60.8 t-20 -112.97 120.59 40.25 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.995 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.0 5.71 1.68 Allowed 'Trans proline' 0 N--CA 1.472 0.251 0 C-N-CA 122.866 2.378 . . . . 0.0 113.489 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -84.87 -50.81 7.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.157 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.53 ' HE3' HG23 ' A' ' 65' ' ' THR . 0.5 OUTLIER -134.59 154.58 51.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.015 0.436 . . . . 0.0 110.879 -176.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 31' ' ' HIS . 50.8 tp -76.18 -43.42 42.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.095 -176.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -142.33 161.25 38.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.511 ' HB3' HG22 ' A' ' 16' ' ' THR . 46.6 t0 -159.36 165.46 33.24 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 60.1 m-85 -93.3 155.05 17.65 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.8 m -103.11 167.99 9.47 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.912 0.387 . . . . 0.0 110.621 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -112.92 56.2 0.68 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.375 0.607 . . . . 0.0 110.033 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.692 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.8 p -95.35 128.46 38.35 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.186 0.517 . . . . 0.0 110.004 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.402 ' HD2' HG23 ' A' ' 77' ' ' VAL . 34.8 Cg_endo -62.77 157.18 49.05 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 C-N-CA 123.565 2.843 . . . . 0.0 113.603 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.7 107.13 7.66 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.093 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -72.98 -39.93 65.71 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.317 179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.72 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--O 1.234 0.244 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.541 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.444 -0.756 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.614 ' HG2' HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.5 150.31 22.33 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.604 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 90.0 m-85 -106.97 101.5 10.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -176.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.56 -106.87 2.09 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.04 -173.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -83.12 -32.77 26.52 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 125.206 1.18 . . . . 0.0 111.126 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.86 21.72 7.32 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.957 -175.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -65.32 -38.99 91.85 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.112 0.482 . . . . 0.0 109.967 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -106.99 26.55 18.84 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.661 ' CE1' HG22 ' A' ' 77' ' ' VAL . 4.3 t80 -70.25 104.07 2.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.58 38.74 2.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.011 0.434 . . . . 0.0 110.76 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.597 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -94.98 -159.77 33.59 Favored Glycine 0 C--N 1.329 0.174 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.943 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 14.5 ptmt -145.07 20.94 1.59 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.846 0.323 . . . . 0.0 111.314 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.698 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.9 mmt180 -67.44 138.8 56.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 173.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.439 HG11 ' HA ' ' A' ' 50' ' ' TYR . 5.0 m -139.98 34.19 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.479 0.657 . . . . 0.0 111.552 -167.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.764 HG22 ' HA2' ' A' ' 19' ' ' GLY . 8.5 m -151.89 135.38 16.1 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -173.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.467 HG21 ' HB3' ' A' ' 73' ' ' ASP . 78.3 p -73.53 -176.72 2.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.941 0.4 . . . . 0.0 112.075 -172.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 m -65.03 -18.67 24.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.439 0.638 . . . . 0.0 111.046 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.8 p -93.12 -14.17 27.57 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.235 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.764 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.41 16.15 62.83 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.426 -174.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.975 HG23 ' HB2' ' A' ' 67' ' ' ASN . 86.3 m -76.8 121.09 84.21 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.633 169.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.49 126.24 15.61 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.768 2.312 . . . . 0.0 113.231 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.5 m -64.88 138.2 58.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.46 0.647 . . . . 0.0 110.697 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -72.12 165.71 23.77 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.441 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 16.9 m-20 -76.42 125.53 29.36 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.742 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 33.6 m95 -55.19 -29.18 57.35 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.8 -23.66 55.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.776 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -97.24 149.72 21.72 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -173.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.64 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.3 mm-40 -104.57 31.96 4.38 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.2 mt-10 -147.61 122.3 5.1 Favored Pre-proline 0 N--CA 1.425 -1.703 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.283 -155.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 87.4 Cg_endo -87.18 28.6 10.81 Favored 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.343 -1.524 . . . . 0.0 112.759 0.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.485 ' HB3' HD13 ' A' ' 71' ' ' LEU . 63.7 m80 -128.73 104.51 7.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.64 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.88 121.11 20.42 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -176.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.478 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.4 p80 -148.91 95.92 2.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.174 0.988 . . . . 0.0 110.172 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 m -77.89 32.15 0.17 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.234 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.478 ' H ' ' C ' ' A' ' 33' ' ' HIS . 30.3 pt -141.77 147.98 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -175.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.588 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 52.3 m-85 48.23 50.78 15.88 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.139 0.971 . . . . 0.0 111.268 -173.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 31.1 p -98.98 175.09 2.63 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.142 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 38.4 Cg_exo -62.99 -20.1 70.76 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.041 1.828 . . . . 0.0 112.236 172.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -99.64 -25.62 14.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.819 0.342 . . . . 0.0 111.207 -172.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.5 p -91.95 -15.75 27.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.83 0.347 . . . . 0.0 110.462 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.588 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.8 m120 -139.73 52.46 3.8 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.721 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 8.2 Cg_exo -71.49 31.61 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.789 2.326 . . . . 0.0 113.59 -176.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.418 ' H ' ' C ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -129.81 -10.5 4.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.628 0.251 . . . . 0.0 111.354 177.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.663 ' HB1' HD13 ' A' ' 46' ' ' LEU . . . -105.76 9.83 32.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.122 0.487 . . . . 0.0 110.039 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.72 43.4 97.85 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.23 -0.895 . . . . 0.0 113.102 173.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.663 HD13 ' HB1' ' A' ' 44' ' ' ALA . 5.1 mp -81.32 94.8 6.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.152 0.501 . . . . 0.0 109.856 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.638 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.5 pt-20 -121.43 152.3 39.23 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.07 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 4.1 mptp? 46.74 -113.08 0.44 Allowed 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.915 0.76 . . . . 0.0 111.763 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -136.68 18.68 3.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.06 0.457 . . . . 0.0 110.128 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.638 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 20.2 m-85 -67.8 128.39 36.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.786 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.519 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 84.5 m -51.33 147.21 6.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.309 0.38 . . . . 0.0 111.254 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.519 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 38.3 mmt-85 -151.53 169.07 22.98 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.695 -176.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -134.27 77.92 59.35 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.85 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.61 ' HG3' HD23 ' A' ' 46' ' ' LEU . 18.8 Cg_exo -64.36 -26.77 63.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.354 2.036 . . . . 0.0 112.123 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -20.07 23.78 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.547 0.689 . . . . 0.0 109.663 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.71 45.19 93.66 Favored Glycine 0 N--CA 1.433 -1.5 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.674 -170.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -45.47 130.29 8.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 172.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 t -66.55 -5.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 O-C-N 123.941 0.776 . . . . 0.0 110.95 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.28 -20.21 36.28 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.309 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 129.42 -179.95 16.39 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.583 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.41 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 73.4 Cg_endo -72.66 159.04 49.6 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.21 1.94 . . . . 0.0 111.824 -175.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.562 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 28.4 p-90 -146.23 -171.98 3.84 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.007 -171.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.742 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.3 p -168.18 -177.87 3.45 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.881 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -100.5 146.68 26.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 171.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.417 ' C ' ' H ' ' A' ' 67' ' ' ASN . 2.5 p -102.13 150.21 23.49 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.847 -171.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.2 p -84.27 31.26 0.51 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.527 0.68 . . . . 0.0 110.085 167.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.975 ' HB2' HG23 ' A' ' 20' ' ' THR . 59.0 t-20 -111.26 122.34 37.97 Favored Pre-proline 0 N--CA 1.462 0.16 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.075 -176.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.39 2.21 2.99 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.73 2.286 . . . . 0.0 113.481 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -83.72 -53.67 5.46 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.98 150.11 49.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.281 0.562 . . . . 0.0 110.571 -176.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 31' ' ' HIS . 53.5 tp -75.91 -43.42 45.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.349 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 11.2 p90 -143.1 158.56 43.5 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' A' ' 16' ' ' THR . 28.6 t0 -153.93 172.22 17.77 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -176.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -94.08 155.06 17.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.6 m -106.34 170.95 7.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.747 0.308 . . . . 0.0 110.626 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -121.63 64.58 0.9 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.52 0.676 . . . . 0.0 109.88 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.698 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 1.7 p -94.81 131.78 29.79 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.328 174.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.424 ' HD2' HG23 ' A' ' 77' ' ' VAL . 12.3 Cg_endo -56.06 152.05 39.2 Favored 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 123.403 2.735 . . . . 0.0 113.277 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.401 ' NE2' ' SD ' ' A' ' 2' ' ' MET . 8.8 tp-100 -74.85 112.65 11.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.631 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.541 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.6 OUTLIER -74.66 -37.2 62.78 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.119 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.802 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.536 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.444 -0.753 0 CA-C-O 120.963 0.411 . . . . 0.0 110.238 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.659 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.9 ptt? -97.61 154.64 17.41 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.663 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 81.1 m-85 -110.5 102.0 10.64 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.65 -115.15 4.18 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.444 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.75 -24.84 41.29 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 124.605 0.826 . . . . 0.0 110.788 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.528 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.09 16.56 14.77 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.817 -1.183 . . . . 0.0 111.486 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -64.74 -46.9 80.25 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.492 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -101.1 28.26 16.82 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.294 173.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.642 ' CE1' HG22 ' A' ' 77' ' ' VAL . 2.3 t80 -70.47 102.01 2.11 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -105.97 32.24 4.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.057 0.456 . . . . 0.0 109.918 -174.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.559 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -84.18 -154.86 20.58 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.528 -175.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.46 24.69 0.79 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.976 0.417 . . . . 0.0 110.329 -173.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.573 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 27.4 mmt180 -72.0 137.83 47.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 170.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 m -138.29 38.04 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.582 0.706 . . . . 0.0 111.088 -169.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.32 144.07 25.29 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.191 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 p -75.51 -176.14 3.09 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.24 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 m -65.47 -16.02 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.283 0.563 . . . . 0.0 110.824 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.4 p -93.22 -15.52 25.81 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.259 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.06 10.69 64.14 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.253 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 67' ' ' ASN . 85.4 m -77.64 120.68 82.38 Favored Pre-proline 0 N--CA 1.448 -0.549 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.867 174.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -51.31 123.87 12.92 Favored 'Trans proline' 0 C--O 1.239 0.53 0 C-N-CA 122.933 2.422 . . . . 0.0 113.243 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -62.59 140.94 58.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.848 174.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -73.21 164.96 25.92 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.16 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.63 124.37 27.85 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.633 ' CE3' HD22 ' A' ' 46' ' ' LEU . 44.4 m95 -54.28 -31.42 53.78 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.25 -9.31 59.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.818 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.67 147.41 33.17 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.681 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 34.8 mm-40 -102.22 31.94 3.75 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 41.1 mt-10 -146.51 122.26 5.57 Favored Pre-proline 0 N--CA 1.426 -1.633 0 CA-C-N 114.259 -1.337 . . . . 0.0 113.879 -156.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 3.3 Cg_endo -86.58 26.8 12.53 Favored 'Cis proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.612 -1.412 . . . . 0.0 113.344 2.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -126.52 109.77 12.53 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.681 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -72.78 113.61 10.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.973 -178.031 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.511 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.9 p80 -143.85 90.99 2.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.92 0.867 . . . . 0.0 110.096 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 40' ' ' THR . 14.7 m -75.61 34.85 0.12 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.508 0.67 . . . . 0.0 110.089 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.511 ' H ' ' C ' ' A' ' 33' ' ' HIS . 17.8 pt -143.84 142.13 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -175.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.559 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 32.5 m-85 57.0 45.26 21.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 121.769 0.795 . . . . 0.0 111.004 -176.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 21.9 p -103.81 173.47 3.38 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.618 168.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 37.2 Cg_exo -59.39 -22.37 65.42 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.793 1.662 . . . . 0.0 111.997 170.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -86.56 -39.17 16.45 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.945 0.402 . . . . 0.0 110.649 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 34' ' ' SER . 1.8 p -90.26 -20.1 23.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.493 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.559 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.4 m120 -135.46 65.14 61.55 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.943 0.401 . . . . 0.0 111.443 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -79.52 32.56 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.358 2.039 . . . . 0.0 111.382 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 41' ' ' ASN . 27.9 ptt180 -120.32 -17.1 8.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.425 -176.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB1' HD12 ' A' ' 46' ' ' LEU . . . -118.14 11.35 13.23 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.804 -172.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.95 44.9 95.32 Favored Glycine 0 C--O 1.23 -0.145 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.323 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.929 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.2 mp -77.73 90.97 4.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.056 0.455 . . . . 0.0 111.334 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.565 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.6 pt-20 -108.84 142.16 39.83 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.493 175.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 58.39 -123.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.994 0.809 . . . . 0.0 110.908 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -130.35 17.09 5.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.659 0.266 . . . . 0.0 110.752 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.565 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 18.0 m-85 -66.4 131.24 45.64 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.597 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 72.1 m -52.24 148.17 6.81 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.422 0.451 . . . . 0.0 111.395 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -153.53 158.93 42.0 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -119.61 78.93 21.84 Favored Pre-proline 0 C--N 1.316 -0.891 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.825 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.929 ' HG3' HD21 ' A' ' 46' ' ' LEU . 26.8 Cg_exo -58.09 -26.49 75.81 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.741 2.294 . . . . 0.0 112.643 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.51 -11.63 18.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.754 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.17 45.57 95.13 Favored Glycine 0 CA--C 1.501 -0.801 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.217 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.505 ' C ' ' H ' ' A' ' 59' ' ' GLY . 4.1 t70 -51.86 133.08 32.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.699 -0.751 . . . . 0.0 109.114 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.79 24.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.844 0.83 . . . . 0.0 110.562 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -116.3 -17.69 6.1 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.82 -179.56 16.1 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.32 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.659 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 71.7 Cg_endo -73.74 157.99 47.42 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.31 2.007 . . . . 0.0 111.481 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.592 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 29.3 p-90 -146.9 -174.16 4.42 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.065 -171.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.605 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.2 p -168.94 178.2 4.62 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.032 177.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.418 ' CD1' ' HG ' ' A' ' 71' ' ' LEU . 47.8 m-85 -100.51 145.39 28.36 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.1 p -101.94 148.36 25.43 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.734 -171.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 p -79.73 19.2 0.68 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.101 0.477 . . . . 0.0 110.921 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.589 ' HB2' HG21 ' A' ' 20' ' ' THR . 63.0 t-20 -100.35 118.29 61.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.216 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 15.2 Cg_exo -68.52 3.64 2.1 Favored 'Trans proline' 0 N--CA 1.47 0.119 0 C-N-CA 123.157 2.572 . . . . 0.0 113.496 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -84.75 -44.43 13.34 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.966 0.412 . . . . 0.0 110.819 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.484 ' HE2' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -144.92 142.56 29.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.482 0.658 . . . . 0.0 111.16 -174.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 64' ' ' TYR . 52.5 tp -70.69 -44.48 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.912 -168.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -146.75 163.83 34.72 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.543 -174.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -154.07 -177.55 6.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.084 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -93.15 162.12 14.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 94.8 m -105.77 171.43 7.34 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.171 0.51 . . . . 0.0 111.266 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -117.43 70.48 0.79 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.225 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.642 HG22 ' CE1' ' A' ' 9' ' ' TYR . 3.4 p -109.67 128.67 24.99 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.31 173.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.84 159.15 34.59 Favored 'Trans proline' 0 CA--C 1.512 -0.595 0 C-N-CA 123.772 2.981 . . . . 0.0 113.634 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -74.39 113.84 12.09 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.068 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.526 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.91 -42.12 58.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.056 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.427 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.595 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.444 -0.725 0 CA-C-O 121.075 0.464 . . . . 0.0 111.149 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.695 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 12.9 ptt? -96.83 154.54 17.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.607 ' CD2' ' HB3' ' A' ' 81' ' ' ALA . 49.6 m-85 -108.87 96.53 6.39 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.15 -115.18 4.05 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -79.49 -25.27 41.86 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.761 0.824 . . . . 0.0 111.148 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.592 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 112.04 13.54 12.16 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 119.834 -1.174 . . . . 0.0 111.568 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.649 ' HZ2' ' HB3' ' A' ' 7' ' ' LYS . 9.1 mtpm? -60.61 -41.74 95.41 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.472 0.653 . . . . 0.0 110.202 175.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.94 28.64 10.86 Favored Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.165 172.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.71 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.7 t80 -68.43 106.31 2.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.896 0.379 . . . . 0.0 110.023 173.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.0 51.47 0.8 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -175.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.562 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -101.97 -148.65 21.38 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.711 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -151.84 20.43 0.69 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.863 0.332 . . . . 0.0 110.773 -174.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.904 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.4 mmt180 -62.38 139.54 58.55 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 m -139.53 35.64 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.06 0.933 . . . . 0.0 109.871 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.07 143.67 25.26 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.091 -177.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.436 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 55.7 p -75.37 -174.75 2.51 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.03 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.12 -16.35 20.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.505 0.669 . . . . 0.0 110.872 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.7 p -93.19 -13.61 28.16 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.44 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.8 10.56 66.84 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.26 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.995 HG21 ' HB2' ' A' ' 67' ' ' ASN . 96.9 m -77.08 120.54 82.05 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.141 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -47.48 123.01 7.43 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.201 2.601 . . . . 0.0 113.802 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.98 141.14 58.86 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.842 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -73.81 166.26 23.64 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.417 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 11.8 m-20 -76.52 124.7 28.0 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 175.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.656 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 38.6 m95 -53.73 -32.55 52.53 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.9 -12.09 59.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.945 -1.479 . . . . 0.0 113.045 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.78 149.09 30.31 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 119.21 0.914 . . . . 0.0 109.052 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.664 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.3 mm-40 -101.84 31.76 3.72 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 44.1 mt-10 -145.57 121.39 5.81 Favored Pre-proline 0 N--CA 1.426 -1.655 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.712 -155.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 93.8 Cg_endo -89.92 33.59 7.83 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.469 -1.471 . . . . 0.0 113.217 1.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.6 ' HB3' HD11 ' A' ' 71' ' ' LEU . 64.3 m80 -134.11 111.16 10.1 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.664 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -72.17 126.6 30.21 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.523 ' C ' ' H ' ' A' ' 35' ' ' ILE . 6.1 p80 -155.02 89.43 1.22 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.033 0.921 . . . . 0.0 110.271 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 m -73.79 34.23 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.528 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.523 ' H ' ' C ' ' A' ' 33' ' ' HIS . 20.7 pt -143.29 147.21 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.557 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 35.7 m-85 52.29 45.49 28.35 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.983 0.897 . . . . 0.0 111.27 -174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 p -100.8 172.59 4.36 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.495 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.15 -14.16 42.02 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.015 1.81 . . . . 0.0 112.003 172.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -92.91 -37.72 12.09 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 110.167 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -87.74 -22.37 24.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.464 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.0 m120 -130.82 60.29 51.96 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.328 . . . . 0.0 111.014 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.81 39.15 0.73 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.641 2.227 . . . . 0.0 112.956 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.467 ' NH1' ' HA ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -141.56 -16.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.645 ' HB1' HD12 ' A' ' 46' ' ' LEU . . . -99.52 12.3 36.81 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.166 -0.334 . . . . 0.0 110.453 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.79 40.21 85.23 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.085 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.645 HD12 ' HB1' ' A' ' 44' ' ' ALA . 5.2 mp -81.76 102.43 10.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.094 0.473 . . . . 0.0 110.435 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -127.27 142.75 51.39 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.448 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 31.5 mmtp 55.14 -116.15 1.02 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.969 0.793 . . . . 0.0 111.211 177.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -136.11 17.42 3.22 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.827 0.346 . . . . 0.0 110.83 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -66.06 130.71 44.19 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.588 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 93.8 m -56.57 146.91 23.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.994 0.426 . . . . 0.0 111.668 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.81 159.88 43.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -176.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 25.1 t-20 -126.37 80.25 69.38 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.746 -0.381 . . . . 0.0 109.98 175.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.603 ' HG3' HD23 ' A' ' 46' ' ' LEU . 37.6 Cg_exo -59.63 -31.71 94.77 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.908 2.405 . . . . 0.0 112.592 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -88.99 -24.0 22.49 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.523 0.677 . . . . 0.0 110.048 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.64 46.36 69.38 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.019 -172.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -48.39 133.64 15.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.73 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.37 -11.29 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 124.451 1.094 . . . . 0.0 111.527 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.29 -10.89 43.73 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.909 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.84 -177.81 16.59 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.684 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.695 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 88.2 Cg_endo -74.69 164.77 32.99 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.575 2.183 . . . . 0.0 111.694 -173.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.58 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 29.8 p-90 -149.97 -172.13 4.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.227 -172.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.656 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.7 p -168.91 -177.71 3.08 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.691 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.444 ' CD1' ' HB3' ' A' ' 72' ' ' TYR . 50.1 m-85 -100.99 147.29 26.35 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 171.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 p -103.35 147.16 27.43 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.081 -170.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.7 p -82.48 21.47 0.96 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.153 0.501 . . . . 0.0 110.411 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.995 ' HB2' HG21 ' A' ' 20' ' ' THR . 52.8 t-20 -99.35 123.11 49.65 Favored Pre-proline 0 N--CA 1.456 -0.164 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.155 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.83 1.98 2.39 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.836 2.357 . . . . 0.0 113.16 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -84.08 -50.75 7.66 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.044 0.449 . . . . 0.0 111.089 175.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -130.14 159.55 36.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.368 0.604 . . . . 0.0 111.212 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 31' ' ' HIS . 45.4 tp -84.81 -45.63 12.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.857 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.444 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 33.6 p90 -143.37 164.18 30.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.863 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.436 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 37.2 t0 -160.01 176.23 12.08 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -94.34 157.51 16.0 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.9 m -106.03 167.64 9.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.712 0.291 . . . . 0.0 110.288 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -117.89 72.44 0.85 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.308 0.575 . . . . 0.0 110.037 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.904 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -106.6 129.48 24.38 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.953 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.93 157.3 16.96 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 124.327 3.351 . . . . 0.0 113.85 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.89 113.83 13.82 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.933 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.595 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.89 -44.4 40.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.589 178.133 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.607 ' HB3' ' CD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.372 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.48 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.537 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 15.9 ptt? -96.28 154.86 17.02 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.539 ' CD2' ' HB2' ' A' ' 81' ' ' ALA . 7.8 m-85 -113.67 96.45 5.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.27 -115.09 3.98 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -79.83 -22.21 43.26 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.282 0.636 . . . . 0.0 109.715 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.5 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.92 11.55 20.44 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.224 -0.988 . . . . 0.0 110.938 -174.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.538 ' HZ2' ' HB3' ' A' ' 7' ' ' LYS . 9.2 mtpm? -65.17 -31.75 73.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.055 0.455 . . . . 0.0 110.124 176.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -111.7 19.45 23.64 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 173.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.671 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.1 t80 -68.19 110.53 4.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -118.32 45.15 2.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 0.0 109.664 -177.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -98.88 -159.85 29.58 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.85 -175.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HZ1' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -139.59 15.12 2.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.495 0.188 . . . . 0.0 110.74 -170.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.61 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 19.8 mmt180 -64.66 135.78 56.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.61 36.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.553 0.692 . . . . 0.0 111.209 -171.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.782 HG22 ' HA2' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -151.35 139.97 20.68 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -178.09 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.632 HG22 ' HB3' ' A' ' 73' ' ' ASP . 75.3 p -75.15 -169.69 1.0 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.892 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -66.25 -21.11 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.312 0.577 . . . . 0.0 110.759 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.2 p -92.84 -13.33 29.22 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.191 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.782 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 82.62 20.69 61.31 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.582 -173.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.5 m -76.48 119.31 76.82 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 168.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.52 135.95 33.2 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.924 2.416 . . . . 0.0 113.225 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 72.9 m -76.45 142.94 40.84 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.734 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -70.96 165.53 23.2 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.297 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.9 128.81 35.24 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.662 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 57.8 m95 -57.82 -30.89 66.09 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.41 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . . . -78.07 -18.1 56.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.853 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.44 149.58 21.24 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.616 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 30.3 mm-40 -104.3 31.24 4.73 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.5 mt-10 -147.62 122.79 5.2 Favored Pre-proline 0 N--CA 1.422 -1.832 0 CA-C-N 113.795 -1.548 . . . . 0.0 114.397 -154.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 91.9 Cg_endo -86.85 29.82 9.03 Favored 'Cis proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.212 -1.578 . . . . 0.0 112.839 -0.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.676 ' HB3' HD11 ' A' ' 71' ' ' LEU . 55.0 m80 -130.58 107.49 9.24 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.616 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -74.48 125.33 28.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.471 ' C ' ' H ' ' A' ' 35' ' ' ILE . 3.9 p80 -155.21 98.13 1.97 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.99 0.9 . . . . 0.0 110.96 -177.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.0 m -79.61 33.78 0.26 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.666 0.746 . . . . 0.0 109.837 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.471 ' H ' ' C ' ' A' ' 33' ' ' HIS . 31.4 pt -142.15 146.16 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.623 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 41.7 m-85 50.06 51.04 17.44 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.931 0.872 . . . . 0.0 111.254 -175.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.526 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 29.3 p -99.44 177.65 1.5 Allowed Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.115 171.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 35.6 Cg_exo -60.53 -29.24 88.18 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 121.872 1.714 . . . . 0.0 111.378 170.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.04 -30.56 16.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.682 -167.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.0 p -89.06 -19.91 25.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.036 0.446 . . . . 0.0 110.23 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.623 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.5 m120 -133.97 67.25 73.74 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.719 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.27 9.94 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.039 1.826 . . . . 0.0 111.783 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -96.38 -24.05 16.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.616 ' HB2' HD13 ' A' ' 46' ' ' LEU . . . -106.58 1.18 25.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.861 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.11 44.68 90.74 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.225 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.661 HD21 ' CE3' ' A' ' 25' ' ' TRP . 5.4 mp -73.12 99.98 2.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.69 0.281 . . . . 0.0 110.381 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.8 pt-20 -118.68 142.99 47.14 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 48' ' ' LYS . 23.5 mmmt 53.39 -115.58 0.97 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.715 0.635 . . . . 0.0 111.576 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -135.34 17.76 3.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.211 0.529 . . . . 0.0 110.589 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.485 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 27.7 m-85 -68.61 129.71 40.72 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.465 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 71.6 m -54.71 153.4 6.0 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 123.219 0.324 . . . . 0.0 111.462 -173.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 35.5 mmt-85 -156.89 169.82 23.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.78 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -128.25 77.35 77.04 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.52 169.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.616 ' HG3' HD23 ' A' ' 46' ' ' LEU . 36.2 Cg_endo -70.78 -13.64 32.25 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.256 1.971 . . . . 0.0 112.474 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.67 -25.95 17.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.036 0.922 . . . . 0.0 109.055 173.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.54 40.64 99.37 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.959 -169.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 59' ' ' GLY . 20.2 t70 -48.54 133.88 16.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 172.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 t -72.63 6.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.611 0.72 . . . . 0.0 110.805 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -98.47 -22.45 14.43 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.07 -179.3 16.94 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 119.513 -1.327 . . . . 0.0 112.02 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.537 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 95.5 Cg_endo -75.6 157.64 40.18 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.386 2.057 . . . . 0.0 111.612 -174.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.511 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 15.7 p-90 -148.26 -169.7 3.41 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.958 -172.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.662 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 28.9 p -168.6 -177.5 3.14 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.458 176.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 67.7 m-85 -100.22 146.09 27.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 170.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.1 p -100.09 145.25 28.17 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.632 -170.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.9 p -78.49 17.8 0.63 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.034 0.445 . . . . 0.0 110.991 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' A' ' 69' ' ' ARG . 16.3 t30 -105.8 120.47 49.06 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 21.8 Cg_exo -65.91 4.96 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.353 2.702 . . . . 0.0 114.072 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.448 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 20.4 mmm180 -82.05 -43.16 18.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.615 0.245 . . . . 0.0 111.21 173.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -134.68 156.47 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.329 0.585 . . . . 0.0 111.068 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.676 HD11 ' HB3' ' A' ' 31' ' ' HIS . 41.5 tp -83.19 -45.09 14.3 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.905 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 29.0 p90 -143.74 164.87 29.25 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.995 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.632 ' HB3' HG22 ' A' ' 16' ' ' THR . 37.4 t0 -160.71 169.4 22.89 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 65.0 m-85 -92.85 155.84 17.36 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 80.9 m -104.46 168.32 9.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.148 0.499 . . . . 0.0 111.11 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -115.47 64.49 0.69 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.398 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.671 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.8 p -104.36 130.72 22.81 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.497 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HD2' HG22 ' A' ' 77' ' ' VAL . 25.2 Cg_endo -61.33 154.78 56.09 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 123.85 3.033 . . . . 0.0 113.625 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -75.66 109.43 9.23 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.286 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.411 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -72.82 -43.17 63.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.305 179.033 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.539 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.027 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.589 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.438 -1.041 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.501 ' HG2' ' HG3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -98.02 143.44 28.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -175.175 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.675 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 74.1 m-85 -102.32 104.07 14.56 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.7 -111.51 3.27 Favored Glycine 0 N--CA 1.424 -2.11 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.495 -174.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -89.14 -20.23 24.51 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 124.444 0.732 . . . . 0.0 110.521 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.03 15.87 13.68 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.79 -1.195 . . . . 0.0 111.886 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -63.94 -38.53 91.42 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.009 0.433 . . . . 0.0 110.271 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.31 24.64 22.15 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 173.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.608 ' CE1' HG23 ' A' ' 77' ' ' VAL . 3.8 t80 -71.24 103.45 2.82 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -110.72 46.43 1.06 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.171 0.51 . . . . 0.0 109.681 -176.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.593 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.17 -158.61 32.0 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.604 -0.725 . . . . 0.0 113.174 -173.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -140.68 14.6 2.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.73 0.3 . . . . 0.0 110.581 -170.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.913 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.9 mmt180 -67.16 135.72 53.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.16 38.84 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.752 0.787 . . . . 0.0 110.854 -170.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.98 148.52 28.48 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.273 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -75.2 -171.41 1.4 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.915 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.82 -18.32 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.398 0.618 . . . . 0.0 110.884 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.4 p -93.54 -12.63 29.14 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.792 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.44 12.75 69.3 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.373 -172.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.864 HG21 ' HB2' ' A' ' 67' ' ' ASN . 99.5 m -75.87 121.63 85.41 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 172.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -50.31 128.3 22.54 Favored 'Trans proline' 0 CA--C 1.514 -0.493 0 C-N-CA 122.641 2.227 . . . . 0.0 113.193 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.42 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 77.0 m -69.13 137.6 53.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.293 171.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -70.06 165.85 21.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.533 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.401 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 13.9 m-20 -76.63 125.93 30.09 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.707 ' CE3' HD23 ' A' ' 46' ' ' LEU . 43.3 m95 -53.77 -30.28 43.88 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.566 0.698 . . . . 0.0 109.182 176.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.4 -19.97 55.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.793 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.401 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.49 150.29 23.2 Favored 'General case' 0 C--O 1.21 -1.017 0 O-C-N 121.639 -0.663 . . . . 0.0 109.528 -170.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 33.2 mm-40 -104.56 23.95 12.48 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -140.54 131.0 13.66 Favored Pre-proline 0 N--CA 1.432 -1.363 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.389 -166.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -86.09 26.61 12.02 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.88 -1.717 . . . . 0.0 113.229 0.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.542 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 30.2 m80 -127.59 109.9 12.17 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.571 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 6.2 mmt180 -73.17 112.26 9.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.446 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.9 p80 -144.24 96.19 2.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.393 1.092 . . . . 0.0 110.51 -176.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.4 m -75.7 23.06 0.13 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.493 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.444 ' H ' ' C ' ' A' ' 33' ' ' HIS . 34.1 pt -140.89 158.31 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.607 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 63.4 m-85 50.71 46.91 25.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.02 0.914 . . . . 0.0 110.727 -173.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 32.0 p -100.01 174.63 2.88 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 114.072 -1.422 . . . . 0.0 108.87 171.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 26.5 Cg_exo -64.12 -16.94 57.78 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 121.827 1.684 . . . . 0.0 111.851 171.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -90.87 -37.64 13.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.442 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.7 p -88.82 -19.94 25.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 -176.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.8 m120 -134.8 65.78 67.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.093 0.473 . . . . 0.0 111.33 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.51 8.64 1.79 Allowed 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.421 2.081 . . . . 0.0 112.056 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -102.51 -16.88 15.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.365 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.606 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -109.63 5.17 22.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.109 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 47' ' ' GLU . . . 62.04 45.87 95.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.448 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.707 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.7 mp -72.36 94.48 1.62 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.195 0.522 . . . . 0.0 110.439 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.752 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.3 pt-20 -108.39 134.53 51.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.089 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm 54.93 -112.15 0.69 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.568 0.543 . . . . 0.0 111.544 176.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -134.77 12.87 3.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.476 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.752 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 21.6 m-85 -64.07 128.71 37.0 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.451 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 80.4 m -51.16 155.31 1.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.398 0.436 . . . . 0.0 111.684 -175.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.451 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 29.3 mmt-85 -158.17 169.4 24.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.988 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -128.19 78.2 75.78 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.525 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.68 ' HG3' HD22 ' A' ' 46' ' ' LEU . 26.9 Cg_endo -69.61 -12.52 33.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.267 1.978 . . . . 0.0 112.248 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -95.71 -27.25 15.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.897 0.856 . . . . 0.0 109.375 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.37 37.28 93.82 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.398 -166.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 59' ' ' GLY . 9.3 t70 -45.16 131.57 7.63 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.219 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.47 34.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.833 0.825 . . . . 0.0 110.339 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -122.05 -19.7 3.22 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.53 179.96 15.92 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.922 -1.133 . . . . 0.0 111.432 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.501 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 94.6 Cg_endo -72.85 152.56 52.49 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.963 1.775 . . . . 0.0 111.399 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.472 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 23.9 p-90 -145.95 -171.49 3.72 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.898 -170.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.644 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.1 p -168.51 179.88 4.17 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.623 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.443 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 40.0 m-85 -100.77 139.68 36.11 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.6 p -98.33 148.74 23.35 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.574 -170.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -80.95 20.45 0.78 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.267 0.556 . . . . 0.0 110.377 169.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.864 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.9 t-20 -98.94 119.08 61.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.848 -177.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.32 -0.55 4.36 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.993 2.462 . . . . 0.0 113.546 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -84.7 -43.46 14.3 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.8 0.333 . . . . 0.0 111.434 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.39 149.54 49.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.326 0.584 . . . . 0.0 110.417 -176.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.542 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 46.6 tp -78.87 -43.09 25.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.382 -175.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -143.27 163.51 32.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.783 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -159.15 178.59 9.86 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -93.79 158.08 15.83 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.84 166.15 10.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.247 0.546 . . . . 0.0 111.231 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -109.38 60.19 0.6 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.289 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.913 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -104.66 128.62 26.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.397 174.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.02 161.81 24.78 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 124.055 3.17 . . . . 0.0 113.743 -176.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -75.73 110.53 10.22 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.454 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.589 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.04 -38.67 61.38 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.205 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.675 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.51 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.593 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.658 ' HG2' ' HG3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -97.95 142.39 29.75 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.526 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 66.0 m-85 -101.41 102.25 13.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -177.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.2 -114.44 3.89 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.618 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -84.87 -23.58 28.92 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.382 0.695 . . . . 0.0 110.267 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.552 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.99 15.33 11.96 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.449 -175.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -67.92 -36.01 79.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.204 0.526 . . . . 0.0 110.33 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -107.57 20.21 32.5 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.603 ' CE1' HG23 ' A' ' 77' ' ' VAL . 2.6 t80 -66.5 101.74 0.8 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.34 46.4 0.93 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.179 0.514 . . . . 0.0 110.551 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.541 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -101.77 -158.14 26.59 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.171 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -149.86 22.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.947 0.374 . . . . 0.0 110.76 -170.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.878 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 21.0 mmt180 -65.2 139.04 58.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.75 30.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.536 0.684 . . . . 0.0 111.654 -170.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.27 142.39 24.05 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.415 HG21 ' HB3' ' A' ' 73' ' ' ASP . 69.4 p -75.31 -176.87 3.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.871 0.367 . . . . 0.0 111.605 -174.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 m -63.8 -19.39 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.47 0.652 . . . . 0.0 110.851 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.5 p -93.42 -12.01 30.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.798 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.79 12.76 68.27 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.28 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.662 HG22 ' HB2' ' A' ' 67' ' ' ASN . 85.6 m -76.86 119.76 78.85 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 171.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -50.62 123.74 12.04 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.811 2.341 . . . . 0.0 112.993 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.33 139.23 58.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.412 0.625 . . . . 0.0 110.565 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -71.4 166.01 22.56 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.807 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.24 127.34 32.43 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.76 ' CE3' HD21 ' A' ' 46' ' ' LEU . 64.6 m95 -57.14 -30.04 64.1 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.533 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . . . -78.69 -18.28 54.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.52 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.89 150.2 20.7 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.663 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.2 mm-40 -104.17 32.54 3.94 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -145.87 122.09 5.84 Favored Pre-proline 0 N--CA 1.428 -1.564 0 CA-C-N 114.027 -1.442 . . . . 0.0 114.104 -157.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -86.69 25.25 15.47 Favored 'Cis proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.597 -1.418 . . . . 0.0 112.79 1.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.409 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 43.1 m80 -128.14 108.72 10.87 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.663 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.1 ppt_? -73.95 120.57 19.72 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.543 -178.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.47 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.3 p80 -148.76 98.12 2.82 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.248 1.023 . . . . 0.0 109.739 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 m -77.79 28.51 0.17 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.595 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.47 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.1 pt -141.5 151.43 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -176.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.558 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 59.5 m-85 52.25 48.03 23.51 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 122.054 0.931 . . . . 0.0 111.146 -176.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 41.8 p -100.32 176.08 2.08 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.394 172.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 7.7 Cg_exo -70.71 -11.63 29.89 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.963 1.775 . . . . 0.0 111.087 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -92.87 -31.26 15.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.03 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.4 p -98.97 -19.8 17.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.092 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.558 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.2 m120 -135.58 57.91 22.1 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -174.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 13.6 Cg_exo -69.81 15.98 0.23 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.234 1.956 . . . . 0.0 112.545 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.472 ' H ' ' C ' ' A' ' 41' ' ' ASN . 18.8 ptt180 -99.6 -17.83 17.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.789 0.328 . . . . 0.0 111.034 -177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.677 ' HB2' HD12 ' A' ' 46' ' ' LEU . . . -118.13 3.4 12.05 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.445 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.05 46.67 90.67 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.566 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.765 HD23 ' HG3' ' A' ' 54' ' ' PRO . 5.3 mp -77.38 67.57 3.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.509 0.195 . . . . 0.0 111.185 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 6.0 pt-20 -97.39 157.6 15.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.764 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 52.07 -125.55 2.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.351 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -129.16 23.21 5.63 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.055 0.455 . . . . 0.0 110.373 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.51 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 38.5 m-85 -65.64 123.14 18.92 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.955 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 71.4 m -50.25 151.29 2.14 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 123.378 0.424 . . . . 0.0 111.42 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 43.2 mmt-85 -157.58 170.99 21.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.228 -174.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -131.36 76.81 75.14 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.347 169.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.765 ' HG3' HD23 ' A' ' 46' ' ' LEU . 33.8 Cg_endo -66.95 -15.9 48.24 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.563 2.176 . . . . 0.0 112.635 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -95.86 -26.04 15.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.938 0.875 . . . . 0.0 109.451 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.28 39.46 97.88 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.598 -166.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' A' ' 59' ' ' GLY . 19.7 t70 -44.82 131.42 7.04 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 124.462 0.742 . . . . 0.0 110.153 173.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 t -76.04 35.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.785 0.803 . . . . 0.0 110.188 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -126.16 -18.34 2.33 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 173.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.76 -179.64 16.07 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.485 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.658 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 92.9 Cg_endo -73.71 150.99 45.82 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.143 1.895 . . . . 0.0 111.33 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 19.1 p-90 -144.66 -170.49 3.4 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.038 -169.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.713 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.1 p -168.86 -179.25 3.64 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -101.23 146.8 27.05 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.418 ' HB ' ' CG2' ' A' ' 20' ' ' THR . 1.2 p -102.91 146.17 28.72 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.879 -171.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.9 p -81.21 20.41 0.83 Allowed 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.826 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.662 ' HB2' HG22 ' A' ' 20' ' ' THR . 57.8 t-20 -99.4 120.81 56.95 Favored Pre-proline 0 C--N 1.337 0.036 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.226 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.04 4.88 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.022 2.481 . . . . 0.0 113.404 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -84.81 -58.26 2.78 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.744 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -119.53 159.29 24.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.797 -174.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.409 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 50.4 tp -87.85 -45.78 10.0 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.553 -177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -143.04 156.38 44.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.07 0.462 . . . . 0.0 109.831 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.415 ' HB3' HG21 ' A' ' 16' ' ' THR . 39.8 t0 -154.37 173.36 16.32 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 59.0 m-85 -93.26 157.84 16.05 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.9 m -105.3 162.39 13.47 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.895 0.378 . . . . 0.0 110.447 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.48 32.15 1.85 Allowed 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.315 0.579 . . . . 0.0 111.14 -172.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.878 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.4 p -80.51 122.6 82.65 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.683 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.12 162.75 25.13 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 C-N-CA 124.219 3.279 . . . . 0.0 113.884 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.44 ' NE2' ' SD ' ' A' ' 2' ' ' MET . 8.8 tp-100 -72.59 110.36 6.9 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.677 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.561 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.3 -41.65 56.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.639 179.048 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.526 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.465 0.275 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.3 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.44 -0.951 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.582 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 7.0 ptt? -97.03 154.28 17.41 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.593 ' HD2' ' HB3' ' A' ' 81' ' ' ALA . 83.0 m-85 -112.38 95.63 5.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.64 -110.8 3.11 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -79.17 -29.77 43.17 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 124.935 1.02 . . . . 0.0 111.005 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . 108.36 17.88 10.25 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 119.614 -1.279 . . . . 0.0 112.079 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -62.5 -43.62 98.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.358 0.599 . . . . 0.0 110.114 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -105.09 27.9 16.82 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.027 174.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.76 ' CE1' HG22 ' A' ' 77' ' ' VAL . 3.2 t80 -68.94 105.47 2.4 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 170.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -109.18 42.54 1.42 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.085 0.469 . . . . 0.0 110.109 -175.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.598 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -93.49 -152.73 29.58 Favored Glycine 0 C--N 1.329 0.17 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.992 -175.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -148.08 16.54 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.763 0.282 . . . . 0.0 110.756 -172.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.752 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.1 mmt180 -66.38 138.17 57.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.469 ' C ' ' HG1' ' A' ' 15' ' ' THR . 3.4 m -138.6 32.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.636 0.732 . . . . 0.0 110.776 -170.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.694 HG22 ' HA2' ' A' ' 19' ' ' GLY . 3.6 m -151.89 136.17 16.72 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -173.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.515 HG22 ' HB3' ' A' ' 73' ' ' ASP . 74.5 p -73.35 -172.51 1.16 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -171.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.7 m -69.27 -18.57 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.546 0.689 . . . . 0.0 110.447 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p -92.13 -14.38 29.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.048 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.694 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 84.96 15.19 67.9 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.243 -174.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.74 HG23 ' HB2' ' A' ' 67' ' ' ASN . 98.3 m -78.36 121.02 83.24 Favored Pre-proline 0 N--CA 1.442 -0.83 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 169.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -49.63 130.56 26.48 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.764 2.309 . . . . 0.0 113.362 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m -67.53 140.56 57.0 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.972 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -73.82 165.92 24.26 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.324 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 2.1 m-20 -76.25 125.94 30.08 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 175.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.632 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 41.0 m95 -54.77 -29.29 53.69 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 173.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.92 -22.1 53.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.1 176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.439 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -99.96 150.11 22.75 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 119.039 0.836 . . . . 0.0 108.748 -172.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.621 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.2 mm-40 -103.19 32.28 3.84 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 36.0 mt-10 -145.68 122.42 6.01 Favored Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -158.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 91.9 Cg_endo -88.37 31.82 8.42 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.29 -1.546 . . . . 0.0 113.375 0.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.525 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 58.7 m80 -130.75 113.58 14.31 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.621 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 25.9 mmm180 -74.06 113.56 11.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.89 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.8 p80 -147.85 94.37 2.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.139 0.971 . . . . 0.0 111.16 -177.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m -79.8 35.81 0.31 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.498 0.665 . . . . 0.0 110.113 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 33' ' ' HIS . 23.4 pt -142.06 146.18 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.596 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 50.2 m-85 51.17 46.71 26.06 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.222 1.011 . . . . 0.0 110.969 -173.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.531 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 35.7 p -99.66 174.26 3.16 Favored Pre-proline 0 N--CA 1.444 -0.743 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.255 171.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 32.0 Cg_exo -59.35 -23.16 68.89 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.922 1.748 . . . . 0.0 112.185 170.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.49 -34.95 13.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.79 0.329 . . . . 0.0 111.296 -173.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.6 p -85.73 -18.67 32.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.997 0.427 . . . . 0.0 110.503 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.596 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.4 m120 -138.21 59.67 19.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.509 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.17 19.97 0.49 Allowed 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.613 2.208 . . . . 0.0 112.809 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -122.45 -8.69 8.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.491 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.695 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -106.51 7.93 31.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.386 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.99 40.85 97.43 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.384 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.695 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.2 mp -77.08 95.83 4.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.998 0.428 . . . . 0.0 110.828 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.467 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.2 pt-20 -118.23 152.16 36.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.504 175.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 34.2 mmtp 50.95 -115.26 0.85 Allowed 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.828 0.705 . . . . 0.0 111.183 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -139.47 19.68 2.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.001 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.467 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 32.8 m-85 -66.5 129.62 40.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.571 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.626 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 74.0 m -56.03 148.94 16.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.086 0.469 . . . . 0.0 111.824 -173.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.632 ' HD2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -155.17 158.2 38.58 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.632 -175.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -123.26 80.71 52.49 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.427 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.583 ' HD2' ' CZ2' ' A' ' 62' ' ' TRP . 3.4 Cg_exo -72.25 -13.04 28.14 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.287 1.992 . . . . 0.0 111.579 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -89.04 -32.28 17.65 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.63 38.76 96.39 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 113.521 -1.672 . . . . 0.0 109.856 -166.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -48.13 133.38 15.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.725 -0.738 . . . . 0.0 109.491 172.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 t -70.14 -0.27 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.489 0.661 . . . . 0.0 110.591 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.88 -17.18 42.03 Favored Glycine 0 N--CA 1.437 -1.274 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.21 -178.8 16.3 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 119.766 -1.207 . . . . 0.0 111.619 176.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.582 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 74.1 Cg_endo -72.5 158.39 51.16 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.251 1.968 . . . . 0.0 111.167 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.583 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 25.8 p-90 -148.3 -171.02 3.74 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.844 -171.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.632 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 28.9 p -168.37 -177.24 3.14 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.559 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.414 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 61.9 m-85 -100.47 150.03 23.07 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 170.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 67' ' ' ASN . 2.5 p -104.69 150.27 24.87 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.248 -173.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.414 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 44.6 p -82.18 27.61 0.48 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.385 0.612 . . . . 0.0 110.102 168.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.74 ' HB2' HG23 ' A' ' 20' ' ' THR . 58.9 t-20 -111.48 114.49 52.74 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.891 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.28 2.74 2.06 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 123.099 2.533 . . . . 0.0 113.976 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -84.32 -33.85 23.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.874 0.368 . . . . 0.0 111.354 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -143.89 143.09 31.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.257 0.551 . . . . 0.0 110.32 -177.483 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.525 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 52.3 tp -73.98 -42.62 60.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.765 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -142.65 159.5 42.12 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.515 ' HB3' HG22 ' A' ' 16' ' ' THR . 25.7 t0 -154.29 171.52 19.11 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -93.1 155.6 17.39 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.5 m -105.04 168.61 8.94 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.167 0.508 . . . . 0.0 110.583 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -117.43 70.28 0.78 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.019 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.76 HG22 ' CE1' ' A' ' 9' ' ' TYR . 2.6 p -106.5 129.52 24.34 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.521 174.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 11.2 Cg_endo -54.82 151.81 31.15 Favored 'Trans proline' 0 CA--C 1.509 -0.738 0 C-N-CA 124.146 3.231 . . . . 0.0 113.766 -178.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.46 110.75 10.1 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.19 -42.2 60.21 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.195 178.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.593 ' HB3' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.715 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.532 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.912 0.387 . . . . 0.0 110.626 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.64 ' HG2' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.61 149.57 23.14 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -177.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.77 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 49.3 m-85 -106.4 107.78 18.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.21 -111.92 3.35 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.908 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -94.1 -9.36 36.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.774 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.754 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 101.97 18.38 17.85 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.675 -175.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -70.4 -45.09 66.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.814 -0.693 . . . . 0.0 110.335 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.64 24.54 29.49 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.754 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 3.8 t80 -65.95 98.18 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.871 0.469 . . . . 0.0 110.205 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.432 ' HE ' ' C ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -103.11 46.6 0.91 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.074 0.464 . . . . 0.0 110.063 179.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.635 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.48 -156.21 30.97 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.674 -176.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.778 ' HB3' ' HZ3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -150.15 23.56 0.84 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.867 0.365 . . . . 0.0 110.82 -171.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.779 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 21.7 mmt180 -71.92 139.87 48.94 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 171.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.412 ' C ' ' HG1' ' A' ' 15' ' ' THR . 5.2 m -140.86 31.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.514 0.673 . . . . 0.0 110.895 -170.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.87 HG21 ' HA2' ' A' ' 19' ' ' GLY . 87.2 m -152.32 130.6 12.02 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -173.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.403 HG21 ' HB3' ' A' ' 73' ' ' ASP . 71.9 p -69.85 -172.83 0.56 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -170.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 m -67.07 -20.01 26.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.869 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -92.19 -13.29 30.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.765 0.793 . . . . 0.0 108.964 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.87 ' HA2' HG21 ' A' ' 15' ' ' THR . . . 82.91 17.65 67.12 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.367 -174.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.867 HG22 ' HB2' ' A' ' 67' ' ' ASN . 96.4 m -77.48 124.32 86.77 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 167.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.43 133.4 48.56 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.343 2.029 . . . . 0.0 113.217 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.9 m -71.8 140.41 49.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.72 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -73.11 167.19 21.66 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.234 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.486 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 4.8 m-20 -76.28 125.86 29.93 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.67 ' CE3' HD23 ' A' ' 46' ' ' LEU . 54.2 m95 -52.92 -32.94 48.2 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.69 0.757 . . . . 0.0 109.006 174.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.6 -16.63 58.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.727 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.486 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.44 150.27 23.21 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 118.668 0.667 . . . . 0.0 109.401 -172.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 33.4 mm-40 -107.74 21.14 17.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -146.6 137.11 12.35 Favored Pre-proline 0 N--CA 1.428 -1.54 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.375 -167.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.35 18.86 11.94 Favored 'Cis proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.367 -1.514 . . . . 0.0 112.993 1.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.588 ' HB3' HD11 ' A' ' 71' ' ' LEU . 62.2 m80 -128.98 106.9 9.2 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.431 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -72.61 126.1 29.06 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.485 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.9 p80 -154.94 94.26 1.63 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.132 0.968 . . . . 0.0 110.835 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -79.08 35.89 0.27 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.616 175.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.485 ' H ' ' C ' ' A' ' 33' ' ' HIS . 31.3 pt -143.12 143.86 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.573 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 32.1 m-85 55.39 47.75 20.55 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 122.16 0.981 . . . . 0.0 110.919 -175.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 p -102.66 174.98 2.48 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.467 168.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.45 -25.58 76.09 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.662 1.574 . . . . 0.0 111.775 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -88.17 -32.61 18.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.744 -174.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 p -90.72 -18.97 24.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.284 -177.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.573 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.8 m120 -133.63 61.58 54.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.733 0.301 . . . . 0.0 110.933 177.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.2 42.26 1.09 Allowed 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.843 2.362 . . . . 0.0 112.829 -176.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.62 -14.02 1.1 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.664 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.656 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -103.5 8.22 37.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.443 0.64 . . . . 0.0 110.69 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . 58.17 49.07 79.05 Favored Glycine 0 C--O 1.221 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.575 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.67 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.4 mp -76.54 93.25 3.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.218 0.533 . . . . 0.0 110.661 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.64 ' HB2' ' HD2' ' A' ' 50' ' ' TYR . 1.5 mt-10 -101.28 136.21 41.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.548 -177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 90.1 mttt 48.4 -104.4 0.12 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.73 0.644 . . . . 0.0 112.118 174.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -138.16 15.15 2.82 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.223 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.64 ' HD2' ' HB2' ' A' ' 47' ' ' GLU . 32.2 m-85 -65.89 125.81 26.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.554 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 78.9 m -49.44 151.98 1.42 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.546 0.529 . . . . 0.0 111.901 -175.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 41.6 mmt-85 -154.41 168.63 26.02 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.475 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -130.36 80.11 71.13 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 169.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.651 ' HG3' HD22 ' A' ' 46' ' ' LEU . 25.2 Cg_exo -60.27 -28.06 86.12 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.837 2.358 . . . . 0.0 111.966 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -93.67 -23.22 18.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.605 0.717 . . . . 0.0 110.424 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.5 38.75 96.32 Favored Glycine 0 CA--C 1.497 -1.034 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.988 -172.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -61.27 141.88 57.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.126 -0.537 . . . . 0.0 110.153 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 t -75.85 49.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.604 0.716 . . . . 0.0 110.928 -175.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -129.53 -16.56 1.84 Allowed Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.77 175.73 18.18 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.48 152.06 59.8 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.754 1.636 . . . . 0.0 111.497 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.603 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 31.4 p-90 -139.63 -173.68 3.69 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.327 -172.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.623 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.4 p -168.3 -179.75 4.13 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.269 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -101.23 145.29 29.02 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 p -101.34 151.23 22.15 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.788 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.7 p -85.82 20.13 2.29 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.332 168.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.867 ' HB2' HG22 ' A' ' 20' ' ' THR . 56.7 t-20 -95.4 116.17 66.08 Favored Pre-proline 0 CA--C 1.518 -0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.409 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.12 -0.2 2.05 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.83 2.354 . . . . 0.0 113.59 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -84.2 -55.46 4.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.799 0.333 . . . . 0.0 111.212 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -117.13 155.03 30.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.403 0.621 . . . . 0.0 110.666 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 31' ' ' HIS . 49.1 tp -85.35 -43.63 13.52 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.499 -176.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -143.38 162.53 35.49 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.403 ' HB3' HG21 ' A' ' 16' ' ' THR . 42.2 t0 -156.96 175.47 14.05 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.87 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -94.41 156.23 16.58 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 90.5 m -105.19 168.37 9.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.945 0.402 . . . . 0.0 110.722 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.84 65.82 0.77 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.915 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.779 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.7 p -105.56 126.58 30.47 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.188 176.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.97 157.59 19.9 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 123.915 3.076 . . . . 0.0 113.906 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.07 113.81 12.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.222 -1.353 . . . . 0.0 110.307 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.532 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.62 -42.43 51.72 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.329 178.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.77 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.2 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.582 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.443 -0.822 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.51 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 11.9 ptt? -96.97 152.44 18.71 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.595 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 82.0 m-85 -109.65 94.64 5.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.18 -114.08 3.77 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -173.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -79.7 -26.36 40.93 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.84 0.965 . . . . 0.0 110.248 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.4 13.96 19.47 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.401 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.695 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 97.4 mttt -65.4 -40.71 93.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.163 0.506 . . . . 0.0 110.065 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -107.37 25.75 20.66 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 172.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.644 ' CE1' HG23 ' A' ' 77' ' ' VAL . 3.7 t80 -66.56 108.83 2.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.71 40.42 2.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.154 0.502 . . . . 0.0 110.097 -175.526 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.567 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -93.98 -162.21 35.59 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.797 -176.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -139.8 18.69 2.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.915 0.388 . . . . 0.0 110.189 -169.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.778 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 18.7 mmt180 -66.88 135.82 54.44 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 m -137.9 34.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 121.75 0.786 . . . . 0.0 110.027 -171.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.915 HG22 ' HA2' ' A' ' 19' ' ' GLY . 86.4 m -153.05 125.65 8.24 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -169.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.619 HG22 ' HB3' ' A' ' 73' ' ' ASP . 81.9 p -69.97 -171.54 0.44 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -170.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.5 -23.11 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 121.505 0.669 . . . . 0.0 111.015 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.9 p -91.89 -15.7 27.73 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.796 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.915 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.48 20.02 55.41 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.955 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 67' ' ' ASN . 52.6 m -76.41 122.78 87.32 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 167.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.36 129.74 26.92 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.717 2.278 . . . . 0.0 113.536 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.8 m -68.68 144.26 54.5 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.46 0.647 . . . . 0.0 111.504 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -76.93 167.51 21.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.45 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.1 129.02 35.47 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.696 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 65.7 m95 -56.49 -32.37 64.96 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.54 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.98 -16.65 56.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.831 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.17 148.06 22.55 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.561 ' CA ' ' HA ' ' A' ' 32' ' ' ARG . 31.8 mm-40 -102.64 29.35 5.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -148.26 124.33 5.3 Favored Pre-proline 0 N--CA 1.421 -1.883 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.656 -156.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.07 25.74 11.61 Favored 'Cis proline' 0 C--N 1.344 0.33 0 C-N-CA 123.944 -1.273 . . . . 0.0 112.942 1.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.693 ' HB3' HD11 ' A' ' 71' ' ' LEU . 54.8 m80 -133.34 108.73 8.89 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.561 ' HA ' ' CA ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -75.17 129.63 37.84 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.234 -175.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.453 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.2 p80 -155.34 101.97 2.24 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.982 0.896 . . . . 0.0 110.154 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 t -80.71 29.67 0.31 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.841 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.453 ' H ' ' C ' ' A' ' 33' ' ' HIS . 22.0 pt -142.23 144.56 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -175.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.563 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 38.0 m-85 54.69 48.68 19.73 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 122.112 0.958 . . . . 0.0 110.639 -175.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 p -101.77 173.97 3.22 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.342 168.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.89 -28.5 87.55 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 121.728 1.618 . . . . 0.0 112.228 173.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -89.85 -33.9 16.31 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.143 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.9 p -85.42 -19.13 31.79 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.723 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.563 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.9 m120 -135.43 64.71 60.14 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.376 177.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.27 20.8 0.56 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.333 2.022 . . . . 0.0 111.915 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.452 ' H ' ' C ' ' A' ' 41' ' ' ASN . 14.6 ptt180 -114.32 -17.41 11.82 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.675 -177.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.625 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -108.1 6.1 26.6 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.135 0.493 . . . . 0.0 110.539 -176.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.93 46.21 94.05 Favored Glycine 0 C--O 1.228 -0.268 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.793 172.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.681 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.4 mp -73.92 104.77 4.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.148 0.499 . . . . 0.0 110.662 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.841 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.6 pt-20 -118.11 137.14 53.14 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.879 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 61.9 mmtt 45.98 -110.79 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.738 0.649 . . . . 0.0 112.569 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -135.45 17.63 3.37 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.17 0.509 . . . . 0.0 110.124 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.841 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 16.3 m-85 -70.47 131.36 43.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.546 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 86.2 m -53.51 145.54 14.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 123.383 0.427 . . . . 0.0 111.231 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.46 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 34.9 mmt-85 -150.18 161.05 43.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.174 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -122.55 79.76 47.03 Favored Pre-proline 0 C--N 1.319 -0.733 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.781 173.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.562 ' HG3' HD22 ' A' ' 46' ' ' LEU . 18.4 Cg_exo -64.35 -25.81 63.79 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.618 2.212 . . . . 0.0 112.33 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.97 -17.17 26.79 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.533 0.682 . . . . 0.0 109.748 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.695 ' HA3' ' HE2' ' A' ' 7' ' ' LYS . . . 55.66 40.57 79.66 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.397 -171.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 59' ' ' GLY . 9.0 t70 -47.88 138.32 8.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 124.4 0.706 . . . . 0.0 109.815 174.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 t -74.77 8.08 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.535 0.683 . . . . 0.0 110.407 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -102.14 -16.73 22.43 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.03 179.69 16.16 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.627 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.51 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 58.2 Cg_endo -71.33 161.09 46.83 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.442 2.095 . . . . 0.0 112.02 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.533 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 23.0 p-90 -150.7 -170.3 3.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.548 -171.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.696 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.4 p -169.19 -178.26 3.15 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.919 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 58.2 m-85 -101.78 147.22 26.74 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 170.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.453 ' HB ' ' CG2' ' A' ' 20' ' ' THR . 0.9 OUTLIER -105.0 147.29 27.96 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.062 -170.131 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.6 p -80.41 13.92 2.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.1 0.476 . . . . 0.0 110.811 172.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.691 ' HB2' HG21 ' A' ' 20' ' ' THR . 55.9 t-20 -93.68 123.31 60.28 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.417 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.63 2.83 1.74 Allowed 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.633 2.222 . . . . 0.0 113.261 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -84.24 -46.37 11.91 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.469 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 4.5 ptmt -134.92 154.92 51.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.531 0.681 . . . . 0.0 111.184 -174.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 31' ' ' HIS . 43.2 tp -83.61 -38.37 21.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.808 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 16.7 p90 -142.54 161.73 37.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.768 -175.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.619 ' HB3' HG22 ' A' ' 16' ' ' THR . 34.5 t0 -165.26 166.54 18.73 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -94.39 158.72 15.44 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.69 169.27 8.57 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -123.25 67.79 0.99 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.381 0.61 . . . . 0.0 110.128 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.778 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.4 p -99.5 130.38 26.98 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.451 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.36 159.09 24.23 Favored 'Trans proline' 0 CA--C 1.512 -0.582 0 C-N-CA 124.061 3.174 . . . . 0.0 113.539 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.09 112.1 12.18 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.696 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.505 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -75.64 -39.36 57.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.599 179.236 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.595 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.107 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.611 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.8 ptt? -97.0 152.96 18.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.397 0.618 . . . . 0.0 112.548 -177.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.587 ' CD2' ' HB1' ' A' ' 81' ' ' ALA . 71.4 m-85 -109.57 99.23 8.46 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.24 -109.04 2.68 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.472 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -78.1 -30.48 49.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 125.005 1.062 . . . . 0.0 110.596 -175.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 111.89 22.28 6.03 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.915 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -71.5 -41.0 69.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.782 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 10' ' ' ARG . . . -99.67 17.34 57.66 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.506 171.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.73 ' CE1' HG22 ' A' ' 77' ' ' VAL . 4.2 t80 -62.43 104.06 0.47 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 173.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -106.83 36.27 2.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 -177.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.621 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -94.25 -161.76 35.12 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.483 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.16 17.93 2.26 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.587 0.232 . . . . 0.0 110.91 -169.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.696 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.7 mmt180 -65.89 138.24 57.73 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.87 40.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.746 0.784 . . . . 0.0 111.018 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.23 148.9 28.78 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.831 -177.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.414 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 44.3 p -75.57 -173.84 2.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.611 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.29 -18.15 22.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.452 0.644 . . . . 0.0 111.137 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.1 p -93.06 -14.66 27.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.569 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.75 11.04 62.45 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.403 -0.904 . . . . 0.0 111.482 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.906 HG21 ' HB2' ' A' ' 67' ' ' ASN . 98.5 m -76.55 121.58 85.11 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.882 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.28 124.62 9.38 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.198 2.599 . . . . 0.0 113.576 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.94 141.15 58.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.904 171.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -72.43 166.89 21.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.387 174.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.467 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 7.6 t0 -76.48 129.13 36.06 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.741 ' CE3' HD22 ' A' ' 46' ' ' LEU . 64.9 m95 -57.32 -31.54 65.79 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.321 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.13 -16.16 57.09 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.116 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 24' ' ' ASP . . . -94.35 147.33 23.32 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.666 -172.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.443 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 32.4 mm-40 -106.66 16.58 24.34 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.467 ' HG2' HH11 ' A' ' 32' ' ' ARG . 35.2 mt-10 -147.65 143.38 17.82 Favored Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.526 -172.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.49 25.16 6.67 Favored 'Cis proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.928 -1.697 . . . . 0.0 113.256 1.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.613 ' HB3' HD11 ' A' ' 71' ' ' LEU . 65.1 m80 -135.33 108.55 7.75 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -75.5 117.87 17.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.891 -174.563 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.443 ' C ' ' H ' ' A' ' 35' ' ' ILE . 3.9 p80 -147.04 99.25 3.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.175 0.988 . . . . 0.0 111.087 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 m -77.71 27.75 0.17 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.804 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.3 pt -140.88 149.76 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.484 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 48.9 m-85 50.97 47.36 24.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 122.069 0.937 . . . . 0.0 110.765 -175.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.6 p -100.61 175.81 2.2 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.04 172.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 11.7 Cg_exo -71.14 -9.33 25.33 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 121.951 1.767 . . . . 0.0 111.253 169.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -91.31 -33.67 15.23 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.786 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.9 p -95.92 -26.69 15.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.185 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.513 ' O ' HD12 ' A' ' 46' ' ' LEU . 14.0 m120 -133.28 60.56 49.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.523 -174.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -77.82 23.45 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.881 1.721 . . . . 0.0 112.272 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -111.35 -22.19 11.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.514 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.585 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -103.17 9.42 38.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.093 0.473 . . . . 0.0 110.911 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.41 46.93 91.5 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.351 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.741 HD22 ' CE3' ' A' ' 25' ' ' TRP . 5.4 mp -76.96 74.39 3.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.596 0.712 . . . . 0.0 110.13 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.683 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.0 pt-20 -97.27 136.45 37.75 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.714 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 25.9 mmmt 51.49 -111.29 0.55 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.814 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -137.6 18.22 2.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.257 0.551 . . . . 0.0 110.317 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.683 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 30.8 m-85 -67.61 130.16 42.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.503 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 89.6 m -54.52 149.54 10.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.298 0.374 . . . . 0.0 111.158 -174.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 39.8 mmt-85 -153.03 170.29 20.81 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.624 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -131.14 77.5 74.63 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.519 170.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.698 ' HG3' HD21 ' A' ' 46' ' ' LEU . 29.7 Cg_endo -68.42 -13.26 37.12 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.285 1.99 . . . . 0.0 112.471 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -96.75 -26.14 15.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.922 0.868 . . . . 0.0 109.507 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.09 39.15 97.66 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.558 -167.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -44.34 132.36 5.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.044 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 t -69.74 -0.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.508 0.671 . . . . 0.0 110.763 -176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.4 -18.64 35.24 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.5 -179.23 16.29 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.698 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.611 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 88.8 Cg_endo -77.14 158.0 33.83 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.224 1.949 . . . . 0.0 111.231 -175.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.486 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 22.1 p-90 -150.08 -170.77 3.73 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.065 -169.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.685 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.2 p -168.81 -178.49 3.39 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.646 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 57.3 m-85 -100.93 147.64 25.91 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 170.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.9 p -103.55 149.2 25.1 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.437 -171.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 p -83.35 28.34 0.54 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.508 0.67 . . . . 0.0 109.963 168.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.906 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.0 t-20 -108.16 121.14 44.64 Favored Pre-proline 0 N--CA 1.456 -0.149 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.238 -175.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.44 -1.03 4.96 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.749 2.299 . . . . 0.0 113.498 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -84.69 -33.11 23.24 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.67 147.69 29.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.108 0.48 . . . . 0.0 110.769 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.613 HD11 ' HB3' ' A' ' 31' ' ' HIS . 37.8 tp -72.4 -45.56 59.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.549 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 21.5 p90 -143.54 162.8 34.92 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.67 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.414 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 14.0 t0 -158.83 172.05 18.94 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 55.6 m-85 -94.62 157.01 16.16 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.6 m -104.76 172.82 6.59 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.289 0.368 . . . . 0.0 110.454 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -122.8 69.0 0.98 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.187 0.518 . . . . 0.0 110.305 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.73 HG22 ' CE1' ' A' ' 9' ' ' TYR . 2.3 p -102.05 132.39 21.62 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.665 176.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 77' ' ' VAL . 11.0 Cg_endo -55.66 150.71 42.71 Favored 'Trans proline' 0 CA--C 1.512 -0.608 0 C-N-CA 124.25 3.3 . . . . 0.0 113.826 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -76.77 109.76 10.82 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.789 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.13 -38.26 57.01 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.694 178.276 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.587 ' HB1' ' CD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.971 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.601 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 120.922 0.391 . . . . 0.0 110.558 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.749 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 12.3 ptt? -96.78 159.33 14.98 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.61 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 85.5 m-85 -114.23 100.63 8.5 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.475 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.36 -115.33 4.0 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.019 -175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -82.41 -19.84 38.27 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 124.411 0.712 . . . . 0.0 110.486 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.623 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.09 17.06 13.4 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.999 -174.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -66.91 -50.97 60.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.493 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -97.88 28.49 14.25 Favored Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 172.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.656 ' CE1' HG23 ' A' ' 77' ' ' VAL . 3.6 t80 -69.51 102.57 1.84 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 173.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -106.45 40.59 1.59 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.337 0.589 . . . . 0.0 109.772 -176.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.649 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -90.41 -154.45 30.05 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.941 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -151.24 23.59 0.73 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.858 0.361 . . . . 0.0 110.556 -172.555 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.934 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 20.2 mmt180 -68.9 135.99 51.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.9 m -136.96 36.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 122.037 0.923 . . . . 0.0 109.573 -174.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 1.047 HG22 ' HA2' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -151.65 133.41 14.88 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.235 -172.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 56.5 p -73.76 -170.6 0.9 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.091 -176.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 m -63.94 -21.66 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.302 0.573 . . . . 0.0 110.712 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.3 p -92.89 -10.79 35.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.115 0.96 . . . . 0.0 109.08 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 1.047 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 82.98 11.92 80.53 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.23 -173.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 67' ' ' ASN . 80.8 m -71.28 121.2 83.59 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 82.6 Cg_exo -51.03 134.76 43.53 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 C-N-CA 122.713 2.276 . . . . 0.0 113.353 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 86.1 m -75.53 141.76 42.93 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.541 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -72.94 165.95 23.97 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.231 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.52 126.2 30.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.705 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 48.7 m95 -54.65 -29.4 52.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 175.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.63 -22.4 54.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.972 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.67 150.45 21.16 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -172.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.585 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.5 mm-40 -104.76 31.45 4.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 26.7 mt-10 -147.2 123.31 5.49 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 113.705 -1.589 . . . . 0.0 114.163 -156.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 86.1 Cg_endo -86.44 27.03 11.9 Favored 'Cis proline' 0 C--N 1.346 0.438 0 C-N-CA 123.445 -1.481 . . . . 0.0 112.97 0.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.508 ' HB3' HD11 ' A' ' 71' ' ' LEU . 56.8 m80 -129.0 108.43 10.4 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.585 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.7 tmm_? -79.23 122.46 26.34 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -173.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.454 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.3 p80 -150.24 97.16 2.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.92 0.867 . . . . 0.0 110.821 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.27 35.46 0.22 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.56 0.695 . . . . 0.0 110.107 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.454 ' H ' ' C ' ' A' ' 33' ' ' HIS . 23.0 pt -143.11 142.5 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -175.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.597 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 42.9 m-85 50.56 51.02 17.72 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 122.124 0.964 . . . . 0.0 111.591 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 26.5 p -99.58 175.94 2.18 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.025 169.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 25.5 Cg_exo -64.59 -21.21 65.79 Favored 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 121.91 1.74 . . . . 0.0 111.877 172.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -100.33 -23.63 14.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.395 -171.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 35.4 p -90.32 -19.18 24.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.262 0.553 . . . . 0.0 109.646 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.597 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.2 m120 -136.16 62.76 46.9 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.888 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.66 9.08 1.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.168 1.912 . . . . 0.0 111.955 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 41' ' ' ASN . 10.1 ptt180 -111.18 -12.33 14.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.476 -177.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.695 ' HB2' HD12 ' A' ' 46' ' ' LEU . . . -104.49 8.2 35.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.135 0.493 . . . . 0.0 110.149 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.35 44.67 97.76 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 114.825 -1.079 . . . . 0.0 113.419 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.703 HD22 ' HG3' ' A' ' 54' ' ' PRO . 5.3 mp -80.17 96.47 6.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.224 0.535 . . . . 0.0 110.834 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.638 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.3 pt-20 -111.59 135.12 52.61 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.658 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 48' ' ' LYS . 23.9 mmtp 56.06 -118.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.663 0.602 . . . . 0.0 111.998 175.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -130.82 14.01 5.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.922 0.392 . . . . 0.0 110.804 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.638 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 20.7 m-85 -66.06 133.13 50.11 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.595 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 73.8 m -54.93 149.78 11.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.848 0.356 . . . . 0.0 111.833 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' CG ' HH11 ' A' ' 52' ' ' ARG . 0.1 OUTLIER -153.48 162.53 41.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.714 -175.608 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -125.69 80.99 65.83 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.268 171.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.703 ' HG3' HD22 ' A' ' 46' ' ' LEU . 15.1 Cg_exo -64.53 -21.09 66.15 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.676 2.25 . . . . 0.0 112.029 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -89.63 -30.74 17.92 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.979 0.895 . . . . 0.0 109.304 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.66 39.53 95.42 Favored Glycine 0 N--CA 1.433 -1.51 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.054 -166.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 59' ' ' GLY . 11.9 t70 -43.79 131.59 5.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 124.452 0.737 . . . . 0.0 109.587 170.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 t -70.82 3.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.274 0.559 . . . . 0.0 111.07 -174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -99.27 -22.13 13.65 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.06 -175.59 19.1 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.761 -1.209 . . . . 0.0 111.78 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.749 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 97.8 Cg_endo -76.82 159.95 34.43 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.515 2.144 . . . . 0.0 111.708 -174.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.551 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.0 p-90 -148.88 -172.85 4.21 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.879 -172.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.705 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.8 p -168.73 -178.87 3.56 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.305 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -100.84 140.83 34.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.3 p -99.84 148.64 24.22 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.36 -171.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.2 p -76.99 15.0 0.74 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.982 0.42 . . . . 0.0 110.968 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 69' ' ' ARG . 24.0 t30 -100.84 119.69 57.64 Favored Pre-proline 0 C--O 1.233 0.2 0 C-N-CA 123.168 0.587 . . . . 0.0 111.057 -177.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.4 Cg_exo -69.47 6.7 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.307 2.671 . . . . 0.0 113.503 -178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.506 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 21.3 mmm180 -82.26 -49.35 10.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.025 0.441 . . . . 0.0 110.704 173.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.14 134.96 33.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.596 0.713 . . . . 0.0 111.186 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 31' ' ' HIS . 40.3 tp -64.78 -39.92 94.39 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.541 -172.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -143.19 164.82 29.12 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.464 ' HB3' HG21 ' A' ' 16' ' ' THR . 44.5 t0 -162.0 172.28 16.22 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -92.81 156.21 17.14 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 96.2 m -104.66 170.01 8.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.236 0.541 . . . . 0.0 111.325 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.85 67.26 0.66 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.136 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.934 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 5.0 p -111.66 129.51 24.08 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.324 0.583 . . . . 0.0 110.994 174.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.43 161.76 33.46 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 123.941 3.094 . . . . 0.0 113.708 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.79 114.47 14.43 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.088 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.601 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.77 -41.23 60.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.333 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.61 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.688 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.502 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.445 -0.678 0 CA-C-O 120.927 0.394 . . . . 0.0 110.7 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.719 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 9.4 ptt? -97.5 154.59 17.4 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.548 0.69 . . . . 0.0 112.65 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.671 ' HD2' ' HB3' ' A' ' 81' ' ' ALA . 53.9 m-85 -110.29 105.8 14.96 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.29 -114.58 3.91 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.162 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -88.21 -16.07 34.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.98 -0.61 . . . . 0.0 109.832 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.718 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.56 11.22 25.58 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.937 -173.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -63.16 -40.5 97.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.511 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.16 22.33 27.45 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.201 173.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.718 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 4.2 t80 -66.46 109.98 2.95 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 172.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -119.01 39.21 3.6 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.472 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -91.33 -152.57 28.41 Favored Glycine 0 C--O 1.235 0.19 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.538 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.07 23.71 0.94 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.916 0.388 . . . . 0.0 110.899 -170.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.71 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.8 mmt180 -69.78 137.55 51.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.441 ' C ' ' HG1' ' A' ' 15' ' ' THR . 3.8 m -138.26 34.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.64 0.733 . . . . 0.0 111.063 -170.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.592 HG22 ' HA2' ' A' ' 19' ' ' GLY . 2.1 m -151.46 138.29 18.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.3 p -74.88 -174.67 2.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.903 -173.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.06 -17.98 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.417 0.627 . . . . 0.0 110.728 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p -92.75 -14.58 27.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.187 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.592 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.6 15.8 63.06 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.5 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.866 HG22 ' HB2' ' A' ' 67' ' ' ASN . 89.7 m -77.11 122.5 86.39 Favored Pre-proline 0 N--CA 1.448 -0.555 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 168.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -51.72 125.05 15.83 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.309 2.006 . . . . 0.0 112.7 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.404 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 85.4 m -63.29 141.83 58.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.348 0.594 . . . . 0.0 110.652 173.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 25.2 tt0 -74.86 165.34 25.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.476 176.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 4.1 m-20 -76.07 124.57 27.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.655 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 40.7 m95 -54.87 -29.98 56.84 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.07 -17.8 58.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.198 -1.364 . . . . 0.0 113.314 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.26 151.78 22.27 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 119.093 0.86 . . . . 0.0 109.339 -173.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.68 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.0 mm-40 -103.18 32.46 3.74 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 49.1 mt-10 -143.62 118.01 6.11 Favored Pre-proline 0 N--CA 1.429 -1.512 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -156.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 70.4 Cg_endo -89.68 31.07 10.26 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.52 -1.45 . . . . 0.0 113.316 1.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.595 ' HB3' HD13 ' A' ' 71' ' ' LEU . 61.9 m80 -130.77 110.76 11.57 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.68 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.1 OUTLIER -74.53 119.26 18.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.648 -176.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.459 ' HE1' ' HA ' ' A' ' 25' ' ' TRP . 4.2 p80 -151.86 99.23 2.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.17 0.986 . . . . 0.0 110.271 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 t -82.15 32.13 0.39 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.568 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.455 ' H ' ' C ' ' A' ' 33' ' ' HIS . 26.5 pt -141.26 151.8 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -177.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.58 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 39.1 m-85 51.04 47.11 25.46 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.04 0.924 . . . . 0.0 111.038 -173.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 28.0 p -99.42 171.16 5.93 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.027 171.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 39.7 Cg_exo -59.64 -21.33 62.18 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.132 1.888 . . . . 0.0 112.219 171.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -101.9 -19.85 15.1 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.533 -170.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.9 p -96.91 -18.02 19.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.134 0.492 . . . . 0.0 110.182 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.58 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.2 m120 -136.02 64.63 55.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.028 -177.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.89 18.07 0.66 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.633 2.222 . . . . 0.0 112.736 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -109.93 -23.54 11.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.411 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' A' ' 46' ' ' LEU . . . -102.13 7.11 41.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.353 0.597 . . . . 0.0 110.469 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.93 42.88 99.58 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.771 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.61 HD12 ' HB1' ' A' ' 44' ' ' ALA . 5.4 mp -74.95 110.39 9.21 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.52 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.3 pt-20 -128.6 149.22 50.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.801 172.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.986 ' HE2' ' HA ' ' A' ' 48' ' ' LYS . 5.0 mmpt? 49.67 -111.05 0.46 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.001 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -139.85 18.1 2.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.11 0.481 . . . . 0.0 110.236 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.52 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 33.4 m-85 -67.34 126.41 29.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.558 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 71.7 m -51.68 152.73 2.68 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.556 0.535 . . . . 0.0 111.689 -174.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 44.0 mmt-85 -154.37 170.69 20.75 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.348 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -133.3 77.11 67.12 Favored Pre-proline 0 C--N 1.319 -0.721 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.438 171.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HD2' ' CE2' ' A' ' 62' ' ' TRP . 27.9 Cg_exo -61.06 -33.39 91.78 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.769 2.313 . . . . 0.0 112.427 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -90.72 -16.04 29.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.491 0.663 . . . . 0.0 110.366 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.09 48.7 84.81 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.358 -175.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 59' ' ' GLY . 4.4 t0 -48.48 129.01 15.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 t -75.91 31.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 122.085 0.945 . . . . 0.0 110.319 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -125.18 -14.49 3.3 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 175.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.78 -179.51 16.2 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.719 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 95.2 Cg_endo -76.31 161.03 35.37 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.348 2.032 . . . . 0.0 111.713 -174.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.507 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.1 p-90 -145.46 -173.07 4.02 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.223 -173.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.655 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.3 p -167.98 -178.94 3.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.5 ' CD1' ' HB3' ' A' ' 72' ' ' TYR . 48.4 m-85 -100.24 145.29 28.25 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.43 ' HB ' HG22 ' A' ' 20' ' ' THR . 4.4 p -98.86 153.91 18.43 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.611 -171.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.0 p -85.77 26.58 0.95 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.334 0.587 . . . . 0.0 110.143 166.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.866 ' HB2' HG22 ' A' ' 20' ' ' THR . 59.3 t-20 -107.52 118.76 52.59 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.495 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.46 2.39 1.96 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.904 2.402 . . . . 0.0 113.392 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -83.77 -46.38 12.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.328 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.05 151.92 51.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.999 0.428 . . . . 0.0 110.558 -176.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 31' ' ' HIS . 41.7 tp -76.29 -43.18 42.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.386 -177.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.5 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 50.4 p90 -143.93 169.33 18.02 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.777 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -161.68 178.37 9.08 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -96.44 156.3 16.4 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 81.5 m -105.89 168.94 8.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.872 0.368 . . . . 0.0 110.888 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -116.89 70.5 0.77 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.263 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.71 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 4.2 p -110.86 127.06 27.53 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.304 0.574 . . . . 0.0 110.883 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.65 160.5 20.64 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 124.165 3.243 . . . . 0.0 113.761 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -75.56 112.71 12.18 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.216 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.487 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -75.87 -43.37 45.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.364 176.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.671 ' HB3' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.031 -179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.46 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.444 -0.735 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.729 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 8.4 ptt? -97.4 158.19 15.6 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.75 ' HD1' ' HB1' ' A' ' 81' ' ' ALA . 79.0 m-85 -113.94 96.15 5.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.36 -111.83 3.34 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -173.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -79.47 -29.52 41.73 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 124.626 0.839 . . . . 0.0 110.889 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.8 19.77 8.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.982 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.753 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 95.1 mttt -66.4 -38.08 86.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.873 0.368 . . . . 0.0 110.299 175.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.8 19.47 38.48 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 173.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.713 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -64.38 99.41 0.29 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 174.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.3 46.35 0.92 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.027 0.441 . . . . 0.0 110.249 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.667 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -97.06 -158.97 31.27 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.687 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -145.87 20.26 1.45 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.992 0.396 . . . . 0.0 110.802 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.739 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.9 mmt180 -68.17 139.74 56.12 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -138.84 35.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.726 0.774 . . . . 0.0 110.677 -171.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.87 140.3 21.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.356 -176.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 46.6 p -75.43 -174.81 2.56 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.106 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.8 m -72.85 -12.62 15.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.454 0.645 . . . . 0.0 110.115 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.1 p -92.57 -13.54 29.54 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.904 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.95 7.57 70.4 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.342 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.881 HG21 ' HB2' ' A' ' 67' ' ' ASN . 92.9 m -75.68 120.06 79.95 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -47.46 123.48 8.05 Favored 'Trans proline' 0 CA--C 1.514 -0.52 0 C-N-CA 122.809 2.339 . . . . 0.0 112.861 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.402 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 84.6 m -62.27 135.43 57.47 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.474 0.654 . . . . 0.0 110.488 173.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 23.2 tt0 -68.26 164.8 19.82 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.225 174.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.466 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 15.0 m-20 -76.3 125.91 30.04 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.749 ' CE3' HD21 ' A' ' 46' ' ' LEU . 40.2 m95 -53.36 -31.71 45.79 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.12 -19.09 57.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.18 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.466 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.52 150.13 23.38 Favored 'General case' 0 C--O 1.21 -0.997 0 O-C-N 121.32 -0.863 . . . . 0.0 109.014 -173.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.728 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.9 mm-40 -103.24 33.64 3.22 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 29.2 mt-10 -141.62 117.38 7.15 Favored Pre-proline 0 N--CA 1.435 -1.195 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -157.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.515 ' HD2' ' HD1' ' A' ' 31' ' ' HIS . 19.6 Cg_endo -91.8 33.38 8.98 Favored 'Cis proline' 0 C--N 1.347 0.464 0 C-N-CA 123.635 -1.402 . . . . 0.0 112.974 0.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.558 ' HB3' HD11 ' A' ' 71' ' ' LEU . 55.1 m80 -130.37 107.46 9.27 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.728 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -74.22 118.48 17.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.451 0.643 . . . . 0.0 109.889 -178.086 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.461 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.4 p80 -147.65 99.15 3.07 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 122.002 0.906 . . . . 0.0 109.957 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -80.12 32.98 0.28 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.601 175.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.461 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.5 pt -141.91 147.85 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -176.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.519 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 38.3 m-85 53.12 45.55 28.46 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 122.01 0.91 . . . . 0.0 110.96 -174.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 18.1 p -99.11 172.46 4.68 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.586 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 28.6 Cg_exo -60.59 -20.45 64.73 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 121.855 1.703 . . . . 0.0 111.818 172.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -91.37 -35.7 14.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.089 -175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.8 p -85.91 -25.23 26.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.822 0.344 . . . . 0.0 110.447 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.519 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.3 m120 -132.8 65.21 73.77 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.015 0.436 . . . . 0.0 110.814 -178.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.89 13.5 1.22 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.327 2.018 . . . . 0.0 112.13 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -103.56 -21.37 13.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.84 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.633 ' HB2' HD13 ' A' ' 46' ' ' LEU . . . -107.57 -0.83 21.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.54 -175.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.82 46.41 67.66 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.684 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.78 HD23 ' HG3' ' A' ' 54' ' ' PRO . 5.4 mp -76.52 67.2 2.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.776 0.322 . . . . 0.0 110.872 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 6.1 pt-20 -94.42 151.28 19.5 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.713 0.292 . . . . 0.0 110.762 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.8 mptp? 48.24 -110.32 0.35 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.442 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -140.18 17.84 2.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.965 0.412 . . . . 0.0 110.613 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.473 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 27.8 m-85 -66.75 126.57 29.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.649 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.497 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 93.6 m -53.79 150.73 7.1 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 123.468 0.48 . . . . 0.0 111.96 -173.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 41.9 mmt-85 -153.74 165.99 34.25 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.924 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -131.33 76.38 75.93 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.002 172.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.78 ' HG3' HD23 ' A' ' 46' ' ' LEU . 34.9 Cg_exo -55.8 -35.7 94.04 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.844 2.362 . . . . 0.0 112.318 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.89 -12.36 25.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.91 -175.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.753 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 59.17 52.15 55.03 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.526 -174.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 59' ' ' GLY . 6.1 t70 -51.26 133.65 28.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 174.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.02 9.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.616 0.722 . . . . 0.0 110.568 -175.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -107.04 -15.98 14.85 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.73 -177.48 17.04 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.295 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.729 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 73.5 Cg_endo -73.8 158.4 46.74 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.37 2.046 . . . . 0.0 110.984 -175.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.547 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 31.5 p-90 -144.13 -176.31 4.96 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.441 -172.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.562 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.4 p -167.92 179.64 4.6 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.472 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CD1' ' HB3' ' A' ' 72' ' ' TYR . 49.5 m-85 -99.18 146.43 26.17 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.463 ' HB ' HG21 ' A' ' 20' ' ' THR . 3.9 p -99.0 150.78 21.62 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.474 -170.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.9 p -85.03 23.14 1.27 Allowed 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.008 166.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.881 ' HB2' HG21 ' A' ' 20' ' ' THR . 56.9 t-20 -99.65 117.79 63.09 Favored Pre-proline 0 N--CA 1.456 -0.135 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.098 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.27 4.96 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.87 2.38 . . . . 0.0 113.632 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -88.37 -38.84 14.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.755 0.312 . . . . 0.0 111.21 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 159.9 41.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.136 0.493 . . . . 0.0 111.38 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 31' ' ' HIS . 49.9 tp -81.37 -49.61 10.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.968 -175.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.548 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 17.8 p90 -143.6 163.65 32.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.958 0.408 . . . . 0.0 110.701 -178.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -154.56 -175.7 5.54 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.103 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -93.79 158.79 15.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 86.9 m -105.94 169.94 8.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.278 0.561 . . . . 0.0 111.474 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -115.27 72.31 0.79 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.096 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.739 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.5 p -113.46 128.54 25.57 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.373 0.606 . . . . 0.0 110.697 174.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.16 155.49 34.21 Favored 'Trans proline' 0 CA--C 1.513 -0.531 0 C-N-CA 123.941 3.094 . . . . 0.0 113.871 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.27 111.3 11.56 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.32 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.453 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.26 -39.38 54.54 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.08 179.218 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.75 ' HB1' ' HD1' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--O 1.233 0.187 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.585 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.589 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.441 -0.909 0 CA-C-O 120.949 0.404 . . . . 0.0 109.916 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.529 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.0 ptt? -95.6 151.2 19.54 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.557 ' HD2' ' HB3' ' A' ' 81' ' ' ALA . 79.5 m-85 -109.26 96.27 6.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.88 -115.97 4.12 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -174.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -79.59 -21.92 44.38 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 124.684 0.873 . . . . 0.0 110.291 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.71 15.68 16.22 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.166 -176.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -63.81 -34.56 78.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.065 0.46 . . . . 0.0 110.146 176.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -109.98 20.01 27.0 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 174.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.737 ' CE1' HG22 ' A' ' 77' ' ' VAL . 4.9 t80 -68.22 101.07 1.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.053 0.454 . . . . 0.0 110.185 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.407 ' HE ' ' C ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -107.63 49.3 0.81 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.611 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.75 -151.76 28.24 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.858 -176.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.52 ' HE2' ' HB3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -150.73 22.78 0.79 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.928 0.394 . . . . 0.0 111.017 -174.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.859 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.8 mmt180 -68.35 137.58 54.72 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 170.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.426 ' C ' ' HG1' ' A' ' 15' ' ' THR . 5.4 m -140.06 30.86 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 121.804 0.811 . . . . 0.0 110.796 -171.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.726 HG21 ' HA2' ' A' ' 19' ' ' GLY . 7.3 m -151.45 134.81 16.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -174.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.401 HG22 HG22 ' A' ' 65' ' ' THR . 75.9 p -73.0 -176.92 2.23 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.122 0.487 . . . . 0.0 112.242 -170.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -67.23 -15.65 19.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.367 0.603 . . . . 0.0 110.806 177.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.0 p -93.09 -15.36 26.16 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.839 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.726 ' HA2' HG21 ' A' ' 15' ' ' THR . . . 85.35 15.53 66.31 Favored Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.352 -174.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.952 HG22 ' HB2' ' A' ' 67' ' ' ASN . 85.1 m -78.32 121.88 84.4 Favored Pre-proline 0 N--CA 1.446 -0.67 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 169.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -48.51 131.59 23.73 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.713 2.275 . . . . 0.0 113.216 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.9 m -71.0 137.13 48.8 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.586 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -71.1 166.09 22.16 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.153 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.558 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 10.0 m-20 -75.98 127.73 33.57 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.7 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 43.3 m95 -54.35 -31.47 54.54 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.04 -16.69 57.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.915 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.558 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -98.02 148.04 23.9 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 118.625 0.648 . . . . 0.0 109.616 -173.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 32' ' ' ARG . 31.4 mm-40 -106.58 14.86 26.52 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -176.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.478 ' HA ' ' N ' ' A' ' 31' ' ' HIS . 44.6 mt-10 -147.77 145.55 21.57 Favored Pre-proline 0 N--CA 1.431 -1.382 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.273 -174.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.93 20.46 5.76 Favored 'Cis proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.458 -1.476 . . . . 0.0 113.334 1.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.478 ' N ' ' HA ' ' A' ' 29' ' ' GLU . 62.9 m80 -131.61 107.65 8.98 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 32' ' ' ARG . 3.4 mpt_? -74.93 115.34 14.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.5 p80 -147.23 98.09 2.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.088 0.946 . . . . 0.0 111.621 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.07 33.1 0.18 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.531 173.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.427 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.9 pt -142.02 147.05 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.579 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 52.0 m-85 49.93 47.68 22.89 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.09 0.947 . . . . 0.0 111.276 -173.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 30.9 p -100.05 174.57 2.92 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.869 170.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 20.9 Cg_exo -66.15 -16.26 51.43 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.868 1.712 . . . . 0.0 111.348 170.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -91.07 -34.33 15.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.371 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.9 p -93.94 -20.4 20.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.551 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.579 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.3 m120 -133.35 65.05 71.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.202 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.9 25.75 0.5 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.487 2.125 . . . . 0.0 111.746 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' H ' ' C ' ' A' ' 41' ' ' ASN . 5.2 ptm180 -115.44 -13.35 11.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.555 -176.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.565 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . -116.1 4.38 13.66 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.53 -175.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.48 41.71 96.17 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.856 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.605 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.5 mp -70.85 99.64 1.78 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.821 0.343 . . . . 0.0 110.287 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.562 ' HB3' ' HD2' ' A' ' 50' ' ' TYR . 28.4 tt0 -109.84 148.95 30.59 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.941 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.49 ' HG2' ' HG2' ' A' ' 47' ' ' GLU . 46.2 mmtm 46.84 -109.62 0.25 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.543 1.152 . . . . 0.0 111.271 173.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -135.63 17.63 3.33 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.874 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.562 ' HD2' ' HB3' ' A' ' 47' ' ' GLU . 34.6 m-85 -66.12 128.68 37.06 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.097 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.589 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 70.8 m -53.62 148.99 8.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.243 0.544 . . . . 0.0 112.284 -174.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' HD2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -154.7 157.47 38.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.89 -174.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.4 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 19.1 t-20 -122.45 81.55 46.55 Favored Pre-proline 0 N--CA 1.446 -0.646 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.243 171.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.569 ' HD2' ' CZ2' ' A' ' 62' ' ' TRP . 19.4 Cg_exo -63.25 -24.67 72.15 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.399 2.066 . . . . 0.0 112.397 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.75 -27.47 21.15 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.025 0.916 . . . . 0.0 109.575 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.29 39.6 98.03 Favored Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.925 -166.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 59' ' ' GLY . 9.4 t70 -43.93 133.26 5.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.909 -0.646 . . . . 0.0 110.042 170.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 t -70.87 5.94 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.62 0.724 . . . . 0.0 110.878 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -99.83 -18.14 23.62 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.42 179.64 16.1 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.269 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.529 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 60.5 Cg_endo -71.59 157.61 55.56 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.272 1.981 . . . . 0.0 111.49 -176.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.569 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 25.1 p-90 -146.68 -170.89 3.63 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.819 -170.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.7 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.6 p -168.36 -178.59 3.63 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.789 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.458 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 53.1 m-85 -100.53 144.43 29.53 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 171.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 3.6 p -101.82 150.7 22.9 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.38 -171.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.7 p -84.41 35.0 0.53 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.358 0.599 . . . . 0.0 109.791 167.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.952 ' HB2' HG22 ' A' ' 20' ' ' THR . 57.8 t-20 -115.63 123.77 30.88 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.269 -176.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.2 Cg_exo -69.13 -1.3 7.71 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.787 2.325 . . . . 0.0 113.682 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -84.02 -38.01 21.43 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.778 0.323 . . . . 0.0 111.777 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -143.9 143.14 31.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.134 0.492 . . . . 0.0 110.116 -176.58 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.458 ' O ' ' HD1' ' A' ' 64' ' ' TYR . 52.5 tp -71.05 -38.03 72.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.645 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -143.55 160.9 39.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -156.17 176.03 13.21 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -94.68 156.59 16.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 77.5 m -106.2 166.13 10.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.964 0.411 . . . . 0.0 111.55 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -101.74 33.0 3.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.023 -172.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.859 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 4.6 p -81.85 127.22 73.13 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-O 121.519 0.675 . . . . 0.0 111.63 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.66 161.61 27.78 Favored 'Trans proline' 0 CA--C 1.515 -0.466 0 C-N-CA 124.378 3.385 . . . . 0.0 113.78 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.33 114.05 13.42 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.605 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.589 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.07 -40.23 53.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.632 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.557 ' HB3' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.655 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -77.52 1.23 20.03 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 77.33 23.07 0.91 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.329 171.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.457 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 17.6 t0 -92.44 62.36 3.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.499 171.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.475 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -153.46 151.74 30.2 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.846 -176.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.624 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 9.8 ptt? -96.64 156.64 16.26 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.602 ' HD2' ' HB3' ' A' ' 81' ' ' ALA . 81.4 m-85 -113.35 97.82 6.72 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.85 -114.26 3.86 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.416 ' OD1' ' HA ' ' A' ' 58' ' ' VAL . 91.8 m-20 -79.35 -24.68 42.54 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.573 0.808 . . . . 0.0 110.58 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.562 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.46 17.65 11.12 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.733 -1.222 . . . . 0.0 111.632 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -65.46 -43.95 88.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.174 0.511 . . . . 0.0 109.822 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -103.68 25.09 27.79 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.739 ' CE1' HG22 ' A' ' 77' ' ' VAL . 3.2 t80 -67.3 103.38 1.25 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 171.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -108.27 45.18 1.04 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.205 0.526 . . . . 0.0 109.677 -176.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.647 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -95.56 -155.37 31.16 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.93 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 7.1 ptmt -148.87 20.06 1.0 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.802 0.334 . . . . 0.0 111.012 -170.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.831 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.1 mmt180 -66.86 139.07 57.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 171.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.64 38.4 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.676 0.75 . . . . 0.0 110.742 -171.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.464 ' HB ' ' HA2' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -151.4 147.94 27.5 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.345 -175.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.0 p -74.32 -172.85 1.54 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.529 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 m -65.22 -16.75 20.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.393 0.616 . . . . 0.0 111.371 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -94.19 -13.75 26.33 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.037 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.464 ' HA2' ' HB ' ' A' ' 15' ' ' THR . . . 87.02 14.84 63.85 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.598 -170.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.952 HG22 ' HB2' ' A' ' 67' ' ' ASN . 86.4 m -75.78 119.52 77.5 Favored Pre-proline 0 N--CA 1.448 -0.564 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 171.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -48.12 129.22 18.23 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.999 2.466 . . . . 0.0 113.564 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.7 m -70.04 134.77 48.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.073 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 24.0 tt0 -67.95 166.36 15.89 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.663 174.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.512 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 3.2 m-20 -76.07 125.99 30.17 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.682 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 39.1 m95 -54.76 -31.07 58.12 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 173.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.2 -21.0 56.97 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.938 -1.483 . . . . 0.0 113.267 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.512 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -103.08 150.64 23.41 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 119.168 0.895 . . . . 0.0 109.061 -172.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.732 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 27.7 mm-40 -103.2 35.31 2.59 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 37.3 mt-10 -145.29 119.64 5.59 Favored Pre-proline 0 N--CA 1.432 -1.327 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -156.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 93.8 Cg_endo -89.43 32.1 9.0 Favored 'Cis proline' 0 C--N 1.346 0.42 0 C-N-CA 123.424 -1.49 . . . . 0.0 112.979 0.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.527 ' HB3' HD12 ' A' ' 71' ' ' LEU . 53.4 m80 -130.91 108.01 9.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.732 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.0 123.07 22.77 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.4 p80 -151.71 94.57 2.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.108 0.956 . . . . 0.0 110.142 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.9 m -75.23 29.63 0.1 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.398 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.526 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.4 pt -141.6 151.0 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.516 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 39.9 m-85 51.74 47.13 25.38 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 122.032 0.92 . . . . 0.0 111.274 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.7 p -99.28 170.88 6.27 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 114.266 -1.334 . . . . 0.0 108.124 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.14 -17.26 59.3 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.704 1.602 . . . . 0.0 111.804 172.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.84 -20.48 14.28 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.37 -171.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.414 ' C ' ' HD3' ' A' ' 42' ' ' PRO . 42.6 p -98.47 -15.48 19.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.196 0.522 . . . . 0.0 110.241 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.57 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 12.8 m120 -135.8 55.12 11.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.064 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 10.1 Cg_exo -71.16 36.61 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.071 2.514 . . . . 0.0 112.842 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -134.77 -9.95 2.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.319 178.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.665 ' HB2' HD11 ' A' ' 46' ' ' LEU . . . -110.58 12.6 22.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.412 . . . . 0.0 111.266 -176.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.15 44.01 97.79 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-N 115.27 -0.877 . . . . 0.0 113.37 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.665 HD11 ' HB2' ' A' ' 44' ' ' ALA . 5.1 mp -80.46 111.78 17.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.056 0.455 . . . . 0.0 110.52 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.643 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 2.0 pt-20 -124.47 134.59 53.0 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.662 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 48' ' ' LYS . 61.0 mmtt 50.75 -107.57 0.3 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -137.11 13.97 3.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.059 0.456 . . . . 0.0 110.19 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.643 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 22.2 m-85 -67.36 131.03 44.91 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.507 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 79.1 m -54.04 149.74 8.92 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.247 0.342 . . . . 0.0 111.571 -173.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.494 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 33.6 mmt-85 -153.94 165.94 34.53 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.438 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -127.88 79.46 73.65 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.238 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.665 ' HG3' HD22 ' A' ' 46' ' ' LEU . 37.6 Cg_exo -58.96 -35.83 97.9 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.556 2.17 . . . . 0.0 112.281 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -91.54 -17.28 25.89 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.252 0.549 . . . . 0.0 110.644 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.65 47.77 86.65 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.313 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 59' ' ' GLY . 9.3 t70 -50.12 131.97 23.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.416 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 3.3 t -74.38 8.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.565 0.698 . . . . 0.0 110.556 -175.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -100.58 -18.95 19.46 Favored Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 177.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.22 179.58 16.15 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.772 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.624 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 90.6 Cg_endo -73.86 156.78 48.07 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.502 2.134 . . . . 0.0 111.277 -175.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.558 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.5 p-90 -144.89 -172.76 3.9 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.292 -171.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.682 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.8 p -168.65 -179.03 3.65 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.034 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.465 ' CD1' ' HG ' ' A' ' 71' ' ' LEU . 39.7 m-85 -100.75 144.77 29.32 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 171.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.5 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.6 p -102.95 146.23 28.65 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.442 -170.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 p -81.87 27.73 0.45 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.482 0.658 . . . . 0.0 109.779 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.952 ' HB2' HG22 ' A' ' 20' ' ' THR . 58.4 t-20 -102.1 120.58 53.28 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.785 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.75 0.04 3.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.246 2.631 . . . . 0.0 113.557 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -84.17 -53.41 5.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.78 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.59 149.78 52.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.36 0.6 . . . . 0.0 111.056 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 31' ' ' HIS . 36.2 tp -69.92 -45.77 66.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.117 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 11.3 p90 -142.66 162.34 35.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -156.88 -177.96 7.01 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -97.97 155.74 16.95 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 93.5 m -103.75 173.74 6.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.098 0.475 . . . . 0.0 111.029 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -119.69 71.47 0.88 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.536 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.831 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.7 p -108.54 130.03 23.26 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.654 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.83 153.91 47.32 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 123.824 3.016 . . . . 0.0 113.68 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.59 112.61 12.12 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.326 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.475 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.45 -40.75 57.12 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.436 178.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.602 ' HB3' ' HD2' ' A' ' 3' ' ' PHE . . . -83.65 59.56 5.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.186 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.073 179.568 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 120.873 0.368 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -85.63 -8.12 58.42 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 70.02 25.85 4.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.731 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.61 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 33.4 t70 -79.5 57.89 2.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.466 1.126 . . . . 0.0 109.833 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.529 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -160.09 156.95 27.69 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.403 177.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.753 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.4 ptt? -96.63 149.57 21.64 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.656 ' HD2' ' HB3' ' A' ' 81' ' ' ALA . 80.8 m-85 -107.07 102.34 11.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.43 -111.65 3.31 Favored Glycine 0 N--CA 1.425 -2.068 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.498 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.562 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 81.4 m-20 -78.87 -27.46 44.02 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.551 0.795 . . . . 0.0 110.555 -176.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.631 ' HA2' ' HB2' ' A' ' 2' ' ' MET . . . 111.61 17.33 8.69 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.562 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 43.1 mtmt -65.46 -47.93 74.42 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.41 -0.895 . . . . 0.0 109.711 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.21 23.32 36.8 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.473 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.661 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.0 t80 -65.42 98.49 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.072 0.463 . . . . 0.0 109.962 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.96 44.47 1.01 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.61 ' CA ' ' HA ' ' A' ' -1' ' ' ASP . . . -95.55 -155.27 31.12 Favored Glycine 0 N--CA 1.454 -0.104 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.741 -175.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -144.35 15.6 1.66 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.873 0.337 . . . . 0.0 110.696 -174.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.683 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 12.8 mmt180 -66.08 133.26 50.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.63 37.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.532 0.682 . . . . 0.0 111.174 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.24 147.7 27.99 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.168 -177.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.514 ' HB ' ' OD2' ' A' ' 73' ' ' ASP . 66.4 p -75.53 -174.17 2.39 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.028 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 m -65.63 -17.53 22.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.58 0.705 . . . . 0.0 110.878 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 50.6 p -93.57 -14.69 26.24 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.903 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.28 11.95 63.9 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.517 -172.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.696 HG22 ' HB2' ' A' ' 67' ' ' ASN . 98.4 m -75.95 119.43 77.18 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 173.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -49.68 127.85 19.71 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.868 2.379 . . . . 0.0 113.244 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.5 m -68.48 138.59 55.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.875 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -69.06 165.65 19.79 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.528 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -77.21 129.08 35.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.674 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 59.5 m95 -58.73 -31.53 68.38 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.33 -15.08 59.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.492 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.21 148.49 26.26 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -175.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.752 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.6 mm-40 -102.28 33.71 3.01 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 41.7 mt-10 -145.22 120.72 5.83 Favored Pre-proline 0 N--CA 1.429 -1.495 0 CA-C-N 114.61 -1.177 . . . . 0.0 114.046 -157.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 97.1 Cg_endo -90.41 37.05 5.16 Favored 'Cis proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.258 -1.559 . . . . 0.0 113.641 0.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.412 ' HB3' HD11 ' A' ' 71' ' ' LEU . 53.3 m80 -133.56 112.56 11.59 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.752 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 23.1 mmm180 -73.35 114.48 11.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -176.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.507 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.8 p80 -146.98 91.11 1.97 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.345 1.069 . . . . 0.0 110.395 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.8 t -77.29 35.46 0.17 Allowed 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.263 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.507 ' H ' ' C ' ' A' ' 33' ' ' HIS . 19.4 pt -143.95 141.42 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.604 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 42.1 m-85 55.85 47.09 20.93 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.062 0.934 . . . . 0.0 111.04 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 18.8 p -99.58 175.23 2.53 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.649 168.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 36.5 Cg_exo -60.91 -22.22 73.5 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 121.713 1.609 . . . . 0.0 112.001 172.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.71 -28.73 13.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.464 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.9 p -88.04 -17.03 32.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.068 0.461 . . . . 0.0 110.241 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.604 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.0 m120 -137.77 55.0 8.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.531 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 8.7 Cg_exo -71.04 35.39 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.807 2.338 . . . . 0.0 112.971 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -131.33 -11.03 3.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.035 177.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.628 ' HB1' HD12 ' A' ' 46' ' ' LEU . . . -110.56 13.27 22.65 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.997 0.427 . . . . 0.0 110.859 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.39 43.98 95.47 Favored Glycine 0 C--O 1.224 -0.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.861 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.628 HD12 ' HB1' ' A' ' 44' ' ' ALA . 5.1 mp -80.16 100.75 8.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.0 0.4 . . . . 0.0 111.161 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.5 pt-20 -121.72 149.88 42.61 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.762 172.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.414 ' O ' ' HD1' ' A' ' 25' ' ' TRP . 42.0 mmtm 50.65 -124.96 2.24 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.22 0.95 . . . . 0.0 111.022 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -128.49 19.39 6.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.039 0.447 . . . . 0.0 110.486 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.456 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 24.1 m-85 -66.87 127.1 31.21 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 175.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.564 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 78.8 m -52.61 150.75 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 111.543 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 51' ' ' CYS . 1.2 mmt85 -154.76 159.59 40.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -175.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -123.28 78.01 53.05 Favored Pre-proline 0 C--N 1.317 -0.819 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.045 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.612 ' HG3' HD23 ' A' ' 46' ' ' LEU . 18.0 Cg_endo -70.37 -11.47 30.1 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.472 2.115 . . . . 0.0 112.971 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -99.07 -22.79 15.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.427 0.632 . . . . 0.0 109.816 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.89 51.02 60.04 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.878 -170.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -53.42 128.58 29.14 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 171.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.3 7.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.427 0.632 . . . . 0.0 110.361 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.86 -15.1 27.46 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 111.221 -0.751 . . . . 0.0 111.221 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.33 178.73 15.58 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 119.705 -1.236 . . . . 0.0 111.87 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.753 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 91.9 Cg_endo -77.45 163.58 29.6 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.686 2.257 . . . . 0.0 111.867 -175.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.522 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.4 p-90 -148.5 -171.28 3.81 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.053 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.674 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.8 p -168.47 -178.25 3.46 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.029 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -100.75 144.59 29.54 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.41 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.1 p -99.91 143.99 29.49 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.239 -172.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 p -78.55 14.24 1.34 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.542 170.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.696 ' HB2' HG22 ' A' ' 20' ' ' THR . 59.8 t-20 -86.86 119.97 71.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -65.02 0.21 2.77 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.728 2.285 . . . . 0.0 113.102 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -85.33 -55.26 4.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.174 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 12.3 ptmt -120.32 160.16 23.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.315 0.579 . . . . 0.0 111.025 -174.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 31' ' ' HIS . 55.0 tp -87.62 -46.76 9.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.452 -176.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -143.79 164.23 31.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.989 0.423 . . . . 0.0 110.461 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.514 ' OD2' ' HB ' ' A' ' 16' ' ' THR . 32.2 t0 -160.47 173.56 15.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.673 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 69.5 m-85 -92.85 156.23 17.11 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.9 m -105.11 170.31 7.94 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.044 0.449 . . . . 0.0 111.154 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -114.57 73.82 0.84 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.338 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.683 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.1 p -114.2 128.04 26.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.491 0.662 . . . . 0.0 111.037 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 17.3 Cg_endo -57.47 158.75 18.26 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 124.489 3.459 . . . . 0.0 114.226 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.0 111.41 10.18 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.451 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.501 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.36 -41.41 56.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.241 178.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.656 ' HB3' ' HD2' ' A' ' 3' ' ' PHE . . . -85.1 49.6 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.948 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.385 177.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 62.3 p . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . 0.534 HD22 ' HD3' ' A' ' 12' ' ' LYS . 51.1 t30 -76.47 -12.16 60.0 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 170.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 67.53 15.35 9.79 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.654 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.623 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 33.0 t0 -90.45 51.41 2.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 122.75 1.262 . . . . 0.0 108.766 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.575 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -153.09 154.02 34.02 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.366 -1.743 . . . . 0.0 108.929 -179.187 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.418 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.8 ptt? -94.86 155.41 16.8 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.553 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 91.2 m-85 -113.53 95.43 5.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.81 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.44 -106.53 2.07 Favored Glycine 0 N--CA 1.426 -1.991 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -172.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.41 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 8.0 m-20 -77.7 -35.89 51.63 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.856 0.974 . . . . 0.0 110.517 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . 112.06 17.89 8.1 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.104 -1.046 . . . . 0.0 110.945 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 46.7 mtmt -70.9 -35.02 72.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.062 -0.569 . . . . 0.0 109.656 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -104.25 19.91 41.69 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.702 171.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.707 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -67.06 109.99 3.23 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 171.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -114.98 48.06 1.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.082 0.467 . . . . 0.0 110.026 -176.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.623 ' CA ' ' HA ' ' A' ' -1' ' ' ASP . . . -99.64 -156.97 28.6 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.815 -0.629 . . . . 0.0 113.565 -172.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.534 ' HD3' HD22 ' A' ' -3' ' ' ASN . 11.4 ptmm? -141.73 13.89 2.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.453 0.168 . . . . 0.0 111.198 -169.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.676 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 32.8 mmt180 -66.05 137.48 57.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.43 36.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.286 0.565 . . . . 0.0 111.997 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.27 146.44 26.79 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.451 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 58.7 p -74.52 -174.06 1.95 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.681 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -66.49 -17.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.414 0.626 . . . . 0.0 110.752 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.4 p -92.77 -14.62 27.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.444 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.74 11.1 64.23 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.302 -173.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.957 HG23 ' HB2' ' A' ' 67' ' ' ASN . 84.6 m -75.85 119.43 77.13 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -45.85 124.13 6.79 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 123.119 2.546 . . . . 0.0 113.532 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 63' ' ' CYS . 80.8 m -65.94 136.12 55.66 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.151 173.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -68.29 164.92 19.62 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.715 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -77.68 127.11 31.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.759 ' CE3' HD22 ' A' ' 46' ' ' LEU . 71.6 m95 -57.24 -31.0 65.09 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.613 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.66 -18.13 54.9 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.615 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.68 151.24 20.32 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.666 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.8 mm-40 -104.41 33.44 3.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 48.3 mt-10 -144.94 120.53 5.92 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -156.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 83.8 Cg_endo -87.91 27.96 12.76 Favored 'Cis proline' 0 C--N 1.344 0.339 0 C-N-CA 123.206 -1.581 . . . . 0.0 112.807 0.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.406 ' HB3' HD13 ' A' ' 71' ' ' LEU . 39.7 m80 -127.87 109.23 11.4 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.666 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.55 118.31 16.36 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.348 -177.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.439 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.0 p80 -149.19 100.12 3.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.255 1.026 . . . . 0.0 110.269 -177.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 m -81.74 30.49 0.37 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.056 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.439 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.7 pt -141.4 147.57 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.624 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 37.0 m-85 52.68 47.65 24.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.886 0.85 . . . . 0.0 111.093 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.4 p -100.19 175.42 2.4 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.314 170.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.448 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 19.0 Cg_exo -65.45 -17.6 57.95 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.371 1.381 . . . . 0.0 111.138 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -87.98 -38.37 15.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.178 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 p -90.32 -22.82 21.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.313 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.624 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.3 m120 -132.7 67.87 78.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.079 0.466 . . . . 0.0 111.021 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.96 5.98 2.32 Favored 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.344 2.029 . . . . 0.0 112.698 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -97.4 -26.99 14.67 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.401 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -99.49 4.85 46.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.406 0.622 . . . . 0.0 111.126 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.92 46.33 94.77 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.176 174.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.759 HD22 ' CE3' ' A' ' 25' ' ' TRP . 5.6 mp -71.18 86.94 0.78 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.385 0.612 . . . . 0.0 109.939 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.947 ' HG2' ' HD3' ' A' ' 48' ' ' LYS . 20.1 tt0 -102.45 145.84 28.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.858 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.947 ' HD3' ' HG2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER 44.12 -106.46 0.1 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.384 1.053 . . . . 0.0 110.949 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -138.68 22.11 2.69 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.984 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.584 ' HD2' ' HB3' ' A' ' 47' ' ' GLU . 28.6 m-85 -69.39 128.35 36.23 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.38 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 77.6 m -51.54 148.22 5.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.446 0.466 . . . . 0.0 111.417 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 36.7 mmt-85 -154.09 164.24 38.8 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.481 -176.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -126.23 77.04 72.35 Favored Pre-proline 0 C--N 1.321 -0.664 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.132 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.541 ' HG3' HD21 ' A' ' 46' ' ' LEU . 27.7 Cg_endo -70.63 -16.9 33.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.207 1.938 . . . . 0.0 112.746 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -90.18 -27.65 19.43 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.671 0.748 . . . . 0.0 109.503 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.75 46.63 91.44 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.621 -169.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.505 ' C ' ' H ' ' A' ' 59' ' ' GLY . 6.8 t70 -54.4 135.79 44.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.4 16.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.918 0.866 . . . . 0.0 109.978 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -104.49 -20.96 9.63 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 175.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.83 176.0 14.6 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.177 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.418 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 57.1 Cg_endo -70.13 159.92 51.43 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.319 2.013 . . . . 0.0 111.613 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.535 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.9 p-90 -149.61 -168.14 3.02 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.954 -169.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.728 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.7 p -168.2 -178.99 3.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.586 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.419 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 39.2 m-85 -100.17 146.48 26.8 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 172.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.44 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.3 p -103.54 144.4 31.47 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.009 -1.076 . . . . 0.0 109.662 -171.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.2 p -79.81 17.37 0.95 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.213 169.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.957 ' HB2' HG23 ' A' ' 20' ' ' THR . 56.4 t-20 -94.48 124.94 53.75 Favored Pre-proline 0 C--O 1.229 -0.026 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.343 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.1 4.62 1.81 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.688 2.259 . . . . 0.0 113.309 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -85.01 -58.26 2.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -122.14 161.05 23.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.732 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.419 ' O ' ' HD1' ' A' ' 64' ' ' TYR . 57.4 tp -86.21 -45.33 11.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.604 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 4.2 p90 -143.34 159.4 42.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.703 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.451 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 47.4 t0 -154.5 172.43 17.8 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.8 155.5 17.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 71.2 m -105.41 171.76 7.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.947 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -115.7 60.99 0.7 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.378 0.609 . . . . 0.0 110.337 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.707 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.4 p -97.87 129.43 31.22 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.427 0.632 . . . . 0.0 110.398 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.496 ' HD2' HG22 ' A' ' 77' ' ' VAL . 36.2 Cg_endo -63.01 160.2 35.01 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 123.986 3.124 . . . . 0.0 113.49 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.34 111.9 11.08 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.028 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.501 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.09 -41.99 57.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.846 178.131 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . -83.24 55.12 3.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.445 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.3 178.787 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -90.71 13.18 16.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 70.61 21.59 5.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.329 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.452 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 26.9 t70 -78.68 63.42 3.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.398 1.094 . . . . 0.0 109.183 171.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.583 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -157.94 152.77 25.19 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.2 -1.363 . . . . 0.0 109.011 178.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.428 ' SD ' ' NE2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -98.07 146.74 25.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.619 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 67.9 m-85 -104.27 103.58 13.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.3 -107.78 2.3 Favored Glycine 0 N--CA 1.422 -2.239 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.336 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.49 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 86.3 m-20 -80.73 -32.46 35.72 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 124.819 0.952 . . . . 0.0 110.415 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 110.59 20.22 7.45 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.079 -1.057 . . . . 0.0 110.97 -174.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.49 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 47.4 mtmt -66.02 -45.14 82.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.89 -0.655 . . . . 0.0 109.812 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.14 27.25 20.16 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.645 ' CE1' ' HA3' ' A' ' 11' ' ' GLY . 2.9 t80 -65.19 101.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HE ' ' C ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -102.24 51.26 0.82 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.013 0.435 . . . . 0.0 110.69 -177.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.645 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -108.42 -163.86 20.89 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.71 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -142.21 16.79 2.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.721 0.26 . . . . 0.0 110.926 -170.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.821 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 19.5 mmt180 -64.42 136.61 57.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.0 m -138.59 40.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.857 0.837 . . . . 0.0 110.422 -172.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.97 HG22 ' HA2' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -150.81 135.08 16.94 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.158 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.543 HG22 ' HB3' ' A' ' 73' ' ' ASP . 54.5 p -74.03 -170.57 0.95 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.026 0.441 . . . . 0.0 112.035 -175.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.2 -18.89 24.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.427 0.632 . . . . 0.0 110.875 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.4 p -93.45 -13.09 28.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.995 0.902 . . . . 0.0 109.063 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.97 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 81.02 20.56 64.86 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.904 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.956 HG21 ' HB2' ' A' ' 67' ' ' ASN . 60.0 m -75.69 123.27 88.32 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 169.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 78.1 Cg_exo -50.28 135.4 38.74 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.497 2.131 . . . . 0.0 113.128 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.0 m -75.49 141.41 43.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.533 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -71.45 163.32 27.92 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.88 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 6.3 m-20 -76.7 125.16 28.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.729 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 38.6 m95 -53.34 -30.56 40.0 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.49 -14.04 59.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.013 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.89 148.52 27.51 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.655 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 36.1 mm-40 -103.39 29.71 5.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 3.1 mt-10 -146.74 127.06 6.91 Favored Pre-proline 0 N--CA 1.426 -1.644 0 CA-C-N 113.581 -1.645 . . . . 0.0 114.104 -159.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 2.9 Cg_endo -85.61 26.32 11.67 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 123.853 -1.311 . . . . 0.0 112.59 1.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.666 ' HB3' HD11 ' A' ' 71' ' ' LEU . 68.3 m80 -129.17 104.01 7.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.655 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -74.61 118.2 17.3 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -176.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.49 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.7 p80 -144.8 92.73 2.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.75 0.786 . . . . 0.0 110.509 -173.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 m -74.1 31.42 0.08 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.705 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.49 ' H ' ' C ' ' A' ' 33' ' ' HIS . 25.7 pt -142.79 143.86 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.596 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 72.2 m-85 49.53 50.81 17.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.92 0.867 . . . . 0.0 111.185 -173.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 60.5 p -103.03 176.48 1.8 Allowed Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.468 171.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 24.2 Cg_exo -66.44 -11.49 31.79 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.98 1.787 . . . . 0.0 111.466 169.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -89.47 -40.72 12.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.09 0.471 . . . . 0.0 110.171 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.5 p -90.56 -22.55 21.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.251 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.624 ' O ' HD13 ' A' ' 46' ' ' LEU . 15.2 m120 -137.15 60.82 30.24 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.368 . . . . 0.0 111.514 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.53 20.33 0.69 Allowed 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 122.026 1.817 . . . . 0.0 112.396 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.58 -8.86 7.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.685 ' HB1' HD12 ' A' ' 46' ' ' LEU . . . -105.19 10.93 33.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.26 0.553 . . . . 0.0 110.324 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.76 41.68 73.19 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.163 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.8 HD22 ' HG3' ' A' ' 54' ' ' PRO . 5.5 mp -80.41 79.12 7.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.71 0.767 . . . . 0.0 110.368 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.809 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 7.2 pt-20 -101.78 136.48 41.54 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.818 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 11.0 mtpp 48.63 -105.98 0.17 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -141.67 11.62 2.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.646 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.809 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 23.2 m-85 -65.53 131.41 46.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.53 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 70.7 m -52.35 144.66 12.53 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.246 0.341 . . . . 0.0 111.028 -176.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.53 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 35.6 mmt-85 -149.32 168.78 22.42 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.268 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -129.49 77.86 76.59 Favored Pre-proline 0 C--N 1.313 -0.981 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.969 171.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.8 ' HG3' HD22 ' A' ' 46' ' ' LEU . 39.5 Cg_endo -72.93 -10.17 24.44 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.082 1.855 . . . . 0.0 111.801 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -90.98 -32.62 15.87 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 172.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.93 36.45 93.3 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.3 -165.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -46.84 134.05 10.36 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.942 -0.629 . . . . 0.0 109.877 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 t -70.09 0.31 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.563 0.697 . . . . 0.0 110.579 -178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.56 -19.95 39.37 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.46 -179.64 16.13 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.757 -1.211 . . . . 0.0 111.41 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -73.44 158.48 47.96 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.194 1.929 . . . . 0.0 111.859 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.487 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 19.2 p-90 -150.72 -169.24 3.33 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.867 -170.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.729 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.3 p -168.53 -176.62 2.87 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.5 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.443 ' OH ' ' HD2' ' A' ' 36' ' ' PHE . 84.1 m-85 -100.4 147.23 26.07 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 169.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.452 ' C ' ' H ' ' A' ' 67' ' ' ASN . 2.7 p -100.62 149.7 23.48 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.741 -169.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.5 p -82.47 24.56 0.69 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.424 0.631 . . . . 0.0 109.89 167.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.956 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.7 t-20 -108.0 118.27 53.14 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.889 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.66 5.95 1.14 Allowed 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.92 2.414 . . . . 0.0 113.585 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 -85.33 -49.13 8.4 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 149.04 52.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.163 0.506 . . . . 0.0 110.595 -175.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.666 HD11 ' HB3' ' A' ' 31' ' ' HIS . 39.4 tp -76.37 -43.75 39.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.999 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.96 153.47 43.06 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.501 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.543 ' HB3' HG22 ' A' ' 16' ' ' THR . 18.9 t0 -152.98 164.85 37.2 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -175.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -92.48 156.56 17.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.59 171.76 7.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.827 0.346 . . . . 0.0 110.67 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -118.76 60.71 0.8 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.389 0.614 . . . . 0.0 109.99 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.821 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.5 p -102.28 130.44 24.18 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.396 0.617 . . . . 0.0 110.512 176.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.41 ' HD2' HG23 ' A' ' 77' ' ' VAL . 21.0 Cg_endo -60.12 160.9 20.96 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 124.691 3.594 . . . . 0.0 114.231 -176.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.428 ' NE2' ' SD ' ' A' ' 2' ' ' MET . 8.8 tp-100 -75.63 112.01 11.55 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.941 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.583 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.96 -41.61 50.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.724 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.619 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . -86.56 62.25 7.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.252 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.958 178.409 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -93.56 12.31 25.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 67.96 35.15 3.88 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.696 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.516 ' OD1' ' HG2' ' A' ' 12' ' ' LYS . 36.5 t0 -80.43 48.12 1.0 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.307 1.051 . . . . 0.0 109.894 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.581 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -159.11 160.84 36.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.204 -177.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.596 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 16.2 ptt? -96.52 146.23 24.99 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.584 ' HD2' ' HB3' ' A' ' 81' ' ' ALA . 90.5 m-85 -105.47 99.47 9.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.25 -119.77 4.96 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.892 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -79.74 -18.12 51.91 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 124.481 0.753 . . . . 0.0 110.585 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.589 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.31 13.45 21.0 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.917 -174.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -64.5 -39.49 93.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.199 -0.501 . . . . 0.0 109.687 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.582 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -107.06 23.05 28.34 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 172.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.703 ' CE1' HG22 ' A' ' 77' ' ' VAL . 2.8 t80 -67.59 105.15 1.78 Allowed 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 172.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.52 39.06 2.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.17 0.509 . . . . 0.0 110.214 -175.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.472 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -94.72 -158.88 33.39 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.978 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.516 ' HG2' ' OD1' ' A' ' -1' ' ' ASP . 9.1 ptmm? -140.48 19.04 2.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.88 0.371 . . . . 0.0 110.33 -168.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.629 ' HB2' ' OH ' ' A' ' 9' ' ' TYR . 2.5 mpt_? -67.98 137.59 55.25 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 m -140.29 33.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.939 0.876 . . . . 0.0 110.322 -170.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.467 HG21 ' HA2' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -150.58 139.11 20.54 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -172.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.59 ' HB ' ' OD2' ' A' ' 73' ' ' ASP . 72.3 p -74.84 -176.22 2.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.647 0.261 . . . . 0.0 111.39 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.411 HG22 ' OD2' ' A' ' 73' ' ' ASP . 15.4 m -65.87 -20.41 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.647 0.737 . . . . 0.0 110.187 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 p -91.99 -14.23 29.77 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.529 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.467 ' HA2' HG21 ' A' ' 15' ' ' THR . . . 89.94 11.97 62.71 Favored Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.846 -174.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.743 HG22 ' HB2' ' A' ' 67' ' ' ASN . 78.4 m -76.58 120.82 83.3 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 120.426 -0.509 . . . . 0.0 109.84 170.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -50.55 125.82 16.45 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.837 2.358 . . . . 0.0 113.198 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.4 m -64.44 137.87 58.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.499 0.666 . . . . 0.0 110.627 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 25.5 tt0 -71.22 166.12 22.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.925 174.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 1.0 OUTLIER -75.98 125.11 28.49 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.726 ' CE3' HD21 ' A' ' 46' ' ' LEU . 45.9 m95 -54.8 -29.25 54.02 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.611 0.719 . . . . 0.0 109.122 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.87 -21.35 55.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.556 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.69 150.38 22.8 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -172.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.736 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.5 mm-40 -103.5 33.0 3.53 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 43.4 mt-10 -143.17 119.58 6.66 Favored Pre-proline 0 N--CA 1.43 -1.474 0 CA-C-N 114.205 -1.361 . . . . 0.0 114.209 -157.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 88.9 Cg_endo -90.04 31.98 9.58 Favored 'Cis proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.298 -1.542 . . . . 0.0 113.456 1.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.497 ' HB3' HD11 ' A' ' 71' ' ' LEU . 61.5 m80 -131.63 113.02 13.1 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.736 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.72 116.55 14.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.823 -176.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.495 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.8 p80 -148.57 89.71 1.72 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.449 1.119 . . . . 0.0 110.543 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.1 m -78.19 35.84 0.22 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.996 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.495 ' H ' ' C ' ' A' ' 33' ' ' HIS . 20.1 pt -143.19 146.63 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 31.0 m-85 53.97 46.51 25.43 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.343 1.068 . . . . 0.0 110.629 -174.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.548 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 42.6 p -99.8 176.77 1.78 Allowed Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.145 170.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 30.3 Cg_exo -61.99 -21.58 72.64 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 121.959 1.773 . . . . 0.0 111.95 169.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -87.49 -34.71 18.56 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.981 0.419 . . . . 0.0 111.122 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.3 p -89.08 -24.03 22.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.973 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.574 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.0 m120 -136.03 59.28 27.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 21.1 Cg_exo -64.48 4.15 0.68 Allowed 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.476 2.117 . . . . 0.0 112.787 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.438 ' H ' ' C ' ' A' ' 41' ' ' ASN . 23.2 ptt180 -95.06 -19.36 20.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.588 0.233 . . . . 0.0 111.376 -173.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.662 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -109.09 2.74 21.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.595 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.05 47.48 85.04 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.262 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.871 HD23 ' HG3' ' A' ' 54' ' ' PRO . 5.6 mp -75.14 74.28 2.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.967 0.413 . . . . 0.0 111.5 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.527 ' HG3' ' CD2' ' A' ' 50' ' ' TYR . 3.0 pt-20 -98.94 152.83 19.35 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.669 176.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 48.0 mttp 49.96 -113.65 0.66 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.418 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -140.69 19.63 2.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.176 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.527 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 30.2 m-85 -61.92 128.83 38.06 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.644 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 80.5 m -53.76 145.23 16.19 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 38.8 mmt-85 -152.5 164.62 37.23 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.225 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -125.57 81.45 64.7 Favored Pre-proline 0 C--N 1.318 -0.762 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.719 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.871 ' HG3' HD23 ' A' ' 46' ' ' LEU . 39.1 Cg_exo -59.17 -31.89 96.15 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.727 2.285 . . . . 0.0 112.458 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -89.76 -20.0 24.07 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.525 0.679 . . . . 0.0 109.97 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.96 44.09 97.5 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.539 -168.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 59' ' ' GLY . 4.9 t70 -48.03 135.09 13.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.414 -0.893 . . . . 0.0 109.443 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 58' ' ' VAL . 11.4 t -71.67 6.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 123.893 0.746 . . . . 0.0 110.868 -173.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -105.42 -17.82 13.0 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.88 -178.15 16.5 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 119.89 -1.148 . . . . 0.0 111.234 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.596 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 74.2 Cg_endo -73.5 157.92 48.43 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.091 1.861 . . . . 0.0 111.815 -174.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.535 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 32.2 p-90 -145.61 -172.09 3.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.717 -172.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.698 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.0 p -168.52 -179.82 4.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.122 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.44 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 43.7 m-85 -100.16 145.61 27.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.3 p -102.84 147.02 27.41 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.664 -170.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.7 p -80.99 23.57 0.55 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.383 0.611 . . . . 0.0 110.517 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.743 ' HB2' HG22 ' A' ' 20' ' ' THR . 57.1 t-20 -103.98 121.76 46.73 Favored Pre-proline 0 CA--C 1.528 0.115 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.086 -177.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 16.5 Cg_exo -67.23 -0.33 4.81 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.888 2.392 . . . . 0.0 113.703 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -84.66 -44.98 12.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.836 0.35 . . . . 0.0 111.619 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -133.13 145.57 50.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.468 0.651 . . . . 0.0 111.048 -175.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 31' ' ' HIS . 41.8 tp -71.28 -43.04 67.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.621 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -143.29 164.29 30.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.089 0.471 . . . . 0.0 110.338 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.59 ' OD2' ' HB ' ' A' ' 16' ' ' THR . 33.0 t70 -157.94 173.89 16.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -93.63 158.67 15.58 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 86.6 m -106.37 171.24 7.46 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -122.64 69.25 0.97 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.3 0.571 . . . . 0.0 109.99 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.703 HG22 ' CE1' ' A' ' 9' ' ' TYR . 2.6 p -105.29 132.72 20.63 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.854 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.5 ' HD2' HG23 ' A' ' 77' ' ' VAL . 51.8 Cg_endo -65.76 162.24 35.51 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 123.631 2.887 . . . . 0.0 113.378 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.477 ' CG ' ' HB2' ' A' ' 82' ' ' ALA . 9.3 tp-100 -75.6 108.96 8.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.231 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.493 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -73.3 -37.94 66.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.306 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.584 ' HB3' ' HD2' ' A' ' 3' ' ' PHE . . . -83.39 52.1 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.194 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.477 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . . . . . . . . 0 C--O 1.245 0.856 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.938 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 64.5 p . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . 0.488 ' ND2' ' HD3' ' A' ' 12' ' ' LYS . 27.6 p-10 -82.41 3.81 26.58 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 68.93 22.9 6.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.513 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.487 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 46.8 t0 -82.67 53.66 2.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.256 1.027 . . . . 0.0 109.364 175.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.512 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -151.51 155.18 37.99 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.258 -178.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.612 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.8 ptt? -97.29 150.74 20.61 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 121.358 0.599 . . . . 0.0 112.514 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.72 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 71.8 m-85 -109.7 102.07 10.91 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.38 -115.48 4.19 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 119.997 -1.097 . . . . 0.0 111.033 -175.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.18 -23.93 40.69 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 124.531 0.783 . . . . 0.0 109.576 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.507 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.31 17.41 10.75 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.313 -0.946 . . . . 0.0 110.969 -174.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -66.48 -39.9 89.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.103 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.569 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -105.61 20.69 36.33 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.643 ' CE1' HG22 ' A' ' 77' ' ' VAL . 4.0 t80 -65.31 105.19 1.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -113.08 35.78 3.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.233 0.54 . . . . 0.0 109.551 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.497 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -88.25 -154.04 27.17 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.995 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 4.7 ptmt -150.29 22.07 0.84 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.912 0.387 . . . . 0.0 110.687 -168.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.692 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 22.5 mmt180 -68.5 137.86 54.74 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 171.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.79 38.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.486 0.66 . . . . 0.0 111.655 -171.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.06 145.31 25.42 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.957 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 73' ' ' ASP . 69.4 p -74.36 -174.05 1.89 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.042 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -63.71 -20.45 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.489 0.661 . . . . 0.0 110.818 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.4 p -92.87 -12.71 30.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.499 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.43 11.41 69.03 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.42 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.96 HG23 ' HB2' ' A' ' 67' ' ' ASN . 95.4 m -76.69 119.15 76.2 Favored Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.329 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -47.25 124.7 9.45 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 123.098 2.532 . . . . 0.0 113.689 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.8 m -63.5 139.48 58.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.425 0.631 . . . . 0.0 110.884 172.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 23.1 tt0 -71.16 164.81 24.9 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.021 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.476 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 5.3 m-20 -76.95 125.56 29.51 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.679 ' CE3' HD23 ' A' ' 46' ' ' LEU . 37.7 m95 -54.06 -31.79 52.62 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.59 -17.08 58.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.749 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.476 ' HB2' ' HB2' ' A' ' 24' ' ' ASP . . . -106.82 150.41 26.38 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -174.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.857 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.3 mm-40 -102.61 29.52 5.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 4.0 mm-40 -133.78 119.47 14.92 Favored Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -159.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 88.7 Cg_endo -94.24 35.65 7.57 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.079 -1.634 . . . . 0.0 112.783 -0.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.446 ' HB3' HD13 ' A' ' 71' ' ' LEU . 58.2 m80 -126.81 107.48 10.16 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.857 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.0 OUTLIER -76.59 113.02 13.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.068 -175.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 5.0 p80 -143.53 92.53 2.37 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.997 0.903 . . . . 0.0 110.422 -172.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.4 m -77.47 39.11 0.25 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.47 0.653 . . . . 0.0 109.534 172.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.4 pt -143.37 135.86 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -173.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.558 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 45.6 m-85 53.58 48.2 22.2 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 122.265 1.031 . . . . 0.0 111.275 -175.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.471 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 46.9 p -99.84 175.54 2.36 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.101 170.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.499 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 22.6 Cg_exo -64.79 -18.52 62.72 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.798 1.666 . . . . 0.0 111.257 168.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -83.17 -38.94 21.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.314 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.3 p -92.04 -25.23 18.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.085 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.558 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.0 m120 -132.41 68.25 79.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.346 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.22 12.37 1.81 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.453 2.102 . . . . 0.0 112.159 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -100.12 -27.7 13.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 -174.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.578 ' HB1' HD12 ' A' ' 46' ' ' LEU . . . -105.41 6.9 32.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 111.689 -172.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.36 46.29 93.09 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.368 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.679 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.6 mp -75.4 78.46 2.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.201 0.524 . . . . 0.0 110.507 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.732 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.6 pt-20 -97.64 139.89 32.86 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.675 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 48' ' ' LYS . 29.4 mmtp 51.82 -111.47 0.57 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.865 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -137.22 14.16 3.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.831 0.348 . . . . 0.0 110.853 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.732 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 18.8 m-85 -66.92 129.5 40.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.5 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 84.1 m -52.88 153.1 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.265 0.353 . . . . 0.0 111.718 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 39.0 mmt-85 -156.26 166.91 32.06 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.17 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -128.32 78.72 75.21 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.941 171.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.673 ' HG3' HD22 ' A' ' 46' ' ' LEU . 28.3 Cg_endo -70.62 -14.08 33.07 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.328 2.019 . . . . 0.0 112.807 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.45 -21.59 20.09 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.468 0.651 . . . . 0.0 109.412 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.74 43.92 86.71 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.51 -167.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 59' ' ' GLY . 7.8 t70 -56.89 140.44 48.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.35 -0.925 . . . . 0.0 109.504 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 58' ' ' VAL . 9.2 t -75.11 13.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 122.045 0.926 . . . . 0.0 110.102 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -103.7 -18.61 13.73 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.28 -177.81 16.61 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.872 -1.156 . . . . 0.0 111.358 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.612 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 86.8 Cg_endo -77.22 153.51 31.76 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.36 2.04 . . . . 0.0 111.304 -175.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.531 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 19.3 p-90 -145.53 -169.23 3.17 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.893 -170.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.675 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.8 p -168.74 -178.11 3.29 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.812 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -101.06 145.36 28.84 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.53 HG23 ' HE3' ' A' ' 70' ' ' LYS . 3.1 p -99.4 149.27 23.34 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.119 -1.033 . . . . 0.0 109.729 -170.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.9 p -83.86 33.54 0.48 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.523 0.678 . . . . 0.0 109.738 166.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.96 ' HB2' HG23 ' A' ' 20' ' ' THR . 60.8 t-20 -112.97 120.59 40.25 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.995 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.0 5.71 1.68 Allowed 'Trans proline' 0 N--CA 1.472 0.251 0 C-N-CA 122.866 2.378 . . . . 0.0 113.489 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -84.87 -50.81 7.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.157 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.53 ' HE3' HG23 ' A' ' 65' ' ' THR . 0.5 OUTLIER -134.59 154.58 51.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.015 0.436 . . . . 0.0 110.879 -176.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.446 HD13 ' HB3' ' A' ' 31' ' ' HIS . 50.8 tp -76.18 -43.42 42.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.095 -176.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -142.33 161.25 38.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.511 ' HB3' HG22 ' A' ' 16' ' ' THR . 46.6 t0 -159.36 165.46 33.24 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 60.1 m-85 -93.3 155.05 17.65 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.8 m -103.11 167.99 9.47 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.912 0.387 . . . . 0.0 110.621 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -112.92 56.2 0.68 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.375 0.607 . . . . 0.0 110.033 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.692 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.8 p -95.35 128.46 38.35 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.186 0.517 . . . . 0.0 110.004 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.402 ' HD2' HG23 ' A' ' 77' ' ' VAL . 34.8 Cg_endo -62.77 157.18 49.05 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 C-N-CA 123.565 2.843 . . . . 0.0 113.603 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.7 107.13 7.66 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.093 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -72.98 -39.93 65.71 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.317 179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.72 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . -93.33 58.97 2.92 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.559 -178.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -88.44 11.7 16.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.83 0.348 . . . . 0.0 110.145 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 71.58 15.3 6.07 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.438 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.636 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 22.8 t0 -82.47 62.54 6.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.172 0.987 . . . . 0.0 109.963 175.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.541 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.8 OUTLIER -157.64 147.67 20.5 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.599 178.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.614 ' HG2' HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.5 150.31 22.33 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.604 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 90.0 m-85 -106.97 101.5 10.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -176.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.56 -106.87 2.09 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.04 -173.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -83.12 -32.77 26.52 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 125.206 1.18 . . . . 0.0 111.126 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.86 21.72 7.32 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.957 -175.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -65.32 -38.99 91.85 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.112 0.482 . . . . 0.0 109.967 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -106.99 26.55 18.84 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.661 ' CE1' HG22 ' A' ' 77' ' ' VAL . 4.3 t80 -70.25 104.07 2.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.58 38.74 2.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.011 0.434 . . . . 0.0 110.76 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.636 ' CA ' ' HA ' ' A' ' -1' ' ' ASP . . . -94.98 -159.77 33.59 Favored Glycine 0 C--N 1.329 0.174 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.943 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 14.5 ptmt -145.07 20.94 1.59 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.846 0.323 . . . . 0.0 111.314 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.698 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.9 mmt180 -67.44 138.8 56.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 173.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.439 HG11 ' HA ' ' A' ' 50' ' ' TYR . 5.0 m -139.98 34.19 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.479 0.657 . . . . 0.0 111.552 -167.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.764 HG22 ' HA2' ' A' ' 19' ' ' GLY . 8.5 m -151.89 135.38 16.1 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -173.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.467 HG21 ' HB3' ' A' ' 73' ' ' ASP . 78.3 p -73.53 -176.72 2.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.941 0.4 . . . . 0.0 112.075 -172.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 m -65.03 -18.67 24.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.439 0.638 . . . . 0.0 111.046 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.8 p -93.12 -14.17 27.57 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.235 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.764 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.41 16.15 62.83 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.426 -174.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.975 HG23 ' HB2' ' A' ' 67' ' ' ASN . 86.3 m -76.8 121.09 84.21 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.633 169.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.49 126.24 15.61 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.768 2.312 . . . . 0.0 113.231 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.5 m -64.88 138.2 58.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.46 0.647 . . . . 0.0 110.697 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -72.12 165.71 23.77 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.441 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.419 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 16.9 m-20 -76.42 125.53 29.36 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.742 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 33.6 m95 -55.19 -29.18 57.35 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.8 -23.66 55.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.776 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -97.24 149.72 21.72 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -173.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.64 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.3 mm-40 -104.57 31.96 4.38 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.2 mt-10 -147.61 122.3 5.1 Favored Pre-proline 0 N--CA 1.425 -1.703 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.283 -155.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 87.4 Cg_endo -87.18 28.6 10.81 Favored 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.343 -1.524 . . . . 0.0 112.759 0.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.485 ' HB3' HD13 ' A' ' 71' ' ' LEU . 63.7 m80 -128.73 104.51 7.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.64 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.88 121.11 20.42 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -176.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.478 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.4 p80 -148.91 95.92 2.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.174 0.988 . . . . 0.0 110.172 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 m -77.89 32.15 0.17 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.234 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.478 ' H ' ' C ' ' A' ' 33' ' ' HIS . 30.3 pt -141.77 147.98 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -175.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.588 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 52.3 m-85 48.23 50.78 15.88 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.139 0.971 . . . . 0.0 111.268 -173.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 31.1 p -98.98 175.09 2.63 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.142 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 38.4 Cg_exo -62.99 -20.1 70.76 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.041 1.828 . . . . 0.0 112.236 172.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -99.64 -25.62 14.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.819 0.342 . . . . 0.0 111.207 -172.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.5 p -91.95 -15.75 27.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.83 0.347 . . . . 0.0 110.462 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.588 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.8 m120 -139.73 52.46 3.8 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.721 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.565 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 8.2 Cg_exo -71.49 31.61 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.789 2.326 . . . . 0.0 113.59 -176.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.418 ' H ' ' C ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -129.81 -10.5 4.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.628 0.251 . . . . 0.0 111.354 177.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.663 ' HB1' HD13 ' A' ' 46' ' ' LEU . . . -105.76 9.83 32.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.122 0.487 . . . . 0.0 110.039 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.72 43.4 97.85 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.23 -0.895 . . . . 0.0 113.102 173.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.663 HD13 ' HB1' ' A' ' 44' ' ' ALA . 5.1 mp -81.32 94.8 6.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.152 0.501 . . . . 0.0 109.856 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.638 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.5 pt-20 -121.43 152.3 39.23 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.07 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 4.1 mptp? 46.74 -113.08 0.44 Allowed 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.915 0.76 . . . . 0.0 111.763 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -136.68 18.68 3.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.06 0.457 . . . . 0.0 110.128 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.638 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 20.2 m-85 -67.8 128.39 36.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.786 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.519 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 84.5 m -51.33 147.21 6.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.309 0.38 . . . . 0.0 111.254 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.519 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 38.3 mmt-85 -151.53 169.07 22.98 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.695 -176.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -134.27 77.92 59.35 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.85 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.61 ' HG3' HD23 ' A' ' 46' ' ' LEU . 18.8 Cg_exo -64.36 -26.77 63.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.354 2.036 . . . . 0.0 112.123 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -20.07 23.78 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.547 0.689 . . . . 0.0 109.663 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.71 45.19 93.66 Favored Glycine 0 N--CA 1.433 -1.5 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.674 -170.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -45.47 130.29 8.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 172.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 t -66.55 -5.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 O-C-N 123.941 0.776 . . . . 0.0 110.95 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.28 -20.21 36.28 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.309 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 129.42 -179.95 16.39 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.583 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.41 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 73.4 Cg_endo -72.66 159.04 49.6 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.21 1.94 . . . . 0.0 111.824 -175.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.562 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 28.4 p-90 -146.23 -171.98 3.84 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.007 -171.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.742 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.3 p -168.18 -177.87 3.45 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.881 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -100.5 146.68 26.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 171.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.417 ' C ' ' H ' ' A' ' 67' ' ' ASN . 2.5 p -102.13 150.21 23.49 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.847 -171.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.2 p -84.27 31.26 0.51 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.527 0.68 . . . . 0.0 110.085 167.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.975 ' HB2' HG23 ' A' ' 20' ' ' THR . 59.0 t-20 -111.26 122.34 37.97 Favored Pre-proline 0 N--CA 1.462 0.16 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.075 -176.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.39 2.21 2.99 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.73 2.286 . . . . 0.0 113.481 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -83.72 -53.67 5.46 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.98 150.11 49.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.281 0.562 . . . . 0.0 110.571 -176.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 31' ' ' HIS . 53.5 tp -75.91 -43.42 45.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.349 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 11.2 p90 -143.1 158.56 43.5 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' A' ' 16' ' ' THR . 28.6 t0 -153.93 172.22 17.77 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -176.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -94.08 155.06 17.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.6 m -106.34 170.95 7.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.747 0.308 . . . . 0.0 110.626 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -121.63 64.58 0.9 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.52 0.676 . . . . 0.0 109.88 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.698 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 1.7 p -94.81 131.78 29.79 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.328 174.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.424 ' HD2' HG23 ' A' ' 77' ' ' VAL . 12.3 Cg_endo -56.06 152.05 39.2 Favored 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 123.403 2.735 . . . . 0.0 113.277 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.43 ' HB3' ' HB1' ' A' ' 82' ' ' ALA . 8.8 tp-100 -74.85 112.65 11.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.631 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.541 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.6 OUTLIER -74.66 -37.2 62.78 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.119 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . -88.39 43.86 1.16 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.802 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 79' ' ' GLN . . . . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.351 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 42.2 m . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . 0.408 ' ND2' ' HD3' ' A' ' 12' ' ' LYS . 54.2 t30 -77.54 -12.75 60.0 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 68.26 19.48 9.02 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.253 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -87.61 59.44 5.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.961 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.536 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -157.4 157.14 33.45 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.238 -177.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.659 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.9 ptt? -97.61 154.64 17.41 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.663 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 81.1 m-85 -110.5 102.0 10.64 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.65 -115.15 4.18 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.444 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.75 -24.84 41.29 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 124.605 0.826 . . . . 0.0 110.788 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.528 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.09 16.56 14.77 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.817 -1.183 . . . . 0.0 111.486 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -64.74 -46.9 80.25 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -101.1 28.26 16.82 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.294 173.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.642 ' CE1' HG22 ' A' ' 77' ' ' VAL . 2.3 t80 -70.47 102.01 2.11 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -105.97 32.24 4.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.057 0.456 . . . . 0.0 109.918 -174.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.559 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -84.18 -154.86 20.58 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.528 -175.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.408 ' HD3' ' ND2' ' A' ' -3' ' ' ASN . 0.0 OUTLIER -150.46 24.69 0.79 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.976 0.417 . . . . 0.0 110.329 -173.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.573 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 27.4 mmt180 -72.0 137.83 47.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 170.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 m -138.29 38.04 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.582 0.706 . . . . 0.0 111.088 -169.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.32 144.07 25.29 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.191 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 p -75.51 -176.14 3.09 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.24 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 m -65.47 -16.02 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.283 0.563 . . . . 0.0 110.824 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.4 p -93.22 -15.52 25.81 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.259 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.06 10.69 64.14 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.253 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 67' ' ' ASN . 85.4 m -77.64 120.68 82.38 Favored Pre-proline 0 N--CA 1.448 -0.549 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.867 174.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -51.31 123.87 12.92 Favored 'Trans proline' 0 C--O 1.239 0.53 0 C-N-CA 122.933 2.422 . . . . 0.0 113.243 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -62.59 140.94 58.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.848 174.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -73.21 164.96 25.92 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.16 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.63 124.37 27.85 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.633 ' CE3' HD22 ' A' ' 46' ' ' LEU . 44.4 m95 -54.28 -31.42 53.78 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.25 -9.31 59.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.818 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.67 147.41 33.17 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.681 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 34.8 mm-40 -102.22 31.94 3.75 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 41.1 mt-10 -146.51 122.26 5.57 Favored Pre-proline 0 N--CA 1.426 -1.633 0 CA-C-N 114.259 -1.337 . . . . 0.0 113.879 -156.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 3.3 Cg_endo -86.58 26.8 12.53 Favored 'Cis proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.612 -1.412 . . . . 0.0 113.344 2.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -126.52 109.77 12.53 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.681 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -72.78 113.61 10.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.973 -178.031 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.511 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.9 p80 -143.85 90.99 2.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.92 0.867 . . . . 0.0 110.096 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 40' ' ' THR . 14.7 m -75.61 34.85 0.12 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.508 0.67 . . . . 0.0 110.089 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.511 ' H ' ' C ' ' A' ' 33' ' ' HIS . 17.8 pt -143.84 142.13 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -175.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.559 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 32.5 m-85 57.0 45.26 21.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 121.769 0.795 . . . . 0.0 111.004 -176.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 21.9 p -103.81 173.47 3.38 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.618 168.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 37.2 Cg_exo -59.39 -22.37 65.42 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.793 1.662 . . . . 0.0 111.997 170.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -86.56 -39.17 16.45 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.945 0.402 . . . . 0.0 110.649 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 34' ' ' SER . 1.8 p -90.26 -20.1 23.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.493 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.559 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.4 m120 -135.46 65.14 61.55 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.943 0.401 . . . . 0.0 111.443 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -79.52 32.56 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.358 2.039 . . . . 0.0 111.382 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 41' ' ' ASN . 27.9 ptt180 -120.32 -17.1 8.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.425 -176.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB1' HD12 ' A' ' 46' ' ' LEU . . . -118.14 11.35 13.23 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.804 -172.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.95 44.9 95.32 Favored Glycine 0 C--O 1.23 -0.145 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.323 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.929 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.2 mp -77.73 90.97 4.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.056 0.455 . . . . 0.0 111.334 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.565 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.6 pt-20 -108.84 142.16 39.83 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.493 175.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 58.39 -123.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.994 0.809 . . . . 0.0 110.908 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -130.35 17.09 5.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.659 0.266 . . . . 0.0 110.752 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.565 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 18.0 m-85 -66.4 131.24 45.64 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.597 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 72.1 m -52.24 148.17 6.81 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.422 0.451 . . . . 0.0 111.395 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -153.53 158.93 42.0 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -119.61 78.93 21.84 Favored Pre-proline 0 C--N 1.316 -0.891 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.825 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.929 ' HG3' HD21 ' A' ' 46' ' ' LEU . 26.8 Cg_exo -58.09 -26.49 75.81 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.741 2.294 . . . . 0.0 112.643 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.51 -11.63 18.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.754 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.17 45.57 95.13 Favored Glycine 0 CA--C 1.501 -0.801 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.217 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.505 ' C ' ' H ' ' A' ' 59' ' ' GLY . 4.1 t70 -51.86 133.08 32.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.699 -0.751 . . . . 0.0 109.114 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.79 24.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.844 0.83 . . . . 0.0 110.562 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -116.3 -17.69 6.1 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.82 -179.56 16.1 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.32 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.659 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 71.7 Cg_endo -73.74 157.99 47.42 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.31 2.007 . . . . 0.0 111.481 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.592 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 29.3 p-90 -146.9 -174.16 4.42 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.065 -171.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.605 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.2 p -168.94 178.2 4.62 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.032 177.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.418 ' CD1' ' HG ' ' A' ' 71' ' ' LEU . 47.8 m-85 -100.51 145.39 28.36 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.1 p -101.94 148.36 25.43 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.734 -171.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 p -79.73 19.2 0.68 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.101 0.477 . . . . 0.0 110.921 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.589 ' HB2' HG21 ' A' ' 20' ' ' THR . 63.0 t-20 -100.35 118.29 61.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.216 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 15.2 Cg_exo -68.52 3.64 2.1 Favored 'Trans proline' 0 N--CA 1.47 0.119 0 C-N-CA 123.157 2.572 . . . . 0.0 113.496 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -84.75 -44.43 13.34 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.966 0.412 . . . . 0.0 110.819 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.484 ' HE2' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -144.92 142.56 29.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.482 0.658 . . . . 0.0 111.16 -174.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 64' ' ' TYR . 52.5 tp -70.69 -44.48 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.912 -168.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -146.75 163.83 34.72 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.543 -174.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -154.07 -177.55 6.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.084 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -93.15 162.12 14.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 94.8 m -105.77 171.43 7.34 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.171 0.51 . . . . 0.0 111.266 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -117.43 70.48 0.79 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.225 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.642 HG22 ' CE1' ' A' ' 9' ' ' TYR . 3.4 p -109.67 128.67 24.99 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.31 173.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.84 159.15 34.59 Favored 'Trans proline' 0 CA--C 1.512 -0.595 0 C-N-CA 123.772 2.981 . . . . 0.0 113.634 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -74.39 113.84 12.09 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.068 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.526 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.91 -42.12 58.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.056 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . -82.67 63.65 6.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.427 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.564 -0.732 . . . . 0.0 109.953 179.868 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -87.3 2.07 51.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 69.85 17.3 7.62 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.228 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.558 ' HB2' ' CD ' ' A' ' 12' ' ' LYS . 27.2 t0 -83.86 65.39 8.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.083 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.595 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.8 OUTLIER -148.6 151.1 34.44 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.149 177.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.695 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 12.9 ptt? -96.83 154.54 17.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.607 ' CD2' ' HB3' ' A' ' 81' ' ' ALA . 49.6 m-85 -108.87 96.53 6.39 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.15 -115.18 4.05 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -79.49 -25.27 41.86 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.761 0.824 . . . . 0.0 111.148 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.592 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 112.04 13.54 12.16 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 119.834 -1.174 . . . . 0.0 111.568 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.649 ' HZ2' ' HB3' ' A' ' 7' ' ' LYS . 9.1 mtpm? -60.61 -41.74 95.41 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.472 0.653 . . . . 0.0 110.202 175.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.94 28.64 10.86 Favored Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.165 172.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.71 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.7 t80 -68.43 106.31 2.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.896 0.379 . . . . 0.0 110.023 173.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.0 51.47 0.8 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -175.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.562 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -101.97 -148.65 21.38 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.711 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.558 ' CD ' ' HB2' ' A' ' -1' ' ' ASP . 0.0 OUTLIER -151.84 20.43 0.69 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.863 0.332 . . . . 0.0 110.773 -174.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.904 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.4 mmt180 -62.38 139.54 58.55 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 m -139.53 35.64 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.06 0.933 . . . . 0.0 109.871 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.07 143.67 25.26 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.091 -177.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.436 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 55.7 p -75.37 -174.75 2.51 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.03 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.12 -16.35 20.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.505 0.669 . . . . 0.0 110.872 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.7 p -93.19 -13.61 28.16 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.44 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.8 10.56 66.84 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.26 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.995 HG21 ' HB2' ' A' ' 67' ' ' ASN . 96.9 m -77.08 120.54 82.05 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.141 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -47.48 123.01 7.43 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.201 2.601 . . . . 0.0 113.802 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.98 141.14 58.86 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.842 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -73.81 166.26 23.64 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.417 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 11.8 m-20 -76.52 124.7 28.0 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 175.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.656 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 38.6 m95 -53.73 -32.55 52.53 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.9 -12.09 59.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.945 -1.479 . . . . 0.0 113.045 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.78 149.09 30.31 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 119.21 0.914 . . . . 0.0 109.052 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.664 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.3 mm-40 -101.84 31.76 3.72 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 44.1 mt-10 -145.57 121.39 5.81 Favored Pre-proline 0 N--CA 1.426 -1.655 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.712 -155.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 93.8 Cg_endo -89.92 33.59 7.83 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.469 -1.471 . . . . 0.0 113.217 1.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.6 ' HB3' HD11 ' A' ' 71' ' ' LEU . 64.3 m80 -134.11 111.16 10.1 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.664 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -72.17 126.6 30.21 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.523 ' C ' ' H ' ' A' ' 35' ' ' ILE . 6.1 p80 -155.02 89.43 1.22 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.033 0.921 . . . . 0.0 110.271 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 m -73.79 34.23 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.528 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.523 ' H ' ' C ' ' A' ' 33' ' ' HIS . 20.7 pt -143.29 147.21 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.557 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 35.7 m-85 52.29 45.49 28.35 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.983 0.897 . . . . 0.0 111.27 -174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 p -100.8 172.59 4.36 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.495 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.15 -14.16 42.02 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.015 1.81 . . . . 0.0 112.003 172.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -92.91 -37.72 12.09 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 110.167 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -87.74 -22.37 24.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.464 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.0 m120 -130.82 60.29 51.96 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.328 . . . . 0.0 111.014 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.81 39.15 0.73 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.641 2.227 . . . . 0.0 112.956 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.467 ' NH1' ' HA ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -141.56 -16.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.645 ' HB1' HD12 ' A' ' 46' ' ' LEU . . . -99.52 12.3 36.81 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.166 -0.334 . . . . 0.0 110.453 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.79 40.21 85.23 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.085 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.645 HD12 ' HB1' ' A' ' 44' ' ' ALA . 5.2 mp -81.76 102.43 10.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.094 0.473 . . . . 0.0 110.435 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -127.27 142.75 51.39 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.448 175.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 31.5 mmtp 55.14 -116.15 1.02 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.969 0.793 . . . . 0.0 111.211 177.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -136.11 17.42 3.22 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.827 0.346 . . . . 0.0 110.83 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -66.06 130.71 44.19 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.588 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 93.8 m -56.57 146.91 23.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.994 0.426 . . . . 0.0 111.668 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.81 159.88 43.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -176.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 25.1 t-20 -126.37 80.25 69.38 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.746 -0.381 . . . . 0.0 109.98 175.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.603 ' HG3' HD23 ' A' ' 46' ' ' LEU . 37.6 Cg_exo -59.63 -31.71 94.77 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.908 2.405 . . . . 0.0 112.592 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -88.99 -24.0 22.49 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.523 0.677 . . . . 0.0 110.048 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.64 46.36 69.38 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.019 -172.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -48.39 133.64 15.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.73 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.37 -11.29 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 124.451 1.094 . . . . 0.0 111.527 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.29 -10.89 43.73 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.909 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.84 -177.81 16.59 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.684 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.695 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 88.2 Cg_endo -74.69 164.77 32.99 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.575 2.183 . . . . 0.0 111.694 -173.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.58 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 29.8 p-90 -149.97 -172.13 4.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.227 -172.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.656 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.7 p -168.91 -177.71 3.08 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.691 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.444 ' CD1' ' HB3' ' A' ' 72' ' ' TYR . 50.1 m-85 -100.99 147.29 26.35 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 171.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 p -103.35 147.16 27.43 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.081 -170.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.7 p -82.48 21.47 0.96 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.153 0.501 . . . . 0.0 110.411 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.995 ' HB2' HG21 ' A' ' 20' ' ' THR . 52.8 t-20 -99.35 123.11 49.65 Favored Pre-proline 0 N--CA 1.456 -0.164 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.155 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.83 1.98 2.39 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.836 2.357 . . . . 0.0 113.16 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -84.08 -50.75 7.66 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.044 0.449 . . . . 0.0 111.089 175.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -130.14 159.55 36.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.368 0.604 . . . . 0.0 111.212 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 31' ' ' HIS . 45.4 tp -84.81 -45.63 12.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.857 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.444 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 33.6 p90 -143.37 164.18 30.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.863 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.436 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 37.2 t0 -160.01 176.23 12.08 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -94.34 157.51 16.0 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.9 m -106.03 167.64 9.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.712 0.291 . . . . 0.0 110.288 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -117.89 72.44 0.85 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.308 0.575 . . . . 0.0 110.037 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.904 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -106.6 129.48 24.38 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.953 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.93 157.3 16.96 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 124.327 3.351 . . . . 0.0 113.85 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.89 113.83 13.82 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.933 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.595 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.89 -44.4 40.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.589 178.133 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.607 ' HB3' ' CD2' ' A' ' 3' ' ' PHE . . . -84.84 65.21 9.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.372 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.13 179.844 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -98.48 -10.98 22.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 68.77 20.11 8.2 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.803 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.464 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 23.3 t70 -86.03 58.69 5.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.451 1.119 . . . . 0.0 109.234 176.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.48 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -157.44 156.93 33.01 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.262 -177.103 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.537 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 15.9 ptt? -96.28 154.86 17.02 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.539 ' CD2' ' HB2' ' A' ' 81' ' ' ALA . 7.8 m-85 -113.67 96.45 5.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.27 -115.09 3.98 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -79.83 -22.21 43.26 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.282 0.636 . . . . 0.0 109.715 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.5 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.92 11.55 20.44 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.224 -0.988 . . . . 0.0 110.938 -174.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.538 ' HZ2' ' HB3' ' A' ' 7' ' ' LYS . 9.2 mtpm? -65.17 -31.75 73.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.055 0.455 . . . . 0.0 110.124 176.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -111.7 19.45 23.64 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 173.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.671 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.1 t80 -68.19 110.53 4.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -118.32 45.15 2.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 0.0 109.664 -177.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.543 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -98.88 -159.85 29.58 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.85 -175.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HZ1' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -139.59 15.12 2.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.495 0.188 . . . . 0.0 110.74 -170.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.61 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 19.8 mmt180 -64.66 135.78 56.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 m -134.61 36.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.553 0.692 . . . . 0.0 111.209 -171.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.782 HG22 ' HA2' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -151.35 139.97 20.68 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -178.09 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.632 HG22 ' HB3' ' A' ' 73' ' ' ASP . 75.3 p -75.15 -169.69 1.0 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.892 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -66.25 -21.11 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.312 0.577 . . . . 0.0 110.759 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.2 p -92.84 -13.33 29.22 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.191 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.782 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 82.62 20.69 61.31 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.582 -173.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.5 m -76.48 119.31 76.82 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 168.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -49.52 135.95 33.2 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.924 2.416 . . . . 0.0 113.225 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 72.9 m -76.45 142.94 40.84 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.734 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -70.96 165.53 23.2 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.297 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.9 128.81 35.24 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.662 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 57.8 m95 -57.82 -30.89 66.09 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.41 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . . . -78.07 -18.1 56.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.853 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.44 149.58 21.24 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.616 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 30.3 mm-40 -104.3 31.24 4.73 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.5 mt-10 -147.62 122.79 5.2 Favored Pre-proline 0 N--CA 1.422 -1.832 0 CA-C-N 113.795 -1.548 . . . . 0.0 114.397 -154.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 91.9 Cg_endo -86.85 29.82 9.03 Favored 'Cis proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.212 -1.578 . . . . 0.0 112.839 -0.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.676 ' HB3' HD11 ' A' ' 71' ' ' LEU . 55.0 m80 -130.58 107.49 9.24 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.616 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -74.48 125.33 28.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.471 ' C ' ' H ' ' A' ' 35' ' ' ILE . 3.9 p80 -155.21 98.13 1.97 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.99 0.9 . . . . 0.0 110.96 -177.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.0 m -79.61 33.78 0.26 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.666 0.746 . . . . 0.0 109.837 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.471 ' H ' ' C ' ' A' ' 33' ' ' HIS . 31.4 pt -142.15 146.16 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.623 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 41.7 m-85 50.06 51.04 17.44 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.931 0.872 . . . . 0.0 111.254 -175.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.526 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 29.3 p -99.44 177.65 1.5 Allowed Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.115 171.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 35.6 Cg_exo -60.53 -29.24 88.18 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 121.872 1.714 . . . . 0.0 111.378 170.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.04 -30.56 16.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.682 -167.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.0 p -89.06 -19.91 25.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.036 0.446 . . . . 0.0 110.23 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.623 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.5 m120 -133.97 67.25 73.74 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.719 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.27 9.94 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.039 1.826 . . . . 0.0 111.783 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -96.38 -24.05 16.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.616 ' HB2' HD13 ' A' ' 46' ' ' LEU . . . -106.58 1.18 25.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.861 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.11 44.68 90.74 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.225 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.661 HD21 ' CE3' ' A' ' 25' ' ' TRP . 5.4 mp -73.12 99.98 2.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.69 0.281 . . . . 0.0 110.381 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.8 pt-20 -118.68 142.99 47.14 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 48' ' ' LYS . 23.5 mmmt 53.39 -115.58 0.97 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.715 0.635 . . . . 0.0 111.576 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -135.34 17.76 3.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.211 0.529 . . . . 0.0 110.589 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.485 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 27.7 m-85 -68.61 129.71 40.72 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.465 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 71.6 m -54.71 153.4 6.0 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 123.219 0.324 . . . . 0.0 111.462 -173.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 35.5 mmt-85 -156.89 169.82 23.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.78 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -128.25 77.35 77.04 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.52 169.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.616 ' HG3' HD23 ' A' ' 46' ' ' LEU . 36.2 Cg_endo -70.78 -13.64 32.25 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.256 1.971 . . . . 0.0 112.474 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.67 -25.95 17.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.036 0.922 . . . . 0.0 109.055 173.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.54 40.64 99.37 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.959 -169.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 59' ' ' GLY . 20.2 t70 -48.54 133.88 16.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 172.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 t -72.63 6.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.611 0.72 . . . . 0.0 110.805 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -98.47 -22.45 14.43 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.07 -179.3 16.94 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 119.513 -1.327 . . . . 0.0 112.02 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.537 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 95.5 Cg_endo -75.6 157.64 40.18 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.386 2.057 . . . . 0.0 111.612 -174.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.511 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 15.7 p-90 -148.26 -169.7 3.41 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.958 -172.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.662 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 28.9 p -168.6 -177.5 3.14 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.458 176.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 67.7 m-85 -100.22 146.09 27.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 170.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.1 p -100.09 145.25 28.17 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.632 -170.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.9 p -78.49 17.8 0.63 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.034 0.445 . . . . 0.0 110.991 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' A' ' 69' ' ' ARG . 16.3 t30 -105.8 120.47 49.06 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 21.8 Cg_exo -65.91 4.96 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.353 2.702 . . . . 0.0 114.072 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.448 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 20.4 mmm180 -82.05 -43.16 18.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.615 0.245 . . . . 0.0 111.21 173.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -134.68 156.47 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.329 0.585 . . . . 0.0 111.068 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.676 HD11 ' HB3' ' A' ' 31' ' ' HIS . 41.5 tp -83.19 -45.09 14.3 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.905 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 29.0 p90 -143.74 164.87 29.25 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.995 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.632 ' HB3' HG22 ' A' ' 16' ' ' THR . 37.4 t0 -160.71 169.4 22.89 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 65.0 m-85 -92.85 155.84 17.36 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 80.9 m -104.46 168.32 9.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.148 0.499 . . . . 0.0 111.11 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -115.47 64.49 0.69 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.398 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.671 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.8 p -104.36 130.72 22.81 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.497 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HD2' HG22 ' A' ' 77' ' ' VAL . 25.2 Cg_endo -61.33 154.78 56.09 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 123.85 3.033 . . . . 0.0 113.625 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -75.66 109.43 9.23 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.286 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.411 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -72.82 -43.17 63.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.305 179.033 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.539 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . . . -104.14 68.39 0.89 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.027 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.182 179.428 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 52.5 m . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -99.17 -11.22 21.57 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 65.65 12.33 8.17 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.602 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.53 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 24.3 t0 -86.3 50.07 1.92 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.871 1.32 . . . . 0.0 109.955 -178.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.589 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -155.82 153.19 29.39 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.51 -1.677 . . . . 0.0 108.456 178.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.501 ' HG2' ' HG3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -98.02 143.44 28.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -175.175 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.675 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 74.1 m-85 -102.32 104.07 14.56 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.7 -111.51 3.27 Favored Glycine 0 N--CA 1.424 -2.11 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.495 -174.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -89.14 -20.23 24.51 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 124.444 0.732 . . . . 0.0 110.521 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.03 15.87 13.68 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.79 -1.195 . . . . 0.0 111.886 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -63.94 -38.53 91.42 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.009 0.433 . . . . 0.0 110.271 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.31 24.64 22.15 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 173.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.608 ' CE1' HG23 ' A' ' 77' ' ' VAL . 3.8 t80 -71.24 103.45 2.82 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -110.72 46.43 1.06 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.171 0.51 . . . . 0.0 109.681 -176.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.593 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.17 -158.61 32.0 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.604 -0.725 . . . . 0.0 113.174 -173.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -140.68 14.6 2.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.73 0.3 . . . . 0.0 110.581 -170.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.913 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.9 mmt180 -67.16 135.72 53.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.16 38.84 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.752 0.787 . . . . 0.0 110.854 -170.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.98 148.52 28.48 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.273 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -75.2 -171.41 1.4 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.915 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.82 -18.32 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.398 0.618 . . . . 0.0 110.884 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.4 p -93.54 -12.63 29.14 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.792 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.44 12.75 69.3 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.373 -172.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.864 HG21 ' HB2' ' A' ' 67' ' ' ASN . 99.5 m -75.87 121.63 85.41 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 172.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -50.31 128.3 22.54 Favored 'Trans proline' 0 CA--C 1.514 -0.493 0 C-N-CA 122.641 2.227 . . . . 0.0 113.193 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.42 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 77.0 m -69.13 137.6 53.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.293 171.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -70.06 165.85 21.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.533 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.401 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 13.9 m-20 -76.63 125.93 30.09 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.707 ' CE3' HD23 ' A' ' 46' ' ' LEU . 43.3 m95 -53.77 -30.28 43.88 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.566 0.698 . . . . 0.0 109.182 176.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.4 -19.97 55.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.793 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.401 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.49 150.29 23.2 Favored 'General case' 0 C--O 1.21 -1.017 0 O-C-N 121.639 -0.663 . . . . 0.0 109.528 -170.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 33.2 mm-40 -104.56 23.95 12.48 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -140.54 131.0 13.66 Favored Pre-proline 0 N--CA 1.432 -1.363 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.389 -166.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -86.09 26.61 12.02 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.88 -1.717 . . . . 0.0 113.229 0.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.542 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 30.2 m80 -127.59 109.9 12.17 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.571 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 6.2 mmt180 -73.17 112.26 9.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.446 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.9 p80 -144.24 96.19 2.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.393 1.092 . . . . 0.0 110.51 -176.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.4 m -75.7 23.06 0.13 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.493 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.444 ' H ' ' C ' ' A' ' 33' ' ' HIS . 34.1 pt -140.89 158.31 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.607 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 63.4 m-85 50.71 46.91 25.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.02 0.914 . . . . 0.0 110.727 -173.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 32.0 p -100.01 174.63 2.88 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 114.072 -1.422 . . . . 0.0 108.87 171.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 26.5 Cg_exo -64.12 -16.94 57.78 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 121.827 1.684 . . . . 0.0 111.851 171.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -90.87 -37.64 13.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.442 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.7 p -88.82 -19.94 25.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 -176.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.607 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.8 m120 -134.8 65.78 67.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.093 0.473 . . . . 0.0 111.33 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.51 8.64 1.79 Allowed 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.421 2.081 . . . . 0.0 112.056 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -102.51 -16.88 15.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.365 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.606 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -109.63 5.17 22.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.109 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 47' ' ' GLU . . . 62.04 45.87 95.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.448 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.707 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.7 mp -72.36 94.48 1.62 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.195 0.522 . . . . 0.0 110.439 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.752 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.3 pt-20 -108.39 134.53 51.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.089 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm 54.93 -112.15 0.69 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.568 0.543 . . . . 0.0 111.544 176.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -134.77 12.87 3.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.476 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.752 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 21.6 m-85 -64.07 128.71 37.0 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.451 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 80.4 m -51.16 155.31 1.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.398 0.436 . . . . 0.0 111.684 -175.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.451 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 29.3 mmt-85 -158.17 169.4 24.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.988 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -128.19 78.2 75.78 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.525 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.68 ' HG3' HD22 ' A' ' 46' ' ' LEU . 26.9 Cg_endo -69.61 -12.52 33.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.267 1.978 . . . . 0.0 112.248 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -95.71 -27.25 15.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.897 0.856 . . . . 0.0 109.375 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.37 37.28 93.82 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.398 -166.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 59' ' ' GLY . 9.3 t70 -45.16 131.57 7.63 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.219 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.47 34.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.833 0.825 . . . . 0.0 110.339 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -122.05 -19.7 3.22 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.53 179.96 15.92 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.922 -1.133 . . . . 0.0 111.432 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.501 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 94.6 Cg_endo -72.85 152.56 52.49 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.963 1.775 . . . . 0.0 111.399 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.472 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 23.9 p-90 -145.95 -171.49 3.72 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.898 -170.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.644 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.1 p -168.51 179.88 4.17 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.623 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.443 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 40.0 m-85 -100.77 139.68 36.11 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.6 p -98.33 148.74 23.35 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.574 -170.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -80.95 20.45 0.78 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.267 0.556 . . . . 0.0 110.377 169.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.864 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.9 t-20 -98.94 119.08 61.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.848 -177.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -66.32 -0.55 4.36 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.993 2.462 . . . . 0.0 113.546 -177.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -84.7 -43.46 14.3 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.8 0.333 . . . . 0.0 111.434 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.39 149.54 49.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.326 0.584 . . . . 0.0 110.417 -176.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.542 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 46.6 tp -78.87 -43.09 25.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.382 -175.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -143.27 163.51 32.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.783 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -159.15 178.59 9.86 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -93.79 158.08 15.83 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.84 166.15 10.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.247 0.546 . . . . 0.0 111.231 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -109.38 60.19 0.6 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.289 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.913 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -104.66 128.62 26.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.397 174.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.02 161.81 24.78 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 124.055 3.17 . . . . 0.0 113.743 -176.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.454 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 8.8 tp-100 -75.73 110.53 10.22 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.454 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.589 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.04 -38.67 61.38 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.205 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.675 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . -90.11 62.41 5.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.51 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.454 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.27 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 N--CA 1.472 0.671 0 CA-C-O 120.775 0.321 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -85.78 -4.16 59.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.902 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 66.74 32.02 7.14 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.415 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.401 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 20.7 t0 -81.4 53.91 2.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.683 1.23 . . . . 0.0 109.23 175.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.593 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -151.84 157.79 42.38 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.165 -179.182 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.658 ' HG2' ' HG3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -97.95 142.39 29.75 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.526 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 66.0 m-85 -101.41 102.25 13.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -177.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.2 -114.44 3.89 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.618 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -84.87 -23.58 28.92 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.382 0.695 . . . . 0.0 110.267 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.552 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.99 15.33 11.96 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.449 -175.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -67.92 -36.01 79.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.204 0.526 . . . . 0.0 110.33 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -107.57 20.21 32.5 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.603 ' CE1' HG23 ' A' ' 77' ' ' VAL . 2.6 t80 -66.5 101.74 0.8 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.34 46.4 0.93 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.179 0.514 . . . . 0.0 110.551 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.541 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -101.77 -158.14 26.59 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.171 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -149.86 22.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.947 0.374 . . . . 0.0 110.76 -170.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.878 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 21.0 mmt180 -65.2 139.04 58.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.75 30.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.536 0.684 . . . . 0.0 111.654 -170.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.27 142.39 24.05 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.415 HG21 ' HB3' ' A' ' 73' ' ' ASP . 69.4 p -75.31 -176.87 3.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.871 0.367 . . . . 0.0 111.605 -174.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 m -63.8 -19.39 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.47 0.652 . . . . 0.0 110.851 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.5 p -93.42 -12.01 30.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.798 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.79 12.76 68.27 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.28 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.662 HG22 ' HB2' ' A' ' 67' ' ' ASN . 85.6 m -76.86 119.76 78.85 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 171.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -50.62 123.74 12.04 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.811 2.341 . . . . 0.0 112.993 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.33 139.23 58.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.412 0.625 . . . . 0.0 110.565 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -71.4 166.01 22.56 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.807 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.24 127.34 32.43 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.76 ' CE3' HD21 ' A' ' 46' ' ' LEU . 64.6 m95 -57.14 -30.04 64.1 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.533 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . . . -78.69 -18.28 54.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.52 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.89 150.2 20.7 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.663 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.2 mm-40 -104.17 32.54 3.94 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -145.87 122.09 5.84 Favored Pre-proline 0 N--CA 1.428 -1.564 0 CA-C-N 114.027 -1.442 . . . . 0.0 114.104 -157.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -86.69 25.25 15.47 Favored 'Cis proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.597 -1.418 . . . . 0.0 112.79 1.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.409 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 43.1 m80 -128.14 108.72 10.87 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.663 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.1 ppt_? -73.95 120.57 19.72 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.543 -178.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.47 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.3 p80 -148.76 98.12 2.82 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.248 1.023 . . . . 0.0 109.739 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 m -77.79 28.51 0.17 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.595 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.47 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.1 pt -141.5 151.43 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -176.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.558 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 59.5 m-85 52.25 48.03 23.51 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 122.054 0.931 . . . . 0.0 111.146 -176.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.449 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 41.8 p -100.32 176.08 2.08 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.394 172.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 7.7 Cg_exo -70.71 -11.63 29.89 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.963 1.775 . . . . 0.0 111.087 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -92.87 -31.26 15.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.03 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.4 p -98.97 -19.8 17.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.092 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.558 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.2 m120 -135.58 57.91 22.1 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -174.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 13.6 Cg_exo -69.81 15.98 0.23 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.234 1.956 . . . . 0.0 112.545 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.472 ' H ' ' C ' ' A' ' 41' ' ' ASN . 18.8 ptt180 -99.6 -17.83 17.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.789 0.328 . . . . 0.0 111.034 -177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.677 ' HB2' HD12 ' A' ' 46' ' ' LEU . . . -118.13 3.4 12.05 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.445 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.05 46.67 90.67 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.566 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.765 HD23 ' HG3' ' A' ' 54' ' ' PRO . 5.3 mp -77.38 67.57 3.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.509 0.195 . . . . 0.0 111.185 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 6.0 pt-20 -97.39 157.6 15.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.764 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 52.07 -125.55 2.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.351 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -129.16 23.21 5.63 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.055 0.455 . . . . 0.0 110.373 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.51 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 38.5 m-85 -65.64 123.14 18.92 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.955 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 71.4 m -50.25 151.29 2.14 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 123.378 0.424 . . . . 0.0 111.42 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 43.2 mmt-85 -157.58 170.99 21.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.228 -174.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -131.36 76.81 75.14 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.347 169.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.765 ' HG3' HD23 ' A' ' 46' ' ' LEU . 33.8 Cg_endo -66.95 -15.9 48.24 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.563 2.176 . . . . 0.0 112.635 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -95.86 -26.04 15.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.938 0.875 . . . . 0.0 109.451 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.28 39.46 97.88 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.598 -166.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' A' ' 59' ' ' GLY . 19.7 t70 -44.82 131.42 7.04 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 124.462 0.742 . . . . 0.0 110.153 173.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 t -76.04 35.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.785 0.803 . . . . 0.0 110.188 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -126.16 -18.34 2.33 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 173.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.76 -179.64 16.07 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.485 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.658 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 92.9 Cg_endo -73.71 150.99 45.82 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.143 1.895 . . . . 0.0 111.33 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 19.1 p-90 -144.66 -170.49 3.4 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.038 -169.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.713 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.1 p -168.86 -179.25 3.64 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -101.23 146.8 27.05 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.418 ' HB ' ' CG2' ' A' ' 20' ' ' THR . 1.2 p -102.91 146.17 28.72 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.879 -171.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.9 p -81.21 20.41 0.83 Allowed 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.826 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.662 ' HB2' HG22 ' A' ' 20' ' ' THR . 57.8 t-20 -99.4 120.81 56.95 Favored Pre-proline 0 C--N 1.337 0.036 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.226 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.04 4.88 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.022 2.481 . . . . 0.0 113.404 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -84.81 -58.26 2.78 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.744 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -119.53 159.29 24.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.797 -174.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.409 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 50.4 tp -87.85 -45.78 10.0 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.553 -177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -143.04 156.38 44.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.07 0.462 . . . . 0.0 109.831 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.415 ' HB3' HG21 ' A' ' 16' ' ' THR . 39.8 t0 -154.37 173.36 16.32 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 59.0 m-85 -93.26 157.84 16.05 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.9 m -105.3 162.39 13.47 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.895 0.378 . . . . 0.0 110.447 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.48 32.15 1.85 Allowed 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.315 0.579 . . . . 0.0 111.14 -172.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.878 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.4 p -80.51 122.6 82.65 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.683 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.12 162.75 25.13 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 C-N-CA 124.219 3.279 . . . . 0.0 113.884 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.44 ' NE2' ' SD ' ' A' ' 2' ' ' MET . 8.8 tp-100 -72.59 110.36 6.9 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.677 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.561 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.3 -41.65 56.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.639 179.048 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.526 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . -85.48 46.0 1.25 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.3 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.467 175.858 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' -2' ' ' ALA . 46.1 t30 -92.03 -3.98 55.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 176.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' -3' ' ' ASN . . . 78.04 5.03 2.81 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 114.359 -1.292 . . . . 0.0 109.683 -173.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.599 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 29.8 t70 -81.09 63.69 5.54 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.845 172.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -160.38 150.14 17.79 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.198 -1.365 . . . . 0.0 109.207 -177.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.582 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 7.0 ptt? -97.03 154.28 17.41 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.593 ' HD2' ' HB3' ' A' ' 81' ' ' ALA . 83.0 m-85 -112.38 95.63 5.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.64 -110.8 3.11 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -79.17 -29.77 43.17 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 124.935 1.02 . . . . 0.0 111.005 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . 108.36 17.88 10.25 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 119.614 -1.279 . . . . 0.0 112.079 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -62.5 -43.62 98.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.358 0.599 . . . . 0.0 110.114 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -105.09 27.9 16.82 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.027 174.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.76 ' CE1' HG22 ' A' ' 77' ' ' VAL . 3.2 t80 -68.94 105.47 2.4 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 170.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -109.18 42.54 1.42 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.085 0.469 . . . . 0.0 110.109 -175.599 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.599 ' CA ' ' HA ' ' A' ' -1' ' ' ASP . . . -93.49 -152.73 29.58 Favored Glycine 0 C--N 1.329 0.17 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.992 -175.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -148.08 16.54 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.763 0.282 . . . . 0.0 110.756 -172.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.752 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.1 mmt180 -66.38 138.17 57.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.469 ' C ' ' HG1' ' A' ' 15' ' ' THR . 3.4 m -138.6 32.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.636 0.732 . . . . 0.0 110.776 -170.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.694 HG22 ' HA2' ' A' ' 19' ' ' GLY . 3.6 m -151.89 136.17 16.72 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -173.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.515 HG22 ' HB3' ' A' ' 73' ' ' ASP . 74.5 p -73.35 -172.51 1.16 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -171.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.7 m -69.27 -18.57 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.546 0.689 . . . . 0.0 110.447 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p -92.13 -14.38 29.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.048 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.694 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 84.96 15.19 67.9 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.243 -174.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.74 HG23 ' HB2' ' A' ' 67' ' ' ASN . 98.3 m -78.36 121.02 83.24 Favored Pre-proline 0 N--CA 1.442 -0.83 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 169.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -49.63 130.56 26.48 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.764 2.309 . . . . 0.0 113.362 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m -67.53 140.56 57.0 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.972 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -73.82 165.92 24.26 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.324 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 2.1 m-20 -76.25 125.94 30.08 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 175.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.632 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 41.0 m95 -54.77 -29.29 53.69 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 173.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.92 -22.1 53.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.1 176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.439 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -99.96 150.11 22.75 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 119.039 0.836 . . . . 0.0 108.748 -172.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.621 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.2 mm-40 -103.19 32.28 3.84 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 36.0 mt-10 -145.68 122.42 6.01 Favored Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -158.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 91.9 Cg_endo -88.37 31.82 8.42 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.29 -1.546 . . . . 0.0 113.375 0.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.525 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 58.7 m80 -130.75 113.58 14.31 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.621 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 25.9 mmm180 -74.06 113.56 11.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.89 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.8 p80 -147.85 94.37 2.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.139 0.971 . . . . 0.0 111.16 -177.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m -79.8 35.81 0.31 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.498 0.665 . . . . 0.0 110.113 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 33' ' ' HIS . 23.4 pt -142.06 146.18 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.596 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 50.2 m-85 51.17 46.71 26.06 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.222 1.011 . . . . 0.0 110.969 -173.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.531 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 35.7 p -99.66 174.26 3.16 Favored Pre-proline 0 N--CA 1.444 -0.743 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.255 171.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 32.0 Cg_exo -59.35 -23.16 68.89 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.922 1.748 . . . . 0.0 112.185 170.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.49 -34.95 13.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.79 0.329 . . . . 0.0 111.296 -173.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.6 p -85.73 -18.67 32.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.997 0.427 . . . . 0.0 110.503 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.596 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.4 m120 -138.21 59.67 19.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.509 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.17 19.97 0.49 Allowed 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.613 2.208 . . . . 0.0 112.809 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -122.45 -8.69 8.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.491 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.695 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -106.51 7.93 31.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.386 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.99 40.85 97.43 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.384 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.695 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.2 mp -77.08 95.83 4.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.998 0.428 . . . . 0.0 110.828 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.467 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.2 pt-20 -118.23 152.16 36.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.504 175.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 34.2 mmtp 50.95 -115.26 0.85 Allowed 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.828 0.705 . . . . 0.0 111.183 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -139.47 19.68 2.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.001 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.467 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 32.8 m-85 -66.5 129.62 40.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.571 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.626 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 74.0 m -56.03 148.94 16.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.086 0.469 . . . . 0.0 111.824 -173.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.632 ' HD2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -155.17 158.2 38.58 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.632 -175.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -123.26 80.71 52.49 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.427 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.583 ' HD2' ' CZ2' ' A' ' 62' ' ' TRP . 3.4 Cg_exo -72.25 -13.04 28.14 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.287 1.992 . . . . 0.0 111.579 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -89.04 -32.28 17.65 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.63 38.76 96.39 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 113.521 -1.672 . . . . 0.0 109.856 -166.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -48.13 133.38 15.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.725 -0.738 . . . . 0.0 109.491 172.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 t -70.14 -0.27 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.489 0.661 . . . . 0.0 110.591 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.88 -17.18 42.03 Favored Glycine 0 N--CA 1.437 -1.274 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.21 -178.8 16.3 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 119.766 -1.207 . . . . 0.0 111.619 176.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.582 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 74.1 Cg_endo -72.5 158.39 51.16 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.251 1.968 . . . . 0.0 111.167 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.583 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 25.8 p-90 -148.3 -171.02 3.74 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.844 -171.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.632 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 28.9 p -168.37 -177.24 3.14 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.559 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.414 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 61.9 m-85 -100.47 150.03 23.07 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 170.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.458 ' C ' ' H ' ' A' ' 67' ' ' ASN . 2.5 p -104.69 150.27 24.87 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.248 -173.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.414 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 44.6 p -82.18 27.61 0.48 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.385 0.612 . . . . 0.0 110.102 168.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.74 ' HB2' HG23 ' A' ' 20' ' ' THR . 58.9 t-20 -111.48 114.49 52.74 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.891 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.28 2.74 2.06 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 123.099 2.533 . . . . 0.0 113.976 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -84.32 -33.85 23.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.874 0.368 . . . . 0.0 111.354 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -143.89 143.09 31.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.257 0.551 . . . . 0.0 110.32 -177.483 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.525 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 52.3 tp -73.98 -42.62 60.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.765 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -142.65 159.5 42.12 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.515 ' HB3' HG22 ' A' ' 16' ' ' THR . 25.7 t0 -154.29 171.52 19.11 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -93.1 155.6 17.39 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.5 m -105.04 168.61 8.94 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.167 0.508 . . . . 0.0 110.583 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -117.43 70.28 0.78 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.019 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.76 HG22 ' CE1' ' A' ' 9' ' ' TYR . 2.6 p -106.5 129.52 24.34 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.521 174.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 11.2 Cg_endo -54.82 151.81 31.15 Favored 'Trans proline' 0 CA--C 1.509 -0.738 0 C-N-CA 124.146 3.231 . . . . 0.0 113.766 -178.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.46 110.75 10.1 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.19 -42.2 60.21 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.195 178.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.593 ' HB3' ' HD2' ' A' ' 3' ' ' PHE . . . -86.15 56.72 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.715 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.922 178.75 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -84.95 2.58 42.23 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 70.64 25.84 4.06 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 124.407 1.067 . . . . 0.0 110.672 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.509 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 38.4 t70 -87.87 60.49 5.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.611 177.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.532 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.7 OUTLIER -156.99 151.06 24.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.626 179.425 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.64 ' HG2' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.61 149.57 23.14 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -177.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.77 ' HD2' ' HB1' ' A' ' 81' ' ' ALA . 49.3 m-85 -106.4 107.78 18.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.21 -111.92 3.35 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.908 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -94.1 -9.36 36.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.774 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.754 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 101.97 18.38 17.85 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.675 -175.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -70.4 -45.09 66.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.814 -0.693 . . . . 0.0 110.335 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.64 24.54 29.49 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.754 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 3.8 t80 -65.95 98.18 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.871 0.469 . . . . 0.0 110.205 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.432 ' HE ' ' C ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -103.11 46.6 0.91 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.074 0.464 . . . . 0.0 110.063 179.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.635 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.48 -156.21 30.97 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.674 -176.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.778 ' HB3' ' HZ3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -150.15 23.56 0.84 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.867 0.365 . . . . 0.0 110.82 -171.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.779 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 21.7 mmt180 -71.92 139.87 48.94 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 171.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.412 ' C ' ' HG1' ' A' ' 15' ' ' THR . 5.2 m -140.86 31.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.514 0.673 . . . . 0.0 110.895 -170.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.87 HG21 ' HA2' ' A' ' 19' ' ' GLY . 87.2 m -152.32 130.6 12.02 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -173.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.403 HG21 ' HB3' ' A' ' 73' ' ' ASP . 71.9 p -69.85 -172.83 0.56 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -170.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 m -67.07 -20.01 26.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.869 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -92.19 -13.29 30.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.765 0.793 . . . . 0.0 108.964 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.87 ' HA2' HG21 ' A' ' 15' ' ' THR . . . 82.91 17.65 67.12 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.367 -174.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.867 HG22 ' HB2' ' A' ' 67' ' ' ASN . 96.4 m -77.48 124.32 86.77 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 167.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.43 133.4 48.56 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.343 2.029 . . . . 0.0 113.217 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.9 m -71.8 140.41 49.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.72 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -73.11 167.19 21.66 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.234 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.486 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 4.8 m-20 -76.28 125.86 29.93 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.67 ' CE3' HD23 ' A' ' 46' ' ' LEU . 54.2 m95 -52.92 -32.94 48.2 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.69 0.757 . . . . 0.0 109.006 174.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.6 -16.63 58.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.727 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.486 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.44 150.27 23.21 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 118.668 0.667 . . . . 0.0 109.401 -172.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 33.4 mm-40 -107.74 21.14 17.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -146.6 137.11 12.35 Favored Pre-proline 0 N--CA 1.428 -1.54 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.375 -167.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.35 18.86 11.94 Favored 'Cis proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.367 -1.514 . . . . 0.0 112.993 1.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.588 ' HB3' HD11 ' A' ' 71' ' ' LEU . 62.2 m80 -128.98 106.9 9.2 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.431 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -72.61 126.1 29.06 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.485 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.9 p80 -154.94 94.26 1.63 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.132 0.968 . . . . 0.0 110.835 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -79.08 35.89 0.27 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.616 175.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.485 ' H ' ' C ' ' A' ' 33' ' ' HIS . 31.3 pt -143.12 143.86 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.573 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 32.1 m-85 55.39 47.75 20.55 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 122.16 0.981 . . . . 0.0 110.919 -175.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 p -102.66 174.98 2.48 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.467 168.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.45 -25.58 76.09 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.662 1.574 . . . . 0.0 111.775 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -88.17 -32.61 18.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.744 -174.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 p -90.72 -18.97 24.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.284 -177.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.573 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.8 m120 -133.63 61.58 54.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.733 0.301 . . . . 0.0 110.933 177.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.2 42.26 1.09 Allowed 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.843 2.362 . . . . 0.0 112.829 -176.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.62 -14.02 1.1 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.664 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.656 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -103.5 8.22 37.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.443 0.64 . . . . 0.0 110.69 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . 58.17 49.07 79.05 Favored Glycine 0 C--O 1.221 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.575 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.67 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.4 mp -76.54 93.25 3.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.218 0.533 . . . . 0.0 110.661 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.64 ' HB2' ' HD2' ' A' ' 50' ' ' TYR . 1.5 mt-10 -101.28 136.21 41.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.548 -177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 90.1 mttt 48.4 -104.4 0.12 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.73 0.644 . . . . 0.0 112.118 174.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -138.16 15.15 2.82 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.223 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.64 ' HD2' ' HB2' ' A' ' 47' ' ' GLU . 32.2 m-85 -65.89 125.81 26.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.554 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 78.9 m -49.44 151.98 1.42 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.546 0.529 . . . . 0.0 111.901 -175.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 41.6 mmt-85 -154.41 168.63 26.02 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.475 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -130.36 80.11 71.13 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 169.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.651 ' HG3' HD22 ' A' ' 46' ' ' LEU . 25.2 Cg_exo -60.27 -28.06 86.12 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.837 2.358 . . . . 0.0 111.966 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -93.67 -23.22 18.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.605 0.717 . . . . 0.0 110.424 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.5 38.75 96.32 Favored Glycine 0 CA--C 1.497 -1.034 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.988 -172.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -61.27 141.88 57.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.126 -0.537 . . . . 0.0 110.153 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 t -75.85 49.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.604 0.716 . . . . 0.0 110.928 -175.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -129.53 -16.56 1.84 Allowed Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.77 175.73 18.18 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.48 152.06 59.8 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.754 1.636 . . . . 0.0 111.497 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.603 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 31.4 p-90 -139.63 -173.68 3.69 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.327 -172.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.623 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.4 p -168.3 -179.75 4.13 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.269 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -101.23 145.29 29.02 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 p -101.34 151.23 22.15 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.788 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.7 p -85.82 20.13 2.29 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.332 168.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.867 ' HB2' HG22 ' A' ' 20' ' ' THR . 56.7 t-20 -95.4 116.17 66.08 Favored Pre-proline 0 CA--C 1.518 -0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.409 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.12 -0.2 2.05 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.83 2.354 . . . . 0.0 113.59 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -84.2 -55.46 4.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.799 0.333 . . . . 0.0 111.212 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -117.13 155.03 30.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.403 0.621 . . . . 0.0 110.666 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' A' ' 31' ' ' HIS . 49.1 tp -85.35 -43.63 13.52 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.499 -176.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -143.38 162.53 35.49 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.403 ' HB3' HG21 ' A' ' 16' ' ' THR . 42.2 t0 -156.96 175.47 14.05 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.87 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -94.41 156.23 16.58 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 90.5 m -105.19 168.37 9.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.945 0.402 . . . . 0.0 110.722 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.84 65.82 0.77 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.915 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.779 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.7 p -105.56 126.58 30.47 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.188 176.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.97 157.59 19.9 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 123.915 3.076 . . . . 0.0 113.906 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.07 113.81 12.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.222 -1.353 . . . . 0.0 110.307 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.532 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.62 -42.43 51.72 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.329 178.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.77 ' HB1' ' HD2' ' A' ' 3' ' ' PHE . . . -93.43 55.22 2.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.2 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.217 179.837 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -82.79 -7.09 59.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 68.36 21.58 8.27 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.861 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.43 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 32.2 t0 -87.09 60.29 6.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 122.139 0.971 . . . . 0.0 109.137 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.582 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -151.3 159.18 44.46 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.908 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.51 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 11.9 ptt? -96.97 152.44 18.71 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.595 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 82.0 m-85 -109.65 94.64 5.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.18 -114.08 3.77 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -173.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -79.7 -26.36 40.93 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.84 0.965 . . . . 0.0 110.248 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.4 13.96 19.47 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.401 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.695 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 97.4 mttt -65.4 -40.71 93.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.163 0.506 . . . . 0.0 110.065 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -107.37 25.75 20.66 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 172.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.644 ' CE1' HG23 ' A' ' 77' ' ' VAL . 3.7 t80 -66.56 108.83 2.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.71 40.42 2.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.154 0.502 . . . . 0.0 110.097 -175.526 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.567 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -93.98 -162.21 35.59 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.797 -176.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -139.8 18.69 2.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.915 0.388 . . . . 0.0 110.189 -169.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.778 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 18.7 mmt180 -66.88 135.82 54.44 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 m -137.9 34.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 121.75 0.786 . . . . 0.0 110.027 -171.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.915 HG22 ' HA2' ' A' ' 19' ' ' GLY . 86.4 m -153.05 125.65 8.24 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -169.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.619 HG22 ' HB3' ' A' ' 73' ' ' ASP . 81.9 p -69.97 -171.54 0.44 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -170.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.5 -23.11 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 121.505 0.669 . . . . 0.0 111.015 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.9 p -91.89 -15.7 27.73 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.796 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.915 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.48 20.02 55.41 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.955 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 67' ' ' ASN . 52.6 m -76.41 122.78 87.32 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 167.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.36 129.74 26.92 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.717 2.278 . . . . 0.0 113.536 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.8 m -68.68 144.26 54.5 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.46 0.647 . . . . 0.0 111.504 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -76.93 167.51 21.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.45 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.1 129.02 35.47 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.696 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 65.7 m95 -56.49 -32.37 64.96 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.54 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.98 -16.65 56.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.831 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.17 148.06 22.55 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.561 ' CA ' ' HA ' ' A' ' 32' ' ' ARG . 31.8 mm-40 -102.64 29.35 5.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -148.26 124.33 5.3 Favored Pre-proline 0 N--CA 1.421 -1.883 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.656 -156.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -85.07 25.74 11.61 Favored 'Cis proline' 0 C--N 1.344 0.33 0 C-N-CA 123.944 -1.273 . . . . 0.0 112.942 1.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.693 ' HB3' HD11 ' A' ' 71' ' ' LEU . 54.8 m80 -133.34 108.73 8.89 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.561 ' HA ' ' CA ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -75.17 129.63 37.84 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.234 -175.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.453 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.2 p80 -155.34 101.97 2.24 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.982 0.896 . . . . 0.0 110.154 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 t -80.71 29.67 0.31 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.841 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.453 ' H ' ' C ' ' A' ' 33' ' ' HIS . 22.0 pt -142.23 144.56 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -175.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.563 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 38.0 m-85 54.69 48.68 19.73 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 122.112 0.958 . . . . 0.0 110.639 -175.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 p -101.77 173.97 3.22 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.342 168.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.89 -28.5 87.55 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 121.728 1.618 . . . . 0.0 112.228 173.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -89.85 -33.9 16.31 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.143 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.9 p -85.42 -19.13 31.79 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.723 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.563 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.9 m120 -135.43 64.71 60.14 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.376 177.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.27 20.8 0.56 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.333 2.022 . . . . 0.0 111.915 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.452 ' H ' ' C ' ' A' ' 41' ' ' ASN . 14.6 ptt180 -114.32 -17.41 11.82 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.675 -177.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.625 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -108.1 6.1 26.6 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.135 0.493 . . . . 0.0 110.539 -176.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.93 46.21 94.05 Favored Glycine 0 C--O 1.228 -0.268 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.793 172.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.681 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.4 mp -73.92 104.77 4.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.148 0.499 . . . . 0.0 110.662 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.841 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.6 pt-20 -118.11 137.14 53.14 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.879 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 61.9 mmtt 45.98 -110.79 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.738 0.649 . . . . 0.0 112.569 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -135.45 17.63 3.37 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.17 0.509 . . . . 0.0 110.124 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.841 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 16.3 m-85 -70.47 131.36 43.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.546 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 86.2 m -53.51 145.54 14.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 123.383 0.427 . . . . 0.0 111.231 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.46 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 34.9 mmt-85 -150.18 161.05 43.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.174 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -122.55 79.76 47.03 Favored Pre-proline 0 C--N 1.319 -0.733 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.781 173.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.562 ' HG3' HD22 ' A' ' 46' ' ' LEU . 18.4 Cg_exo -64.35 -25.81 63.79 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.618 2.212 . . . . 0.0 112.33 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.97 -17.17 26.79 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.533 0.682 . . . . 0.0 109.748 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.695 ' HA3' ' HE2' ' A' ' 7' ' ' LYS . . . 55.66 40.57 79.66 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.397 -171.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 59' ' ' GLY . 9.0 t70 -47.88 138.32 8.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 124.4 0.706 . . . . 0.0 109.815 174.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 t -74.77 8.08 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.535 0.683 . . . . 0.0 110.407 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -102.14 -16.73 22.43 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.03 179.69 16.16 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.627 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.51 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 58.2 Cg_endo -71.33 161.09 46.83 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.442 2.095 . . . . 0.0 112.02 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.533 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 23.0 p-90 -150.7 -170.3 3.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.548 -171.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.696 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.4 p -169.19 -178.26 3.15 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.919 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 58.2 m-85 -101.78 147.22 26.74 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 170.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.453 ' HB ' ' CG2' ' A' ' 20' ' ' THR . 0.9 OUTLIER -105.0 147.29 27.96 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.062 -170.131 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.6 p -80.41 13.92 2.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.1 0.476 . . . . 0.0 110.811 172.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.691 ' HB2' HG21 ' A' ' 20' ' ' THR . 55.9 t-20 -93.68 123.31 60.28 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.417 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.63 2.83 1.74 Allowed 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.633 2.222 . . . . 0.0 113.261 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -84.24 -46.37 11.91 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.469 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 4.5 ptmt -134.92 154.92 51.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.531 0.681 . . . . 0.0 111.184 -174.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 31' ' ' HIS . 43.2 tp -83.61 -38.37 21.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.808 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 16.7 p90 -142.54 161.73 37.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.768 -175.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.619 ' HB3' HG22 ' A' ' 16' ' ' THR . 34.5 t0 -165.26 166.54 18.73 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -94.39 158.72 15.44 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.69 169.27 8.57 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -123.25 67.79 0.99 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.381 0.61 . . . . 0.0 110.128 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.778 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.4 p -99.5 130.38 26.98 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.451 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.36 159.09 24.23 Favored 'Trans proline' 0 CA--C 1.512 -0.582 0 C-N-CA 124.061 3.174 . . . . 0.0 113.539 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.09 112.1 12.18 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.696 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.505 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -75.64 -39.36 57.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.599 179.236 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.595 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -86.09 44.6 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.107 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.2 -179.531 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 65.7 p . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -94.61 9.72 37.61 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 70.67 2.82 4.28 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.215 -174.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.619 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 32.6 t70 -85.51 63.53 8.12 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.876 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -160.56 150.49 17.77 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.266 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.611 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.8 ptt? -97.0 152.96 18.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.397 0.618 . . . . 0.0 112.548 -177.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.587 ' CD2' ' HB1' ' A' ' 81' ' ' ALA . 71.4 m-85 -109.57 99.23 8.46 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.24 -109.04 2.68 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.472 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -78.1 -30.48 49.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 125.005 1.062 . . . . 0.0 110.596 -175.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 111.89 22.28 6.03 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.915 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -71.5 -41.0 69.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.782 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 10' ' ' ARG . . . -99.67 17.34 57.66 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.506 171.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.73 ' CE1' HG22 ' A' ' 77' ' ' VAL . 4.2 t80 -62.43 104.06 0.47 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 173.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -106.83 36.27 2.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 -177.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.621 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -94.25 -161.76 35.12 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.483 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.16 17.93 2.26 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.587 0.232 . . . . 0.0 110.91 -169.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.696 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.7 mmt180 -65.89 138.24 57.73 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.87 40.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.746 0.784 . . . . 0.0 111.018 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.23 148.9 28.78 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.831 -177.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.414 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 44.3 p -75.57 -173.84 2.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.611 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.29 -18.15 22.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.452 0.644 . . . . 0.0 111.137 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.1 p -93.06 -14.66 27.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.569 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.75 11.04 62.45 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.403 -0.904 . . . . 0.0 111.482 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.906 HG21 ' HB2' ' A' ' 67' ' ' ASN . 98.5 m -76.55 121.58 85.11 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.882 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.28 124.62 9.38 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.198 2.599 . . . . 0.0 113.576 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.94 141.15 58.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.904 171.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -72.43 166.89 21.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.387 174.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.467 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 7.6 t0 -76.48 129.13 36.06 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.741 ' CE3' HD22 ' A' ' 46' ' ' LEU . 64.9 m95 -57.32 -31.54 65.79 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.321 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.13 -16.16 57.09 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.116 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 24' ' ' ASP . . . -94.35 147.33 23.32 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.666 -172.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.443 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 32.4 mm-40 -106.66 16.58 24.34 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.467 ' HG2' HH11 ' A' ' 32' ' ' ARG . 35.2 mt-10 -147.65 143.38 17.82 Favored Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.526 -172.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.49 25.16 6.67 Favored 'Cis proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.928 -1.697 . . . . 0.0 113.256 1.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.613 ' HB3' HD11 ' A' ' 71' ' ' LEU . 65.1 m80 -135.33 108.55 7.75 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -75.5 117.87 17.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.891 -174.563 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.443 ' C ' ' H ' ' A' ' 35' ' ' ILE . 3.9 p80 -147.04 99.25 3.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.175 0.988 . . . . 0.0 111.087 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 m -77.71 27.75 0.17 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.804 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.3 pt -140.88 149.76 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.484 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 48.9 m-85 50.97 47.36 24.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 122.069 0.937 . . . . 0.0 110.765 -175.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 58.6 p -100.61 175.81 2.2 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.04 172.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 11.7 Cg_exo -71.14 -9.33 25.33 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 121.951 1.767 . . . . 0.0 111.253 169.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -91.31 -33.67 15.23 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.786 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.9 p -95.92 -26.69 15.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.185 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.513 ' O ' HD12 ' A' ' 46' ' ' LEU . 14.0 m120 -133.28 60.56 49.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.523 -174.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -77.82 23.45 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.881 1.721 . . . . 0.0 112.272 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -111.35 -22.19 11.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.514 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.585 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -103.17 9.42 38.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.093 0.473 . . . . 0.0 110.911 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.41 46.93 91.5 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.351 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.741 HD22 ' CE3' ' A' ' 25' ' ' TRP . 5.4 mp -76.96 74.39 3.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.596 0.712 . . . . 0.0 110.13 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.683 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.0 pt-20 -97.27 136.45 37.75 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.714 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 25.9 mmmt 51.49 -111.29 0.55 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.814 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -137.6 18.22 2.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.257 0.551 . . . . 0.0 110.317 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.683 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 30.8 m-85 -67.61 130.16 42.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.503 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 89.6 m -54.52 149.54 10.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.298 0.374 . . . . 0.0 111.158 -174.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.503 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 39.8 mmt-85 -153.03 170.29 20.81 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.624 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -131.14 77.5 74.63 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.519 170.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.698 ' HG3' HD21 ' A' ' 46' ' ' LEU . 29.7 Cg_endo -68.42 -13.26 37.12 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.285 1.99 . . . . 0.0 112.471 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -96.75 -26.14 15.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.922 0.868 . . . . 0.0 109.507 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.09 39.15 97.66 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.558 -167.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -44.34 132.36 5.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.044 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 t -69.74 -0.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.508 0.671 . . . . 0.0 110.763 -176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.4 -18.64 35.24 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.5 -179.23 16.29 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.698 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.611 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 88.8 Cg_endo -77.14 158.0 33.83 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.224 1.949 . . . . 0.0 111.231 -175.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.486 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 22.1 p-90 -150.08 -170.77 3.73 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.065 -169.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.685 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.2 p -168.81 -178.49 3.39 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.646 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 57.3 m-85 -100.93 147.64 25.91 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 170.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.9 p -103.55 149.2 25.1 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.437 -171.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 p -83.35 28.34 0.54 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.508 0.67 . . . . 0.0 109.963 168.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.906 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.0 t-20 -108.16 121.14 44.64 Favored Pre-proline 0 N--CA 1.456 -0.149 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.238 -175.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.44 -1.03 4.96 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.749 2.299 . . . . 0.0 113.498 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -84.69 -33.11 23.24 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.67 147.69 29.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.108 0.48 . . . . 0.0 110.769 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.613 HD11 ' HB3' ' A' ' 31' ' ' HIS . 37.8 tp -72.4 -45.56 59.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.549 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 21.5 p90 -143.54 162.8 34.92 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.67 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.414 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 14.0 t0 -158.83 172.05 18.94 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 55.6 m-85 -94.62 157.01 16.16 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.6 m -104.76 172.82 6.59 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.289 0.368 . . . . 0.0 110.454 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -122.8 69.0 0.98 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.187 0.518 . . . . 0.0 110.305 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.73 HG22 ' CE1' ' A' ' 9' ' ' TYR . 2.3 p -102.05 132.39 21.62 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.665 176.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 77' ' ' VAL . 11.0 Cg_endo -55.66 150.71 42.71 Favored 'Trans proline' 0 CA--C 1.512 -0.608 0 C-N-CA 124.25 3.3 . . . . 0.0 113.826 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -76.77 109.76 10.82 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.789 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.13 -38.26 57.01 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.694 178.276 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.587 ' HB1' ' CD2' ' A' ' 3' ' ' PHE . . . -90.97 61.33 4.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.971 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.054 178.789 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 76.7 p . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -94.94 -5.4 44.85 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . 0.431 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . 66.29 15.4 10.08 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.432 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.671 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 41.3 t0 -99.78 59.42 1.07 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.086 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.601 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -150.79 152.51 33.92 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.558 -179.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.749 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 12.3 ptt? -96.78 159.33 14.98 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.61 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 85.5 m-85 -114.23 100.63 8.5 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.475 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.36 -115.33 4.0 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.019 -175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -82.41 -19.84 38.27 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 124.411 0.712 . . . . 0.0 110.486 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.623 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.09 17.06 13.4 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.999 -174.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -66.91 -50.97 60.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.493 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -97.88 28.49 14.25 Favored Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 172.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.656 ' CE1' HG23 ' A' ' 77' ' ' VAL . 3.6 t80 -69.51 102.57 1.84 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 173.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -106.45 40.59 1.59 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.337 0.589 . . . . 0.0 109.772 -176.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.649 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -90.41 -154.45 30.05 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.941 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -151.24 23.59 0.73 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.858 0.361 . . . . 0.0 110.556 -172.555 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.934 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 20.2 mmt180 -68.9 135.99 51.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.9 m -136.96 36.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 122.037 0.923 . . . . 0.0 109.573 -174.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 1.047 HG22 ' HA2' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -151.65 133.41 14.88 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.235 -172.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 56.5 p -73.76 -170.6 0.9 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.091 -176.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 m -63.94 -21.66 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.302 0.573 . . . . 0.0 110.712 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.3 p -92.89 -10.79 35.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.115 0.96 . . . . 0.0 109.08 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 1.047 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 82.98 11.92 80.53 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.23 -173.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.409 HG22 ' HB2' ' A' ' 67' ' ' ASN . 80.8 m -71.28 121.2 83.59 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 82.6 Cg_exo -51.03 134.76 43.53 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 C-N-CA 122.713 2.276 . . . . 0.0 113.353 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 86.1 m -75.53 141.76 42.93 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.541 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -72.94 165.95 23.97 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.231 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.52 126.2 30.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.705 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 48.7 m95 -54.65 -29.4 52.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 175.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.63 -22.4 54.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.972 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.67 150.45 21.16 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -172.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.585 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.5 mm-40 -104.76 31.45 4.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 26.7 mt-10 -147.2 123.31 5.49 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 113.705 -1.589 . . . . 0.0 114.163 -156.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 86.1 Cg_endo -86.44 27.03 11.9 Favored 'Cis proline' 0 C--N 1.346 0.438 0 C-N-CA 123.445 -1.481 . . . . 0.0 112.97 0.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.508 ' HB3' HD11 ' A' ' 71' ' ' LEU . 56.8 m80 -129.0 108.43 10.4 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.585 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.7 tmm_? -79.23 122.46 26.34 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -173.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.454 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.3 p80 -150.24 97.16 2.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.92 0.867 . . . . 0.0 110.821 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.27 35.46 0.22 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.56 0.695 . . . . 0.0 110.107 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.454 ' H ' ' C ' ' A' ' 33' ' ' HIS . 23.0 pt -143.11 142.5 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -175.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.597 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 42.9 m-85 50.56 51.02 17.72 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 122.124 0.964 . . . . 0.0 111.591 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 26.5 p -99.58 175.94 2.18 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.025 169.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 25.5 Cg_exo -64.59 -21.21 65.79 Favored 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 121.91 1.74 . . . . 0.0 111.877 172.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -100.33 -23.63 14.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.395 -171.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 35.4 p -90.32 -19.18 24.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.262 0.553 . . . . 0.0 109.646 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.597 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.2 m120 -136.16 62.76 46.9 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.888 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.66 9.08 1.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.168 1.912 . . . . 0.0 111.955 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 41' ' ' ASN . 10.1 ptt180 -111.18 -12.33 14.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.476 -177.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.695 ' HB2' HD12 ' A' ' 46' ' ' LEU . . . -104.49 8.2 35.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.135 0.493 . . . . 0.0 110.149 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.35 44.67 97.76 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 114.825 -1.079 . . . . 0.0 113.419 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.703 HD22 ' HG3' ' A' ' 54' ' ' PRO . 5.3 mp -80.17 96.47 6.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.224 0.535 . . . . 0.0 110.834 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.638 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.3 pt-20 -111.59 135.12 52.61 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.658 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 48' ' ' LYS . 23.9 mmtp 56.06 -118.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.663 0.602 . . . . 0.0 111.998 175.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -130.82 14.01 5.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.922 0.392 . . . . 0.0 110.804 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.638 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 20.7 m-85 -66.06 133.13 50.11 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.595 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 73.8 m -54.93 149.78 11.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.848 0.356 . . . . 0.0 111.833 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' CG ' HH11 ' A' ' 52' ' ' ARG . 0.1 OUTLIER -153.48 162.53 41.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.714 -175.608 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -125.69 80.99 65.83 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.268 171.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.703 ' HG3' HD22 ' A' ' 46' ' ' LEU . 15.1 Cg_exo -64.53 -21.09 66.15 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.676 2.25 . . . . 0.0 112.029 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -89.63 -30.74 17.92 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.979 0.895 . . . . 0.0 109.304 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.66 39.53 95.42 Favored Glycine 0 N--CA 1.433 -1.51 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.054 -166.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 59' ' ' GLY . 11.9 t70 -43.79 131.59 5.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 124.452 0.737 . . . . 0.0 109.587 170.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 t -70.82 3.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.274 0.559 . . . . 0.0 111.07 -174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -99.27 -22.13 13.65 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.06 -175.59 19.1 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.761 -1.209 . . . . 0.0 111.78 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.749 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 97.8 Cg_endo -76.82 159.95 34.43 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.515 2.144 . . . . 0.0 111.708 -174.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.551 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.0 p-90 -148.88 -172.85 4.21 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.879 -172.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.705 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.8 p -168.73 -178.87 3.56 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.305 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -100.84 140.83 34.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.3 p -99.84 148.64 24.22 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.36 -171.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.2 p -76.99 15.0 0.74 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.982 0.42 . . . . 0.0 110.968 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 69' ' ' ARG . 24.0 t30 -100.84 119.69 57.64 Favored Pre-proline 0 C--O 1.233 0.2 0 C-N-CA 123.168 0.587 . . . . 0.0 111.057 -177.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.4 Cg_exo -69.47 6.7 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.307 2.671 . . . . 0.0 113.503 -178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.506 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 21.3 mmm180 -82.26 -49.35 10.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.025 0.441 . . . . 0.0 110.704 173.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.14 134.96 33.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.596 0.713 . . . . 0.0 111.186 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 31' ' ' HIS . 40.3 tp -64.78 -39.92 94.39 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.541 -172.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -143.19 164.82 29.12 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.464 ' HB3' HG21 ' A' ' 16' ' ' THR . 44.5 t0 -162.0 172.28 16.22 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -92.81 156.21 17.14 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 96.2 m -104.66 170.01 8.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.236 0.541 . . . . 0.0 111.325 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.85 67.26 0.66 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.136 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.934 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 5.0 p -111.66 129.51 24.08 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.324 0.583 . . . . 0.0 110.994 174.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.43 161.76 33.46 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 123.941 3.094 . . . . 0.0 113.708 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.79 114.47 14.43 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.088 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.601 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.77 -41.23 60.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.333 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.61 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -80.73 48.59 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.688 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.592 -0.718 . . . . 0.0 110.448 -179.622 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.982 0.42 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -88.2 -9.48 52.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.373 -176.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 66.28 21.08 11.05 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.511 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.407 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 26.3 t70 -90.35 59.4 4.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.981 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.502 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -152.24 158.69 43.18 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.7 178.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.719 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 9.4 ptt? -97.5 154.59 17.4 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.548 0.69 . . . . 0.0 112.65 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.671 ' HD2' ' HB3' ' A' ' 81' ' ' ALA . 53.9 m-85 -110.29 105.8 14.96 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.29 -114.58 3.91 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.162 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -88.21 -16.07 34.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.98 -0.61 . . . . 0.0 109.832 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.718 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.56 11.22 25.58 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.937 -173.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -63.16 -40.5 97.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.511 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.16 22.33 27.45 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.201 173.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.718 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 4.2 t80 -66.46 109.98 2.95 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 172.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -119.01 39.21 3.6 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.472 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -91.33 -152.57 28.41 Favored Glycine 0 C--O 1.235 0.19 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.538 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.403 ' HD3' ' HB2' ' A' ' -1' ' ' ASP . 0.0 OUTLIER -149.07 23.71 0.94 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.916 0.388 . . . . 0.0 110.899 -170.763 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.71 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.8 mmt180 -69.78 137.55 51.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.441 ' C ' ' HG1' ' A' ' 15' ' ' THR . 3.8 m -138.26 34.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.64 0.733 . . . . 0.0 111.063 -170.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.592 HG22 ' HA2' ' A' ' 19' ' ' GLY . 2.1 m -151.46 138.29 18.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.3 p -74.88 -174.67 2.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.903 -173.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.06 -17.98 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.417 0.627 . . . . 0.0 110.728 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p -92.75 -14.58 27.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.187 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.592 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.6 15.8 63.06 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.5 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.866 HG22 ' HB2' ' A' ' 67' ' ' ASN . 89.7 m -77.11 122.5 86.39 Favored Pre-proline 0 N--CA 1.448 -0.555 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 168.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -51.72 125.05 15.83 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.309 2.006 . . . . 0.0 112.7 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.404 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 85.4 m -63.29 141.83 58.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.348 0.594 . . . . 0.0 110.652 173.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 25.2 tt0 -74.86 165.34 25.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.476 176.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 4.1 m-20 -76.07 124.57 27.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.655 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 40.7 m95 -54.87 -29.98 56.84 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.07 -17.8 58.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.198 -1.364 . . . . 0.0 113.314 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.26 151.78 22.27 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 119.093 0.86 . . . . 0.0 109.339 -173.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.68 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.0 mm-40 -103.18 32.46 3.74 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 49.1 mt-10 -143.62 118.01 6.11 Favored Pre-proline 0 N--CA 1.429 -1.512 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -156.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 70.4 Cg_endo -89.68 31.07 10.26 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.52 -1.45 . . . . 0.0 113.316 1.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.595 ' HB3' HD13 ' A' ' 71' ' ' LEU . 61.9 m80 -130.77 110.76 11.57 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.68 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.1 OUTLIER -74.53 119.26 18.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.648 -176.52 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.459 ' HE1' ' HA ' ' A' ' 25' ' ' TRP . 4.2 p80 -151.86 99.23 2.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.17 0.986 . . . . 0.0 110.271 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 t -82.15 32.13 0.39 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.568 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.455 ' H ' ' C ' ' A' ' 33' ' ' HIS . 26.5 pt -141.26 151.8 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -177.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.58 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 39.1 m-85 51.04 47.11 25.46 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.04 0.924 . . . . 0.0 111.038 -173.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.427 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 28.0 p -99.42 171.16 5.93 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.027 171.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 39.7 Cg_exo -59.64 -21.33 62.18 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.132 1.888 . . . . 0.0 112.219 171.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -101.9 -19.85 15.1 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.533 -170.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.9 p -96.91 -18.02 19.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.134 0.492 . . . . 0.0 110.182 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.58 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.2 m120 -136.02 64.63 55.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.028 -177.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.89 18.07 0.66 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.633 2.222 . . . . 0.0 112.736 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -109.93 -23.54 11.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.411 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.61 ' HB1' HD12 ' A' ' 46' ' ' LEU . . . -102.13 7.11 41.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.353 0.597 . . . . 0.0 110.469 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.93 42.88 99.58 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.771 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.61 HD12 ' HB1' ' A' ' 44' ' ' ALA . 5.4 mp -74.95 110.39 9.21 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.52 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.3 pt-20 -128.6 149.22 50.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.801 172.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.986 ' HE2' ' HA ' ' A' ' 48' ' ' LYS . 5.0 mmpt? 49.67 -111.05 0.46 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.001 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -139.85 18.1 2.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.11 0.481 . . . . 0.0 110.236 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.52 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 33.4 m-85 -67.34 126.41 29.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.558 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 71.7 m -51.68 152.73 2.68 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.556 0.535 . . . . 0.0 111.689 -174.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 44.0 mmt-85 -154.37 170.69 20.75 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.348 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -133.3 77.11 67.12 Favored Pre-proline 0 C--N 1.319 -0.721 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.438 171.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HD2' ' CE2' ' A' ' 62' ' ' TRP . 27.9 Cg_exo -61.06 -33.39 91.78 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.769 2.313 . . . . 0.0 112.427 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -90.72 -16.04 29.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.491 0.663 . . . . 0.0 110.366 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.09 48.7 84.81 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.358 -175.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 59' ' ' GLY . 4.4 t0 -48.48 129.01 15.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 t -75.91 31.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 122.085 0.945 . . . . 0.0 110.319 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -125.18 -14.49 3.3 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 175.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.78 -179.51 16.2 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.719 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 95.2 Cg_endo -76.31 161.03 35.37 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.348 2.032 . . . . 0.0 111.713 -174.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.507 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.1 p-90 -145.46 -173.07 4.02 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.223 -173.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.655 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.3 p -167.98 -178.94 3.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.5 ' CD1' ' HB3' ' A' ' 72' ' ' TYR . 48.4 m-85 -100.24 145.29 28.25 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.43 ' HB ' HG22 ' A' ' 20' ' ' THR . 4.4 p -98.86 153.91 18.43 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.611 -171.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.0 p -85.77 26.58 0.95 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.334 0.587 . . . . 0.0 110.143 166.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.866 ' HB2' HG22 ' A' ' 20' ' ' THR . 59.3 t-20 -107.52 118.76 52.59 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.495 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.46 2.39 1.96 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.904 2.402 . . . . 0.0 113.392 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -83.77 -46.38 12.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.328 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.05 151.92 51.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.999 0.428 . . . . 0.0 110.558 -176.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 31' ' ' HIS . 41.7 tp -76.29 -43.18 42.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.386 -177.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.5 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 50.4 p90 -143.93 169.33 18.02 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.777 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -161.68 178.37 9.08 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -96.44 156.3 16.4 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 81.5 m -105.89 168.94 8.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.872 0.368 . . . . 0.0 110.888 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -116.89 70.5 0.77 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.263 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.71 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 4.2 p -110.86 127.06 27.53 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.304 0.574 . . . . 0.0 110.883 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.65 160.5 20.64 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 124.165 3.243 . . . . 0.0 113.761 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -75.56 112.71 12.18 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.216 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.487 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -75.87 -43.37 45.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.364 176.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.671 ' HB3' ' HD2' ' A' ' 3' ' ' PHE . . . -83.33 61.16 6.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.031 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.949 178.641 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . 0.637 HD22 ' HD3' ' A' ' 12' ' ' LYS . 55.7 t30 -117.63 -8.31 10.94 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 67.92 15.63 9.55 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.335 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.446 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 20.6 t0 -90.27 61.37 5.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.645 -1.162 . . . . 0.0 108.791 175.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.46 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.6 OUTLIER -156.4 151.55 26.43 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.906 -176.43 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.729 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 8.4 ptt? -97.4 158.19 15.6 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.75 ' HD1' ' HB1' ' A' ' 81' ' ' ALA . 79.0 m-85 -113.94 96.15 5.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.36 -111.83 3.34 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -173.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -79.47 -29.52 41.73 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 124.626 0.839 . . . . 0.0 110.889 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.8 19.77 8.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.982 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.753 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 95.1 mttt -66.4 -38.08 86.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.873 0.368 . . . . 0.0 110.299 175.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.8 19.47 38.48 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 173.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.713 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -64.38 99.41 0.29 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 174.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.3 46.35 0.92 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.027 0.441 . . . . 0.0 110.249 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.667 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -97.06 -158.97 31.27 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.687 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.637 ' HD3' HD22 ' A' ' -3' ' ' ASN . 10.3 ptmm? -145.87 20.26 1.45 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.992 0.396 . . . . 0.0 110.802 -170.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.739 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.9 mmt180 -68.17 139.74 56.12 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -138.84 35.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.726 0.774 . . . . 0.0 110.677 -171.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.87 140.3 21.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.356 -176.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 46.6 p -75.43 -174.81 2.56 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.106 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.8 m -72.85 -12.62 15.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.454 0.645 . . . . 0.0 110.115 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.1 p -92.57 -13.54 29.54 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.904 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.95 7.57 70.4 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.342 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.881 HG21 ' HB2' ' A' ' 67' ' ' ASN . 92.9 m -75.68 120.06 79.95 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -47.46 123.48 8.05 Favored 'Trans proline' 0 CA--C 1.514 -0.52 0 C-N-CA 122.809 2.339 . . . . 0.0 112.861 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.402 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 84.6 m -62.27 135.43 57.47 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.474 0.654 . . . . 0.0 110.488 173.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 23.2 tt0 -68.26 164.8 19.82 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.225 174.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.466 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 15.0 m-20 -76.3 125.91 30.04 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.749 ' CE3' HD21 ' A' ' 46' ' ' LEU . 40.2 m95 -53.36 -31.71 45.79 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.12 -19.09 57.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.18 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.466 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.52 150.13 23.38 Favored 'General case' 0 C--O 1.21 -0.997 0 O-C-N 121.32 -0.863 . . . . 0.0 109.014 -173.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.728 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.9 mm-40 -103.24 33.64 3.22 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 23' ' ' GLN . 29.2 mt-10 -141.62 117.38 7.15 Favored Pre-proline 0 N--CA 1.435 -1.195 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -157.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.515 ' HD2' ' HD1' ' A' ' 31' ' ' HIS . 19.6 Cg_endo -91.8 33.38 8.98 Favored 'Cis proline' 0 C--N 1.347 0.464 0 C-N-CA 123.635 -1.402 . . . . 0.0 112.974 0.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.558 ' HB3' HD11 ' A' ' 71' ' ' LEU . 55.1 m80 -130.37 107.46 9.27 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.728 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -74.22 118.48 17.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.451 0.643 . . . . 0.0 109.889 -178.086 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.461 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.4 p80 -147.65 99.15 3.07 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 122.002 0.906 . . . . 0.0 109.957 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -80.12 32.98 0.28 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.601 175.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.461 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.5 pt -141.91 147.85 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -176.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.519 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 38.3 m-85 53.12 45.55 28.46 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 122.01 0.91 . . . . 0.0 110.96 -174.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 18.1 p -99.11 172.46 4.68 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.586 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 28.6 Cg_exo -60.59 -20.45 64.73 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 121.855 1.703 . . . . 0.0 111.818 172.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -91.37 -35.7 14.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.089 -175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.8 p -85.91 -25.23 26.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.822 0.344 . . . . 0.0 110.447 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.519 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.3 m120 -132.8 65.21 73.77 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.015 0.436 . . . . 0.0 110.814 -178.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.89 13.5 1.22 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.327 2.018 . . . . 0.0 112.13 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -103.56 -21.37 13.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.84 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.633 ' HB2' HD13 ' A' ' 46' ' ' LEU . . . -107.57 -0.83 21.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.54 -175.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.82 46.41 67.66 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.684 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.78 HD23 ' HG3' ' A' ' 54' ' ' PRO . 5.4 mp -76.52 67.2 2.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.776 0.322 . . . . 0.0 110.872 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 6.1 pt-20 -94.42 151.28 19.5 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.713 0.292 . . . . 0.0 110.762 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.8 mptp? 48.24 -110.32 0.35 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.442 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -140.18 17.84 2.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.965 0.412 . . . . 0.0 110.613 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.473 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 27.8 m-85 -66.75 126.57 29.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.649 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.497 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 93.6 m -53.79 150.73 7.1 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 123.468 0.48 . . . . 0.0 111.96 -173.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 41.9 mmt-85 -153.74 165.99 34.25 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.924 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -131.33 76.38 75.93 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.002 172.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.78 ' HG3' HD23 ' A' ' 46' ' ' LEU . 34.9 Cg_exo -55.8 -35.7 94.04 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.844 2.362 . . . . 0.0 112.318 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.89 -12.36 25.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.91 -175.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.753 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 59.17 52.15 55.03 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.526 -174.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.475 ' C ' ' H ' ' A' ' 59' ' ' GLY . 6.1 t70 -51.26 133.65 28.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 174.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.02 9.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.616 0.722 . . . . 0.0 110.568 -175.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -107.04 -15.98 14.85 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.73 -177.48 17.04 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.295 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.729 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 73.5 Cg_endo -73.8 158.4 46.74 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.37 2.046 . . . . 0.0 110.984 -175.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.547 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 31.5 p-90 -144.13 -176.31 4.96 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.441 -172.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.562 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.4 p -167.92 179.64 4.6 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.472 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.473 ' CD1' ' HB3' ' A' ' 72' ' ' TYR . 49.5 m-85 -99.18 146.43 26.17 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.463 ' HB ' HG21 ' A' ' 20' ' ' THR . 3.9 p -99.0 150.78 21.62 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.474 -170.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.9 p -85.03 23.14 1.27 Allowed 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.008 166.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.881 ' HB2' HG21 ' A' ' 20' ' ' THR . 56.9 t-20 -99.65 117.79 63.09 Favored Pre-proline 0 N--CA 1.456 -0.135 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.098 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.27 4.96 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.87 2.38 . . . . 0.0 113.632 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -88.37 -38.84 14.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.755 0.312 . . . . 0.0 111.21 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 159.9 41.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.136 0.493 . . . . 0.0 111.38 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 31' ' ' HIS . 49.9 tp -81.37 -49.61 10.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.968 -175.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.548 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 17.8 p90 -143.6 163.65 32.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.958 0.408 . . . . 0.0 110.701 -178.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -154.56 -175.7 5.54 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.103 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -93.79 158.79 15.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 86.9 m -105.94 169.94 8.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.278 0.561 . . . . 0.0 111.474 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -115.27 72.31 0.79 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.096 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.739 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.5 p -113.46 128.54 25.57 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.373 0.606 . . . . 0.0 110.697 174.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.16 155.49 34.21 Favored 'Trans proline' 0 CA--C 1.513 -0.531 0 C-N-CA 123.941 3.094 . . . . 0.0 113.871 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.27 111.3 11.56 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.32 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.453 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.26 -39.38 54.54 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.08 179.218 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.75 ' HB1' ' HD1' ' A' ' 3' ' ' PHE . . . -87.44 62.13 6.98 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.585 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.969 179.06 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.801 0.334 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -83.51 -5.58 59.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 73.87 10.96 4.59 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.706 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' ASP . . . . . 0.529 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 24.1 t0 -88.55 58.85 4.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.228 1.013 . . . . 0.0 109.576 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.589 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -156.35 152.9 28.17 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.916 -179.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.529 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.0 ptt? -95.6 151.2 19.54 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.557 ' HD2' ' HB3' ' A' ' 81' ' ' ALA . 79.5 m-85 -109.26 96.27 6.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.88 -115.97 4.12 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -174.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -79.59 -21.92 44.38 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 124.684 0.873 . . . . 0.0 110.291 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.71 15.68 16.22 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.166 -176.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -63.81 -34.56 78.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.065 0.46 . . . . 0.0 110.146 176.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -109.98 20.01 27.0 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 174.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.737 ' CE1' HG22 ' A' ' 77' ' ' VAL . 4.9 t80 -68.22 101.07 1.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.053 0.454 . . . . 0.0 110.185 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.407 ' HE ' ' C ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -107.63 49.3 0.81 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.611 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.75 -151.76 28.24 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.858 -176.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.52 ' HE2' ' HB3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -150.73 22.78 0.79 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.928 0.394 . . . . 0.0 111.017 -174.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.859 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.8 mmt180 -68.35 137.58 54.72 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 170.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.426 ' C ' ' HG1' ' A' ' 15' ' ' THR . 5.4 m -140.06 30.86 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 121.804 0.811 . . . . 0.0 110.796 -171.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.726 HG21 ' HA2' ' A' ' 19' ' ' GLY . 7.3 m -151.45 134.81 16.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -174.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.401 HG22 HG22 ' A' ' 65' ' ' THR . 75.9 p -73.0 -176.92 2.23 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.122 0.487 . . . . 0.0 112.242 -170.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -67.23 -15.65 19.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.367 0.603 . . . . 0.0 110.806 177.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.0 p -93.09 -15.36 26.16 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.839 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.726 ' HA2' HG21 ' A' ' 15' ' ' THR . . . 85.35 15.53 66.31 Favored Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.352 -174.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.952 HG22 ' HB2' ' A' ' 67' ' ' ASN . 85.1 m -78.32 121.88 84.4 Favored Pre-proline 0 N--CA 1.446 -0.67 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 169.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -48.51 131.59 23.73 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.713 2.275 . . . . 0.0 113.216 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.9 m -71.0 137.13 48.8 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.586 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -71.1 166.09 22.16 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.153 174.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.558 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 10.0 m-20 -75.98 127.73 33.57 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.7 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 43.3 m95 -54.35 -31.47 54.54 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.04 -16.69 57.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.915 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.558 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -98.02 148.04 23.9 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 118.625 0.648 . . . . 0.0 109.616 -173.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 32' ' ' ARG . 31.4 mm-40 -106.58 14.86 26.52 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -176.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.478 ' HA ' ' N ' ' A' ' 31' ' ' HIS . 44.6 mt-10 -147.77 145.55 21.57 Favored Pre-proline 0 N--CA 1.431 -1.382 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.273 -174.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.93 20.46 5.76 Favored 'Cis proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.458 -1.476 . . . . 0.0 113.334 1.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.478 ' N ' ' HA ' ' A' ' 29' ' ' GLU . 62.9 m80 -131.61 107.65 8.98 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 32' ' ' ARG . 3.4 mpt_? -74.93 115.34 14.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.5 p80 -147.23 98.09 2.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.088 0.946 . . . . 0.0 111.621 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.07 33.1 0.18 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.531 173.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.427 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.9 pt -142.02 147.05 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.579 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 52.0 m-85 49.93 47.68 22.89 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.09 0.947 . . . . 0.0 111.276 -173.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 30.9 p -100.05 174.57 2.92 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.869 170.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 20.9 Cg_exo -66.15 -16.26 51.43 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.868 1.712 . . . . 0.0 111.348 170.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -91.07 -34.33 15.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.371 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.9 p -93.94 -20.4 20.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.551 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.579 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.3 m120 -133.35 65.05 71.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.202 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.9 25.75 0.5 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.487 2.125 . . . . 0.0 111.746 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' H ' ' C ' ' A' ' 41' ' ' ASN . 5.2 ptm180 -115.44 -13.35 11.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.555 -176.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.565 ' O ' ' HD2' ' A' ' 52' ' ' ARG . . . -116.1 4.38 13.66 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.53 -175.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.48 41.71 96.17 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.856 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.605 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.5 mp -70.85 99.64 1.78 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.821 0.343 . . . . 0.0 110.287 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.562 ' HB3' ' HD2' ' A' ' 50' ' ' TYR . 28.4 tt0 -109.84 148.95 30.59 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.941 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.49 ' HG2' ' HG2' ' A' ' 47' ' ' GLU . 46.2 mmtm 46.84 -109.62 0.25 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.543 1.152 . . . . 0.0 111.271 173.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -135.63 17.63 3.33 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.874 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.562 ' HD2' ' HB3' ' A' ' 47' ' ' GLU . 34.6 m-85 -66.12 128.68 37.06 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.097 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.589 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 70.8 m -53.62 148.99 8.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.243 0.544 . . . . 0.0 112.284 -174.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' HD2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -154.7 157.47 38.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.89 -174.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.4 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 19.1 t-20 -122.45 81.55 46.55 Favored Pre-proline 0 N--CA 1.446 -0.646 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.243 171.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.569 ' HD2' ' CZ2' ' A' ' 62' ' ' TRP . 19.4 Cg_exo -63.25 -24.67 72.15 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.399 2.066 . . . . 0.0 112.397 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.75 -27.47 21.15 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.025 0.916 . . . . 0.0 109.575 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.29 39.6 98.03 Favored Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.925 -166.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' C ' ' H ' ' A' ' 59' ' ' GLY . 9.4 t70 -43.93 133.26 5.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.909 -0.646 . . . . 0.0 110.042 170.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 t -70.87 5.94 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.62 0.724 . . . . 0.0 110.878 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -99.83 -18.14 23.62 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.42 179.64 16.1 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.269 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.529 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 60.5 Cg_endo -71.59 157.61 55.56 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.272 1.981 . . . . 0.0 111.49 -176.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.569 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 25.1 p-90 -146.68 -170.89 3.63 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.819 -170.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.7 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.6 p -168.36 -178.59 3.63 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.789 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.458 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 53.1 m-85 -100.53 144.43 29.53 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 171.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 3.6 p -101.82 150.7 22.9 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.38 -171.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.7 p -84.41 35.0 0.53 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.358 0.599 . . . . 0.0 109.791 167.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.952 ' HB2' HG22 ' A' ' 20' ' ' THR . 57.8 t-20 -115.63 123.77 30.88 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.269 -176.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.2 Cg_exo -69.13 -1.3 7.71 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.787 2.325 . . . . 0.0 113.682 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -84.02 -38.01 21.43 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.778 0.323 . . . . 0.0 111.777 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -143.9 143.14 31.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.134 0.492 . . . . 0.0 110.116 -176.58 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.458 ' O ' ' HD1' ' A' ' 64' ' ' TYR . 52.5 tp -71.05 -38.03 72.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.645 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -143.55 160.9 39.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -156.17 176.03 13.21 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -94.68 156.59 16.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 77.5 m -106.2 166.13 10.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.964 0.411 . . . . 0.0 111.55 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -101.74 33.0 3.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.023 -172.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.859 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 4.6 p -81.85 127.22 73.13 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-O 121.519 0.675 . . . . 0.0 111.63 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.66 161.61 27.78 Favored 'Trans proline' 0 CA--C 1.515 -0.466 0 C-N-CA 124.378 3.385 . . . . 0.0 113.78 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.33 114.05 13.42 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.605 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.589 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.07 -40.23 53.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.632 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.557 ' HB3' ' HD2' ' A' ' 3' ' ' PHE . . . -79.91 51.07 1.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.655 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.844 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.831 179.76 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.486 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.644 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 9.8 ptt? -96.64 156.64 16.26 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.611 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 81.4 m-85 -113.35 97.82 6.72 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.85 -114.26 3.86 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.426 ' OD1' ' HA ' ' A' ' 58' ' ' VAL . 91.8 m-20 -79.35 -24.68 42.54 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.573 0.808 . . . . 0.0 110.58 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.46 17.65 11.12 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.733 -1.222 . . . . 0.0 111.632 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -65.46 -43.95 88.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.174 0.511 . . . . 0.0 109.822 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -103.68 25.09 27.79 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.749 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.2 t80 -67.3 103.38 1.25 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 171.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -108.27 45.18 1.04 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.205 0.526 . . . . 0.0 109.677 -176.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.639 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -95.56 -155.37 31.16 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.93 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 7.1 ptmt -148.87 20.06 1.0 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.802 0.334 . . . . 0.0 111.012 -170.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.864 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.1 mmt180 -66.86 139.07 57.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 171.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.64 38.4 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.676 0.75 . . . . 0.0 110.742 -171.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.47 ' HB ' ' HA2' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -151.4 147.94 27.5 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.345 -175.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.0 p -74.32 -172.85 1.54 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.529 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 m -65.22 -16.75 20.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.393 0.616 . . . . 0.0 111.371 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -94.19 -13.75 26.33 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.037 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 15' ' ' THR . . . 87.02 14.84 63.85 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.598 -170.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.975 HG21 ' HB2' ' A' ' 67' ' ' ASN . 86.4 m -75.78 119.52 77.5 Favored Pre-proline 0 N--CA 1.448 -0.564 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 171.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -48.12 129.22 18.23 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.999 2.466 . . . . 0.0 113.564 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.7 m -70.04 134.77 48.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.073 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 24.0 tt0 -67.95 166.36 15.89 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.663 174.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.521 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 3.2 m-20 -76.07 125.99 30.17 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.696 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 39.1 m95 -54.76 -31.07 58.12 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 173.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.2 -21.0 56.97 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.938 -1.483 . . . . 0.0 113.267 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -103.08 150.64 23.41 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 119.168 0.895 . . . . 0.0 109.061 -172.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.778 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 27.7 mm-40 -103.2 35.31 2.59 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 37.3 mt-10 -145.29 119.64 5.59 Favored Pre-proline 0 N--CA 1.432 -1.327 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -156.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 93.8 Cg_endo -89.43 32.1 9.0 Favored 'Cis proline' 0 C--N 1.346 0.42 0 C-N-CA 123.424 -1.49 . . . . 0.0 112.979 0.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.536 ' HB3' HD12 ' A' ' 71' ' ' LEU . 53.4 m80 -130.91 108.01 9.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.778 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.0 123.07 22.77 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.516 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.4 p80 -151.71 94.57 2.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.108 0.956 . . . . 0.0 110.142 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.9 m -75.23 29.63 0.1 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.398 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.516 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.4 pt -141.6 151.0 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.51 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 39.9 m-85 51.74 47.13 25.38 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 122.032 0.92 . . . . 0.0 111.274 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.7 p -99.28 170.88 6.27 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 114.266 -1.334 . . . . 0.0 108.124 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.14 -17.26 59.3 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.704 1.602 . . . . 0.0 111.804 172.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.84 -20.48 14.28 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.37 -171.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.432 ' C ' ' HD3' ' A' ' 42' ' ' PRO . 42.6 p -98.47 -15.48 19.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.196 0.522 . . . . 0.0 110.241 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.575 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 12.8 m120 -135.8 55.12 11.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.064 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 10.1 Cg_exo -71.16 36.61 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.071 2.514 . . . . 0.0 112.842 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.77 -9.95 2.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.319 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.735 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -110.58 12.6 22.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.412 . . . . 0.0 111.266 -176.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.15 44.01 97.79 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-N 115.27 -0.877 . . . . 0.0 113.37 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.1 mp -80.46 111.78 17.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.056 0.455 . . . . 0.0 110.52 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.636 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 2.0 pt-20 -124.47 134.59 53.0 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.662 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 48' ' ' LYS . 61.0 mmtt 50.75 -107.57 0.3 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -137.11 13.97 3.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.059 0.456 . . . . 0.0 110.19 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.636 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 22.2 m-85 -67.36 131.03 44.91 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.537 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 79.1 m -54.04 149.74 8.92 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.247 0.342 . . . . 0.0 111.571 -173.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 33.6 mmt-85 -153.94 165.94 34.53 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.438 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -127.88 79.46 73.65 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.238 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.71 ' HG3' HD21 ' A' ' 46' ' ' LEU . 37.6 Cg_exo -58.96 -35.83 97.9 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.556 2.17 . . . . 0.0 112.281 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -91.54 -17.28 25.89 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.252 0.549 . . . . 0.0 110.644 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.65 47.77 86.65 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.313 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.12 131.97 23.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.426 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 3.3 t -74.38 8.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.565 0.698 . . . . 0.0 110.556 -175.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.58 -18.95 19.46 Favored Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.22 179.58 16.15 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.772 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.644 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 90.6 Cg_endo -73.86 156.78 48.07 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.502 2.134 . . . . 0.0 111.277 -175.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.572 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.5 p-90 -144.89 -172.76 3.9 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.292 -171.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.696 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.8 p -168.65 -179.03 3.65 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.034 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.471 ' CD1' ' HG ' ' A' ' 71' ' ' LEU . 39.7 m-85 -100.75 144.77 29.32 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 171.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.6 p -102.95 146.23 28.65 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.442 -170.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 p -81.87 27.73 0.45 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.482 0.658 . . . . 0.0 109.779 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.975 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.4 t-20 -102.1 120.58 53.28 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.785 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.75 0.04 3.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.246 2.631 . . . . 0.0 113.557 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -84.17 -53.41 5.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.78 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.59 149.78 52.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.36 0.6 . . . . 0.0 111.056 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 31' ' ' HIS . 36.2 tp -69.92 -45.77 66.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.117 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 11.3 p90 -142.66 162.34 35.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -156.88 -177.96 7.01 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -97.97 155.74 16.95 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 93.5 m -103.75 173.74 6.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.098 0.475 . . . . 0.0 111.029 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -119.69 71.47 0.88 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.536 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.864 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.7 p -108.54 130.03 23.26 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.654 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.83 153.91 47.32 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 123.824 3.016 . . . . 0.0 113.68 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.59 112.61 12.12 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.326 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.486 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.45 -40.75 57.12 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.436 178.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.611 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.186 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.527 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.441 -0.9 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.774 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.4 ptt? -96.63 149.57 21.64 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.673 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 80.8 m-85 -107.07 102.34 11.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.43 -111.65 3.31 Favored Glycine 0 N--CA 1.425 -2.068 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.498 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.594 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 81.4 m-20 -78.87 -27.46 44.02 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.551 0.795 . . . . 0.0 110.555 -176.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.668 ' HA2' ' HB2' ' A' ' 2' ' ' MET . . . 111.61 17.33 8.69 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.594 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 43.1 mtmt -65.46 -47.93 74.42 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.41 -0.895 . . . . 0.0 109.711 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.21 23.32 36.8 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.473 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.0 t80 -65.42 98.49 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.072 0.463 . . . . 0.0 109.962 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.408 ' HE ' ' HA ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -102.96 44.47 1.01 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -177.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.613 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -95.55 -155.27 31.12 Favored Glycine 0 N--CA 1.454 -0.104 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.741 -175.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -144.35 15.6 1.66 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.873 0.337 . . . . 0.0 110.696 -174.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.71 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 12.8 mmt180 -66.08 133.26 50.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.63 37.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.532 0.682 . . . . 0.0 111.174 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.24 147.7 27.99 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.168 -177.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.518 ' HB ' ' OD2' ' A' ' 73' ' ' ASP . 66.4 p -75.53 -174.17 2.39 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.028 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 m -65.63 -17.53 22.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.58 0.705 . . . . 0.0 110.878 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 50.6 p -93.57 -14.69 26.24 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.903 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.28 11.95 63.9 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.517 -172.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.722 HG21 ' HB2' ' A' ' 67' ' ' ASN . 98.4 m -75.95 119.43 77.18 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 173.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -49.68 127.85 19.71 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.868 2.379 . . . . 0.0 113.244 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.5 m -68.48 138.59 55.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.875 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -69.06 165.65 19.79 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.528 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 26' ' ' ALA . 5.8 t70 -77.21 129.08 35.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.689 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 59.5 m95 -58.73 -31.53 68.38 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.414 ' HB3' ' OD1' ' A' ' 24' ' ' ASP . . . -78.33 -15.08 59.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.492 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.21 148.49 26.26 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -175.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.768 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.6 mm-40 -102.28 33.71 3.01 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 41.7 mt-10 -145.22 120.72 5.83 Favored Pre-proline 0 N--CA 1.429 -1.495 0 CA-C-N 114.61 -1.177 . . . . 0.0 114.046 -157.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 97.1 Cg_endo -90.41 37.05 5.16 Favored 'Cis proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.258 -1.559 . . . . 0.0 113.641 0.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.414 ' HB3' HD12 ' A' ' 71' ' ' LEU . 53.3 m80 -133.56 112.56 11.59 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.768 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 23.1 mmm180 -73.35 114.48 11.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -176.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.8 p80 -146.98 91.11 1.97 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.345 1.069 . . . . 0.0 110.395 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.8 t -77.29 35.46 0.17 Allowed 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.263 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.521 ' H ' ' C ' ' A' ' 33' ' ' HIS . 19.4 pt -143.95 141.42 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.586 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 42.1 m-85 55.85 47.09 20.93 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.062 0.934 . . . . 0.0 111.04 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 18.8 p -99.58 175.23 2.53 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.649 168.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 36.5 Cg_exo -60.91 -22.22 73.5 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 121.713 1.609 . . . . 0.0 112.001 172.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.71 -28.73 13.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.464 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.9 p -88.04 -17.03 32.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.068 0.461 . . . . 0.0 110.241 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.586 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.0 m120 -137.77 55.0 8.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.531 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 8.7 Cg_exo -71.04 35.39 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.807 2.338 . . . . 0.0 112.971 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 -11.03 3.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.035 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.708 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -110.56 13.27 22.65 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.997 0.427 . . . . 0.0 110.859 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.39 43.98 95.47 Favored Glycine 0 C--O 1.224 -0.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.861 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.1 mp -80.16 100.75 8.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.0 0.4 . . . . 0.0 111.161 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.5 pt-20 -121.72 149.88 42.61 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.762 172.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.403 ' O ' ' HD1' ' A' ' 25' ' ' TRP . 42.0 mmtm 50.65 -124.96 2.24 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.22 0.95 . . . . 0.0 111.022 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -128.49 19.39 6.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.039 0.447 . . . . 0.0 110.486 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.466 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 24.1 m-85 -66.87 127.1 31.21 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 175.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.593 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 78.8 m -52.61 150.75 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 111.543 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -154.76 159.59 40.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -123.28 78.01 53.05 Favored Pre-proline 0 C--N 1.317 -0.819 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.045 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.623 ' HG3' HD21 ' A' ' 46' ' ' LEU . 18.0 Cg_endo -70.37 -11.47 30.1 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.472 2.115 . . . . 0.0 112.971 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -99.07 -22.79 15.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.427 0.632 . . . . 0.0 109.816 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.89 51.02 60.04 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.878 -170.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -53.42 128.58 29.14 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 171.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.3 7.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.427 0.632 . . . . 0.0 110.361 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.86 -15.1 27.46 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 111.221 -0.751 . . . . 0.0 111.221 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.33 178.73 15.58 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 119.705 -1.236 . . . . 0.0 111.87 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.774 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 91.9 Cg_endo -77.45 163.58 29.6 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.686 2.257 . . . . 0.0 111.867 -175.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.527 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.4 p-90 -148.5 -171.28 3.81 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.053 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.689 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.8 p -168.47 -178.25 3.46 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.029 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.415 ' HE2' ' HB2' ' A' ' 36' ' ' PHE . 56.3 m-85 -100.75 144.59 29.54 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 171.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 p -99.91 143.99 29.49 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.239 -172.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 p -78.55 14.24 1.34 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.542 170.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.722 ' HB2' HG21 ' A' ' 20' ' ' THR . 59.8 t-20 -86.86 119.97 71.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 18.7 Cg_exo -65.02 0.21 2.77 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.728 2.285 . . . . 0.0 113.102 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -85.33 -55.26 4.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.174 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 12.3 ptmt -120.32 160.16 23.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.315 0.579 . . . . 0.0 111.025 -174.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.414 HD12 ' HB3' ' A' ' 31' ' ' HIS . 55.0 tp -87.62 -46.76 9.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.452 -176.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -143.79 164.23 31.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.989 0.423 . . . . 0.0 110.461 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.518 ' OD2' ' HB ' ' A' ' 16' ' ' THR . 32.2 t0 -160.47 173.56 15.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.673 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 69.5 m-85 -92.85 156.23 17.11 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.9 m -105.11 170.31 7.94 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.044 0.449 . . . . 0.0 111.154 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -114.57 73.82 0.84 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.338 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.71 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.1 p -114.2 128.04 26.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.491 0.662 . . . . 0.0 111.037 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 17.3 Cg_endo -57.47 158.75 18.26 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 124.489 3.459 . . . . 0.0 114.226 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.0 111.41 10.18 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.451 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.503 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.36 -41.41 56.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.241 178.089 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.673 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.948 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.568 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.441 -0.88 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.449 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.8 ptt? -94.86 155.41 16.8 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.563 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 91.2 m-85 -113.53 95.43 5.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.81 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.44 -106.53 2.07 Favored Glycine 0 N--CA 1.426 -1.991 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -172.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.436 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 8.0 m-20 -77.7 -35.89 51.63 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.856 0.974 . . . . 0.0 110.517 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . 112.06 17.89 8.1 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.104 -1.046 . . . . 0.0 110.945 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 46.7 mtmt -70.9 -35.02 72.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.062 -0.569 . . . . 0.0 109.656 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -104.25 19.91 41.69 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.702 171.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.714 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -67.06 109.99 3.23 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 171.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -114.98 48.06 1.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.082 0.467 . . . . 0.0 110.026 -176.681 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.614 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -99.64 -156.97 28.6 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.815 -0.629 . . . . 0.0 113.565 -172.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.42 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 11.4 ptmm? -141.73 13.89 2.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.453 0.168 . . . . 0.0 111.198 -169.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.706 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 32.8 mmt180 -66.05 137.48 57.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.43 36.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.286 0.565 . . . . 0.0 111.997 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.27 146.44 26.79 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.461 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 58.7 p -74.52 -174.06 1.95 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.681 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -66.49 -17.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.414 0.626 . . . . 0.0 110.752 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.4 p -92.77 -14.62 27.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.444 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.74 11.1 64.23 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.302 -173.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.983 HG21 ' HB2' ' A' ' 67' ' ' ASN . 84.6 m -75.85 119.43 77.13 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -45.85 124.13 6.79 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 123.119 2.546 . . . . 0.0 113.532 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.8 m -65.94 136.12 55.66 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.151 173.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -68.29 164.92 19.62 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.715 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -77.68 127.11 31.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.764 ' CE3' HD23 ' A' ' 46' ' ' LEU . 71.6 m95 -57.24 -31.0 65.09 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.613 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.66 -18.13 54.9 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.615 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.68 151.24 20.32 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.693 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.8 mm-40 -104.41 33.44 3.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 48.3 mt-10 -144.94 120.53 5.92 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -156.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 83.8 Cg_endo -87.91 27.96 12.76 Favored 'Cis proline' 0 C--N 1.344 0.339 0 C-N-CA 123.206 -1.581 . . . . 0.0 112.807 0.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.411 ' HB3' HD12 ' A' ' 71' ' ' LEU . 39.7 m80 -127.87 109.23 11.4 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.693 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.55 118.31 16.36 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.348 -177.221 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.425 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.0 p80 -149.19 100.12 3.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.255 1.026 . . . . 0.0 110.269 -177.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 m -81.74 30.49 0.37 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.056 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.7 pt -141.4 147.57 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.624 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 37.0 m-85 52.68 47.65 24.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.886 0.85 . . . . 0.0 111.093 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 22.4 p -100.19 175.42 2.4 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.314 170.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 19.0 Cg_exo -65.45 -17.6 57.95 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.371 1.381 . . . . 0.0 111.138 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -87.98 -38.37 15.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.178 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 p -90.32 -22.82 21.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.313 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.624 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.3 m120 -132.7 67.87 78.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.079 0.466 . . . . 0.0 111.021 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.96 5.98 2.32 Favored 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.344 2.029 . . . . 0.0 112.698 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -97.4 -26.99 14.67 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.401 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -99.49 4.85 46.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.406 0.622 . . . . 0.0 111.126 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.92 46.33 94.77 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.176 174.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.764 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.6 mp -71.18 86.94 0.78 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.385 0.612 . . . . 0.0 109.939 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.948 ' HG2' ' HD3' ' A' ' 48' ' ' LYS . 20.1 tt0 -102.45 145.84 28.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.858 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.948 ' HD3' ' HG2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER 44.12 -106.46 0.1 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.384 1.053 . . . . 0.0 110.949 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -138.68 22.11 2.69 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.984 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.595 ' HD2' ' HB3' ' A' ' 47' ' ' GLU . 28.6 m-85 -69.39 128.35 36.23 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.38 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 77.6 m -51.54 148.22 5.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.446 0.466 . . . . 0.0 111.417 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 36.7 mmt-85 -154.09 164.24 38.8 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.481 -176.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -126.23 77.04 72.35 Favored Pre-proline 0 C--N 1.321 -0.664 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.132 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.563 ' HG3' HD21 ' A' ' 46' ' ' LEU . 27.7 Cg_endo -70.63 -16.9 33.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.207 1.938 . . . . 0.0 112.746 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -90.18 -27.65 19.43 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.671 0.748 . . . . 0.0 109.503 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.75 46.63 91.44 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.621 -169.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 59' ' ' GLY . 6.8 t70 -54.4 135.79 44.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.4 16.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.918 0.866 . . . . 0.0 109.978 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -104.49 -20.96 9.63 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 175.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.83 176.0 14.6 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.177 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 57.1 Cg_endo -70.13 159.92 51.43 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.319 2.013 . . . . 0.0 111.613 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.54 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.9 p-90 -149.61 -168.14 3.02 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.954 -169.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.74 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.7 p -168.2 -178.99 3.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.586 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.419 ' HE2' ' HB2' ' A' ' 36' ' ' PHE . 39.2 m-85 -100.17 146.48 26.8 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 172.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.3 p -103.54 144.4 31.47 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.009 -1.076 . . . . 0.0 109.662 -171.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.413 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 36.2 p -79.81 17.37 0.95 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.213 169.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.983 ' HB2' HG21 ' A' ' 20' ' ' THR . 56.4 t-20 -94.48 124.94 53.75 Favored Pre-proline 0 C--O 1.229 -0.026 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.343 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.1 4.62 1.81 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.688 2.259 . . . . 0.0 113.309 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -85.01 -58.26 2.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -122.14 161.05 23.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.732 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.413 ' O ' ' HD1' ' A' ' 64' ' ' TYR . 57.4 tp -86.21 -45.33 11.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.604 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 4.2 p90 -143.34 159.4 42.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.703 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.461 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 47.4 t0 -154.5 172.43 17.8 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.8 155.5 17.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 71.2 m -105.41 171.76 7.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.947 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -115.7 60.99 0.7 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.378 0.609 . . . . 0.0 110.337 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.714 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.4 p -97.87 129.43 31.22 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.427 0.632 . . . . 0.0 110.398 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.478 ' HD2' HG23 ' A' ' 77' ' ' VAL . 36.2 Cg_endo -63.01 160.2 35.01 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 123.986 3.124 . . . . 0.0 113.49 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.34 111.9 11.08 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.028 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.506 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.09 -41.99 57.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.846 178.131 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.563 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.445 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.587 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.428 ' SD ' ' NE2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -98.07 146.74 25.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.64 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 67.9 m-85 -104.27 103.58 13.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.3 -107.78 2.3 Favored Glycine 0 N--CA 1.422 -2.239 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.336 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.522 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 86.3 m-20 -80.73 -32.46 35.72 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 124.819 0.952 . . . . 0.0 110.415 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 110.59 20.22 7.45 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.079 -1.057 . . . . 0.0 110.97 -174.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.522 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 47.4 mtmt -66.02 -45.14 82.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.89 -0.655 . . . . 0.0 109.812 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.14 27.25 20.16 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.635 ' CE1' ' HA3' ' A' ' 11' ' ' GLY . 2.9 t80 -65.19 101.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HE ' ' C ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -102.24 51.26 0.82 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.013 0.435 . . . . 0.0 110.69 -177.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.635 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -108.42 -163.86 20.89 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.71 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -142.21 16.79 2.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.721 0.26 . . . . 0.0 110.926 -170.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.843 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 19.5 mmt180 -64.42 136.61 57.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.0 m -138.59 40.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.857 0.837 . . . . 0.0 110.422 -172.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.993 HG23 ' HA2' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -150.81 135.08 16.94 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.158 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.564 HG21 ' HB3' ' A' ' 73' ' ' ASP . 54.5 p -74.03 -170.57 0.95 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.026 0.441 . . . . 0.0 112.035 -175.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.2 -18.89 24.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.427 0.632 . . . . 0.0 110.875 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.4 p -93.45 -13.09 28.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.995 0.902 . . . . 0.0 109.063 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.993 ' HA2' HG23 ' A' ' 15' ' ' THR . . . 81.02 20.56 64.86 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.904 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.961 HG21 ' HB2' ' A' ' 67' ' ' ASN . 60.0 m -75.69 123.27 88.32 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 169.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 78.1 Cg_exo -50.28 135.4 38.74 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.497 2.131 . . . . 0.0 113.128 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.0 m -75.49 141.41 43.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.533 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -71.45 163.32 27.92 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.88 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 6.3 m-20 -76.7 125.16 28.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.738 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 38.6 m95 -53.34 -30.56 40.0 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.49 -14.04 59.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.013 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.89 148.52 27.51 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.694 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 36.1 mm-40 -103.39 29.71 5.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.74 127.06 6.91 Favored Pre-proline 0 N--CA 1.426 -1.644 0 CA-C-N 113.581 -1.645 . . . . 0.0 114.104 -159.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -85.61 26.32 11.67 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 123.853 -1.311 . . . . 0.0 112.59 1.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.673 ' HB3' HD12 ' A' ' 71' ' ' LEU . 68.3 m80 -129.17 104.01 7.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.694 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -74.61 118.2 17.3 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -176.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.491 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.7 p80 -144.8 92.73 2.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.75 0.786 . . . . 0.0 110.509 -173.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 m -74.1 31.42 0.08 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.705 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.491 ' H ' ' C ' ' A' ' 33' ' ' HIS . 25.7 pt -142.79 143.86 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.593 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 72.2 m-85 49.53 50.81 17.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.92 0.867 . . . . 0.0 111.185 -173.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 60.5 p -103.03 176.48 1.8 Allowed Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.468 171.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 24.2 Cg_exo -66.44 -11.49 31.79 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.98 1.787 . . . . 0.0 111.466 169.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -89.47 -40.72 12.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.09 0.471 . . . . 0.0 110.171 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.5 p -90.56 -22.55 21.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.251 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.625 ' O ' HD13 ' A' ' 46' ' ' LEU . 15.2 m120 -137.15 60.82 30.24 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.368 . . . . 0.0 111.514 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.53 20.33 0.69 Allowed 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 122.026 1.817 . . . . 0.0 112.396 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.58 -8.86 7.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.713 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -105.19 10.93 33.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.26 0.553 . . . . 0.0 110.324 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.76 41.68 73.19 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.163 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.796 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.5 mp -80.41 79.12 7.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.71 0.767 . . . . 0.0 110.368 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.819 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 7.2 pt-20 -101.78 136.48 41.54 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.818 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 11.0 mtpp 48.63 -105.98 0.17 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -141.67 11.62 2.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.646 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.819 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 23.2 m-85 -65.53 131.41 46.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.522 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 70.7 m -52.35 144.66 12.53 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.246 0.341 . . . . 0.0 111.028 -176.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 35.6 mmt-85 -149.32 168.78 22.42 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.268 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -129.49 77.86 76.59 Favored Pre-proline 0 C--N 1.313 -0.981 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.969 171.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.796 ' HG3' HD21 ' A' ' 46' ' ' LEU . 39.5 Cg_endo -72.93 -10.17 24.44 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.082 1.855 . . . . 0.0 111.801 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -90.98 -32.62 15.87 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 172.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.93 36.45 93.3 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.3 -165.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -46.84 134.05 10.36 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.942 -0.629 . . . . 0.0 109.877 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 13.0 t -70.09 0.31 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.563 0.697 . . . . 0.0 110.579 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.56 -19.95 39.37 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.46 -179.64 16.13 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.757 -1.211 . . . . 0.0 111.41 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -73.44 158.48 47.96 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.194 1.929 . . . . 0.0 111.859 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.497 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 19.2 p-90 -150.72 -169.24 3.33 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.867 -170.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.738 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.3 p -168.53 -176.62 2.87 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.5 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.556 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 84.1 m-85 -100.4 147.23 26.07 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 169.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 67' ' ' ASN . 2.7 p -100.62 149.7 23.48 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.741 -169.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.5 p -82.47 24.56 0.69 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.424 0.631 . . . . 0.0 109.89 167.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.961 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.7 t-20 -108.0 118.27 53.14 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.889 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 15.9 Cg_exo -68.66 5.95 1.14 Allowed 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.92 2.414 . . . . 0.0 113.585 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 -85.33 -49.13 8.4 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 149.04 52.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.163 0.506 . . . . 0.0 110.595 -175.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 31' ' ' HIS . 39.4 tp -76.37 -43.75 39.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.999 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 1.9 p90 -142.96 153.47 43.06 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.501 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.564 ' HB3' HG21 ' A' ' 16' ' ' THR . 18.9 t0 -152.98 164.85 37.2 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -175.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -92.48 156.56 17.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.59 171.76 7.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.827 0.346 . . . . 0.0 110.67 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -118.76 60.71 0.8 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.389 0.614 . . . . 0.0 109.99 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.843 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.5 p -102.28 130.44 24.18 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.396 0.617 . . . . 0.0 110.512 176.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.418 ' HD2' HG23 ' A' ' 77' ' ' VAL . 21.0 Cg_endo -60.12 160.9 20.96 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 124.691 3.594 . . . . 0.0 114.231 -176.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.428 ' NE2' ' SD ' ' A' ' 2' ' ' MET . 8.8 tp-100 -75.63 112.01 11.55 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.941 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.587 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.96 -41.61 50.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.724 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.64 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.252 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.582 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.624 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 16.2 ptt? -96.52 146.23 24.99 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.614 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 90.5 m-85 -105.47 99.47 9.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.25 -119.77 4.96 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.892 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -79.74 -18.12 51.91 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 124.481 0.753 . . . . 0.0 110.585 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.619 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.31 13.45 21.0 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.917 -174.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -64.5 -39.49 93.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.199 -0.501 . . . . 0.0 109.687 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.594 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -107.06 23.05 28.34 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 172.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.712 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.8 t80 -67.59 105.15 1.78 Allowed 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 172.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.52 39.06 2.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.17 0.509 . . . . 0.0 110.214 -175.124 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.459 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -94.72 -158.88 33.39 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.978 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.496 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 9.1 ptmm? -140.48 19.04 2.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.88 0.371 . . . . 0.0 110.33 -168.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.645 ' HB2' ' OH ' ' A' ' 9' ' ' TYR . 2.5 mpt_? -67.98 137.59 55.25 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 m -140.29 33.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.939 0.876 . . . . 0.0 110.322 -170.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.451 HG22 ' HA2' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -150.58 139.11 20.54 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -172.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.593 ' HB ' ' OD2' ' A' ' 73' ' ' ASP . 72.3 p -74.84 -176.22 2.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.647 0.261 . . . . 0.0 111.39 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.407 HG22 ' OD2' ' A' ' 73' ' ' ASP . 15.4 m -65.87 -20.41 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.647 0.737 . . . . 0.0 110.187 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 p -91.99 -14.23 29.77 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.529 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.451 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 89.94 11.97 62.71 Favored Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.846 -174.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.773 HG21 ' HB2' ' A' ' 67' ' ' ASN . 78.4 m -76.58 120.82 83.3 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 120.426 -0.509 . . . . 0.0 109.84 170.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -50.55 125.82 16.45 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.837 2.358 . . . . 0.0 113.198 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.4 m -64.44 137.87 58.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.499 0.666 . . . . 0.0 110.627 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 25.5 tt0 -71.22 166.12 22.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.925 174.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 1.0 OUTLIER -75.98 125.11 28.49 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.113 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.739 ' CE3' HD23 ' A' ' 46' ' ' LEU . 45.9 m95 -54.8 -29.25 54.02 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.611 0.719 . . . . 0.0 109.122 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.87 -21.35 55.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.556 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.69 150.38 22.8 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -172.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.755 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.5 mm-40 -103.5 33.0 3.53 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 43.4 mt-10 -143.17 119.58 6.66 Favored Pre-proline 0 N--CA 1.43 -1.474 0 CA-C-N 114.205 -1.361 . . . . 0.0 114.209 -157.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 88.9 Cg_endo -90.04 31.98 9.58 Favored 'Cis proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.298 -1.542 . . . . 0.0 113.456 1.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.491 ' HB3' HD12 ' A' ' 71' ' ' LEU . 61.5 m80 -131.63 113.02 13.1 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.755 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.72 116.55 14.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.823 -176.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.494 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.8 p80 -148.57 89.71 1.72 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.449 1.119 . . . . 0.0 110.543 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.1 m -78.19 35.84 0.22 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.996 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.494 ' H ' ' C ' ' A' ' 33' ' ' HIS . 20.1 pt -143.19 146.63 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.559 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 31.0 m-85 53.97 46.51 25.43 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.343 1.068 . . . . 0.0 110.629 -174.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.573 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 42.6 p -99.8 176.77 1.78 Allowed Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.145 170.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 30.3 Cg_exo -61.99 -21.58 72.64 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 121.959 1.773 . . . . 0.0 111.95 169.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -87.49 -34.71 18.56 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.981 0.419 . . . . 0.0 111.122 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.3 p -89.08 -24.03 22.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.973 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.559 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.0 m120 -136.03 59.28 27.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 21.1 Cg_exo -64.48 4.15 0.68 Allowed 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.476 2.117 . . . . 0.0 112.787 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.414 ' H ' ' C ' ' A' ' 41' ' ' ASN . 23.2 ptt180 -95.06 -19.36 20.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.588 0.233 . . . . 0.0 111.376 -173.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.737 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -109.09 2.74 21.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.595 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.05 47.48 85.04 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.262 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.899 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.6 mp -75.14 74.28 2.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.967 0.413 . . . . 0.0 111.5 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.528 ' HG3' ' CD2' ' A' ' 50' ' ' TYR . 3.0 pt-20 -98.94 152.83 19.35 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.669 176.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 48.0 mttp 49.96 -113.65 0.66 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.418 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -140.69 19.63 2.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.176 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.528 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 30.2 m-85 -61.92 128.83 38.06 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.676 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 80.5 m -53.76 145.23 16.19 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 38.8 mmt-85 -152.5 164.62 37.23 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.225 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -125.57 81.45 64.7 Favored Pre-proline 0 C--N 1.318 -0.762 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.719 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.899 ' HG3' HD21 ' A' ' 46' ' ' LEU . 39.1 Cg_exo -59.17 -31.89 96.15 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.727 2.285 . . . . 0.0 112.458 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -89.76 -20.0 24.07 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.525 0.679 . . . . 0.0 109.97 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.96 44.09 97.5 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.539 -168.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -48.03 135.09 13.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.414 -0.893 . . . . 0.0 109.443 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 58' ' ' VAL . 11.4 t -71.67 6.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 123.893 0.746 . . . . 0.0 110.868 -173.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.42 -17.82 13.0 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.88 -178.15 16.5 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 119.89 -1.148 . . . . 0.0 111.234 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.624 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 74.2 Cg_endo -73.5 157.92 48.43 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.091 1.861 . . . . 0.0 111.815 -174.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.551 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 32.2 p-90 -145.61 -172.09 3.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.717 -172.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.711 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.0 p -168.52 -179.82 4.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.122 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 43.7 m-85 -100.16 145.61 27.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.3 p -102.84 147.02 27.41 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.664 -170.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.7 p -80.99 23.57 0.55 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.383 0.611 . . . . 0.0 110.517 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.773 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.1 t-20 -103.98 121.76 46.73 Favored Pre-proline 0 CA--C 1.528 0.115 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.086 -177.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 16.5 Cg_exo -67.23 -0.33 4.81 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.888 2.392 . . . . 0.0 113.703 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -84.66 -44.98 12.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.836 0.35 . . . . 0.0 111.619 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.13 145.57 50.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.468 0.651 . . . . 0.0 111.048 -175.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 31' ' ' HIS . 41.8 tp -71.28 -43.04 67.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.621 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -143.29 164.29 30.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.089 0.471 . . . . 0.0 110.338 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.593 ' OD2' ' HB ' ' A' ' 16' ' ' THR . 33.0 t70 -157.94 173.89 16.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -93.63 158.67 15.58 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 86.6 m -106.37 171.24 7.46 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -122.64 69.25 0.97 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.3 0.571 . . . . 0.0 109.99 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.712 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.6 p -105.29 132.72 20.63 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.854 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 77' ' ' VAL . 51.8 Cg_endo -65.76 162.24 35.51 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 123.631 2.887 . . . . 0.0 113.378 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.437 ' OE1' ' HB3' ' A' ' 81' ' ' ALA . 9.3 tp-100 -75.6 108.96 8.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.231 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.492 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -73.3 -37.94 66.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.306 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.614 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.194 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.502 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.63 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.8 ptt? -97.29 150.74 20.61 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 121.358 0.599 . . . . 0.0 112.514 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.733 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 71.8 m-85 -109.7 102.07 10.91 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.38 -115.48 4.19 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 119.997 -1.097 . . . . 0.0 111.033 -175.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.18 -23.93 40.69 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 124.531 0.783 . . . . 0.0 109.576 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.535 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.31 17.41 10.75 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.313 -0.946 . . . . 0.0 110.969 -174.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -66.48 -39.9 89.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.103 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.575 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -105.61 20.69 36.33 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.653 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.0 t80 -65.31 105.19 1.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -113.08 35.78 3.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.233 0.54 . . . . 0.0 109.551 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -88.25 -154.04 27.17 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.995 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 4.7 ptmt -150.29 22.07 0.84 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.912 0.387 . . . . 0.0 110.687 -168.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.722 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 22.5 mmt180 -68.5 137.86 54.74 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 171.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.79 38.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.486 0.66 . . . . 0.0 111.655 -171.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.06 145.31 25.42 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.957 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.504 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 69.4 p -74.36 -174.05 1.89 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.042 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -63.71 -20.45 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.489 0.661 . . . . 0.0 110.818 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.4 p -92.87 -12.71 30.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.499 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.43 11.41 69.03 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.42 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.975 HG21 ' HB2' ' A' ' 67' ' ' ASN . 95.4 m -76.69 119.15 76.2 Favored Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.329 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -47.25 124.7 9.45 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 123.098 2.532 . . . . 0.0 113.689 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.8 m -63.5 139.48 58.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.425 0.631 . . . . 0.0 110.884 172.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 23.1 tt0 -71.16 164.81 24.9 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.021 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 5.3 m-20 -76.95 125.56 29.51 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.693 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 37.7 m95 -54.06 -31.79 52.62 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.59 -17.08 58.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.749 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . . . -106.82 150.41 26.38 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -174.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.89 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.3 mm-40 -102.61 29.52 5.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 4.0 mm-40 -133.78 119.47 14.92 Favored Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -159.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 88.7 Cg_endo -94.24 35.65 7.57 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.079 -1.634 . . . . 0.0 112.783 -0.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.451 ' HB3' HD12 ' A' ' 71' ' ' LEU . 58.2 m80 -126.81 107.48 10.16 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.89 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.0 OUTLIER -76.59 113.02 13.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.068 -175.135 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 5.0 p80 -143.53 92.53 2.37 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.997 0.903 . . . . 0.0 110.422 -172.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.4 m -77.47 39.11 0.25 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.47 0.653 . . . . 0.0 109.534 172.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.465 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.4 pt -143.37 135.86 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -173.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 45.6 m-85 53.58 48.2 22.2 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 122.265 1.031 . . . . 0.0 111.275 -175.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 46.9 p -99.84 175.54 2.36 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.101 170.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 22.6 Cg_exo -64.79 -18.52 62.72 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.798 1.666 . . . . 0.0 111.257 168.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -83.17 -38.94 21.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.314 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.3 p -92.04 -25.23 18.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.085 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.547 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.0 m120 -132.41 68.25 79.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.346 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.22 12.37 1.81 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.453 2.102 . . . . 0.0 112.159 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -100.12 -27.7 13.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 -174.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.678 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -105.41 6.9 32.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 111.689 -172.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.36 46.29 93.09 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.368 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.689 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.6 mp -75.4 78.46 2.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.201 0.524 . . . . 0.0 110.507 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.749 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.6 pt-20 -97.64 139.89 32.86 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.675 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 29.4 mmtp 51.82 -111.47 0.57 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.865 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -137.22 14.16 3.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.831 0.348 . . . . 0.0 110.853 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.749 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 18.8 m-85 -66.92 129.5 40.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.528 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 84.1 m -52.88 153.1 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.265 0.353 . . . . 0.0 111.718 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 39.0 mmt-85 -156.26 166.91 32.06 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.17 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -128.32 78.72 75.21 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.941 171.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.672 ' HG3' HD21 ' A' ' 46' ' ' LEU . 28.3 Cg_endo -70.62 -14.08 33.07 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.328 2.019 . . . . 0.0 112.807 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.45 -21.59 20.09 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.468 0.651 . . . . 0.0 109.412 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.74 43.92 86.71 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.51 -167.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 59' ' ' GLY . 7.8 t70 -56.89 140.44 48.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.35 -0.925 . . . . 0.0 109.504 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 58' ' ' VAL . 9.2 t -75.11 13.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 122.045 0.926 . . . . 0.0 110.102 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -103.7 -18.61 13.73 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.28 -177.81 16.61 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.872 -1.156 . . . . 0.0 111.358 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.63 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 86.8 Cg_endo -77.22 153.51 31.76 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.36 2.04 . . . . 0.0 111.304 -175.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.538 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 19.3 p-90 -145.53 -169.23 3.17 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.893 -170.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.693 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.8 p -168.74 -178.11 3.29 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.812 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -101.06 145.36 28.84 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 ' HE3' ' A' ' 70' ' ' LYS . 3.1 p -99.4 149.27 23.34 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.119 -1.033 . . . . 0.0 109.729 -170.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.9 p -83.86 33.54 0.48 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.523 0.678 . . . . 0.0 109.738 166.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.975 ' HB2' HG21 ' A' ' 20' ' ' THR . 60.8 t-20 -112.97 120.59 40.25 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.995 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.1 Cg_exo -70.0 5.71 1.68 Allowed 'Trans proline' 0 N--CA 1.472 0.251 0 C-N-CA 122.866 2.378 . . . . 0.0 113.489 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -84.87 -50.81 7.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.157 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HE3' HG21 ' A' ' 65' ' ' THR . 0.5 OUTLIER -134.59 154.58 51.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.015 0.436 . . . . 0.0 110.879 -176.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 31' ' ' HIS . 50.8 tp -76.18 -43.42 42.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.095 -176.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -142.33 161.25 38.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.504 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 46.6 t0 -159.36 165.46 33.24 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 60.1 m-85 -93.3 155.05 17.65 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.8 m -103.11 167.99 9.47 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.912 0.387 . . . . 0.0 110.621 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -112.92 56.2 0.68 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.375 0.607 . . . . 0.0 110.033 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.722 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.8 p -95.35 128.46 38.35 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.186 0.517 . . . . 0.0 110.004 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 77' ' ' VAL . 34.8 Cg_endo -62.77 157.18 49.05 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 C-N-CA 123.565 2.843 . . . . 0.0 113.603 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.7 107.13 7.66 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.093 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -39.93 65.71 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.317 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.733 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--O 1.234 0.244 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.546 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.444 -0.756 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.613 ' HG2' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.5 150.31 22.33 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.098 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.608 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 90.0 m-85 -106.97 101.5 10.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -176.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.56 -106.87 2.09 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.04 -173.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -83.12 -32.77 26.52 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 125.206 1.18 . . . . 0.0 111.126 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.86 21.72 7.32 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.957 -175.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -65.32 -38.99 91.85 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.112 0.482 . . . . 0.0 109.967 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -106.99 26.55 18.84 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -70.25 104.07 2.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.58 38.74 2.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.011 0.434 . . . . 0.0 110.76 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.588 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -94.98 -159.77 33.59 Favored Glycine 0 C--N 1.329 0.174 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.943 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 14.5 ptmt -145.07 20.94 1.59 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.846 0.323 . . . . 0.0 111.314 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.721 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.9 mmt180 -67.44 138.8 56.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 173.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 50' ' ' TYR . 5.0 m -139.98 34.19 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.479 0.657 . . . . 0.0 111.552 -167.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.771 HG22 ' HA2' ' A' ' 19' ' ' GLY . 8.5 m -151.89 135.38 16.1 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -173.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.428 HG21 ' HB3' ' A' ' 73' ' ' ASP . 78.3 p -73.53 -176.72 2.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.941 0.4 . . . . 0.0 112.075 -172.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 m -65.03 -18.67 24.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.439 0.638 . . . . 0.0 111.046 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.8 p -93.12 -14.17 27.57 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.235 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.771 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.41 16.15 62.83 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.426 -174.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.973 HG21 ' HB2' ' A' ' 67' ' ' ASN . 86.3 m -76.8 121.09 84.21 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.633 169.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.49 126.24 15.61 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.768 2.312 . . . . 0.0 113.231 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.5 m -64.88 138.2 58.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.46 0.647 . . . . 0.0 110.697 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -72.12 165.71 23.77 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.441 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 16.9 m-20 -76.42 125.53 29.36 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.753 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 33.6 m95 -55.19 -29.18 57.35 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.8 -23.66 55.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.776 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -97.24 149.72 21.72 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -173.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.675 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.3 mm-40 -104.57 31.96 4.38 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.2 mt-10 -147.61 122.3 5.1 Favored Pre-proline 0 N--CA 1.425 -1.703 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.283 -155.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 87.4 Cg_endo -87.18 28.6 10.81 Favored 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.343 -1.524 . . . . 0.0 112.759 0.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.477 ' HB3' HD12 ' A' ' 71' ' ' LEU . 63.7 m80 -128.73 104.51 7.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.675 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.88 121.11 20.42 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -176.542 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.477 ' HE1' ' HA ' ' A' ' 25' ' ' TRP . 5.4 p80 -148.91 95.92 2.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.174 0.988 . . . . 0.0 110.172 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 m -77.89 32.15 0.17 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.234 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.473 ' H ' ' C ' ' A' ' 33' ' ' HIS . 30.3 pt -141.77 147.98 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -175.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.587 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 52.3 m-85 48.23 50.78 15.88 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.139 0.971 . . . . 0.0 111.268 -173.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 31.1 p -98.98 175.09 2.63 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.142 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 38.4 Cg_exo -62.99 -20.1 70.76 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.041 1.828 . . . . 0.0 112.236 172.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -99.64 -25.62 14.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.819 0.342 . . . . 0.0 111.207 -172.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.5 p -91.95 -15.75 27.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.83 0.347 . . . . 0.0 110.462 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.587 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.8 m120 -139.73 52.46 3.8 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.721 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 8.2 Cg_exo -71.49 31.61 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.789 2.326 . . . . 0.0 113.59 -176.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.81 -10.5 4.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.628 0.251 . . . . 0.0 111.354 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.697 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -105.76 9.83 32.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.122 0.487 . . . . 0.0 110.039 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.72 43.4 97.85 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.23 -0.895 . . . . 0.0 113.102 173.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.1 mp -81.32 94.8 6.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.152 0.501 . . . . 0.0 109.856 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.659 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.5 pt-20 -121.43 152.3 39.23 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.07 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 4.1 mptp? 46.74 -113.08 0.44 Allowed 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.915 0.76 . . . . 0.0 111.763 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -136.68 18.68 3.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.06 0.457 . . . . 0.0 110.128 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.659 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 20.2 m-85 -67.8 128.39 36.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.786 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.51 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 84.5 m -51.33 147.21 6.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.309 0.38 . . . . 0.0 111.254 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.51 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 38.3 mmt-85 -151.53 169.07 22.98 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.695 -176.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -134.27 77.92 59.35 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.85 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.643 ' HG3' HD21 ' A' ' 46' ' ' LEU . 18.8 Cg_exo -64.36 -26.77 63.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.354 2.036 . . . . 0.0 112.123 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -20.07 23.78 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.547 0.689 . . . . 0.0 109.663 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.71 45.19 93.66 Favored Glycine 0 N--CA 1.433 -1.5 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.674 -170.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -45.47 130.29 8.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 172.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 t -66.55 -5.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 O-C-N 123.941 0.776 . . . . 0.0 110.95 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.28 -20.21 36.28 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.309 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 129.42 -179.95 16.39 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.583 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 73.4 Cg_endo -72.66 159.04 49.6 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.21 1.94 . . . . 0.0 111.824 -175.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.569 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 28.4 p-90 -146.23 -171.98 3.84 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.007 -171.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.753 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.3 p -168.18 -177.87 3.45 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.881 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.543 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 57.5 m-85 -100.5 146.68 26.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 171.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 2.5 p -102.13 150.21 23.49 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.847 -171.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.2 p -84.27 31.26 0.51 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.527 0.68 . . . . 0.0 110.085 167.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.973 ' HB2' HG21 ' A' ' 20' ' ' THR . 59.0 t-20 -111.26 122.34 37.97 Favored Pre-proline 0 N--CA 1.462 0.16 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.075 -176.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.39 2.21 2.99 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.73 2.286 . . . . 0.0 113.481 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -83.72 -53.67 5.46 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.98 150.11 49.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.281 0.562 . . . . 0.0 110.571 -176.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 31' ' ' HIS . 53.5 tp -75.91 -43.42 45.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.349 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 11.2 p90 -143.1 158.56 43.5 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 16' ' ' THR . 28.6 t0 -153.93 172.22 17.77 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -176.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -94.08 155.06 17.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.6 m -106.34 170.95 7.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.747 0.308 . . . . 0.0 110.626 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -121.63 64.58 0.9 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.52 0.676 . . . . 0.0 109.88 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.721 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 1.7 p -94.81 131.78 29.79 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.328 174.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 77' ' ' VAL . 12.3 Cg_endo -56.06 152.05 39.2 Favored 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 123.403 2.735 . . . . 0.0 113.277 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.401 ' NE2' ' SD ' ' A' ' 2' ' ' MET . 8.8 tp-100 -74.85 112.65 11.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.631 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.546 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.6 OUTLIER -74.66 -37.2 62.78 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.119 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.608 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.802 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.54 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.444 -0.753 0 CA-C-O 120.963 0.411 . . . . 0.0 110.238 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.683 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.9 ptt? -97.61 154.64 17.41 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.689 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 81.1 m-85 -110.5 102.0 10.64 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.65 -115.15 4.18 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.444 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.75 -24.84 41.29 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 124.605 0.826 . . . . 0.0 110.788 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.559 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.09 16.56 14.77 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.817 -1.183 . . . . 0.0 111.486 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -64.74 -46.9 80.25 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.5 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -101.1 28.26 16.82 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.294 173.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.651 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.3 t80 -70.47 102.01 2.11 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -105.97 32.24 4.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.057 0.456 . . . . 0.0 109.918 -174.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.567 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -84.18 -154.86 20.58 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.528 -175.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.46 24.69 0.79 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.976 0.417 . . . . 0.0 110.329 -173.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.592 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 27.4 mmt180 -72.0 137.83 47.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 170.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 50' ' ' TYR . 4.0 m -138.29 38.04 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.582 0.706 . . . . 0.0 111.088 -169.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.32 144.07 25.29 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.191 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.437 HG21 HG22 ' A' ' 65' ' ' THR . 42.7 p -75.51 -176.14 3.09 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.24 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 m -65.47 -16.02 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.283 0.563 . . . . 0.0 110.824 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.4 p -93.22 -15.52 25.81 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.259 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.06 10.69 64.14 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.253 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 67' ' ' ASN . 85.4 m -77.64 120.68 82.38 Favored Pre-proline 0 N--CA 1.448 -0.549 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.867 174.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -51.31 123.87 12.92 Favored 'Trans proline' 0 C--O 1.239 0.53 0 C-N-CA 122.933 2.422 . . . . 0.0 113.243 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -62.59 140.94 58.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.848 174.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -73.21 164.96 25.92 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.16 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.63 124.37 27.85 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.639 ' CE3' HD23 ' A' ' 46' ' ' LEU . 44.4 m95 -54.28 -31.42 53.78 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.25 -9.31 59.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.818 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.67 147.41 33.17 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.699 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 34.8 mm-40 -102.22 31.94 3.75 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 41.1 mt-10 -146.51 122.26 5.57 Favored Pre-proline 0 N--CA 1.426 -1.633 0 CA-C-N 114.259 -1.337 . . . . 0.0 113.879 -156.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 3.3 Cg_endo -86.58 26.8 12.53 Favored 'Cis proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.612 -1.412 . . . . 0.0 113.344 2.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.401 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 59.1 m80 -126.52 109.77 12.53 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.699 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -72.78 113.61 10.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.973 -178.031 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.9 p80 -143.85 90.99 2.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.92 0.867 . . . . 0.0 110.096 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 40' ' ' THR . 14.7 m -75.61 34.85 0.12 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.508 0.67 . . . . 0.0 110.089 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.521 ' H ' ' C ' ' A' ' 33' ' ' HIS . 17.8 pt -143.84 142.13 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -175.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.542 ' CG ' ' HH2' ' A' ' 62' ' ' TRP . 32.5 m-85 57.0 45.26 21.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 121.769 0.795 . . . . 0.0 111.004 -176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 21.9 p -103.81 173.47 3.38 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.618 168.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 37.2 Cg_exo -59.39 -22.37 65.42 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.793 1.662 . . . . 0.0 111.997 170.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -86.56 -39.17 16.45 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.945 0.402 . . . . 0.0 110.649 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 34' ' ' SER . 1.8 p -90.26 -20.1 23.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.493 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.54 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.4 m120 -135.46 65.14 61.55 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.943 0.401 . . . . 0.0 111.443 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -79.52 32.56 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.358 2.039 . . . . 0.0 111.382 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -120.32 -17.1 8.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.425 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.667 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -118.14 11.35 13.23 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.804 -172.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.95 44.9 95.32 Favored Glycine 0 C--O 1.23 -0.145 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.323 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.952 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.2 mp -77.73 90.97 4.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.056 0.455 . . . . 0.0 111.334 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.576 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.6 pt-20 -108.84 142.16 39.83 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.493 175.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 58.39 -123.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.994 0.809 . . . . 0.0 110.908 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -130.35 17.09 5.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.659 0.266 . . . . 0.0 110.752 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.576 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 18.0 m-85 -66.4 131.24 45.64 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.627 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 72.1 m -52.24 148.17 6.81 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.422 0.451 . . . . 0.0 111.395 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HG3' ' HA ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -153.53 158.93 42.0 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -119.61 78.93 21.84 Favored Pre-proline 0 C--N 1.316 -0.891 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.825 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.952 ' HG3' HD21 ' A' ' 46' ' ' LEU . 26.8 Cg_exo -58.09 -26.49 75.81 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.741 2.294 . . . . 0.0 112.643 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.51 -11.63 18.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.754 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.17 45.57 95.13 Favored Glycine 0 CA--C 1.501 -0.801 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.217 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 59' ' ' GLY . 4.1 t70 -51.86 133.08 32.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.699 -0.751 . . . . 0.0 109.114 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.79 24.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.844 0.83 . . . . 0.0 110.562 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -116.3 -17.69 6.1 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.82 -179.56 16.1 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.32 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.683 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 71.7 Cg_endo -73.74 157.99 47.42 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.31 2.007 . . . . 0.0 111.481 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.604 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 29.3 p-90 -146.9 -174.16 4.42 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.065 -171.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.614 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.2 p -168.94 178.2 4.62 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.032 177.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.497 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 47.8 m-85 -100.51 145.39 28.36 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.437 HG22 HG21 ' A' ' 16' ' ' THR . 1.1 p -101.94 148.36 25.43 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.734 -171.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 p -79.73 19.2 0.68 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.101 0.477 . . . . 0.0 110.921 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.629 ' HB2' HG21 ' A' ' 20' ' ' THR . 63.0 t-20 -100.35 118.29 61.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.216 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 15.2 Cg_exo -68.52 3.64 2.1 Favored 'Trans proline' 0 N--CA 1.47 0.119 0 C-N-CA 123.157 2.572 . . . . 0.0 113.496 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -84.75 -44.43 13.34 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.966 0.412 . . . . 0.0 110.819 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.504 ' HE2' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -144.92 142.56 29.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.482 0.658 . . . . 0.0 111.16 -174.475 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HG ' ' CD1' ' A' ' 64' ' ' TYR . 52.5 tp -70.69 -44.48 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.912 -168.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -146.75 163.83 34.72 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.543 -174.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -154.07 -177.55 6.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.084 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -93.15 162.12 14.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 94.8 m -105.77 171.43 7.34 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.171 0.51 . . . . 0.0 111.266 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -117.43 70.48 0.79 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.225 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.651 HG21 ' CE1' ' A' ' 9' ' ' TYR . 3.4 p -109.67 128.67 24.99 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.31 173.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.84 159.15 34.59 Favored 'Trans proline' 0 CA--C 1.512 -0.595 0 C-N-CA 123.772 2.981 . . . . 0.0 113.634 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -74.39 113.84 12.09 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.068 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.522 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.91 -42.12 58.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.056 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.689 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.427 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.593 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.444 -0.725 0 CA-C-O 121.075 0.464 . . . . 0.0 111.149 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.722 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 12.9 ptt? -96.83 154.54 17.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 81' ' ' ALA . 49.6 m-85 -108.87 96.53 6.39 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.15 -115.18 4.05 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -79.49 -25.27 41.86 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.761 0.824 . . . . 0.0 111.148 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.627 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 112.04 13.54 12.16 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 119.834 -1.174 . . . . 0.0 111.568 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HB3' ' NZ ' ' A' ' 7' ' ' LYS . 9.1 mtpm? -60.61 -41.74 95.41 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.472 0.653 . . . . 0.0 110.202 175.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.517 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.94 28.64 10.86 Favored Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.165 172.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.72 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.7 t80 -68.43 106.31 2.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.896 0.379 . . . . 0.0 110.023 173.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.0 51.47 0.8 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -175.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.552 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -101.97 -148.65 21.38 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.711 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HB3' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -151.84 20.43 0.69 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.863 0.332 . . . . 0.0 110.773 -174.397 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.935 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.4 mmt180 -62.38 139.54 58.55 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.3 m -139.53 35.64 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.06 0.933 . . . . 0.0 109.871 -174.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.07 143.67 25.26 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.091 -177.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.445 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 55.7 p -75.37 -174.75 2.51 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.03 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.12 -16.35 20.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.505 0.669 . . . . 0.0 110.872 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.7 p -93.19 -13.61 28.16 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.44 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.8 10.56 66.84 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.26 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 1.015 HG21 ' HB2' ' A' ' 67' ' ' ASN . 96.9 m -77.08 120.54 82.05 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.141 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 58.2 Cg_exo -47.48 123.01 7.43 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.201 2.601 . . . . 0.0 113.802 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.98 141.14 58.86 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.842 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -73.81 166.26 23.64 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.417 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 11.8 m-20 -76.52 124.7 28.0 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 175.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.671 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 38.6 m95 -53.73 -32.55 52.53 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.9 -12.09 59.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.945 -1.479 . . . . 0.0 113.045 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.78 149.09 30.31 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 119.21 0.914 . . . . 0.0 109.052 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.693 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.3 mm-40 -101.84 31.76 3.72 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 44.1 mt-10 -145.57 121.39 5.81 Favored Pre-proline 0 N--CA 1.426 -1.655 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.712 -155.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 93.8 Cg_endo -89.92 33.59 7.83 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.469 -1.471 . . . . 0.0 113.217 1.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.6 ' HB3' HD12 ' A' ' 71' ' ' LEU . 64.3 m80 -134.11 111.16 10.1 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.693 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -72.17 126.6 30.21 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.248 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 35' ' ' ILE . 6.1 p80 -155.02 89.43 1.22 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.033 0.921 . . . . 0.0 110.271 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 m -73.79 34.23 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.528 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.526 ' H ' ' C ' ' A' ' 33' ' ' HIS . 20.7 pt -143.29 147.21 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.561 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 35.7 m-85 52.29 45.49 28.35 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.983 0.897 . . . . 0.0 111.27 -174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 p -100.8 172.59 4.36 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.495 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.15 -14.16 42.02 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.015 1.81 . . . . 0.0 112.003 172.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -92.91 -37.72 12.09 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 110.167 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -87.74 -22.37 24.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.464 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.561 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.0 m120 -130.82 60.29 51.96 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.328 . . . . 0.0 111.014 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.81 39.15 0.73 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.641 2.227 . . . . 0.0 112.956 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.478 ' NH1' ' HA ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -141.56 -16.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.644 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -99.52 12.3 36.81 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.166 -0.334 . . . . 0.0 110.453 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.79 40.21 85.23 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.085 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.644 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.2 mp -81.76 102.43 10.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.094 0.473 . . . . 0.0 110.435 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.403 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.4 pt-20 -127.27 142.75 51.39 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.448 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 31.5 mmtp 55.14 -116.15 1.02 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.969 0.793 . . . . 0.0 111.211 177.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -136.11 17.42 3.22 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.827 0.346 . . . . 0.0 110.83 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.403 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 30.0 m-85 -66.06 130.71 44.19 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.615 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 93.8 m -56.57 146.91 23.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.994 0.426 . . . . 0.0 111.668 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.81 159.88 43.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -176.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -126.37 80.25 69.38 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.746 -0.381 . . . . 0.0 109.98 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.64 ' HG3' HD21 ' A' ' 46' ' ' LEU . 37.6 Cg_exo -59.63 -31.71 94.77 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.908 2.405 . . . . 0.0 112.592 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -88.99 -24.0 22.49 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.523 0.677 . . . . 0.0 110.048 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.64 46.36 69.38 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.019 -172.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -48.39 133.64 15.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.73 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.37 -11.29 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 124.451 1.094 . . . . 0.0 111.527 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.29 -10.89 43.73 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.909 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.84 -177.81 16.59 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.684 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.722 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 88.2 Cg_endo -74.69 164.77 32.99 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.575 2.183 . . . . 0.0 111.694 -173.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.598 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 29.8 p-90 -149.97 -172.13 4.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.227 -172.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.671 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.7 p -168.91 -177.71 3.08 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.691 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.462 ' CD1' ' HB3' ' A' ' 72' ' ' TYR . 50.1 m-85 -100.99 147.29 26.35 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 171.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 p -103.35 147.16 27.43 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.081 -170.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.7 p -82.48 21.47 0.96 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.153 0.501 . . . . 0.0 110.411 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 1.015 ' HB2' HG21 ' A' ' 20' ' ' THR . 52.8 t-20 -99.35 123.11 49.65 Favored Pre-proline 0 N--CA 1.456 -0.164 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.155 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.83 1.98 2.39 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.836 2.357 . . . . 0.0 113.16 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -84.08 -50.75 7.66 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.044 0.449 . . . . 0.0 111.089 175.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -130.14 159.55 36.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.368 0.604 . . . . 0.0 111.212 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 31' ' ' HIS . 45.4 tp -84.81 -45.63 12.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.857 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.462 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 33.6 p90 -143.37 164.18 30.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.863 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 37.2 t0 -160.01 176.23 12.08 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -94.34 157.51 16.0 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.9 m -106.03 167.64 9.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.712 0.291 . . . . 0.0 110.288 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -117.89 72.44 0.85 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.308 0.575 . . . . 0.0 110.037 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.935 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -106.6 129.48 24.38 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.953 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.93 157.3 16.96 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 124.327 3.351 . . . . 0.0 113.85 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.89 113.83 13.82 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.933 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.593 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.89 -44.4 40.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.589 178.133 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.615 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.372 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.477 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.56 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 15.9 ptt? -96.28 154.86 17.02 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.508 ' CD2' ' HB2' ' A' ' 81' ' ' ALA . 7.8 m-85 -113.67 96.45 5.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.27 -115.09 3.98 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -79.83 -22.21 43.26 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.282 0.636 . . . . 0.0 109.715 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.92 11.55 20.44 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.224 -0.988 . . . . 0.0 110.938 -174.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 7' ' ' LYS . 9.2 mtpm? -65.17 -31.75 73.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.055 0.455 . . . . 0.0 110.124 176.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -111.7 19.45 23.64 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 173.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.1 t80 -68.19 110.53 4.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -118.32 45.15 2.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 0.0 109.664 -177.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.531 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -98.88 -159.85 29.58 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.85 -175.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -139.59 15.12 2.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.495 0.188 . . . . 0.0 110.74 -170.304 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.638 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 19.8 mmt180 -64.66 135.78 56.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 2.8 m -134.61 36.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.553 0.692 . . . . 0.0 111.209 -171.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.764 HG23 ' HA2' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -151.35 139.97 20.68 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -178.09 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.629 HG21 ' HB3' ' A' ' 73' ' ' ASP . 75.3 p -75.15 -169.69 1.0 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.892 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -66.25 -21.11 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.312 0.577 . . . . 0.0 110.759 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.2 p -92.84 -13.33 29.22 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.191 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.764 ' HA2' HG23 ' A' ' 15' ' ' THR . . . 82.62 20.69 61.31 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.582 -173.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.5 m -76.48 119.31 76.82 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 168.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 86.0 Cg_exo -49.52 135.95 33.2 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.924 2.416 . . . . 0.0 113.225 176.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 72.9 m -76.45 142.94 40.84 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.734 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -70.96 165.53 23.2 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.297 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.9 128.81 35.24 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.679 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 57.8 m95 -57.82 -30.89 66.09 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.437 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . . . -78.07 -18.1 56.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.853 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.44 149.58 21.24 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 30.3 mm-40 -104.3 31.24 4.73 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.5 mt-10 -147.62 122.79 5.2 Favored Pre-proline 0 N--CA 1.422 -1.832 0 CA-C-N 113.795 -1.548 . . . . 0.0 114.397 -154.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 91.9 Cg_endo -86.85 29.82 9.03 Favored 'Cis proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.212 -1.578 . . . . 0.0 112.839 -0.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.689 ' HB3' HD12 ' A' ' 71' ' ' LEU . 55.0 m80 -130.58 107.49 9.24 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.641 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -74.48 125.33 28.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.443 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.47 ' C ' ' H ' ' A' ' 35' ' ' ILE . 3.9 p80 -155.21 98.13 1.97 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.99 0.9 . . . . 0.0 110.96 -177.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.0 m -79.61 33.78 0.26 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.666 0.746 . . . . 0.0 109.837 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.47 ' H ' ' C ' ' A' ' 33' ' ' HIS . 31.4 pt -142.15 146.16 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.623 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 41.7 m-85 50.06 51.04 17.44 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.931 0.872 . . . . 0.0 111.254 -175.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 29.3 p -99.44 177.65 1.5 Allowed Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.115 171.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 35.6 Cg_exo -60.53 -29.24 88.18 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 121.872 1.714 . . . . 0.0 111.378 170.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.04 -30.56 16.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.682 -167.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.0 p -89.06 -19.91 25.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.036 0.446 . . . . 0.0 110.23 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.623 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.5 m120 -133.97 67.25 73.74 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.719 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.27 9.94 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.039 1.826 . . . . 0.0 111.783 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -96.38 -24.05 16.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.724 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -106.58 1.18 25.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.861 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.11 44.68 90.74 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.225 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.724 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -73.12 99.98 2.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.69 0.281 . . . . 0.0 110.381 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.489 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.8 pt-20 -118.68 142.99 47.14 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 23.5 mmmt 53.39 -115.58 0.97 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.715 0.635 . . . . 0.0 111.576 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -135.34 17.76 3.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.211 0.529 . . . . 0.0 110.589 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.489 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 27.7 m-85 -68.61 129.71 40.72 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 71.6 m -54.71 153.4 6.0 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 123.219 0.324 . . . . 0.0 111.462 -173.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 35.5 mmt-85 -156.89 169.82 23.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.78 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -128.25 77.35 77.04 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.52 169.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HG3' HD21 ' A' ' 46' ' ' LEU . 36.2 Cg_endo -70.78 -13.64 32.25 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.256 1.971 . . . . 0.0 112.474 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.67 -25.95 17.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.036 0.922 . . . . 0.0 109.055 173.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.54 40.64 99.37 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.959 -169.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -48.54 133.88 16.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 172.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 t -72.63 6.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.611 0.72 . . . . 0.0 110.805 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.47 -22.45 14.43 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.07 -179.3 16.94 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 119.513 -1.327 . . . . 0.0 112.02 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.56 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 95.5 Cg_endo -75.6 157.64 40.18 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.386 2.057 . . . . 0.0 111.612 -174.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.513 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 15.7 p-90 -148.26 -169.7 3.41 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.958 -172.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.679 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 28.9 p -168.6 -177.5 3.14 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.458 176.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 67.7 m-85 -100.22 146.09 27.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 170.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 p -100.09 145.25 28.17 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.632 -170.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.9 p -78.49 17.8 0.63 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.034 0.445 . . . . 0.0 110.991 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 16.3 t30 -105.8 120.47 49.06 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 21.8 Cg_exo -65.91 4.96 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.353 2.702 . . . . 0.0 114.072 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.453 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 20.4 mmm180 -82.05 -43.16 18.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.615 0.245 . . . . 0.0 111.21 173.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -134.68 156.47 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.329 0.585 . . . . 0.0 111.068 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.689 HD12 ' HB3' ' A' ' 31' ' ' HIS . 41.5 tp -83.19 -45.09 14.3 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.905 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 29.0 p90 -143.74 164.87 29.25 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.995 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.629 ' HB3' HG21 ' A' ' 16' ' ' THR . 37.4 t0 -160.71 169.4 22.89 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 65.0 m-85 -92.85 155.84 17.36 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 80.9 m -104.46 168.32 9.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.148 0.499 . . . . 0.0 111.11 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -115.47 64.49 0.69 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.398 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.683 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.8 p -104.36 130.72 22.81 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.497 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 77' ' ' VAL . 25.2 Cg_endo -61.33 154.78 56.09 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 123.85 3.033 . . . . 0.0 113.625 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -75.66 109.43 9.23 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.286 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.423 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -72.82 -43.17 63.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.305 179.033 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.027 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.592 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.438 -1.041 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.516 ' HG2' ' HG3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -98.02 143.44 28.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -175.175 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.685 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 74.1 m-85 -102.32 104.07 14.56 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.7 -111.51 3.27 Favored Glycine 0 N--CA 1.424 -2.11 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.495 -174.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -89.14 -20.23 24.51 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 124.444 0.732 . . . . 0.0 110.521 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.03 15.87 13.68 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.79 -1.195 . . . . 0.0 111.886 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -63.94 -38.53 91.42 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.009 0.433 . . . . 0.0 110.271 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.31 24.64 22.15 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 173.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.8 t80 -71.24 103.45 2.82 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -110.72 46.43 1.06 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.171 0.51 . . . . 0.0 109.681 -176.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.17 -158.61 32.0 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.604 -0.725 . . . . 0.0 113.174 -173.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -140.68 14.6 2.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.73 0.3 . . . . 0.0 110.581 -170.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.917 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.9 mmt180 -67.16 135.72 53.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.16 38.84 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.752 0.787 . . . . 0.0 110.854 -170.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.98 148.52 28.48 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.273 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -75.2 -171.41 1.4 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.915 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.82 -18.32 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.398 0.618 . . . . 0.0 110.884 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.4 p -93.54 -12.63 29.14 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.792 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.44 12.75 69.3 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.373 -172.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.886 HG21 ' HB2' ' A' ' 67' ' ' ASN . 99.5 m -75.87 121.63 85.41 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 172.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -50.31 128.3 22.54 Favored 'Trans proline' 0 CA--C 1.514 -0.493 0 C-N-CA 122.641 2.227 . . . . 0.0 113.193 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.42 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 77.0 m -69.13 137.6 53.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.293 171.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -70.06 165.85 21.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.533 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 13.9 m-20 -76.63 125.93 30.09 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.708 ' CE3' HD23 ' A' ' 46' ' ' LEU . 43.3 m95 -53.77 -30.28 43.88 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.566 0.698 . . . . 0.0 109.182 176.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.4 -19.97 55.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.793 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.49 150.29 23.2 Favored 'General case' 0 C--O 1.21 -1.017 0 O-C-N 121.639 -0.663 . . . . 0.0 109.528 -170.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 33.2 mm-40 -104.56 23.95 12.48 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -140.54 131.0 13.66 Favored Pre-proline 0 N--CA 1.432 -1.363 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.389 -166.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -86.09 26.61 12.02 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.88 -1.717 . . . . 0.0 113.229 0.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.553 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 30.2 m80 -127.59 109.9 12.17 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.587 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 6.2 mmt180 -73.17 112.26 9.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.446 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.9 p80 -144.24 96.19 2.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.393 1.092 . . . . 0.0 110.51 -176.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.4 m -75.7 23.06 0.13 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.493 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 33' ' ' HIS . 34.1 pt -140.89 158.31 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.594 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 63.4 m-85 50.71 46.91 25.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.02 0.914 . . . . 0.0 110.727 -173.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.485 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 32.0 p -100.01 174.63 2.88 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 114.072 -1.422 . . . . 0.0 108.87 171.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 26.5 Cg_exo -64.12 -16.94 57.78 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 121.827 1.684 . . . . 0.0 111.851 171.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -90.87 -37.64 13.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.442 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.7 p -88.82 -19.94 25.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 -176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.594 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.8 m120 -134.8 65.78 67.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.093 0.473 . . . . 0.0 111.33 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.51 8.64 1.79 Allowed 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.421 2.081 . . . . 0.0 112.056 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -102.51 -16.88 15.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.365 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.684 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -109.63 5.17 22.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.109 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 47' ' ' GLU . . . 62.04 45.87 95.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.448 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.719 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.7 mp -72.36 94.48 1.62 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.195 0.522 . . . . 0.0 110.439 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.747 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.3 pt-20 -108.39 134.53 51.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.089 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm 54.93 -112.15 0.69 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.568 0.543 . . . . 0.0 111.544 176.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -134.77 12.87 3.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.476 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.747 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 21.6 m-85 -64.07 128.71 37.0 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 80.4 m -51.16 155.31 1.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.398 0.436 . . . . 0.0 111.684 -175.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 29.3 mmt-85 -158.17 169.4 24.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.988 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -128.19 78.2 75.78 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.525 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.719 ' HG3' HD21 ' A' ' 46' ' ' LEU . 26.9 Cg_endo -69.61 -12.52 33.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.267 1.978 . . . . 0.0 112.248 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -95.71 -27.25 15.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.897 0.856 . . . . 0.0 109.375 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.37 37.28 93.82 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.398 -166.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 59' ' ' GLY . 9.3 t70 -45.16 131.57 7.63 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.219 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.47 34.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.833 0.825 . . . . 0.0 110.339 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -122.05 -19.7 3.22 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.53 179.96 15.92 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.922 -1.133 . . . . 0.0 111.432 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.516 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 94.6 Cg_endo -72.85 152.56 52.49 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.963 1.775 . . . . 0.0 111.399 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.476 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 23.9 p-90 -145.95 -171.49 3.72 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.898 -170.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.653 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.1 p -168.51 179.88 4.17 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.623 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.439 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 40.0 m-85 -100.77 139.68 36.11 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.6 p -98.33 148.74 23.35 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.574 -170.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -80.95 20.45 0.78 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.267 0.556 . . . . 0.0 110.377 169.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.886 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.9 t-20 -98.94 119.08 61.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.848 -177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 17.6 Cg_exo -66.32 -0.55 4.36 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.993 2.462 . . . . 0.0 113.546 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -84.7 -43.46 14.3 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.8 0.333 . . . . 0.0 111.434 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.39 149.54 49.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.326 0.584 . . . . 0.0 110.417 -176.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.553 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 46.6 tp -78.87 -43.09 25.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.382 -175.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -143.27 163.51 32.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.783 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -159.15 178.59 9.86 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -93.79 158.08 15.83 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.84 166.15 10.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.247 0.546 . . . . 0.0 111.231 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -109.38 60.19 0.6 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.289 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.917 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -104.66 128.62 26.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.397 174.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.02 161.81 24.78 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 124.055 3.17 . . . . 0.0 113.743 -176.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -75.73 110.53 10.22 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.454 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.592 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.04 -38.67 61.38 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.205 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.685 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.51 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.586 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.674 ' HG2' ' HG3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -97.95 142.39 29.75 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.561 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 66.0 m-85 -101.41 102.25 13.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -177.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.2 -114.44 3.89 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.618 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -84.87 -23.58 28.92 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.382 0.695 . . . . 0.0 110.267 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.99 15.33 11.96 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.449 -175.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -67.92 -36.01 79.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.204 0.526 . . . . 0.0 110.33 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -107.57 20.21 32.5 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.608 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.6 t80 -66.5 101.74 0.8 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.34 46.4 0.93 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.179 0.514 . . . . 0.0 110.551 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -101.77 -158.14 26.59 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.171 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -149.86 22.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.947 0.374 . . . . 0.0 110.76 -170.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.873 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 21.0 mmt180 -65.2 139.04 58.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.75 30.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.536 0.684 . . . . 0.0 111.654 -170.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.27 142.39 24.05 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.4 p -75.31 -176.87 3.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.871 0.367 . . . . 0.0 111.605 -174.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 m -63.8 -19.39 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.47 0.652 . . . . 0.0 110.851 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.5 p -93.42 -12.01 30.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.798 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.79 12.76 68.27 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.28 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.714 HG21 ' HB2' ' A' ' 67' ' ' ASN . 85.6 m -76.86 119.76 78.85 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 171.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -50.62 123.74 12.04 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.811 2.341 . . . . 0.0 112.993 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.33 139.23 58.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.412 0.625 . . . . 0.0 110.565 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -71.4 166.01 22.56 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.807 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.24 127.34 32.43 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.773 ' CE3' HD23 ' A' ' 46' ' ' LEU . 64.6 m95 -57.14 -30.04 64.1 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.533 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . . . -78.69 -18.28 54.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.52 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.89 150.2 20.7 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.688 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.2 mm-40 -104.17 32.54 3.94 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 34.7 mt-10 -145.87 122.09 5.84 Favored Pre-proline 0 N--CA 1.428 -1.564 0 CA-C-N 114.027 -1.442 . . . . 0.0 114.104 -157.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 2.4 Cg_endo -86.69 25.25 15.47 Favored 'Cis proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.597 -1.418 . . . . 0.0 112.79 1.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.42 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 43.1 m80 -128.14 108.72 10.87 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.688 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.1 ppt_? -73.95 120.57 19.72 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.543 -178.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.458 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.3 p80 -148.76 98.12 2.82 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.248 1.023 . . . . 0.0 109.739 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 m -77.79 28.51 0.17 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.595 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.458 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.1 pt -141.5 151.43 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -176.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.55 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 59.5 m-85 52.25 48.03 23.51 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 122.054 0.931 . . . . 0.0 111.146 -176.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 41.8 p -100.32 176.08 2.08 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.394 172.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 7.7 Cg_exo -70.71 -11.63 29.89 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.963 1.775 . . . . 0.0 111.087 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -92.87 -31.26 15.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.03 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.4 p -98.97 -19.8 17.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.092 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.2 m120 -135.58 57.91 22.1 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -174.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 13.6 Cg_exo -69.81 15.98 0.23 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.234 1.956 . . . . 0.0 112.545 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 41' ' ' ASN . 18.8 ptt180 -99.6 -17.83 17.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.789 0.328 . . . . 0.0 111.034 -177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.743 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -118.13 3.4 12.05 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.445 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.05 46.67 90.67 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.566 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.773 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.3 mp -77.38 67.57 3.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.509 0.195 . . . . 0.0 111.185 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.526 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 6.0 pt-20 -97.39 157.6 15.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.764 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 52.07 -125.55 2.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.351 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -129.16 23.21 5.63 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.055 0.455 . . . . 0.0 110.373 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.526 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 38.5 m-85 -65.64 123.14 18.92 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.955 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 71.4 m -50.25 151.29 2.14 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 123.378 0.424 . . . . 0.0 111.42 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 43.2 mmt-85 -157.58 170.99 21.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.228 -174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -131.36 76.81 75.14 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.347 169.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.77 ' HG3' HD21 ' A' ' 46' ' ' LEU . 33.8 Cg_endo -66.95 -15.9 48.24 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.563 2.176 . . . . 0.0 112.635 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -95.86 -26.04 15.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.938 0.875 . . . . 0.0 109.451 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.28 39.46 97.88 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.598 -166.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 59' ' ' GLY . 19.7 t70 -44.82 131.42 7.04 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 124.462 0.742 . . . . 0.0 110.153 173.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 t -76.04 35.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.785 0.803 . . . . 0.0 110.188 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -126.16 -18.34 2.33 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 173.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.76 -179.64 16.07 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.485 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.674 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 92.9 Cg_endo -73.71 150.99 45.82 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.143 1.895 . . . . 0.0 111.33 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 19.1 p-90 -144.66 -170.49 3.4 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.038 -169.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.727 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.1 p -168.86 -179.25 3.64 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -101.23 146.8 27.05 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.426 ' HB ' ' CG2' ' A' ' 20' ' ' THR . 1.2 p -102.91 146.17 28.72 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.879 -171.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.9 p -81.21 20.41 0.83 Allowed 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.826 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.714 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.8 t-20 -99.4 120.81 56.95 Favored Pre-proline 0 C--N 1.337 0.036 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.226 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 16.7 Cg_exo -67.04 4.88 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.022 2.481 . . . . 0.0 113.404 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -84.81 -58.26 2.78 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.744 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -119.53 159.29 24.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.797 -174.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 50.4 tp -87.85 -45.78 10.0 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.553 -177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -143.04 156.38 44.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.07 0.462 . . . . 0.0 109.831 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -154.37 173.36 16.32 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 59.0 m-85 -93.26 157.84 16.05 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.9 m -105.3 162.39 13.47 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.895 0.378 . . . . 0.0 110.447 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.48 32.15 1.85 Allowed 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.315 0.579 . . . . 0.0 111.14 -172.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.873 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.4 p -80.51 122.6 82.65 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.683 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.12 162.75 25.13 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 C-N-CA 124.219 3.279 . . . . 0.0 113.884 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.44 ' NE2' ' SD ' ' A' ' 2' ' ' MET . 8.8 tp-100 -72.59 110.36 6.9 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.677 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.561 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.3 -41.65 56.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.639 179.048 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.561 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.465 0.275 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.3 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.492 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.44 -0.951 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.609 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 7.0 ptt? -97.03 154.28 17.41 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.616 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 83.0 m-85 -112.38 95.63 5.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.64 -110.8 3.11 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -79.17 -29.77 43.17 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 124.935 1.02 . . . . 0.0 111.005 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . 108.36 17.88 10.25 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 119.614 -1.279 . . . . 0.0 112.079 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -62.5 -43.62 98.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.358 0.599 . . . . 0.0 110.114 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -105.09 27.9 16.82 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.027 174.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.774 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.2 t80 -68.94 105.47 2.4 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 170.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -109.18 42.54 1.42 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.085 0.469 . . . . 0.0 110.109 -175.599 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.588 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -93.49 -152.73 29.58 Favored Glycine 0 C--N 1.329 0.17 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.992 -175.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -148.08 16.54 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.763 0.282 . . . . 0.0 110.756 -172.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.774 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.1 mmt180 -66.38 138.17 57.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.6 32.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.636 0.732 . . . . 0.0 110.776 -170.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.688 HG22 ' HA2' ' A' ' 19' ' ' GLY . 3.6 m -151.89 136.17 16.72 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -173.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.5 HG21 ' HB3' ' A' ' 73' ' ' ASP . 74.5 p -73.35 -172.51 1.16 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -171.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.7 m -69.27 -18.57 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.546 0.689 . . . . 0.0 110.447 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p -92.13 -14.38 29.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.048 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.688 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 84.96 15.19 67.9 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.243 -174.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.77 HG21 ' HB2' ' A' ' 67' ' ' ASN . 98.3 m -78.36 121.02 83.24 Favored Pre-proline 0 N--CA 1.442 -0.83 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 169.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -49.63 130.56 26.48 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.764 2.309 . . . . 0.0 113.362 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m -67.53 140.56 57.0 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.972 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -73.82 165.92 24.26 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.324 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.454 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 2.1 m-20 -76.25 125.94 30.08 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 175.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.645 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 41.0 m95 -54.77 -29.29 53.69 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 173.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.92 -22.1 53.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.1 176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.454 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -99.96 150.11 22.75 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 119.039 0.836 . . . . 0.0 108.748 -172.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.637 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.2 mm-40 -103.19 32.28 3.84 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 36.0 mt-10 -145.68 122.42 6.01 Favored Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -158.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 91.9 Cg_endo -88.37 31.82 8.42 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.29 -1.546 . . . . 0.0 113.375 0.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.536 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 58.7 m80 -130.75 113.58 14.31 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.637 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 25.9 mmm180 -74.06 113.56 11.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.89 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.8 p80 -147.85 94.37 2.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.139 0.971 . . . . 0.0 111.16 -177.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m -79.8 35.81 0.31 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.498 0.665 . . . . 0.0 110.113 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.445 ' H ' ' C ' ' A' ' 33' ' ' HIS . 23.4 pt -142.06 146.18 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.583 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 50.2 m-85 51.17 46.71 26.06 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.222 1.011 . . . . 0.0 110.969 -173.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 35.7 p -99.66 174.26 3.16 Favored Pre-proline 0 N--CA 1.444 -0.743 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.255 171.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 32.0 Cg_exo -59.35 -23.16 68.89 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.922 1.748 . . . . 0.0 112.185 170.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.49 -34.95 13.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.79 0.329 . . . . 0.0 111.296 -173.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.6 p -85.73 -18.67 32.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.997 0.427 . . . . 0.0 110.503 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.583 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.4 m120 -138.21 59.67 19.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.509 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.17 19.97 0.49 Allowed 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.613 2.208 . . . . 0.0 112.809 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -122.45 -8.69 8.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.491 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -106.51 7.93 31.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.386 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.99 40.85 97.43 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.384 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.2 mp -77.08 95.83 4.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.998 0.428 . . . . 0.0 110.828 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.472 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.2 pt-20 -118.23 152.16 36.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.504 175.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 34.2 mmtp 50.95 -115.26 0.85 Allowed 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.828 0.705 . . . . 0.0 111.183 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -139.47 19.68 2.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.001 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.472 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 32.8 m-85 -66.5 129.62 40.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.571 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.656 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 74.0 m -56.03 148.94 16.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.086 0.469 . . . . 0.0 111.824 -173.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.651 ' HD2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -155.17 158.2 38.58 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.632 -175.565 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -123.26 80.71 52.49 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.427 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HD2' ' CZ2' ' A' ' 62' ' ' TRP . 3.4 Cg_exo -72.25 -13.04 28.14 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.287 1.992 . . . . 0.0 111.579 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -89.04 -32.28 17.65 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.63 38.76 96.39 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 113.521 -1.672 . . . . 0.0 109.856 -166.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -48.13 133.38 15.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.725 -0.738 . . . . 0.0 109.491 172.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 t -70.14 -0.27 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.489 0.661 . . . . 0.0 110.591 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.88 -17.18 42.03 Favored Glycine 0 N--CA 1.437 -1.274 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.21 -178.8 16.3 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 119.766 -1.207 . . . . 0.0 111.619 176.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.609 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 74.1 Cg_endo -72.5 158.39 51.16 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.251 1.968 . . . . 0.0 111.167 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.593 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 25.8 p-90 -148.3 -171.02 3.74 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.844 -171.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.645 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 28.9 p -168.37 -177.24 3.14 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.559 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.5 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 61.9 m-85 -100.47 150.03 23.07 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 170.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 67' ' ' ASN . 2.5 p -104.69 150.27 24.87 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.248 -173.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 44.6 p -82.18 27.61 0.48 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.385 0.612 . . . . 0.0 110.102 168.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.77 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.9 t-20 -111.48 114.49 52.74 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.891 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 17.2 Cg_exo -67.28 2.74 2.06 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 123.099 2.533 . . . . 0.0 113.976 -177.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -84.32 -33.85 23.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.874 0.368 . . . . 0.0 111.354 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -143.89 143.09 31.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.257 0.551 . . . . 0.0 110.32 -177.483 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 52.3 tp -73.98 -42.62 60.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.765 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 5.3 p90 -142.65 159.5 42.12 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.5 ' HB3' HG21 ' A' ' 16' ' ' THR . 25.7 t0 -154.29 171.52 19.11 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -93.1 155.6 17.39 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.5 m -105.04 168.61 8.94 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.167 0.508 . . . . 0.0 110.583 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -117.43 70.28 0.78 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.019 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.774 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -106.5 129.52 24.34 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.521 174.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 11.2 Cg_endo -54.82 151.81 31.15 Favored 'Trans proline' 0 CA--C 1.509 -0.738 0 C-N-CA 124.146 3.231 . . . . 0.0 113.766 -178.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.46 110.75 10.1 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.492 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.19 -42.2 60.21 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.195 178.409 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.616 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.715 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.531 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.912 0.387 . . . . 0.0 110.626 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.668 ' HG2' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.61 149.57 23.14 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -177.444 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.768 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 49.3 m-85 -106.4 107.78 18.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.21 -111.92 3.35 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.908 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -94.1 -9.36 36.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.774 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.778 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 101.97 18.38 17.85 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.675 -175.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 52.4 mtpt -70.4 -45.09 66.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.814 -0.693 . . . . 0.0 110.335 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.64 24.54 29.49 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.778 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 3.8 t80 -65.95 98.18 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.871 0.469 . . . . 0.0 110.205 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HE ' ' C ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -103.11 46.6 0.91 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.074 0.464 . . . . 0.0 110.063 179.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.626 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.48 -156.21 30.97 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.674 -176.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.479 ' NZ ' ' HB3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -150.15 23.56 0.84 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.867 0.365 . . . . 0.0 110.82 -171.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.799 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 21.7 mmt180 -71.92 139.87 48.94 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 171.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 50' ' ' TYR . 5.2 m -140.86 31.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.514 0.673 . . . . 0.0 110.895 -170.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.869 HG22 ' HA2' ' A' ' 19' ' ' GLY . 87.2 m -152.32 130.6 12.02 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -173.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.429 HG21 ' HB3' ' A' ' 73' ' ' ASP . 71.9 p -69.85 -172.83 0.56 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -170.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 m -67.07 -20.01 26.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.869 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -92.19 -13.29 30.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.765 0.793 . . . . 0.0 108.964 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.869 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 82.91 17.65 67.12 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.367 -174.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.9 HG21 ' HB2' ' A' ' 67' ' ' ASN . 96.4 m -77.48 124.32 86.77 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 167.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.43 133.4 48.56 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.343 2.029 . . . . 0.0 113.217 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.9 m -71.8 140.41 49.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.72 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -73.11 167.19 21.66 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.234 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.498 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 4.8 m-20 -76.28 125.86 29.93 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.686 ' CE3' HD23 ' A' ' 46' ' ' LEU . 54.2 m95 -52.92 -32.94 48.2 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.69 0.757 . . . . 0.0 109.006 174.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.6 -16.63 58.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.727 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.44 150.27 23.21 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 118.668 0.667 . . . . 0.0 109.401 -172.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 33.4 mm-40 -107.74 21.14 17.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -146.6 137.11 12.35 Favored Pre-proline 0 N--CA 1.428 -1.54 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.375 -167.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.35 18.86 11.94 Favored 'Cis proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.367 -1.514 . . . . 0.0 112.993 1.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.583 ' HB3' HD12 ' A' ' 71' ' ' LEU . 62.2 m80 -128.98 106.9 9.2 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.53 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -72.61 126.1 29.06 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.48 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.9 p80 -154.94 94.26 1.63 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.132 0.968 . . . . 0.0 110.835 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -79.08 35.89 0.27 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.616 175.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 33' ' ' HIS . 31.3 pt -143.12 143.86 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 32.1 m-85 55.39 47.75 20.55 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 122.16 0.981 . . . . 0.0 110.919 -175.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 10.9 p -102.66 174.98 2.48 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.467 168.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 27.7 Cg_exo -62.45 -25.58 76.09 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.662 1.574 . . . . 0.0 111.775 172.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -88.17 -32.61 18.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.744 -174.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 p -90.72 -18.97 24.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.284 -177.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.8 m120 -133.63 61.58 54.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.733 0.301 . . . . 0.0 110.933 177.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.2 42.26 1.09 Allowed 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.843 2.362 . . . . 0.0 112.829 -176.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.62 -14.02 1.1 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.664 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -103.5 8.22 37.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.443 0.64 . . . . 0.0 110.69 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . 58.17 49.07 79.05 Favored Glycine 0 C--O 1.221 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.575 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -76.54 93.25 3.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.218 0.533 . . . . 0.0 110.661 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.641 ' HB2' ' HD2' ' A' ' 50' ' ' TYR . 1.5 mt-10 -101.28 136.21 41.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.548 -177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 90.1 mttt 48.4 -104.4 0.12 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.73 0.644 . . . . 0.0 112.118 174.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -138.16 15.15 2.82 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.223 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.641 ' HD2' ' HB2' ' A' ' 47' ' ' GLU . 32.2 m-85 -65.89 125.81 26.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.582 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 78.9 m -49.44 151.98 1.42 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.546 0.529 . . . . 0.0 111.901 -175.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 41.6 mmt-85 -154.41 168.63 26.02 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.475 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -130.36 80.11 71.13 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 169.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.709 ' HG3' HD21 ' A' ' 46' ' ' LEU . 25.2 Cg_exo -60.27 -28.06 86.12 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.837 2.358 . . . . 0.0 111.966 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -93.67 -23.22 18.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.605 0.717 . . . . 0.0 110.424 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.41 ' HA3' ' HG2' ' A' ' 7' ' ' LYS . . . 61.5 38.75 96.32 Favored Glycine 0 CA--C 1.497 -1.034 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.988 -172.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -61.27 141.88 57.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.126 -0.537 . . . . 0.0 110.153 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 t -75.85 49.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.604 0.716 . . . . 0.0 110.928 -175.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -129.53 -16.56 1.84 Allowed Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.77 175.73 18.18 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.48 152.06 59.8 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.754 1.636 . . . . 0.0 111.497 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.624 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 31.4 p-90 -139.63 -173.68 3.69 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.327 -172.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.639 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.4 p -168.3 -179.75 4.13 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.269 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -101.23 145.29 29.02 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 p -101.34 151.23 22.15 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.788 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.7 p -85.82 20.13 2.29 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.332 168.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.9 ' HB2' HG21 ' A' ' 20' ' ' THR . 56.7 t-20 -95.4 116.17 66.08 Favored Pre-proline 0 CA--C 1.518 -0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.409 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.12 -0.2 2.05 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.83 2.354 . . . . 0.0 113.59 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -84.2 -55.46 4.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.799 0.333 . . . . 0.0 111.212 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -117.13 155.03 30.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.403 0.621 . . . . 0.0 110.666 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' A' ' 31' ' ' HIS . 49.1 tp -85.35 -43.63 13.52 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.499 -176.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -143.38 162.53 35.49 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB3' HG21 ' A' ' 16' ' ' THR . 42.2 t0 -156.96 175.47 14.05 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.87 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -94.41 156.23 16.58 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 90.5 m -105.19 168.37 9.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.945 0.402 . . . . 0.0 110.722 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.84 65.82 0.77 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.915 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.799 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.7 p -105.56 126.58 30.47 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.188 176.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.97 157.59 19.9 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 123.915 3.076 . . . . 0.0 113.906 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.07 113.81 12.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.222 -1.353 . . . . 0.0 110.307 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.531 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.62 -42.43 51.72 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.329 178.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.768 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.2 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.588 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.443 -0.822 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.539 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 11.9 ptt? -96.97 152.44 18.71 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.62 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 82.0 m-85 -109.65 94.64 5.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.18 -114.08 3.77 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -173.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -79.7 -26.36 40.93 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.84 0.965 . . . . 0.0 110.248 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.611 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.4 13.96 19.47 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.401 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.731 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 97.4 mttt -65.4 -40.71 93.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.163 0.506 . . . . 0.0 110.065 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -107.37 25.75 20.66 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 172.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.654 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.7 t80 -66.56 108.83 2.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.71 40.42 2.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.154 0.502 . . . . 0.0 110.097 -175.526 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.556 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -93.98 -162.21 35.59 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.797 -176.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -139.8 18.69 2.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.915 0.388 . . . . 0.0 110.189 -169.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.788 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 18.7 mmt180 -66.88 135.82 54.44 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 m -137.9 34.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 121.75 0.786 . . . . 0.0 110.027 -171.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.915 HG22 ' HA2' ' A' ' 19' ' ' GLY . 86.4 m -153.05 125.65 8.24 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -169.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.623 HG21 ' HB3' ' A' ' 73' ' ' ASP . 81.9 p -69.97 -171.54 0.44 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -170.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.5 -23.11 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 121.505 0.669 . . . . 0.0 111.015 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.9 p -91.89 -15.7 27.73 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.796 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.915 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.48 20.02 55.41 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.955 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.715 HG21 ' HB2' ' A' ' 67' ' ' ASN . 52.6 m -76.41 122.78 87.32 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 167.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.36 129.74 26.92 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.717 2.278 . . . . 0.0 113.536 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.8 m -68.68 144.26 54.5 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.46 0.647 . . . . 0.0 111.504 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -76.93 167.51 21.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.45 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.1 129.02 35.47 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.704 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 65.7 m95 -56.49 -32.37 64.96 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.54 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.98 -16.65 56.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.831 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.17 148.06 22.55 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.8 mm-40 -102.64 29.35 5.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 44.8 mt-10 -148.26 124.33 5.3 Favored Pre-proline 0 N--CA 1.421 -1.883 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.656 -156.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -85.07 25.74 11.61 Favored 'Cis proline' 0 C--N 1.344 0.33 0 C-N-CA 123.944 -1.273 . . . . 0.0 112.942 1.636 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.707 ' HB3' HD12 ' A' ' 71' ' ' LEU . 54.8 m80 -133.34 108.73 8.89 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.555 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -75.17 129.63 37.84 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.234 -175.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.439 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.2 p80 -155.34 101.97 2.24 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.982 0.896 . . . . 0.0 110.154 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 t -80.71 29.67 0.31 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.841 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.439 ' H ' ' C ' ' A' ' 33' ' ' HIS . 22.0 pt -142.23 144.56 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -175.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.539 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 38.0 m-85 54.69 48.68 19.73 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 122.112 0.958 . . . . 0.0 110.639 -175.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 7.5 p -101.77 173.97 3.22 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.342 168.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 38.0 Cg_exo -58.89 -28.5 87.55 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 121.728 1.618 . . . . 0.0 112.228 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -89.85 -33.9 16.31 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.143 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.9 p -85.42 -19.13 31.79 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.723 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.539 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.9 m120 -135.43 64.71 60.14 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.376 177.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.27 20.8 0.56 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.333 2.022 . . . . 0.0 111.915 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 43' ' ' ARG . 14.6 ptt180 -114.32 -17.41 11.82 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.675 -177.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -108.1 6.1 26.6 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.135 0.493 . . . . 0.0 110.539 -176.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.93 46.21 94.05 Favored Glycine 0 C--O 1.228 -0.268 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.793 172.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -73.92 104.77 4.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.148 0.499 . . . . 0.0 110.662 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.847 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.6 pt-20 -118.11 137.14 53.14 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.879 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.474 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 61.9 mmtt 45.98 -110.79 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.738 0.649 . . . . 0.0 112.569 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -135.45 17.63 3.37 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.17 0.509 . . . . 0.0 110.124 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.847 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 16.3 m-85 -70.47 131.36 43.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.573 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 86.2 m -53.51 145.54 14.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 123.383 0.427 . . . . 0.0 111.231 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 34.9 mmt-85 -150.18 161.05 43.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.174 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -122.55 79.76 47.03 Favored Pre-proline 0 C--N 1.319 -0.733 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.781 173.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.608 ' HG3' HD21 ' A' ' 46' ' ' LEU . 18.4 Cg_exo -64.35 -25.81 63.79 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.618 2.212 . . . . 0.0 112.33 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.97 -17.17 26.79 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.533 0.682 . . . . 0.0 109.748 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.731 ' HA3' ' HE2' ' A' ' 7' ' ' LYS . . . 55.66 40.57 79.66 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.397 -171.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -47.88 138.32 8.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 124.4 0.706 . . . . 0.0 109.815 174.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 t -74.77 8.08 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.535 0.683 . . . . 0.0 110.407 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.14 -16.73 22.43 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.03 179.69 16.16 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.627 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.539 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 58.2 Cg_endo -71.33 161.09 46.83 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.442 2.095 . . . . 0.0 112.02 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.554 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.0 p-90 -150.7 -170.3 3.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.548 -171.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.704 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.4 p -169.19 -178.26 3.15 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.919 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 58.2 m-85 -101.78 147.22 26.74 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 170.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.461 ' HB ' ' CG2' ' A' ' 20' ' ' THR . 0.9 OUTLIER -105.0 147.29 27.96 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.062 -170.131 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.6 p -80.41 13.92 2.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.1 0.476 . . . . 0.0 110.811 172.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.715 ' HB2' HG21 ' A' ' 20' ' ' THR . 55.9 t-20 -93.68 123.31 60.28 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.417 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.63 2.83 1.74 Allowed 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.633 2.222 . . . . 0.0 113.261 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -84.24 -46.37 11.91 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.469 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 4.5 ptmt -134.92 154.92 51.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.531 0.681 . . . . 0.0 111.184 -174.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 31' ' ' HIS . 43.2 tp -83.61 -38.37 21.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.808 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 16.7 p90 -142.54 161.73 37.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.768 -175.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.623 ' HB3' HG21 ' A' ' 16' ' ' THR . 34.5 t0 -165.26 166.54 18.73 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -94.39 158.72 15.44 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.69 169.27 8.57 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -123.25 67.79 0.99 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.381 0.61 . . . . 0.0 110.128 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.788 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.4 p -99.5 130.38 26.98 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.451 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.36 159.09 24.23 Favored 'Trans proline' 0 CA--C 1.512 -0.582 0 C-N-CA 124.061 3.174 . . . . 0.0 113.539 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.09 112.1 12.18 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.696 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.505 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -75.64 -39.36 57.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.599 179.236 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.107 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.632 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.8 ptt? -97.0 152.96 18.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.397 0.618 . . . . 0.0 112.548 -177.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 81' ' ' ALA . 71.4 m-85 -109.57 99.23 8.46 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.24 -109.04 2.68 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.472 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -78.1 -30.48 49.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 125.005 1.062 . . . . 0.0 110.596 -175.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 111.89 22.28 6.03 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.915 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -71.5 -41.0 69.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.782 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.41 ' O ' ' HD2' ' A' ' 10' ' ' ARG . . . -99.67 17.34 57.66 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.506 171.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.739 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.2 t80 -62.43 104.06 0.47 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 173.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -106.83 36.27 2.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 -177.537 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.612 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -94.25 -161.76 35.12 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.483 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.16 17.93 2.26 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.587 0.232 . . . . 0.0 110.91 -169.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.713 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.7 mmt180 -65.89 138.24 57.73 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.87 40.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.746 0.784 . . . . 0.0 111.018 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.23 148.9 28.78 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.831 -177.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.427 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 44.3 p -75.57 -173.84 2.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.611 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.29 -18.15 22.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.452 0.644 . . . . 0.0 111.137 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.1 p -93.06 -14.66 27.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.569 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.75 11.04 62.45 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.403 -0.904 . . . . 0.0 111.482 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.927 HG21 ' HB2' ' A' ' 67' ' ' ASN . 98.5 m -76.55 121.58 85.11 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.882 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.28 124.62 9.38 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.198 2.599 . . . . 0.0 113.576 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.94 141.15 58.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.904 171.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -72.43 166.89 21.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.387 174.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 7.6 t0 -76.48 129.13 36.06 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.746 ' CE3' HD23 ' A' ' 46' ' ' LEU . 64.9 m95 -57.32 -31.54 65.79 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.321 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.13 -16.16 57.09 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.116 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 24' ' ' ASP . . . -94.35 147.33 23.32 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.666 -172.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 32.4 mm-40 -106.66 16.58 24.34 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.493 ' HG2' HH11 ' A' ' 32' ' ' ARG . 35.2 mt-10 -147.65 143.38 17.82 Favored Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.526 -172.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.49 25.16 6.67 Favored 'Cis proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.928 -1.697 . . . . 0.0 113.256 1.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.602 ' HB3' HD12 ' A' ' 71' ' ' LEU . 65.1 m80 -135.33 108.55 7.75 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -75.5 117.87 17.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.891 -174.563 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.428 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 3.9 p80 -147.04 99.25 3.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.175 0.988 . . . . 0.0 111.087 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 m -77.71 27.75 0.17 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.804 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.3 pt -140.88 149.76 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.472 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 48.9 m-85 50.97 47.36 24.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 122.069 0.937 . . . . 0.0 110.765 -175.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 58.6 p -100.61 175.81 2.2 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.04 172.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 11.7 Cg_exo -71.14 -9.33 25.33 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 121.951 1.767 . . . . 0.0 111.253 169.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -91.31 -33.67 15.23 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.786 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.9 p -95.92 -26.69 15.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.185 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.515 ' O ' HD13 ' A' ' 46' ' ' LEU . 14.0 m120 -133.28 60.56 49.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.523 -174.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -77.82 23.45 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.881 1.721 . . . . 0.0 112.272 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -111.35 -22.19 11.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.514 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.674 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -103.17 9.42 38.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.093 0.473 . . . . 0.0 110.911 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.41 46.93 91.5 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.351 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.746 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.4 mp -76.96 74.39 3.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.596 0.712 . . . . 0.0 110.13 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.699 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.0 pt-20 -97.27 136.45 37.75 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.714 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 25.9 mmmt 51.49 -111.29 0.55 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.814 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -137.6 18.22 2.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.257 0.551 . . . . 0.0 110.317 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.699 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 30.8 m-85 -67.61 130.16 42.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.499 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 89.6 m -54.52 149.54 10.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.298 0.374 . . . . 0.0 111.158 -174.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 39.8 mmt-85 -153.03 170.29 20.81 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.624 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -131.14 77.5 74.63 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.519 170.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.699 ' HG3' HD21 ' A' ' 46' ' ' LEU . 29.7 Cg_endo -68.42 -13.26 37.12 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.285 1.99 . . . . 0.0 112.471 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -96.75 -26.14 15.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.922 0.868 . . . . 0.0 109.507 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.09 39.15 97.66 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.558 -167.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -44.34 132.36 5.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.044 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 t -69.74 -0.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.508 0.671 . . . . 0.0 110.763 -176.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.4 -18.64 35.24 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.5 -179.23 16.29 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.698 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.632 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 88.8 Cg_endo -77.14 158.0 33.83 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.224 1.949 . . . . 0.0 111.231 -175.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.488 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 22.1 p-90 -150.08 -170.77 3.73 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.065 -169.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.697 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.2 p -168.81 -178.49 3.39 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.646 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 57.3 m-85 -100.93 147.64 25.91 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 170.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.9 p -103.55 149.2 25.1 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.437 -171.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 p -83.35 28.34 0.54 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.508 0.67 . . . . 0.0 109.963 168.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.927 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.0 t-20 -108.16 121.14 44.64 Favored Pre-proline 0 N--CA 1.456 -0.149 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.238 -175.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 18.7 Cg_exo -66.44 -1.03 4.96 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.749 2.299 . . . . 0.0 113.498 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -84.69 -33.11 23.24 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.67 147.69 29.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.108 0.48 . . . . 0.0 110.769 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.602 HD12 ' HB3' ' A' ' 31' ' ' HIS . 37.8 tp -72.4 -45.56 59.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.549 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 21.5 p90 -143.54 162.8 34.92 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.67 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.427 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 14.0 t0 -158.83 172.05 18.94 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 55.6 m-85 -94.62 157.01 16.16 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.6 m -104.76 172.82 6.59 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.289 0.368 . . . . 0.0 110.454 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -122.8 69.0 0.98 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.187 0.518 . . . . 0.0 110.305 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.739 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.3 p -102.05 132.39 21.62 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.665 176.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.42 ' HD2' HG23 ' A' ' 77' ' ' VAL . 11.0 Cg_endo -55.66 150.71 42.71 Favored 'Trans proline' 0 CA--C 1.512 -0.608 0 C-N-CA 124.25 3.3 . . . . 0.0 113.826 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -76.77 109.76 10.82 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.789 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.13 -38.26 57.01 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.694 178.276 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.971 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.599 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 120.922 0.391 . . . . 0.0 110.558 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.766 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 12.3 ptt? -96.78 159.33 14.98 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.629 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 85.5 m-85 -114.23 100.63 8.5 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.475 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.36 -115.33 4.0 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.019 -175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -82.41 -19.84 38.27 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 124.411 0.712 . . . . 0.0 110.486 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.651 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.09 17.06 13.4 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.999 -174.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -66.91 -50.97 60.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -97.88 28.49 14.25 Favored Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 172.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.666 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.6 t80 -69.51 102.57 1.84 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 173.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -106.45 40.59 1.59 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.337 0.589 . . . . 0.0 109.772 -176.291 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.641 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -90.41 -154.45 30.05 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.941 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -151.24 23.59 0.73 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.858 0.361 . . . . 0.0 110.556 -172.555 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.974 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 20.2 mmt180 -68.9 135.99 51.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.9 m -136.96 36.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 122.037 0.923 . . . . 0.0 109.573 -174.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 1.048 HG23 ' HA2' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -151.65 133.41 14.88 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.235 -172.654 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 56.5 p -73.76 -170.6 0.9 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.091 -176.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 m -63.94 -21.66 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.302 0.573 . . . . 0.0 110.712 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.3 p -92.89 -10.79 35.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.115 0.96 . . . . 0.0 109.08 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 1.048 ' HA2' HG23 ' A' ' 15' ' ' THR . . . 82.98 11.92 80.53 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.23 -173.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.409 HG21 ' HB2' ' A' ' 67' ' ' ASN . 80.8 m -71.28 121.2 83.59 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 82.6 Cg_exo -51.03 134.76 43.53 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 C-N-CA 122.713 2.276 . . . . 0.0 113.353 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 86.1 m -75.53 141.76 42.93 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.541 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -72.94 165.95 23.97 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.231 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 12.4 m-20 -76.52 126.2 30.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 175.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.717 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 48.7 m95 -54.65 -29.4 52.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 175.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.63 -22.4 54.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.972 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -97.67 150.45 21.16 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -172.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.619 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.5 mm-40 -104.76 31.45 4.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 26.7 mt-10 -147.2 123.31 5.49 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 113.705 -1.589 . . . . 0.0 114.163 -156.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 86.1 Cg_endo -86.44 27.03 11.9 Favored 'Cis proline' 0 C--N 1.346 0.438 0 C-N-CA 123.445 -1.481 . . . . 0.0 112.97 0.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.514 ' HB3' HD12 ' A' ' 71' ' ' LEU . 56.8 m80 -129.0 108.43 10.4 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.619 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.7 tmm_? -79.23 122.46 26.34 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -173.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.46 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.3 p80 -150.24 97.16 2.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.92 0.867 . . . . 0.0 110.821 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.27 35.46 0.22 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.56 0.695 . . . . 0.0 110.107 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.46 ' H ' ' C ' ' A' ' 33' ' ' HIS . 23.0 pt -143.11 142.5 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -175.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.599 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 42.9 m-85 50.56 51.02 17.72 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 122.124 0.964 . . . . 0.0 111.591 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 26.5 p -99.58 175.94 2.18 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.025 169.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 25.5 Cg_exo -64.59 -21.21 65.79 Favored 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 121.91 1.74 . . . . 0.0 111.877 172.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -100.33 -23.63 14.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.395 -171.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 35.4 p -90.32 -19.18 24.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.262 0.553 . . . . 0.0 109.646 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.2 m120 -136.16 62.76 46.9 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.888 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.66 9.08 1.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.168 1.912 . . . . 0.0 111.955 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -111.18 -12.33 14.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.476 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.76 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -104.49 8.2 35.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.135 0.493 . . . . 0.0 110.149 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.35 44.67 97.76 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 114.825 -1.079 . . . . 0.0 113.419 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.76 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.3 mp -80.17 96.47 6.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.224 0.535 . . . . 0.0 110.834 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.642 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.3 pt-20 -111.59 135.12 52.61 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.658 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.473 ' HD3' ' HA ' ' A' ' 48' ' ' LYS . 23.9 mmtp 56.06 -118.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.663 0.602 . . . . 0.0 111.998 175.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -130.82 14.01 5.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.922 0.392 . . . . 0.0 110.804 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.642 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 20.7 m-85 -66.06 133.13 50.11 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.623 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 73.8 m -54.93 149.78 11.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.848 0.356 . . . . 0.0 111.833 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.452 ' CG ' HH11 ' A' ' 52' ' ' ARG . 0.1 OUTLIER -153.48 162.53 41.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.714 -175.608 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -125.69 80.99 65.83 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.268 171.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.735 ' HG3' HD21 ' A' ' 46' ' ' LEU . 15.1 Cg_exo -64.53 -21.09 66.15 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.676 2.25 . . . . 0.0 112.029 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -89.63 -30.74 17.92 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.979 0.895 . . . . 0.0 109.304 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.66 39.53 95.42 Favored Glycine 0 N--CA 1.433 -1.51 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.054 -166.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -43.79 131.59 5.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 124.452 0.737 . . . . 0.0 109.587 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 t -70.82 3.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.274 0.559 . . . . 0.0 111.07 -174.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.27 -22.13 13.65 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.06 -175.59 19.1 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.761 -1.209 . . . . 0.0 111.78 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.766 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 97.8 Cg_endo -76.82 159.95 34.43 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.515 2.144 . . . . 0.0 111.708 -174.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.573 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.0 p-90 -148.88 -172.85 4.21 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.879 -172.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.717 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.8 p -168.73 -178.87 3.56 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.305 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -100.84 140.83 34.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.3 p -99.84 148.64 24.22 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.36 -171.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.2 p -76.99 15.0 0.74 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.982 0.42 . . . . 0.0 110.968 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' A' ' 69' ' ' ARG . 24.0 t30 -100.84 119.69 57.64 Favored Pre-proline 0 C--O 1.233 0.2 0 C-N-CA 123.168 0.587 . . . . 0.0 111.057 -177.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.4 Cg_exo -69.47 6.7 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.307 2.671 . . . . 0.0 113.503 -178.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 21.3 mmm180 -82.26 -49.35 10.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.025 0.441 . . . . 0.0 110.704 173.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HE2' HD22 ' A' ' 67' ' ' ASN . 0.0 OUTLIER -139.14 134.96 33.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.596 0.713 . . . . 0.0 111.186 -176.119 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 31' ' ' HIS . 40.3 tp -64.78 -39.92 94.39 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.541 -172.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -143.19 164.82 29.12 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.483 ' HB3' HG21 ' A' ' 16' ' ' THR . 44.5 t0 -162.0 172.28 16.22 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -92.81 156.21 17.14 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 96.2 m -104.66 170.01 8.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.236 0.541 . . . . 0.0 111.325 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.85 67.26 0.66 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.136 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.974 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 5.0 p -111.66 129.51 24.08 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.324 0.583 . . . . 0.0 110.994 174.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.43 161.76 33.46 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 123.941 3.094 . . . . 0.0 113.708 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.79 114.47 14.43 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.088 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.599 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.77 -41.23 60.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.333 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.629 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.688 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.514 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.445 -0.678 0 CA-C-O 120.927 0.394 . . . . 0.0 110.7 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.741 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 9.4 ptt? -97.5 154.59 17.4 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.548 0.69 . . . . 0.0 112.65 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.698 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 53.9 m-85 -110.29 105.8 14.96 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.29 -114.58 3.91 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.162 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -88.21 -16.07 34.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.98 -0.61 . . . . 0.0 109.832 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.744 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.56 11.22 25.58 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.937 -173.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -63.16 -40.5 97.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.514 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.16 22.33 27.45 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.201 173.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.744 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 4.2 t80 -66.46 109.98 2.95 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 172.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -119.01 39.21 3.6 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.358 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.472 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -91.33 -152.57 28.41 Favored Glycine 0 C--O 1.235 0.19 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.538 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.07 23.71 0.94 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.916 0.388 . . . . 0.0 110.899 -170.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.723 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.8 mmt180 -69.78 137.55 51.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -138.26 34.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.64 0.733 . . . . 0.0 111.063 -170.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.599 HG22 ' HA2' ' A' ' 19' ' ' GLY . 2.1 m -151.46 138.29 18.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.407 HG21 HG22 ' A' ' 65' ' ' THR . 68.3 p -74.88 -174.67 2.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.903 -173.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.06 -17.98 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.417 0.627 . . . . 0.0 110.728 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p -92.75 -14.58 27.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.187 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.599 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.6 15.8 63.06 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.5 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.884 HG21 ' HB2' ' A' ' 67' ' ' ASN . 89.7 m -77.11 122.5 86.39 Favored Pre-proline 0 N--CA 1.448 -0.555 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 168.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -51.72 125.05 15.83 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.309 2.006 . . . . 0.0 112.7 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.404 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 85.4 m -63.29 141.83 58.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.348 0.594 . . . . 0.0 110.652 173.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 25.2 tt0 -74.86 165.34 25.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.476 176.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 4.1 m-20 -76.07 124.57 27.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.673 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 40.7 m95 -54.87 -29.98 56.84 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.07 -17.8 58.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.198 -1.364 . . . . 0.0 113.314 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.26 151.78 22.27 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 119.093 0.86 . . . . 0.0 109.339 -173.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.713 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.0 mm-40 -103.18 32.46 3.74 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 49.1 mt-10 -143.62 118.01 6.11 Favored Pre-proline 0 N--CA 1.429 -1.512 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -156.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 70.4 Cg_endo -89.68 31.07 10.26 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.52 -1.45 . . . . 0.0 113.316 1.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.611 ' HB3' HD12 ' A' ' 71' ' ' LEU . 61.9 m80 -130.77 110.76 11.57 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.713 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.1 OUTLIER -74.53 119.26 18.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.648 -176.52 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.479 ' HE1' ' HA ' ' A' ' 25' ' ' TRP . 4.2 p80 -151.86 99.23 2.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.17 0.986 . . . . 0.0 110.271 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 t -82.15 32.13 0.39 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.568 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' H ' ' C ' ' A' ' 33' ' ' HIS . 26.5 pt -141.26 151.8 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -177.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.568 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 39.1 m-85 51.04 47.11 25.46 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.04 0.924 . . . . 0.0 111.038 -173.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 28.0 p -99.42 171.16 5.93 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.027 171.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 39.7 Cg_exo -59.64 -21.33 62.18 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.132 1.888 . . . . 0.0 112.219 171.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -101.9 -19.85 15.1 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.533 -170.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.9 p -96.91 -18.02 19.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.134 0.492 . . . . 0.0 110.182 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.568 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.2 m120 -136.02 64.63 55.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.028 -177.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.89 18.07 0.66 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.633 2.222 . . . . 0.0 112.736 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -109.93 -23.54 11.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.411 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.697 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -102.13 7.11 41.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.353 0.597 . . . . 0.0 110.469 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.93 42.88 99.58 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.771 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -74.95 110.39 9.21 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.535 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.3 pt-20 -128.6 149.22 50.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.801 172.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.978 ' HE2' ' HA ' ' A' ' 48' ' ' LYS . 5.0 mmpt? 49.67 -111.05 0.46 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.001 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -139.85 18.1 2.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.11 0.481 . . . . 0.0 110.236 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.535 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 33.4 m-85 -67.34 126.41 29.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.589 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 71.7 m -51.68 152.73 2.68 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.556 0.535 . . . . 0.0 111.689 -174.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 44.0 mmt-85 -154.37 170.69 20.75 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.348 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -133.3 77.11 67.12 Favored Pre-proline 0 C--N 1.319 -0.721 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.438 171.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.526 ' HD2' ' CE2' ' A' ' 62' ' ' TRP . 27.9 Cg_exo -61.06 -33.39 91.78 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.769 2.313 . . . . 0.0 112.427 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -90.72 -16.04 29.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.491 0.663 . . . . 0.0 110.366 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.09 48.7 84.81 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.358 -175.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 59' ' ' GLY . 4.4 t0 -48.48 129.01 15.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 t -75.91 31.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 122.085 0.945 . . . . 0.0 110.319 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -125.18 -14.49 3.3 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 175.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.78 -179.51 16.2 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.741 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 95.2 Cg_endo -76.31 161.03 35.37 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.348 2.032 . . . . 0.0 111.713 -174.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.526 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.1 p-90 -145.46 -173.07 4.02 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.223 -173.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.673 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.3 p -167.98 -178.94 3.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' A' ' 72' ' ' TYR . 48.4 m-85 -100.24 145.29 28.25 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.447 ' HB ' HG21 ' A' ' 20' ' ' THR . 4.4 p -98.86 153.91 18.43 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.611 -171.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.416 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 31.0 p -85.77 26.58 0.95 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.334 0.587 . . . . 0.0 110.143 166.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.884 ' HB2' HG21 ' A' ' 20' ' ' THR . 59.3 t-20 -107.52 118.76 52.59 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.495 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.46 2.39 1.96 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.904 2.402 . . . . 0.0 113.392 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -83.77 -46.38 12.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.328 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.05 151.92 51.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.999 0.428 . . . . 0.0 110.558 -176.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 31' ' ' HIS . 41.7 tp -76.29 -43.18 42.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.386 -177.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.516 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 50.4 p90 -143.93 169.33 18.02 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.777 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -161.68 178.37 9.08 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -96.44 156.3 16.4 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 81.5 m -105.89 168.94 8.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.872 0.368 . . . . 0.0 110.888 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -116.89 70.5 0.77 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.263 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.723 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 4.2 p -110.86 127.06 27.53 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.304 0.574 . . . . 0.0 110.883 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.65 160.5 20.64 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 124.165 3.243 . . . . 0.0 113.761 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -75.56 112.71 12.18 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.216 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.485 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -75.87 -43.37 45.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.364 176.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.698 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.031 -179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.462 ' HA ' HG22 ' A' ' 77' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.444 -0.735 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.749 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 8.4 ptt? -97.4 158.19 15.6 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.755 ' HD1' ' HB2' ' A' ' 81' ' ' ALA . 79.0 m-85 -113.94 96.15 5.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.36 -111.83 3.34 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -173.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -79.47 -29.52 41.73 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 124.626 0.839 . . . . 0.0 110.889 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.613 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.8 19.77 8.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.982 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.792 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 95.1 mttt -66.4 -38.08 86.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.873 0.368 . . . . 0.0 110.299 175.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.8 19.47 38.48 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 173.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.731 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -64.38 99.41 0.29 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 174.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.3 46.35 0.92 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.027 0.441 . . . . 0.0 110.249 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.657 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -97.06 -158.97 31.27 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.687 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -145.87 20.26 1.45 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.992 0.396 . . . . 0.0 110.802 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.761 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.9 mmt180 -68.17 139.74 56.12 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -138.84 35.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.726 0.774 . . . . 0.0 110.677 -171.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.87 140.3 21.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.356 -176.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 46.6 p -75.43 -174.81 2.56 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.106 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.8 m -72.85 -12.62 15.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.454 0.645 . . . . 0.0 110.115 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.1 p -92.57 -13.54 29.54 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.904 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.95 7.57 70.4 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.342 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.938 HG21 ' HB2' ' A' ' 67' ' ' ASN . 92.9 m -75.68 120.06 79.95 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -47.46 123.48 8.05 Favored 'Trans proline' 0 CA--C 1.514 -0.52 0 C-N-CA 122.809 2.339 . . . . 0.0 112.861 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.402 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 84.6 m -62.27 135.43 57.47 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.474 0.654 . . . . 0.0 110.488 173.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 23.2 tt0 -68.26 164.8 19.82 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.225 174.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.48 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 15.0 m-20 -76.3 125.91 30.04 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.758 ' CE3' HD23 ' A' ' 46' ' ' LEU . 40.2 m95 -53.36 -31.71 45.79 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.12 -19.09 57.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.18 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.48 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.52 150.13 23.38 Favored 'General case' 0 C--O 1.21 -0.997 0 O-C-N 121.32 -0.863 . . . . 0.0 109.014 -173.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.765 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.9 mm-40 -103.24 33.64 3.22 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 29.2 mt-10 -141.62 117.38 7.15 Favored Pre-proline 0 N--CA 1.435 -1.195 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -157.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.6 Cg_endo -91.8 33.38 8.98 Favored 'Cis proline' 0 C--N 1.347 0.464 0 C-N-CA 123.635 -1.402 . . . . 0.0 112.974 0.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.562 ' HB3' HD12 ' A' ' 71' ' ' LEU . 55.1 m80 -130.37 107.46 9.27 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.765 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -74.22 118.48 17.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.451 0.643 . . . . 0.0 109.889 -178.086 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.467 ' HE1' ' HA ' ' A' ' 25' ' ' TRP . 4.4 p80 -147.65 99.15 3.07 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 122.002 0.906 . . . . 0.0 109.957 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -80.12 32.98 0.28 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.601 175.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.453 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.5 pt -141.91 147.85 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -176.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.501 ' HD2' ' HH ' ' A' ' 64' ' ' TYR . 38.3 m-85 53.12 45.55 28.46 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 122.01 0.91 . . . . 0.0 110.96 -174.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 18.1 p -99.11 172.46 4.68 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.586 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 28.6 Cg_exo -60.59 -20.45 64.73 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 121.855 1.703 . . . . 0.0 111.818 172.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -91.37 -35.7 14.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.089 -175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.8 p -85.91 -25.23 26.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.822 0.344 . . . . 0.0 110.447 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.5 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.3 m120 -132.8 65.21 73.77 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.015 0.436 . . . . 0.0 110.814 -178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.89 13.5 1.22 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.327 2.018 . . . . 0.0 112.13 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -103.56 -21.37 13.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.84 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -107.57 -0.83 21.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.54 -175.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.82 46.41 67.66 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.684 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.818 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.4 mp -76.52 67.2 2.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.776 0.322 . . . . 0.0 110.872 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.49 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 6.1 pt-20 -94.42 151.28 19.5 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.713 0.292 . . . . 0.0 110.762 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.8 mptp? 48.24 -110.32 0.35 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.442 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -140.18 17.84 2.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.965 0.412 . . . . 0.0 110.613 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.49 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 27.8 m-85 -66.75 126.57 29.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.649 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 93.6 m -53.79 150.73 7.1 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 123.468 0.48 . . . . 0.0 111.96 -173.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 41.9 mmt-85 -153.74 165.99 34.25 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.924 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -131.33 76.38 75.93 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.002 172.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.818 ' HG3' HD21 ' A' ' 46' ' ' LEU . 34.9 Cg_exo -55.8 -35.7 94.04 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.844 2.362 . . . . 0.0 112.318 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.89 -12.36 25.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.91 -175.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.792 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 59.17 52.15 55.03 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.526 -174.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 59' ' ' GLY . 6.1 t70 -51.26 133.65 28.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 174.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.02 9.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.616 0.722 . . . . 0.0 110.568 -175.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -107.04 -15.98 14.85 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.73 -177.48 17.04 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.295 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.749 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 73.5 Cg_endo -73.8 158.4 46.74 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.37 2.046 . . . . 0.0 110.984 -175.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.558 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 31.5 p-90 -144.13 -176.31 4.96 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.441 -172.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.575 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.4 p -167.92 179.64 4.6 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.472 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.501 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 49.5 m-85 -99.18 146.43 26.17 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.433 ' HB ' HG21 ' A' ' 20' ' ' THR . 3.9 p -99.0 150.78 21.62 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.474 -170.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.9 p -85.03 23.14 1.27 Allowed 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.008 166.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.938 ' HB2' HG21 ' A' ' 20' ' ' THR . 56.9 t-20 -99.65 117.79 63.09 Favored Pre-proline 0 N--CA 1.456 -0.135 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.098 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 15.1 Cg_exo -68.27 4.96 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.87 2.38 . . . . 0.0 113.632 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -88.37 -38.84 14.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.755 0.312 . . . . 0.0 111.21 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 159.9 41.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.136 0.493 . . . . 0.0 111.38 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.562 HD12 ' HB3' ' A' ' 31' ' ' HIS . 49.9 tp -81.37 -49.61 10.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.968 -175.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.567 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 17.8 p90 -143.6 163.65 32.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.958 0.408 . . . . 0.0 110.701 -178.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -154.56 -175.7 5.54 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.103 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -93.79 158.79 15.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 86.9 m -105.94 169.94 8.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.278 0.561 . . . . 0.0 111.474 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -115.27 72.31 0.79 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.096 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.761 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.5 p -113.46 128.54 25.57 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.373 0.606 . . . . 0.0 110.697 174.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 17.6 Cg_endo -58.16 155.49 34.21 Favored 'Trans proline' 0 CA--C 1.513 -0.531 0 C-N-CA 123.941 3.094 . . . . 0.0 113.871 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.27 111.3 11.56 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.32 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.46 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.26 -39.38 54.54 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.08 179.218 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.755 ' HB2' ' HD1' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--O 1.233 0.187 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.585 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.584 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.441 -0.909 0 CA-C-O 120.949 0.404 . . . . 0.0 109.916 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.556 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.0 ptt? -95.6 151.2 19.54 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.564 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 79.5 m-85 -109.26 96.27 6.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.88 -115.97 4.12 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -174.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -79.59 -21.92 44.38 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 124.684 0.873 . . . . 0.0 110.291 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.71 15.68 16.22 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.166 -176.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -63.81 -34.56 78.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.065 0.46 . . . . 0.0 110.146 176.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -109.98 20.01 27.0 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 174.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.748 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.9 t80 -68.22 101.07 1.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.053 0.454 . . . . 0.0 110.185 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.63 49.3 0.81 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.604 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.75 -151.76 28.24 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.858 -176.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HE2' ' HB3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -150.73 22.78 0.79 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.928 0.394 . . . . 0.0 111.017 -174.272 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.864 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.8 mmt180 -68.35 137.58 54.72 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 170.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 m -140.06 30.86 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 121.804 0.811 . . . . 0.0 110.796 -171.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.722 HG22 ' HA2' ' A' ' 19' ' ' GLY . 7.3 m -151.45 134.81 16.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -174.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.425 HG21 HG22 ' A' ' 65' ' ' THR . 75.9 p -73.0 -176.92 2.23 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.122 0.487 . . . . 0.0 112.242 -170.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -67.23 -15.65 19.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.367 0.603 . . . . 0.0 110.806 177.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.0 p -93.09 -15.36 26.16 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.839 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.722 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 85.35 15.53 66.31 Favored Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.352 -174.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.977 HG21 ' HB2' ' A' ' 67' ' ' ASN . 85.1 m -78.32 121.88 84.4 Favored Pre-proline 0 N--CA 1.446 -0.67 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 169.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -48.51 131.59 23.73 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.713 2.275 . . . . 0.0 113.216 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.9 m -71.0 137.13 48.8 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.586 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.401 ' HG2' ' N ' ' A' ' 24' ' ' ASP . 24.1 tt0 -71.1 166.09 22.16 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.153 174.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.568 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 10.0 m-20 -75.98 127.73 33.57 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.709 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 43.3 m95 -54.35 -31.47 54.54 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.04 -16.69 57.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.915 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.568 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -98.02 148.04 23.9 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 118.625 0.648 . . . . 0.0 109.616 -173.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 32' ' ' ARG . 31.4 mm-40 -106.58 14.86 26.52 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -176.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.502 ' HA ' ' N ' ' A' ' 31' ' ' HIS . 44.6 mt-10 -147.77 145.55 21.57 Favored Pre-proline 0 N--CA 1.431 -1.382 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.273 -174.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.93 20.46 5.76 Favored 'Cis proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.458 -1.476 . . . . 0.0 113.334 1.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.502 ' N ' ' HA ' ' A' ' 29' ' ' GLU . 62.9 m80 -131.61 107.65 8.98 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.437 ' HD2' ' N ' ' A' ' 32' ' ' ARG . 3.4 mpt_? -74.93 115.34 14.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.5 p80 -147.23 98.09 2.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.088 0.946 . . . . 0.0 111.621 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.07 33.1 0.18 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.531 173.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.9 pt -142.02 147.05 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.563 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 52.0 m-85 49.93 47.68 22.89 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.09 0.947 . . . . 0.0 111.276 -173.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 30.9 p -100.05 174.57 2.92 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.869 170.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 20.9 Cg_exo -66.15 -16.26 51.43 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.868 1.712 . . . . 0.0 111.348 170.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -91.07 -34.33 15.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.371 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.9 p -93.94 -20.4 20.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.551 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.563 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.3 m120 -133.35 65.05 71.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.202 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.9 25.75 0.5 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.487 2.125 . . . . 0.0 111.746 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -115.44 -13.35 11.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.555 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.667 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -116.1 4.38 13.66 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.53 -175.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.48 41.71 96.17 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.856 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.5 mp -70.85 99.64 1.78 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.821 0.343 . . . . 0.0 110.287 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.575 ' HB3' ' HD2' ' A' ' 50' ' ' TYR . 28.4 tt0 -109.84 148.95 30.59 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.941 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.477 ' HG2' ' HG2' ' A' ' 47' ' ' GLU . 46.2 mmtm 46.84 -109.62 0.25 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.543 1.152 . . . . 0.0 111.271 173.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -135.63 17.63 3.33 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.874 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.575 ' HD2' ' HB3' ' A' ' 47' ' ' GLU . 34.6 m-85 -66.12 128.68 37.06 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.097 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.616 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 70.8 m -53.62 148.99 8.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.243 0.544 . . . . 0.0 112.284 -174.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' HD2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -154.7 157.47 38.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.89 -174.704 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -122.45 81.55 46.55 Favored Pre-proline 0 N--CA 1.446 -0.646 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.243 171.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.577 ' HD2' ' CE2' ' A' ' 62' ' ' TRP . 19.4 Cg_exo -63.25 -24.67 72.15 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.399 2.066 . . . . 0.0 112.397 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.75 -27.47 21.15 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.025 0.916 . . . . 0.0 109.575 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.29 39.6 98.03 Favored Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.925 -166.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -43.93 133.26 5.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.909 -0.646 . . . . 0.0 110.042 170.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 t -70.87 5.94 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.62 0.724 . . . . 0.0 110.878 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.83 -18.14 23.62 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.42 179.64 16.1 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.269 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.556 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 60.5 Cg_endo -71.59 157.61 55.56 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.272 1.981 . . . . 0.0 111.49 -176.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.577 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 25.1 p-90 -146.68 -170.89 3.63 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.819 -170.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.709 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.6 p -168.36 -178.59 3.63 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.789 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.54 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 53.1 m-85 -100.53 144.43 29.53 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 171.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 3.6 p -101.82 150.7 22.9 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.38 -171.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.7 p -84.41 35.0 0.53 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.358 0.599 . . . . 0.0 109.791 167.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.977 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.8 t-20 -115.63 123.77 30.88 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.269 -176.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.2 Cg_exo -69.13 -1.3 7.71 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.787 2.325 . . . . 0.0 113.682 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -84.02 -38.01 21.43 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.778 0.323 . . . . 0.0 111.777 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -143.9 143.14 31.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.134 0.492 . . . . 0.0 110.116 -176.58 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.454 ' O ' ' HD1' ' A' ' 64' ' ' TYR . 52.5 tp -71.05 -38.03 72.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.645 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -143.55 160.9 39.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -156.17 176.03 13.21 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -94.68 156.59 16.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 77.5 m -106.2 166.13 10.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.964 0.411 . . . . 0.0 111.55 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -101.74 33.0 3.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.023 -172.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.864 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 4.6 p -81.85 127.22 73.13 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-O 121.519 0.675 . . . . 0.0 111.63 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.66 161.61 27.78 Favored 'Trans proline' 0 CA--C 1.515 -0.466 0 C-N-CA 124.378 3.385 . . . . 0.0 113.78 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.33 114.05 13.42 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.605 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.584 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.07 -40.23 53.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.632 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.655 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -77.52 1.23 20.03 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 77.33 23.07 0.91 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.329 171.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.469 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 17.6 t0 -92.44 62.36 3.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.499 171.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.486 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -153.46 151.74 30.2 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.846 -176.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.644 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 9.8 ptt? -96.64 156.64 16.26 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.611 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 81.4 m-85 -113.35 97.82 6.72 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.85 -114.26 3.86 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.426 ' OD1' ' HA ' ' A' ' 58' ' ' VAL . 91.8 m-20 -79.35 -24.68 42.54 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.573 0.808 . . . . 0.0 110.58 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.46 17.65 11.12 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.733 -1.222 . . . . 0.0 111.632 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -65.46 -43.95 88.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.174 0.511 . . . . 0.0 109.822 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -103.68 25.09 27.79 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.749 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.2 t80 -67.3 103.38 1.25 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 171.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -108.27 45.18 1.04 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.205 0.526 . . . . 0.0 109.677 -176.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.639 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -95.56 -155.37 31.16 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.93 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 7.1 ptmt -148.87 20.06 1.0 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.802 0.334 . . . . 0.0 111.012 -170.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.864 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.1 mmt180 -66.86 139.07 57.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 171.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.64 38.4 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.676 0.75 . . . . 0.0 110.742 -171.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.47 ' HB ' ' HA2' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -151.4 147.94 27.5 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.345 -175.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.0 p -74.32 -172.85 1.54 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.529 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 m -65.22 -16.75 20.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.393 0.616 . . . . 0.0 111.371 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -94.19 -13.75 26.33 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.037 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 15' ' ' THR . . . 87.02 14.84 63.85 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.598 -170.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.975 HG21 ' HB2' ' A' ' 67' ' ' ASN . 86.4 m -75.78 119.52 77.5 Favored Pre-proline 0 N--CA 1.448 -0.564 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 171.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -48.12 129.22 18.23 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.999 2.466 . . . . 0.0 113.564 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.7 m -70.04 134.77 48.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.073 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 24.0 tt0 -67.95 166.36 15.89 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.663 174.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.521 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 3.2 m-20 -76.07 125.99 30.17 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.696 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 39.1 m95 -54.76 -31.07 58.12 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 173.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.2 -21.0 56.97 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.938 -1.483 . . . . 0.0 113.267 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -103.08 150.64 23.41 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 119.168 0.895 . . . . 0.0 109.061 -172.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.778 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 27.7 mm-40 -103.2 35.31 2.59 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 37.3 mt-10 -145.29 119.64 5.59 Favored Pre-proline 0 N--CA 1.432 -1.327 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -156.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 93.8 Cg_endo -89.43 32.1 9.0 Favored 'Cis proline' 0 C--N 1.346 0.42 0 C-N-CA 123.424 -1.49 . . . . 0.0 112.979 0.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.536 ' HB3' HD12 ' A' ' 71' ' ' LEU . 53.4 m80 -130.91 108.01 9.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.778 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.0 123.07 22.77 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.516 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.4 p80 -151.71 94.57 2.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.108 0.956 . . . . 0.0 110.142 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.9 m -75.23 29.63 0.1 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.398 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.516 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.4 pt -141.6 151.0 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.51 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 39.9 m-85 51.74 47.13 25.38 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 122.032 0.92 . . . . 0.0 111.274 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.7 p -99.28 170.88 6.27 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 114.266 -1.334 . . . . 0.0 108.124 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.14 -17.26 59.3 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.704 1.602 . . . . 0.0 111.804 172.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.84 -20.48 14.28 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.37 -171.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.432 ' C ' ' HD3' ' A' ' 42' ' ' PRO . 42.6 p -98.47 -15.48 19.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.196 0.522 . . . . 0.0 110.241 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.575 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 12.8 m120 -135.8 55.12 11.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.064 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 10.1 Cg_exo -71.16 36.61 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.071 2.514 . . . . 0.0 112.842 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.77 -9.95 2.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.319 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.735 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -110.58 12.6 22.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.412 . . . . 0.0 111.266 -176.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.15 44.01 97.79 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-N 115.27 -0.877 . . . . 0.0 113.37 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.1 mp -80.46 111.78 17.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.056 0.455 . . . . 0.0 110.52 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.636 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 2.0 pt-20 -124.47 134.59 53.0 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.662 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 48' ' ' LYS . 61.0 mmtt 50.75 -107.57 0.3 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -137.11 13.97 3.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.059 0.456 . . . . 0.0 110.19 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.636 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 22.2 m-85 -67.36 131.03 44.91 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.537 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 79.1 m -54.04 149.74 8.92 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.247 0.342 . . . . 0.0 111.571 -173.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 33.6 mmt-85 -153.94 165.94 34.53 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.438 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -127.88 79.46 73.65 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.238 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.71 ' HG3' HD21 ' A' ' 46' ' ' LEU . 37.6 Cg_exo -58.96 -35.83 97.9 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.556 2.17 . . . . 0.0 112.281 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -91.54 -17.28 25.89 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.252 0.549 . . . . 0.0 110.644 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.65 47.77 86.65 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.313 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.12 131.97 23.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.426 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 3.3 t -74.38 8.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.565 0.698 . . . . 0.0 110.556 -175.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.58 -18.95 19.46 Favored Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.22 179.58 16.15 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.772 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.644 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 90.6 Cg_endo -73.86 156.78 48.07 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.502 2.134 . . . . 0.0 111.277 -175.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.572 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.5 p-90 -144.89 -172.76 3.9 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.292 -171.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.696 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.8 p -168.65 -179.03 3.65 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.034 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.471 ' CD1' ' HG ' ' A' ' 71' ' ' LEU . 39.7 m-85 -100.75 144.77 29.32 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 171.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.6 p -102.95 146.23 28.65 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.442 -170.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 p -81.87 27.73 0.45 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.482 0.658 . . . . 0.0 109.779 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.975 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.4 t-20 -102.1 120.58 53.28 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.785 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.75 0.04 3.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.246 2.631 . . . . 0.0 113.557 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -84.17 -53.41 5.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.78 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.59 149.78 52.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.36 0.6 . . . . 0.0 111.056 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 31' ' ' HIS . 36.2 tp -69.92 -45.77 66.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.117 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 11.3 p90 -142.66 162.34 35.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -156.88 -177.96 7.01 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -97.97 155.74 16.95 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 93.5 m -103.75 173.74 6.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.098 0.475 . . . . 0.0 111.029 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -119.69 71.47 0.88 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.536 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.864 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.7 p -108.54 130.03 23.26 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.654 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.83 153.91 47.32 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 123.824 3.016 . . . . 0.0 113.68 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.401 ' CG ' ' HB2' ' A' ' 82' ' ' ALA . 9.3 tp-100 -75.59 112.61 12.12 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.326 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.486 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.45 -40.75 57.12 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.436 178.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.611 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -83.65 59.56 5.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.186 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.401 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . . . . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.073 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 120.873 0.368 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -85.63 -8.12 58.42 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 70.02 25.85 4.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.731 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.619 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 33.4 t70 -79.5 57.89 2.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.466 1.126 . . . . 0.0 109.833 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.527 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -160.09 156.95 27.69 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.403 177.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.774 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.4 ptt? -96.63 149.57 21.64 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.673 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 80.8 m-85 -107.07 102.34 11.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.43 -111.65 3.31 Favored Glycine 0 N--CA 1.425 -2.068 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.498 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.594 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 81.4 m-20 -78.87 -27.46 44.02 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.551 0.795 . . . . 0.0 110.555 -176.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.668 ' HA2' ' HB2' ' A' ' 2' ' ' MET . . . 111.61 17.33 8.69 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.594 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 43.1 mtmt -65.46 -47.93 74.42 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.41 -0.895 . . . . 0.0 109.711 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.21 23.32 36.8 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.473 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.0 t80 -65.42 98.49 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.072 0.463 . . . . 0.0 109.962 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.408 ' HE ' ' HA ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -102.96 44.47 1.01 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -177.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.619 ' CA ' ' HA ' ' A' ' -1' ' ' ASP . . . -95.55 -155.27 31.12 Favored Glycine 0 N--CA 1.454 -0.104 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.741 -175.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -144.35 15.6 1.66 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.873 0.337 . . . . 0.0 110.696 -174.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.71 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 12.8 mmt180 -66.08 133.26 50.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.63 37.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.532 0.682 . . . . 0.0 111.174 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.24 147.7 27.99 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.168 -177.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.518 ' HB ' ' OD2' ' A' ' 73' ' ' ASP . 66.4 p -75.53 -174.17 2.39 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.028 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 m -65.63 -17.53 22.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.58 0.705 . . . . 0.0 110.878 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 50.6 p -93.57 -14.69 26.24 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.903 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.28 11.95 63.9 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.517 -172.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.722 HG21 ' HB2' ' A' ' 67' ' ' ASN . 98.4 m -75.95 119.43 77.18 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 173.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -49.68 127.85 19.71 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.868 2.379 . . . . 0.0 113.244 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.5 m -68.48 138.59 55.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.875 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -69.06 165.65 19.79 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.528 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 26' ' ' ALA . 5.8 t70 -77.21 129.08 35.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.689 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 59.5 m95 -58.73 -31.53 68.38 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.414 ' HB3' ' OD1' ' A' ' 24' ' ' ASP . . . -78.33 -15.08 59.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.492 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.21 148.49 26.26 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -175.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.768 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.6 mm-40 -102.28 33.71 3.01 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 41.7 mt-10 -145.22 120.72 5.83 Favored Pre-proline 0 N--CA 1.429 -1.495 0 CA-C-N 114.61 -1.177 . . . . 0.0 114.046 -157.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 97.1 Cg_endo -90.41 37.05 5.16 Favored 'Cis proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.258 -1.559 . . . . 0.0 113.641 0.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.414 ' HB3' HD12 ' A' ' 71' ' ' LEU . 53.3 m80 -133.56 112.56 11.59 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.768 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 23.1 mmm180 -73.35 114.48 11.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -176.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.8 p80 -146.98 91.11 1.97 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.345 1.069 . . . . 0.0 110.395 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.8 t -77.29 35.46 0.17 Allowed 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.263 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.521 ' H ' ' C ' ' A' ' 33' ' ' HIS . 19.4 pt -143.95 141.42 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.586 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 42.1 m-85 55.85 47.09 20.93 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.062 0.934 . . . . 0.0 111.04 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 18.8 p -99.58 175.23 2.53 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.649 168.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 36.5 Cg_exo -60.91 -22.22 73.5 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 121.713 1.609 . . . . 0.0 112.001 172.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.71 -28.73 13.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.464 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.9 p -88.04 -17.03 32.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.068 0.461 . . . . 0.0 110.241 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.586 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.0 m120 -137.77 55.0 8.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.531 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 8.7 Cg_exo -71.04 35.39 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.807 2.338 . . . . 0.0 112.971 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 -11.03 3.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.035 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.708 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -110.56 13.27 22.65 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.997 0.427 . . . . 0.0 110.859 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.39 43.98 95.47 Favored Glycine 0 C--O 1.224 -0.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.861 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.1 mp -80.16 100.75 8.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.0 0.4 . . . . 0.0 111.161 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.5 pt-20 -121.72 149.88 42.61 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.762 172.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.403 ' O ' ' HD1' ' A' ' 25' ' ' TRP . 42.0 mmtm 50.65 -124.96 2.24 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.22 0.95 . . . . 0.0 111.022 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -128.49 19.39 6.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.039 0.447 . . . . 0.0 110.486 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.466 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 24.1 m-85 -66.87 127.1 31.21 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 175.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.593 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 78.8 m -52.61 150.75 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 111.543 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -154.76 159.59 40.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -123.28 78.01 53.05 Favored Pre-proline 0 C--N 1.317 -0.819 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.045 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.623 ' HG3' HD21 ' A' ' 46' ' ' LEU . 18.0 Cg_endo -70.37 -11.47 30.1 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.472 2.115 . . . . 0.0 112.971 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -99.07 -22.79 15.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.427 0.632 . . . . 0.0 109.816 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.89 51.02 60.04 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.878 -170.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -53.42 128.58 29.14 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 171.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.3 7.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.427 0.632 . . . . 0.0 110.361 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.86 -15.1 27.46 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 111.221 -0.751 . . . . 0.0 111.221 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.33 178.73 15.58 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 119.705 -1.236 . . . . 0.0 111.87 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.774 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 91.9 Cg_endo -77.45 163.58 29.6 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.686 2.257 . . . . 0.0 111.867 -175.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.527 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.4 p-90 -148.5 -171.28 3.81 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.053 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.689 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.8 p -168.47 -178.25 3.46 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.029 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.415 ' HE2' ' HB2' ' A' ' 36' ' ' PHE . 56.3 m-85 -100.75 144.59 29.54 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 171.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 p -99.91 143.99 29.49 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.239 -172.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 p -78.55 14.24 1.34 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.542 170.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.722 ' HB2' HG21 ' A' ' 20' ' ' THR . 59.8 t-20 -86.86 119.97 71.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 18.7 Cg_exo -65.02 0.21 2.77 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.728 2.285 . . . . 0.0 113.102 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -85.33 -55.26 4.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.174 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 12.3 ptmt -120.32 160.16 23.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.315 0.579 . . . . 0.0 111.025 -174.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.414 HD12 ' HB3' ' A' ' 31' ' ' HIS . 55.0 tp -87.62 -46.76 9.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.452 -176.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -143.79 164.23 31.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.989 0.423 . . . . 0.0 110.461 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.518 ' OD2' ' HB ' ' A' ' 16' ' ' THR . 32.2 t0 -160.47 173.56 15.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.673 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 69.5 m-85 -92.85 156.23 17.11 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.9 m -105.11 170.31 7.94 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.044 0.449 . . . . 0.0 111.154 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -114.57 73.82 0.84 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.338 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.71 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.1 p -114.2 128.04 26.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.491 0.662 . . . . 0.0 111.037 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 17.3 Cg_endo -57.47 158.75 18.26 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 124.489 3.459 . . . . 0.0 114.226 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.0 111.41 10.18 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.451 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.503 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.36 -41.41 56.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.241 178.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.673 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -85.1 49.6 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.948 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.385 177.981 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 62.3 p . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -76.47 -12.16 60.0 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 170.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 67.53 15.35 9.79 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.654 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.633 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 33.0 t0 -90.45 51.41 2.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 122.75 1.262 . . . . 0.0 108.766 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.568 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -153.09 154.02 34.02 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.366 -1.743 . . . . 0.0 108.929 -179.187 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.449 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.8 ptt? -94.86 155.41 16.8 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.563 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 91.2 m-85 -113.53 95.43 5.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.81 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.44 -106.53 2.07 Favored Glycine 0 N--CA 1.426 -1.991 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -172.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.436 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 8.0 m-20 -77.7 -35.89 51.63 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.856 0.974 . . . . 0.0 110.517 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . 112.06 17.89 8.1 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.104 -1.046 . . . . 0.0 110.945 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 46.7 mtmt -70.9 -35.02 72.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.062 -0.569 . . . . 0.0 109.656 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -104.25 19.91 41.69 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.702 171.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.714 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -67.06 109.99 3.23 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 171.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -114.98 48.06 1.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.082 0.467 . . . . 0.0 110.026 -176.681 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.633 ' CA ' ' HA ' ' A' ' -1' ' ' ASP . . . -99.64 -156.97 28.6 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.815 -0.629 . . . . 0.0 113.565 -172.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.425 ' HG2' ' CG ' ' A' ' -1' ' ' ASP . 11.4 ptmm? -141.73 13.89 2.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.453 0.168 . . . . 0.0 111.198 -169.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.706 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 32.8 mmt180 -66.05 137.48 57.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.43 36.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.286 0.565 . . . . 0.0 111.997 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.27 146.44 26.79 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.461 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 58.7 p -74.52 -174.06 1.95 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.681 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -66.49 -17.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.414 0.626 . . . . 0.0 110.752 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.4 p -92.77 -14.62 27.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.444 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.74 11.1 64.23 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.302 -173.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.983 HG21 ' HB2' ' A' ' 67' ' ' ASN . 84.6 m -75.85 119.43 77.13 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -45.85 124.13 6.79 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 123.119 2.546 . . . . 0.0 113.532 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.8 m -65.94 136.12 55.66 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.151 173.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -68.29 164.92 19.62 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.715 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -77.68 127.11 31.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.764 ' CE3' HD23 ' A' ' 46' ' ' LEU . 71.6 m95 -57.24 -31.0 65.09 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.613 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.66 -18.13 54.9 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.615 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.68 151.24 20.32 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.693 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.8 mm-40 -104.41 33.44 3.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 48.3 mt-10 -144.94 120.53 5.92 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -156.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 83.8 Cg_endo -87.91 27.96 12.76 Favored 'Cis proline' 0 C--N 1.344 0.339 0 C-N-CA 123.206 -1.581 . . . . 0.0 112.807 0.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.411 ' HB3' HD12 ' A' ' 71' ' ' LEU . 39.7 m80 -127.87 109.23 11.4 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.693 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.55 118.31 16.36 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.348 -177.221 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.425 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.0 p80 -149.19 100.12 3.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.255 1.026 . . . . 0.0 110.269 -177.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 m -81.74 30.49 0.37 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.056 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.7 pt -141.4 147.57 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.624 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 37.0 m-85 52.68 47.65 24.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.886 0.85 . . . . 0.0 111.093 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 22.4 p -100.19 175.42 2.4 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.314 170.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 19.0 Cg_exo -65.45 -17.6 57.95 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.371 1.381 . . . . 0.0 111.138 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -87.98 -38.37 15.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.178 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 p -90.32 -22.82 21.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.313 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.624 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.3 m120 -132.7 67.87 78.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.079 0.466 . . . . 0.0 111.021 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.96 5.98 2.32 Favored 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.344 2.029 . . . . 0.0 112.698 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -97.4 -26.99 14.67 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.401 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -99.49 4.85 46.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.406 0.622 . . . . 0.0 111.126 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.92 46.33 94.77 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.176 174.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.764 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.6 mp -71.18 86.94 0.78 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.385 0.612 . . . . 0.0 109.939 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.948 ' HG2' ' HD3' ' A' ' 48' ' ' LYS . 20.1 tt0 -102.45 145.84 28.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.858 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.948 ' HD3' ' HG2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER 44.12 -106.46 0.1 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.384 1.053 . . . . 0.0 110.949 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -138.68 22.11 2.69 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.984 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.595 ' HD2' ' HB3' ' A' ' 47' ' ' GLU . 28.6 m-85 -69.39 128.35 36.23 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.38 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 77.6 m -51.54 148.22 5.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.446 0.466 . . . . 0.0 111.417 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 36.7 mmt-85 -154.09 164.24 38.8 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.481 -176.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -126.23 77.04 72.35 Favored Pre-proline 0 C--N 1.321 -0.664 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.132 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.563 ' HG3' HD21 ' A' ' 46' ' ' LEU . 27.7 Cg_endo -70.63 -16.9 33.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.207 1.938 . . . . 0.0 112.746 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -90.18 -27.65 19.43 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.671 0.748 . . . . 0.0 109.503 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.75 46.63 91.44 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.621 -169.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 59' ' ' GLY . 6.8 t70 -54.4 135.79 44.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.4 16.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.918 0.866 . . . . 0.0 109.978 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -104.49 -20.96 9.63 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 175.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.83 176.0 14.6 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.177 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 57.1 Cg_endo -70.13 159.92 51.43 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.319 2.013 . . . . 0.0 111.613 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.54 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.9 p-90 -149.61 -168.14 3.02 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.954 -169.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.74 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.7 p -168.2 -178.99 3.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.586 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.419 ' HE2' ' HB2' ' A' ' 36' ' ' PHE . 39.2 m-85 -100.17 146.48 26.8 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 172.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.3 p -103.54 144.4 31.47 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.009 -1.076 . . . . 0.0 109.662 -171.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.413 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 36.2 p -79.81 17.37 0.95 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.213 169.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.983 ' HB2' HG21 ' A' ' 20' ' ' THR . 56.4 t-20 -94.48 124.94 53.75 Favored Pre-proline 0 C--O 1.229 -0.026 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.343 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.1 4.62 1.81 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.688 2.259 . . . . 0.0 113.309 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -85.01 -58.26 2.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -122.14 161.05 23.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.732 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.413 ' O ' ' HD1' ' A' ' 64' ' ' TYR . 57.4 tp -86.21 -45.33 11.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.604 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 4.2 p90 -143.34 159.4 42.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.703 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.461 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 47.4 t0 -154.5 172.43 17.8 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.8 155.5 17.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 71.2 m -105.41 171.76 7.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.947 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -115.7 60.99 0.7 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.378 0.609 . . . . 0.0 110.337 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.714 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.4 p -97.87 129.43 31.22 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.427 0.632 . . . . 0.0 110.398 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.478 ' HD2' HG23 ' A' ' 77' ' ' VAL . 36.2 Cg_endo -63.01 160.2 35.01 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 123.986 3.124 . . . . 0.0 113.49 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.34 111.9 11.08 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.028 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.506 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.09 -41.99 57.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.846 178.131 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.563 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -83.24 55.12 3.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.445 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.3 178.787 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -90.71 13.18 16.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 70.61 21.59 5.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.329 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.469 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 26.9 t70 -78.68 63.42 3.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.398 1.094 . . . . 0.0 109.183 171.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.587 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -157.94 152.77 25.19 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.2 -1.363 . . . . 0.0 109.011 178.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.428 ' SD ' ' NE2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -98.07 146.74 25.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.64 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 67.9 m-85 -104.27 103.58 13.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.3 -107.78 2.3 Favored Glycine 0 N--CA 1.422 -2.239 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.336 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.522 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 86.3 m-20 -80.73 -32.46 35.72 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 124.819 0.952 . . . . 0.0 110.415 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 110.59 20.22 7.45 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.079 -1.057 . . . . 0.0 110.97 -174.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.522 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 47.4 mtmt -66.02 -45.14 82.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.89 -0.655 . . . . 0.0 109.812 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.14 27.25 20.16 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.635 ' CE1' ' HA3' ' A' ' 11' ' ' GLY . 2.9 t80 -65.19 101.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HE ' ' C ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -102.24 51.26 0.82 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.013 0.435 . . . . 0.0 110.69 -177.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.635 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -108.42 -163.86 20.89 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.71 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -142.21 16.79 2.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.721 0.26 . . . . 0.0 110.926 -170.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.843 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 19.5 mmt180 -64.42 136.61 57.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.0 m -138.59 40.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.857 0.837 . . . . 0.0 110.422 -172.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.993 HG23 ' HA2' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -150.81 135.08 16.94 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.158 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.564 HG21 ' HB3' ' A' ' 73' ' ' ASP . 54.5 p -74.03 -170.57 0.95 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.026 0.441 . . . . 0.0 112.035 -175.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.2 -18.89 24.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.427 0.632 . . . . 0.0 110.875 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.4 p -93.45 -13.09 28.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.995 0.902 . . . . 0.0 109.063 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.993 ' HA2' HG23 ' A' ' 15' ' ' THR . . . 81.02 20.56 64.86 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.904 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.961 HG21 ' HB2' ' A' ' 67' ' ' ASN . 60.0 m -75.69 123.27 88.32 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 169.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 78.1 Cg_exo -50.28 135.4 38.74 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.497 2.131 . . . . 0.0 113.128 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.0 m -75.49 141.41 43.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.533 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -71.45 163.32 27.92 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.88 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 6.3 m-20 -76.7 125.16 28.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.738 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 38.6 m95 -53.34 -30.56 40.0 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.49 -14.04 59.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.013 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.89 148.52 27.51 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.694 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 36.1 mm-40 -103.39 29.71 5.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.74 127.06 6.91 Favored Pre-proline 0 N--CA 1.426 -1.644 0 CA-C-N 113.581 -1.645 . . . . 0.0 114.104 -159.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -85.61 26.32 11.67 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 123.853 -1.311 . . . . 0.0 112.59 1.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.673 ' HB3' HD12 ' A' ' 71' ' ' LEU . 68.3 m80 -129.17 104.01 7.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.694 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -74.61 118.2 17.3 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -176.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.491 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.7 p80 -144.8 92.73 2.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.75 0.786 . . . . 0.0 110.509 -173.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 m -74.1 31.42 0.08 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.705 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.491 ' H ' ' C ' ' A' ' 33' ' ' HIS . 25.7 pt -142.79 143.86 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.593 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 72.2 m-85 49.53 50.81 17.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.92 0.867 . . . . 0.0 111.185 -173.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 60.5 p -103.03 176.48 1.8 Allowed Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.468 171.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 24.2 Cg_exo -66.44 -11.49 31.79 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.98 1.787 . . . . 0.0 111.466 169.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -89.47 -40.72 12.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.09 0.471 . . . . 0.0 110.171 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.5 p -90.56 -22.55 21.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.251 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.625 ' O ' HD13 ' A' ' 46' ' ' LEU . 15.2 m120 -137.15 60.82 30.24 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.368 . . . . 0.0 111.514 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.53 20.33 0.69 Allowed 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 122.026 1.817 . . . . 0.0 112.396 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.58 -8.86 7.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.713 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -105.19 10.93 33.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.26 0.553 . . . . 0.0 110.324 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.76 41.68 73.19 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.163 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.796 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.5 mp -80.41 79.12 7.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.71 0.767 . . . . 0.0 110.368 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.819 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 7.2 pt-20 -101.78 136.48 41.54 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.818 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 11.0 mtpp 48.63 -105.98 0.17 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -141.67 11.62 2.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.646 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.819 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 23.2 m-85 -65.53 131.41 46.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.522 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 70.7 m -52.35 144.66 12.53 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.246 0.341 . . . . 0.0 111.028 -176.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 35.6 mmt-85 -149.32 168.78 22.42 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.268 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -129.49 77.86 76.59 Favored Pre-proline 0 C--N 1.313 -0.981 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.969 171.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.796 ' HG3' HD21 ' A' ' 46' ' ' LEU . 39.5 Cg_endo -72.93 -10.17 24.44 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.082 1.855 . . . . 0.0 111.801 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -90.98 -32.62 15.87 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 172.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.93 36.45 93.3 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.3 -165.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -46.84 134.05 10.36 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.942 -0.629 . . . . 0.0 109.877 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 13.0 t -70.09 0.31 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.563 0.697 . . . . 0.0 110.579 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.56 -19.95 39.37 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.46 -179.64 16.13 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.757 -1.211 . . . . 0.0 111.41 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -73.44 158.48 47.96 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.194 1.929 . . . . 0.0 111.859 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.497 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 19.2 p-90 -150.72 -169.24 3.33 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.867 -170.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.738 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.3 p -168.53 -176.62 2.87 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.5 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.556 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 84.1 m-85 -100.4 147.23 26.07 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 169.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 67' ' ' ASN . 2.7 p -100.62 149.7 23.48 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.741 -169.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.5 p -82.47 24.56 0.69 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.424 0.631 . . . . 0.0 109.89 167.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.961 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.7 t-20 -108.0 118.27 53.14 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.889 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 15.9 Cg_exo -68.66 5.95 1.14 Allowed 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.92 2.414 . . . . 0.0 113.585 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 -85.33 -49.13 8.4 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 149.04 52.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.163 0.506 . . . . 0.0 110.595 -175.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 31' ' ' HIS . 39.4 tp -76.37 -43.75 39.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.999 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 1.9 p90 -142.96 153.47 43.06 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.501 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.564 ' HB3' HG21 ' A' ' 16' ' ' THR . 18.9 t0 -152.98 164.85 37.2 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -175.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -92.48 156.56 17.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.59 171.76 7.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.827 0.346 . . . . 0.0 110.67 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -118.76 60.71 0.8 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.389 0.614 . . . . 0.0 109.99 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.843 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.5 p -102.28 130.44 24.18 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.396 0.617 . . . . 0.0 110.512 176.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.418 ' HD2' HG23 ' A' ' 77' ' ' VAL . 21.0 Cg_endo -60.12 160.9 20.96 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 124.691 3.594 . . . . 0.0 114.231 -176.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.428 ' NE2' ' SD ' ' A' ' 2' ' ' MET . 8.8 tp-100 -75.63 112.01 11.55 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.941 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.587 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.96 -41.61 50.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.724 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.64 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -86.56 62.25 7.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.252 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.958 178.409 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -93.56 12.31 25.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 67.96 35.15 3.88 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.696 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.527 ' OD1' ' HG2' ' A' ' 12' ' ' LYS . 36.5 t0 -80.43 48.12 1.0 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.307 1.051 . . . . 0.0 109.894 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.582 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -159.11 160.84 36.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.204 -177.388 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.624 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 16.2 ptt? -96.52 146.23 24.99 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.614 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 90.5 m-85 -105.47 99.47 9.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.25 -119.77 4.96 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.892 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -79.74 -18.12 51.91 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 124.481 0.753 . . . . 0.0 110.585 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.619 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.31 13.45 21.0 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.917 -174.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -64.5 -39.49 93.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.199 -0.501 . . . . 0.0 109.687 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.594 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -107.06 23.05 28.34 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 172.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.712 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.8 t80 -67.59 105.15 1.78 Allowed 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 172.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.52 39.06 2.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.17 0.509 . . . . 0.0 110.214 -175.124 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.459 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -94.72 -158.88 33.39 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.978 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.527 ' HG2' ' OD1' ' A' ' -1' ' ' ASP . 9.1 ptmm? -140.48 19.04 2.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.88 0.371 . . . . 0.0 110.33 -168.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.645 ' HB2' ' OH ' ' A' ' 9' ' ' TYR . 2.5 mpt_? -67.98 137.59 55.25 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 m -140.29 33.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.939 0.876 . . . . 0.0 110.322 -170.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.451 HG22 ' HA2' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -150.58 139.11 20.54 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -172.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.593 ' HB ' ' OD2' ' A' ' 73' ' ' ASP . 72.3 p -74.84 -176.22 2.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.647 0.261 . . . . 0.0 111.39 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.407 HG22 ' OD2' ' A' ' 73' ' ' ASP . 15.4 m -65.87 -20.41 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.647 0.737 . . . . 0.0 110.187 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 p -91.99 -14.23 29.77 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.529 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.451 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 89.94 11.97 62.71 Favored Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.846 -174.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.773 HG21 ' HB2' ' A' ' 67' ' ' ASN . 78.4 m -76.58 120.82 83.3 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 120.426 -0.509 . . . . 0.0 109.84 170.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -50.55 125.82 16.45 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.837 2.358 . . . . 0.0 113.198 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.4 m -64.44 137.87 58.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.499 0.666 . . . . 0.0 110.627 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 25.5 tt0 -71.22 166.12 22.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.925 174.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 1.0 OUTLIER -75.98 125.11 28.49 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.113 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.739 ' CE3' HD23 ' A' ' 46' ' ' LEU . 45.9 m95 -54.8 -29.25 54.02 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.611 0.719 . . . . 0.0 109.122 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.87 -21.35 55.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.556 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.69 150.38 22.8 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -172.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.755 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.5 mm-40 -103.5 33.0 3.53 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 43.4 mt-10 -143.17 119.58 6.66 Favored Pre-proline 0 N--CA 1.43 -1.474 0 CA-C-N 114.205 -1.361 . . . . 0.0 114.209 -157.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 88.9 Cg_endo -90.04 31.98 9.58 Favored 'Cis proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.298 -1.542 . . . . 0.0 113.456 1.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.491 ' HB3' HD12 ' A' ' 71' ' ' LEU . 61.5 m80 -131.63 113.02 13.1 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.755 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.72 116.55 14.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.823 -176.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.494 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.8 p80 -148.57 89.71 1.72 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.449 1.119 . . . . 0.0 110.543 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.1 m -78.19 35.84 0.22 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.996 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.494 ' H ' ' C ' ' A' ' 33' ' ' HIS . 20.1 pt -143.19 146.63 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.559 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 31.0 m-85 53.97 46.51 25.43 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.343 1.068 . . . . 0.0 110.629 -174.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.573 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 42.6 p -99.8 176.77 1.78 Allowed Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.145 170.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 30.3 Cg_exo -61.99 -21.58 72.64 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 121.959 1.773 . . . . 0.0 111.95 169.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -87.49 -34.71 18.56 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.981 0.419 . . . . 0.0 111.122 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.3 p -89.08 -24.03 22.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.973 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.559 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.0 m120 -136.03 59.28 27.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 21.1 Cg_exo -64.48 4.15 0.68 Allowed 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.476 2.117 . . . . 0.0 112.787 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.414 ' H ' ' C ' ' A' ' 41' ' ' ASN . 23.2 ptt180 -95.06 -19.36 20.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.588 0.233 . . . . 0.0 111.376 -173.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.737 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -109.09 2.74 21.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.595 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.05 47.48 85.04 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.262 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.899 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.6 mp -75.14 74.28 2.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.967 0.413 . . . . 0.0 111.5 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.528 ' HG3' ' CD2' ' A' ' 50' ' ' TYR . 3.0 pt-20 -98.94 152.83 19.35 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.669 176.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 48.0 mttp 49.96 -113.65 0.66 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.418 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -140.69 19.63 2.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.176 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.528 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 30.2 m-85 -61.92 128.83 38.06 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.676 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 80.5 m -53.76 145.23 16.19 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 38.8 mmt-85 -152.5 164.62 37.23 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.225 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -125.57 81.45 64.7 Favored Pre-proline 0 C--N 1.318 -0.762 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.719 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.899 ' HG3' HD21 ' A' ' 46' ' ' LEU . 39.1 Cg_exo -59.17 -31.89 96.15 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.727 2.285 . . . . 0.0 112.458 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -89.76 -20.0 24.07 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.525 0.679 . . . . 0.0 109.97 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.96 44.09 97.5 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.539 -168.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -48.03 135.09 13.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.414 -0.893 . . . . 0.0 109.443 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 58' ' ' VAL . 11.4 t -71.67 6.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 123.893 0.746 . . . . 0.0 110.868 -173.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.42 -17.82 13.0 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.88 -178.15 16.5 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 119.89 -1.148 . . . . 0.0 111.234 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.624 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 74.2 Cg_endo -73.5 157.92 48.43 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.091 1.861 . . . . 0.0 111.815 -174.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.551 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 32.2 p-90 -145.61 -172.09 3.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.717 -172.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.711 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.0 p -168.52 -179.82 4.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.122 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 43.7 m-85 -100.16 145.61 27.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.3 p -102.84 147.02 27.41 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.664 -170.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.7 p -80.99 23.57 0.55 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.383 0.611 . . . . 0.0 110.517 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.773 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.1 t-20 -103.98 121.76 46.73 Favored Pre-proline 0 CA--C 1.528 0.115 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.086 -177.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 16.5 Cg_exo -67.23 -0.33 4.81 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.888 2.392 . . . . 0.0 113.703 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -84.66 -44.98 12.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.836 0.35 . . . . 0.0 111.619 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.13 145.57 50.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.468 0.651 . . . . 0.0 111.048 -175.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 31' ' ' HIS . 41.8 tp -71.28 -43.04 67.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.621 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -143.29 164.29 30.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.089 0.471 . . . . 0.0 110.338 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.593 ' OD2' ' HB ' ' A' ' 16' ' ' THR . 33.0 t70 -157.94 173.89 16.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -93.63 158.67 15.58 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 86.6 m -106.37 171.24 7.46 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -122.64 69.25 0.97 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.3 0.571 . . . . 0.0 109.99 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.712 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.6 p -105.29 132.72 20.63 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.854 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 77' ' ' VAL . 51.8 Cg_endo -65.76 162.24 35.51 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 123.631 2.887 . . . . 0.0 113.378 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.47 ' CG ' ' HB2' ' A' ' 82' ' ' ALA . 9.3 tp-100 -75.6 108.96 8.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.231 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.492 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -73.3 -37.94 66.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.306 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.614 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -83.39 52.1 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.194 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.47 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . . . . . . . . 0 C--O 1.245 0.856 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.938 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 64.5 p . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -3' ' ' ASN . . . . . 0.507 ' ND2' ' HD3' ' A' ' 12' ' ' LYS . 27.6 p-10 -82.41 3.81 26.58 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 68.93 22.9 6.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.513 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.491 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 46.8 t0 -82.67 53.66 2.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.256 1.027 . . . . 0.0 109.364 175.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.502 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -151.51 155.18 37.99 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.258 -178.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.63 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.8 ptt? -97.29 150.74 20.61 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 121.358 0.599 . . . . 0.0 112.514 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.733 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 71.8 m-85 -109.7 102.07 10.91 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.38 -115.48 4.19 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 119.997 -1.097 . . . . 0.0 111.033 -175.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.18 -23.93 40.69 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 124.531 0.783 . . . . 0.0 109.576 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.535 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.31 17.41 10.75 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.313 -0.946 . . . . 0.0 110.969 -174.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -66.48 -39.9 89.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.103 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.575 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -105.61 20.69 36.33 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.653 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.0 t80 -65.31 105.19 1.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -113.08 35.78 3.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.233 0.54 . . . . 0.0 109.551 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -88.25 -154.04 27.17 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.995 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.507 ' HD3' ' ND2' ' A' ' -3' ' ' ASN . 4.7 ptmt -150.29 22.07 0.84 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.912 0.387 . . . . 0.0 110.687 -168.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.722 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 22.5 mmt180 -68.5 137.86 54.74 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 171.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.79 38.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.486 0.66 . . . . 0.0 111.655 -171.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.06 145.31 25.42 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.957 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.504 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 69.4 p -74.36 -174.05 1.89 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.042 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -63.71 -20.45 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.489 0.661 . . . . 0.0 110.818 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.4 p -92.87 -12.71 30.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.499 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.43 11.41 69.03 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.42 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.975 HG21 ' HB2' ' A' ' 67' ' ' ASN . 95.4 m -76.69 119.15 76.2 Favored Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.329 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -47.25 124.7 9.45 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 123.098 2.532 . . . . 0.0 113.689 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.8 m -63.5 139.48 58.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.425 0.631 . . . . 0.0 110.884 172.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 23.1 tt0 -71.16 164.81 24.9 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.021 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 5.3 m-20 -76.95 125.56 29.51 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.693 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 37.7 m95 -54.06 -31.79 52.62 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.59 -17.08 58.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.749 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . . . -106.82 150.41 26.38 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -174.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.89 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.3 mm-40 -102.61 29.52 5.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 4.0 mm-40 -133.78 119.47 14.92 Favored Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -159.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 88.7 Cg_endo -94.24 35.65 7.57 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.079 -1.634 . . . . 0.0 112.783 -0.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.451 ' HB3' HD12 ' A' ' 71' ' ' LEU . 58.2 m80 -126.81 107.48 10.16 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.89 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.0 OUTLIER -76.59 113.02 13.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.068 -175.135 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 5.0 p80 -143.53 92.53 2.37 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.997 0.903 . . . . 0.0 110.422 -172.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.4 m -77.47 39.11 0.25 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.47 0.653 . . . . 0.0 109.534 172.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.465 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.4 pt -143.37 135.86 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -173.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 45.6 m-85 53.58 48.2 22.2 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 122.265 1.031 . . . . 0.0 111.275 -175.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 46.9 p -99.84 175.54 2.36 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.101 170.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 22.6 Cg_exo -64.79 -18.52 62.72 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.798 1.666 . . . . 0.0 111.257 168.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -83.17 -38.94 21.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.314 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.3 p -92.04 -25.23 18.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.085 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.547 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.0 m120 -132.41 68.25 79.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.346 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.22 12.37 1.81 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.453 2.102 . . . . 0.0 112.159 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -100.12 -27.7 13.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 -174.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.678 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -105.41 6.9 32.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 111.689 -172.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.36 46.29 93.09 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.368 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.689 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.6 mp -75.4 78.46 2.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.201 0.524 . . . . 0.0 110.507 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.749 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.6 pt-20 -97.64 139.89 32.86 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.675 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 29.4 mmtp 51.82 -111.47 0.57 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.865 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -137.22 14.16 3.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.831 0.348 . . . . 0.0 110.853 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.749 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 18.8 m-85 -66.92 129.5 40.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.528 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 84.1 m -52.88 153.1 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.265 0.353 . . . . 0.0 111.718 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 39.0 mmt-85 -156.26 166.91 32.06 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.17 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -128.32 78.72 75.21 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.941 171.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.672 ' HG3' HD21 ' A' ' 46' ' ' LEU . 28.3 Cg_endo -70.62 -14.08 33.07 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.328 2.019 . . . . 0.0 112.807 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.45 -21.59 20.09 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.468 0.651 . . . . 0.0 109.412 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.74 43.92 86.71 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.51 -167.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 59' ' ' GLY . 7.8 t70 -56.89 140.44 48.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.35 -0.925 . . . . 0.0 109.504 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 58' ' ' VAL . 9.2 t -75.11 13.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 122.045 0.926 . . . . 0.0 110.102 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -103.7 -18.61 13.73 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.28 -177.81 16.61 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.872 -1.156 . . . . 0.0 111.358 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.63 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 86.8 Cg_endo -77.22 153.51 31.76 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.36 2.04 . . . . 0.0 111.304 -175.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.538 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 19.3 p-90 -145.53 -169.23 3.17 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.893 -170.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.693 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.8 p -168.74 -178.11 3.29 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.812 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -101.06 145.36 28.84 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 ' HE3' ' A' ' 70' ' ' LYS . 3.1 p -99.4 149.27 23.34 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.119 -1.033 . . . . 0.0 109.729 -170.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.9 p -83.86 33.54 0.48 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.523 0.678 . . . . 0.0 109.738 166.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.975 ' HB2' HG21 ' A' ' 20' ' ' THR . 60.8 t-20 -112.97 120.59 40.25 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.995 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.1 Cg_exo -70.0 5.71 1.68 Allowed 'Trans proline' 0 N--CA 1.472 0.251 0 C-N-CA 122.866 2.378 . . . . 0.0 113.489 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -84.87 -50.81 7.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.157 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HE3' HG21 ' A' ' 65' ' ' THR . 0.5 OUTLIER -134.59 154.58 51.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.015 0.436 . . . . 0.0 110.879 -176.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 31' ' ' HIS . 50.8 tp -76.18 -43.42 42.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.095 -176.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -142.33 161.25 38.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.504 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 46.6 t0 -159.36 165.46 33.24 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 60.1 m-85 -93.3 155.05 17.65 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.8 m -103.11 167.99 9.47 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.912 0.387 . . . . 0.0 110.621 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -112.92 56.2 0.68 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.375 0.607 . . . . 0.0 110.033 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.722 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.8 p -95.35 128.46 38.35 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.186 0.517 . . . . 0.0 110.004 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 77' ' ' VAL . 34.8 Cg_endo -62.77 157.18 49.05 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 C-N-CA 123.565 2.843 . . . . 0.0 113.603 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.7 107.13 7.66 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.093 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -39.93 65.71 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.317 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.733 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -93.33 58.97 2.92 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.559 -178.972 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -88.44 11.7 16.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.83 0.348 . . . . 0.0 110.145 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 71.58 15.3 6.07 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.438 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.646 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 22.8 t0 -82.47 62.54 6.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.172 0.987 . . . . 0.0 109.963 175.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.546 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.8 OUTLIER -157.64 147.67 20.5 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.599 178.287 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.613 ' HG2' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.5 150.31 22.33 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.098 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.608 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 90.0 m-85 -106.97 101.5 10.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -176.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.56 -106.87 2.09 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.04 -173.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -83.12 -32.77 26.52 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 125.206 1.18 . . . . 0.0 111.126 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.86 21.72 7.32 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.957 -175.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -65.32 -38.99 91.85 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.112 0.482 . . . . 0.0 109.967 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -106.99 26.55 18.84 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -70.25 104.07 2.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.58 38.74 2.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.011 0.434 . . . . 0.0 110.76 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.646 ' CA ' ' HA ' ' A' ' -1' ' ' ASP . . . -94.98 -159.77 33.59 Favored Glycine 0 C--N 1.329 0.174 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.943 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 14.5 ptmt -145.07 20.94 1.59 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.846 0.323 . . . . 0.0 111.314 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.721 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.9 mmt180 -67.44 138.8 56.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 173.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 50' ' ' TYR . 5.0 m -139.98 34.19 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.479 0.657 . . . . 0.0 111.552 -167.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.771 HG22 ' HA2' ' A' ' 19' ' ' GLY . 8.5 m -151.89 135.38 16.1 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -173.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.428 HG21 ' HB3' ' A' ' 73' ' ' ASP . 78.3 p -73.53 -176.72 2.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.941 0.4 . . . . 0.0 112.075 -172.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 m -65.03 -18.67 24.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.439 0.638 . . . . 0.0 111.046 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.8 p -93.12 -14.17 27.57 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.235 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.771 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.41 16.15 62.83 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.426 -174.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.973 HG21 ' HB2' ' A' ' 67' ' ' ASN . 86.3 m -76.8 121.09 84.21 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.633 169.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.49 126.24 15.61 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.768 2.312 . . . . 0.0 113.231 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.5 m -64.88 138.2 58.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.46 0.647 . . . . 0.0 110.697 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -72.12 165.71 23.77 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.441 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 16.9 m-20 -76.42 125.53 29.36 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.753 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 33.6 m95 -55.19 -29.18 57.35 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.8 -23.66 55.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.776 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -97.24 149.72 21.72 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -173.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.675 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.3 mm-40 -104.57 31.96 4.38 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.2 mt-10 -147.61 122.3 5.1 Favored Pre-proline 0 N--CA 1.425 -1.703 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.283 -155.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 87.4 Cg_endo -87.18 28.6 10.81 Favored 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.343 -1.524 . . . . 0.0 112.759 0.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.477 ' HB3' HD12 ' A' ' 71' ' ' LEU . 63.7 m80 -128.73 104.51 7.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.675 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.88 121.11 20.42 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -176.542 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.477 ' HE1' ' HA ' ' A' ' 25' ' ' TRP . 5.4 p80 -148.91 95.92 2.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.174 0.988 . . . . 0.0 110.172 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 m -77.89 32.15 0.17 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.234 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.473 ' H ' ' C ' ' A' ' 33' ' ' HIS . 30.3 pt -141.77 147.98 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -175.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.587 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 52.3 m-85 48.23 50.78 15.88 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.139 0.971 . . . . 0.0 111.268 -173.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 31.1 p -98.98 175.09 2.63 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.142 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 38.4 Cg_exo -62.99 -20.1 70.76 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.041 1.828 . . . . 0.0 112.236 172.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -99.64 -25.62 14.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.819 0.342 . . . . 0.0 111.207 -172.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.5 p -91.95 -15.75 27.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.83 0.347 . . . . 0.0 110.462 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.587 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.8 m120 -139.73 52.46 3.8 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.721 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 8.2 Cg_exo -71.49 31.61 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.789 2.326 . . . . 0.0 113.59 -176.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.81 -10.5 4.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.628 0.251 . . . . 0.0 111.354 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.697 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -105.76 9.83 32.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.122 0.487 . . . . 0.0 110.039 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.72 43.4 97.85 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.23 -0.895 . . . . 0.0 113.102 173.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.1 mp -81.32 94.8 6.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.152 0.501 . . . . 0.0 109.856 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.659 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.5 pt-20 -121.43 152.3 39.23 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.07 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 4.1 mptp? 46.74 -113.08 0.44 Allowed 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.915 0.76 . . . . 0.0 111.763 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -136.68 18.68 3.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.06 0.457 . . . . 0.0 110.128 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.659 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 20.2 m-85 -67.8 128.39 36.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.786 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.51 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 84.5 m -51.33 147.21 6.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.309 0.38 . . . . 0.0 111.254 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.51 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 38.3 mmt-85 -151.53 169.07 22.98 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.695 -176.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -134.27 77.92 59.35 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.85 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.643 ' HG3' HD21 ' A' ' 46' ' ' LEU . 18.8 Cg_exo -64.36 -26.77 63.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.354 2.036 . . . . 0.0 112.123 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -20.07 23.78 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.547 0.689 . . . . 0.0 109.663 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.71 45.19 93.66 Favored Glycine 0 N--CA 1.433 -1.5 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.674 -170.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -45.47 130.29 8.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 172.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 t -66.55 -5.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 O-C-N 123.941 0.776 . . . . 0.0 110.95 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.28 -20.21 36.28 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.309 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 129.42 -179.95 16.39 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.583 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 73.4 Cg_endo -72.66 159.04 49.6 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.21 1.94 . . . . 0.0 111.824 -175.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.569 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 28.4 p-90 -146.23 -171.98 3.84 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.007 -171.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.753 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.3 p -168.18 -177.87 3.45 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.881 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.543 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 57.5 m-85 -100.5 146.68 26.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 171.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 2.5 p -102.13 150.21 23.49 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.847 -171.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.2 p -84.27 31.26 0.51 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.527 0.68 . . . . 0.0 110.085 167.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.973 ' HB2' HG21 ' A' ' 20' ' ' THR . 59.0 t-20 -111.26 122.34 37.97 Favored Pre-proline 0 N--CA 1.462 0.16 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.075 -176.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.39 2.21 2.99 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.73 2.286 . . . . 0.0 113.481 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -83.72 -53.67 5.46 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.98 150.11 49.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.281 0.562 . . . . 0.0 110.571 -176.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 31' ' ' HIS . 53.5 tp -75.91 -43.42 45.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.349 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 11.2 p90 -143.1 158.56 43.5 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 16' ' ' THR . 28.6 t0 -153.93 172.22 17.77 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -176.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -94.08 155.06 17.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.6 m -106.34 170.95 7.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.747 0.308 . . . . 0.0 110.626 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -121.63 64.58 0.9 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.52 0.676 . . . . 0.0 109.88 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.721 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 1.7 p -94.81 131.78 29.79 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.328 174.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 77' ' ' VAL . 12.3 Cg_endo -56.06 152.05 39.2 Favored 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 123.403 2.735 . . . . 0.0 113.277 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.434 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 8.8 tp-100 -74.85 112.65 11.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.631 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.546 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.6 OUTLIER -74.66 -37.2 62.78 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.119 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.608 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -88.39 43.86 1.16 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.802 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . . . . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.351 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 42.2 m . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -77.54 -12.75 60.0 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 174.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 68.26 19.48 9.02 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.253 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.404 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 32.9 t0 -87.61 59.44 5.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.961 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.54 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -157.4 157.14 33.45 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.238 -177.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.683 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.9 ptt? -97.61 154.64 17.41 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.689 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 81.1 m-85 -110.5 102.0 10.64 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.65 -115.15 4.18 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.444 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.75 -24.84 41.29 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 124.605 0.826 . . . . 0.0 110.788 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.559 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.09 16.56 14.77 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.817 -1.183 . . . . 0.0 111.486 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -64.74 -46.9 80.25 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -101.1 28.26 16.82 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.294 173.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.651 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.3 t80 -70.47 102.01 2.11 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -105.97 32.24 4.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.057 0.456 . . . . 0.0 109.918 -174.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.567 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -84.18 -154.86 20.58 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.528 -175.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HD3' ' HB2' ' A' ' -1' ' ' ASP . 0.0 OUTLIER -150.46 24.69 0.79 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.976 0.417 . . . . 0.0 110.329 -173.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.592 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 27.4 mmt180 -72.0 137.83 47.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 170.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 50' ' ' TYR . 4.0 m -138.29 38.04 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.582 0.706 . . . . 0.0 111.088 -169.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.32 144.07 25.29 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.191 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.437 HG21 HG22 ' A' ' 65' ' ' THR . 42.7 p -75.51 -176.14 3.09 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.24 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 m -65.47 -16.02 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.283 0.563 . . . . 0.0 110.824 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.4 p -93.22 -15.52 25.81 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.259 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.06 10.69 64.14 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.253 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 67' ' ' ASN . 85.4 m -77.64 120.68 82.38 Favored Pre-proline 0 N--CA 1.448 -0.549 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.867 174.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -51.31 123.87 12.92 Favored 'Trans proline' 0 C--O 1.239 0.53 0 C-N-CA 122.933 2.422 . . . . 0.0 113.243 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -62.59 140.94 58.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.848 174.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -73.21 164.96 25.92 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.16 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.63 124.37 27.85 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.639 ' CE3' HD23 ' A' ' 46' ' ' LEU . 44.4 m95 -54.28 -31.42 53.78 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.25 -9.31 59.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.818 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.67 147.41 33.17 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.699 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 34.8 mm-40 -102.22 31.94 3.75 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 41.1 mt-10 -146.51 122.26 5.57 Favored Pre-proline 0 N--CA 1.426 -1.633 0 CA-C-N 114.259 -1.337 . . . . 0.0 113.879 -156.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 3.3 Cg_endo -86.58 26.8 12.53 Favored 'Cis proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.612 -1.412 . . . . 0.0 113.344 2.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.401 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 59.1 m80 -126.52 109.77 12.53 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.699 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -72.78 113.61 10.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.973 -178.031 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.9 p80 -143.85 90.99 2.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.92 0.867 . . . . 0.0 110.096 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 40' ' ' THR . 14.7 m -75.61 34.85 0.12 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.508 0.67 . . . . 0.0 110.089 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.521 ' H ' ' C ' ' A' ' 33' ' ' HIS . 17.8 pt -143.84 142.13 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -175.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.542 ' CG ' ' HH2' ' A' ' 62' ' ' TRP . 32.5 m-85 57.0 45.26 21.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 121.769 0.795 . . . . 0.0 111.004 -176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 21.9 p -103.81 173.47 3.38 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.618 168.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 37.2 Cg_exo -59.39 -22.37 65.42 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.793 1.662 . . . . 0.0 111.997 170.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -86.56 -39.17 16.45 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.945 0.402 . . . . 0.0 110.649 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 34' ' ' SER . 1.8 p -90.26 -20.1 23.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.493 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.54 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.4 m120 -135.46 65.14 61.55 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.943 0.401 . . . . 0.0 111.443 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -79.52 32.56 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.358 2.039 . . . . 0.0 111.382 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -120.32 -17.1 8.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.425 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.667 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -118.14 11.35 13.23 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.804 -172.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.95 44.9 95.32 Favored Glycine 0 C--O 1.23 -0.145 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.323 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.952 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.2 mp -77.73 90.97 4.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.056 0.455 . . . . 0.0 111.334 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.576 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.6 pt-20 -108.84 142.16 39.83 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.493 175.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 58.39 -123.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.994 0.809 . . . . 0.0 110.908 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -130.35 17.09 5.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.659 0.266 . . . . 0.0 110.752 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.576 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 18.0 m-85 -66.4 131.24 45.64 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.627 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 72.1 m -52.24 148.17 6.81 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.422 0.451 . . . . 0.0 111.395 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HG3' ' HA ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -153.53 158.93 42.0 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -119.61 78.93 21.84 Favored Pre-proline 0 C--N 1.316 -0.891 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.825 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.952 ' HG3' HD21 ' A' ' 46' ' ' LEU . 26.8 Cg_exo -58.09 -26.49 75.81 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.741 2.294 . . . . 0.0 112.643 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.51 -11.63 18.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.754 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.17 45.57 95.13 Favored Glycine 0 CA--C 1.501 -0.801 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.217 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 59' ' ' GLY . 4.1 t70 -51.86 133.08 32.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.699 -0.751 . . . . 0.0 109.114 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.79 24.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.844 0.83 . . . . 0.0 110.562 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -116.3 -17.69 6.1 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.82 -179.56 16.1 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.32 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.683 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 71.7 Cg_endo -73.74 157.99 47.42 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.31 2.007 . . . . 0.0 111.481 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.604 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 29.3 p-90 -146.9 -174.16 4.42 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.065 -171.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.614 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.2 p -168.94 178.2 4.62 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.032 177.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.497 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 47.8 m-85 -100.51 145.39 28.36 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.437 HG22 HG21 ' A' ' 16' ' ' THR . 1.1 p -101.94 148.36 25.43 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.734 -171.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 p -79.73 19.2 0.68 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.101 0.477 . . . . 0.0 110.921 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.629 ' HB2' HG21 ' A' ' 20' ' ' THR . 63.0 t-20 -100.35 118.29 61.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.216 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 15.2 Cg_exo -68.52 3.64 2.1 Favored 'Trans proline' 0 N--CA 1.47 0.119 0 C-N-CA 123.157 2.572 . . . . 0.0 113.496 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -84.75 -44.43 13.34 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.966 0.412 . . . . 0.0 110.819 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.504 ' HE2' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -144.92 142.56 29.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.482 0.658 . . . . 0.0 111.16 -174.475 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HG ' ' CD1' ' A' ' 64' ' ' TYR . 52.5 tp -70.69 -44.48 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.912 -168.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -146.75 163.83 34.72 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.543 -174.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -154.07 -177.55 6.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.084 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -93.15 162.12 14.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 94.8 m -105.77 171.43 7.34 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.171 0.51 . . . . 0.0 111.266 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -117.43 70.48 0.79 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.225 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.651 HG21 ' CE1' ' A' ' 9' ' ' TYR . 3.4 p -109.67 128.67 24.99 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.31 173.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.84 159.15 34.59 Favored 'Trans proline' 0 CA--C 1.512 -0.595 0 C-N-CA 123.772 2.981 . . . . 0.0 113.634 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -74.39 113.84 12.09 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.068 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.522 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.91 -42.12 58.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.056 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.689 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -82.67 63.65 6.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.427 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.564 -0.732 . . . . 0.0 109.953 179.868 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -87.3 2.07 51.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 69.85 17.3 7.62 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.228 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.553 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 27.2 t0 -83.86 65.39 8.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.083 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.593 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.8 OUTLIER -148.6 151.1 34.44 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.149 177.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.722 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 12.9 ptt? -96.83 154.54 17.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 81' ' ' ALA . 49.6 m-85 -108.87 96.53 6.39 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.15 -115.18 4.05 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -79.49 -25.27 41.86 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.761 0.824 . . . . 0.0 111.148 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.627 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 112.04 13.54 12.16 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 119.834 -1.174 . . . . 0.0 111.568 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HB3' ' NZ ' ' A' ' 7' ' ' LYS . 9.1 mtpm? -60.61 -41.74 95.41 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.472 0.653 . . . . 0.0 110.202 175.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.517 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.94 28.64 10.86 Favored Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.165 172.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.72 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.7 t80 -68.43 106.31 2.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.896 0.379 . . . . 0.0 110.023 173.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.0 51.47 0.8 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -175.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.552 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -101.97 -148.65 21.38 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.711 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.553 ' HD3' ' HB2' ' A' ' -1' ' ' ASP . 0.0 OUTLIER -151.84 20.43 0.69 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.863 0.332 . . . . 0.0 110.773 -174.397 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.935 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.4 mmt180 -62.38 139.54 58.55 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.3 m -139.53 35.64 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.06 0.933 . . . . 0.0 109.871 -174.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.07 143.67 25.26 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.091 -177.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.445 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 55.7 p -75.37 -174.75 2.51 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.03 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.12 -16.35 20.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.505 0.669 . . . . 0.0 110.872 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.7 p -93.19 -13.61 28.16 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.44 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.8 10.56 66.84 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.26 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 1.015 HG21 ' HB2' ' A' ' 67' ' ' ASN . 96.9 m -77.08 120.54 82.05 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.141 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 58.2 Cg_exo -47.48 123.01 7.43 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.201 2.601 . . . . 0.0 113.802 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.98 141.14 58.86 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.842 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -73.81 166.26 23.64 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.417 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 11.8 m-20 -76.52 124.7 28.0 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 175.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.671 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 38.6 m95 -53.73 -32.55 52.53 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.9 -12.09 59.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.945 -1.479 . . . . 0.0 113.045 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.78 149.09 30.31 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 119.21 0.914 . . . . 0.0 109.052 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.693 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.3 mm-40 -101.84 31.76 3.72 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 44.1 mt-10 -145.57 121.39 5.81 Favored Pre-proline 0 N--CA 1.426 -1.655 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.712 -155.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 93.8 Cg_endo -89.92 33.59 7.83 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.469 -1.471 . . . . 0.0 113.217 1.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.6 ' HB3' HD12 ' A' ' 71' ' ' LEU . 64.3 m80 -134.11 111.16 10.1 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.693 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -72.17 126.6 30.21 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.248 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 35' ' ' ILE . 6.1 p80 -155.02 89.43 1.22 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.033 0.921 . . . . 0.0 110.271 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 m -73.79 34.23 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.528 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.526 ' H ' ' C ' ' A' ' 33' ' ' HIS . 20.7 pt -143.29 147.21 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.561 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 35.7 m-85 52.29 45.49 28.35 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.983 0.897 . . . . 0.0 111.27 -174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 p -100.8 172.59 4.36 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.495 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.15 -14.16 42.02 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.015 1.81 . . . . 0.0 112.003 172.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -92.91 -37.72 12.09 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 110.167 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -87.74 -22.37 24.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.464 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.561 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.0 m120 -130.82 60.29 51.96 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.328 . . . . 0.0 111.014 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.81 39.15 0.73 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.641 2.227 . . . . 0.0 112.956 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.478 ' NH1' ' HA ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -141.56 -16.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.644 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -99.52 12.3 36.81 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.166 -0.334 . . . . 0.0 110.453 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.79 40.21 85.23 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.085 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.644 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.2 mp -81.76 102.43 10.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.094 0.473 . . . . 0.0 110.435 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.403 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.4 pt-20 -127.27 142.75 51.39 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.448 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 31.5 mmtp 55.14 -116.15 1.02 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.969 0.793 . . . . 0.0 111.211 177.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -136.11 17.42 3.22 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.827 0.346 . . . . 0.0 110.83 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.403 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 30.0 m-85 -66.06 130.71 44.19 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.615 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 93.8 m -56.57 146.91 23.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.994 0.426 . . . . 0.0 111.668 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.81 159.88 43.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -176.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -126.37 80.25 69.38 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.746 -0.381 . . . . 0.0 109.98 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.64 ' HG3' HD21 ' A' ' 46' ' ' LEU . 37.6 Cg_exo -59.63 -31.71 94.77 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.908 2.405 . . . . 0.0 112.592 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -88.99 -24.0 22.49 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.523 0.677 . . . . 0.0 110.048 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.64 46.36 69.38 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.019 -172.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -48.39 133.64 15.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.73 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.37 -11.29 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 124.451 1.094 . . . . 0.0 111.527 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.29 -10.89 43.73 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.909 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.84 -177.81 16.59 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.684 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.722 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 88.2 Cg_endo -74.69 164.77 32.99 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.575 2.183 . . . . 0.0 111.694 -173.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.598 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 29.8 p-90 -149.97 -172.13 4.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.227 -172.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.671 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.7 p -168.91 -177.71 3.08 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.691 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.462 ' CD1' ' HB3' ' A' ' 72' ' ' TYR . 50.1 m-85 -100.99 147.29 26.35 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 171.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 p -103.35 147.16 27.43 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.081 -170.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.7 p -82.48 21.47 0.96 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.153 0.501 . . . . 0.0 110.411 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 1.015 ' HB2' HG21 ' A' ' 20' ' ' THR . 52.8 t-20 -99.35 123.11 49.65 Favored Pre-proline 0 N--CA 1.456 -0.164 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.155 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.83 1.98 2.39 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.836 2.357 . . . . 0.0 113.16 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -84.08 -50.75 7.66 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.044 0.449 . . . . 0.0 111.089 175.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -130.14 159.55 36.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.368 0.604 . . . . 0.0 111.212 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 31' ' ' HIS . 45.4 tp -84.81 -45.63 12.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.857 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.462 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 33.6 p90 -143.37 164.18 30.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.863 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 37.2 t0 -160.01 176.23 12.08 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -94.34 157.51 16.0 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.9 m -106.03 167.64 9.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.712 0.291 . . . . 0.0 110.288 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -117.89 72.44 0.85 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.308 0.575 . . . . 0.0 110.037 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.935 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -106.6 129.48 24.38 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.953 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.93 157.3 16.96 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 124.327 3.351 . . . . 0.0 113.85 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.89 113.83 13.82 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.933 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.593 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.89 -44.4 40.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.589 178.133 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.615 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . . . -84.84 65.21 9.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.372 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.13 179.844 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -98.48 -10.98 22.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 68.77 20.11 8.2 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.803 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.475 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 23.3 t70 -86.03 58.69 5.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.451 1.119 . . . . 0.0 109.234 176.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.477 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -157.44 156.93 33.01 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.262 -177.103 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.56 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 15.9 ptt? -96.28 154.86 17.02 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.508 ' CD2' ' HB2' ' A' ' 81' ' ' ALA . 7.8 m-85 -113.67 96.45 5.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.27 -115.09 3.98 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -79.83 -22.21 43.26 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.282 0.636 . . . . 0.0 109.715 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.92 11.55 20.44 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.224 -0.988 . . . . 0.0 110.938 -174.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 7' ' ' LYS . 9.2 mtpm? -65.17 -31.75 73.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.055 0.455 . . . . 0.0 110.124 176.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -111.7 19.45 23.64 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 173.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.1 t80 -68.19 110.53 4.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -118.32 45.15 2.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 0.0 109.664 -177.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.531 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -98.88 -159.85 29.58 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.85 -175.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -139.59 15.12 2.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.495 0.188 . . . . 0.0 110.74 -170.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.638 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 19.8 mmt180 -64.66 135.78 56.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 2.8 m -134.61 36.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.553 0.692 . . . . 0.0 111.209 -171.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.764 HG23 ' HA2' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -151.35 139.97 20.68 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -178.09 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.629 HG21 ' HB3' ' A' ' 73' ' ' ASP . 75.3 p -75.15 -169.69 1.0 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.892 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -66.25 -21.11 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.312 0.577 . . . . 0.0 110.759 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.2 p -92.84 -13.33 29.22 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.191 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.764 ' HA2' HG23 ' A' ' 15' ' ' THR . . . 82.62 20.69 61.31 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.582 -173.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.5 m -76.48 119.31 76.82 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 168.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 86.0 Cg_exo -49.52 135.95 33.2 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.924 2.416 . . . . 0.0 113.225 176.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 72.9 m -76.45 142.94 40.84 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.734 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -70.96 165.53 23.2 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.297 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.9 128.81 35.24 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.679 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 57.8 m95 -57.82 -30.89 66.09 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.437 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . . . -78.07 -18.1 56.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.853 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.44 149.58 21.24 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 30.3 mm-40 -104.3 31.24 4.73 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.5 mt-10 -147.62 122.79 5.2 Favored Pre-proline 0 N--CA 1.422 -1.832 0 CA-C-N 113.795 -1.548 . . . . 0.0 114.397 -154.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 91.9 Cg_endo -86.85 29.82 9.03 Favored 'Cis proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.212 -1.578 . . . . 0.0 112.839 -0.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.689 ' HB3' HD12 ' A' ' 71' ' ' LEU . 55.0 m80 -130.58 107.49 9.24 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.641 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -74.48 125.33 28.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.443 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.47 ' C ' ' H ' ' A' ' 35' ' ' ILE . 3.9 p80 -155.21 98.13 1.97 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.99 0.9 . . . . 0.0 110.96 -177.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.0 m -79.61 33.78 0.26 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.666 0.746 . . . . 0.0 109.837 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.47 ' H ' ' C ' ' A' ' 33' ' ' HIS . 31.4 pt -142.15 146.16 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.623 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 41.7 m-85 50.06 51.04 17.44 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.931 0.872 . . . . 0.0 111.254 -175.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 29.3 p -99.44 177.65 1.5 Allowed Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.115 171.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 35.6 Cg_exo -60.53 -29.24 88.18 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 121.872 1.714 . . . . 0.0 111.378 170.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.04 -30.56 16.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.682 -167.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.0 p -89.06 -19.91 25.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.036 0.446 . . . . 0.0 110.23 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.623 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.5 m120 -133.97 67.25 73.74 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.719 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.27 9.94 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.039 1.826 . . . . 0.0 111.783 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -96.38 -24.05 16.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.724 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -106.58 1.18 25.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.861 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.11 44.68 90.74 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.225 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.724 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -73.12 99.98 2.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.69 0.281 . . . . 0.0 110.381 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.489 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.8 pt-20 -118.68 142.99 47.14 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 23.5 mmmt 53.39 -115.58 0.97 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.715 0.635 . . . . 0.0 111.576 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -135.34 17.76 3.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.211 0.529 . . . . 0.0 110.589 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.489 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 27.7 m-85 -68.61 129.71 40.72 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 71.6 m -54.71 153.4 6.0 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 123.219 0.324 . . . . 0.0 111.462 -173.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 35.5 mmt-85 -156.89 169.82 23.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.78 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -128.25 77.35 77.04 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.52 169.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HG3' HD21 ' A' ' 46' ' ' LEU . 36.2 Cg_endo -70.78 -13.64 32.25 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.256 1.971 . . . . 0.0 112.474 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.67 -25.95 17.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.036 0.922 . . . . 0.0 109.055 173.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.54 40.64 99.37 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.959 -169.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -48.54 133.88 16.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 172.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 t -72.63 6.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.611 0.72 . . . . 0.0 110.805 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.47 -22.45 14.43 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.07 -179.3 16.94 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 119.513 -1.327 . . . . 0.0 112.02 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.56 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 95.5 Cg_endo -75.6 157.64 40.18 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.386 2.057 . . . . 0.0 111.612 -174.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.513 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 15.7 p-90 -148.26 -169.7 3.41 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.958 -172.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.679 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 28.9 p -168.6 -177.5 3.14 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.458 176.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 67.7 m-85 -100.22 146.09 27.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 170.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 p -100.09 145.25 28.17 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.632 -170.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.9 p -78.49 17.8 0.63 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.034 0.445 . . . . 0.0 110.991 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 16.3 t30 -105.8 120.47 49.06 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 21.8 Cg_exo -65.91 4.96 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.353 2.702 . . . . 0.0 114.072 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.453 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 20.4 mmm180 -82.05 -43.16 18.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.615 0.245 . . . . 0.0 111.21 173.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -134.68 156.47 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.329 0.585 . . . . 0.0 111.068 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.689 HD12 ' HB3' ' A' ' 31' ' ' HIS . 41.5 tp -83.19 -45.09 14.3 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.905 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 29.0 p90 -143.74 164.87 29.25 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.995 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.629 ' HB3' HG21 ' A' ' 16' ' ' THR . 37.4 t0 -160.71 169.4 22.89 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 65.0 m-85 -92.85 155.84 17.36 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 80.9 m -104.46 168.32 9.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.148 0.499 . . . . 0.0 111.11 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -115.47 64.49 0.69 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.398 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.683 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.8 p -104.36 130.72 22.81 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.497 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 77' ' ' VAL . 25.2 Cg_endo -61.33 154.78 56.09 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 123.85 3.033 . . . . 0.0 113.625 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -75.66 109.43 9.23 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.286 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.423 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -72.82 -43.17 63.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.305 179.033 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . . . -104.14 68.39 0.89 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.027 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.182 179.428 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 52.5 m . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -99.17 -11.22 21.57 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 65.65 12.33 8.17 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.602 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.538 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 24.3 t0 -86.3 50.07 1.92 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.871 1.32 . . . . 0.0 109.955 -178.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.592 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -155.82 153.19 29.39 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.51 -1.677 . . . . 0.0 108.456 178.694 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.516 ' HG2' ' HG3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -98.02 143.44 28.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -175.175 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.685 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 74.1 m-85 -102.32 104.07 14.56 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.7 -111.51 3.27 Favored Glycine 0 N--CA 1.424 -2.11 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.495 -174.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -89.14 -20.23 24.51 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 124.444 0.732 . . . . 0.0 110.521 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.03 15.87 13.68 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.79 -1.195 . . . . 0.0 111.886 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -63.94 -38.53 91.42 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.009 0.433 . . . . 0.0 110.271 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.31 24.64 22.15 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 173.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.8 t80 -71.24 103.45 2.82 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -110.72 46.43 1.06 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.171 0.51 . . . . 0.0 109.681 -176.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.17 -158.61 32.0 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.604 -0.725 . . . . 0.0 113.174 -173.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -140.68 14.6 2.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.73 0.3 . . . . 0.0 110.581 -170.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.917 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.9 mmt180 -67.16 135.72 53.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.16 38.84 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.752 0.787 . . . . 0.0 110.854 -170.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.98 148.52 28.48 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.273 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -75.2 -171.41 1.4 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.915 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.82 -18.32 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.398 0.618 . . . . 0.0 110.884 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.4 p -93.54 -12.63 29.14 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.792 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.44 12.75 69.3 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.373 -172.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.886 HG21 ' HB2' ' A' ' 67' ' ' ASN . 99.5 m -75.87 121.63 85.41 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 172.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -50.31 128.3 22.54 Favored 'Trans proline' 0 CA--C 1.514 -0.493 0 C-N-CA 122.641 2.227 . . . . 0.0 113.193 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.42 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 77.0 m -69.13 137.6 53.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.293 171.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -70.06 165.85 21.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.533 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 13.9 m-20 -76.63 125.93 30.09 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.708 ' CE3' HD23 ' A' ' 46' ' ' LEU . 43.3 m95 -53.77 -30.28 43.88 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.566 0.698 . . . . 0.0 109.182 176.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.4 -19.97 55.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.793 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.49 150.29 23.2 Favored 'General case' 0 C--O 1.21 -1.017 0 O-C-N 121.639 -0.663 . . . . 0.0 109.528 -170.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 33.2 mm-40 -104.56 23.95 12.48 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -140.54 131.0 13.66 Favored Pre-proline 0 N--CA 1.432 -1.363 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.389 -166.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -86.09 26.61 12.02 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.88 -1.717 . . . . 0.0 113.229 0.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.553 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 30.2 m80 -127.59 109.9 12.17 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.587 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 6.2 mmt180 -73.17 112.26 9.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.446 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.9 p80 -144.24 96.19 2.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.393 1.092 . . . . 0.0 110.51 -176.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.4 m -75.7 23.06 0.13 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.493 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 33' ' ' HIS . 34.1 pt -140.89 158.31 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.594 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 63.4 m-85 50.71 46.91 25.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.02 0.914 . . . . 0.0 110.727 -173.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.485 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 32.0 p -100.01 174.63 2.88 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 114.072 -1.422 . . . . 0.0 108.87 171.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 26.5 Cg_exo -64.12 -16.94 57.78 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 121.827 1.684 . . . . 0.0 111.851 171.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -90.87 -37.64 13.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.442 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.7 p -88.82 -19.94 25.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 -176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.594 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.8 m120 -134.8 65.78 67.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.093 0.473 . . . . 0.0 111.33 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.51 8.64 1.79 Allowed 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.421 2.081 . . . . 0.0 112.056 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -102.51 -16.88 15.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.365 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.684 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -109.63 5.17 22.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.109 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 47' ' ' GLU . . . 62.04 45.87 95.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.448 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.719 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.7 mp -72.36 94.48 1.62 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.195 0.522 . . . . 0.0 110.439 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.747 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.3 pt-20 -108.39 134.53 51.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.089 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm 54.93 -112.15 0.69 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.568 0.543 . . . . 0.0 111.544 176.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -134.77 12.87 3.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.476 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.747 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 21.6 m-85 -64.07 128.71 37.0 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 80.4 m -51.16 155.31 1.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.398 0.436 . . . . 0.0 111.684 -175.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 29.3 mmt-85 -158.17 169.4 24.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.988 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -128.19 78.2 75.78 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.525 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.719 ' HG3' HD21 ' A' ' 46' ' ' LEU . 26.9 Cg_endo -69.61 -12.52 33.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.267 1.978 . . . . 0.0 112.248 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -95.71 -27.25 15.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.897 0.856 . . . . 0.0 109.375 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.37 37.28 93.82 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.398 -166.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 59' ' ' GLY . 9.3 t70 -45.16 131.57 7.63 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.219 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.47 34.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.833 0.825 . . . . 0.0 110.339 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -122.05 -19.7 3.22 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.53 179.96 15.92 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.922 -1.133 . . . . 0.0 111.432 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.516 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 94.6 Cg_endo -72.85 152.56 52.49 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.963 1.775 . . . . 0.0 111.399 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.476 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 23.9 p-90 -145.95 -171.49 3.72 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.898 -170.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.653 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.1 p -168.51 179.88 4.17 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.623 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.439 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 40.0 m-85 -100.77 139.68 36.11 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.6 p -98.33 148.74 23.35 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.574 -170.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -80.95 20.45 0.78 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.267 0.556 . . . . 0.0 110.377 169.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.886 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.9 t-20 -98.94 119.08 61.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.848 -177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 17.6 Cg_exo -66.32 -0.55 4.36 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.993 2.462 . . . . 0.0 113.546 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -84.7 -43.46 14.3 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.8 0.333 . . . . 0.0 111.434 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.39 149.54 49.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.326 0.584 . . . . 0.0 110.417 -176.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.553 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 46.6 tp -78.87 -43.09 25.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.382 -175.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -143.27 163.51 32.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.783 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -159.15 178.59 9.86 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -93.79 158.08 15.83 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.84 166.15 10.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.247 0.546 . . . . 0.0 111.231 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -109.38 60.19 0.6 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.289 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.917 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -104.66 128.62 26.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.397 174.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.02 161.81 24.78 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 124.055 3.17 . . . . 0.0 113.743 -176.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.456 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 8.8 tp-100 -75.73 110.53 10.22 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.454 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.592 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.04 -38.67 61.38 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.205 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.685 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -90.11 62.41 5.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.51 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.456 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.27 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 N--CA 1.472 0.671 0 CA-C-O 120.775 0.321 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -85.78 -4.16 59.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.902 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 66.74 32.02 7.14 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.415 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.413 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 20.7 t0 -81.4 53.91 2.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.683 1.23 . . . . 0.0 109.23 175.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.586 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -151.84 157.79 42.38 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.165 -179.182 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.674 ' HG2' ' HG3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -97.95 142.39 29.75 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.561 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 66.0 m-85 -101.41 102.25 13.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -177.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.2 -114.44 3.89 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.618 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -84.87 -23.58 28.92 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.382 0.695 . . . . 0.0 110.267 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.99 15.33 11.96 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.449 -175.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -67.92 -36.01 79.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.204 0.526 . . . . 0.0 110.33 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -107.57 20.21 32.5 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.608 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.6 t80 -66.5 101.74 0.8 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.34 46.4 0.93 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.179 0.514 . . . . 0.0 110.551 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -101.77 -158.14 26.59 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.171 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -149.86 22.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.947 0.374 . . . . 0.0 110.76 -170.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.873 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 21.0 mmt180 -65.2 139.04 58.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.75 30.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.536 0.684 . . . . 0.0 111.654 -170.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.27 142.39 24.05 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.4 p -75.31 -176.87 3.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.871 0.367 . . . . 0.0 111.605 -174.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 m -63.8 -19.39 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.47 0.652 . . . . 0.0 110.851 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.5 p -93.42 -12.01 30.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.798 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.79 12.76 68.27 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.28 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.714 HG21 ' HB2' ' A' ' 67' ' ' ASN . 85.6 m -76.86 119.76 78.85 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 171.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -50.62 123.74 12.04 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.811 2.341 . . . . 0.0 112.993 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.33 139.23 58.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.412 0.625 . . . . 0.0 110.565 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -71.4 166.01 22.56 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.807 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.24 127.34 32.43 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.773 ' CE3' HD23 ' A' ' 46' ' ' LEU . 64.6 m95 -57.14 -30.04 64.1 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.533 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . . . -78.69 -18.28 54.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.52 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.89 150.2 20.7 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.688 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.2 mm-40 -104.17 32.54 3.94 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 34.7 mt-10 -145.87 122.09 5.84 Favored Pre-proline 0 N--CA 1.428 -1.564 0 CA-C-N 114.027 -1.442 . . . . 0.0 114.104 -157.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 2.4 Cg_endo -86.69 25.25 15.47 Favored 'Cis proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.597 -1.418 . . . . 0.0 112.79 1.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.42 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 43.1 m80 -128.14 108.72 10.87 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.688 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.1 ppt_? -73.95 120.57 19.72 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.543 -178.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.458 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.3 p80 -148.76 98.12 2.82 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.248 1.023 . . . . 0.0 109.739 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 m -77.79 28.51 0.17 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.595 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.458 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.1 pt -141.5 151.43 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -176.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.55 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 59.5 m-85 52.25 48.03 23.51 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 122.054 0.931 . . . . 0.0 111.146 -176.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 41.8 p -100.32 176.08 2.08 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.394 172.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 7.7 Cg_exo -70.71 -11.63 29.89 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.963 1.775 . . . . 0.0 111.087 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -92.87 -31.26 15.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.03 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.4 p -98.97 -19.8 17.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.092 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.2 m120 -135.58 57.91 22.1 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -174.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 13.6 Cg_exo -69.81 15.98 0.23 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.234 1.956 . . . . 0.0 112.545 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 41' ' ' ASN . 18.8 ptt180 -99.6 -17.83 17.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.789 0.328 . . . . 0.0 111.034 -177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.743 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -118.13 3.4 12.05 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.445 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.05 46.67 90.67 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.566 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.773 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.3 mp -77.38 67.57 3.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.509 0.195 . . . . 0.0 111.185 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.526 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 6.0 pt-20 -97.39 157.6 15.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.764 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 52.07 -125.55 2.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.351 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -129.16 23.21 5.63 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.055 0.455 . . . . 0.0 110.373 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.526 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 38.5 m-85 -65.64 123.14 18.92 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.955 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 71.4 m -50.25 151.29 2.14 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 123.378 0.424 . . . . 0.0 111.42 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 43.2 mmt-85 -157.58 170.99 21.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.228 -174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -131.36 76.81 75.14 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.347 169.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.77 ' HG3' HD21 ' A' ' 46' ' ' LEU . 33.8 Cg_endo -66.95 -15.9 48.24 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.563 2.176 . . . . 0.0 112.635 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -95.86 -26.04 15.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.938 0.875 . . . . 0.0 109.451 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.28 39.46 97.88 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.598 -166.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 59' ' ' GLY . 19.7 t70 -44.82 131.42 7.04 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 124.462 0.742 . . . . 0.0 110.153 173.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 t -76.04 35.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.785 0.803 . . . . 0.0 110.188 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -126.16 -18.34 2.33 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 173.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.76 -179.64 16.07 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.485 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.674 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 92.9 Cg_endo -73.71 150.99 45.82 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.143 1.895 . . . . 0.0 111.33 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 19.1 p-90 -144.66 -170.49 3.4 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.038 -169.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.727 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.1 p -168.86 -179.25 3.64 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -101.23 146.8 27.05 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.426 ' HB ' ' CG2' ' A' ' 20' ' ' THR . 1.2 p -102.91 146.17 28.72 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.879 -171.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.9 p -81.21 20.41 0.83 Allowed 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.826 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.714 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.8 t-20 -99.4 120.81 56.95 Favored Pre-proline 0 C--N 1.337 0.036 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.226 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 16.7 Cg_exo -67.04 4.88 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.022 2.481 . . . . 0.0 113.404 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -84.81 -58.26 2.78 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.744 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -119.53 159.29 24.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.797 -174.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 50.4 tp -87.85 -45.78 10.0 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.553 -177.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -143.04 156.38 44.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.07 0.462 . . . . 0.0 109.831 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -154.37 173.36 16.32 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 59.0 m-85 -93.26 157.84 16.05 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.9 m -105.3 162.39 13.47 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.895 0.378 . . . . 0.0 110.447 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.48 32.15 1.85 Allowed 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.315 0.579 . . . . 0.0 111.14 -172.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.873 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.4 p -80.51 122.6 82.65 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.683 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.12 162.75 25.13 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 C-N-CA 124.219 3.279 . . . . 0.0 113.884 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.44 ' NE2' ' SD ' ' A' ' 2' ' ' MET . 8.8 tp-100 -72.59 110.36 6.9 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.677 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.561 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.3 -41.65 56.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.639 179.048 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.561 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -85.48 46.0 1.25 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.3 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.467 175.858 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -3' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' A' ' -2' ' ' ALA . 46.1 t30 -92.03 -3.98 55.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 176.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' -2' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' -3' ' ' ASN . . . 78.04 5.03 2.81 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 114.359 -1.292 . . . . 0.0 109.683 -173.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.616 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 29.8 t70 -81.09 63.69 5.54 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.845 172.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.492 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -160.38 150.14 17.79 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.198 -1.365 . . . . 0.0 109.207 -177.68 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.609 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 7.0 ptt? -97.03 154.28 17.41 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.616 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 83.0 m-85 -112.38 95.63 5.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.64 -110.8 3.11 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -79.17 -29.77 43.17 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 124.935 1.02 . . . . 0.0 111.005 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . 108.36 17.88 10.25 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 119.614 -1.279 . . . . 0.0 112.079 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -62.5 -43.62 98.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.358 0.599 . . . . 0.0 110.114 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -105.09 27.9 16.82 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.027 174.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.774 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.2 t80 -68.94 105.47 2.4 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 170.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -109.18 42.54 1.42 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.085 0.469 . . . . 0.0 110.109 -175.599 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.616 ' CA ' ' HA ' ' A' ' -1' ' ' ASP . . . -93.49 -152.73 29.58 Favored Glycine 0 C--N 1.329 0.17 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.992 -175.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -148.08 16.54 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.763 0.282 . . . . 0.0 110.756 -172.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.774 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.1 mmt180 -66.38 138.17 57.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.6 32.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.636 0.732 . . . . 0.0 110.776 -170.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.688 HG22 ' HA2' ' A' ' 19' ' ' GLY . 3.6 m -151.89 136.17 16.72 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -173.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.5 HG21 ' HB3' ' A' ' 73' ' ' ASP . 74.5 p -73.35 -172.51 1.16 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -171.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.7 m -69.27 -18.57 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.546 0.689 . . . . 0.0 110.447 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p -92.13 -14.38 29.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.048 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.688 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 84.96 15.19 67.9 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.243 -174.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.77 HG21 ' HB2' ' A' ' 67' ' ' ASN . 98.3 m -78.36 121.02 83.24 Favored Pre-proline 0 N--CA 1.442 -0.83 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 169.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -49.63 130.56 26.48 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.764 2.309 . . . . 0.0 113.362 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m -67.53 140.56 57.0 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.972 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -73.82 165.92 24.26 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.324 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.454 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 2.1 m-20 -76.25 125.94 30.08 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 175.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.645 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 41.0 m95 -54.77 -29.29 53.69 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 173.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.92 -22.1 53.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.1 176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -99.96 150.11 22.75 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 119.039 0.836 . . . . 0.0 108.748 -172.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.637 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.2 mm-40 -103.19 32.28 3.84 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 36.0 mt-10 -145.68 122.42 6.01 Favored Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -158.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 91.9 Cg_endo -88.37 31.82 8.42 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.29 -1.546 . . . . 0.0 113.375 0.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.536 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 58.7 m80 -130.75 113.58 14.31 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.637 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 25.9 mmm180 -74.06 113.56 11.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.89 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.8 p80 -147.85 94.37 2.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.139 0.971 . . . . 0.0 111.16 -177.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m -79.8 35.81 0.31 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.498 0.665 . . . . 0.0 110.113 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.445 ' H ' ' C ' ' A' ' 33' ' ' HIS . 23.4 pt -142.06 146.18 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.583 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 50.2 m-85 51.17 46.71 26.06 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.222 1.011 . . . . 0.0 110.969 -173.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 35.7 p -99.66 174.26 3.16 Favored Pre-proline 0 N--CA 1.444 -0.743 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.255 171.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 32.0 Cg_exo -59.35 -23.16 68.89 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.922 1.748 . . . . 0.0 112.185 170.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.49 -34.95 13.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.79 0.329 . . . . 0.0 111.296 -173.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.6 p -85.73 -18.67 32.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.997 0.427 . . . . 0.0 110.503 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.583 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.4 m120 -138.21 59.67 19.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.509 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.17 19.97 0.49 Allowed 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.613 2.208 . . . . 0.0 112.809 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -122.45 -8.69 8.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.491 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -106.51 7.93 31.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.386 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.99 40.85 97.43 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.384 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.2 mp -77.08 95.83 4.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.998 0.428 . . . . 0.0 110.828 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.472 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.2 pt-20 -118.23 152.16 36.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.504 175.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 34.2 mmtp 50.95 -115.26 0.85 Allowed 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.828 0.705 . . . . 0.0 111.183 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -139.47 19.68 2.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.001 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.472 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 32.8 m-85 -66.5 129.62 40.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.571 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.656 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 74.0 m -56.03 148.94 16.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.086 0.469 . . . . 0.0 111.824 -173.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.651 ' HD2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -155.17 158.2 38.58 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.632 -175.565 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -123.26 80.71 52.49 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.427 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HD2' ' CZ2' ' A' ' 62' ' ' TRP . 3.4 Cg_exo -72.25 -13.04 28.14 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.287 1.992 . . . . 0.0 111.579 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -89.04 -32.28 17.65 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.63 38.76 96.39 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 113.521 -1.672 . . . . 0.0 109.856 -166.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -48.13 133.38 15.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.725 -0.738 . . . . 0.0 109.491 172.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 t -70.14 -0.27 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.489 0.661 . . . . 0.0 110.591 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.88 -17.18 42.03 Favored Glycine 0 N--CA 1.437 -1.274 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.21 -178.8 16.3 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 119.766 -1.207 . . . . 0.0 111.619 176.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.609 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 74.1 Cg_endo -72.5 158.39 51.16 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.251 1.968 . . . . 0.0 111.167 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.593 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 25.8 p-90 -148.3 -171.02 3.74 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.844 -171.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.645 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 28.9 p -168.37 -177.24 3.14 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.559 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.5 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 61.9 m-85 -100.47 150.03 23.07 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 170.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 67' ' ' ASN . 2.5 p -104.69 150.27 24.87 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.248 -173.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 44.6 p -82.18 27.61 0.48 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.385 0.612 . . . . 0.0 110.102 168.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.77 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.9 t-20 -111.48 114.49 52.74 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.891 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 17.2 Cg_exo -67.28 2.74 2.06 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 123.099 2.533 . . . . 0.0 113.976 -177.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -84.32 -33.85 23.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.874 0.368 . . . . 0.0 111.354 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -143.89 143.09 31.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.257 0.551 . . . . 0.0 110.32 -177.483 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 52.3 tp -73.98 -42.62 60.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.765 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 5.3 p90 -142.65 159.5 42.12 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.5 ' HB3' HG21 ' A' ' 16' ' ' THR . 25.7 t0 -154.29 171.52 19.11 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -93.1 155.6 17.39 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.5 m -105.04 168.61 8.94 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.167 0.508 . . . . 0.0 110.583 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -117.43 70.28 0.78 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.019 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.774 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -106.5 129.52 24.34 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.521 174.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 11.2 Cg_endo -54.82 151.81 31.15 Favored 'Trans proline' 0 CA--C 1.509 -0.738 0 C-N-CA 124.146 3.231 . . . . 0.0 113.766 -178.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.46 110.75 10.1 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.492 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.19 -42.2 60.21 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.195 178.409 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.616 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -86.15 56.72 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.715 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.922 178.75 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -84.95 2.58 42.23 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 70.64 25.84 4.06 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 124.407 1.067 . . . . 0.0 110.672 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.522 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 38.4 t70 -87.87 60.49 5.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.611 177.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.531 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.7 OUTLIER -156.99 151.06 24.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.626 179.425 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.668 ' HG2' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.61 149.57 23.14 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -177.444 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.768 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 49.3 m-85 -106.4 107.78 18.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.21 -111.92 3.35 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.908 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -94.1 -9.36 36.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.774 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.778 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 101.97 18.38 17.85 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.675 -175.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 52.4 mtpt -70.4 -45.09 66.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.814 -0.693 . . . . 0.0 110.335 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.64 24.54 29.49 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.778 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 3.8 t80 -65.95 98.18 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.871 0.469 . . . . 0.0 110.205 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HE ' ' C ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -103.11 46.6 0.91 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.074 0.464 . . . . 0.0 110.063 179.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.626 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.48 -156.21 30.97 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.674 -176.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.522 ' HD3' ' HB2' ' A' ' -1' ' ' ASP . 0.0 OUTLIER -150.15 23.56 0.84 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.867 0.365 . . . . 0.0 110.82 -171.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.799 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 21.7 mmt180 -71.92 139.87 48.94 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 171.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 50' ' ' TYR . 5.2 m -140.86 31.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.514 0.673 . . . . 0.0 110.895 -170.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.869 HG22 ' HA2' ' A' ' 19' ' ' GLY . 87.2 m -152.32 130.6 12.02 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -173.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.429 HG21 ' HB3' ' A' ' 73' ' ' ASP . 71.9 p -69.85 -172.83 0.56 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -170.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 m -67.07 -20.01 26.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.869 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -92.19 -13.29 30.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.765 0.793 . . . . 0.0 108.964 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.869 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 82.91 17.65 67.12 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.367 -174.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.9 HG21 ' HB2' ' A' ' 67' ' ' ASN . 96.4 m -77.48 124.32 86.77 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 167.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.43 133.4 48.56 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.343 2.029 . . . . 0.0 113.217 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.9 m -71.8 140.41 49.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.72 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -73.11 167.19 21.66 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.234 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.498 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 4.8 m-20 -76.28 125.86 29.93 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.686 ' CE3' HD23 ' A' ' 46' ' ' LEU . 54.2 m95 -52.92 -32.94 48.2 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.69 0.757 . . . . 0.0 109.006 174.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.6 -16.63 58.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.727 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.44 150.27 23.21 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 118.668 0.667 . . . . 0.0 109.401 -172.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 33.4 mm-40 -107.74 21.14 17.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -146.6 137.11 12.35 Favored Pre-proline 0 N--CA 1.428 -1.54 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.375 -167.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.35 18.86 11.94 Favored 'Cis proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.367 -1.514 . . . . 0.0 112.993 1.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.583 ' HB3' HD12 ' A' ' 71' ' ' LEU . 62.2 m80 -128.98 106.9 9.2 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.53 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -72.61 126.1 29.06 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.48 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.9 p80 -154.94 94.26 1.63 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.132 0.968 . . . . 0.0 110.835 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -79.08 35.89 0.27 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.616 175.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 33' ' ' HIS . 31.3 pt -143.12 143.86 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 32.1 m-85 55.39 47.75 20.55 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 122.16 0.981 . . . . 0.0 110.919 -175.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 10.9 p -102.66 174.98 2.48 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.467 168.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 27.7 Cg_exo -62.45 -25.58 76.09 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.662 1.574 . . . . 0.0 111.775 172.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -88.17 -32.61 18.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.744 -174.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 p -90.72 -18.97 24.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.284 -177.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.8 m120 -133.63 61.58 54.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.733 0.301 . . . . 0.0 110.933 177.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.2 42.26 1.09 Allowed 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.843 2.362 . . . . 0.0 112.829 -176.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.62 -14.02 1.1 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.664 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -103.5 8.22 37.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.443 0.64 . . . . 0.0 110.69 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . 58.17 49.07 79.05 Favored Glycine 0 C--O 1.221 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.575 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -76.54 93.25 3.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.218 0.533 . . . . 0.0 110.661 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.641 ' HB2' ' HD2' ' A' ' 50' ' ' TYR . 1.5 mt-10 -101.28 136.21 41.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.548 -177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 90.1 mttt 48.4 -104.4 0.12 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.73 0.644 . . . . 0.0 112.118 174.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -138.16 15.15 2.82 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.223 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.641 ' HD2' ' HB2' ' A' ' 47' ' ' GLU . 32.2 m-85 -65.89 125.81 26.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.582 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 78.9 m -49.44 151.98 1.42 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.546 0.529 . . . . 0.0 111.901 -175.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 41.6 mmt-85 -154.41 168.63 26.02 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.475 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -130.36 80.11 71.13 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 169.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.709 ' HG3' HD21 ' A' ' 46' ' ' LEU . 25.2 Cg_exo -60.27 -28.06 86.12 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.837 2.358 . . . . 0.0 111.966 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -93.67 -23.22 18.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.605 0.717 . . . . 0.0 110.424 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.41 ' HA3' ' HG2' ' A' ' 7' ' ' LYS . . . 61.5 38.75 96.32 Favored Glycine 0 CA--C 1.497 -1.034 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.988 -172.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -61.27 141.88 57.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.126 -0.537 . . . . 0.0 110.153 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 t -75.85 49.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.604 0.716 . . . . 0.0 110.928 -175.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -129.53 -16.56 1.84 Allowed Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.77 175.73 18.18 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.48 152.06 59.8 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.754 1.636 . . . . 0.0 111.497 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.624 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 31.4 p-90 -139.63 -173.68 3.69 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.327 -172.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.639 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.4 p -168.3 -179.75 4.13 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.269 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -101.23 145.29 29.02 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 p -101.34 151.23 22.15 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.788 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.7 p -85.82 20.13 2.29 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.332 168.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.9 ' HB2' HG21 ' A' ' 20' ' ' THR . 56.7 t-20 -95.4 116.17 66.08 Favored Pre-proline 0 CA--C 1.518 -0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.409 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.12 -0.2 2.05 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.83 2.354 . . . . 0.0 113.59 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -84.2 -55.46 4.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.799 0.333 . . . . 0.0 111.212 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -117.13 155.03 30.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.403 0.621 . . . . 0.0 110.666 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' A' ' 31' ' ' HIS . 49.1 tp -85.35 -43.63 13.52 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.499 -176.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -143.38 162.53 35.49 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB3' HG21 ' A' ' 16' ' ' THR . 42.2 t0 -156.96 175.47 14.05 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.87 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -94.41 156.23 16.58 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 90.5 m -105.19 168.37 9.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.945 0.402 . . . . 0.0 110.722 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.84 65.82 0.77 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.915 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.799 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.7 p -105.56 126.58 30.47 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.188 176.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.97 157.59 19.9 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 123.915 3.076 . . . . 0.0 113.906 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.07 113.81 12.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.222 -1.353 . . . . 0.0 110.307 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.531 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.62 -42.43 51.72 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.329 178.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.768 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -93.43 55.22 2.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.2 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.217 179.837 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -82.79 -7.09 59.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 68.36 21.58 8.27 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.861 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.441 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 32.2 t0 -87.09 60.29 6.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 122.139 0.971 . . . . 0.0 109.137 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.588 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -151.3 159.18 44.46 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.908 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.539 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 11.9 ptt? -96.97 152.44 18.71 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.62 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 82.0 m-85 -109.65 94.64 5.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.18 -114.08 3.77 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -173.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -79.7 -26.36 40.93 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.84 0.965 . . . . 0.0 110.248 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.611 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.4 13.96 19.47 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.401 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.731 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 97.4 mttt -65.4 -40.71 93.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.163 0.506 . . . . 0.0 110.065 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -107.37 25.75 20.66 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 172.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.654 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.7 t80 -66.56 108.83 2.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.71 40.42 2.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.154 0.502 . . . . 0.0 110.097 -175.526 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.556 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -93.98 -162.21 35.59 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.797 -176.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -139.8 18.69 2.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.915 0.388 . . . . 0.0 110.189 -169.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.788 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 18.7 mmt180 -66.88 135.82 54.44 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 m -137.9 34.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 121.75 0.786 . . . . 0.0 110.027 -171.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.915 HG22 ' HA2' ' A' ' 19' ' ' GLY . 86.4 m -153.05 125.65 8.24 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -169.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.623 HG21 ' HB3' ' A' ' 73' ' ' ASP . 81.9 p -69.97 -171.54 0.44 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -170.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.5 -23.11 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 121.505 0.669 . . . . 0.0 111.015 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.9 p -91.89 -15.7 27.73 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.796 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.915 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.48 20.02 55.41 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.955 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.715 HG21 ' HB2' ' A' ' 67' ' ' ASN . 52.6 m -76.41 122.78 87.32 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 167.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.36 129.74 26.92 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.717 2.278 . . . . 0.0 113.536 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.8 m -68.68 144.26 54.5 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.46 0.647 . . . . 0.0 111.504 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -76.93 167.51 21.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.45 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.1 129.02 35.47 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.704 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 65.7 m95 -56.49 -32.37 64.96 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.54 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.98 -16.65 56.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.831 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.17 148.06 22.55 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.8 mm-40 -102.64 29.35 5.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 44.8 mt-10 -148.26 124.33 5.3 Favored Pre-proline 0 N--CA 1.421 -1.883 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.656 -156.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -85.07 25.74 11.61 Favored 'Cis proline' 0 C--N 1.344 0.33 0 C-N-CA 123.944 -1.273 . . . . 0.0 112.942 1.636 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.707 ' HB3' HD12 ' A' ' 71' ' ' LEU . 54.8 m80 -133.34 108.73 8.89 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.555 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -75.17 129.63 37.84 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.234 -175.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.439 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.2 p80 -155.34 101.97 2.24 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.982 0.896 . . . . 0.0 110.154 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 t -80.71 29.67 0.31 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.841 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.439 ' H ' ' C ' ' A' ' 33' ' ' HIS . 22.0 pt -142.23 144.56 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -175.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.539 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 38.0 m-85 54.69 48.68 19.73 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 122.112 0.958 . . . . 0.0 110.639 -175.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 7.5 p -101.77 173.97 3.22 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.342 168.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 38.0 Cg_exo -58.89 -28.5 87.55 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 121.728 1.618 . . . . 0.0 112.228 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -89.85 -33.9 16.31 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.143 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.9 p -85.42 -19.13 31.79 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.723 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.539 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.9 m120 -135.43 64.71 60.14 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.376 177.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.27 20.8 0.56 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.333 2.022 . . . . 0.0 111.915 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 43' ' ' ARG . 14.6 ptt180 -114.32 -17.41 11.82 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.675 -177.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -108.1 6.1 26.6 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.135 0.493 . . . . 0.0 110.539 -176.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.93 46.21 94.05 Favored Glycine 0 C--O 1.228 -0.268 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.793 172.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -73.92 104.77 4.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.148 0.499 . . . . 0.0 110.662 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.847 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.6 pt-20 -118.11 137.14 53.14 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.879 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.474 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 61.9 mmtt 45.98 -110.79 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.738 0.649 . . . . 0.0 112.569 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -135.45 17.63 3.37 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.17 0.509 . . . . 0.0 110.124 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.847 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 16.3 m-85 -70.47 131.36 43.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.573 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 86.2 m -53.51 145.54 14.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 123.383 0.427 . . . . 0.0 111.231 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 34.9 mmt-85 -150.18 161.05 43.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.174 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -122.55 79.76 47.03 Favored Pre-proline 0 C--N 1.319 -0.733 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.781 173.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.608 ' HG3' HD21 ' A' ' 46' ' ' LEU . 18.4 Cg_exo -64.35 -25.81 63.79 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.618 2.212 . . . . 0.0 112.33 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.97 -17.17 26.79 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.533 0.682 . . . . 0.0 109.748 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.731 ' HA3' ' HE2' ' A' ' 7' ' ' LYS . . . 55.66 40.57 79.66 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.397 -171.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -47.88 138.32 8.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 124.4 0.706 . . . . 0.0 109.815 174.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 t -74.77 8.08 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.535 0.683 . . . . 0.0 110.407 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.14 -16.73 22.43 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.03 179.69 16.16 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.627 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.539 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 58.2 Cg_endo -71.33 161.09 46.83 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.442 2.095 . . . . 0.0 112.02 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.554 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.0 p-90 -150.7 -170.3 3.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.548 -171.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.704 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.4 p -169.19 -178.26 3.15 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.919 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 58.2 m-85 -101.78 147.22 26.74 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 170.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.461 ' HB ' ' CG2' ' A' ' 20' ' ' THR . 0.9 OUTLIER -105.0 147.29 27.96 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.062 -170.131 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.6 p -80.41 13.92 2.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.1 0.476 . . . . 0.0 110.811 172.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.715 ' HB2' HG21 ' A' ' 20' ' ' THR . 55.9 t-20 -93.68 123.31 60.28 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.417 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.63 2.83 1.74 Allowed 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.633 2.222 . . . . 0.0 113.261 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -84.24 -46.37 11.91 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.469 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 4.5 ptmt -134.92 154.92 51.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.531 0.681 . . . . 0.0 111.184 -174.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 31' ' ' HIS . 43.2 tp -83.61 -38.37 21.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.808 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 16.7 p90 -142.54 161.73 37.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.768 -175.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.623 ' HB3' HG21 ' A' ' 16' ' ' THR . 34.5 t0 -165.26 166.54 18.73 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -94.39 158.72 15.44 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.69 169.27 8.57 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -123.25 67.79 0.99 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.381 0.61 . . . . 0.0 110.128 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.788 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.4 p -99.5 130.38 26.98 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.451 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.36 159.09 24.23 Favored 'Trans proline' 0 CA--C 1.512 -0.582 0 C-N-CA 124.061 3.174 . . . . 0.0 113.539 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.09 112.1 12.18 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.696 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.505 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -75.64 -39.36 57.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.599 179.236 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -86.09 44.6 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.107 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.2 -179.531 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 65.7 p . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -94.61 9.72 37.61 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 70.67 2.82 4.28 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.215 -174.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.626 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 32.6 t70 -85.51 63.53 8.12 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.876 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -160.56 150.49 17.77 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.266 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.632 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.8 ptt? -97.0 152.96 18.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.397 0.618 . . . . 0.0 112.548 -177.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 81' ' ' ALA . 71.4 m-85 -109.57 99.23 8.46 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.24 -109.04 2.68 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.472 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -78.1 -30.48 49.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 125.005 1.062 . . . . 0.0 110.596 -175.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 111.89 22.28 6.03 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.915 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -71.5 -41.0 69.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.782 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.41 ' O ' ' HD2' ' A' ' 10' ' ' ARG . . . -99.67 17.34 57.66 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.506 171.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.739 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.2 t80 -62.43 104.06 0.47 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 173.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -106.83 36.27 2.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 -177.537 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.626 ' CA ' ' HA ' ' A' ' -1' ' ' ASP . . . -94.25 -161.76 35.12 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.483 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.16 17.93 2.26 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.587 0.232 . . . . 0.0 110.91 -169.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.713 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.7 mmt180 -65.89 138.24 57.73 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.87 40.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.746 0.784 . . . . 0.0 111.018 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.23 148.9 28.78 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.831 -177.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.427 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 44.3 p -75.57 -173.84 2.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.611 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.29 -18.15 22.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.452 0.644 . . . . 0.0 111.137 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.1 p -93.06 -14.66 27.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.569 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.75 11.04 62.45 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.403 -0.904 . . . . 0.0 111.482 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.927 HG21 ' HB2' ' A' ' 67' ' ' ASN . 98.5 m -76.55 121.58 85.11 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.882 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.28 124.62 9.38 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.198 2.599 . . . . 0.0 113.576 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.94 141.15 58.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.904 171.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -72.43 166.89 21.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.387 174.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 7.6 t0 -76.48 129.13 36.06 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.746 ' CE3' HD23 ' A' ' 46' ' ' LEU . 64.9 m95 -57.32 -31.54 65.79 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.321 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.13 -16.16 57.09 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.116 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 24' ' ' ASP . . . -94.35 147.33 23.32 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.666 -172.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 32.4 mm-40 -106.66 16.58 24.34 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.493 ' HG2' HH11 ' A' ' 32' ' ' ARG . 35.2 mt-10 -147.65 143.38 17.82 Favored Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.526 -172.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.49 25.16 6.67 Favored 'Cis proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.928 -1.697 . . . . 0.0 113.256 1.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.602 ' HB3' HD12 ' A' ' 71' ' ' LEU . 65.1 m80 -135.33 108.55 7.75 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -75.5 117.87 17.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.891 -174.563 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.428 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 3.9 p80 -147.04 99.25 3.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.175 0.988 . . . . 0.0 111.087 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 m -77.71 27.75 0.17 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.804 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.3 pt -140.88 149.76 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.472 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 48.9 m-85 50.97 47.36 24.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 122.069 0.937 . . . . 0.0 110.765 -175.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 58.6 p -100.61 175.81 2.2 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.04 172.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 11.7 Cg_exo -71.14 -9.33 25.33 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 121.951 1.767 . . . . 0.0 111.253 169.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -91.31 -33.67 15.23 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.786 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.9 p -95.92 -26.69 15.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.185 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.515 ' O ' HD13 ' A' ' 46' ' ' LEU . 14.0 m120 -133.28 60.56 49.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.523 -174.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -77.82 23.45 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.881 1.721 . . . . 0.0 112.272 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -111.35 -22.19 11.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.514 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.674 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -103.17 9.42 38.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.093 0.473 . . . . 0.0 110.911 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.41 46.93 91.5 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.351 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.746 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.4 mp -76.96 74.39 3.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.596 0.712 . . . . 0.0 110.13 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.699 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.0 pt-20 -97.27 136.45 37.75 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.714 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 25.9 mmmt 51.49 -111.29 0.55 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.814 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -137.6 18.22 2.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.257 0.551 . . . . 0.0 110.317 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.699 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 30.8 m-85 -67.61 130.16 42.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.499 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 89.6 m -54.52 149.54 10.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.298 0.374 . . . . 0.0 111.158 -174.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 39.8 mmt-85 -153.03 170.29 20.81 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.624 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -131.14 77.5 74.63 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.519 170.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.699 ' HG3' HD21 ' A' ' 46' ' ' LEU . 29.7 Cg_endo -68.42 -13.26 37.12 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.285 1.99 . . . . 0.0 112.471 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -96.75 -26.14 15.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.922 0.868 . . . . 0.0 109.507 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.09 39.15 97.66 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.558 -167.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -44.34 132.36 5.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.044 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 t -69.74 -0.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.508 0.671 . . . . 0.0 110.763 -176.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.4 -18.64 35.24 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.5 -179.23 16.29 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.698 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.632 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 88.8 Cg_endo -77.14 158.0 33.83 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.224 1.949 . . . . 0.0 111.231 -175.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.488 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 22.1 p-90 -150.08 -170.77 3.73 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.065 -169.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.697 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.2 p -168.81 -178.49 3.39 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.646 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 57.3 m-85 -100.93 147.64 25.91 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 170.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.9 p -103.55 149.2 25.1 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.437 -171.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 p -83.35 28.34 0.54 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.508 0.67 . . . . 0.0 109.963 168.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.927 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.0 t-20 -108.16 121.14 44.64 Favored Pre-proline 0 N--CA 1.456 -0.149 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.238 -175.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 18.7 Cg_exo -66.44 -1.03 4.96 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.749 2.299 . . . . 0.0 113.498 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -84.69 -33.11 23.24 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.67 147.69 29.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.108 0.48 . . . . 0.0 110.769 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.602 HD12 ' HB3' ' A' ' 31' ' ' HIS . 37.8 tp -72.4 -45.56 59.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.549 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 21.5 p90 -143.54 162.8 34.92 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.67 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.427 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 14.0 t0 -158.83 172.05 18.94 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 55.6 m-85 -94.62 157.01 16.16 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.6 m -104.76 172.82 6.59 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.289 0.368 . . . . 0.0 110.454 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -122.8 69.0 0.98 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.187 0.518 . . . . 0.0 110.305 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.739 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.3 p -102.05 132.39 21.62 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.665 176.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.42 ' HD2' HG23 ' A' ' 77' ' ' VAL . 11.0 Cg_endo -55.66 150.71 42.71 Favored 'Trans proline' 0 CA--C 1.512 -0.608 0 C-N-CA 124.25 3.3 . . . . 0.0 113.826 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -76.77 109.76 10.82 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.789 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.13 -38.26 57.01 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.694 178.276 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . . . -90.97 61.33 4.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.971 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.054 178.789 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 76.7 p . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -94.94 -5.4 44.85 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -2' ' ' ALA . . . . . 0.445 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . 66.29 15.4 10.08 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.432 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.678 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 41.3 t0 -99.78 59.42 1.07 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.086 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.599 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -150.79 152.51 33.92 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.558 -179.103 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.766 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 12.3 ptt? -96.78 159.33 14.98 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.629 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 85.5 m-85 -114.23 100.63 8.5 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.475 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.36 -115.33 4.0 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.019 -175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -82.41 -19.84 38.27 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 124.411 0.712 . . . . 0.0 110.486 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.651 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.09 17.06 13.4 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.999 -174.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -66.91 -50.97 60.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -97.88 28.49 14.25 Favored Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 172.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.666 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.6 t80 -69.51 102.57 1.84 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 173.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -106.45 40.59 1.59 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.337 0.589 . . . . 0.0 109.772 -176.291 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.641 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -90.41 -154.45 30.05 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.941 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -151.24 23.59 0.73 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.858 0.361 . . . . 0.0 110.556 -172.555 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.974 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 20.2 mmt180 -68.9 135.99 51.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.9 m -136.96 36.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 122.037 0.923 . . . . 0.0 109.573 -174.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 1.048 HG23 ' HA2' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -151.65 133.41 14.88 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.235 -172.654 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 56.5 p -73.76 -170.6 0.9 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.091 -176.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 m -63.94 -21.66 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.302 0.573 . . . . 0.0 110.712 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.3 p -92.89 -10.79 35.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.115 0.96 . . . . 0.0 109.08 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 1.048 ' HA2' HG23 ' A' ' 15' ' ' THR . . . 82.98 11.92 80.53 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.23 -173.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.409 HG21 ' HB2' ' A' ' 67' ' ' ASN . 80.8 m -71.28 121.2 83.59 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 82.6 Cg_exo -51.03 134.76 43.53 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 C-N-CA 122.713 2.276 . . . . 0.0 113.353 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 86.1 m -75.53 141.76 42.93 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.541 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -72.94 165.95 23.97 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.231 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 12.4 m-20 -76.52 126.2 30.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 175.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.717 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 48.7 m95 -54.65 -29.4 52.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 175.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.63 -22.4 54.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.972 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -97.67 150.45 21.16 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -172.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.619 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.5 mm-40 -104.76 31.45 4.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 26.7 mt-10 -147.2 123.31 5.49 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 113.705 -1.589 . . . . 0.0 114.163 -156.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 86.1 Cg_endo -86.44 27.03 11.9 Favored 'Cis proline' 0 C--N 1.346 0.438 0 C-N-CA 123.445 -1.481 . . . . 0.0 112.97 0.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.514 ' HB3' HD12 ' A' ' 71' ' ' LEU . 56.8 m80 -129.0 108.43 10.4 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.619 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.7 tmm_? -79.23 122.46 26.34 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -173.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.46 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.3 p80 -150.24 97.16 2.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.92 0.867 . . . . 0.0 110.821 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.27 35.46 0.22 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.56 0.695 . . . . 0.0 110.107 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.46 ' H ' ' C ' ' A' ' 33' ' ' HIS . 23.0 pt -143.11 142.5 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -175.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.599 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 42.9 m-85 50.56 51.02 17.72 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 122.124 0.964 . . . . 0.0 111.591 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 26.5 p -99.58 175.94 2.18 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.025 169.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 25.5 Cg_exo -64.59 -21.21 65.79 Favored 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 121.91 1.74 . . . . 0.0 111.877 172.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -100.33 -23.63 14.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.395 -171.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 35.4 p -90.32 -19.18 24.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.262 0.553 . . . . 0.0 109.646 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.2 m120 -136.16 62.76 46.9 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.888 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.66 9.08 1.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.168 1.912 . . . . 0.0 111.955 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -111.18 -12.33 14.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.476 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.76 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -104.49 8.2 35.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.135 0.493 . . . . 0.0 110.149 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.35 44.67 97.76 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 114.825 -1.079 . . . . 0.0 113.419 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.76 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.3 mp -80.17 96.47 6.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.224 0.535 . . . . 0.0 110.834 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.642 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.3 pt-20 -111.59 135.12 52.61 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.658 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.473 ' HD3' ' HA ' ' A' ' 48' ' ' LYS . 23.9 mmtp 56.06 -118.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.663 0.602 . . . . 0.0 111.998 175.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -130.82 14.01 5.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.922 0.392 . . . . 0.0 110.804 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.642 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 20.7 m-85 -66.06 133.13 50.11 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.623 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 73.8 m -54.93 149.78 11.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.848 0.356 . . . . 0.0 111.833 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.452 ' CG ' HH11 ' A' ' 52' ' ' ARG . 0.1 OUTLIER -153.48 162.53 41.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.714 -175.608 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -125.69 80.99 65.83 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.268 171.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.735 ' HG3' HD21 ' A' ' 46' ' ' LEU . 15.1 Cg_exo -64.53 -21.09 66.15 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.676 2.25 . . . . 0.0 112.029 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -89.63 -30.74 17.92 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.979 0.895 . . . . 0.0 109.304 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.66 39.53 95.42 Favored Glycine 0 N--CA 1.433 -1.51 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.054 -166.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -43.79 131.59 5.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 124.452 0.737 . . . . 0.0 109.587 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 t -70.82 3.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.274 0.559 . . . . 0.0 111.07 -174.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.27 -22.13 13.65 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.06 -175.59 19.1 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.761 -1.209 . . . . 0.0 111.78 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.766 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 97.8 Cg_endo -76.82 159.95 34.43 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.515 2.144 . . . . 0.0 111.708 -174.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.573 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.0 p-90 -148.88 -172.85 4.21 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.879 -172.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.717 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.8 p -168.73 -178.87 3.56 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.305 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -100.84 140.83 34.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.3 p -99.84 148.64 24.22 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.36 -171.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.2 p -76.99 15.0 0.74 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.982 0.42 . . . . 0.0 110.968 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' A' ' 69' ' ' ARG . 24.0 t30 -100.84 119.69 57.64 Favored Pre-proline 0 C--O 1.233 0.2 0 C-N-CA 123.168 0.587 . . . . 0.0 111.057 -177.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.4 Cg_exo -69.47 6.7 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.307 2.671 . . . . 0.0 113.503 -178.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 21.3 mmm180 -82.26 -49.35 10.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.025 0.441 . . . . 0.0 110.704 173.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HE2' HD22 ' A' ' 67' ' ' ASN . 0.0 OUTLIER -139.14 134.96 33.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.596 0.713 . . . . 0.0 111.186 -176.119 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 31' ' ' HIS . 40.3 tp -64.78 -39.92 94.39 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.541 -172.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -143.19 164.82 29.12 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.483 ' HB3' HG21 ' A' ' 16' ' ' THR . 44.5 t0 -162.0 172.28 16.22 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -92.81 156.21 17.14 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 96.2 m -104.66 170.01 8.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.236 0.541 . . . . 0.0 111.325 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.85 67.26 0.66 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.136 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.974 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 5.0 p -111.66 129.51 24.08 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.324 0.583 . . . . 0.0 110.994 174.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.43 161.76 33.46 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 123.941 3.094 . . . . 0.0 113.708 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.79 114.47 14.43 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.088 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.599 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.77 -41.23 60.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.333 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.629 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -80.73 48.59 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.688 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.592 -0.718 . . . . 0.0 110.448 -179.622 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.982 0.42 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -88.2 -9.48 52.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.373 -176.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 66.28 21.08 11.05 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.511 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.426 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 26.3 t70 -90.35 59.4 4.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.981 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.514 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -152.24 158.69 43.18 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.7 178.597 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.741 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 9.4 ptt? -97.5 154.59 17.4 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.548 0.69 . . . . 0.0 112.65 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.698 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 53.9 m-85 -110.29 105.8 14.96 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.29 -114.58 3.91 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.162 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -88.21 -16.07 34.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.98 -0.61 . . . . 0.0 109.832 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.744 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.56 11.22 25.58 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.937 -173.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -63.16 -40.5 97.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.514 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.16 22.33 27.45 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.201 173.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.744 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 4.2 t80 -66.46 109.98 2.95 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 172.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -119.01 39.21 3.6 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.358 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.472 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -91.33 -152.57 28.41 Favored Glycine 0 C--O 1.235 0.19 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.538 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HD3' ' HB2' ' A' ' -1' ' ' ASP . 0.0 OUTLIER -149.07 23.71 0.94 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.916 0.388 . . . . 0.0 110.899 -170.763 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.723 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.8 mmt180 -69.78 137.55 51.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -138.26 34.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.64 0.733 . . . . 0.0 111.063 -170.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.599 HG22 ' HA2' ' A' ' 19' ' ' GLY . 2.1 m -151.46 138.29 18.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.407 HG21 HG22 ' A' ' 65' ' ' THR . 68.3 p -74.88 -174.67 2.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.903 -173.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.06 -17.98 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.417 0.627 . . . . 0.0 110.728 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p -92.75 -14.58 27.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.187 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.599 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.6 15.8 63.06 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.5 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.884 HG21 ' HB2' ' A' ' 67' ' ' ASN . 89.7 m -77.11 122.5 86.39 Favored Pre-proline 0 N--CA 1.448 -0.555 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 168.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -51.72 125.05 15.83 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.309 2.006 . . . . 0.0 112.7 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.404 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 85.4 m -63.29 141.83 58.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.348 0.594 . . . . 0.0 110.652 173.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 25.2 tt0 -74.86 165.34 25.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.476 176.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 4.1 m-20 -76.07 124.57 27.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.673 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 40.7 m95 -54.87 -29.98 56.84 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.07 -17.8 58.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.198 -1.364 . . . . 0.0 113.314 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.26 151.78 22.27 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 119.093 0.86 . . . . 0.0 109.339 -173.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.713 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.0 mm-40 -103.18 32.46 3.74 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 49.1 mt-10 -143.62 118.01 6.11 Favored Pre-proline 0 N--CA 1.429 -1.512 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -156.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 70.4 Cg_endo -89.68 31.07 10.26 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.52 -1.45 . . . . 0.0 113.316 1.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.611 ' HB3' HD12 ' A' ' 71' ' ' LEU . 61.9 m80 -130.77 110.76 11.57 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.713 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.1 OUTLIER -74.53 119.26 18.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.648 -176.52 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.479 ' HE1' ' HA ' ' A' ' 25' ' ' TRP . 4.2 p80 -151.86 99.23 2.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.17 0.986 . . . . 0.0 110.271 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 t -82.15 32.13 0.39 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.568 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' H ' ' C ' ' A' ' 33' ' ' HIS . 26.5 pt -141.26 151.8 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -177.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.568 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 39.1 m-85 51.04 47.11 25.46 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.04 0.924 . . . . 0.0 111.038 -173.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 28.0 p -99.42 171.16 5.93 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.027 171.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 39.7 Cg_exo -59.64 -21.33 62.18 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.132 1.888 . . . . 0.0 112.219 171.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -101.9 -19.85 15.1 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.533 -170.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.9 p -96.91 -18.02 19.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.134 0.492 . . . . 0.0 110.182 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.568 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.2 m120 -136.02 64.63 55.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.028 -177.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.89 18.07 0.66 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.633 2.222 . . . . 0.0 112.736 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -109.93 -23.54 11.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.411 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.697 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -102.13 7.11 41.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.353 0.597 . . . . 0.0 110.469 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.93 42.88 99.58 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.771 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -74.95 110.39 9.21 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.535 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.3 pt-20 -128.6 149.22 50.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.801 172.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.978 ' HE2' ' HA ' ' A' ' 48' ' ' LYS . 5.0 mmpt? 49.67 -111.05 0.46 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.001 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -139.85 18.1 2.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.11 0.481 . . . . 0.0 110.236 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.535 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 33.4 m-85 -67.34 126.41 29.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.589 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 71.7 m -51.68 152.73 2.68 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.556 0.535 . . . . 0.0 111.689 -174.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 44.0 mmt-85 -154.37 170.69 20.75 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.348 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -133.3 77.11 67.12 Favored Pre-proline 0 C--N 1.319 -0.721 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.438 171.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.526 ' HD2' ' CE2' ' A' ' 62' ' ' TRP . 27.9 Cg_exo -61.06 -33.39 91.78 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.769 2.313 . . . . 0.0 112.427 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -90.72 -16.04 29.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.491 0.663 . . . . 0.0 110.366 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.09 48.7 84.81 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.358 -175.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 59' ' ' GLY . 4.4 t0 -48.48 129.01 15.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 t -75.91 31.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 122.085 0.945 . . . . 0.0 110.319 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -125.18 -14.49 3.3 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 175.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.78 -179.51 16.2 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.741 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 95.2 Cg_endo -76.31 161.03 35.37 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.348 2.032 . . . . 0.0 111.713 -174.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.526 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.1 p-90 -145.46 -173.07 4.02 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.223 -173.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.673 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.3 p -167.98 -178.94 3.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' A' ' 72' ' ' TYR . 48.4 m-85 -100.24 145.29 28.25 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.447 ' HB ' HG21 ' A' ' 20' ' ' THR . 4.4 p -98.86 153.91 18.43 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.611 -171.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.416 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 31.0 p -85.77 26.58 0.95 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.334 0.587 . . . . 0.0 110.143 166.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.884 ' HB2' HG21 ' A' ' 20' ' ' THR . 59.3 t-20 -107.52 118.76 52.59 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.495 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.46 2.39 1.96 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.904 2.402 . . . . 0.0 113.392 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -83.77 -46.38 12.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.328 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.05 151.92 51.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.999 0.428 . . . . 0.0 110.558 -176.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 31' ' ' HIS . 41.7 tp -76.29 -43.18 42.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.386 -177.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.516 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 50.4 p90 -143.93 169.33 18.02 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.777 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -161.68 178.37 9.08 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -96.44 156.3 16.4 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 81.5 m -105.89 168.94 8.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.872 0.368 . . . . 0.0 110.888 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -116.89 70.5 0.77 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.263 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.723 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 4.2 p -110.86 127.06 27.53 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.304 0.574 . . . . 0.0 110.883 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.65 160.5 20.64 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 124.165 3.243 . . . . 0.0 113.761 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -75.56 112.71 12.18 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.216 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.485 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -75.87 -43.37 45.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.364 176.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.698 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -83.33 61.16 6.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.031 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.949 178.641 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -117.63 -8.31 10.94 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 67.92 15.63 9.55 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.335 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.448 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 20.6 t0 -90.27 61.37 5.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.645 -1.162 . . . . 0.0 108.791 175.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.462 ' HA ' HG22 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -156.4 151.55 26.43 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.906 -176.43 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.749 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 8.4 ptt? -97.4 158.19 15.6 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.755 ' HD1' ' HB2' ' A' ' 81' ' ' ALA . 79.0 m-85 -113.94 96.15 5.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.36 -111.83 3.34 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -173.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -79.47 -29.52 41.73 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 124.626 0.839 . . . . 0.0 110.889 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.613 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.8 19.77 8.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.982 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.792 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 95.1 mttt -66.4 -38.08 86.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.873 0.368 . . . . 0.0 110.299 175.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.8 19.47 38.48 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 173.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.731 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -64.38 99.41 0.29 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 174.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.3 46.35 0.92 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.027 0.441 . . . . 0.0 110.249 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.657 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -97.06 -158.97 31.27 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.687 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -145.87 20.26 1.45 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.992 0.396 . . . . 0.0 110.802 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.761 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.9 mmt180 -68.17 139.74 56.12 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -138.84 35.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.726 0.774 . . . . 0.0 110.677 -171.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.87 140.3 21.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.356 -176.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 46.6 p -75.43 -174.81 2.56 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.106 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.8 m -72.85 -12.62 15.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.454 0.645 . . . . 0.0 110.115 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.1 p -92.57 -13.54 29.54 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.904 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.95 7.57 70.4 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.342 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.938 HG21 ' HB2' ' A' ' 67' ' ' ASN . 92.9 m -75.68 120.06 79.95 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -47.46 123.48 8.05 Favored 'Trans proline' 0 CA--C 1.514 -0.52 0 C-N-CA 122.809 2.339 . . . . 0.0 112.861 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.402 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 84.6 m -62.27 135.43 57.47 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.474 0.654 . . . . 0.0 110.488 173.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 23.2 tt0 -68.26 164.8 19.82 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.225 174.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.48 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 15.0 m-20 -76.3 125.91 30.04 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.758 ' CE3' HD23 ' A' ' 46' ' ' LEU . 40.2 m95 -53.36 -31.71 45.79 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.12 -19.09 57.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.18 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.48 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.52 150.13 23.38 Favored 'General case' 0 C--O 1.21 -0.997 0 O-C-N 121.32 -0.863 . . . . 0.0 109.014 -173.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.765 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.9 mm-40 -103.24 33.64 3.22 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 29.2 mt-10 -141.62 117.38 7.15 Favored Pre-proline 0 N--CA 1.435 -1.195 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -157.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.6 Cg_endo -91.8 33.38 8.98 Favored 'Cis proline' 0 C--N 1.347 0.464 0 C-N-CA 123.635 -1.402 . . . . 0.0 112.974 0.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.562 ' HB3' HD12 ' A' ' 71' ' ' LEU . 55.1 m80 -130.37 107.46 9.27 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.765 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -74.22 118.48 17.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.451 0.643 . . . . 0.0 109.889 -178.086 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.467 ' HE1' ' HA ' ' A' ' 25' ' ' TRP . 4.4 p80 -147.65 99.15 3.07 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 122.002 0.906 . . . . 0.0 109.957 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -80.12 32.98 0.28 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.601 175.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.453 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.5 pt -141.91 147.85 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -176.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.501 ' HD2' ' HH ' ' A' ' 64' ' ' TYR . 38.3 m-85 53.12 45.55 28.46 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 122.01 0.91 . . . . 0.0 110.96 -174.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 18.1 p -99.11 172.46 4.68 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.586 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 28.6 Cg_exo -60.59 -20.45 64.73 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 121.855 1.703 . . . . 0.0 111.818 172.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -91.37 -35.7 14.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.089 -175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.8 p -85.91 -25.23 26.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.822 0.344 . . . . 0.0 110.447 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.5 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.3 m120 -132.8 65.21 73.77 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.015 0.436 . . . . 0.0 110.814 -178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.89 13.5 1.22 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.327 2.018 . . . . 0.0 112.13 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -103.56 -21.37 13.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.84 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -107.57 -0.83 21.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.54 -175.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.82 46.41 67.66 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.684 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.818 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.4 mp -76.52 67.2 2.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.776 0.322 . . . . 0.0 110.872 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 6.1 pt-20 -94.42 151.28 19.5 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.713 0.292 . . . . 0.0 110.762 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.8 mptp? 48.24 -110.32 0.35 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.442 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -140.18 17.84 2.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.965 0.412 . . . . 0.0 110.613 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.49 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 27.8 m-85 -66.75 126.57 29.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.649 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 93.6 m -53.79 150.73 7.1 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 123.468 0.48 . . . . 0.0 111.96 -173.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 41.9 mmt-85 -153.74 165.99 34.25 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.924 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -131.33 76.38 75.93 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.002 172.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.818 ' HG3' HD21 ' A' ' 46' ' ' LEU . 34.9 Cg_exo -55.8 -35.7 94.04 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.844 2.362 . . . . 0.0 112.318 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.89 -12.36 25.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.91 -175.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.792 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 59.17 52.15 55.03 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.526 -174.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 59' ' ' GLY . 6.1 t70 -51.26 133.65 28.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 174.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.02 9.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.616 0.722 . . . . 0.0 110.568 -175.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -107.04 -15.98 14.85 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.73 -177.48 17.04 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.295 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.749 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 73.5 Cg_endo -73.8 158.4 46.74 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.37 2.046 . . . . 0.0 110.984 -175.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.558 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 31.5 p-90 -144.13 -176.31 4.96 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.441 -172.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.575 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.4 p -167.92 179.64 4.6 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.472 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.501 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 49.5 m-85 -99.18 146.43 26.17 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.433 ' HB ' HG21 ' A' ' 20' ' ' THR . 3.9 p -99.0 150.78 21.62 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.474 -170.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.9 p -85.03 23.14 1.27 Allowed 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.008 166.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.938 ' HB2' HG21 ' A' ' 20' ' ' THR . 56.9 t-20 -99.65 117.79 63.09 Favored Pre-proline 0 N--CA 1.456 -0.135 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.098 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 15.1 Cg_exo -68.27 4.96 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.87 2.38 . . . . 0.0 113.632 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -88.37 -38.84 14.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.755 0.312 . . . . 0.0 111.21 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 159.9 41.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.136 0.493 . . . . 0.0 111.38 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.562 HD12 ' HB3' ' A' ' 31' ' ' HIS . 49.9 tp -81.37 -49.61 10.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.968 -175.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.567 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 17.8 p90 -143.6 163.65 32.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.958 0.408 . . . . 0.0 110.701 -178.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -154.56 -175.7 5.54 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.103 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -93.79 158.79 15.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 86.9 m -105.94 169.94 8.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.278 0.561 . . . . 0.0 111.474 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -115.27 72.31 0.79 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.096 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.761 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.5 p -113.46 128.54 25.57 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.373 0.606 . . . . 0.0 110.697 174.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 17.6 Cg_endo -58.16 155.49 34.21 Favored 'Trans proline' 0 CA--C 1.513 -0.531 0 C-N-CA 123.941 3.094 . . . . 0.0 113.871 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.27 111.3 11.56 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.32 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.46 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.26 -39.38 54.54 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.08 179.218 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.755 ' HB2' ' HD1' ' A' ' 3' ' ' PHE . . . -87.44 62.13 6.98 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.585 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.969 179.06 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.801 0.334 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -83.51 -5.58 59.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 73.87 10.96 4.59 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.706 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' ASP . . . . . 0.54 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 24.1 t0 -88.55 58.85 4.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.228 1.013 . . . . 0.0 109.576 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.584 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -156.35 152.9 28.17 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.916 -179.649 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.556 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.0 ptt? -95.6 151.2 19.54 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.564 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 79.5 m-85 -109.26 96.27 6.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.88 -115.97 4.12 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -174.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -79.59 -21.92 44.38 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 124.684 0.873 . . . . 0.0 110.291 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.71 15.68 16.22 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.166 -176.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -63.81 -34.56 78.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.065 0.46 . . . . 0.0 110.146 176.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -109.98 20.01 27.0 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 174.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.748 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.9 t80 -68.22 101.07 1.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.053 0.454 . . . . 0.0 110.185 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.63 49.3 0.81 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.604 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.75 -151.76 28.24 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.858 -176.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HE2' ' HB3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -150.73 22.78 0.79 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.928 0.394 . . . . 0.0 111.017 -174.272 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.864 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.8 mmt180 -68.35 137.58 54.72 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 170.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 m -140.06 30.86 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 121.804 0.811 . . . . 0.0 110.796 -171.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.722 HG22 ' HA2' ' A' ' 19' ' ' GLY . 7.3 m -151.45 134.81 16.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -174.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.425 HG21 HG22 ' A' ' 65' ' ' THR . 75.9 p -73.0 -176.92 2.23 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.122 0.487 . . . . 0.0 112.242 -170.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -67.23 -15.65 19.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.367 0.603 . . . . 0.0 110.806 177.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.0 p -93.09 -15.36 26.16 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.839 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.722 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 85.35 15.53 66.31 Favored Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.352 -174.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.977 HG21 ' HB2' ' A' ' 67' ' ' ASN . 85.1 m -78.32 121.88 84.4 Favored Pre-proline 0 N--CA 1.446 -0.67 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 169.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -48.51 131.59 23.73 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.713 2.275 . . . . 0.0 113.216 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.9 m -71.0 137.13 48.8 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.586 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.401 ' HG2' ' N ' ' A' ' 24' ' ' ASP . 24.1 tt0 -71.1 166.09 22.16 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.153 174.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.568 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 10.0 m-20 -75.98 127.73 33.57 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.709 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 43.3 m95 -54.35 -31.47 54.54 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.04 -16.69 57.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.915 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.568 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -98.02 148.04 23.9 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 118.625 0.648 . . . . 0.0 109.616 -173.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 32' ' ' ARG . 31.4 mm-40 -106.58 14.86 26.52 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -176.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.502 ' HA ' ' N ' ' A' ' 31' ' ' HIS . 44.6 mt-10 -147.77 145.55 21.57 Favored Pre-proline 0 N--CA 1.431 -1.382 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.273 -174.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.93 20.46 5.76 Favored 'Cis proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.458 -1.476 . . . . 0.0 113.334 1.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.502 ' N ' ' HA ' ' A' ' 29' ' ' GLU . 62.9 m80 -131.61 107.65 8.98 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.437 ' HD2' ' N ' ' A' ' 32' ' ' ARG . 3.4 mpt_? -74.93 115.34 14.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.5 p80 -147.23 98.09 2.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.088 0.946 . . . . 0.0 111.621 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.07 33.1 0.18 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.531 173.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.9 pt -142.02 147.05 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.563 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 52.0 m-85 49.93 47.68 22.89 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.09 0.947 . . . . 0.0 111.276 -173.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 30.9 p -100.05 174.57 2.92 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.869 170.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 20.9 Cg_exo -66.15 -16.26 51.43 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.868 1.712 . . . . 0.0 111.348 170.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -91.07 -34.33 15.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.371 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.9 p -93.94 -20.4 20.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.551 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.563 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.3 m120 -133.35 65.05 71.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.202 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.9 25.75 0.5 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.487 2.125 . . . . 0.0 111.746 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -115.44 -13.35 11.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.555 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.667 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -116.1 4.38 13.66 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.53 -175.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.48 41.71 96.17 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.856 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.5 mp -70.85 99.64 1.78 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.821 0.343 . . . . 0.0 110.287 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.575 ' HB3' ' HD2' ' A' ' 50' ' ' TYR . 28.4 tt0 -109.84 148.95 30.59 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.941 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.477 ' HG2' ' HG2' ' A' ' 47' ' ' GLU . 46.2 mmtm 46.84 -109.62 0.25 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.543 1.152 . . . . 0.0 111.271 173.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -135.63 17.63 3.33 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.874 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.575 ' HD2' ' HB3' ' A' ' 47' ' ' GLU . 34.6 m-85 -66.12 128.68 37.06 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.097 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.616 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 70.8 m -53.62 148.99 8.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.243 0.544 . . . . 0.0 112.284 -174.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' HD2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -154.7 157.47 38.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.89 -174.704 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -122.45 81.55 46.55 Favored Pre-proline 0 N--CA 1.446 -0.646 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.243 171.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.577 ' HD2' ' CE2' ' A' ' 62' ' ' TRP . 19.4 Cg_exo -63.25 -24.67 72.15 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.399 2.066 . . . . 0.0 112.397 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.75 -27.47 21.15 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.025 0.916 . . . . 0.0 109.575 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.29 39.6 98.03 Favored Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.925 -166.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -43.93 133.26 5.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.909 -0.646 . . . . 0.0 110.042 170.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 t -70.87 5.94 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.62 0.724 . . . . 0.0 110.878 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.83 -18.14 23.62 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.42 179.64 16.1 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.269 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.556 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 60.5 Cg_endo -71.59 157.61 55.56 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.272 1.981 . . . . 0.0 111.49 -176.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.577 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 25.1 p-90 -146.68 -170.89 3.63 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.819 -170.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.709 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.6 p -168.36 -178.59 3.63 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.789 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.54 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 53.1 m-85 -100.53 144.43 29.53 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 171.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 3.6 p -101.82 150.7 22.9 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.38 -171.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.7 p -84.41 35.0 0.53 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.358 0.599 . . . . 0.0 109.791 167.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.977 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.8 t-20 -115.63 123.77 30.88 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.269 -176.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.2 Cg_exo -69.13 -1.3 7.71 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.787 2.325 . . . . 0.0 113.682 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -84.02 -38.01 21.43 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.778 0.323 . . . . 0.0 111.777 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -143.9 143.14 31.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.134 0.492 . . . . 0.0 110.116 -176.58 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.454 ' O ' ' HD1' ' A' ' 64' ' ' TYR . 52.5 tp -71.05 -38.03 72.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.645 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -143.55 160.9 39.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -156.17 176.03 13.21 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -94.68 156.59 16.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 77.5 m -106.2 166.13 10.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.964 0.411 . . . . 0.0 111.55 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -101.74 33.0 3.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.023 -172.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.864 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 4.6 p -81.85 127.22 73.13 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-O 121.519 0.675 . . . . 0.0 111.63 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.66 161.61 27.78 Favored 'Trans proline' 0 CA--C 1.515 -0.466 0 C-N-CA 124.378 3.385 . . . . 0.0 113.78 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.33 114.05 13.42 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.605 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.584 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.07 -40.23 53.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.632 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -79.91 51.07 1.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.655 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.844 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.831 179.76 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.486 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.644 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 9.8 ptt? -96.64 156.64 16.26 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.611 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 81.4 m-85 -113.35 97.82 6.72 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.85 -114.26 3.86 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.426 ' OD1' ' HA ' ' A' ' 58' ' ' VAL . 91.8 m-20 -79.35 -24.68 42.54 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.573 0.808 . . . . 0.0 110.58 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.46 17.65 11.12 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.733 -1.222 . . . . 0.0 111.632 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -65.46 -43.95 88.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.174 0.511 . . . . 0.0 109.822 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -103.68 25.09 27.79 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.749 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.2 t80 -67.3 103.38 1.25 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 171.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -108.27 45.18 1.04 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.205 0.526 . . . . 0.0 109.677 -176.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.639 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -95.56 -155.37 31.16 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.93 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 7.1 ptmt -148.87 20.06 1.0 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.802 0.334 . . . . 0.0 111.012 -170.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.864 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.1 mmt180 -66.86 139.07 57.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 171.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.64 38.4 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.676 0.75 . . . . 0.0 110.742 -171.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.47 ' HB ' ' HA2' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -151.4 147.94 27.5 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.345 -175.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.0 p -74.32 -172.85 1.54 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.529 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 m -65.22 -16.75 20.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.393 0.616 . . . . 0.0 111.371 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -94.19 -13.75 26.33 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.037 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 15' ' ' THR . . . 87.02 14.84 63.85 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.598 -170.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.975 HG21 ' HB2' ' A' ' 67' ' ' ASN . 86.4 m -75.78 119.52 77.5 Favored Pre-proline 0 N--CA 1.448 -0.564 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 171.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -48.12 129.22 18.23 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.999 2.466 . . . . 0.0 113.564 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.7 m -70.04 134.77 48.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.073 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 24.0 tt0 -67.95 166.36 15.89 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.663 174.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.521 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 3.2 m-20 -76.07 125.99 30.17 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.696 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 39.1 m95 -54.76 -31.07 58.12 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 173.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.2 -21.0 56.97 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.938 -1.483 . . . . 0.0 113.267 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -103.08 150.64 23.41 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 119.168 0.895 . . . . 0.0 109.061 -172.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.778 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 27.7 mm-40 -103.2 35.31 2.59 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 37.3 mt-10 -145.29 119.64 5.59 Favored Pre-proline 0 N--CA 1.432 -1.327 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -156.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 93.8 Cg_endo -89.43 32.1 9.0 Favored 'Cis proline' 0 C--N 1.346 0.42 0 C-N-CA 123.424 -1.49 . . . . 0.0 112.979 0.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.536 ' HB3' HD12 ' A' ' 71' ' ' LEU . 53.4 m80 -130.91 108.01 9.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.778 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.0 123.07 22.77 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.516 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.4 p80 -151.71 94.57 2.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.108 0.956 . . . . 0.0 110.142 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.9 m -75.23 29.63 0.1 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.398 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.516 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.4 pt -141.6 151.0 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.51 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 39.9 m-85 51.74 47.13 25.38 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 122.032 0.92 . . . . 0.0 111.274 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.7 p -99.28 170.88 6.27 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 114.266 -1.334 . . . . 0.0 108.124 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.14 -17.26 59.3 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.704 1.602 . . . . 0.0 111.804 172.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.84 -20.48 14.28 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.37 -171.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.432 ' C ' ' HD3' ' A' ' 42' ' ' PRO . 42.6 p -98.47 -15.48 19.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.196 0.522 . . . . 0.0 110.241 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.575 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 12.8 m120 -135.8 55.12 11.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.064 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 10.1 Cg_exo -71.16 36.61 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.071 2.514 . . . . 0.0 112.842 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.77 -9.95 2.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.319 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.735 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -110.58 12.6 22.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.412 . . . . 0.0 111.266 -176.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.15 44.01 97.79 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-N 115.27 -0.877 . . . . 0.0 113.37 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.1 mp -80.46 111.78 17.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.056 0.455 . . . . 0.0 110.52 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.636 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 2.0 pt-20 -124.47 134.59 53.0 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.662 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 48' ' ' LYS . 61.0 mmtt 50.75 -107.57 0.3 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -137.11 13.97 3.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.059 0.456 . . . . 0.0 110.19 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.636 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 22.2 m-85 -67.36 131.03 44.91 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.537 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 79.1 m -54.04 149.74 8.92 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.247 0.342 . . . . 0.0 111.571 -173.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 33.6 mmt-85 -153.94 165.94 34.53 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.438 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -127.88 79.46 73.65 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.238 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.71 ' HG3' HD21 ' A' ' 46' ' ' LEU . 37.6 Cg_exo -58.96 -35.83 97.9 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.556 2.17 . . . . 0.0 112.281 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -91.54 -17.28 25.89 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.252 0.549 . . . . 0.0 110.644 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.65 47.77 86.65 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.313 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.12 131.97 23.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.426 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 3.3 t -74.38 8.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.565 0.698 . . . . 0.0 110.556 -175.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.58 -18.95 19.46 Favored Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.22 179.58 16.15 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.772 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.644 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 90.6 Cg_endo -73.86 156.78 48.07 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.502 2.134 . . . . 0.0 111.277 -175.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.572 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.5 p-90 -144.89 -172.76 3.9 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.292 -171.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.696 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.8 p -168.65 -179.03 3.65 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.034 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.471 ' CD1' ' HG ' ' A' ' 71' ' ' LEU . 39.7 m-85 -100.75 144.77 29.32 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 171.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.6 p -102.95 146.23 28.65 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.442 -170.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 p -81.87 27.73 0.45 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.482 0.658 . . . . 0.0 109.779 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.975 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.4 t-20 -102.1 120.58 53.28 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.785 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.75 0.04 3.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.246 2.631 . . . . 0.0 113.557 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -84.17 -53.41 5.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.78 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.59 149.78 52.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.36 0.6 . . . . 0.0 111.056 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 31' ' ' HIS . 36.2 tp -69.92 -45.77 66.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.117 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 11.3 p90 -142.66 162.34 35.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -156.88 -177.96 7.01 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -97.97 155.74 16.95 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 93.5 m -103.75 173.74 6.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.098 0.475 . . . . 0.0 111.029 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -119.69 71.47 0.88 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.536 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.864 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.7 p -108.54 130.03 23.26 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.654 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.83 153.91 47.32 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 123.824 3.016 . . . . 0.0 113.68 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.59 112.61 12.12 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.326 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.486 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.45 -40.75 57.12 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.436 178.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.611 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.186 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.527 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.441 -0.9 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.774 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.4 ptt? -96.63 149.57 21.64 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.673 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 80.8 m-85 -107.07 102.34 11.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.43 -111.65 3.31 Favored Glycine 0 N--CA 1.425 -2.068 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.498 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.594 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 81.4 m-20 -78.87 -27.46 44.02 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.551 0.795 . . . . 0.0 110.555 -176.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.668 ' HA2' ' HB2' ' A' ' 2' ' ' MET . . . 111.61 17.33 8.69 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.594 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 43.1 mtmt -65.46 -47.93 74.42 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.41 -0.895 . . . . 0.0 109.711 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.21 23.32 36.8 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.473 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.0 t80 -65.42 98.49 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.072 0.463 . . . . 0.0 109.962 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.408 ' HE ' ' HA ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -102.96 44.47 1.01 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -177.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.613 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -95.55 -155.27 31.12 Favored Glycine 0 N--CA 1.454 -0.104 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.741 -175.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -144.35 15.6 1.66 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.873 0.337 . . . . 0.0 110.696 -174.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.71 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 12.8 mmt180 -66.08 133.26 50.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.63 37.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.532 0.682 . . . . 0.0 111.174 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.24 147.7 27.99 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.168 -177.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.518 ' HB ' ' OD2' ' A' ' 73' ' ' ASP . 66.4 p -75.53 -174.17 2.39 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.028 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 m -65.63 -17.53 22.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.58 0.705 . . . . 0.0 110.878 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 50.6 p -93.57 -14.69 26.24 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.903 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.28 11.95 63.9 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.517 -172.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.722 HG21 ' HB2' ' A' ' 67' ' ' ASN . 98.4 m -75.95 119.43 77.18 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 173.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -49.68 127.85 19.71 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.868 2.379 . . . . 0.0 113.244 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.5 m -68.48 138.59 55.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.875 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -69.06 165.65 19.79 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.528 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 26' ' ' ALA . 5.8 t70 -77.21 129.08 35.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.689 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 59.5 m95 -58.73 -31.53 68.38 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.414 ' HB3' ' OD1' ' A' ' 24' ' ' ASP . . . -78.33 -15.08 59.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.492 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.21 148.49 26.26 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -175.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.768 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.6 mm-40 -102.28 33.71 3.01 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 41.7 mt-10 -145.22 120.72 5.83 Favored Pre-proline 0 N--CA 1.429 -1.495 0 CA-C-N 114.61 -1.177 . . . . 0.0 114.046 -157.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 97.1 Cg_endo -90.41 37.05 5.16 Favored 'Cis proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.258 -1.559 . . . . 0.0 113.641 0.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.414 ' HB3' HD12 ' A' ' 71' ' ' LEU . 53.3 m80 -133.56 112.56 11.59 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.768 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 23.1 mmm180 -73.35 114.48 11.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -176.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.8 p80 -146.98 91.11 1.97 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.345 1.069 . . . . 0.0 110.395 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.8 t -77.29 35.46 0.17 Allowed 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.263 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.521 ' H ' ' C ' ' A' ' 33' ' ' HIS . 19.4 pt -143.95 141.42 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.586 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 42.1 m-85 55.85 47.09 20.93 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.062 0.934 . . . . 0.0 111.04 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 18.8 p -99.58 175.23 2.53 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.649 168.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 36.5 Cg_exo -60.91 -22.22 73.5 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 121.713 1.609 . . . . 0.0 112.001 172.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.71 -28.73 13.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.464 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.9 p -88.04 -17.03 32.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.068 0.461 . . . . 0.0 110.241 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.586 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.0 m120 -137.77 55.0 8.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.531 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 8.7 Cg_exo -71.04 35.39 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.807 2.338 . . . . 0.0 112.971 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 -11.03 3.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.035 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.708 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -110.56 13.27 22.65 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.997 0.427 . . . . 0.0 110.859 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.39 43.98 95.47 Favored Glycine 0 C--O 1.224 -0.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.861 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.1 mp -80.16 100.75 8.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.0 0.4 . . . . 0.0 111.161 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.5 pt-20 -121.72 149.88 42.61 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.762 172.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.403 ' O ' ' HD1' ' A' ' 25' ' ' TRP . 42.0 mmtm 50.65 -124.96 2.24 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.22 0.95 . . . . 0.0 111.022 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -128.49 19.39 6.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.039 0.447 . . . . 0.0 110.486 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.466 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 24.1 m-85 -66.87 127.1 31.21 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 175.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.593 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 78.8 m -52.61 150.75 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 111.543 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -154.76 159.59 40.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -123.28 78.01 53.05 Favored Pre-proline 0 C--N 1.317 -0.819 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.045 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.623 ' HG3' HD21 ' A' ' 46' ' ' LEU . 18.0 Cg_endo -70.37 -11.47 30.1 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.472 2.115 . . . . 0.0 112.971 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -99.07 -22.79 15.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.427 0.632 . . . . 0.0 109.816 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.89 51.02 60.04 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.878 -170.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -53.42 128.58 29.14 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 171.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.3 7.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.427 0.632 . . . . 0.0 110.361 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.86 -15.1 27.46 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 111.221 -0.751 . . . . 0.0 111.221 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.33 178.73 15.58 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 119.705 -1.236 . . . . 0.0 111.87 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.774 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 91.9 Cg_endo -77.45 163.58 29.6 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.686 2.257 . . . . 0.0 111.867 -175.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.527 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.4 p-90 -148.5 -171.28 3.81 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.053 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.689 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.8 p -168.47 -178.25 3.46 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.029 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.415 ' HE2' ' HB2' ' A' ' 36' ' ' PHE . 56.3 m-85 -100.75 144.59 29.54 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 171.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 p -99.91 143.99 29.49 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.239 -172.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 p -78.55 14.24 1.34 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.542 170.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.722 ' HB2' HG21 ' A' ' 20' ' ' THR . 59.8 t-20 -86.86 119.97 71.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 18.7 Cg_exo -65.02 0.21 2.77 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.728 2.285 . . . . 0.0 113.102 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -85.33 -55.26 4.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.174 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 12.3 ptmt -120.32 160.16 23.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.315 0.579 . . . . 0.0 111.025 -174.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.414 HD12 ' HB3' ' A' ' 31' ' ' HIS . 55.0 tp -87.62 -46.76 9.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.452 -176.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -143.79 164.23 31.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.989 0.423 . . . . 0.0 110.461 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.518 ' OD2' ' HB ' ' A' ' 16' ' ' THR . 32.2 t0 -160.47 173.56 15.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.673 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 69.5 m-85 -92.85 156.23 17.11 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.9 m -105.11 170.31 7.94 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.044 0.449 . . . . 0.0 111.154 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -114.57 73.82 0.84 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.338 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.71 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.1 p -114.2 128.04 26.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.491 0.662 . . . . 0.0 111.037 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 17.3 Cg_endo -57.47 158.75 18.26 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 124.489 3.459 . . . . 0.0 114.226 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.0 111.41 10.18 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.451 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.503 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.36 -41.41 56.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.241 178.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.673 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.948 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.568 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.441 -0.88 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.449 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.8 ptt? -94.86 155.41 16.8 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.563 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 91.2 m-85 -113.53 95.43 5.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.81 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.44 -106.53 2.07 Favored Glycine 0 N--CA 1.426 -1.991 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -172.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.436 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 8.0 m-20 -77.7 -35.89 51.63 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.856 0.974 . . . . 0.0 110.517 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . 112.06 17.89 8.1 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.104 -1.046 . . . . 0.0 110.945 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 46.7 mtmt -70.9 -35.02 72.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.062 -0.569 . . . . 0.0 109.656 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -104.25 19.91 41.69 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.702 171.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.714 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -67.06 109.99 3.23 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 171.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -114.98 48.06 1.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.082 0.467 . . . . 0.0 110.026 -176.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.614 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -99.64 -156.97 28.6 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.815 -0.629 . . . . 0.0 113.565 -172.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.42 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 11.4 ptmm? -141.73 13.89 2.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.453 0.168 . . . . 0.0 111.198 -169.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.706 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 32.8 mmt180 -66.05 137.48 57.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.43 36.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.286 0.565 . . . . 0.0 111.997 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.27 146.44 26.79 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.461 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 58.7 p -74.52 -174.06 1.95 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.681 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -66.49 -17.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.414 0.626 . . . . 0.0 110.752 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.4 p -92.77 -14.62 27.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.444 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.74 11.1 64.23 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.302 -173.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.983 HG21 ' HB2' ' A' ' 67' ' ' ASN . 84.6 m -75.85 119.43 77.13 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -45.85 124.13 6.79 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 123.119 2.546 . . . . 0.0 113.532 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.8 m -65.94 136.12 55.66 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.151 173.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -68.29 164.92 19.62 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.715 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -77.68 127.11 31.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.764 ' CE3' HD23 ' A' ' 46' ' ' LEU . 71.6 m95 -57.24 -31.0 65.09 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.613 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.66 -18.13 54.9 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.615 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.68 151.24 20.32 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.693 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.8 mm-40 -104.41 33.44 3.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 48.3 mt-10 -144.94 120.53 5.92 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -156.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 83.8 Cg_endo -87.91 27.96 12.76 Favored 'Cis proline' 0 C--N 1.344 0.339 0 C-N-CA 123.206 -1.581 . . . . 0.0 112.807 0.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.411 ' HB3' HD12 ' A' ' 71' ' ' LEU . 39.7 m80 -127.87 109.23 11.4 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.693 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.55 118.31 16.36 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.348 -177.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.425 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.0 p80 -149.19 100.12 3.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.255 1.026 . . . . 0.0 110.269 -177.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 m -81.74 30.49 0.37 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.056 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.7 pt -141.4 147.57 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.624 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 37.0 m-85 52.68 47.65 24.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.886 0.85 . . . . 0.0 111.093 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 22.4 p -100.19 175.42 2.4 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.314 170.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 19.0 Cg_exo -65.45 -17.6 57.95 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.371 1.381 . . . . 0.0 111.138 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -87.98 -38.37 15.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.178 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 p -90.32 -22.82 21.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.313 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.624 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.3 m120 -132.7 67.87 78.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.079 0.466 . . . . 0.0 111.021 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.96 5.98 2.32 Favored 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.344 2.029 . . . . 0.0 112.698 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -97.4 -26.99 14.67 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.401 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -99.49 4.85 46.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.406 0.622 . . . . 0.0 111.126 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.92 46.33 94.77 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.176 174.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.764 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.6 mp -71.18 86.94 0.78 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.385 0.612 . . . . 0.0 109.939 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.948 ' HG2' ' HD3' ' A' ' 48' ' ' LYS . 20.1 tt0 -102.45 145.84 28.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.858 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.948 ' HD3' ' HG2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER 44.12 -106.46 0.1 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.384 1.053 . . . . 0.0 110.949 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -138.68 22.11 2.69 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.984 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.595 ' HD2' ' HB3' ' A' ' 47' ' ' GLU . 28.6 m-85 -69.39 128.35 36.23 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.38 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 77.6 m -51.54 148.22 5.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.446 0.466 . . . . 0.0 111.417 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 36.7 mmt-85 -154.09 164.24 38.8 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.481 -176.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -126.23 77.04 72.35 Favored Pre-proline 0 C--N 1.321 -0.664 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.132 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.563 ' HG3' HD21 ' A' ' 46' ' ' LEU . 27.7 Cg_endo -70.63 -16.9 33.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.207 1.938 . . . . 0.0 112.746 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -90.18 -27.65 19.43 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.671 0.748 . . . . 0.0 109.503 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.75 46.63 91.44 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.621 -169.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 59' ' ' GLY . 6.8 t70 -54.4 135.79 44.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.4 16.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.918 0.866 . . . . 0.0 109.978 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -104.49 -20.96 9.63 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 175.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.83 176.0 14.6 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.177 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 57.1 Cg_endo -70.13 159.92 51.43 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.319 2.013 . . . . 0.0 111.613 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.54 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.9 p-90 -149.61 -168.14 3.02 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.954 -169.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.74 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.7 p -168.2 -178.99 3.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.586 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.419 ' HE2' ' HB2' ' A' ' 36' ' ' PHE . 39.2 m-85 -100.17 146.48 26.8 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 172.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.3 p -103.54 144.4 31.47 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.009 -1.076 . . . . 0.0 109.662 -171.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.413 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 36.2 p -79.81 17.37 0.95 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.213 169.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.983 ' HB2' HG21 ' A' ' 20' ' ' THR . 56.4 t-20 -94.48 124.94 53.75 Favored Pre-proline 0 C--O 1.229 -0.026 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.343 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.1 4.62 1.81 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.688 2.259 . . . . 0.0 113.309 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -85.01 -58.26 2.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -122.14 161.05 23.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.732 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.413 ' O ' ' HD1' ' A' ' 64' ' ' TYR . 57.4 tp -86.21 -45.33 11.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.604 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 4.2 p90 -143.34 159.4 42.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.703 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.461 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 47.4 t0 -154.5 172.43 17.8 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.8 155.5 17.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 71.2 m -105.41 171.76 7.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.947 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -115.7 60.99 0.7 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.378 0.609 . . . . 0.0 110.337 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.714 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.4 p -97.87 129.43 31.22 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.427 0.632 . . . . 0.0 110.398 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.478 ' HD2' HG23 ' A' ' 77' ' ' VAL . 36.2 Cg_endo -63.01 160.2 35.01 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 123.986 3.124 . . . . 0.0 113.49 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.34 111.9 11.08 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.028 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.506 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.09 -41.99 57.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.846 178.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.563 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.445 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.587 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.428 ' SD ' ' NE2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -98.07 146.74 25.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.64 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 67.9 m-85 -104.27 103.58 13.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.3 -107.78 2.3 Favored Glycine 0 N--CA 1.422 -2.239 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.336 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.522 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 86.3 m-20 -80.73 -32.46 35.72 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 124.819 0.952 . . . . 0.0 110.415 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 110.59 20.22 7.45 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.079 -1.057 . . . . 0.0 110.97 -174.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.522 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 47.4 mtmt -66.02 -45.14 82.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.89 -0.655 . . . . 0.0 109.812 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.14 27.25 20.16 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.635 ' CE1' ' HA3' ' A' ' 11' ' ' GLY . 2.9 t80 -65.19 101.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HE ' ' C ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -102.24 51.26 0.82 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.013 0.435 . . . . 0.0 110.69 -177.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.635 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -108.42 -163.86 20.89 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.71 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -142.21 16.79 2.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.721 0.26 . . . . 0.0 110.926 -170.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.843 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 19.5 mmt180 -64.42 136.61 57.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.0 m -138.59 40.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.857 0.837 . . . . 0.0 110.422 -172.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.993 HG23 ' HA2' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -150.81 135.08 16.94 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.158 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.564 HG21 ' HB3' ' A' ' 73' ' ' ASP . 54.5 p -74.03 -170.57 0.95 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.026 0.441 . . . . 0.0 112.035 -175.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.2 -18.89 24.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.427 0.632 . . . . 0.0 110.875 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.4 p -93.45 -13.09 28.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.995 0.902 . . . . 0.0 109.063 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.993 ' HA2' HG23 ' A' ' 15' ' ' THR . . . 81.02 20.56 64.86 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.904 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.961 HG21 ' HB2' ' A' ' 67' ' ' ASN . 60.0 m -75.69 123.27 88.32 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 169.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 78.1 Cg_exo -50.28 135.4 38.74 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.497 2.131 . . . . 0.0 113.128 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.0 m -75.49 141.41 43.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.533 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -71.45 163.32 27.92 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.88 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 6.3 m-20 -76.7 125.16 28.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.738 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 38.6 m95 -53.34 -30.56 40.0 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.49 -14.04 59.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.013 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.89 148.52 27.51 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.694 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 36.1 mm-40 -103.39 29.71 5.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.74 127.06 6.91 Favored Pre-proline 0 N--CA 1.426 -1.644 0 CA-C-N 113.581 -1.645 . . . . 0.0 114.104 -159.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -85.61 26.32 11.67 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 123.853 -1.311 . . . . 0.0 112.59 1.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.673 ' HB3' HD12 ' A' ' 71' ' ' LEU . 68.3 m80 -129.17 104.01 7.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.694 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -74.61 118.2 17.3 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -176.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.491 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.7 p80 -144.8 92.73 2.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.75 0.786 . . . . 0.0 110.509 -173.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 m -74.1 31.42 0.08 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.705 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.491 ' H ' ' C ' ' A' ' 33' ' ' HIS . 25.7 pt -142.79 143.86 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.593 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 72.2 m-85 49.53 50.81 17.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.92 0.867 . . . . 0.0 111.185 -173.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 60.5 p -103.03 176.48 1.8 Allowed Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.468 171.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 24.2 Cg_exo -66.44 -11.49 31.79 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.98 1.787 . . . . 0.0 111.466 169.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -89.47 -40.72 12.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.09 0.471 . . . . 0.0 110.171 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.5 p -90.56 -22.55 21.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.251 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.625 ' O ' HD13 ' A' ' 46' ' ' LEU . 15.2 m120 -137.15 60.82 30.24 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.368 . . . . 0.0 111.514 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.53 20.33 0.69 Allowed 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 122.026 1.817 . . . . 0.0 112.396 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.58 -8.86 7.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.713 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -105.19 10.93 33.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.26 0.553 . . . . 0.0 110.324 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.76 41.68 73.19 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.163 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.796 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.5 mp -80.41 79.12 7.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.71 0.767 . . . . 0.0 110.368 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.819 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 7.2 pt-20 -101.78 136.48 41.54 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.818 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 11.0 mtpp 48.63 -105.98 0.17 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -141.67 11.62 2.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.646 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.819 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 23.2 m-85 -65.53 131.41 46.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.522 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 70.7 m -52.35 144.66 12.53 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.246 0.341 . . . . 0.0 111.028 -176.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 35.6 mmt-85 -149.32 168.78 22.42 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.268 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -129.49 77.86 76.59 Favored Pre-proline 0 C--N 1.313 -0.981 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.969 171.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.796 ' HG3' HD21 ' A' ' 46' ' ' LEU . 39.5 Cg_endo -72.93 -10.17 24.44 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.082 1.855 . . . . 0.0 111.801 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -90.98 -32.62 15.87 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 172.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.93 36.45 93.3 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.3 -165.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -46.84 134.05 10.36 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.942 -0.629 . . . . 0.0 109.877 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 13.0 t -70.09 0.31 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.563 0.697 . . . . 0.0 110.579 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.56 -19.95 39.37 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.46 -179.64 16.13 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.757 -1.211 . . . . 0.0 111.41 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -73.44 158.48 47.96 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.194 1.929 . . . . 0.0 111.859 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.497 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 19.2 p-90 -150.72 -169.24 3.33 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.867 -170.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.738 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.3 p -168.53 -176.62 2.87 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.5 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.556 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 84.1 m-85 -100.4 147.23 26.07 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 169.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 67' ' ' ASN . 2.7 p -100.62 149.7 23.48 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.741 -169.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.5 p -82.47 24.56 0.69 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.424 0.631 . . . . 0.0 109.89 167.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.961 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.7 t-20 -108.0 118.27 53.14 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.889 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 15.9 Cg_exo -68.66 5.95 1.14 Allowed 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.92 2.414 . . . . 0.0 113.585 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 -85.33 -49.13 8.4 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 149.04 52.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.163 0.506 . . . . 0.0 110.595 -175.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 31' ' ' HIS . 39.4 tp -76.37 -43.75 39.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.999 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 1.9 p90 -142.96 153.47 43.06 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.501 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.564 ' HB3' HG21 ' A' ' 16' ' ' THR . 18.9 t0 -152.98 164.85 37.2 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -175.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -92.48 156.56 17.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.59 171.76 7.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.827 0.346 . . . . 0.0 110.67 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -118.76 60.71 0.8 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.389 0.614 . . . . 0.0 109.99 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.843 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.5 p -102.28 130.44 24.18 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.396 0.617 . . . . 0.0 110.512 176.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.418 ' HD2' HG23 ' A' ' 77' ' ' VAL . 21.0 Cg_endo -60.12 160.9 20.96 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 124.691 3.594 . . . . 0.0 114.231 -176.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.428 ' NE2' ' SD ' ' A' ' 2' ' ' MET . 8.8 tp-100 -75.63 112.01 11.55 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.941 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.587 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.96 -41.61 50.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.724 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.64 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.252 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.582 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.624 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 16.2 ptt? -96.52 146.23 24.99 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.614 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 90.5 m-85 -105.47 99.47 9.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.25 -119.77 4.96 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.892 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -79.74 -18.12 51.91 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 124.481 0.753 . . . . 0.0 110.585 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.619 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.31 13.45 21.0 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.917 -174.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -64.5 -39.49 93.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.199 -0.501 . . . . 0.0 109.687 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.594 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -107.06 23.05 28.34 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 172.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.712 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.8 t80 -67.59 105.15 1.78 Allowed 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 172.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.52 39.06 2.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.17 0.509 . . . . 0.0 110.214 -175.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.459 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -94.72 -158.88 33.39 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.978 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.496 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 9.1 ptmm? -140.48 19.04 2.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.88 0.371 . . . . 0.0 110.33 -168.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.645 ' HB2' ' OH ' ' A' ' 9' ' ' TYR . 2.5 mpt_? -67.98 137.59 55.25 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 m -140.29 33.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.939 0.876 . . . . 0.0 110.322 -170.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.451 HG22 ' HA2' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -150.58 139.11 20.54 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -172.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.593 ' HB ' ' OD2' ' A' ' 73' ' ' ASP . 72.3 p -74.84 -176.22 2.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.647 0.261 . . . . 0.0 111.39 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.407 HG22 ' OD2' ' A' ' 73' ' ' ASP . 15.4 m -65.87 -20.41 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.647 0.737 . . . . 0.0 110.187 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 p -91.99 -14.23 29.77 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.529 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.451 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 89.94 11.97 62.71 Favored Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.846 -174.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.773 HG21 ' HB2' ' A' ' 67' ' ' ASN . 78.4 m -76.58 120.82 83.3 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 120.426 -0.509 . . . . 0.0 109.84 170.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -50.55 125.82 16.45 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.837 2.358 . . . . 0.0 113.198 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.4 m -64.44 137.87 58.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.499 0.666 . . . . 0.0 110.627 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 25.5 tt0 -71.22 166.12 22.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.925 174.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 1.0 OUTLIER -75.98 125.11 28.49 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.739 ' CE3' HD23 ' A' ' 46' ' ' LEU . 45.9 m95 -54.8 -29.25 54.02 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.611 0.719 . . . . 0.0 109.122 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.87 -21.35 55.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.556 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.69 150.38 22.8 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -172.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.755 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.5 mm-40 -103.5 33.0 3.53 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 43.4 mt-10 -143.17 119.58 6.66 Favored Pre-proline 0 N--CA 1.43 -1.474 0 CA-C-N 114.205 -1.361 . . . . 0.0 114.209 -157.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 88.9 Cg_endo -90.04 31.98 9.58 Favored 'Cis proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.298 -1.542 . . . . 0.0 113.456 1.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.491 ' HB3' HD12 ' A' ' 71' ' ' LEU . 61.5 m80 -131.63 113.02 13.1 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.755 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.72 116.55 14.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.823 -176.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.494 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.8 p80 -148.57 89.71 1.72 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.449 1.119 . . . . 0.0 110.543 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.1 m -78.19 35.84 0.22 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.996 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.494 ' H ' ' C ' ' A' ' 33' ' ' HIS . 20.1 pt -143.19 146.63 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.559 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 31.0 m-85 53.97 46.51 25.43 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.343 1.068 . . . . 0.0 110.629 -174.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.573 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 42.6 p -99.8 176.77 1.78 Allowed Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.145 170.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 30.3 Cg_exo -61.99 -21.58 72.64 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 121.959 1.773 . . . . 0.0 111.95 169.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -87.49 -34.71 18.56 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.981 0.419 . . . . 0.0 111.122 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.3 p -89.08 -24.03 22.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.973 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.559 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.0 m120 -136.03 59.28 27.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 21.1 Cg_exo -64.48 4.15 0.68 Allowed 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.476 2.117 . . . . 0.0 112.787 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.414 ' H ' ' C ' ' A' ' 41' ' ' ASN . 23.2 ptt180 -95.06 -19.36 20.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.588 0.233 . . . . 0.0 111.376 -173.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.737 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -109.09 2.74 21.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.595 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.05 47.48 85.04 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.262 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.899 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.6 mp -75.14 74.28 2.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.967 0.413 . . . . 0.0 111.5 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.528 ' HG3' ' CD2' ' A' ' 50' ' ' TYR . 3.0 pt-20 -98.94 152.83 19.35 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.669 176.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 48.0 mttp 49.96 -113.65 0.66 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.418 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -140.69 19.63 2.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.176 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.528 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 30.2 m-85 -61.92 128.83 38.06 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.676 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 80.5 m -53.76 145.23 16.19 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 38.8 mmt-85 -152.5 164.62 37.23 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.225 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -125.57 81.45 64.7 Favored Pre-proline 0 C--N 1.318 -0.762 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.719 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.899 ' HG3' HD21 ' A' ' 46' ' ' LEU . 39.1 Cg_exo -59.17 -31.89 96.15 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.727 2.285 . . . . 0.0 112.458 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -89.76 -20.0 24.07 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.525 0.679 . . . . 0.0 109.97 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.96 44.09 97.5 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.539 -168.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -48.03 135.09 13.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.414 -0.893 . . . . 0.0 109.443 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 58' ' ' VAL . 11.4 t -71.67 6.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 123.893 0.746 . . . . 0.0 110.868 -173.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.42 -17.82 13.0 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.88 -178.15 16.5 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 119.89 -1.148 . . . . 0.0 111.234 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.624 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 74.2 Cg_endo -73.5 157.92 48.43 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.091 1.861 . . . . 0.0 111.815 -174.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.551 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 32.2 p-90 -145.61 -172.09 3.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.717 -172.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.711 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.0 p -168.52 -179.82 4.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.122 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 43.7 m-85 -100.16 145.61 27.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.3 p -102.84 147.02 27.41 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.664 -170.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.7 p -80.99 23.57 0.55 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.383 0.611 . . . . 0.0 110.517 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.773 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.1 t-20 -103.98 121.76 46.73 Favored Pre-proline 0 CA--C 1.528 0.115 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.086 -177.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 16.5 Cg_exo -67.23 -0.33 4.81 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.888 2.392 . . . . 0.0 113.703 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -84.66 -44.98 12.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.836 0.35 . . . . 0.0 111.619 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.13 145.57 50.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.468 0.651 . . . . 0.0 111.048 -175.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 31' ' ' HIS . 41.8 tp -71.28 -43.04 67.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.621 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -143.29 164.29 30.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.089 0.471 . . . . 0.0 110.338 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.593 ' OD2' ' HB ' ' A' ' 16' ' ' THR . 33.0 t70 -157.94 173.89 16.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -93.63 158.67 15.58 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 86.6 m -106.37 171.24 7.46 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -122.64 69.25 0.97 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.3 0.571 . . . . 0.0 109.99 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.712 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.6 p -105.29 132.72 20.63 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.854 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 77' ' ' VAL . 51.8 Cg_endo -65.76 162.24 35.51 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 123.631 2.887 . . . . 0.0 113.378 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.437 ' OE1' ' HB3' ' A' ' 81' ' ' ALA . 9.3 tp-100 -75.6 108.96 8.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.231 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.492 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -73.3 -37.94 66.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.306 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.614 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.194 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.502 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.63 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.8 ptt? -97.29 150.74 20.61 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 121.358 0.599 . . . . 0.0 112.514 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.733 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 71.8 m-85 -109.7 102.07 10.91 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.38 -115.48 4.19 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 119.997 -1.097 . . . . 0.0 111.033 -175.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.18 -23.93 40.69 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 124.531 0.783 . . . . 0.0 109.576 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.535 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.31 17.41 10.75 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.313 -0.946 . . . . 0.0 110.969 -174.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -66.48 -39.9 89.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.103 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.575 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -105.61 20.69 36.33 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.653 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.0 t80 -65.31 105.19 1.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -113.08 35.78 3.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.233 0.54 . . . . 0.0 109.551 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -88.25 -154.04 27.17 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.995 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 4.7 ptmt -150.29 22.07 0.84 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.912 0.387 . . . . 0.0 110.687 -168.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.722 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 22.5 mmt180 -68.5 137.86 54.74 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 171.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.79 38.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.486 0.66 . . . . 0.0 111.655 -171.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.06 145.31 25.42 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.957 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.504 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 69.4 p -74.36 -174.05 1.89 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.042 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -63.71 -20.45 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.489 0.661 . . . . 0.0 110.818 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.4 p -92.87 -12.71 30.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.499 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.43 11.41 69.03 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.42 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.975 HG21 ' HB2' ' A' ' 67' ' ' ASN . 95.4 m -76.69 119.15 76.2 Favored Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.329 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -47.25 124.7 9.45 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 123.098 2.532 . . . . 0.0 113.689 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.8 m -63.5 139.48 58.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.425 0.631 . . . . 0.0 110.884 172.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 23.1 tt0 -71.16 164.81 24.9 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.021 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 5.3 m-20 -76.95 125.56 29.51 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.693 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 37.7 m95 -54.06 -31.79 52.62 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.59 -17.08 58.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.749 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . . . -106.82 150.41 26.38 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -174.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.89 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.3 mm-40 -102.61 29.52 5.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 4.0 mm-40 -133.78 119.47 14.92 Favored Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -159.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 88.7 Cg_endo -94.24 35.65 7.57 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.079 -1.634 . . . . 0.0 112.783 -0.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.451 ' HB3' HD12 ' A' ' 71' ' ' LEU . 58.2 m80 -126.81 107.48 10.16 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.89 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.0 OUTLIER -76.59 113.02 13.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.068 -175.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 5.0 p80 -143.53 92.53 2.37 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.997 0.903 . . . . 0.0 110.422 -172.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.4 m -77.47 39.11 0.25 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.47 0.653 . . . . 0.0 109.534 172.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.465 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.4 pt -143.37 135.86 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -173.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 45.6 m-85 53.58 48.2 22.2 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 122.265 1.031 . . . . 0.0 111.275 -175.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 46.9 p -99.84 175.54 2.36 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.101 170.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 22.6 Cg_exo -64.79 -18.52 62.72 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.798 1.666 . . . . 0.0 111.257 168.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -83.17 -38.94 21.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.314 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.3 p -92.04 -25.23 18.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.085 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.547 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.0 m120 -132.41 68.25 79.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.346 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.22 12.37 1.81 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.453 2.102 . . . . 0.0 112.159 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -100.12 -27.7 13.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 -174.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.678 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -105.41 6.9 32.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 111.689 -172.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.36 46.29 93.09 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.368 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.689 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.6 mp -75.4 78.46 2.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.201 0.524 . . . . 0.0 110.507 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.749 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.6 pt-20 -97.64 139.89 32.86 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.675 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 29.4 mmtp 51.82 -111.47 0.57 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.865 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -137.22 14.16 3.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.831 0.348 . . . . 0.0 110.853 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.749 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 18.8 m-85 -66.92 129.5 40.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.528 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 84.1 m -52.88 153.1 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.265 0.353 . . . . 0.0 111.718 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 39.0 mmt-85 -156.26 166.91 32.06 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.17 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -128.32 78.72 75.21 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.941 171.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.672 ' HG3' HD21 ' A' ' 46' ' ' LEU . 28.3 Cg_endo -70.62 -14.08 33.07 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.328 2.019 . . . . 0.0 112.807 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.45 -21.59 20.09 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.468 0.651 . . . . 0.0 109.412 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.74 43.92 86.71 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.51 -167.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 59' ' ' GLY . 7.8 t70 -56.89 140.44 48.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.35 -0.925 . . . . 0.0 109.504 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 58' ' ' VAL . 9.2 t -75.11 13.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 122.045 0.926 . . . . 0.0 110.102 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -103.7 -18.61 13.73 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.28 -177.81 16.61 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.872 -1.156 . . . . 0.0 111.358 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.63 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 86.8 Cg_endo -77.22 153.51 31.76 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.36 2.04 . . . . 0.0 111.304 -175.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.538 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 19.3 p-90 -145.53 -169.23 3.17 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.893 -170.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.693 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.8 p -168.74 -178.11 3.29 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.812 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -101.06 145.36 28.84 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 ' HE3' ' A' ' 70' ' ' LYS . 3.1 p -99.4 149.27 23.34 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.119 -1.033 . . . . 0.0 109.729 -170.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.9 p -83.86 33.54 0.48 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.523 0.678 . . . . 0.0 109.738 166.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.975 ' HB2' HG21 ' A' ' 20' ' ' THR . 60.8 t-20 -112.97 120.59 40.25 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.995 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.1 Cg_exo -70.0 5.71 1.68 Allowed 'Trans proline' 0 N--CA 1.472 0.251 0 C-N-CA 122.866 2.378 . . . . 0.0 113.489 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -84.87 -50.81 7.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.157 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HE3' HG21 ' A' ' 65' ' ' THR . 0.5 OUTLIER -134.59 154.58 51.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.015 0.436 . . . . 0.0 110.879 -176.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 31' ' ' HIS . 50.8 tp -76.18 -43.42 42.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.095 -176.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -142.33 161.25 38.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.504 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 46.6 t0 -159.36 165.46 33.24 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 60.1 m-85 -93.3 155.05 17.65 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.8 m -103.11 167.99 9.47 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.912 0.387 . . . . 0.0 110.621 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -112.92 56.2 0.68 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.375 0.607 . . . . 0.0 110.033 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.722 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.8 p -95.35 128.46 38.35 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.186 0.517 . . . . 0.0 110.004 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 77' ' ' VAL . 34.8 Cg_endo -62.77 157.18 49.05 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 C-N-CA 123.565 2.843 . . . . 0.0 113.603 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.7 107.13 7.66 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.093 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -39.93 65.71 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.317 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.733 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--O 1.234 0.244 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.546 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.444 -0.756 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.613 ' HG2' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.5 150.31 22.33 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.608 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 90.0 m-85 -106.97 101.5 10.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -176.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.56 -106.87 2.09 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.04 -173.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -83.12 -32.77 26.52 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 125.206 1.18 . . . . 0.0 111.126 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.86 21.72 7.32 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.957 -175.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -65.32 -38.99 91.85 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.112 0.482 . . . . 0.0 109.967 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -106.99 26.55 18.84 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -70.25 104.07 2.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.58 38.74 2.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.011 0.434 . . . . 0.0 110.76 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.588 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -94.98 -159.77 33.59 Favored Glycine 0 C--N 1.329 0.174 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.943 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 14.5 ptmt -145.07 20.94 1.59 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.846 0.323 . . . . 0.0 111.314 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.721 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.9 mmt180 -67.44 138.8 56.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 173.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 50' ' ' TYR . 5.0 m -139.98 34.19 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.479 0.657 . . . . 0.0 111.552 -167.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.771 HG22 ' HA2' ' A' ' 19' ' ' GLY . 8.5 m -151.89 135.38 16.1 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -173.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.428 HG21 ' HB3' ' A' ' 73' ' ' ASP . 78.3 p -73.53 -176.72 2.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.941 0.4 . . . . 0.0 112.075 -172.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 m -65.03 -18.67 24.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.439 0.638 . . . . 0.0 111.046 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.8 p -93.12 -14.17 27.57 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.235 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.771 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.41 16.15 62.83 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.426 -174.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.973 HG21 ' HB2' ' A' ' 67' ' ' ASN . 86.3 m -76.8 121.09 84.21 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.633 169.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.49 126.24 15.61 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.768 2.312 . . . . 0.0 113.231 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.5 m -64.88 138.2 58.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.46 0.647 . . . . 0.0 110.697 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -72.12 165.71 23.77 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.441 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 16.9 m-20 -76.42 125.53 29.36 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.753 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 33.6 m95 -55.19 -29.18 57.35 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.8 -23.66 55.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.776 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -97.24 149.72 21.72 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -173.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.675 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.3 mm-40 -104.57 31.96 4.38 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.2 mt-10 -147.61 122.3 5.1 Favored Pre-proline 0 N--CA 1.425 -1.703 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.283 -155.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 87.4 Cg_endo -87.18 28.6 10.81 Favored 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.343 -1.524 . . . . 0.0 112.759 0.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.477 ' HB3' HD12 ' A' ' 71' ' ' LEU . 63.7 m80 -128.73 104.51 7.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.675 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.88 121.11 20.42 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -176.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.477 ' HE1' ' HA ' ' A' ' 25' ' ' TRP . 5.4 p80 -148.91 95.92 2.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.174 0.988 . . . . 0.0 110.172 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 m -77.89 32.15 0.17 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.234 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.473 ' H ' ' C ' ' A' ' 33' ' ' HIS . 30.3 pt -141.77 147.98 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -175.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.587 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 52.3 m-85 48.23 50.78 15.88 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.139 0.971 . . . . 0.0 111.268 -173.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 31.1 p -98.98 175.09 2.63 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.142 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 38.4 Cg_exo -62.99 -20.1 70.76 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.041 1.828 . . . . 0.0 112.236 172.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -99.64 -25.62 14.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.819 0.342 . . . . 0.0 111.207 -172.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.5 p -91.95 -15.75 27.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.83 0.347 . . . . 0.0 110.462 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.587 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.8 m120 -139.73 52.46 3.8 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.721 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 8.2 Cg_exo -71.49 31.61 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.789 2.326 . . . . 0.0 113.59 -176.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.81 -10.5 4.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.628 0.251 . . . . 0.0 111.354 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.697 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -105.76 9.83 32.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.122 0.487 . . . . 0.0 110.039 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.72 43.4 97.85 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.23 -0.895 . . . . 0.0 113.102 173.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.1 mp -81.32 94.8 6.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.152 0.501 . . . . 0.0 109.856 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.659 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.5 pt-20 -121.43 152.3 39.23 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.07 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 4.1 mptp? 46.74 -113.08 0.44 Allowed 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.915 0.76 . . . . 0.0 111.763 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -136.68 18.68 3.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.06 0.457 . . . . 0.0 110.128 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.659 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 20.2 m-85 -67.8 128.39 36.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.786 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.51 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 84.5 m -51.33 147.21 6.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.309 0.38 . . . . 0.0 111.254 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.51 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 38.3 mmt-85 -151.53 169.07 22.98 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.695 -176.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -134.27 77.92 59.35 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.85 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.643 ' HG3' HD21 ' A' ' 46' ' ' LEU . 18.8 Cg_exo -64.36 -26.77 63.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.354 2.036 . . . . 0.0 112.123 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -20.07 23.78 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.547 0.689 . . . . 0.0 109.663 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.71 45.19 93.66 Favored Glycine 0 N--CA 1.433 -1.5 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.674 -170.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -45.47 130.29 8.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 172.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 t -66.55 -5.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 O-C-N 123.941 0.776 . . . . 0.0 110.95 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.28 -20.21 36.28 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.309 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 129.42 -179.95 16.39 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.583 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 73.4 Cg_endo -72.66 159.04 49.6 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.21 1.94 . . . . 0.0 111.824 -175.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.569 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 28.4 p-90 -146.23 -171.98 3.84 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.007 -171.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.753 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.3 p -168.18 -177.87 3.45 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.881 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.543 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 57.5 m-85 -100.5 146.68 26.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 171.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 2.5 p -102.13 150.21 23.49 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.847 -171.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.2 p -84.27 31.26 0.51 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.527 0.68 . . . . 0.0 110.085 167.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.973 ' HB2' HG21 ' A' ' 20' ' ' THR . 59.0 t-20 -111.26 122.34 37.97 Favored Pre-proline 0 N--CA 1.462 0.16 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.075 -176.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.39 2.21 2.99 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.73 2.286 . . . . 0.0 113.481 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -83.72 -53.67 5.46 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.98 150.11 49.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.281 0.562 . . . . 0.0 110.571 -176.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 31' ' ' HIS . 53.5 tp -75.91 -43.42 45.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.349 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 11.2 p90 -143.1 158.56 43.5 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 16' ' ' THR . 28.6 t0 -153.93 172.22 17.77 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -176.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -94.08 155.06 17.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.6 m -106.34 170.95 7.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.747 0.308 . . . . 0.0 110.626 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -121.63 64.58 0.9 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.52 0.676 . . . . 0.0 109.88 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.721 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 1.7 p -94.81 131.78 29.79 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.328 174.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 77' ' ' VAL . 12.3 Cg_endo -56.06 152.05 39.2 Favored 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 123.403 2.735 . . . . 0.0 113.277 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.401 ' NE2' ' SD ' ' A' ' 2' ' ' MET . 8.8 tp-100 -74.85 112.65 11.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.631 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.546 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.6 OUTLIER -74.66 -37.2 62.78 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.119 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.608 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.802 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.54 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.444 -0.753 0 CA-C-O 120.963 0.411 . . . . 0.0 110.238 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.683 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.9 ptt? -97.61 154.64 17.41 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.689 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 81.1 m-85 -110.5 102.0 10.64 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.65 -115.15 4.18 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.444 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.75 -24.84 41.29 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 124.605 0.826 . . . . 0.0 110.788 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.559 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.09 16.56 14.77 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.817 -1.183 . . . . 0.0 111.486 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -64.74 -46.9 80.25 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.5 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -101.1 28.26 16.82 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.294 173.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.651 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.3 t80 -70.47 102.01 2.11 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -105.97 32.24 4.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.057 0.456 . . . . 0.0 109.918 -174.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.567 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -84.18 -154.86 20.58 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.528 -175.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.46 24.69 0.79 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.976 0.417 . . . . 0.0 110.329 -173.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.592 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 27.4 mmt180 -72.0 137.83 47.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 170.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 50' ' ' TYR . 4.0 m -138.29 38.04 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.582 0.706 . . . . 0.0 111.088 -169.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.32 144.07 25.29 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.191 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.437 HG21 HG22 ' A' ' 65' ' ' THR . 42.7 p -75.51 -176.14 3.09 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.24 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 m -65.47 -16.02 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.283 0.563 . . . . 0.0 110.824 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.4 p -93.22 -15.52 25.81 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.259 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.06 10.69 64.14 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.253 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 67' ' ' ASN . 85.4 m -77.64 120.68 82.38 Favored Pre-proline 0 N--CA 1.448 -0.549 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.867 174.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -51.31 123.87 12.92 Favored 'Trans proline' 0 C--O 1.239 0.53 0 C-N-CA 122.933 2.422 . . . . 0.0 113.243 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -62.59 140.94 58.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.848 174.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -73.21 164.96 25.92 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.16 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.63 124.37 27.85 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.639 ' CE3' HD23 ' A' ' 46' ' ' LEU . 44.4 m95 -54.28 -31.42 53.78 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.25 -9.31 59.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.818 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.67 147.41 33.17 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.699 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 34.8 mm-40 -102.22 31.94 3.75 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 41.1 mt-10 -146.51 122.26 5.57 Favored Pre-proline 0 N--CA 1.426 -1.633 0 CA-C-N 114.259 -1.337 . . . . 0.0 113.879 -156.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 3.3 Cg_endo -86.58 26.8 12.53 Favored 'Cis proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.612 -1.412 . . . . 0.0 113.344 2.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.401 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 59.1 m80 -126.52 109.77 12.53 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.699 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -72.78 113.61 10.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.973 -178.031 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.9 p80 -143.85 90.99 2.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.92 0.867 . . . . 0.0 110.096 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 40' ' ' THR . 14.7 m -75.61 34.85 0.12 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.508 0.67 . . . . 0.0 110.089 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.521 ' H ' ' C ' ' A' ' 33' ' ' HIS . 17.8 pt -143.84 142.13 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -175.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.542 ' CG ' ' HH2' ' A' ' 62' ' ' TRP . 32.5 m-85 57.0 45.26 21.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 121.769 0.795 . . . . 0.0 111.004 -176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 21.9 p -103.81 173.47 3.38 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.618 168.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 37.2 Cg_exo -59.39 -22.37 65.42 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.793 1.662 . . . . 0.0 111.997 170.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -86.56 -39.17 16.45 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.945 0.402 . . . . 0.0 110.649 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 34' ' ' SER . 1.8 p -90.26 -20.1 23.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.493 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.54 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.4 m120 -135.46 65.14 61.55 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.943 0.401 . . . . 0.0 111.443 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -79.52 32.56 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.358 2.039 . . . . 0.0 111.382 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -120.32 -17.1 8.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.425 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.667 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -118.14 11.35 13.23 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.804 -172.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.95 44.9 95.32 Favored Glycine 0 C--O 1.23 -0.145 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.323 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.952 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.2 mp -77.73 90.97 4.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.056 0.455 . . . . 0.0 111.334 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.576 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.6 pt-20 -108.84 142.16 39.83 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.493 175.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 58.39 -123.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.994 0.809 . . . . 0.0 110.908 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -130.35 17.09 5.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.659 0.266 . . . . 0.0 110.752 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.576 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 18.0 m-85 -66.4 131.24 45.64 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.627 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 72.1 m -52.24 148.17 6.81 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.422 0.451 . . . . 0.0 111.395 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HG3' ' HA ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -153.53 158.93 42.0 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -119.61 78.93 21.84 Favored Pre-proline 0 C--N 1.316 -0.891 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.825 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.952 ' HG3' HD21 ' A' ' 46' ' ' LEU . 26.8 Cg_exo -58.09 -26.49 75.81 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.741 2.294 . . . . 0.0 112.643 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.51 -11.63 18.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.754 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.17 45.57 95.13 Favored Glycine 0 CA--C 1.501 -0.801 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.217 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 59' ' ' GLY . 4.1 t70 -51.86 133.08 32.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.699 -0.751 . . . . 0.0 109.114 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.79 24.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.844 0.83 . . . . 0.0 110.562 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -116.3 -17.69 6.1 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.82 -179.56 16.1 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.32 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.683 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 71.7 Cg_endo -73.74 157.99 47.42 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.31 2.007 . . . . 0.0 111.481 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.604 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 29.3 p-90 -146.9 -174.16 4.42 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.065 -171.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.614 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.2 p -168.94 178.2 4.62 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.032 177.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.497 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 47.8 m-85 -100.51 145.39 28.36 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.437 HG22 HG21 ' A' ' 16' ' ' THR . 1.1 p -101.94 148.36 25.43 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.734 -171.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 p -79.73 19.2 0.68 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.101 0.477 . . . . 0.0 110.921 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.629 ' HB2' HG21 ' A' ' 20' ' ' THR . 63.0 t-20 -100.35 118.29 61.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.216 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 15.2 Cg_exo -68.52 3.64 2.1 Favored 'Trans proline' 0 N--CA 1.47 0.119 0 C-N-CA 123.157 2.572 . . . . 0.0 113.496 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -84.75 -44.43 13.34 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.966 0.412 . . . . 0.0 110.819 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.504 ' HE2' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -144.92 142.56 29.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.482 0.658 . . . . 0.0 111.16 -174.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HG ' ' CD1' ' A' ' 64' ' ' TYR . 52.5 tp -70.69 -44.48 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.912 -168.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -146.75 163.83 34.72 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.543 -174.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -154.07 -177.55 6.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.084 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -93.15 162.12 14.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 94.8 m -105.77 171.43 7.34 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.171 0.51 . . . . 0.0 111.266 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -117.43 70.48 0.79 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.225 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.651 HG21 ' CE1' ' A' ' 9' ' ' TYR . 3.4 p -109.67 128.67 24.99 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.31 173.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.84 159.15 34.59 Favored 'Trans proline' 0 CA--C 1.512 -0.595 0 C-N-CA 123.772 2.981 . . . . 0.0 113.634 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -74.39 113.84 12.09 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.068 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.522 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.91 -42.12 58.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.056 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.689 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.427 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.593 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.444 -0.725 0 CA-C-O 121.075 0.464 . . . . 0.0 111.149 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.722 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 12.9 ptt? -96.83 154.54 17.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 81' ' ' ALA . 49.6 m-85 -108.87 96.53 6.39 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.15 -115.18 4.05 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -79.49 -25.27 41.86 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.761 0.824 . . . . 0.0 111.148 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.627 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 112.04 13.54 12.16 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 119.834 -1.174 . . . . 0.0 111.568 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HB3' ' NZ ' ' A' ' 7' ' ' LYS . 9.1 mtpm? -60.61 -41.74 95.41 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.472 0.653 . . . . 0.0 110.202 175.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.517 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.94 28.64 10.86 Favored Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.165 172.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.72 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.7 t80 -68.43 106.31 2.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.896 0.379 . . . . 0.0 110.023 173.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.0 51.47 0.8 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -175.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.552 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -101.97 -148.65 21.38 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.711 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.459 ' HB3' ' HE2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -151.84 20.43 0.69 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.863 0.332 . . . . 0.0 110.773 -174.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.935 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.4 mmt180 -62.38 139.54 58.55 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.3 m -139.53 35.64 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.06 0.933 . . . . 0.0 109.871 -174.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.07 143.67 25.26 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.091 -177.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.445 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 55.7 p -75.37 -174.75 2.51 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.03 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.12 -16.35 20.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.505 0.669 . . . . 0.0 110.872 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.7 p -93.19 -13.61 28.16 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.44 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.8 10.56 66.84 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.26 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 1.015 HG21 ' HB2' ' A' ' 67' ' ' ASN . 96.9 m -77.08 120.54 82.05 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.141 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 58.2 Cg_exo -47.48 123.01 7.43 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.201 2.601 . . . . 0.0 113.802 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.98 141.14 58.86 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.842 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -73.81 166.26 23.64 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.417 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 11.8 m-20 -76.52 124.7 28.0 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 175.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.671 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 38.6 m95 -53.73 -32.55 52.53 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.9 -12.09 59.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.945 -1.479 . . . . 0.0 113.045 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.78 149.09 30.31 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 119.21 0.914 . . . . 0.0 109.052 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.693 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.3 mm-40 -101.84 31.76 3.72 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 44.1 mt-10 -145.57 121.39 5.81 Favored Pre-proline 0 N--CA 1.426 -1.655 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.712 -155.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 93.8 Cg_endo -89.92 33.59 7.83 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.469 -1.471 . . . . 0.0 113.217 1.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.6 ' HB3' HD12 ' A' ' 71' ' ' LEU . 64.3 m80 -134.11 111.16 10.1 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.693 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -72.17 126.6 30.21 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 35' ' ' ILE . 6.1 p80 -155.02 89.43 1.22 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.033 0.921 . . . . 0.0 110.271 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 m -73.79 34.23 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.528 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.526 ' H ' ' C ' ' A' ' 33' ' ' HIS . 20.7 pt -143.29 147.21 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.561 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 35.7 m-85 52.29 45.49 28.35 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.983 0.897 . . . . 0.0 111.27 -174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 p -100.8 172.59 4.36 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.495 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.15 -14.16 42.02 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.015 1.81 . . . . 0.0 112.003 172.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -92.91 -37.72 12.09 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 110.167 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -87.74 -22.37 24.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.464 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.561 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.0 m120 -130.82 60.29 51.96 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.328 . . . . 0.0 111.014 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.81 39.15 0.73 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.641 2.227 . . . . 0.0 112.956 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.478 ' NH1' ' HA ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -141.56 -16.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.644 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -99.52 12.3 36.81 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.166 -0.334 . . . . 0.0 110.453 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.79 40.21 85.23 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.085 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.644 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.2 mp -81.76 102.43 10.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.094 0.473 . . . . 0.0 110.435 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.403 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.4 pt-20 -127.27 142.75 51.39 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.448 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 31.5 mmtp 55.14 -116.15 1.02 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.969 0.793 . . . . 0.0 111.211 177.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -136.11 17.42 3.22 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.827 0.346 . . . . 0.0 110.83 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.403 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 30.0 m-85 -66.06 130.71 44.19 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.615 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 93.8 m -56.57 146.91 23.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.994 0.426 . . . . 0.0 111.668 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.81 159.88 43.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -176.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -126.37 80.25 69.38 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.746 -0.381 . . . . 0.0 109.98 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.64 ' HG3' HD21 ' A' ' 46' ' ' LEU . 37.6 Cg_exo -59.63 -31.71 94.77 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.908 2.405 . . . . 0.0 112.592 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -88.99 -24.0 22.49 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.523 0.677 . . . . 0.0 110.048 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.64 46.36 69.38 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.019 -172.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -48.39 133.64 15.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.73 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.37 -11.29 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 124.451 1.094 . . . . 0.0 111.527 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.29 -10.89 43.73 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.909 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.84 -177.81 16.59 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.684 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.722 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 88.2 Cg_endo -74.69 164.77 32.99 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.575 2.183 . . . . 0.0 111.694 -173.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.598 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 29.8 p-90 -149.97 -172.13 4.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.227 -172.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.671 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.7 p -168.91 -177.71 3.08 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.691 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.462 ' CD1' ' HB3' ' A' ' 72' ' ' TYR . 50.1 m-85 -100.99 147.29 26.35 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 171.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 p -103.35 147.16 27.43 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.081 -170.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.7 p -82.48 21.47 0.96 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.153 0.501 . . . . 0.0 110.411 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 1.015 ' HB2' HG21 ' A' ' 20' ' ' THR . 52.8 t-20 -99.35 123.11 49.65 Favored Pre-proline 0 N--CA 1.456 -0.164 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.155 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.83 1.98 2.39 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.836 2.357 . . . . 0.0 113.16 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -84.08 -50.75 7.66 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.044 0.449 . . . . 0.0 111.089 175.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -130.14 159.55 36.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.368 0.604 . . . . 0.0 111.212 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 31' ' ' HIS . 45.4 tp -84.81 -45.63 12.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.857 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.462 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 33.6 p90 -143.37 164.18 30.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.863 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 37.2 t0 -160.01 176.23 12.08 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -94.34 157.51 16.0 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.9 m -106.03 167.64 9.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.712 0.291 . . . . 0.0 110.288 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -117.89 72.44 0.85 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.308 0.575 . . . . 0.0 110.037 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.935 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -106.6 129.48 24.38 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.953 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.93 157.3 16.96 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 124.327 3.351 . . . . 0.0 113.85 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.89 113.83 13.82 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.933 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.593 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.89 -44.4 40.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.589 178.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.615 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.372 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.477 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.56 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 15.9 ptt? -96.28 154.86 17.02 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.508 ' CD2' ' HB2' ' A' ' 81' ' ' ALA . 7.8 m-85 -113.67 96.45 5.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.27 -115.09 3.98 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -79.83 -22.21 43.26 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.282 0.636 . . . . 0.0 109.715 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.92 11.55 20.44 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.224 -0.988 . . . . 0.0 110.938 -174.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 7' ' ' LYS . 9.2 mtpm? -65.17 -31.75 73.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.055 0.455 . . . . 0.0 110.124 176.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -111.7 19.45 23.64 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 173.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.1 t80 -68.19 110.53 4.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -118.32 45.15 2.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 0.0 109.664 -177.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.531 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -98.88 -159.85 29.58 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.85 -175.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -139.59 15.12 2.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.495 0.188 . . . . 0.0 110.74 -170.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.638 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 19.8 mmt180 -64.66 135.78 56.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 2.8 m -134.61 36.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.553 0.692 . . . . 0.0 111.209 -171.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.764 HG23 ' HA2' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -151.35 139.97 20.68 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -178.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.629 HG21 ' HB3' ' A' ' 73' ' ' ASP . 75.3 p -75.15 -169.69 1.0 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.892 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -66.25 -21.11 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.312 0.577 . . . . 0.0 110.759 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.2 p -92.84 -13.33 29.22 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.191 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.764 ' HA2' HG23 ' A' ' 15' ' ' THR . . . 82.62 20.69 61.31 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.582 -173.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.5 m -76.48 119.31 76.82 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 168.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 86.0 Cg_exo -49.52 135.95 33.2 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.924 2.416 . . . . 0.0 113.225 176.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 72.9 m -76.45 142.94 40.84 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.734 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -70.96 165.53 23.2 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.297 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.9 128.81 35.24 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.679 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 57.8 m95 -57.82 -30.89 66.09 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.437 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . . . -78.07 -18.1 56.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.853 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.44 149.58 21.24 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 30.3 mm-40 -104.3 31.24 4.73 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.5 mt-10 -147.62 122.79 5.2 Favored Pre-proline 0 N--CA 1.422 -1.832 0 CA-C-N 113.795 -1.548 . . . . 0.0 114.397 -154.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 91.9 Cg_endo -86.85 29.82 9.03 Favored 'Cis proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.212 -1.578 . . . . 0.0 112.839 -0.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.689 ' HB3' HD12 ' A' ' 71' ' ' LEU . 55.0 m80 -130.58 107.49 9.24 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.641 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -74.48 125.33 28.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.47 ' C ' ' H ' ' A' ' 35' ' ' ILE . 3.9 p80 -155.21 98.13 1.97 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.99 0.9 . . . . 0.0 110.96 -177.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.0 m -79.61 33.78 0.26 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.666 0.746 . . . . 0.0 109.837 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.47 ' H ' ' C ' ' A' ' 33' ' ' HIS . 31.4 pt -142.15 146.16 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.623 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 41.7 m-85 50.06 51.04 17.44 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.931 0.872 . . . . 0.0 111.254 -175.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 29.3 p -99.44 177.65 1.5 Allowed Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.115 171.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 35.6 Cg_exo -60.53 -29.24 88.18 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 121.872 1.714 . . . . 0.0 111.378 170.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.04 -30.56 16.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.682 -167.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.0 p -89.06 -19.91 25.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.036 0.446 . . . . 0.0 110.23 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.623 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.5 m120 -133.97 67.25 73.74 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.719 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.27 9.94 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.039 1.826 . . . . 0.0 111.783 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -96.38 -24.05 16.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.724 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -106.58 1.18 25.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.861 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.11 44.68 90.74 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.225 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.724 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -73.12 99.98 2.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.69 0.281 . . . . 0.0 110.381 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.489 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.8 pt-20 -118.68 142.99 47.14 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 23.5 mmmt 53.39 -115.58 0.97 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.715 0.635 . . . . 0.0 111.576 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -135.34 17.76 3.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.211 0.529 . . . . 0.0 110.589 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.489 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 27.7 m-85 -68.61 129.71 40.72 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 71.6 m -54.71 153.4 6.0 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 123.219 0.324 . . . . 0.0 111.462 -173.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 35.5 mmt-85 -156.89 169.82 23.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.78 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -128.25 77.35 77.04 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.52 169.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HG3' HD21 ' A' ' 46' ' ' LEU . 36.2 Cg_endo -70.78 -13.64 32.25 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.256 1.971 . . . . 0.0 112.474 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.67 -25.95 17.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.036 0.922 . . . . 0.0 109.055 173.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.54 40.64 99.37 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.959 -169.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -48.54 133.88 16.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 172.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 t -72.63 6.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.611 0.72 . . . . 0.0 110.805 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.47 -22.45 14.43 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.07 -179.3 16.94 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 119.513 -1.327 . . . . 0.0 112.02 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.56 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 95.5 Cg_endo -75.6 157.64 40.18 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.386 2.057 . . . . 0.0 111.612 -174.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.513 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 15.7 p-90 -148.26 -169.7 3.41 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.958 -172.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.679 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 28.9 p -168.6 -177.5 3.14 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.458 176.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 67.7 m-85 -100.22 146.09 27.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 170.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 p -100.09 145.25 28.17 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.632 -170.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.9 p -78.49 17.8 0.63 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.034 0.445 . . . . 0.0 110.991 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 16.3 t30 -105.8 120.47 49.06 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 21.8 Cg_exo -65.91 4.96 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.353 2.702 . . . . 0.0 114.072 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.453 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 20.4 mmm180 -82.05 -43.16 18.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.615 0.245 . . . . 0.0 111.21 173.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -134.68 156.47 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.329 0.585 . . . . 0.0 111.068 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.689 HD12 ' HB3' ' A' ' 31' ' ' HIS . 41.5 tp -83.19 -45.09 14.3 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.905 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 29.0 p90 -143.74 164.87 29.25 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.995 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.629 ' HB3' HG21 ' A' ' 16' ' ' THR . 37.4 t0 -160.71 169.4 22.89 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 65.0 m-85 -92.85 155.84 17.36 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 80.9 m -104.46 168.32 9.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.148 0.499 . . . . 0.0 111.11 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -115.47 64.49 0.69 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.398 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.683 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.8 p -104.36 130.72 22.81 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.497 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 77' ' ' VAL . 25.2 Cg_endo -61.33 154.78 56.09 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 123.85 3.033 . . . . 0.0 113.625 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -75.66 109.43 9.23 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.286 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.423 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -72.82 -43.17 63.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.305 179.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.027 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.592 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.438 -1.041 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.516 ' HG2' ' HG3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -98.02 143.44 28.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -175.175 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.685 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 74.1 m-85 -102.32 104.07 14.56 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.7 -111.51 3.27 Favored Glycine 0 N--CA 1.424 -2.11 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.495 -174.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -89.14 -20.23 24.51 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 124.444 0.732 . . . . 0.0 110.521 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.03 15.87 13.68 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.79 -1.195 . . . . 0.0 111.886 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -63.94 -38.53 91.42 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.009 0.433 . . . . 0.0 110.271 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.31 24.64 22.15 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 173.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.8 t80 -71.24 103.45 2.82 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -110.72 46.43 1.06 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.171 0.51 . . . . 0.0 109.681 -176.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.17 -158.61 32.0 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.604 -0.725 . . . . 0.0 113.174 -173.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -140.68 14.6 2.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.73 0.3 . . . . 0.0 110.581 -170.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.917 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.9 mmt180 -67.16 135.72 53.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.16 38.84 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.752 0.787 . . . . 0.0 110.854 -170.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.98 148.52 28.48 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.273 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -75.2 -171.41 1.4 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.915 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.82 -18.32 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.398 0.618 . . . . 0.0 110.884 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.4 p -93.54 -12.63 29.14 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.792 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.44 12.75 69.3 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.373 -172.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.886 HG21 ' HB2' ' A' ' 67' ' ' ASN . 99.5 m -75.87 121.63 85.41 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 172.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -50.31 128.3 22.54 Favored 'Trans proline' 0 CA--C 1.514 -0.493 0 C-N-CA 122.641 2.227 . . . . 0.0 113.193 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.42 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 77.0 m -69.13 137.6 53.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.293 171.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -70.06 165.85 21.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.533 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 13.9 m-20 -76.63 125.93 30.09 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.708 ' CE3' HD23 ' A' ' 46' ' ' LEU . 43.3 m95 -53.77 -30.28 43.88 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.566 0.698 . . . . 0.0 109.182 176.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.4 -19.97 55.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.793 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.49 150.29 23.2 Favored 'General case' 0 C--O 1.21 -1.017 0 O-C-N 121.639 -0.663 . . . . 0.0 109.528 -170.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 33.2 mm-40 -104.56 23.95 12.48 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -140.54 131.0 13.66 Favored Pre-proline 0 N--CA 1.432 -1.363 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.389 -166.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -86.09 26.61 12.02 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.88 -1.717 . . . . 0.0 113.229 0.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.553 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 30.2 m80 -127.59 109.9 12.17 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.587 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 6.2 mmt180 -73.17 112.26 9.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.446 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.9 p80 -144.24 96.19 2.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.393 1.092 . . . . 0.0 110.51 -176.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.4 m -75.7 23.06 0.13 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.493 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 33' ' ' HIS . 34.1 pt -140.89 158.31 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.594 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 63.4 m-85 50.71 46.91 25.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.02 0.914 . . . . 0.0 110.727 -173.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.485 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 32.0 p -100.01 174.63 2.88 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 114.072 -1.422 . . . . 0.0 108.87 171.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 26.5 Cg_exo -64.12 -16.94 57.78 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 121.827 1.684 . . . . 0.0 111.851 171.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -90.87 -37.64 13.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.442 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.7 p -88.82 -19.94 25.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 -176.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.594 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.8 m120 -134.8 65.78 67.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.093 0.473 . . . . 0.0 111.33 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.51 8.64 1.79 Allowed 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.421 2.081 . . . . 0.0 112.056 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -102.51 -16.88 15.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.365 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.684 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -109.63 5.17 22.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.109 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 47' ' ' GLU . . . 62.04 45.87 95.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.448 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.719 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.7 mp -72.36 94.48 1.62 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.195 0.522 . . . . 0.0 110.439 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.747 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.3 pt-20 -108.39 134.53 51.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.089 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm 54.93 -112.15 0.69 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.568 0.543 . . . . 0.0 111.544 176.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -134.77 12.87 3.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.476 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.747 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 21.6 m-85 -64.07 128.71 37.0 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 80.4 m -51.16 155.31 1.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.398 0.436 . . . . 0.0 111.684 -175.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 29.3 mmt-85 -158.17 169.4 24.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.988 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -128.19 78.2 75.78 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.525 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.719 ' HG3' HD21 ' A' ' 46' ' ' LEU . 26.9 Cg_endo -69.61 -12.52 33.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.267 1.978 . . . . 0.0 112.248 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -95.71 -27.25 15.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.897 0.856 . . . . 0.0 109.375 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.37 37.28 93.82 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.398 -166.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 59' ' ' GLY . 9.3 t70 -45.16 131.57 7.63 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.219 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.47 34.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.833 0.825 . . . . 0.0 110.339 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -122.05 -19.7 3.22 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.53 179.96 15.92 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.922 -1.133 . . . . 0.0 111.432 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.516 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 94.6 Cg_endo -72.85 152.56 52.49 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.963 1.775 . . . . 0.0 111.399 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.476 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 23.9 p-90 -145.95 -171.49 3.72 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.898 -170.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.653 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.1 p -168.51 179.88 4.17 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.623 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.439 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 40.0 m-85 -100.77 139.68 36.11 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.6 p -98.33 148.74 23.35 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.574 -170.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -80.95 20.45 0.78 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.267 0.556 . . . . 0.0 110.377 169.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.886 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.9 t-20 -98.94 119.08 61.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.848 -177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 17.6 Cg_exo -66.32 -0.55 4.36 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.993 2.462 . . . . 0.0 113.546 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -84.7 -43.46 14.3 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.8 0.333 . . . . 0.0 111.434 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.39 149.54 49.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.326 0.584 . . . . 0.0 110.417 -176.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.553 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 46.6 tp -78.87 -43.09 25.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.382 -175.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -143.27 163.51 32.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.783 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -159.15 178.59 9.86 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -93.79 158.08 15.83 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.84 166.15 10.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.247 0.546 . . . . 0.0 111.231 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -109.38 60.19 0.6 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.289 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.917 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -104.66 128.62 26.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.397 174.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.02 161.81 24.78 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 124.055 3.17 . . . . 0.0 113.743 -176.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -75.73 110.53 10.22 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.454 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.592 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.04 -38.67 61.38 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.205 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.685 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.51 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.586 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.674 ' HG2' ' HG3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -97.95 142.39 29.75 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.561 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 66.0 m-85 -101.41 102.25 13.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -177.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.2 -114.44 3.89 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.618 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -84.87 -23.58 28.92 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.382 0.695 . . . . 0.0 110.267 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.99 15.33 11.96 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.449 -175.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -67.92 -36.01 79.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.204 0.526 . . . . 0.0 110.33 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -107.57 20.21 32.5 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.608 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.6 t80 -66.5 101.74 0.8 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.34 46.4 0.93 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.179 0.514 . . . . 0.0 110.551 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -101.77 -158.14 26.59 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.171 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -149.86 22.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.947 0.374 . . . . 0.0 110.76 -170.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.873 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 21.0 mmt180 -65.2 139.04 58.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.75 30.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.536 0.684 . . . . 0.0 111.654 -170.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.27 142.39 24.05 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.4 p -75.31 -176.87 3.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.871 0.367 . . . . 0.0 111.605 -174.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 m -63.8 -19.39 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.47 0.652 . . . . 0.0 110.851 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.5 p -93.42 -12.01 30.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.798 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.79 12.76 68.27 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.28 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.714 HG21 ' HB2' ' A' ' 67' ' ' ASN . 85.6 m -76.86 119.76 78.85 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 171.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -50.62 123.74 12.04 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.811 2.341 . . . . 0.0 112.993 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.33 139.23 58.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.412 0.625 . . . . 0.0 110.565 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -71.4 166.01 22.56 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.807 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.24 127.34 32.43 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.773 ' CE3' HD23 ' A' ' 46' ' ' LEU . 64.6 m95 -57.14 -30.04 64.1 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.533 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . . . -78.69 -18.28 54.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.52 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.89 150.2 20.7 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.688 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.2 mm-40 -104.17 32.54 3.94 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 34.7 mt-10 -145.87 122.09 5.84 Favored Pre-proline 0 N--CA 1.428 -1.564 0 CA-C-N 114.027 -1.442 . . . . 0.0 114.104 -157.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 2.4 Cg_endo -86.69 25.25 15.47 Favored 'Cis proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.597 -1.418 . . . . 0.0 112.79 1.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.42 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 43.1 m80 -128.14 108.72 10.87 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.688 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.1 ppt_? -73.95 120.57 19.72 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.543 -178.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.458 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.3 p80 -148.76 98.12 2.82 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.248 1.023 . . . . 0.0 109.739 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 m -77.79 28.51 0.17 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.595 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.458 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.1 pt -141.5 151.43 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -176.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.55 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 59.5 m-85 52.25 48.03 23.51 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 122.054 0.931 . . . . 0.0 111.146 -176.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 41.8 p -100.32 176.08 2.08 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.394 172.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 7.7 Cg_exo -70.71 -11.63 29.89 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.963 1.775 . . . . 0.0 111.087 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -92.87 -31.26 15.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.03 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.4 p -98.97 -19.8 17.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.092 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.2 m120 -135.58 57.91 22.1 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -174.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 13.6 Cg_exo -69.81 15.98 0.23 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.234 1.956 . . . . 0.0 112.545 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 41' ' ' ASN . 18.8 ptt180 -99.6 -17.83 17.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.789 0.328 . . . . 0.0 111.034 -177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.743 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -118.13 3.4 12.05 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.445 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.05 46.67 90.67 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.566 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.773 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.3 mp -77.38 67.57 3.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.509 0.195 . . . . 0.0 111.185 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.526 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 6.0 pt-20 -97.39 157.6 15.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.764 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 52.07 -125.55 2.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.351 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -129.16 23.21 5.63 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.055 0.455 . . . . 0.0 110.373 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.526 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 38.5 m-85 -65.64 123.14 18.92 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.955 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 71.4 m -50.25 151.29 2.14 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 123.378 0.424 . . . . 0.0 111.42 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 43.2 mmt-85 -157.58 170.99 21.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.228 -174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -131.36 76.81 75.14 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.347 169.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.77 ' HG3' HD21 ' A' ' 46' ' ' LEU . 33.8 Cg_endo -66.95 -15.9 48.24 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.563 2.176 . . . . 0.0 112.635 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -95.86 -26.04 15.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.938 0.875 . . . . 0.0 109.451 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.28 39.46 97.88 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.598 -166.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 59' ' ' GLY . 19.7 t70 -44.82 131.42 7.04 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 124.462 0.742 . . . . 0.0 110.153 173.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 t -76.04 35.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.785 0.803 . . . . 0.0 110.188 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -126.16 -18.34 2.33 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 173.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.76 -179.64 16.07 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.485 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.674 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 92.9 Cg_endo -73.71 150.99 45.82 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.143 1.895 . . . . 0.0 111.33 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 19.1 p-90 -144.66 -170.49 3.4 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.038 -169.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.727 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.1 p -168.86 -179.25 3.64 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -101.23 146.8 27.05 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.426 ' HB ' ' CG2' ' A' ' 20' ' ' THR . 1.2 p -102.91 146.17 28.72 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.879 -171.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.9 p -81.21 20.41 0.83 Allowed 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.826 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.714 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.8 t-20 -99.4 120.81 56.95 Favored Pre-proline 0 C--N 1.337 0.036 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.226 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 16.7 Cg_exo -67.04 4.88 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.022 2.481 . . . . 0.0 113.404 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -84.81 -58.26 2.78 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.744 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -119.53 159.29 24.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.797 -174.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 50.4 tp -87.85 -45.78 10.0 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.553 -177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -143.04 156.38 44.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.07 0.462 . . . . 0.0 109.831 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -154.37 173.36 16.32 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 59.0 m-85 -93.26 157.84 16.05 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.9 m -105.3 162.39 13.47 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.895 0.378 . . . . 0.0 110.447 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.48 32.15 1.85 Allowed 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.315 0.579 . . . . 0.0 111.14 -172.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.873 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.4 p -80.51 122.6 82.65 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.683 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.12 162.75 25.13 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 C-N-CA 124.219 3.279 . . . . 0.0 113.884 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.44 ' NE2' ' SD ' ' A' ' 2' ' ' MET . 8.8 tp-100 -72.59 110.36 6.9 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.677 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.561 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.3 -41.65 56.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.639 179.048 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.561 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 N--CA 1.465 0.275 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.3 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.492 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.44 -0.951 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.609 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 7.0 ptt? -97.03 154.28 17.41 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.616 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 83.0 m-85 -112.38 95.63 5.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.64 -110.8 3.11 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -79.17 -29.77 43.17 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 124.935 1.02 . . . . 0.0 111.005 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . 108.36 17.88 10.25 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 119.614 -1.279 . . . . 0.0 112.079 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -62.5 -43.62 98.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.358 0.599 . . . . 0.0 110.114 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -105.09 27.9 16.82 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.027 174.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.774 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.2 t80 -68.94 105.47 2.4 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 170.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -109.18 42.54 1.42 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.085 0.469 . . . . 0.0 110.109 -175.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.588 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -93.49 -152.73 29.58 Favored Glycine 0 C--N 1.329 0.17 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.992 -175.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -148.08 16.54 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.763 0.282 . . . . 0.0 110.756 -172.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.774 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.1 mmt180 -66.38 138.17 57.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.6 32.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.636 0.732 . . . . 0.0 110.776 -170.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.688 HG22 ' HA2' ' A' ' 19' ' ' GLY . 3.6 m -151.89 136.17 16.72 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -173.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.5 HG21 ' HB3' ' A' ' 73' ' ' ASP . 74.5 p -73.35 -172.51 1.16 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -171.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.7 m -69.27 -18.57 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.546 0.689 . . . . 0.0 110.447 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p -92.13 -14.38 29.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.048 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.688 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 84.96 15.19 67.9 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.243 -174.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.77 HG21 ' HB2' ' A' ' 67' ' ' ASN . 98.3 m -78.36 121.02 83.24 Favored Pre-proline 0 N--CA 1.442 -0.83 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 169.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -49.63 130.56 26.48 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.764 2.309 . . . . 0.0 113.362 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m -67.53 140.56 57.0 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.972 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -73.82 165.92 24.26 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.324 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.454 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 2.1 m-20 -76.25 125.94 30.08 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 175.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.645 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 41.0 m95 -54.77 -29.29 53.69 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 173.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.92 -22.1 53.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.1 176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.454 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -99.96 150.11 22.75 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 119.039 0.836 . . . . 0.0 108.748 -172.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.637 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.2 mm-40 -103.19 32.28 3.84 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 36.0 mt-10 -145.68 122.42 6.01 Favored Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -158.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 91.9 Cg_endo -88.37 31.82 8.42 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.29 -1.546 . . . . 0.0 113.375 0.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.536 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 58.7 m80 -130.75 113.58 14.31 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.637 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 25.9 mmm180 -74.06 113.56 11.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.89 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.8 p80 -147.85 94.37 2.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.139 0.971 . . . . 0.0 111.16 -177.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m -79.8 35.81 0.31 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.498 0.665 . . . . 0.0 110.113 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.445 ' H ' ' C ' ' A' ' 33' ' ' HIS . 23.4 pt -142.06 146.18 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.583 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 50.2 m-85 51.17 46.71 26.06 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.222 1.011 . . . . 0.0 110.969 -173.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 35.7 p -99.66 174.26 3.16 Favored Pre-proline 0 N--CA 1.444 -0.743 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.255 171.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 32.0 Cg_exo -59.35 -23.16 68.89 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.922 1.748 . . . . 0.0 112.185 170.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.49 -34.95 13.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.79 0.329 . . . . 0.0 111.296 -173.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.6 p -85.73 -18.67 32.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.997 0.427 . . . . 0.0 110.503 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.583 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.4 m120 -138.21 59.67 19.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.509 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.17 19.97 0.49 Allowed 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.613 2.208 . . . . 0.0 112.809 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -122.45 -8.69 8.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.491 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -106.51 7.93 31.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.386 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.99 40.85 97.43 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.384 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.2 mp -77.08 95.83 4.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.998 0.428 . . . . 0.0 110.828 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.472 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.2 pt-20 -118.23 152.16 36.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.504 175.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 34.2 mmtp 50.95 -115.26 0.85 Allowed 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.828 0.705 . . . . 0.0 111.183 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -139.47 19.68 2.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.001 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.472 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 32.8 m-85 -66.5 129.62 40.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.571 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.656 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 74.0 m -56.03 148.94 16.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.086 0.469 . . . . 0.0 111.824 -173.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.651 ' HD2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -155.17 158.2 38.58 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.632 -175.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -123.26 80.71 52.49 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.427 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HD2' ' CZ2' ' A' ' 62' ' ' TRP . 3.4 Cg_exo -72.25 -13.04 28.14 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.287 1.992 . . . . 0.0 111.579 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -89.04 -32.28 17.65 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.63 38.76 96.39 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 113.521 -1.672 . . . . 0.0 109.856 -166.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -48.13 133.38 15.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.725 -0.738 . . . . 0.0 109.491 172.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 t -70.14 -0.27 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.489 0.661 . . . . 0.0 110.591 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.88 -17.18 42.03 Favored Glycine 0 N--CA 1.437 -1.274 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.21 -178.8 16.3 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 119.766 -1.207 . . . . 0.0 111.619 176.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.609 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 74.1 Cg_endo -72.5 158.39 51.16 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.251 1.968 . . . . 0.0 111.167 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.593 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 25.8 p-90 -148.3 -171.02 3.74 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.844 -171.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.645 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 28.9 p -168.37 -177.24 3.14 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.559 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.5 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 61.9 m-85 -100.47 150.03 23.07 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 170.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 67' ' ' ASN . 2.5 p -104.69 150.27 24.87 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.248 -173.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 44.6 p -82.18 27.61 0.48 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.385 0.612 . . . . 0.0 110.102 168.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.77 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.9 t-20 -111.48 114.49 52.74 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.891 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 17.2 Cg_exo -67.28 2.74 2.06 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 123.099 2.533 . . . . 0.0 113.976 -177.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -84.32 -33.85 23.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.874 0.368 . . . . 0.0 111.354 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -143.89 143.09 31.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.257 0.551 . . . . 0.0 110.32 -177.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 52.3 tp -73.98 -42.62 60.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.765 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 5.3 p90 -142.65 159.5 42.12 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.5 ' HB3' HG21 ' A' ' 16' ' ' THR . 25.7 t0 -154.29 171.52 19.11 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -93.1 155.6 17.39 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.5 m -105.04 168.61 8.94 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.167 0.508 . . . . 0.0 110.583 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -117.43 70.28 0.78 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.019 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.774 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -106.5 129.52 24.34 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.521 174.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 11.2 Cg_endo -54.82 151.81 31.15 Favored 'Trans proline' 0 CA--C 1.509 -0.738 0 C-N-CA 124.146 3.231 . . . . 0.0 113.766 -178.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.46 110.75 10.1 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.492 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.19 -42.2 60.21 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.195 178.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.616 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.715 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.531 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.912 0.387 . . . . 0.0 110.626 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.668 ' HG2' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.61 149.57 23.14 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -177.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.768 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 49.3 m-85 -106.4 107.78 18.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.21 -111.92 3.35 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.908 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -94.1 -9.36 36.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.774 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.778 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 101.97 18.38 17.85 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.675 -175.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 52.4 mtpt -70.4 -45.09 66.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.814 -0.693 . . . . 0.0 110.335 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.64 24.54 29.49 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.778 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 3.8 t80 -65.95 98.18 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.871 0.469 . . . . 0.0 110.205 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HE ' ' C ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -103.11 46.6 0.91 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.074 0.464 . . . . 0.0 110.063 179.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.626 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.48 -156.21 30.97 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.674 -176.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.479 ' NZ ' ' HB3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -150.15 23.56 0.84 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.867 0.365 . . . . 0.0 110.82 -171.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.799 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 21.7 mmt180 -71.92 139.87 48.94 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 171.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 50' ' ' TYR . 5.2 m -140.86 31.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.514 0.673 . . . . 0.0 110.895 -170.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.869 HG22 ' HA2' ' A' ' 19' ' ' GLY . 87.2 m -152.32 130.6 12.02 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -173.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.429 HG21 ' HB3' ' A' ' 73' ' ' ASP . 71.9 p -69.85 -172.83 0.56 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -170.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 m -67.07 -20.01 26.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.869 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -92.19 -13.29 30.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.765 0.793 . . . . 0.0 108.964 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.869 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 82.91 17.65 67.12 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.367 -174.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.9 HG21 ' HB2' ' A' ' 67' ' ' ASN . 96.4 m -77.48 124.32 86.77 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 167.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.43 133.4 48.56 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.343 2.029 . . . . 0.0 113.217 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.9 m -71.8 140.41 49.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.72 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -73.11 167.19 21.66 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.234 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.498 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 4.8 m-20 -76.28 125.86 29.93 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.686 ' CE3' HD23 ' A' ' 46' ' ' LEU . 54.2 m95 -52.92 -32.94 48.2 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.69 0.757 . . . . 0.0 109.006 174.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.6 -16.63 58.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.727 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.44 150.27 23.21 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 118.668 0.667 . . . . 0.0 109.401 -172.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 33.4 mm-40 -107.74 21.14 17.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -146.6 137.11 12.35 Favored Pre-proline 0 N--CA 1.428 -1.54 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.375 -167.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.35 18.86 11.94 Favored 'Cis proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.367 -1.514 . . . . 0.0 112.993 1.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.583 ' HB3' HD12 ' A' ' 71' ' ' LEU . 62.2 m80 -128.98 106.9 9.2 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.53 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -72.61 126.1 29.06 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.48 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.9 p80 -154.94 94.26 1.63 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.132 0.968 . . . . 0.0 110.835 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -79.08 35.89 0.27 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.616 175.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 33' ' ' HIS . 31.3 pt -143.12 143.86 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 32.1 m-85 55.39 47.75 20.55 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 122.16 0.981 . . . . 0.0 110.919 -175.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 10.9 p -102.66 174.98 2.48 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.467 168.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 27.7 Cg_exo -62.45 -25.58 76.09 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.662 1.574 . . . . 0.0 111.775 172.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -88.17 -32.61 18.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.744 -174.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 p -90.72 -18.97 24.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.284 -177.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.8 m120 -133.63 61.58 54.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.733 0.301 . . . . 0.0 110.933 177.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.2 42.26 1.09 Allowed 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.843 2.362 . . . . 0.0 112.829 -176.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.62 -14.02 1.1 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.664 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -103.5 8.22 37.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.443 0.64 . . . . 0.0 110.69 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . 58.17 49.07 79.05 Favored Glycine 0 C--O 1.221 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.575 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -76.54 93.25 3.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.218 0.533 . . . . 0.0 110.661 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.641 ' HB2' ' HD2' ' A' ' 50' ' ' TYR . 1.5 mt-10 -101.28 136.21 41.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.548 -177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 90.1 mttt 48.4 -104.4 0.12 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.73 0.644 . . . . 0.0 112.118 174.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -138.16 15.15 2.82 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.223 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.641 ' HD2' ' HB2' ' A' ' 47' ' ' GLU . 32.2 m-85 -65.89 125.81 26.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.582 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 78.9 m -49.44 151.98 1.42 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.546 0.529 . . . . 0.0 111.901 -175.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 41.6 mmt-85 -154.41 168.63 26.02 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.475 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -130.36 80.11 71.13 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 169.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.709 ' HG3' HD21 ' A' ' 46' ' ' LEU . 25.2 Cg_exo -60.27 -28.06 86.12 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.837 2.358 . . . . 0.0 111.966 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -93.67 -23.22 18.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.605 0.717 . . . . 0.0 110.424 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.41 ' HA3' ' HG2' ' A' ' 7' ' ' LYS . . . 61.5 38.75 96.32 Favored Glycine 0 CA--C 1.497 -1.034 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.988 -172.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -61.27 141.88 57.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.126 -0.537 . . . . 0.0 110.153 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 t -75.85 49.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.604 0.716 . . . . 0.0 110.928 -175.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -129.53 -16.56 1.84 Allowed Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.77 175.73 18.18 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.48 152.06 59.8 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.754 1.636 . . . . 0.0 111.497 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.624 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 31.4 p-90 -139.63 -173.68 3.69 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.327 -172.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.639 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.4 p -168.3 -179.75 4.13 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.269 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -101.23 145.29 29.02 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 p -101.34 151.23 22.15 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.788 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.7 p -85.82 20.13 2.29 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.332 168.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.9 ' HB2' HG21 ' A' ' 20' ' ' THR . 56.7 t-20 -95.4 116.17 66.08 Favored Pre-proline 0 CA--C 1.518 -0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.409 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.12 -0.2 2.05 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.83 2.354 . . . . 0.0 113.59 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -84.2 -55.46 4.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.799 0.333 . . . . 0.0 111.212 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -117.13 155.03 30.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.403 0.621 . . . . 0.0 110.666 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' A' ' 31' ' ' HIS . 49.1 tp -85.35 -43.63 13.52 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.499 -176.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -143.38 162.53 35.49 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB3' HG21 ' A' ' 16' ' ' THR . 42.2 t0 -156.96 175.47 14.05 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.87 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -94.41 156.23 16.58 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 90.5 m -105.19 168.37 9.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.945 0.402 . . . . 0.0 110.722 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.84 65.82 0.77 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.915 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.799 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.7 p -105.56 126.58 30.47 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.188 176.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.97 157.59 19.9 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 123.915 3.076 . . . . 0.0 113.906 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.07 113.81 12.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.222 -1.353 . . . . 0.0 110.307 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.531 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.62 -42.43 51.72 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.329 178.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.768 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.2 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.588 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.443 -0.822 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.539 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 11.9 ptt? -96.97 152.44 18.71 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.62 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 82.0 m-85 -109.65 94.64 5.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.18 -114.08 3.77 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -173.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -79.7 -26.36 40.93 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.84 0.965 . . . . 0.0 110.248 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.611 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.4 13.96 19.47 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.401 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.731 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 97.4 mttt -65.4 -40.71 93.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.163 0.506 . . . . 0.0 110.065 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -107.37 25.75 20.66 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 172.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.654 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.7 t80 -66.56 108.83 2.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.71 40.42 2.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.154 0.502 . . . . 0.0 110.097 -175.526 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.556 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -93.98 -162.21 35.59 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.797 -176.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -139.8 18.69 2.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.915 0.388 . . . . 0.0 110.189 -169.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.788 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 18.7 mmt180 -66.88 135.82 54.44 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 m -137.9 34.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 121.75 0.786 . . . . 0.0 110.027 -171.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.915 HG22 ' HA2' ' A' ' 19' ' ' GLY . 86.4 m -153.05 125.65 8.24 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -169.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.623 HG21 ' HB3' ' A' ' 73' ' ' ASP . 81.9 p -69.97 -171.54 0.44 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -170.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.5 -23.11 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 121.505 0.669 . . . . 0.0 111.015 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.9 p -91.89 -15.7 27.73 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.796 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.915 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.48 20.02 55.41 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.955 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.715 HG21 ' HB2' ' A' ' 67' ' ' ASN . 52.6 m -76.41 122.78 87.32 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 167.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.36 129.74 26.92 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.717 2.278 . . . . 0.0 113.536 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.8 m -68.68 144.26 54.5 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.46 0.647 . . . . 0.0 111.504 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -76.93 167.51 21.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.45 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.1 129.02 35.47 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.704 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 65.7 m95 -56.49 -32.37 64.96 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.54 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.98 -16.65 56.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.831 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.17 148.06 22.55 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.8 mm-40 -102.64 29.35 5.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 44.8 mt-10 -148.26 124.33 5.3 Favored Pre-proline 0 N--CA 1.421 -1.883 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.656 -156.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -85.07 25.74 11.61 Favored 'Cis proline' 0 C--N 1.344 0.33 0 C-N-CA 123.944 -1.273 . . . . 0.0 112.942 1.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.707 ' HB3' HD12 ' A' ' 71' ' ' LEU . 54.8 m80 -133.34 108.73 8.89 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.555 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -75.17 129.63 37.84 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.234 -175.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.439 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.2 p80 -155.34 101.97 2.24 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.982 0.896 . . . . 0.0 110.154 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 t -80.71 29.67 0.31 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.841 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.439 ' H ' ' C ' ' A' ' 33' ' ' HIS . 22.0 pt -142.23 144.56 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -175.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.539 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 38.0 m-85 54.69 48.68 19.73 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 122.112 0.958 . . . . 0.0 110.639 -175.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 7.5 p -101.77 173.97 3.22 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.342 168.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 38.0 Cg_exo -58.89 -28.5 87.55 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 121.728 1.618 . . . . 0.0 112.228 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -89.85 -33.9 16.31 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.143 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.9 p -85.42 -19.13 31.79 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.723 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.539 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.9 m120 -135.43 64.71 60.14 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.376 177.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.27 20.8 0.56 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.333 2.022 . . . . 0.0 111.915 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 43' ' ' ARG . 14.6 ptt180 -114.32 -17.41 11.82 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.675 -177.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -108.1 6.1 26.6 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.135 0.493 . . . . 0.0 110.539 -176.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.93 46.21 94.05 Favored Glycine 0 C--O 1.228 -0.268 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.793 172.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -73.92 104.77 4.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.148 0.499 . . . . 0.0 110.662 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.847 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.6 pt-20 -118.11 137.14 53.14 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.879 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.474 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 61.9 mmtt 45.98 -110.79 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.738 0.649 . . . . 0.0 112.569 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -135.45 17.63 3.37 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.17 0.509 . . . . 0.0 110.124 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.847 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 16.3 m-85 -70.47 131.36 43.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.573 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 86.2 m -53.51 145.54 14.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 123.383 0.427 . . . . 0.0 111.231 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 34.9 mmt-85 -150.18 161.05 43.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.174 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -122.55 79.76 47.03 Favored Pre-proline 0 C--N 1.319 -0.733 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.781 173.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.608 ' HG3' HD21 ' A' ' 46' ' ' LEU . 18.4 Cg_exo -64.35 -25.81 63.79 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.618 2.212 . . . . 0.0 112.33 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.97 -17.17 26.79 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.533 0.682 . . . . 0.0 109.748 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.731 ' HA3' ' HE2' ' A' ' 7' ' ' LYS . . . 55.66 40.57 79.66 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.397 -171.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -47.88 138.32 8.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 124.4 0.706 . . . . 0.0 109.815 174.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 t -74.77 8.08 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.535 0.683 . . . . 0.0 110.407 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.14 -16.73 22.43 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.03 179.69 16.16 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.627 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.539 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 58.2 Cg_endo -71.33 161.09 46.83 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.442 2.095 . . . . 0.0 112.02 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.554 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.0 p-90 -150.7 -170.3 3.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.548 -171.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.704 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.4 p -169.19 -178.26 3.15 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.919 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 58.2 m-85 -101.78 147.22 26.74 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 170.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.461 ' HB ' ' CG2' ' A' ' 20' ' ' THR . 0.9 OUTLIER -105.0 147.29 27.96 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.062 -170.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.6 p -80.41 13.92 2.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.1 0.476 . . . . 0.0 110.811 172.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.715 ' HB2' HG21 ' A' ' 20' ' ' THR . 55.9 t-20 -93.68 123.31 60.28 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.417 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.63 2.83 1.74 Allowed 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.633 2.222 . . . . 0.0 113.261 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -84.24 -46.37 11.91 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.469 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 4.5 ptmt -134.92 154.92 51.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.531 0.681 . . . . 0.0 111.184 -174.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 31' ' ' HIS . 43.2 tp -83.61 -38.37 21.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.808 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 16.7 p90 -142.54 161.73 37.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.768 -175.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.623 ' HB3' HG21 ' A' ' 16' ' ' THR . 34.5 t0 -165.26 166.54 18.73 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -94.39 158.72 15.44 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.69 169.27 8.57 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -123.25 67.79 0.99 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.381 0.61 . . . . 0.0 110.128 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.788 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.4 p -99.5 130.38 26.98 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.451 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.36 159.09 24.23 Favored 'Trans proline' 0 CA--C 1.512 -0.582 0 C-N-CA 124.061 3.174 . . . . 0.0 113.539 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.09 112.1 12.18 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.696 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.505 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -75.64 -39.36 57.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.599 179.236 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.107 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.632 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.8 ptt? -97.0 152.96 18.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.397 0.618 . . . . 0.0 112.548 -177.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 81' ' ' ALA . 71.4 m-85 -109.57 99.23 8.46 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.24 -109.04 2.68 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.472 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -78.1 -30.48 49.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 125.005 1.062 . . . . 0.0 110.596 -175.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 111.89 22.28 6.03 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.915 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -71.5 -41.0 69.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.782 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.41 ' O ' ' HD2' ' A' ' 10' ' ' ARG . . . -99.67 17.34 57.66 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.506 171.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.739 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.2 t80 -62.43 104.06 0.47 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 173.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -106.83 36.27 2.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 -177.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.612 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -94.25 -161.76 35.12 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.483 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.16 17.93 2.26 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.587 0.232 . . . . 0.0 110.91 -169.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.713 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.7 mmt180 -65.89 138.24 57.73 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.87 40.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.746 0.784 . . . . 0.0 111.018 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.23 148.9 28.78 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.831 -177.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.427 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 44.3 p -75.57 -173.84 2.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.611 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.29 -18.15 22.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.452 0.644 . . . . 0.0 111.137 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.1 p -93.06 -14.66 27.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.569 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.75 11.04 62.45 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.403 -0.904 . . . . 0.0 111.482 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.927 HG21 ' HB2' ' A' ' 67' ' ' ASN . 98.5 m -76.55 121.58 85.11 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.882 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.28 124.62 9.38 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.198 2.599 . . . . 0.0 113.576 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.94 141.15 58.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.904 171.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -72.43 166.89 21.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.387 174.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 7.6 t0 -76.48 129.13 36.06 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.746 ' CE3' HD23 ' A' ' 46' ' ' LEU . 64.9 m95 -57.32 -31.54 65.79 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.321 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.13 -16.16 57.09 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.116 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 24' ' ' ASP . . . -94.35 147.33 23.32 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.666 -172.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 32.4 mm-40 -106.66 16.58 24.34 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.493 ' HG2' HH11 ' A' ' 32' ' ' ARG . 35.2 mt-10 -147.65 143.38 17.82 Favored Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.526 -172.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.49 25.16 6.67 Favored 'Cis proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.928 -1.697 . . . . 0.0 113.256 1.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.602 ' HB3' HD12 ' A' ' 71' ' ' LEU . 65.1 m80 -135.33 108.55 7.75 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -75.5 117.87 17.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.891 -174.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.428 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 3.9 p80 -147.04 99.25 3.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.175 0.988 . . . . 0.0 111.087 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 m -77.71 27.75 0.17 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.804 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.3 pt -140.88 149.76 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.472 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 48.9 m-85 50.97 47.36 24.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 122.069 0.937 . . . . 0.0 110.765 -175.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 58.6 p -100.61 175.81 2.2 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.04 172.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 11.7 Cg_exo -71.14 -9.33 25.33 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 121.951 1.767 . . . . 0.0 111.253 169.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -91.31 -33.67 15.23 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.786 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.9 p -95.92 -26.69 15.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.185 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.515 ' O ' HD13 ' A' ' 46' ' ' LEU . 14.0 m120 -133.28 60.56 49.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.523 -174.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -77.82 23.45 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.881 1.721 . . . . 0.0 112.272 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -111.35 -22.19 11.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.514 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.674 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -103.17 9.42 38.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.093 0.473 . . . . 0.0 110.911 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.41 46.93 91.5 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.351 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.746 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.4 mp -76.96 74.39 3.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.596 0.712 . . . . 0.0 110.13 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.699 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.0 pt-20 -97.27 136.45 37.75 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.714 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 25.9 mmmt 51.49 -111.29 0.55 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.814 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -137.6 18.22 2.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.257 0.551 . . . . 0.0 110.317 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.699 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 30.8 m-85 -67.61 130.16 42.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.499 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 89.6 m -54.52 149.54 10.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.298 0.374 . . . . 0.0 111.158 -174.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 39.8 mmt-85 -153.03 170.29 20.81 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.624 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -131.14 77.5 74.63 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.519 170.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.699 ' HG3' HD21 ' A' ' 46' ' ' LEU . 29.7 Cg_endo -68.42 -13.26 37.12 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.285 1.99 . . . . 0.0 112.471 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -96.75 -26.14 15.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.922 0.868 . . . . 0.0 109.507 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.09 39.15 97.66 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.558 -167.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -44.34 132.36 5.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.044 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 t -69.74 -0.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.508 0.671 . . . . 0.0 110.763 -176.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.4 -18.64 35.24 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.5 -179.23 16.29 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.698 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.632 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 88.8 Cg_endo -77.14 158.0 33.83 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.224 1.949 . . . . 0.0 111.231 -175.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.488 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 22.1 p-90 -150.08 -170.77 3.73 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.065 -169.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.697 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.2 p -168.81 -178.49 3.39 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.646 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 57.3 m-85 -100.93 147.64 25.91 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 170.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.9 p -103.55 149.2 25.1 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.437 -171.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 p -83.35 28.34 0.54 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.508 0.67 . . . . 0.0 109.963 168.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.927 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.0 t-20 -108.16 121.14 44.64 Favored Pre-proline 0 N--CA 1.456 -0.149 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.238 -175.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 18.7 Cg_exo -66.44 -1.03 4.96 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.749 2.299 . . . . 0.0 113.498 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -84.69 -33.11 23.24 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.67 147.69 29.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.108 0.48 . . . . 0.0 110.769 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.602 HD12 ' HB3' ' A' ' 31' ' ' HIS . 37.8 tp -72.4 -45.56 59.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.549 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 21.5 p90 -143.54 162.8 34.92 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.67 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.427 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 14.0 t0 -158.83 172.05 18.94 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 55.6 m-85 -94.62 157.01 16.16 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.6 m -104.76 172.82 6.59 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.289 0.368 . . . . 0.0 110.454 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -122.8 69.0 0.98 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.187 0.518 . . . . 0.0 110.305 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.739 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.3 p -102.05 132.39 21.62 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.665 176.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.42 ' HD2' HG23 ' A' ' 77' ' ' VAL . 11.0 Cg_endo -55.66 150.71 42.71 Favored 'Trans proline' 0 CA--C 1.512 -0.608 0 C-N-CA 124.25 3.3 . . . . 0.0 113.826 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -76.77 109.76 10.82 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.789 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.13 -38.26 57.01 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.694 178.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.971 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.599 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.663 0 CA-C-O 120.922 0.391 . . . . 0.0 110.558 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.766 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 12.3 ptt? -96.78 159.33 14.98 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.629 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 85.5 m-85 -114.23 100.63 8.5 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.475 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.36 -115.33 4.0 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.019 -175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -82.41 -19.84 38.27 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 124.411 0.712 . . . . 0.0 110.486 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.651 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.09 17.06 13.4 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.999 -174.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -66.91 -50.97 60.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -97.88 28.49 14.25 Favored Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 172.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.666 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.6 t80 -69.51 102.57 1.84 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 173.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -106.45 40.59 1.59 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.337 0.589 . . . . 0.0 109.772 -176.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.641 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -90.41 -154.45 30.05 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.941 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -151.24 23.59 0.73 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.858 0.361 . . . . 0.0 110.556 -172.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.974 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 20.2 mmt180 -68.9 135.99 51.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.9 m -136.96 36.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 122.037 0.923 . . . . 0.0 109.573 -174.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 1.048 HG23 ' HA2' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -151.65 133.41 14.88 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.235 -172.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 56.5 p -73.76 -170.6 0.9 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.091 -176.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 m -63.94 -21.66 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.302 0.573 . . . . 0.0 110.712 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.3 p -92.89 -10.79 35.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.115 0.96 . . . . 0.0 109.08 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 1.048 ' HA2' HG23 ' A' ' 15' ' ' THR . . . 82.98 11.92 80.53 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.23 -173.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.409 HG21 ' HB2' ' A' ' 67' ' ' ASN . 80.8 m -71.28 121.2 83.59 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 82.6 Cg_exo -51.03 134.76 43.53 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 C-N-CA 122.713 2.276 . . . . 0.0 113.353 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 86.1 m -75.53 141.76 42.93 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.541 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -72.94 165.95 23.97 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.231 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 12.4 m-20 -76.52 126.2 30.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 175.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.717 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 48.7 m95 -54.65 -29.4 52.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 175.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.63 -22.4 54.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.972 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.403 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -97.67 150.45 21.16 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -172.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.619 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.5 mm-40 -104.76 31.45 4.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 26.7 mt-10 -147.2 123.31 5.49 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 113.705 -1.589 . . . . 0.0 114.163 -156.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 86.1 Cg_endo -86.44 27.03 11.9 Favored 'Cis proline' 0 C--N 1.346 0.438 0 C-N-CA 123.445 -1.481 . . . . 0.0 112.97 0.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.514 ' HB3' HD12 ' A' ' 71' ' ' LEU . 56.8 m80 -129.0 108.43 10.4 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.619 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.7 tmm_? -79.23 122.46 26.34 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -173.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.46 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.3 p80 -150.24 97.16 2.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.92 0.867 . . . . 0.0 110.821 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.27 35.46 0.22 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.56 0.695 . . . . 0.0 110.107 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.46 ' H ' ' C ' ' A' ' 33' ' ' HIS . 23.0 pt -143.11 142.5 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -175.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.599 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 42.9 m-85 50.56 51.02 17.72 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 122.124 0.964 . . . . 0.0 111.591 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 26.5 p -99.58 175.94 2.18 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.025 169.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 25.5 Cg_exo -64.59 -21.21 65.79 Favored 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 121.91 1.74 . . . . 0.0 111.877 172.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -100.33 -23.63 14.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.395 -171.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 35.4 p -90.32 -19.18 24.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.262 0.553 . . . . 0.0 109.646 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.2 m120 -136.16 62.76 46.9 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.888 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.66 9.08 1.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.168 1.912 . . . . 0.0 111.955 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -111.18 -12.33 14.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.476 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.76 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -104.49 8.2 35.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.135 0.493 . . . . 0.0 110.149 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.35 44.67 97.76 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 114.825 -1.079 . . . . 0.0 113.419 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.76 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.3 mp -80.17 96.47 6.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.224 0.535 . . . . 0.0 110.834 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.642 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.3 pt-20 -111.59 135.12 52.61 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.658 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.473 ' HD3' ' HA ' ' A' ' 48' ' ' LYS . 23.9 mmtp 56.06 -118.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.663 0.602 . . . . 0.0 111.998 175.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -130.82 14.01 5.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.922 0.392 . . . . 0.0 110.804 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.642 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 20.7 m-85 -66.06 133.13 50.11 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.623 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 73.8 m -54.93 149.78 11.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.848 0.356 . . . . 0.0 111.833 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.452 ' CG ' HH11 ' A' ' 52' ' ' ARG . 0.1 OUTLIER -153.48 162.53 41.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.714 -175.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -125.69 80.99 65.83 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.268 171.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.735 ' HG3' HD21 ' A' ' 46' ' ' LEU . 15.1 Cg_exo -64.53 -21.09 66.15 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.676 2.25 . . . . 0.0 112.029 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -89.63 -30.74 17.92 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.979 0.895 . . . . 0.0 109.304 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.66 39.53 95.42 Favored Glycine 0 N--CA 1.433 -1.51 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.054 -166.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -43.79 131.59 5.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 124.452 0.737 . . . . 0.0 109.587 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 t -70.82 3.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.274 0.559 . . . . 0.0 111.07 -174.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.27 -22.13 13.65 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.06 -175.59 19.1 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.761 -1.209 . . . . 0.0 111.78 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.766 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 97.8 Cg_endo -76.82 159.95 34.43 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.515 2.144 . . . . 0.0 111.708 -174.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.573 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.0 p-90 -148.88 -172.85 4.21 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.879 -172.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.717 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.8 p -168.73 -178.87 3.56 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.305 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -100.84 140.83 34.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.3 p -99.84 148.64 24.22 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.36 -171.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.2 p -76.99 15.0 0.74 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.982 0.42 . . . . 0.0 110.968 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' A' ' 69' ' ' ARG . 24.0 t30 -100.84 119.69 57.64 Favored Pre-proline 0 C--O 1.233 0.2 0 C-N-CA 123.168 0.587 . . . . 0.0 111.057 -177.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.4 Cg_exo -69.47 6.7 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.307 2.671 . . . . 0.0 113.503 -178.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 21.3 mmm180 -82.26 -49.35 10.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.025 0.441 . . . . 0.0 110.704 173.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HE2' HD22 ' A' ' 67' ' ' ASN . 0.0 OUTLIER -139.14 134.96 33.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.596 0.713 . . . . 0.0 111.186 -176.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 31' ' ' HIS . 40.3 tp -64.78 -39.92 94.39 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.541 -172.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -143.19 164.82 29.12 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.483 ' HB3' HG21 ' A' ' 16' ' ' THR . 44.5 t0 -162.0 172.28 16.22 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -92.81 156.21 17.14 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 96.2 m -104.66 170.01 8.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.236 0.541 . . . . 0.0 111.325 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.85 67.26 0.66 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.136 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.974 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 5.0 p -111.66 129.51 24.08 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.324 0.583 . . . . 0.0 110.994 174.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.43 161.76 33.46 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 123.941 3.094 . . . . 0.0 113.708 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.79 114.47 14.43 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.088 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.599 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.77 -41.23 60.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.333 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.629 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.688 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.514 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.445 -0.678 0 CA-C-O 120.927 0.394 . . . . 0.0 110.7 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.741 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 9.4 ptt? -97.5 154.59 17.4 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.548 0.69 . . . . 0.0 112.65 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.698 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 53.9 m-85 -110.29 105.8 14.96 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.29 -114.58 3.91 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.162 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -88.21 -16.07 34.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.98 -0.61 . . . . 0.0 109.832 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.744 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.56 11.22 25.58 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.937 -173.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -63.16 -40.5 97.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.514 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.16 22.33 27.45 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.201 173.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.744 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 4.2 t80 -66.46 109.98 2.95 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 172.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -119.01 39.21 3.6 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.472 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -91.33 -152.57 28.41 Favored Glycine 0 C--O 1.235 0.19 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.538 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.07 23.71 0.94 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.916 0.388 . . . . 0.0 110.899 -170.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.723 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.8 mmt180 -69.78 137.55 51.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -138.26 34.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.64 0.733 . . . . 0.0 111.063 -170.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.599 HG22 ' HA2' ' A' ' 19' ' ' GLY . 2.1 m -151.46 138.29 18.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.407 HG21 HG22 ' A' ' 65' ' ' THR . 68.3 p -74.88 -174.67 2.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.903 -173.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.06 -17.98 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.417 0.627 . . . . 0.0 110.728 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p -92.75 -14.58 27.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.187 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.599 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.6 15.8 63.06 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.5 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.884 HG21 ' HB2' ' A' ' 67' ' ' ASN . 89.7 m -77.11 122.5 86.39 Favored Pre-proline 0 N--CA 1.448 -0.555 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 168.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -51.72 125.05 15.83 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.309 2.006 . . . . 0.0 112.7 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.404 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 85.4 m -63.29 141.83 58.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.348 0.594 . . . . 0.0 110.652 173.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 25.2 tt0 -74.86 165.34 25.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.476 176.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 4.1 m-20 -76.07 124.57 27.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.673 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 40.7 m95 -54.87 -29.98 56.84 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.07 -17.8 58.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.198 -1.364 . . . . 0.0 113.314 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.26 151.78 22.27 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 119.093 0.86 . . . . 0.0 109.339 -173.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.713 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.0 mm-40 -103.18 32.46 3.74 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 49.1 mt-10 -143.62 118.01 6.11 Favored Pre-proline 0 N--CA 1.429 -1.512 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -156.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 70.4 Cg_endo -89.68 31.07 10.26 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.52 -1.45 . . . . 0.0 113.316 1.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.611 ' HB3' HD12 ' A' ' 71' ' ' LEU . 61.9 m80 -130.77 110.76 11.57 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.713 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.1 OUTLIER -74.53 119.26 18.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.648 -176.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.479 ' HE1' ' HA ' ' A' ' 25' ' ' TRP . 4.2 p80 -151.86 99.23 2.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.17 0.986 . . . . 0.0 110.271 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 t -82.15 32.13 0.39 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.568 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' H ' ' C ' ' A' ' 33' ' ' HIS . 26.5 pt -141.26 151.8 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -177.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.568 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 39.1 m-85 51.04 47.11 25.46 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.04 0.924 . . . . 0.0 111.038 -173.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 28.0 p -99.42 171.16 5.93 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.027 171.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 39.7 Cg_exo -59.64 -21.33 62.18 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.132 1.888 . . . . 0.0 112.219 171.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -101.9 -19.85 15.1 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.533 -170.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.9 p -96.91 -18.02 19.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.134 0.492 . . . . 0.0 110.182 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.568 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.2 m120 -136.02 64.63 55.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.028 -177.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.89 18.07 0.66 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.633 2.222 . . . . 0.0 112.736 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -109.93 -23.54 11.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.411 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.697 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -102.13 7.11 41.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.353 0.597 . . . . 0.0 110.469 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.93 42.88 99.58 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.771 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -74.95 110.39 9.21 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.535 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.3 pt-20 -128.6 149.22 50.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.801 172.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.978 ' HE2' ' HA ' ' A' ' 48' ' ' LYS . 5.0 mmpt? 49.67 -111.05 0.46 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.001 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -139.85 18.1 2.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.11 0.481 . . . . 0.0 110.236 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.535 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 33.4 m-85 -67.34 126.41 29.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.589 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 71.7 m -51.68 152.73 2.68 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.556 0.535 . . . . 0.0 111.689 -174.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 44.0 mmt-85 -154.37 170.69 20.75 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.348 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -133.3 77.11 67.12 Favored Pre-proline 0 C--N 1.319 -0.721 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.438 171.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.526 ' HD2' ' CE2' ' A' ' 62' ' ' TRP . 27.9 Cg_exo -61.06 -33.39 91.78 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.769 2.313 . . . . 0.0 112.427 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -90.72 -16.04 29.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.491 0.663 . . . . 0.0 110.366 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.09 48.7 84.81 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.358 -175.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 59' ' ' GLY . 4.4 t0 -48.48 129.01 15.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 t -75.91 31.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 122.085 0.945 . . . . 0.0 110.319 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -125.18 -14.49 3.3 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 175.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.78 -179.51 16.2 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.741 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 95.2 Cg_endo -76.31 161.03 35.37 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.348 2.032 . . . . 0.0 111.713 -174.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.526 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.1 p-90 -145.46 -173.07 4.02 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.223 -173.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.673 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.3 p -167.98 -178.94 3.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' A' ' 72' ' ' TYR . 48.4 m-85 -100.24 145.29 28.25 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.447 ' HB ' HG21 ' A' ' 20' ' ' THR . 4.4 p -98.86 153.91 18.43 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.611 -171.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.416 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 31.0 p -85.77 26.58 0.95 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.334 0.587 . . . . 0.0 110.143 166.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.884 ' HB2' HG21 ' A' ' 20' ' ' THR . 59.3 t-20 -107.52 118.76 52.59 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.495 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.46 2.39 1.96 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.904 2.402 . . . . 0.0 113.392 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -83.77 -46.38 12.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.328 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.05 151.92 51.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.999 0.428 . . . . 0.0 110.558 -176.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 31' ' ' HIS . 41.7 tp -76.29 -43.18 42.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.386 -177.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.516 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 50.4 p90 -143.93 169.33 18.02 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.777 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -161.68 178.37 9.08 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -96.44 156.3 16.4 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 81.5 m -105.89 168.94 8.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.872 0.368 . . . . 0.0 110.888 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -116.89 70.5 0.77 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.263 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.723 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 4.2 p -110.86 127.06 27.53 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.304 0.574 . . . . 0.0 110.883 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.65 160.5 20.64 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 124.165 3.243 . . . . 0.0 113.761 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -75.56 112.71 12.18 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.216 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.485 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -75.87 -43.37 45.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.364 176.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.698 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.031 -179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.462 ' HA ' HG22 ' A' ' 77' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.444 -0.735 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.749 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 8.4 ptt? -97.4 158.19 15.6 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.755 ' HD1' ' HB2' ' A' ' 81' ' ' ALA . 79.0 m-85 -113.94 96.15 5.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.36 -111.83 3.34 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -173.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -79.47 -29.52 41.73 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 124.626 0.839 . . . . 0.0 110.889 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.613 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.8 19.77 8.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.982 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.792 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 95.1 mttt -66.4 -38.08 86.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.873 0.368 . . . . 0.0 110.299 175.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.8 19.47 38.48 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 173.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.731 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -64.38 99.41 0.29 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 174.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.3 46.35 0.92 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.027 0.441 . . . . 0.0 110.249 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.657 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -97.06 -158.97 31.27 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.687 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -145.87 20.26 1.45 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.992 0.396 . . . . 0.0 110.802 -170.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.761 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.9 mmt180 -68.17 139.74 56.12 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -138.84 35.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.726 0.774 . . . . 0.0 110.677 -171.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.87 140.3 21.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.356 -176.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 46.6 p -75.43 -174.81 2.56 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.106 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.8 m -72.85 -12.62 15.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.454 0.645 . . . . 0.0 110.115 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.1 p -92.57 -13.54 29.54 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.904 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.95 7.57 70.4 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.342 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.938 HG21 ' HB2' ' A' ' 67' ' ' ASN . 92.9 m -75.68 120.06 79.95 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -47.46 123.48 8.05 Favored 'Trans proline' 0 CA--C 1.514 -0.52 0 C-N-CA 122.809 2.339 . . . . 0.0 112.861 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.402 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 84.6 m -62.27 135.43 57.47 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.474 0.654 . . . . 0.0 110.488 173.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 23.2 tt0 -68.26 164.8 19.82 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.225 174.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.48 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 15.0 m-20 -76.3 125.91 30.04 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.758 ' CE3' HD23 ' A' ' 46' ' ' LEU . 40.2 m95 -53.36 -31.71 45.79 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.12 -19.09 57.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.18 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.48 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.52 150.13 23.38 Favored 'General case' 0 C--O 1.21 -0.997 0 O-C-N 121.32 -0.863 . . . . 0.0 109.014 -173.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.765 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.9 mm-40 -103.24 33.64 3.22 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 29.2 mt-10 -141.62 117.38 7.15 Favored Pre-proline 0 N--CA 1.435 -1.195 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -157.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.6 Cg_endo -91.8 33.38 8.98 Favored 'Cis proline' 0 C--N 1.347 0.464 0 C-N-CA 123.635 -1.402 . . . . 0.0 112.974 0.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.562 ' HB3' HD12 ' A' ' 71' ' ' LEU . 55.1 m80 -130.37 107.46 9.27 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.765 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -74.22 118.48 17.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.451 0.643 . . . . 0.0 109.889 -178.086 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.467 ' HE1' ' HA ' ' A' ' 25' ' ' TRP . 4.4 p80 -147.65 99.15 3.07 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 122.002 0.906 . . . . 0.0 109.957 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -80.12 32.98 0.28 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.601 175.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.453 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.5 pt -141.91 147.85 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -176.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.501 ' HD2' ' HH ' ' A' ' 64' ' ' TYR . 38.3 m-85 53.12 45.55 28.46 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 122.01 0.91 . . . . 0.0 110.96 -174.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 18.1 p -99.11 172.46 4.68 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.586 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 28.6 Cg_exo -60.59 -20.45 64.73 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 121.855 1.703 . . . . 0.0 111.818 172.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -91.37 -35.7 14.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.089 -175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.8 p -85.91 -25.23 26.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.822 0.344 . . . . 0.0 110.447 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.5 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.3 m120 -132.8 65.21 73.77 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.015 0.436 . . . . 0.0 110.814 -178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.89 13.5 1.22 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.327 2.018 . . . . 0.0 112.13 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -103.56 -21.37 13.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.84 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -107.57 -0.83 21.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.54 -175.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.82 46.41 67.66 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.684 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.818 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.4 mp -76.52 67.2 2.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.776 0.322 . . . . 0.0 110.872 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.49 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 6.1 pt-20 -94.42 151.28 19.5 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.713 0.292 . . . . 0.0 110.762 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.8 mptp? 48.24 -110.32 0.35 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.442 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -140.18 17.84 2.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.965 0.412 . . . . 0.0 110.613 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.49 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 27.8 m-85 -66.75 126.57 29.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.649 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 93.6 m -53.79 150.73 7.1 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 123.468 0.48 . . . . 0.0 111.96 -173.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 41.9 mmt-85 -153.74 165.99 34.25 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.924 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -131.33 76.38 75.93 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.002 172.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.818 ' HG3' HD21 ' A' ' 46' ' ' LEU . 34.9 Cg_exo -55.8 -35.7 94.04 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.844 2.362 . . . . 0.0 112.318 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.89 -12.36 25.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.91 -175.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.792 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 59.17 52.15 55.03 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.526 -174.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 59' ' ' GLY . 6.1 t70 -51.26 133.65 28.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 174.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.02 9.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.616 0.722 . . . . 0.0 110.568 -175.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -107.04 -15.98 14.85 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.73 -177.48 17.04 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.295 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.749 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 73.5 Cg_endo -73.8 158.4 46.74 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.37 2.046 . . . . 0.0 110.984 -175.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.558 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 31.5 p-90 -144.13 -176.31 4.96 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.441 -172.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.575 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.4 p -167.92 179.64 4.6 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.472 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.501 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 49.5 m-85 -99.18 146.43 26.17 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.433 ' HB ' HG21 ' A' ' 20' ' ' THR . 3.9 p -99.0 150.78 21.62 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.474 -170.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.9 p -85.03 23.14 1.27 Allowed 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.008 166.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.938 ' HB2' HG21 ' A' ' 20' ' ' THR . 56.9 t-20 -99.65 117.79 63.09 Favored Pre-proline 0 N--CA 1.456 -0.135 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.098 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 15.1 Cg_exo -68.27 4.96 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.87 2.38 . . . . 0.0 113.632 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -88.37 -38.84 14.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.755 0.312 . . . . 0.0 111.21 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 159.9 41.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.136 0.493 . . . . 0.0 111.38 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.562 HD12 ' HB3' ' A' ' 31' ' ' HIS . 49.9 tp -81.37 -49.61 10.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.968 -175.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.567 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 17.8 p90 -143.6 163.65 32.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.958 0.408 . . . . 0.0 110.701 -178.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -154.56 -175.7 5.54 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.103 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -93.79 158.79 15.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 86.9 m -105.94 169.94 8.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.278 0.561 . . . . 0.0 111.474 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -115.27 72.31 0.79 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.096 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.761 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.5 p -113.46 128.54 25.57 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.373 0.606 . . . . 0.0 110.697 174.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 17.6 Cg_endo -58.16 155.49 34.21 Favored 'Trans proline' 0 CA--C 1.513 -0.531 0 C-N-CA 123.941 3.094 . . . . 0.0 113.871 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.27 111.3 11.56 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.32 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.46 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.26 -39.38 54.54 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.08 179.218 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.755 ' HB2' ' HD1' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--O 1.233 0.187 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.585 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.584 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.441 -0.909 0 CA-C-O 120.949 0.404 . . . . 0.0 109.916 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.556 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.0 ptt? -95.6 151.2 19.54 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.564 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 79.5 m-85 -109.26 96.27 6.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.88 -115.97 4.12 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -174.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -79.59 -21.92 44.38 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 124.684 0.873 . . . . 0.0 110.291 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.71 15.68 16.22 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.166 -176.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -63.81 -34.56 78.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.065 0.46 . . . . 0.0 110.146 176.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -109.98 20.01 27.0 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 174.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.748 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.9 t80 -68.22 101.07 1.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.053 0.454 . . . . 0.0 110.185 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.63 49.3 0.81 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.604 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.75 -151.76 28.24 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.858 -176.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HE2' ' HB3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -150.73 22.78 0.79 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.928 0.394 . . . . 0.0 111.017 -174.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.864 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.8 mmt180 -68.35 137.58 54.72 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 170.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 m -140.06 30.86 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 121.804 0.811 . . . . 0.0 110.796 -171.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.722 HG22 ' HA2' ' A' ' 19' ' ' GLY . 7.3 m -151.45 134.81 16.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -174.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.425 HG21 HG22 ' A' ' 65' ' ' THR . 75.9 p -73.0 -176.92 2.23 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.122 0.487 . . . . 0.0 112.242 -170.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -67.23 -15.65 19.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.367 0.603 . . . . 0.0 110.806 177.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.0 p -93.09 -15.36 26.16 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.839 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.722 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 85.35 15.53 66.31 Favored Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.352 -174.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.977 HG21 ' HB2' ' A' ' 67' ' ' ASN . 85.1 m -78.32 121.88 84.4 Favored Pre-proline 0 N--CA 1.446 -0.67 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 169.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -48.51 131.59 23.73 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.713 2.275 . . . . 0.0 113.216 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.9 m -71.0 137.13 48.8 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.586 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.401 ' HG2' ' N ' ' A' ' 24' ' ' ASP . 24.1 tt0 -71.1 166.09 22.16 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.153 174.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.568 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 10.0 m-20 -75.98 127.73 33.57 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.709 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 43.3 m95 -54.35 -31.47 54.54 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.04 -16.69 57.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.915 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.568 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -98.02 148.04 23.9 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 118.625 0.648 . . . . 0.0 109.616 -173.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 32' ' ' ARG . 31.4 mm-40 -106.58 14.86 26.52 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -176.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.502 ' HA ' ' N ' ' A' ' 31' ' ' HIS . 44.6 mt-10 -147.77 145.55 21.57 Favored Pre-proline 0 N--CA 1.431 -1.382 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.273 -174.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.93 20.46 5.76 Favored 'Cis proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.458 -1.476 . . . . 0.0 113.334 1.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.502 ' N ' ' HA ' ' A' ' 29' ' ' GLU . 62.9 m80 -131.61 107.65 8.98 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.437 ' HD2' ' N ' ' A' ' 32' ' ' ARG . 3.4 mpt_? -74.93 115.34 14.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.5 p80 -147.23 98.09 2.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.088 0.946 . . . . 0.0 111.621 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.07 33.1 0.18 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.531 173.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.9 pt -142.02 147.05 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.563 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 52.0 m-85 49.93 47.68 22.89 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.09 0.947 . . . . 0.0 111.276 -173.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 30.9 p -100.05 174.57 2.92 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.869 170.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 20.9 Cg_exo -66.15 -16.26 51.43 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.868 1.712 . . . . 0.0 111.348 170.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -91.07 -34.33 15.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.371 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.9 p -93.94 -20.4 20.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.551 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.563 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.3 m120 -133.35 65.05 71.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.202 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.9 25.75 0.5 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.487 2.125 . . . . 0.0 111.746 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -115.44 -13.35 11.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.555 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.667 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -116.1 4.38 13.66 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.53 -175.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.48 41.71 96.17 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.856 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.5 mp -70.85 99.64 1.78 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.821 0.343 . . . . 0.0 110.287 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.575 ' HB3' ' HD2' ' A' ' 50' ' ' TYR . 28.4 tt0 -109.84 148.95 30.59 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.941 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.477 ' HG2' ' HG2' ' A' ' 47' ' ' GLU . 46.2 mmtm 46.84 -109.62 0.25 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.543 1.152 . . . . 0.0 111.271 173.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -135.63 17.63 3.33 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.874 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.575 ' HD2' ' HB3' ' A' ' 47' ' ' GLU . 34.6 m-85 -66.12 128.68 37.06 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.097 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.616 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 70.8 m -53.62 148.99 8.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.243 0.544 . . . . 0.0 112.284 -174.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' HD2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -154.7 157.47 38.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.89 -174.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -122.45 81.55 46.55 Favored Pre-proline 0 N--CA 1.446 -0.646 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.243 171.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.577 ' HD2' ' CE2' ' A' ' 62' ' ' TRP . 19.4 Cg_exo -63.25 -24.67 72.15 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.399 2.066 . . . . 0.0 112.397 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.75 -27.47 21.15 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.025 0.916 . . . . 0.0 109.575 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.29 39.6 98.03 Favored Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.925 -166.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -43.93 133.26 5.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.909 -0.646 . . . . 0.0 110.042 170.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 t -70.87 5.94 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.62 0.724 . . . . 0.0 110.878 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.83 -18.14 23.62 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.42 179.64 16.1 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.269 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.556 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 60.5 Cg_endo -71.59 157.61 55.56 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.272 1.981 . . . . 0.0 111.49 -176.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.577 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 25.1 p-90 -146.68 -170.89 3.63 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.819 -170.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.709 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.6 p -168.36 -178.59 3.63 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.789 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.54 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 53.1 m-85 -100.53 144.43 29.53 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 171.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 3.6 p -101.82 150.7 22.9 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.38 -171.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.7 p -84.41 35.0 0.53 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.358 0.599 . . . . 0.0 109.791 167.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.977 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.8 t-20 -115.63 123.77 30.88 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.269 -176.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.2 Cg_exo -69.13 -1.3 7.71 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.787 2.325 . . . . 0.0 113.682 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -84.02 -38.01 21.43 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.778 0.323 . . . . 0.0 111.777 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -143.9 143.14 31.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.134 0.492 . . . . 0.0 110.116 -176.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.454 ' O ' ' HD1' ' A' ' 64' ' ' TYR . 52.5 tp -71.05 -38.03 72.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.645 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -143.55 160.9 39.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -156.17 176.03 13.21 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -94.68 156.59 16.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 77.5 m -106.2 166.13 10.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.964 0.411 . . . . 0.0 111.55 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -101.74 33.0 3.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.023 -172.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.864 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 4.6 p -81.85 127.22 73.13 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-O 121.519 0.675 . . . . 0.0 111.63 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.66 161.61 27.78 Favored 'Trans proline' 0 CA--C 1.515 -0.466 0 C-N-CA 124.378 3.385 . . . . 0.0 113.78 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.33 114.05 13.42 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.605 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.584 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.07 -40.23 53.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.632 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.655 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -77.52 1.23 20.03 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 77.33 23.07 0.91 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.329 171.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.469 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 17.6 t0 -92.44 62.36 3.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.499 171.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.486 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -153.46 151.74 30.2 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.846 -176.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.644 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 9.8 ptt? -96.64 156.64 16.26 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.611 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 81.4 m-85 -113.35 97.82 6.72 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.85 -114.26 3.86 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 -174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.426 ' OD1' ' HA ' ' A' ' 58' ' ' VAL . 91.8 m-20 -79.35 -24.68 42.54 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.573 0.808 . . . . 0.0 110.58 -176.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.46 17.65 11.12 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 119.733 -1.222 . . . . 0.0 111.632 -176.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -65.46 -43.95 88.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.174 0.511 . . . . 0.0 109.822 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -103.68 25.09 27.79 Favored Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.749 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.2 t80 -67.3 103.38 1.25 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 171.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -108.27 45.18 1.04 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.205 0.526 . . . . 0.0 109.677 -176.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.639 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -95.56 -155.37 31.16 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.93 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 7.1 ptmt -148.87 20.06 1.0 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.802 0.334 . . . . 0.0 111.012 -170.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.864 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.1 mmt180 -66.86 139.07 57.74 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 171.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 m -136.64 38.4 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.676 0.75 . . . . 0.0 110.742 -171.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.47 ' HB ' ' HA2' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -151.4 147.94 27.5 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.345 -175.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.0 p -74.32 -172.85 1.54 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.529 176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.3 m -65.22 -16.75 20.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.393 0.616 . . . . 0.0 111.371 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -94.19 -13.75 26.33 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.037 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 15' ' ' THR . . . 87.02 14.84 63.85 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.106 -1.045 . . . . 0.0 111.598 -170.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.975 HG21 ' HB2' ' A' ' 67' ' ' ASN . 86.4 m -75.78 119.52 77.5 Favored Pre-proline 0 N--CA 1.448 -0.564 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 171.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -48.12 129.22 18.23 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.999 2.466 . . . . 0.0 113.564 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.7 m -70.04 134.77 48.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.073 171.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 24.0 tt0 -67.95 166.36 15.89 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.663 174.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.521 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 3.2 m-20 -76.07 125.99 30.17 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.696 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 39.1 m95 -54.76 -31.07 58.12 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 173.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.2 -21.0 56.97 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.938 -1.483 . . . . 0.0 113.267 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -103.08 150.64 23.41 Favored 'General case' 0 C--O 1.208 -1.101 0 CA-C-N 119.168 0.895 . . . . 0.0 109.061 -172.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.778 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 27.7 mm-40 -103.2 35.31 2.59 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 37.3 mt-10 -145.29 119.64 5.59 Favored Pre-proline 0 N--CA 1.432 -1.327 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -156.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 93.8 Cg_endo -89.43 32.1 9.0 Favored 'Cis proline' 0 C--N 1.346 0.42 0 C-N-CA 123.424 -1.49 . . . . 0.0 112.979 0.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.536 ' HB3' HD12 ' A' ' 71' ' ' LEU . 53.4 m80 -130.91 108.01 9.52 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.778 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.0 123.07 22.77 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -177.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.516 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.4 p80 -151.71 94.57 2.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.108 0.956 . . . . 0.0 110.142 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.9 m -75.23 29.63 0.1 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.398 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.516 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.4 pt -141.6 151.0 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.51 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 39.9 m-85 51.74 47.13 25.38 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 122.032 0.92 . . . . 0.0 111.274 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.7 p -99.28 170.88 6.27 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 114.266 -1.334 . . . . 0.0 108.124 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.14 -17.26 59.3 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 121.704 1.602 . . . . 0.0 111.804 172.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -102.84 -20.48 14.28 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.37 -171.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.432 ' C ' ' HD3' ' A' ' 42' ' ' PRO . 42.6 p -98.47 -15.48 19.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.196 0.522 . . . . 0.0 110.241 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.575 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 12.8 m120 -135.8 55.12 11.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.064 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 10.1 Cg_exo -71.16 36.61 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.071 2.514 . . . . 0.0 112.842 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.77 -9.95 2.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.319 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.735 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -110.58 12.6 22.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.412 . . . . 0.0 111.266 -176.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.15 44.01 97.79 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-N 115.27 -0.877 . . . . 0.0 113.37 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.1 mp -80.46 111.78 17.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.056 0.455 . . . . 0.0 110.52 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.636 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 2.0 pt-20 -124.47 134.59 53.0 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.662 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 48' ' ' LYS . 61.0 mmtt 50.75 -107.57 0.3 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -137.11 13.97 3.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.059 0.456 . . . . 0.0 110.19 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.636 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 22.2 m-85 -67.36 131.03 44.91 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.537 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 79.1 m -54.04 149.74 8.92 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 123.247 0.342 . . . . 0.0 111.571 -173.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 33.6 mmt-85 -153.94 165.94 34.53 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.438 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -127.88 79.46 73.65 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.238 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.71 ' HG3' HD21 ' A' ' 46' ' ' LEU . 37.6 Cg_exo -58.96 -35.83 97.9 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.556 2.17 . . . . 0.0 112.281 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -91.54 -17.28 25.89 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.252 0.549 . . . . 0.0 110.644 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.65 47.77 86.65 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.313 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -50.12 131.97 23.5 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.426 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 3.3 t -74.38 8.41 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.565 0.698 . . . . 0.0 110.556 -175.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.58 -18.95 19.46 Favored Glycine 0 N--CA 1.434 -1.496 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.22 179.58 16.15 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.772 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.644 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 90.6 Cg_endo -73.86 156.78 48.07 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.502 2.134 . . . . 0.0 111.277 -175.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.572 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.5 p-90 -144.89 -172.76 3.9 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.292 -171.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.696 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.8 p -168.65 -179.03 3.65 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.034 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.471 ' CD1' ' HG ' ' A' ' 71' ' ' LEU . 39.7 m-85 -100.75 144.77 29.32 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 171.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.6 p -102.95 146.23 28.65 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.442 -170.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.2 p -81.87 27.73 0.45 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.482 0.658 . . . . 0.0 109.779 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.975 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.4 t-20 -102.1 120.58 53.28 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.785 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.75 0.04 3.39 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.246 2.631 . . . . 0.0 113.557 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -84.17 -53.41 5.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.78 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.59 149.78 52.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.36 0.6 . . . . 0.0 111.056 -175.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 31' ' ' HIS . 36.2 tp -69.92 -45.77 66.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.117 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 11.3 p90 -142.66 162.34 35.71 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -156.88 -177.96 7.01 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -97.97 155.74 16.95 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 93.5 m -103.75 173.74 6.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.098 0.475 . . . . 0.0 111.029 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -119.69 71.47 0.88 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.536 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.864 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.7 p -108.54 130.03 23.26 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.654 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.83 153.91 47.32 Favored 'Trans proline' 0 CA--C 1.511 -0.66 0 C-N-CA 123.824 3.016 . . . . 0.0 113.68 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.401 ' CG ' ' HB2' ' A' ' 82' ' ' ALA . 9.3 tp-100 -75.59 112.61 12.12 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 113.923 -1.489 . . . . 0.0 110.326 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.486 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.45 -40.75 57.12 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.436 178.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.611 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -83.65 59.56 5.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.186 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.401 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . . . . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.421 -0.8 . . . . 0.0 110.073 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.473 0.725 0 CA-C-O 120.873 0.368 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -85.63 -8.12 58.42 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 70.02 25.85 4.72 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.731 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.619 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 33.4 t70 -79.5 57.89 2.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.466 1.126 . . . . 0.0 109.833 177.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.527 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -160.09 156.95 27.69 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.403 177.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.774 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.4 ptt? -96.63 149.57 21.64 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.673 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 80.8 m-85 -107.07 102.34 11.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.43 -111.65 3.31 Favored Glycine 0 N--CA 1.425 -2.068 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.498 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.594 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 81.4 m-20 -78.87 -27.46 44.02 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.551 0.795 . . . . 0.0 110.555 -176.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.668 ' HA2' ' HB2' ' A' ' 2' ' ' MET . . . 111.61 17.33 8.69 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.229 -1.149 . . . . 0.0 110.229 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.594 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 43.1 mtmt -65.46 -47.93 74.42 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.41 -0.895 . . . . 0.0 109.711 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -99.21 23.32 36.8 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.473 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.0 t80 -65.42 98.49 0.35 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.072 0.463 . . . . 0.0 109.962 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.408 ' HE ' ' HA ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -102.96 44.47 1.01 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.772 -177.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.619 ' CA ' ' HA ' ' A' ' -1' ' ' ASP . . . -95.55 -155.27 31.12 Favored Glycine 0 N--CA 1.454 -0.104 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.741 -175.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -144.35 15.6 1.66 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.873 0.337 . . . . 0.0 110.696 -174.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.71 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 12.8 mmt180 -66.08 133.26 50.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.63 37.36 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.532 0.682 . . . . 0.0 111.174 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.24 147.7 27.99 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.168 -177.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.518 ' HB ' ' OD2' ' A' ' 73' ' ' ASP . 66.4 p -75.53 -174.17 2.39 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.028 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.3 m -65.63 -17.53 22.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.58 0.705 . . . . 0.0 110.878 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 50.6 p -93.57 -14.69 26.24 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.903 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.28 11.95 63.9 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.517 -172.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.722 HG21 ' HB2' ' A' ' 67' ' ' ASN . 98.4 m -75.95 119.43 77.18 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 173.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -49.68 127.85 19.71 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.868 2.379 . . . . 0.0 113.244 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.5 m -68.48 138.59 55.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.875 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -69.06 165.65 19.79 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.528 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 26' ' ' ALA . 5.8 t70 -77.21 129.08 35.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.689 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 59.5 m95 -58.73 -31.53 68.38 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.414 ' HB3' ' OD1' ' A' ' 24' ' ' ASP . . . -78.33 -15.08 59.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.492 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.21 148.49 26.26 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -175.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.768 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.6 mm-40 -102.28 33.71 3.01 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 41.7 mt-10 -145.22 120.72 5.83 Favored Pre-proline 0 N--CA 1.429 -1.495 0 CA-C-N 114.61 -1.177 . . . . 0.0 114.046 -157.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 97.1 Cg_endo -90.41 37.05 5.16 Favored 'Cis proline' 0 CA--C 1.535 0.553 0 C-N-CA 123.258 -1.559 . . . . 0.0 113.641 0.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.414 ' HB3' HD12 ' A' ' 71' ' ' LEU . 53.3 m80 -133.56 112.56 11.59 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.768 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 23.1 mmm180 -73.35 114.48 11.61 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -176.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.8 p80 -146.98 91.11 1.97 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 122.345 1.069 . . . . 0.0 110.395 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.8 t -77.29 35.46 0.17 Allowed 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.263 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.521 ' H ' ' C ' ' A' ' 33' ' ' HIS . 19.4 pt -143.95 141.42 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.586 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 42.1 m-85 55.85 47.09 20.93 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-O 122.062 0.934 . . . . 0.0 111.04 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 18.8 p -99.58 175.23 2.53 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.649 168.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 36.5 Cg_exo -60.91 -22.22 73.5 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 121.713 1.609 . . . . 0.0 112.001 172.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.71 -28.73 13.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.464 -171.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 70.9 p -88.04 -17.03 32.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.068 0.461 . . . . 0.0 110.241 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.586 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.0 m120 -137.77 55.0 8.52 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.531 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 8.7 Cg_exo -71.04 35.39 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.807 2.338 . . . . 0.0 112.971 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 -11.03 3.64 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.035 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.708 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -110.56 13.27 22.65 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.997 0.427 . . . . 0.0 110.859 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.39 43.98 95.47 Favored Glycine 0 C--O 1.224 -0.49 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.861 173.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.1 mp -80.16 100.75 8.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 117.0 0.4 . . . . 0.0 111.161 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.5 pt-20 -121.72 149.88 42.61 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.762 172.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.403 ' O ' ' HD1' ' A' ' 25' ' ' TRP . 42.0 mmtm 50.65 -124.96 2.24 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.22 0.95 . . . . 0.0 111.022 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -128.49 19.39 6.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.039 0.447 . . . . 0.0 110.486 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.466 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 24.1 m-85 -66.87 127.1 31.21 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 175.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.593 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 78.8 m -52.61 150.75 4.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.041 0.448 . . . . 0.0 111.543 -175.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -154.76 159.59 40.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -123.28 78.01 53.05 Favored Pre-proline 0 C--N 1.317 -0.819 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.045 173.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.623 ' HG3' HD21 ' A' ' 46' ' ' LEU . 18.0 Cg_endo -70.37 -11.47 30.1 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.472 2.115 . . . . 0.0 112.971 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -99.07 -22.79 15.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.427 0.632 . . . . 0.0 109.816 172.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.89 51.02 60.04 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.878 -170.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -53.42 128.58 29.14 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 171.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -74.3 7.95 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.427 0.632 . . . . 0.0 110.361 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -101.86 -15.1 27.46 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 111.221 -0.751 . . . . 0.0 111.221 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.33 178.73 15.58 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 119.705 -1.236 . . . . 0.0 111.87 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.774 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 91.9 Cg_endo -77.45 163.58 29.6 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.686 2.257 . . . . 0.0 111.867 -175.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.527 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.4 p-90 -148.5 -171.28 3.81 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.053 -172.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.689 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.8 p -168.47 -178.25 3.46 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.029 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.415 ' HE2' ' HB2' ' A' ' 36' ' ' PHE . 56.3 m-85 -100.75 144.59 29.54 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 171.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 p -99.91 143.99 29.49 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.239 -172.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.5 p -78.55 14.24 1.34 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.542 170.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.722 ' HB2' HG21 ' A' ' 20' ' ' THR . 59.8 t-20 -86.86 119.97 71.43 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 18.7 Cg_exo -65.02 0.21 2.77 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.728 2.285 . . . . 0.0 113.102 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -85.33 -55.26 4.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.174 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 12.3 ptmt -120.32 160.16 23.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.315 0.579 . . . . 0.0 111.025 -174.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.414 HD12 ' HB3' ' A' ' 31' ' ' HIS . 55.0 tp -87.62 -46.76 9.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.452 -176.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -143.79 164.23 31.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.989 0.423 . . . . 0.0 110.461 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.518 ' OD2' ' HB ' ' A' ' 16' ' ' THR . 32.2 t0 -160.47 173.56 15.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.673 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 69.5 m-85 -92.85 156.23 17.11 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 75.9 m -105.11 170.31 7.94 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.044 0.449 . . . . 0.0 111.154 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -114.57 73.82 0.84 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.338 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.71 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.1 p -114.2 128.04 26.21 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.491 0.662 . . . . 0.0 111.037 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 17.3 Cg_endo -57.47 158.75 18.26 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 124.489 3.459 . . . . 0.0 114.226 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.0 111.41 10.18 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.451 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.503 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.36 -41.41 56.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.241 178.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.673 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -85.1 49.6 1.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.948 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.385 177.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 62.3 p . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . 0.6 HD21 ' HD3' ' A' ' 12' ' ' LYS . 51.1 t30 -76.47 -12.16 60.0 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 170.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 67.53 15.35 9.79 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.654 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.633 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 33.0 t0 -90.45 51.41 2.01 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 122.75 1.262 . . . . 0.0 108.766 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.568 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -153.09 154.02 34.02 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.366 -1.743 . . . . 0.0 108.929 -179.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.449 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.8 ptt? -94.86 155.41 16.8 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.563 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 91.2 m-85 -113.53 95.43 5.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.81 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.44 -106.53 2.07 Favored Glycine 0 N--CA 1.426 -1.991 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -172.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.436 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 8.0 m-20 -77.7 -35.89 51.63 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.856 0.974 . . . . 0.0 110.517 -176.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . 112.06 17.89 8.1 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.104 -1.046 . . . . 0.0 110.945 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 46.7 mtmt -70.9 -35.02 72.12 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.062 -0.569 . . . . 0.0 109.656 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -104.25 19.91 41.69 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.702 171.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.714 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -67.06 109.99 3.23 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 171.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -114.98 48.06 1.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.082 0.467 . . . . 0.0 110.026 -176.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.633 ' CA ' ' HA ' ' A' ' -1' ' ' ASP . . . -99.64 -156.97 28.6 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.815 -0.629 . . . . 0.0 113.565 -172.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.6 ' HD3' HD21 ' A' ' -3' ' ' ASN . 11.4 ptmm? -141.73 13.89 2.11 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.453 0.168 . . . . 0.0 111.198 -169.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.706 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 32.8 mmt180 -66.05 137.48 57.11 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.43 36.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.286 0.565 . . . . 0.0 111.997 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.27 146.44 26.79 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.461 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 58.7 p -74.52 -174.06 1.95 Allowed 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.681 -178.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.7 m -66.49 -17.37 22.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.414 0.626 . . . . 0.0 110.752 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 35.4 p -92.77 -14.62 27.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.444 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.74 11.1 64.23 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.302 -173.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.983 HG21 ' HB2' ' A' ' 67' ' ' ASN . 84.6 m -75.85 119.43 77.13 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -45.85 124.13 6.79 Favored 'Trans proline' 0 C--O 1.239 0.553 0 C-N-CA 123.119 2.546 . . . . 0.0 113.532 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.8 m -65.94 136.12 55.66 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.151 173.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -68.29 164.92 19.62 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.715 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -77.68 127.11 31.92 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.764 ' CE3' HD23 ' A' ' 46' ' ' LEU . 71.6 m95 -57.24 -31.0 65.09 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.613 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.66 -18.13 54.9 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.615 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.68 151.24 20.32 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.693 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.8 mm-40 -104.41 33.44 3.52 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 48.3 mt-10 -144.94 120.53 5.92 Favored Pre-proline 0 N--CA 1.431 -1.398 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -156.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 83.8 Cg_endo -87.91 27.96 12.76 Favored 'Cis proline' 0 C--N 1.344 0.339 0 C-N-CA 123.206 -1.581 . . . . 0.0 112.807 0.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.411 ' HB3' HD12 ' A' ' 71' ' ' LEU . 39.7 m80 -127.87 109.23 11.4 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.693 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.55 118.31 16.36 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.348 -177.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.425 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.0 p80 -149.19 100.12 3.01 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.255 1.026 . . . . 0.0 110.269 -177.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 m -81.74 30.49 0.37 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.056 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.7 pt -141.4 147.57 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -175.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.624 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 37.0 m-85 52.68 47.65 24.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 121.886 0.85 . . . . 0.0 111.093 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 22.4 p -100.19 175.42 2.4 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.314 170.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 19.0 Cg_exo -65.45 -17.6 57.95 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 121.371 1.381 . . . . 0.0 111.138 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -87.98 -38.37 15.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.178 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 p -90.32 -22.82 21.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.313 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.624 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.3 m120 -132.7 67.87 78.57 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.079 0.466 . . . . 0.0 111.021 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.96 5.98 2.32 Favored 'Trans proline' 0 C--N 1.33 -0.428 0 C-N-CA 122.344 2.029 . . . . 0.0 112.698 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -97.4 -26.99 14.67 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.401 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -99.49 4.85 46.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.406 0.622 . . . . 0.0 111.126 -173.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.92 46.33 94.77 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.176 174.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.764 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.6 mp -71.18 86.94 0.78 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.385 0.612 . . . . 0.0 109.939 -177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.948 ' HG2' ' HD3' ' A' ' 48' ' ' LYS . 20.1 tt0 -102.45 145.84 28.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.858 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.948 ' HD3' ' HG2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER 44.12 -106.46 0.1 Allowed 'General case' 0 C--N 1.323 -0.576 0 O-C-N 124.384 1.053 . . . . 0.0 110.949 -179.235 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -138.68 22.11 2.69 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.984 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.595 ' HD2' ' HB3' ' A' ' 47' ' ' GLU . 28.6 m-85 -69.39 128.35 36.23 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.38 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 77.6 m -51.54 148.22 5.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.446 0.466 . . . . 0.0 111.417 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 36.7 mmt-85 -154.09 164.24 38.8 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.481 -176.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -126.23 77.04 72.35 Favored Pre-proline 0 C--N 1.321 -0.664 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.132 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.563 ' HG3' HD21 ' A' ' 46' ' ' LEU . 27.7 Cg_endo -70.63 -16.9 33.92 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.207 1.938 . . . . 0.0 112.746 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -90.18 -27.65 19.43 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.671 0.748 . . . . 0.0 109.503 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.75 46.63 91.44 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.621 -169.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 59' ' ' GLY . 6.8 t70 -54.4 135.79 44.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.5 t -75.4 16.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.918 0.866 . . . . 0.0 109.978 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -104.49 -20.96 9.63 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 175.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.83 176.0 14.6 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.177 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 57.1 Cg_endo -70.13 159.92 51.43 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.319 2.013 . . . . 0.0 111.613 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.54 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.9 p-90 -149.61 -168.14 3.02 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.954 -169.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.74 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.7 p -168.2 -178.99 3.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.586 178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.419 ' HE2' ' HB2' ' A' ' 36' ' ' PHE . 39.2 m-85 -100.17 146.48 26.8 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 172.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.3 p -103.54 144.4 31.47 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.009 -1.076 . . . . 0.0 109.662 -171.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.413 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 36.2 p -79.81 17.37 0.95 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.213 169.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.983 ' HB2' HG21 ' A' ' 20' ' ' THR . 56.4 t-20 -94.48 124.94 53.75 Favored Pre-proline 0 C--O 1.229 -0.026 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.343 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.1 4.62 1.81 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.688 2.259 . . . . 0.0 113.309 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -85.01 -58.26 2.76 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -122.14 161.05 23.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.732 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.413 ' O ' ' HD1' ' A' ' 64' ' ' TYR . 57.4 tp -86.21 -45.33 11.41 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.604 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 4.2 p90 -143.34 159.4 42.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.703 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.461 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 47.4 t0 -154.5 172.43 17.8 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -92.8 155.5 17.61 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 71.2 m -105.41 171.76 7.16 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.947 177.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -115.7 60.99 0.7 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.378 0.609 . . . . 0.0 110.337 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.714 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.4 p -97.87 129.43 31.22 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-O 121.427 0.632 . . . . 0.0 110.398 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.478 ' HD2' HG23 ' A' ' 77' ' ' VAL . 36.2 Cg_endo -63.01 160.2 35.01 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 123.986 3.124 . . . . 0.0 113.49 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.34 111.9 11.08 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.028 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.506 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.09 -41.99 57.58 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.146 -0.933 . . . . 0.0 108.846 178.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.563 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -83.24 55.12 3.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.445 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.3 178.787 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 28.1 m . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -90.71 13.18 16.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 70.61 21.59 5.35 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.067 -0.97 . . . . 0.0 111.329 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.469 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 26.9 t70 -78.68 63.42 3.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.398 1.094 . . . . 0.0 109.183 171.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.587 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -157.94 152.77 25.19 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.2 -1.363 . . . . 0.0 109.011 178.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.428 ' SD ' ' NE2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -98.07 146.74 25.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.64 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 67.9 m-85 -104.27 103.58 13.35 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.3 -107.78 2.3 Favored Glycine 0 N--CA 1.422 -2.239 0 C-N-CA 119.52 -1.324 . . . . 0.0 110.336 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.522 ' HB2' ' HG3' ' A' ' 7' ' ' LYS . 86.3 m-20 -80.73 -32.46 35.72 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 124.819 0.952 . . . . 0.0 110.415 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 110.59 20.22 7.45 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.079 -1.057 . . . . 0.0 110.97 -174.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.522 ' HG3' ' HB2' ' A' ' 5' ' ' ASN . 47.4 mtmt -66.02 -45.14 82.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.89 -0.655 . . . . 0.0 109.812 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.14 27.25 20.16 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.635 ' CE1' ' HA3' ' A' ' 11' ' ' GLY . 2.9 t80 -65.19 101.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HE ' ' C ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -102.24 51.26 0.82 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.013 0.435 . . . . 0.0 110.69 -177.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.635 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -108.42 -163.86 20.89 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.71 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -142.21 16.79 2.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.721 0.26 . . . . 0.0 110.926 -170.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.843 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 19.5 mmt180 -64.42 136.61 57.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 4.0 m -138.59 40.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-O 121.857 0.837 . . . . 0.0 110.422 -172.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.993 HG23 ' HA2' ' A' ' 19' ' ' GLY . 0.3 OUTLIER -150.81 135.08 16.94 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -177.158 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.564 HG21 ' HB3' ' A' ' 73' ' ' ASP . 54.5 p -74.03 -170.57 0.95 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.026 0.441 . . . . 0.0 112.035 -175.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.2 -18.89 24.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.427 0.632 . . . . 0.0 110.875 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.4 p -93.45 -13.09 28.34 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.995 0.902 . . . . 0.0 109.063 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.993 ' HA2' HG23 ' A' ' 15' ' ' THR . . . 81.02 20.56 64.86 Favored Glycine 0 N--CA 1.442 -0.938 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.904 -172.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.961 HG21 ' HB2' ' A' ' 67' ' ' ASN . 60.0 m -75.69 123.27 88.32 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 169.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.556 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 78.1 Cg_exo -50.28 135.4 38.74 Favored 'Trans proline' 0 C--O 1.237 0.441 0 C-N-CA 122.497 2.131 . . . . 0.0 113.128 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.0 m -75.49 141.41 43.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.533 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -71.45 163.32 27.92 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.88 173.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 6.3 m-20 -76.7 125.16 28.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.738 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 38.6 m95 -53.34 -30.56 40.0 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.49 -14.04 59.77 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.013 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.89 148.52 27.51 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.694 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 36.1 mm-40 -103.39 29.71 5.44 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.74 127.06 6.91 Favored Pre-proline 0 N--CA 1.426 -1.644 0 CA-C-N 113.581 -1.645 . . . . 0.0 114.104 -159.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -85.61 26.32 11.67 Favored 'Cis proline' 0 C--N 1.347 0.497 0 C-N-CA 123.853 -1.311 . . . . 0.0 112.59 1.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.673 ' HB3' HD12 ' A' ' 71' ' ' LEU . 68.3 m80 -129.17 104.01 7.3 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.694 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -74.61 118.2 17.3 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -176.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.491 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.7 p80 -144.8 92.73 2.32 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.75 0.786 . . . . 0.0 110.509 -173.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 m -74.1 31.42 0.08 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.705 175.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.491 ' H ' ' C ' ' A' ' 33' ' ' HIS . 25.7 pt -142.79 143.86 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -174.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.593 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 72.2 m-85 49.53 50.81 17.58 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 121.92 0.867 . . . . 0.0 111.185 -173.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 60.5 p -103.03 176.48 1.8 Allowed Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.468 171.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 24.2 Cg_exo -66.44 -11.49 31.79 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 121.98 1.787 . . . . 0.0 111.466 169.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -89.47 -40.72 12.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.09 0.471 . . . . 0.0 110.171 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.5 p -90.56 -22.55 21.22 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.251 -177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.625 ' O ' HD13 ' A' ' 46' ' ' LEU . 15.2 m120 -137.15 60.82 30.24 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.368 . . . . 0.0 111.514 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -77.53 20.33 0.69 Allowed 'Trans proline' 0 C--N 1.332 -0.301 0 C-N-CA 122.026 1.817 . . . . 0.0 112.396 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.58 -8.86 7.96 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.713 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -105.19 10.93 33.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.26 0.553 . . . . 0.0 110.324 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.76 41.68 73.19 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.063 -0.971 . . . . 0.0 113.163 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.796 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.5 mp -80.41 79.12 7.06 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.71 0.767 . . . . 0.0 110.368 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.819 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 7.2 pt-20 -101.78 136.48 41.54 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.818 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 11.0 mtpp 48.63 -105.98 0.17 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -141.67 11.62 2.07 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.646 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.819 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 23.2 m-85 -65.53 131.41 46.32 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.522 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 70.7 m -52.35 144.66 12.53 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.246 0.341 . . . . 0.0 111.028 -176.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 35.6 mmt-85 -149.32 168.78 22.42 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.268 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -129.49 77.86 76.59 Favored Pre-proline 0 C--N 1.313 -0.981 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.969 171.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.796 ' HG3' HD21 ' A' ' 46' ' ' LEU . 39.5 Cg_endo -72.93 -10.17 24.44 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.082 1.855 . . . . 0.0 111.801 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -90.98 -32.62 15.87 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 172.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.93 36.45 93.3 Favored Glycine 0 N--CA 1.436 -1.333 0 CA-C-N 113.896 -1.502 . . . . 0.0 110.3 -165.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -46.84 134.05 10.36 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.942 -0.629 . . . . 0.0 109.877 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 13.0 t -70.09 0.31 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.563 0.697 . . . . 0.0 110.579 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.56 -19.95 39.37 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.46 -179.64 16.13 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 119.757 -1.211 . . . . 0.0 111.41 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -73.44 158.48 47.96 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.194 1.929 . . . . 0.0 111.859 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.497 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 19.2 p-90 -150.72 -169.24 3.33 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.627 -1.17 . . . . 0.0 108.867 -170.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.738 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.3 p -168.53 -176.62 2.87 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.5 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.556 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 84.1 m-85 -100.4 147.23 26.07 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 169.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 67' ' ' ASN . 2.7 p -100.62 149.7 23.48 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.741 -169.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.5 p -82.47 24.56 0.69 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.424 0.631 . . . . 0.0 109.89 167.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.961 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.7 t-20 -108.0 118.27 53.14 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.889 -175.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 15.9 Cg_exo -68.66 5.95 1.14 Allowed 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.92 2.414 . . . . 0.0 113.585 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 mmm-85 -85.33 -49.13 8.4 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.75 149.04 52.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.163 0.506 . . . . 0.0 110.595 -175.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 31' ' ' HIS . 39.4 tp -76.37 -43.75 39.37 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.999 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 1.9 p90 -142.96 153.47 43.06 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.501 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.564 ' HB3' HG21 ' A' ' 16' ' ' THR . 18.9 t0 -152.98 164.85 37.2 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -175.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -92.48 156.56 17.09 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.59 171.76 7.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.827 0.346 . . . . 0.0 110.67 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -118.76 60.71 0.8 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.389 0.614 . . . . 0.0 109.99 -176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.843 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.5 p -102.28 130.44 24.18 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.396 0.617 . . . . 0.0 110.512 176.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.418 ' HD2' HG23 ' A' ' 77' ' ' VAL . 21.0 Cg_endo -60.12 160.9 20.96 Favored 'Trans proline' 0 CA--C 1.512 -0.612 0 C-N-CA 124.691 3.594 . . . . 0.0 114.231 -176.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.428 ' NE2' ' SD ' ' A' ' 2' ' ' MET . 8.8 tp-100 -75.63 112.01 11.55 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.941 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.587 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.96 -41.61 50.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.724 179.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.64 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -86.56 62.25 7.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.252 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.958 178.409 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 89.1 p . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -93.56 12.31 25.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 67.96 35.15 3.88 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.696 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.527 ' OD1' ' HG2' ' A' ' 12' ' ' LYS . 36.5 t0 -80.43 48.12 1.0 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.307 1.051 . . . . 0.0 109.894 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.582 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -159.11 160.84 36.12 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.204 -177.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.624 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 16.2 ptt? -96.52 146.23 24.99 Favored 'General case' 0 C--O 1.218 -0.596 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.614 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 90.5 m-85 -105.47 99.47 9.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.25 -119.77 4.96 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.892 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -79.74 -18.12 51.91 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 124.481 0.753 . . . . 0.0 110.585 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.619 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.31 13.45 21.0 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 119.893 -1.146 . . . . 0.0 110.917 -174.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -64.5 -39.49 93.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.199 -0.501 . . . . 0.0 109.687 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.594 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -107.06 23.05 28.34 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 172.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.712 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.8 t80 -67.59 105.15 1.78 Allowed 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 172.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.52 39.06 2.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.17 0.509 . . . . 0.0 110.214 -175.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.459 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -94.72 -158.88 33.39 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.978 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.527 ' HG2' ' OD1' ' A' ' -1' ' ' ASP . 9.1 ptmm? -140.48 19.04 2.38 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 120.88 0.371 . . . . 0.0 110.33 -168.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.645 ' HB2' ' OH ' ' A' ' 9' ' ' TYR . 2.5 mpt_? -67.98 137.59 55.25 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 m -140.29 33.62 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.939 0.876 . . . . 0.0 110.322 -170.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.451 HG22 ' HA2' ' A' ' 19' ' ' GLY . 0.2 OUTLIER -150.58 139.11 20.54 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 -172.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.593 ' HB ' ' OD2' ' A' ' 73' ' ' ASP . 72.3 p -74.84 -176.22 2.8 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.647 0.261 . . . . 0.0 111.39 -174.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.407 HG22 ' OD2' ' A' ' 73' ' ' ASP . 15.4 m -65.87 -20.41 27.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.647 0.737 . . . . 0.0 110.187 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 p -91.99 -14.23 29.77 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.529 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.451 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 89.94 11.97 62.71 Favored Glycine 0 N--CA 1.435 -1.391 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.846 -174.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.773 HG21 ' HB2' ' A' ' 67' ' ' ASN . 78.4 m -76.58 120.82 83.3 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 120.426 -0.509 . . . . 0.0 109.84 170.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -50.55 125.82 16.45 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.837 2.358 . . . . 0.0 113.198 177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 68.4 m -64.44 137.87 58.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.499 0.666 . . . . 0.0 110.627 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 25.5 tt0 -71.22 166.12 22.19 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.925 174.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 1.0 OUTLIER -75.98 125.11 28.49 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 175.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.739 ' CE3' HD23 ' A' ' 46' ' ' LEU . 45.9 m95 -54.8 -29.25 54.02 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.611 0.719 . . . . 0.0 109.122 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.87 -21.35 55.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.556 177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.69 150.38 22.8 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -172.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.755 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.5 mm-40 -103.5 33.0 3.53 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 43.4 mt-10 -143.17 119.58 6.66 Favored Pre-proline 0 N--CA 1.43 -1.474 0 CA-C-N 114.205 -1.361 . . . . 0.0 114.209 -157.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 88.9 Cg_endo -90.04 31.98 9.58 Favored 'Cis proline' 0 CA--C 1.534 0.489 0 C-N-CA 123.298 -1.542 . . . . 0.0 113.456 1.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.491 ' HB3' HD12 ' A' ' 71' ' ' LEU . 61.5 m80 -131.63 113.02 13.1 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.755 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.72 116.55 14.44 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.823 -176.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.494 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.8 p80 -148.57 89.71 1.72 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.449 1.119 . . . . 0.0 110.543 -177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.1 m -78.19 35.84 0.22 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.996 173.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.494 ' H ' ' C ' ' A' ' 33' ' ' HIS . 20.1 pt -143.19 146.63 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.559 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 31.0 m-85 53.97 46.51 25.43 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.343 1.068 . . . . 0.0 110.629 -174.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.573 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 42.6 p -99.8 176.77 1.78 Allowed Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.145 170.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 30.3 Cg_exo -61.99 -21.58 72.64 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 121.959 1.773 . . . . 0.0 111.95 169.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -87.49 -34.71 18.56 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.981 0.419 . . . . 0.0 111.122 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 49.3 p -89.08 -24.03 22.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.973 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.559 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.0 m120 -136.03 59.28 27.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -175.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 21.1 Cg_exo -64.48 4.15 0.68 Allowed 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.476 2.117 . . . . 0.0 112.787 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.414 ' H ' ' C ' ' A' ' 41' ' ' ASN . 23.2 ptt180 -95.06 -19.36 20.21 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.588 0.233 . . . . 0.0 111.376 -173.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.737 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -109.09 2.74 21.34 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.595 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.05 47.48 85.04 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.262 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.899 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.6 mp -75.14 74.28 2.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.967 0.413 . . . . 0.0 111.5 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.528 ' HG3' ' CD2' ' A' ' 50' ' ' TYR . 3.0 pt-20 -98.94 152.83 19.35 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.669 176.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 48.0 mttp 49.96 -113.65 0.66 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.418 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -140.69 19.63 2.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.176 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.528 ' CD2' ' HG3' ' A' ' 47' ' ' GLU . 30.2 m-85 -61.92 128.83 38.06 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.676 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 80.5 m -53.76 145.23 16.19 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 38.8 mmt-85 -152.5 164.62 37.23 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.225 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -125.57 81.45 64.7 Favored Pre-proline 0 C--N 1.318 -0.762 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.719 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.899 ' HG3' HD21 ' A' ' 46' ' ' LEU . 39.1 Cg_exo -59.17 -31.89 96.15 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.727 2.285 . . . . 0.0 112.458 176.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -89.76 -20.0 24.07 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.525 0.679 . . . . 0.0 109.97 -177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.96 44.09 97.5 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.539 -168.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -48.03 135.09 13.19 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 114.414 -0.893 . . . . 0.0 109.443 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 58' ' ' VAL . 11.4 t -71.67 6.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 123.893 0.746 . . . . 0.0 110.868 -173.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.42 -17.82 13.0 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.88 -178.15 16.5 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 119.89 -1.148 . . . . 0.0 111.234 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.624 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 74.2 Cg_endo -73.5 157.92 48.43 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.091 1.861 . . . . 0.0 111.815 -174.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.551 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 32.2 p-90 -145.61 -172.09 3.82 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.717 -172.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.711 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.0 p -168.52 -179.82 4.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.122 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 43.7 m-85 -100.16 145.61 27.81 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.3 p -102.84 147.02 27.41 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.664 -170.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.7 p -80.99 23.57 0.55 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.383 0.611 . . . . 0.0 110.517 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.773 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.1 t-20 -103.98 121.76 46.73 Favored Pre-proline 0 CA--C 1.528 0.115 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.086 -177.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 16.5 Cg_exo -67.23 -0.33 4.81 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.888 2.392 . . . . 0.0 113.703 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -84.66 -44.98 12.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.836 0.35 . . . . 0.0 111.619 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.13 145.57 50.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.468 0.651 . . . . 0.0 111.048 -175.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.491 HD12 ' HB3' ' A' ' 31' ' ' HIS . 41.8 tp -71.28 -43.04 67.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.621 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -143.29 164.29 30.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.089 0.471 . . . . 0.0 110.338 -177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.593 ' OD2' ' HB ' ' A' ' 16' ' ' THR . 33.0 t70 -157.94 173.89 16.09 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -93.63 158.67 15.58 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 86.6 m -106.37 171.24 7.46 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -122.64 69.25 0.97 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.3 0.571 . . . . 0.0 109.99 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.712 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.6 p -105.29 132.72 20.63 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.854 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.508 ' HD2' HG23 ' A' ' 77' ' ' VAL . 51.8 Cg_endo -65.76 162.24 35.51 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 123.631 2.887 . . . . 0.0 113.378 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.47 ' CG ' ' HB2' ' A' ' 82' ' ' ALA . 9.3 tp-100 -75.6 108.96 8.79 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.231 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.492 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -73.3 -37.94 66.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.306 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.614 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -83.39 52.1 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.194 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.47 ' HB2' ' CG ' ' A' ' 79' ' ' GLN . . . . . . . . 0 C--O 1.245 0.856 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.938 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 64.5 p . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . 0.507 ' ND2' ' HD3' ' A' ' 12' ' ' LYS . 27.6 p-10 -82.41 3.81 26.58 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 68.93 22.9 6.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.513 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.491 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 46.8 t0 -82.67 53.66 2.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.256 1.027 . . . . 0.0 109.364 175.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.502 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -151.51 155.18 37.99 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.258 -178.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.63 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.8 ptt? -97.29 150.74 20.61 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 121.358 0.599 . . . . 0.0 112.514 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.733 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 71.8 m-85 -109.7 102.07 10.91 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.38 -115.48 4.19 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 119.997 -1.097 . . . . 0.0 111.033 -175.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.18 -23.93 40.69 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 124.531 0.783 . . . . 0.0 109.576 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.535 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.31 17.41 10.75 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.313 -0.946 . . . . 0.0 110.969 -174.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -66.48 -39.9 89.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.213 -0.494 . . . . 0.0 110.103 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.575 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -105.61 20.69 36.33 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 111.194 -0.763 . . . . 0.0 111.194 172.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.653 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.0 t80 -65.31 105.19 1.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -113.08 35.78 3.79 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.233 0.54 . . . . 0.0 109.551 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -88.25 -154.04 27.17 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.995 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.507 ' HD3' ' ND2' ' A' ' -3' ' ' ASN . 4.7 ptmt -150.29 22.07 0.84 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.912 0.387 . . . . 0.0 110.687 -168.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.722 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 22.5 mmt180 -68.5 137.86 54.74 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 171.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 m -135.79 38.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.486 0.66 . . . . 0.0 111.655 -171.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.06 145.31 25.42 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.957 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.504 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 69.4 p -74.36 -174.05 1.89 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.042 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -63.71 -20.45 26.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.489 0.661 . . . . 0.0 110.818 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.4 p -92.87 -12.71 30.31 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.499 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.43 11.41 69.03 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.305 -0.95 . . . . 0.0 111.42 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.975 HG21 ' HB2' ' A' ' 67' ' ' ASN . 95.4 m -76.69 119.15 76.2 Favored Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.329 173.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -47.25 124.7 9.45 Favored 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 123.098 2.532 . . . . 0.0 113.689 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 85.8 m -63.5 139.48 58.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.425 0.631 . . . . 0.0 110.884 172.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 23.1 tt0 -71.16 164.81 24.9 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.021 173.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 5.3 m-20 -76.95 125.56 29.51 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.693 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 37.7 m95 -54.06 -31.79 52.62 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.59 -17.08 58.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.244 -1.343 . . . . 0.0 112.749 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 24' ' ' ASP . . . -106.82 150.41 26.38 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -174.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.89 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.3 mm-40 -102.61 29.52 5.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 4.0 mm-40 -133.78 119.47 14.92 Favored Pre-proline 0 N--CA 1.431 -1.393 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -159.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 88.7 Cg_endo -94.24 35.65 7.57 Favored 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.079 -1.634 . . . . 0.0 112.783 -0.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.451 ' HB3' HD12 ' A' ' 71' ' ' LEU . 58.2 m80 -126.81 107.48 10.16 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.89 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.0 OUTLIER -76.59 113.02 13.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.068 -175.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.471 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 5.0 p80 -143.53 92.53 2.37 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.997 0.903 . . . . 0.0 110.422 -172.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.4 m -77.47 39.11 0.25 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.47 0.653 . . . . 0.0 109.534 172.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.465 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.4 pt -143.37 135.86 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -173.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.547 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 45.6 m-85 53.58 48.2 22.2 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 122.265 1.031 . . . . 0.0 111.275 -175.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 46.9 p -99.84 175.54 2.36 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.101 170.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 22.6 Cg_exo -64.79 -18.52 62.72 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.798 1.666 . . . . 0.0 111.257 168.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -83.17 -38.94 21.67 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.314 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.3 p -92.04 -25.23 18.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.085 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.547 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.0 m120 -132.41 68.25 79.39 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.346 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.22 12.37 1.81 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.453 2.102 . . . . 0.0 112.159 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -100.12 -27.7 13.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.156 -174.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.678 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -105.41 6.9 32.92 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.08 0.467 . . . . 0.0 111.689 -172.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.36 46.29 93.09 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.368 174.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.689 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.6 mp -75.4 78.46 2.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.201 0.524 . . . . 0.0 110.507 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.749 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.6 pt-20 -97.64 139.89 32.86 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.675 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 29.4 mmtp 51.82 -111.47 0.57 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.865 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -137.22 14.16 3.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.831 0.348 . . . . 0.0 110.853 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.749 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 18.8 m-85 -66.92 129.5 40.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.528 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 84.1 m -52.88 153.1 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.265 0.353 . . . . 0.0 111.718 -173.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 39.0 mmt-85 -156.26 166.91 32.06 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.17 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -128.32 78.72 75.21 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.941 171.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.672 ' HG3' HD21 ' A' ' 46' ' ' LEU . 28.3 Cg_endo -70.62 -14.08 33.07 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.328 2.019 . . . . 0.0 112.807 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.45 -21.59 20.09 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.468 0.651 . . . . 0.0 109.412 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.74 43.92 86.71 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.51 -167.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 59' ' ' GLY . 7.8 t70 -56.89 140.44 48.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.35 -0.925 . . . . 0.0 109.504 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 58' ' ' VAL . 9.2 t -75.11 13.58 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 122.045 0.926 . . . . 0.0 110.102 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -103.7 -18.61 13.73 Favored Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.28 -177.81 16.61 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.872 -1.156 . . . . 0.0 111.358 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.63 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 86.8 Cg_endo -77.22 153.51 31.76 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.36 2.04 . . . . 0.0 111.304 -175.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.538 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 19.3 p-90 -145.53 -169.23 3.17 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.893 -170.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.693 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.8 p -168.74 -178.11 3.29 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.812 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -101.06 145.36 28.84 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 170.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 ' HE3' ' A' ' 70' ' ' LYS . 3.1 p -99.4 149.27 23.34 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.119 -1.033 . . . . 0.0 109.729 -170.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.9 p -83.86 33.54 0.48 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.523 0.678 . . . . 0.0 109.738 166.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.975 ' HB2' HG21 ' A' ' 20' ' ' THR . 60.8 t-20 -112.97 120.59 40.25 Favored Pre-proline 0 C--N 1.332 -0.158 0 CA-C-N 115.228 -0.897 . . . . 0.0 109.995 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.1 Cg_exo -70.0 5.71 1.68 Allowed 'Trans proline' 0 N--CA 1.472 0.251 0 C-N-CA 122.866 2.378 . . . . 0.0 113.489 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -84.87 -50.81 7.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.157 175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.537 ' HE3' HG21 ' A' ' 65' ' ' THR . 0.5 OUTLIER -134.59 154.58 51.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.015 0.436 . . . . 0.0 110.879 -176.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 31' ' ' HIS . 50.8 tp -76.18 -43.42 42.68 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.095 -176.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -142.33 161.25 38.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -177.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.504 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 46.6 t0 -159.36 165.46 33.24 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 60.1 m-85 -93.3 155.05 17.65 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.8 m -103.11 167.99 9.47 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.912 0.387 . . . . 0.0 110.621 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -112.92 56.2 0.68 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.375 0.607 . . . . 0.0 110.033 -176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.722 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.8 p -95.35 128.46 38.35 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 121.186 0.517 . . . . 0.0 110.004 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 77' ' ' VAL . 34.8 Cg_endo -62.77 157.18 49.05 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 C-N-CA 123.565 2.843 . . . . 0.0 113.603 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -75.7 107.13 7.66 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.093 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -39.93 65.71 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.317 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.733 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -93.33 58.97 2.92 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 178.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.559 -178.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -88.44 11.7 16.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.83 0.348 . . . . 0.0 110.145 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 71.58 15.3 6.07 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.438 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.646 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 22.8 t0 -82.47 62.54 6.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.172 0.987 . . . . 0.0 109.963 175.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.546 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.8 OUTLIER -157.64 147.67 20.5 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.599 178.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.613 ' HG2' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.5 150.31 22.33 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -177.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.608 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 90.0 m-85 -106.97 101.5 10.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -176.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.56 -106.87 2.09 Favored Glycine 0 N--CA 1.421 -2.354 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.04 -173.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -83.12 -32.77 26.52 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 125.206 1.18 . . . . 0.0 111.126 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.86 21.72 7.32 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.866 -1.159 . . . . 0.0 111.957 -175.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -65.32 -38.99 91.85 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.112 0.482 . . . . 0.0 109.967 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -106.99 26.55 18.84 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -70.25 104.07 2.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.58 38.74 2.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.011 0.434 . . . . 0.0 110.76 -178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.646 ' CA ' ' HA ' ' A' ' -1' ' ' ASP . . . -94.98 -159.77 33.59 Favored Glycine 0 C--N 1.329 0.174 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.943 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 14.5 ptmt -145.07 20.94 1.59 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.846 0.323 . . . . 0.0 111.314 -172.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.721 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.9 mmt180 -67.44 138.8 56.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 173.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 50' ' ' TYR . 5.0 m -139.98 34.19 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.479 0.657 . . . . 0.0 111.552 -167.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.771 HG22 ' HA2' ' A' ' 19' ' ' GLY . 8.5 m -151.89 135.38 16.1 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -173.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.428 HG21 ' HB3' ' A' ' 73' ' ' ASP . 78.3 p -73.53 -176.72 2.4 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.941 0.4 . . . . 0.0 112.075 -172.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 m -65.03 -18.67 24.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.439 0.638 . . . . 0.0 111.046 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.8 p -93.12 -14.17 27.57 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.235 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.771 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.41 16.15 62.83 Favored Glycine 0 N--CA 1.433 -1.519 0 CA-C-N 114.694 -1.139 . . . . 0.0 111.426 -174.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.973 HG21 ' HB2' ' A' ' 67' ' ' ASN . 86.3 m -76.8 121.09 84.21 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.633 169.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.49 126.24 15.61 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.768 2.312 . . . . 0.0 113.231 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.5 m -64.88 138.2 58.23 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.46 0.647 . . . . 0.0 110.697 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -72.12 165.71 23.77 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.441 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 16.9 m-20 -76.42 125.53 29.36 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.753 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 33.6 m95 -55.19 -29.18 57.35 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 174.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.8 -23.66 55.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.776 175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -97.24 149.72 21.72 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -173.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.675 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.3 mm-40 -104.57 31.96 4.38 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.2 mt-10 -147.61 122.3 5.1 Favored Pre-proline 0 N--CA 1.425 -1.703 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.283 -155.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 87.4 Cg_endo -87.18 28.6 10.81 Favored 'Cis proline' 0 C--N 1.346 0.44 0 C-N-CA 123.343 -1.524 . . . . 0.0 112.759 0.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.477 ' HB3' HD12 ' A' ' 71' ' ' LEU . 63.7 m80 -128.73 104.51 7.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.675 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -73.88 121.11 20.42 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -176.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.477 ' HE1' ' HA ' ' A' ' 25' ' ' TRP . 5.4 p80 -148.91 95.92 2.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 122.174 0.988 . . . . 0.0 110.172 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 m -77.89 32.15 0.17 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.234 175.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.473 ' H ' ' C ' ' A' ' 33' ' ' HIS . 30.3 pt -141.77 147.98 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -175.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.587 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 52.3 m-85 48.23 50.78 15.88 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.139 0.971 . . . . 0.0 111.268 -173.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 31.1 p -98.98 175.09 2.63 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.142 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 38.4 Cg_exo -62.99 -20.1 70.76 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.041 1.828 . . . . 0.0 112.236 172.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -99.64 -25.62 14.34 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.819 0.342 . . . . 0.0 111.207 -172.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.5 p -91.95 -15.75 27.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.83 0.347 . . . . 0.0 110.462 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.587 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.8 m120 -139.73 52.46 3.8 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.721 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 8.2 Cg_exo -71.49 31.61 0.24 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.789 2.326 . . . . 0.0 113.59 -176.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.81 -10.5 4.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.628 0.251 . . . . 0.0 111.354 177.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.697 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -105.76 9.83 32.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.122 0.487 . . . . 0.0 110.039 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.72 43.4 97.85 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.23 -0.895 . . . . 0.0 113.102 173.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.1 mp -81.32 94.8 6.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.152 0.501 . . . . 0.0 109.856 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.659 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.5 pt-20 -121.43 152.3 39.23 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.07 176.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 4.1 mptp? 46.74 -113.08 0.44 Allowed 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.915 0.76 . . . . 0.0 111.763 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -136.68 18.68 3.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.06 0.457 . . . . 0.0 110.128 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.659 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 20.2 m-85 -67.8 128.39 36.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.786 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.51 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 84.5 m -51.33 147.21 6.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 123.309 0.38 . . . . 0.0 111.254 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.51 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 38.3 mmt-85 -151.53 169.07 22.98 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.695 -176.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -134.27 77.92 59.35 Favored Pre-proline 0 C--N 1.32 -0.712 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.85 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.643 ' HG3' HD21 ' A' ' 46' ' ' LEU . 18.8 Cg_exo -64.36 -26.77 63.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.354 2.036 . . . . 0.0 112.123 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.93 -20.07 23.78 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.547 0.689 . . . . 0.0 109.663 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.71 45.19 93.66 Favored Glycine 0 N--CA 1.433 -1.5 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.674 -170.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -45.47 130.29 8.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 172.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 t -66.55 -5.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 O-C-N 123.941 0.776 . . . . 0.0 110.95 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.28 -20.21 36.28 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.309 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 129.42 -179.95 16.39 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 119.588 -1.291 . . . . 0.0 111.583 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 73.4 Cg_endo -72.66 159.04 49.6 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.21 1.94 . . . . 0.0 111.824 -175.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.569 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 28.4 p-90 -146.23 -171.98 3.84 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.007 -171.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.753 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.3 p -168.18 -177.87 3.45 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.291 -0.868 . . . . 0.0 108.881 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.543 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 57.5 m-85 -100.5 146.68 26.77 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 171.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 2.5 p -102.13 150.21 23.49 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.847 -171.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.2 p -84.27 31.26 0.51 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.527 0.68 . . . . 0.0 110.085 167.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.973 ' HB2' HG21 ' A' ' 20' ' ' THR . 59.0 t-20 -111.26 122.34 37.97 Favored Pre-proline 0 N--CA 1.462 0.16 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.075 -176.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.39 2.21 2.99 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.73 2.286 . . . . 0.0 113.481 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -83.72 -53.67 5.46 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.98 150.11 49.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.281 0.562 . . . . 0.0 110.571 -176.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 31' ' ' HIS . 53.5 tp -75.91 -43.42 45.31 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.349 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 11.2 p90 -143.1 158.56 43.5 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.428 ' HB3' HG21 ' A' ' 16' ' ' THR . 28.6 t0 -153.93 172.22 17.77 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -176.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -94.08 155.06 17.29 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.6 m -106.34 170.95 7.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.747 0.308 . . . . 0.0 110.626 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -121.63 64.58 0.9 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.52 0.676 . . . . 0.0 109.88 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.721 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 1.7 p -94.81 131.78 29.79 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.328 174.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.423 ' HD2' HG23 ' A' ' 77' ' ' VAL . 12.3 Cg_endo -56.06 152.05 39.2 Favored 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 123.403 2.735 . . . . 0.0 113.277 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.434 ' HB3' ' HB2' ' A' ' 82' ' ' ALA . 8.8 tp-100 -74.85 112.65 11.29 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.846 -1.525 . . . . 0.0 109.631 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.546 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.6 OUTLIER -74.66 -37.2 62.78 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.119 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.608 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -88.39 43.86 1.16 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.802 175.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . . . . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.351 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 42.2 m . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . 0.411 ' ND2' ' HD3' ' A' ' 12' ' ' LYS . 54.2 t30 -77.54 -12.75 60.0 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 174.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 68.26 19.48 9.02 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.253 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.404 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 32.9 t0 -87.61 59.44 5.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.961 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.54 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -157.4 157.14 33.45 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.238 -177.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.683 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.9 ptt? -97.61 154.64 17.41 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.689 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 81.1 m-85 -110.5 102.0 10.64 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.65 -115.15 4.18 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.444 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -79.75 -24.84 41.29 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 124.605 0.826 . . . . 0.0 110.788 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.559 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.09 16.56 14.77 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.817 -1.183 . . . . 0.0 111.486 -175.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -64.74 -46.9 80.25 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -101.1 28.26 16.82 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.294 173.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.651 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.3 t80 -70.47 102.01 2.11 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -105.97 32.24 4.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.057 0.456 . . . . 0.0 109.918 -174.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.567 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -84.18 -154.86 20.58 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.528 -175.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HD3' ' ND2' ' A' ' -3' ' ' ASN . 0.0 OUTLIER -150.46 24.69 0.79 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.976 0.417 . . . . 0.0 110.329 -173.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.592 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 27.4 mmt180 -72.0 137.83 47.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 170.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 50' ' ' TYR . 4.0 m -138.29 38.04 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.582 0.706 . . . . 0.0 111.088 -169.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.32 144.07 25.29 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.191 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.437 HG21 HG22 ' A' ' 65' ' ' THR . 42.7 p -75.51 -176.14 3.09 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.24 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 m -65.47 -16.02 19.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.283 0.563 . . . . 0.0 110.824 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 48.4 p -93.22 -15.52 25.81 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.259 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.06 10.69 64.14 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.253 -173.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.629 HG21 ' HB2' ' A' ' 67' ' ' ASN . 85.4 m -77.64 120.68 82.38 Favored Pre-proline 0 N--CA 1.448 -0.549 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.867 174.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -51.31 123.87 12.92 Favored 'Trans proline' 0 C--O 1.239 0.53 0 C-N-CA 122.933 2.422 . . . . 0.0 113.243 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.3 m -62.59 140.94 58.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.848 174.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -73.21 164.96 25.92 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.16 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.63 124.37 27.85 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.639 ' CE3' HD23 ' A' ' 46' ' ' LEU . 44.4 m95 -54.28 -31.42 53.78 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.25 -9.31 59.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.818 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.67 147.41 33.17 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.699 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 34.8 mm-40 -102.22 31.94 3.75 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 41.1 mt-10 -146.51 122.26 5.57 Favored Pre-proline 0 N--CA 1.426 -1.633 0 CA-C-N 114.259 -1.337 . . . . 0.0 113.879 -156.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 3.3 Cg_endo -86.58 26.8 12.53 Favored 'Cis proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.612 -1.412 . . . . 0.0 113.344 2.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.401 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 59.1 m80 -126.52 109.77 12.53 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.699 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -72.78 113.61 10.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.32 -0.855 . . . . 0.0 108.973 -178.031 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.521 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.9 p80 -143.85 90.99 2.18 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.92 0.867 . . . . 0.0 110.096 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 40' ' ' THR . 14.7 m -75.61 34.85 0.12 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.508 0.67 . . . . 0.0 110.089 175.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.521 ' H ' ' C ' ' A' ' 33' ' ' HIS . 17.8 pt -143.84 142.13 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 -175.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.542 ' CG ' ' HH2' ' A' ' 62' ' ' TRP . 32.5 m-85 57.0 45.26 21.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 121.769 0.795 . . . . 0.0 111.004 -176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 21.9 p -103.81 173.47 3.38 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 114.526 -1.215 . . . . 0.0 108.618 168.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 37.2 Cg_exo -59.39 -22.37 65.42 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 121.793 1.662 . . . . 0.0 111.997 170.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -86.56 -39.17 16.45 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.945 0.402 . . . . 0.0 110.649 -177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 34' ' ' SER . 1.8 p -90.26 -20.1 23.36 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.493 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.54 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.4 m120 -135.46 65.14 61.55 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.943 0.401 . . . . 0.0 111.443 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -79.52 32.56 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.358 2.039 . . . . 0.0 111.382 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -120.32 -17.1 8.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.425 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.667 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -118.14 11.35 13.23 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.804 -172.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.95 44.9 95.32 Favored Glycine 0 C--O 1.23 -0.145 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.323 171.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.952 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.2 mp -77.73 90.97 4.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.056 0.455 . . . . 0.0 111.334 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.576 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.6 pt-20 -108.84 142.16 39.83 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.493 175.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp 58.39 -123.64 1.41 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 123.994 0.809 . . . . 0.0 110.908 173.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -130.35 17.09 5.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.659 0.266 . . . . 0.0 110.752 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.576 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 18.0 m-85 -66.4 131.24 45.64 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.627 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 72.1 m -52.24 148.17 6.81 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.422 0.451 . . . . 0.0 111.395 -176.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.412 ' HG3' ' HA ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -153.53 158.93 42.0 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -176.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -119.61 78.93 21.84 Favored Pre-proline 0 C--N 1.316 -0.891 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.825 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.952 ' HG3' HD21 ' A' ' 46' ' ' LEU . 26.8 Cg_exo -58.09 -26.49 75.81 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.741 2.294 . . . . 0.0 112.643 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -102.51 -11.63 18.4 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.754 -178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.17 45.57 95.13 Favored Glycine 0 CA--C 1.501 -0.801 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.217 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 59' ' ' GLY . 4.1 t70 -51.86 133.08 32.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.699 -0.751 . . . . 0.0 109.114 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.6 t -75.79 24.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.844 0.83 . . . . 0.0 110.562 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -116.3 -17.69 6.1 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.82 -179.56 16.1 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.127 -1.035 . . . . 0.0 111.32 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.683 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 71.7 Cg_endo -73.74 157.99 47.42 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.31 2.007 . . . . 0.0 111.481 -175.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.604 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 29.3 p-90 -146.9 -174.16 4.42 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.065 -171.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.614 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.2 p -168.94 178.2 4.62 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.032 177.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.497 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 47.8 m-85 -100.51 145.39 28.36 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.437 HG22 HG21 ' A' ' 16' ' ' THR . 1.1 p -101.94 148.36 25.43 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.734 -171.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 p -79.73 19.2 0.68 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.101 0.477 . . . . 0.0 110.921 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.629 ' HB2' HG21 ' A' ' 20' ' ' THR . 63.0 t-20 -100.35 118.29 61.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.216 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 15.2 Cg_exo -68.52 3.64 2.1 Favored 'Trans proline' 0 N--CA 1.47 0.119 0 C-N-CA 123.157 2.572 . . . . 0.0 113.496 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -84.75 -44.43 13.34 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.966 0.412 . . . . 0.0 110.819 177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.504 ' HE2' ' ND2' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -144.92 142.56 29.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.482 0.658 . . . . 0.0 111.16 -174.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HG ' ' CD1' ' A' ' 64' ' ' TYR . 52.5 tp -70.69 -44.48 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.912 -168.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -146.75 163.83 34.72 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.543 -174.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -154.07 -177.55 6.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.084 172.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -93.15 162.12 14.15 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 94.8 m -105.77 171.43 7.34 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.171 0.51 . . . . 0.0 111.266 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -117.43 70.48 0.79 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.225 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.651 HG21 ' CE1' ' A' ' 9' ' ' TYR . 3.4 p -109.67 128.67 24.99 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.31 173.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.84 159.15 34.59 Favored 'Trans proline' 0 CA--C 1.512 -0.595 0 C-N-CA 123.772 2.981 . . . . 0.0 113.634 -178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -74.39 113.84 12.09 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.068 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.522 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.91 -42.12 58.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.056 179.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.689 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -82.67 63.65 6.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.427 177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.564 -0.732 . . . . 0.0 109.953 179.868 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -87.3 2.07 51.32 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 175.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 69.85 17.3 7.62 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.228 173.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.553 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 27.2 t0 -83.86 65.39 8.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.083 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.593 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.8 OUTLIER -148.6 151.1 34.44 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.149 177.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.722 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 12.9 ptt? -96.83 154.54 17.23 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 81' ' ' ALA . 49.6 m-85 -108.87 96.53 6.39 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.15 -115.18 4.05 Favored Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -79.49 -25.27 41.86 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.761 0.824 . . . . 0.0 111.148 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.627 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 112.04 13.54 12.16 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 119.834 -1.174 . . . . 0.0 111.568 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HB3' ' NZ ' ' A' ' 7' ' ' LYS . 9.1 mtpm? -60.61 -41.74 95.41 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.472 0.653 . . . . 0.0 110.202 175.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.517 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.94 28.64 10.86 Favored Glycine 0 N--CA 1.433 -1.549 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.165 172.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.72 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.7 t80 -68.43 106.31 2.48 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.896 0.379 . . . . 0.0 110.023 173.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.0 51.47 0.8 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -175.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.552 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -101.97 -148.65 21.38 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.711 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.553 ' HD3' ' HB2' ' A' ' -1' ' ' ASP . 0.0 OUTLIER -151.84 20.43 0.69 Allowed 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 116.863 0.332 . . . . 0.0 110.773 -174.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.935 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.4 mmt180 -62.38 139.54 58.55 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.3 m -139.53 35.64 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.06 0.933 . . . . 0.0 109.871 -174.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.07 143.67 25.26 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.091 -177.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.445 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 55.7 p -75.37 -174.75 2.51 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.03 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.12 -16.35 20.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.505 0.669 . . . . 0.0 110.872 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.7 p -93.19 -13.61 28.16 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.44 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.8 10.56 66.84 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.26 -174.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 1.015 HG21 ' HB2' ' A' ' 67' ' ' ASN . 96.9 m -77.08 120.54 82.05 Favored Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.141 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 58.2 Cg_exo -47.48 123.01 7.43 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 123.201 2.601 . . . . 0.0 113.802 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.98 141.14 58.86 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.842 172.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -73.81 166.26 23.64 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.417 173.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 11.8 m-20 -76.52 124.7 28.0 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 175.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.671 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 38.6 m95 -53.73 -32.55 52.53 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 174.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.9 -12.09 59.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 113.945 -1.479 . . . . 0.0 113.045 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.78 149.09 30.31 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-N 119.21 0.914 . . . . 0.0 109.052 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.693 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 29.3 mm-40 -101.84 31.76 3.72 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 44.1 mt-10 -145.57 121.39 5.81 Favored Pre-proline 0 N--CA 1.426 -1.655 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.712 -155.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 93.8 Cg_endo -89.92 33.59 7.83 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.469 -1.471 . . . . 0.0 113.217 1.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.6 ' HB3' HD12 ' A' ' 71' ' ' LEU . 64.3 m80 -134.11 111.16 10.1 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.693 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -72.17 126.6 30.21 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -177.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.526 ' C ' ' H ' ' A' ' 35' ' ' ILE . 6.1 p80 -155.02 89.43 1.22 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.033 0.921 . . . . 0.0 110.271 179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 m -73.79 34.23 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.528 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.526 ' H ' ' C ' ' A' ' 33' ' ' HIS . 20.7 pt -143.29 147.21 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -177.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.561 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 35.7 m-85 52.29 45.49 28.35 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.983 0.897 . . . . 0.0 111.27 -174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.6 p -100.8 172.59 4.36 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.495 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.15 -14.16 42.02 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.015 1.81 . . . . 0.0 112.003 172.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -92.91 -37.72 12.09 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.929 0.395 . . . . 0.0 110.167 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -87.74 -22.37 24.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.464 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.561 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.0 m120 -130.82 60.29 51.96 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 120.79 0.328 . . . . 0.0 111.014 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.81 39.15 0.73 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.641 2.227 . . . . 0.0 112.956 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.478 ' NH1' ' HA ' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -141.56 -16.01 0.82 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.644 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -99.52 12.3 36.81 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.166 -0.334 . . . . 0.0 110.453 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.79 40.21 85.23 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.681 -0.69 . . . . 0.0 113.085 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.644 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.2 mp -81.76 102.43 10.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.094 0.473 . . . . 0.0 110.435 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.403 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.4 pt-20 -127.27 142.75 51.39 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.448 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 31.5 mmtp 55.14 -116.15 1.02 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.969 0.793 . . . . 0.0 111.211 177.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -136.11 17.42 3.22 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 120.827 0.346 . . . . 0.0 110.83 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.403 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 30.0 m-85 -66.06 130.71 44.19 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.615 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 93.8 m -56.57 146.91 23.6 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.994 0.426 . . . . 0.0 111.668 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -152.81 159.88 43.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -176.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -126.37 80.25 69.38 Favored Pre-proline 0 N--CA 1.445 -0.685 0 C-N-CA 120.746 -0.381 . . . . 0.0 109.98 175.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.64 ' HG3' HD21 ' A' ' 46' ' ' LEU . 37.6 Cg_exo -59.63 -31.71 94.77 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.908 2.405 . . . . 0.0 112.592 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -88.99 -24.0 22.49 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 121.523 0.677 . . . . 0.0 110.048 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.64 46.36 69.38 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.019 -172.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -48.39 133.64 15.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.628 -0.786 . . . . 0.0 109.73 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.37 -11.29 4.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 124.451 1.094 . . . . 0.0 111.527 -176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -100.29 -10.89 43.73 Favored Glycine 0 N--CA 1.438 -1.176 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.909 -174.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.84 -177.81 16.59 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 119.753 -1.213 . . . . 0.0 111.684 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.722 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 88.2 Cg_endo -74.69 164.77 32.99 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.575 2.183 . . . . 0.0 111.694 -173.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.598 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 29.8 p-90 -149.97 -172.13 4.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.227 -172.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.671 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.7 p -168.91 -177.71 3.08 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.691 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.462 ' CD1' ' HB3' ' A' ' 72' ' ' TYR . 50.1 m-85 -100.99 147.29 26.35 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 171.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 p -103.35 147.16 27.43 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.081 -170.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.7 p -82.48 21.47 0.96 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.153 0.501 . . . . 0.0 110.411 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 1.015 ' HB2' HG21 ' A' ' 20' ' ' THR . 52.8 t-20 -99.35 123.11 49.65 Favored Pre-proline 0 N--CA 1.456 -0.164 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.155 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.83 1.98 2.39 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.836 2.357 . . . . 0.0 113.16 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -84.08 -50.75 7.66 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.044 0.449 . . . . 0.0 111.089 175.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -130.14 159.55 36.48 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.368 0.604 . . . . 0.0 111.212 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 31' ' ' HIS . 45.4 tp -84.81 -45.63 12.15 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.857 -177.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.462 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 33.6 p90 -143.37 164.18 30.98 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.863 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 37.2 t0 -160.01 176.23 12.08 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -94.34 157.51 16.0 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.9 m -106.03 167.64 9.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.712 0.291 . . . . 0.0 110.288 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -117.89 72.44 0.85 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.308 0.575 . . . . 0.0 110.037 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.935 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -106.6 129.48 24.38 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.953 175.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.93 157.3 16.96 Favored 'Trans proline' 0 CA--C 1.516 -0.392 0 C-N-CA 124.327 3.351 . . . . 0.0 113.85 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.89 113.83 13.82 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.933 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.593 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.89 -44.4 40.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.589 178.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.615 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . . . -84.84 65.21 9.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.372 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.13 179.844 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -98.48 -10.98 22.78 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 68.77 20.11 8.2 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.803 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.475 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 23.3 t70 -86.03 58.69 5.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.451 1.119 . . . . 0.0 109.234 176.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.477 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -157.44 156.93 33.01 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.262 -177.103 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.56 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 15.9 ptt? -96.28 154.86 17.02 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.508 ' CD2' ' HB2' ' A' ' 81' ' ' ALA . 7.8 m-85 -113.67 96.45 5.87 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.27 -115.09 3.98 Favored Glycine 0 N--CA 1.431 -1.669 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -79.83 -22.21 43.26 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.282 0.636 . . . . 0.0 109.715 -176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.92 11.55 20.44 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.224 -0.988 . . . . 0.0 110.938 -174.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 7' ' ' LYS . 9.2 mtpm? -65.17 -31.75 73.1 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.055 0.455 . . . . 0.0 110.124 176.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.481 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -111.7 19.45 23.64 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 173.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.683 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.1 t80 -68.19 110.53 4.06 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -118.32 45.15 2.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 0.0 109.664 -177.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.531 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -98.88 -159.85 29.58 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.85 -175.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -139.59 15.12 2.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.495 0.188 . . . . 0.0 110.74 -170.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.638 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 19.8 mmt180 -64.66 135.78 56.28 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 175.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 2.8 m -134.61 36.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.553 0.692 . . . . 0.0 111.209 -171.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.764 HG23 ' HA2' ' A' ' 19' ' ' GLY . 0.4 OUTLIER -151.35 139.97 20.68 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -178.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.629 HG21 ' HB3' ' A' ' 73' ' ' ASP . 75.3 p -75.15 -169.69 1.0 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.892 -175.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -66.25 -21.11 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.312 0.577 . . . . 0.0 110.759 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.2 p -92.84 -13.33 29.22 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.191 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.764 ' HA2' HG23 ' A' ' 15' ' ' THR . . . 82.62 20.69 61.31 Favored Glycine 0 N--CA 1.44 -1.063 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.582 -173.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 99.5 m -76.48 119.31 76.82 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 168.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 86.0 Cg_exo -49.52 135.95 33.2 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.924 2.416 . . . . 0.0 113.225 176.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.408 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 72.9 m -76.45 142.94 40.84 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.734 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -70.96 165.53 23.2 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.297 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.9 128.81 35.24 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.679 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 57.8 m95 -57.82 -30.89 66.09 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.437 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . . . -78.07 -18.1 56.17 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.853 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.44 149.58 21.24 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -174.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 30.3 mm-40 -104.3 31.24 4.73 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 35.5 mt-10 -147.62 122.79 5.2 Favored Pre-proline 0 N--CA 1.422 -1.832 0 CA-C-N 113.795 -1.548 . . . . 0.0 114.397 -154.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 91.9 Cg_endo -86.85 29.82 9.03 Favored 'Cis proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.212 -1.578 . . . . 0.0 112.839 -0.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.689 ' HB3' HD12 ' A' ' 71' ' ' LEU . 55.0 m80 -130.58 107.49 9.24 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.641 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.3 OUTLIER -74.48 125.33 28.35 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -174.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.47 ' C ' ' H ' ' A' ' 35' ' ' ILE . 3.9 p80 -155.21 98.13 1.97 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.99 0.9 . . . . 0.0 110.96 -177.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.0 m -79.61 33.78 0.26 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.666 0.746 . . . . 0.0 109.837 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.47 ' H ' ' C ' ' A' ' 33' ' ' HIS . 31.4 pt -142.15 146.16 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.623 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 41.7 m-85 50.06 51.04 17.44 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 121.931 0.872 . . . . 0.0 111.254 -175.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 29.3 p -99.44 177.65 1.5 Allowed Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 114.451 -1.25 . . . . 0.0 109.115 171.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 35.6 Cg_exo -60.53 -29.24 88.18 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 121.872 1.714 . . . . 0.0 111.378 170.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.04 -30.56 16.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.682 -167.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 38.0 p -89.06 -19.91 25.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.036 0.446 . . . . 0.0 110.23 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.623 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 16.5 m120 -133.97 67.25 73.74 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.719 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.27 9.94 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.039 1.826 . . . . 0.0 111.783 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -96.38 -24.05 16.33 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.724 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -106.58 1.18 25.09 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.861 -177.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.11 44.68 90.74 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.225 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.724 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -73.12 99.98 2.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.69 0.281 . . . . 0.0 110.381 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.489 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.8 pt-20 -118.68 142.99 47.14 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 175.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 23.5 mmmt 53.39 -115.58 0.97 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 123.715 0.635 . . . . 0.0 111.576 178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -135.34 17.76 3.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.211 0.529 . . . . 0.0 110.589 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.489 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 27.7 m-85 -68.61 129.71 40.72 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 71.6 m -54.71 153.4 6.0 Favored 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 123.219 0.324 . . . . 0.0 111.462 -173.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 35.5 mmt-85 -156.89 169.82 23.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.78 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -128.25 77.35 77.04 Favored Pre-proline 0 C--N 1.316 -0.852 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.52 169.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HG3' HD21 ' A' ' 46' ' ' LEU . 36.2 Cg_endo -70.78 -13.64 32.25 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.256 1.971 . . . . 0.0 112.474 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.67 -25.95 17.26 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.036 0.922 . . . . 0.0 109.055 173.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.54 40.64 99.37 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 113.968 -1.469 . . . . 0.0 110.959 -169.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -48.54 133.88 16.13 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 172.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 t -72.63 6.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.611 0.72 . . . . 0.0 110.805 -175.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -98.47 -22.45 14.43 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.07 -179.3 16.94 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 119.513 -1.327 . . . . 0.0 112.02 178.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.56 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 95.5 Cg_endo -75.6 157.64 40.18 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.386 2.057 . . . . 0.0 111.612 -174.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.513 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 15.7 p-90 -148.26 -169.7 3.41 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.958 -172.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.679 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 28.9 p -168.6 -177.5 3.14 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.458 176.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 67.7 m-85 -100.22 146.09 27.29 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 170.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 p -100.09 145.25 28.17 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.632 -170.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 76.9 p -78.49 17.8 0.63 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.034 0.445 . . . . 0.0 110.991 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 16.3 t30 -105.8 120.47 49.06 Favored Pre-proline 0 C--N 1.333 -0.125 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 21.8 Cg_exo -65.91 4.96 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.353 2.702 . . . . 0.0 114.072 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.453 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 20.4 mmm180 -82.05 -43.16 18.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.615 0.245 . . . . 0.0 111.21 173.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -134.68 156.47 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.329 0.585 . . . . 0.0 111.068 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.689 HD12 ' HB3' ' A' ' 31' ' ' HIS . 41.5 tp -83.19 -45.09 14.3 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.905 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 29.0 p90 -143.74 164.87 29.25 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.995 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.629 ' HB3' HG21 ' A' ' 16' ' ' THR . 37.4 t0 -160.71 169.4 22.89 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 65.0 m-85 -92.85 155.84 17.36 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 80.9 m -104.46 168.32 9.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.148 0.499 . . . . 0.0 111.11 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -115.47 64.49 0.69 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.398 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.683 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.8 p -104.36 130.72 22.81 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.497 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 77' ' ' VAL . 25.2 Cg_endo -61.33 154.78 56.09 Favored 'Trans proline' 0 CA--C 1.511 -0.67 0 C-N-CA 123.85 3.033 . . . . 0.0 113.625 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -75.66 109.43 9.23 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.286 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.423 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -72.82 -43.17 63.01 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.305 179.033 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.508 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . . . -104.14 68.39 0.89 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.027 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.66 -0.686 . . . . 0.0 110.182 179.428 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 52.5 m . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -99.17 -11.22 21.57 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 65.65 12.33 8.17 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.602 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.538 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 24.3 t0 -86.3 50.07 1.92 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.871 1.32 . . . . 0.0 109.955 -178.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.592 ' C ' ' HB2' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -155.82 153.19 29.39 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.51 -1.677 . . . . 0.0 108.456 178.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.516 ' HG2' ' HG3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -98.02 143.44 28.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -175.175 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.685 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 74.1 m-85 -102.32 104.07 14.56 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.7 -111.51 3.27 Favored Glycine 0 N--CA 1.424 -2.11 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.495 -174.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -89.14 -20.23 24.51 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 124.444 0.732 . . . . 0.0 110.521 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 108.03 15.87 13.68 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 119.79 -1.195 . . . . 0.0 111.886 -177.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -63.94 -38.53 91.42 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.009 0.433 . . . . 0.0 110.271 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.31 24.64 22.15 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 173.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.8 t80 -71.24 103.45 2.82 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 174.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -110.72 46.43 1.06 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.171 0.51 . . . . 0.0 109.681 -176.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.586 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.17 -158.61 32.0 Favored Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.604 -0.725 . . . . 0.0 113.174 -173.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -140.68 14.6 2.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.73 0.3 . . . . 0.0 110.581 -170.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.917 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.9 mmt180 -67.16 135.72 53.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.16 38.84 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.752 0.787 . . . . 0.0 110.854 -170.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.98 148.52 28.48 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.273 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -75.2 -171.41 1.4 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.915 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.82 -18.32 24.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.398 0.618 . . . . 0.0 110.884 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.4 p -93.54 -12.63 29.14 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.792 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.44 12.75 69.3 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.195 -1.002 . . . . 0.0 111.373 -172.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.886 HG21 ' HB2' ' A' ' 67' ' ' ASN . 99.5 m -75.87 121.63 85.41 Favored Pre-proline 0 N--CA 1.447 -0.595 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 172.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -50.31 128.3 22.54 Favored 'Trans proline' 0 CA--C 1.514 -0.493 0 C-N-CA 122.641 2.227 . . . . 0.0 113.193 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.42 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 77.0 m -69.13 137.6 53.53 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.293 171.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -70.06 165.85 21.02 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.533 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 13.9 m-20 -76.63 125.93 30.09 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.708 ' CE3' HD23 ' A' ' 46' ' ' LEU . 43.3 m95 -53.77 -30.28 43.88 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.566 0.698 . . . . 0.0 109.182 176.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.4 -19.97 55.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.793 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.49 150.29 23.2 Favored 'General case' 0 C--O 1.21 -1.017 0 O-C-N 121.639 -0.663 . . . . 0.0 109.528 -170.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 33.2 mm-40 -104.56 23.95 12.48 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -140.54 131.0 13.66 Favored Pre-proline 0 N--CA 1.432 -1.363 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.389 -166.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -86.09 26.61 12.02 Favored 'Cis proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.88 -1.717 . . . . 0.0 113.229 0.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.553 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 30.2 m80 -127.59 109.9 12.17 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.587 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 6.2 mmt180 -73.17 112.26 9.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.446 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.9 p80 -144.24 96.19 2.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.393 1.092 . . . . 0.0 110.51 -176.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.4 m -75.7 23.06 0.13 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.493 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 33' ' ' HIS . 34.1 pt -140.89 158.31 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.594 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 63.4 m-85 50.71 46.91 25.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 122.02 0.914 . . . . 0.0 110.727 -173.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.485 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 32.0 p -100.01 174.63 2.88 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 114.072 -1.422 . . . . 0.0 108.87 171.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 26.5 Cg_exo -64.12 -16.94 57.78 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 121.827 1.684 . . . . 0.0 111.851 171.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -90.87 -37.64 13.44 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.442 -175.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.7 p -88.82 -19.94 25.31 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 -176.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.594 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.8 m120 -134.8 65.78 67.13 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.093 0.473 . . . . 0.0 111.33 -177.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.51 8.64 1.79 Allowed 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.421 2.081 . . . . 0.0 112.056 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -102.51 -16.88 15.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.365 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.684 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -109.63 5.17 22.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.109 -178.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 47' ' ' GLU . . . 62.04 45.87 95.2 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.448 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.719 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.7 mp -72.36 94.48 1.62 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.195 0.522 . . . . 0.0 110.439 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.747 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.3 pt-20 -108.39 134.53 51.06 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.089 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm 54.93 -112.15 0.69 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.568 0.543 . . . . 0.0 111.544 176.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -134.77 12.87 3.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.476 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.747 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 21.6 m-85 -64.07 128.71 37.0 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 177.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 80.4 m -51.16 155.31 1.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.398 0.436 . . . . 0.0 111.684 -175.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 29.3 mmt-85 -158.17 169.4 24.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.988 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -128.19 78.2 75.78 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 120.188 -0.605 . . . . 0.0 109.525 168.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.719 ' HG3' HD21 ' A' ' 46' ' ' LEU . 26.9 Cg_endo -69.61 -12.52 33.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.267 1.978 . . . . 0.0 112.248 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -95.71 -27.25 15.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.897 0.856 . . . . 0.0 109.375 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.37 37.28 93.82 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 114.055 -1.429 . . . . 0.0 110.398 -166.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 59' ' ' GLY . 9.3 t70 -45.16 131.57 7.63 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.672 -0.764 . . . . 0.0 110.219 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.47 34.05 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.833 0.825 . . . . 0.0 110.339 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -122.05 -19.7 3.22 Favored Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.53 179.96 15.92 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.922 -1.133 . . . . 0.0 111.432 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.516 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 94.6 Cg_endo -72.85 152.56 52.49 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.963 1.775 . . . . 0.0 111.399 -176.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.476 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 23.9 p-90 -145.95 -171.49 3.72 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.679 -1.146 . . . . 0.0 108.898 -170.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.653 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.1 p -168.51 179.88 4.17 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.623 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.439 ' HD1' ' O ' ' A' ' 71' ' ' LEU . 40.0 m-85 -100.77 139.68 36.11 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.6 p -98.33 148.74 23.35 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.574 -170.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.5 p -80.95 20.45 0.78 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.267 0.556 . . . . 0.0 110.377 169.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.886 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.9 t-20 -98.94 119.08 61.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.848 -177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 17.6 Cg_exo -66.32 -0.55 4.36 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.993 2.462 . . . . 0.0 113.546 -177.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -84.7 -43.46 14.3 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.8 0.333 . . . . 0.0 111.434 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.39 149.54 49.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.326 0.584 . . . . 0.0 110.417 -176.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.553 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 46.6 tp -78.87 -43.09 25.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.382 -175.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -143.27 163.51 32.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.783 -178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 62' ' ' TRP . 1.0 OUTLIER -159.15 178.59 9.86 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -93.79 158.08 15.83 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.84 166.15 10.58 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.247 0.546 . . . . 0.0 111.231 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -109.38 60.19 0.6 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.289 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.917 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -104.66 128.62 26.5 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.397 174.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -62.02 161.81 24.78 Favored 'Trans proline' 0 CA--C 1.511 -0.671 0 C-N-CA 124.055 3.17 . . . . 0.0 113.743 -176.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.456 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 8.8 tp-100 -75.73 110.53 10.22 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.454 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.592 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.04 -38.67 61.38 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.205 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.685 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -90.11 62.41 5.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.51 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.456 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.27 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 N--CA 1.472 0.671 0 CA-C-O 120.775 0.321 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -85.78 -4.16 59.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.902 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 66.74 32.02 7.14 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.415 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.413 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 20.7 t0 -81.4 53.91 2.19 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.683 1.23 . . . . 0.0 109.23 175.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.586 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -151.84 157.79 42.38 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.165 -179.182 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.674 ' HG2' ' HG3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -97.95 142.39 29.75 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.561 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 66.0 m-85 -101.41 102.25 13.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -177.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.2 -114.44 3.89 Favored Glycine 0 N--CA 1.426 -1.985 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.618 -173.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -84.87 -23.58 28.92 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.382 0.695 . . . . 0.0 110.267 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.99 15.33 11.96 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.449 -175.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.6 mtpt -67.92 -36.01 79.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.204 0.526 . . . . 0.0 110.33 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -107.57 20.21 32.5 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.608 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.6 t80 -66.5 101.74 0.8 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.34 46.4 0.93 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.179 0.514 . . . . 0.0 110.551 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -101.77 -158.14 26.59 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.171 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 ptmm? -149.86 22.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.947 0.374 . . . . 0.0 110.76 -170.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.873 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 21.0 mmt180 -65.2 139.04 58.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.75 30.79 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.536 0.684 . . . . 0.0 111.654 -170.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.27 142.39 24.05 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -176.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 69.4 p -75.31 -176.87 3.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.871 0.367 . . . . 0.0 111.605 -174.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 m -63.8 -19.39 24.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.47 0.652 . . . . 0.0 110.851 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.5 p -93.42 -12.01 30.82 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.798 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.79 12.76 68.27 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.28 -173.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.714 HG21 ' HB2' ' A' ' 67' ' ' ASN . 85.6 m -76.86 119.76 78.85 Favored Pre-proline 0 N--CA 1.449 -0.486 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 171.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_exo -50.62 123.74 12.04 Favored 'Trans proline' 0 C--O 1.238 0.499 0 C-N-CA 122.811 2.341 . . . . 0.0 112.993 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.1 m -64.33 139.23 58.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.412 0.625 . . . . 0.0 110.565 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -71.4 166.01 22.56 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.807 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -77.24 127.34 32.43 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.773 ' CE3' HD23 ' A' ' 46' ' ' LEU . 64.6 m95 -57.14 -30.04 64.1 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.533 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . . . -78.69 -18.28 54.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.52 177.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.89 150.2 20.7 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.688 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.2 mm-40 -104.17 32.54 3.94 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 34.7 mt-10 -145.87 122.09 5.84 Favored Pre-proline 0 N--CA 1.428 -1.564 0 CA-C-N 114.027 -1.442 . . . . 0.0 114.104 -157.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 2.4 Cg_endo -86.69 25.25 15.47 Favored 'Cis proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.597 -1.418 . . . . 0.0 112.79 1.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.42 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 43.1 m80 -128.14 108.72 10.87 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.688 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.1 ppt_? -73.95 120.57 19.72 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.543 -178.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.458 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.3 p80 -148.76 98.12 2.82 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.248 1.023 . . . . 0.0 109.739 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.5 m -77.79 28.51 0.17 Allowed 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.595 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.458 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.1 pt -141.5 151.43 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -176.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.55 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 59.5 m-85 52.25 48.03 23.51 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 122.054 0.931 . . . . 0.0 111.146 -176.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 41.8 p -100.32 176.08 2.08 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.394 172.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 7.7 Cg_exo -70.71 -11.63 29.89 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 121.963 1.775 . . . . 0.0 111.087 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -92.87 -31.26 15.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.03 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.4 p -98.97 -19.8 17.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.092 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.2 m120 -135.58 57.91 22.1 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -174.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 41' ' ' ASN . 13.6 Cg_exo -69.81 15.98 0.23 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.234 1.956 . . . . 0.0 112.545 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 41' ' ' ASN . 18.8 ptt180 -99.6 -17.83 17.64 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.789 0.328 . . . . 0.0 111.034 -177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.743 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -118.13 3.4 12.05 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.445 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.05 46.67 90.67 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.566 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.773 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.3 mp -77.38 67.57 3.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.509 0.195 . . . . 0.0 111.185 -178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.526 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 6.0 pt-20 -97.39 157.6 15.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.764 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm 52.07 -125.55 2.36 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.351 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -129.16 23.21 5.63 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.055 0.455 . . . . 0.0 110.373 174.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.526 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 38.5 m-85 -65.64 123.14 18.92 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.955 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.445 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 71.4 m -50.25 151.29 2.14 Favored 'General case' 0 CA--C 1.517 -0.324 0 O-C-N 123.378 0.424 . . . . 0.0 111.42 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 43.2 mmt-85 -157.58 170.99 21.16 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.228 -174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -131.36 76.81 75.14 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.347 169.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.77 ' HG3' HD21 ' A' ' 46' ' ' LEU . 33.8 Cg_endo -66.95 -15.9 48.24 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.563 2.176 . . . . 0.0 112.635 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -95.86 -26.04 15.77 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.938 0.875 . . . . 0.0 109.451 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.28 39.46 97.88 Favored Glycine 0 N--CA 1.436 -1.301 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.598 -166.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.498 ' C ' ' H ' ' A' ' 59' ' ' GLY . 19.7 t70 -44.82 131.42 7.04 Favored 'General case' 0 CA--C 1.511 -0.533 0 O-C-N 124.462 0.742 . . . . 0.0 110.153 173.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.8 t -76.04 35.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.785 0.803 . . . . 0.0 110.188 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -126.16 -18.34 2.33 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 173.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.76 -179.64 16.07 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.485 177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.674 ' HG3' ' HG2' ' A' ' 2' ' ' MET . 92.9 Cg_endo -73.71 150.99 45.82 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.143 1.895 . . . . 0.0 111.33 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 74' ' ' TYR . 19.1 p-90 -144.66 -170.49 3.4 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.038 -169.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.727 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.1 p -168.86 -179.25 3.64 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -101.23 146.8 27.05 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 171.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.426 ' HB ' ' CG2' ' A' ' 20' ' ' THR . 1.2 p -102.91 146.17 28.72 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.879 -171.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.9 p -81.21 20.41 0.83 Allowed 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.826 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.714 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.8 t-20 -99.4 120.81 56.95 Favored Pre-proline 0 C--N 1.337 0.036 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.226 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 16.7 Cg_exo -67.04 4.88 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.022 2.481 . . . . 0.0 113.404 -179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -84.81 -58.26 2.78 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.744 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -119.53 159.29 24.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.797 -174.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 50.4 tp -87.85 -45.78 10.0 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.553 -177.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -143.04 156.38 44.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.07 0.462 . . . . 0.0 109.831 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -154.37 173.36 16.32 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 59.0 m-85 -93.26 157.84 16.05 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 69.9 m -105.3 162.39 13.47 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.895 0.378 . . . . 0.0 110.447 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -95.48 32.15 1.85 Allowed 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.315 0.579 . . . . 0.0 111.14 -172.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.873 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.4 p -80.51 122.6 82.65 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.683 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.12 162.75 25.13 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 C-N-CA 124.219 3.279 . . . . 0.0 113.884 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.44 ' NE2' ' SD ' ' A' ' 2' ' ' MET . 8.8 tp-100 -72.59 110.36 6.9 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.282 -1.326 . . . . 0.0 110.677 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.561 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.3 -41.65 56.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.639 179.048 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.561 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -85.48 46.0 1.25 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.3 -177.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.724 -0.655 . . . . 0.0 109.467 175.858 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' A' ' -2' ' ' ALA . 46.1 t30 -92.03 -3.98 55.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 176.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' -3' ' ' ASN . . . 78.04 5.03 2.81 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 114.359 -1.292 . . . . 0.0 109.683 -173.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.616 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 29.8 t70 -81.09 63.69 5.54 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.845 172.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.492 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -160.38 150.14 17.79 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.198 -1.365 . . . . 0.0 109.207 -177.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.609 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 7.0 ptt? -97.03 154.28 17.41 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.616 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 83.0 m-85 -112.38 95.63 5.55 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.64 -110.8 3.11 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -79.17 -29.77 43.17 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 124.935 1.02 . . . . 0.0 111.005 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 9' ' ' TYR . . . 108.36 17.88 10.25 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 119.614 -1.279 . . . . 0.0 112.079 -177.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -62.5 -43.62 98.38 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.358 0.599 . . . . 0.0 110.114 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.471 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -105.09 27.9 16.82 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.027 174.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.774 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.2 t80 -68.94 105.47 2.4 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 170.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -109.18 42.54 1.42 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.085 0.469 . . . . 0.0 110.109 -175.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.616 ' CA ' ' HA ' ' A' ' -1' ' ' ASP . . . -93.49 -152.73 29.58 Favored Glycine 0 C--N 1.329 0.17 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.992 -175.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -148.08 16.54 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.763 0.282 . . . . 0.0 110.756 -172.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.774 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 17.1 mmt180 -66.38 138.17 57.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 m -138.6 32.36 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.636 0.732 . . . . 0.0 110.776 -170.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.688 HG22 ' HA2' ' A' ' 19' ' ' GLY . 3.6 m -151.89 136.17 16.72 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -173.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.5 HG21 ' HB3' ' A' ' 73' ' ' ASP . 74.5 p -73.35 -172.51 1.16 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -171.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.7 m -69.27 -18.57 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.546 0.689 . . . . 0.0 110.447 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p -92.13 -14.38 29.24 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.048 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.688 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 84.96 15.19 67.9 Favored Glycine 0 N--CA 1.435 -1.43 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.243 -174.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.77 HG21 ' HB2' ' A' ' 67' ' ' ASN . 98.3 m -78.36 121.02 83.24 Favored Pre-proline 0 N--CA 1.442 -0.83 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 169.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -49.63 130.56 26.48 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.764 2.309 . . . . 0.0 113.362 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.2 m -67.53 140.56 57.0 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.972 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -73.82 165.92 24.26 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.324 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.454 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 2.1 m-20 -76.25 125.94 30.08 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 175.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.645 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 41.0 m95 -54.77 -29.29 53.69 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 173.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.92 -22.1 53.85 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.276 -1.329 . . . . 0.0 113.1 176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -99.96 150.11 22.75 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 119.039 0.836 . . . . 0.0 108.748 -172.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.637 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.2 mm-40 -103.19 32.28 3.84 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 36.0 mt-10 -145.68 122.42 6.01 Favored Pre-proline 0 N--CA 1.43 -1.439 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -158.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 91.9 Cg_endo -88.37 31.82 8.42 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.29 -1.546 . . . . 0.0 113.375 0.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.536 ' CD2' ' HA ' ' A' ' 71' ' ' LEU . 58.7 m80 -130.75 113.58 14.31 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.637 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 25.9 mmm180 -74.06 113.56 11.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.89 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.459 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.8 p80 -147.85 94.37 2.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.139 0.971 . . . . 0.0 111.16 -177.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m -79.8 35.81 0.31 Allowed 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.498 0.665 . . . . 0.0 110.113 172.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.445 ' H ' ' C ' ' A' ' 33' ' ' HIS . 23.4 pt -142.06 146.18 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.583 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 50.2 m-85 51.17 46.71 26.06 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 122.222 1.011 . . . . 0.0 110.969 -173.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.554 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 35.7 p -99.66 174.26 3.16 Favored Pre-proline 0 N--CA 1.444 -0.743 0 CA-C-N 114.019 -1.446 . . . . 0.0 109.255 171.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 32.0 Cg_exo -59.35 -23.16 68.89 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.922 1.748 . . . . 0.0 112.185 170.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.49 -34.95 13.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 120.79 0.329 . . . . 0.0 111.296 -173.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.6 p -85.73 -18.67 32.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.997 0.427 . . . . 0.0 110.503 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.583 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.4 m120 -138.21 59.67 19.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.509 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -75.17 19.97 0.49 Allowed 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.613 2.208 . . . . 0.0 112.809 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -122.45 -8.69 8.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.491 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -106.51 7.93 31.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.386 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.99 40.85 97.43 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.384 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.2 mp -77.08 95.83 4.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.998 0.428 . . . . 0.0 110.828 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.472 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.2 pt-20 -118.23 152.16 36.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.504 175.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 34.2 mmtp 50.95 -115.26 0.85 Allowed 'General case' 0 C--O 1.233 0.232 0 O-C-N 123.828 0.705 . . . . 0.0 111.183 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -139.47 19.68 2.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.001 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.472 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 32.8 m-85 -66.5 129.62 40.46 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.571 178.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.656 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 74.0 m -56.03 148.94 16.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.086 0.469 . . . . 0.0 111.824 -173.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.651 ' HD2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -155.17 158.2 38.58 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.632 -175.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -123.26 80.71 52.49 Favored Pre-proline 0 C--N 1.322 -0.613 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.427 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HD2' ' CZ2' ' A' ' 62' ' ' TRP . 3.4 Cg_exo -72.25 -13.04 28.14 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.287 1.992 . . . . 0.0 111.579 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -89.04 -32.28 17.65 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.63 38.76 96.39 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 113.521 -1.672 . . . . 0.0 109.856 -166.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -48.13 133.38 15.22 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.725 -0.738 . . . . 0.0 109.491 172.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 t -70.14 -0.27 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.489 0.661 . . . . 0.0 110.591 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.88 -17.18 42.03 Favored Glycine 0 N--CA 1.437 -1.274 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.21 -178.8 16.3 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 119.766 -1.207 . . . . 0.0 111.619 176.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.609 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 74.1 Cg_endo -72.5 158.39 51.16 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.251 1.968 . . . . 0.0 111.167 -175.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.593 ' CZ2' ' HD2' ' A' ' 54' ' ' PRO . 25.8 p-90 -148.3 -171.02 3.74 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.844 -171.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.645 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 28.9 p -168.37 -177.24 3.14 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.559 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.5 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 61.9 m-85 -100.47 150.03 23.07 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 170.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 67' ' ' ASN . 2.5 p -104.69 150.27 24.87 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.248 -173.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 44.6 p -82.18 27.61 0.48 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.385 0.612 . . . . 0.0 110.102 168.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.77 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.9 t-20 -111.48 114.49 52.74 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.891 -177.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 17.2 Cg_exo -67.28 2.74 2.06 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 123.099 2.533 . . . . 0.0 113.976 -177.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -84.32 -33.85 23.83 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.874 0.368 . . . . 0.0 111.354 175.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -143.89 143.09 31.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.257 0.551 . . . . 0.0 110.32 -177.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 52.3 tp -73.98 -42.62 60.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.765 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 5.3 p90 -142.65 159.5 42.12 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -178.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.5 ' HB3' HG21 ' A' ' 16' ' ' THR . 25.7 t0 -154.29 171.52 19.11 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -93.1 155.6 17.39 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 85.5 m -105.04 168.61 8.94 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.167 0.508 . . . . 0.0 110.583 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -117.43 70.28 0.78 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.019 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.774 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.6 p -106.5 129.52 24.34 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.521 174.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 11.2 Cg_endo -54.82 151.81 31.15 Favored 'Trans proline' 0 CA--C 1.509 -0.738 0 C-N-CA 124.146 3.231 . . . . 0.0 113.766 -178.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.46 110.75 10.1 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.08 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.492 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.19 -42.2 60.21 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.195 178.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.616 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -86.15 56.72 4.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.715 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.678 -0.677 . . . . 0.0 109.922 178.75 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 22.6 m . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -84.95 2.58 42.23 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 70.64 25.84 4.06 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 124.407 1.067 . . . . 0.0 110.672 175.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.522 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 38.4 t70 -87.87 60.49 5.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.611 177.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.531 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.7 OUTLIER -156.99 151.06 24.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.626 179.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.668 ' HG2' HG13 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -99.61 149.57 23.14 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -177.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.768 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 49.3 m-85 -106.4 107.78 18.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.21 -111.92 3.35 Favored Glycine 0 N--CA 1.427 -1.955 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.908 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -94.1 -9.36 36.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.774 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.778 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 101.97 18.38 17.85 Favored Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.675 -175.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HG2' ' HA3' ' A' ' 56' ' ' GLY . 52.4 mtpt -70.4 -45.09 66.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.814 -0.693 . . . . 0.0 110.335 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.64 24.54 29.49 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.778 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 3.8 t80 -65.95 98.18 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 122.871 0.469 . . . . 0.0 110.205 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HE ' ' C ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -103.11 46.6 0.91 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.074 0.464 . . . . 0.0 110.063 179.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.626 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.48 -156.21 30.97 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.674 -176.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.522 ' HD3' ' HB2' ' A' ' -1' ' ' ASP . 0.0 OUTLIER -150.15 23.56 0.84 Allowed 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 120.867 0.365 . . . . 0.0 110.82 -171.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.799 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 21.7 mmt180 -71.92 139.87 48.94 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 171.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 50' ' ' TYR . 5.2 m -140.86 31.32 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.514 0.673 . . . . 0.0 110.895 -170.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.869 HG22 ' HA2' ' A' ' 19' ' ' GLY . 87.2 m -152.32 130.6 12.02 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -173.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.429 HG21 ' HB3' ' A' ' 73' ' ' ASP . 71.9 p -69.85 -172.83 0.56 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -170.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 m -67.07 -20.01 26.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.869 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 p -92.19 -13.29 30.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.765 0.793 . . . . 0.0 108.964 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.869 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 82.91 17.65 67.12 Favored Glycine 0 N--CA 1.43 -1.712 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.367 -174.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.9 HG21 ' HB2' ' A' ' 67' ' ' ASN . 96.4 m -77.48 124.32 86.77 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 167.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.43 133.4 48.56 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.343 2.029 . . . . 0.0 113.217 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 84.9 m -71.8 140.41 49.42 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.72 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -73.11 167.19 21.66 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.234 174.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.498 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 4.8 m-20 -76.28 125.86 29.93 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.686 ' CE3' HD23 ' A' ' 46' ' ' LEU . 54.2 m95 -52.92 -32.94 48.2 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.69 0.757 . . . . 0.0 109.006 174.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.6 -16.63 58.48 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.727 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.44 150.27 23.21 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 118.668 0.667 . . . . 0.0 109.401 -172.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.433 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 33.4 mm-40 -107.74 21.14 17.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -146.6 137.11 12.35 Favored Pre-proline 0 N--CA 1.428 -1.54 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.375 -167.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.35 18.86 11.94 Favored 'Cis proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.367 -1.514 . . . . 0.0 112.993 1.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.583 ' HB3' HD12 ' A' ' 71' ' ' LEU . 62.2 m80 -128.98 106.9 9.2 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.53 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -72.61 126.1 29.06 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -176.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.48 ' C ' ' H ' ' A' ' 35' ' ' ILE . 5.9 p80 -154.94 94.26 1.63 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.132 0.968 . . . . 0.0 110.835 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -79.08 35.89 0.27 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.616 175.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 33' ' ' HIS . 31.3 pt -143.12 143.86 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 32.1 m-85 55.39 47.75 20.55 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 122.16 0.981 . . . . 0.0 110.919 -175.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 10.9 p -102.66 174.98 2.48 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.467 168.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 27.7 Cg_exo -62.45 -25.58 76.09 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.662 1.574 . . . . 0.0 111.775 172.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -88.17 -32.61 18.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.744 -174.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 p -90.72 -18.97 24.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.284 -177.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.8 m120 -133.63 61.58 54.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.733 0.301 . . . . 0.0 110.933 177.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -77.2 42.26 1.09 Allowed 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.843 2.362 . . . . 0.0 112.829 -176.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.62 -14.02 1.1 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.664 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -103.5 8.22 37.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.443 0.64 . . . . 0.0 110.69 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 47' ' ' GLU . . . 58.17 49.07 79.05 Favored Glycine 0 C--O 1.221 -0.669 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.575 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.73 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -76.54 93.25 3.53 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.218 0.533 . . . . 0.0 110.661 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.641 ' HB2' ' HD2' ' A' ' 50' ' ' TYR . 1.5 mt-10 -101.28 136.21 41.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.548 -177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 90.1 mttt 48.4 -104.4 0.12 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.73 0.644 . . . . 0.0 112.118 174.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -138.16 15.15 2.82 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.223 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.641 ' HD2' ' HB2' ' A' ' 47' ' ' GLU . 32.2 m-85 -65.89 125.81 26.54 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.582 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 78.9 m -49.44 151.98 1.42 Allowed 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.546 0.529 . . . . 0.0 111.901 -175.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 41.6 mmt-85 -154.41 168.63 26.02 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.475 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -130.36 80.11 71.13 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 169.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.709 ' HG3' HD21 ' A' ' 46' ' ' LEU . 25.2 Cg_exo -60.27 -28.06 86.12 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.837 2.358 . . . . 0.0 111.966 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -93.67 -23.22 18.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.605 0.717 . . . . 0.0 110.424 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.41 ' HA3' ' HG2' ' A' ' 7' ' ' LYS . . . 61.5 38.75 96.32 Favored Glycine 0 CA--C 1.497 -1.034 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.988 -172.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -61.27 141.88 57.23 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.126 -0.537 . . . . 0.0 110.153 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 t -75.85 49.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.604 0.716 . . . . 0.0 110.928 -175.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -129.53 -16.56 1.84 Allowed Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.77 175.73 18.18 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -178.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.48 152.06 59.8 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.754 1.636 . . . . 0.0 111.497 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.624 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 31.4 p-90 -139.63 -173.68 3.69 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.327 -172.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.639 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.4 p -168.3 -179.75 4.13 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.269 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -101.23 145.29 29.02 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 170.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.4 p -101.34 151.23 22.15 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.788 -170.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.7 p -85.82 20.13 2.29 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.332 168.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.9 ' HB2' HG21 ' A' ' 20' ' ' THR . 56.7 t-20 -95.4 116.17 66.08 Favored Pre-proline 0 CA--C 1.518 -0.26 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.409 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.12 -0.2 2.05 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.83 2.354 . . . . 0.0 113.59 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -84.2 -55.46 4.17 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.799 0.333 . . . . 0.0 111.212 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -117.13 155.03 30.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.403 0.621 . . . . 0.0 110.666 -175.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' A' ' 31' ' ' HIS . 49.1 tp -85.35 -43.63 13.52 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.499 -176.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -143.38 162.53 35.49 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' HB3' HG21 ' A' ' 16' ' ' THR . 42.2 t0 -156.96 175.47 14.05 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.87 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -94.41 156.23 16.58 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 90.5 m -105.19 168.37 9.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.945 0.402 . . . . 0.0 110.722 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.84 65.82 0.77 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.915 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.799 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.7 p -105.56 126.58 30.47 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.188 176.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.97 157.59 19.9 Favored 'Trans proline' 0 CA--C 1.515 -0.426 0 C-N-CA 123.915 3.076 . . . . 0.0 113.906 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -75.07 113.81 12.83 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.222 -1.353 . . . . 0.0 110.307 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.531 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -75.62 -42.43 51.72 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.329 178.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.768 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -93.43 55.22 2.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.2 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.217 179.837 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -82.79 -7.09 59.68 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 68.36 21.58 8.27 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.861 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.441 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 32.2 t0 -87.09 60.29 6.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 122.139 0.971 . . . . 0.0 109.137 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.588 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -151.3 159.18 44.46 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.517 -1.219 . . . . 0.0 109.908 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.539 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 11.9 ptt? -96.97 152.44 18.71 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.62 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 82.0 m-85 -109.65 94.64 5.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.18 -114.08 3.77 Favored Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -173.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -79.7 -26.36 40.93 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.84 0.965 . . . . 0.0 110.248 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.611 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.4 13.96 19.47 Favored Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 120.212 -0.994 . . . . 0.0 111.401 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.731 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 97.4 mttt -65.4 -40.71 93.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.163 0.506 . . . . 0.0 110.065 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -107.37 25.75 20.66 Favored Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 172.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.654 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.7 t80 -66.56 108.83 2.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.54 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -112.71 40.42 2.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.154 0.502 . . . . 0.0 110.097 -175.526 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.556 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -93.98 -162.21 35.59 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.797 -176.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -139.8 18.69 2.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.915 0.388 . . . . 0.0 110.189 -169.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.788 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 18.7 mmt180 -66.88 135.82 54.44 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 m -137.9 34.39 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 121.75 0.786 . . . . 0.0 110.027 -171.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.915 HG22 ' HA2' ' A' ' 19' ' ' GLY . 86.4 m -153.05 125.65 8.24 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -169.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.623 HG21 ' HB3' ' A' ' 73' ' ' ASP . 81.9 p -69.97 -171.54 0.44 Allowed 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -170.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.5 -23.11 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 121.505 0.669 . . . . 0.0 111.015 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.9 p -91.89 -15.7 27.73 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.796 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.915 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.48 20.02 55.41 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.955 -173.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.715 HG21 ' HB2' ' A' ' 67' ' ' ASN . 52.6 m -76.41 122.78 87.32 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 167.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -50.36 129.74 26.92 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.717 2.278 . . . . 0.0 113.536 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.8 m -68.68 144.26 54.5 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.46 0.647 . . . . 0.0 111.504 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -76.93 167.51 21.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.45 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -77.1 129.02 35.47 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.704 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 65.7 m95 -56.49 -32.37 64.96 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.54 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.98 -16.65 56.65 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.831 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -94.17 148.06 22.55 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.555 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 31.8 mm-40 -102.64 29.35 5.36 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 44.8 mt-10 -148.26 124.33 5.3 Favored Pre-proline 0 N--CA 1.421 -1.883 0 CA-C-N 113.581 -1.645 . . . . 0.0 113.656 -156.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 1.0 OUTLIER -85.07 25.74 11.61 Favored 'Cis proline' 0 C--N 1.344 0.33 0 C-N-CA 123.944 -1.273 . . . . 0.0 112.942 1.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.707 ' HB3' HD12 ' A' ' 71' ' ' LEU . 54.8 m80 -133.34 108.73 8.89 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.555 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -75.17 129.63 37.84 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.234 -175.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.439 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.2 p80 -155.34 101.97 2.24 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.982 0.896 . . . . 0.0 110.154 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 t -80.71 29.67 0.31 Allowed 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.841 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.439 ' H ' ' C ' ' A' ' 33' ' ' HIS . 22.0 pt -142.23 144.56 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -175.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.539 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 38.0 m-85 54.69 48.68 19.73 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 122.112 0.958 . . . . 0.0 110.639 -175.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 7.5 p -101.77 173.97 3.22 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.342 168.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 38.0 Cg_exo -58.89 -28.5 87.55 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 121.728 1.618 . . . . 0.0 112.228 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -89.85 -33.9 16.31 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.143 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.9 p -85.42 -19.13 31.79 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.723 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.539 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.9 m120 -135.43 64.71 60.14 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.376 177.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.27 20.8 0.56 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.333 2.022 . . . . 0.0 111.915 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 43' ' ' ARG . 14.6 ptt180 -114.32 -17.41 11.82 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.675 -177.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -108.1 6.1 26.6 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.135 0.493 . . . . 0.0 110.539 -176.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.93 46.21 94.05 Favored Glycine 0 C--O 1.228 -0.268 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.793 172.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -73.92 104.77 4.9 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.148 0.499 . . . . 0.0 110.662 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.847 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 3.6 pt-20 -118.11 137.14 53.14 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.879 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.474 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . 61.9 mmtt 45.98 -110.79 0.27 Allowed 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.738 0.649 . . . . 0.0 112.569 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -135.45 17.63 3.37 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.17 0.509 . . . . 0.0 110.124 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.847 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 16.3 m-85 -70.47 131.36 43.92 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.573 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 86.2 m -53.51 145.54 14.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 123.383 0.427 . . . . 0.0 111.231 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.465 ' HD3' ' HA ' ' A' ' 52' ' ' ARG . 34.9 mmt-85 -150.18 161.05 43.16 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.174 -177.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -122.55 79.76 47.03 Favored Pre-proline 0 C--N 1.319 -0.733 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.781 173.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.608 ' HG3' HD21 ' A' ' 46' ' ' LEU . 18.4 Cg_exo -64.35 -25.81 63.79 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.618 2.212 . . . . 0.0 112.33 178.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.97 -17.17 26.79 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 121.533 0.682 . . . . 0.0 109.748 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.731 ' HA3' ' HE2' ' A' ' 7' ' ' LYS . . . 55.66 40.57 79.66 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.397 -171.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -47.88 138.32 8.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 124.4 0.706 . . . . 0.0 109.815 174.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.1 t -74.77 8.08 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.535 0.683 . . . . 0.0 110.407 -176.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -102.14 -16.73 22.43 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.03 179.69 16.16 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 119.902 -1.142 . . . . 0.0 111.627 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.539 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 58.2 Cg_endo -71.33 161.09 46.83 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.442 2.095 . . . . 0.0 112.02 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.554 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 23.0 p-90 -150.7 -170.3 3.62 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.548 -171.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.704 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.4 p -169.19 -178.26 3.15 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.919 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 58.2 m-85 -101.78 147.22 26.74 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 170.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.461 ' HB ' ' CG2' ' A' ' 20' ' ' THR . 0.9 OUTLIER -105.0 147.29 27.96 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.062 -170.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.6 p -80.41 13.92 2.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.1 0.476 . . . . 0.0 110.811 172.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.715 ' HB2' HG21 ' A' ' 20' ' ' THR . 55.9 t-20 -93.68 123.31 60.28 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.417 -176.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.63 2.83 1.74 Allowed 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.633 2.222 . . . . 0.0 113.261 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -84.24 -46.37 11.91 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.469 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 73' ' ' ASP . 4.5 ptmt -134.92 154.92 51.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.531 0.681 . . . . 0.0 111.184 -174.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 31' ' ' HIS . 43.2 tp -83.61 -38.37 21.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.808 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 16.7 p90 -142.54 161.73 37.3 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.768 -175.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.623 ' HB3' HG21 ' A' ' 16' ' ' THR . 34.5 t0 -165.26 166.54 18.73 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -94.39 158.72 15.44 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 72.3 m -105.69 169.27 8.57 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -123.25 67.79 0.99 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.381 0.61 . . . . 0.0 110.128 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.788 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 2.4 p -99.5 130.38 26.98 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.451 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.36 159.09 24.23 Favored 'Trans proline' 0 CA--C 1.512 -0.582 0 C-N-CA 124.061 3.174 . . . . 0.0 113.539 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.09 112.1 12.18 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.696 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.505 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.2 OUTLIER -75.64 -39.36 57.86 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.599 179.236 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.62 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -86.09 44.6 1.14 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.107 178.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.2 -179.531 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 65.7 p . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -94.61 9.72 37.61 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 70.67 2.82 4.28 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.215 -174.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.626 ' HA ' ' CA ' ' A' ' 11' ' ' GLY . 32.6 t70 -85.51 63.53 8.12 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.876 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -160.56 150.49 17.77 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.266 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.632 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 10.8 ptt? -97.0 152.96 18.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.397 0.618 . . . . 0.0 112.548 -177.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 81' ' ' ALA . 71.4 m-85 -109.57 99.23 8.46 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.24 -109.04 2.68 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.472 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -78.1 -30.48 49.52 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 125.005 1.062 . . . . 0.0 110.596 -175.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 111.89 22.28 6.03 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.04 -1.076 . . . . 0.0 110.915 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -71.5 -41.0 69.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.782 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.41 ' O ' ' HD2' ' A' ' 10' ' ' ARG . . . -99.67 17.34 57.66 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.506 171.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.739 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.2 t80 -62.43 104.06 0.47 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 173.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -106.83 36.27 2.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.848 0.356 . . . . 0.0 110.86 -177.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.626 ' CA ' ' HA ' ' A' ' -1' ' ' ASP . . . -94.25 -161.76 35.12 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.483 -173.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -141.16 17.93 2.26 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.587 0.232 . . . . 0.0 110.91 -169.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.713 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.7 mmt180 -65.89 138.24 57.73 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.87 40.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.746 0.784 . . . . 0.0 111.018 -169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.23 148.9 28.78 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.831 -177.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.427 ' CG2' ' HB3' ' A' ' 73' ' ' ASP . 44.3 p -75.57 -173.84 2.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.611 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.1 m -64.29 -18.15 22.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.452 0.644 . . . . 0.0 111.137 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.1 p -93.06 -14.66 27.03 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.569 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.75 11.04 62.45 Favored Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.403 -0.904 . . . . 0.0 111.482 -172.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.927 HG21 ' HB2' ' A' ' 67' ' ' ASN . 98.5 m -76.55 121.58 85.11 Favored Pre-proline 0 N--CA 1.448 -0.534 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.882 174.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.28 124.62 9.38 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 123.198 2.599 . . . . 0.0 113.576 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.94 141.15 58.31 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.904 171.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -72.43 166.89 21.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.387 174.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 7.6 t0 -76.48 129.13 36.06 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 175.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.746 ' CE3' HD23 ' A' ' 46' ' ' LEU . 64.9 m95 -57.32 -31.54 65.79 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.321 177.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.13 -16.16 57.09 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.116 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 24' ' ' ASP . . . -94.35 147.33 23.32 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.666 -172.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 32.4 mm-40 -106.66 16.58 24.34 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.493 ' HG2' HH11 ' A' ' 32' ' ' ARG . 35.2 mt-10 -147.65 143.38 17.82 Favored Pre-proline 0 N--CA 1.432 -1.341 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.526 -172.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.49 25.16 6.67 Favored 'Cis proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.928 -1.697 . . . . 0.0 113.256 1.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.602 ' HB3' HD12 ' A' ' 71' ' ' LEU . 65.1 m80 -135.33 108.55 7.75 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.493 HH11 ' HG2' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -75.5 117.87 17.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.229 -0.896 . . . . 0.0 108.891 -174.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.428 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 3.9 p80 -147.04 99.25 3.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.175 0.988 . . . . 0.0 111.087 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.7 m -77.71 27.75 0.17 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.804 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.3 pt -140.88 149.76 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.472 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 48.9 m-85 50.97 47.36 24.96 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 122.069 0.937 . . . . 0.0 110.765 -175.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 58.6 p -100.61 175.81 2.2 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.04 172.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 11.7 Cg_exo -71.14 -9.33 25.33 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 121.951 1.767 . . . . 0.0 111.253 169.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -91.31 -33.67 15.23 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.786 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.9 p -95.92 -26.69 15.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.185 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.515 ' O ' HD13 ' A' ' 46' ' ' LEU . 14.0 m120 -133.28 60.56 49.22 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.523 -174.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -77.82 23.45 0.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.881 1.721 . . . . 0.0 112.272 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -111.35 -22.19 11.46 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.514 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.674 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -103.17 9.42 38.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.093 0.473 . . . . 0.0 110.911 -176.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.41 46.93 91.5 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.351 173.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.746 HD23 ' CE3' ' A' ' 25' ' ' TRP . 5.4 mp -76.96 74.39 3.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.596 0.712 . . . . 0.0 110.13 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.699 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 5.0 pt-20 -97.27 136.45 37.75 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.714 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 25.9 mmmt 51.49 -111.29 0.55 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.814 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -137.6 18.22 2.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.257 0.551 . . . . 0.0 110.317 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.699 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 30.8 m-85 -67.61 130.16 42.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.499 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 89.6 m -54.52 149.54 10.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 123.298 0.374 . . . . 0.0 111.158 -174.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 39.8 mmt-85 -153.03 170.29 20.81 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.624 -176.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -131.14 77.5 74.63 Favored Pre-proline 0 C--N 1.316 -0.87 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.519 170.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.699 ' HG3' HD21 ' A' ' 46' ' ' LEU . 29.7 Cg_endo -68.42 -13.26 37.12 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.285 1.99 . . . . 0.0 112.471 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -96.75 -26.14 15.26 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.922 0.868 . . . . 0.0 109.507 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.09 39.15 97.66 Favored Glycine 0 N--CA 1.436 -1.309 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.558 -167.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -44.34 132.36 5.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.773 -0.713 . . . . 0.0 110.044 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.4 t -69.74 -0.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.508 0.671 . . . . 0.0 110.763 -176.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.4 -18.64 35.24 Favored Glycine 0 N--CA 1.436 -1.335 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.5 -179.23 16.29 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.698 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.632 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 88.8 Cg_endo -77.14 158.0 33.83 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.224 1.949 . . . . 0.0 111.231 -175.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.488 ' NE1' ' HD2' ' A' ' 54' ' ' PRO . 22.1 p-90 -150.08 -170.77 3.73 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.065 -169.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.697 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.2 p -168.81 -178.49 3.39 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.646 178.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . 57.3 m-85 -100.93 147.64 25.91 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 170.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 1.9 p -103.55 149.2 25.1 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 118.807 -1.157 . . . . 0.0 109.437 -171.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 p -83.35 28.34 0.54 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.508 0.67 . . . . 0.0 109.963 168.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.927 ' HB2' HG21 ' A' ' 20' ' ' THR . 58.0 t-20 -108.16 121.14 44.64 Favored Pre-proline 0 N--CA 1.456 -0.149 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.238 -175.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 18.7 Cg_exo -66.44 -1.03 4.96 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.749 2.299 . . . . 0.0 113.498 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -84.69 -33.11 23.24 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.67 147.69 29.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.108 0.48 . . . . 0.0 110.769 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.602 HD12 ' HB3' ' A' ' 31' ' ' HIS . 37.8 tp -72.4 -45.56 59.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.549 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 21.5 p90 -143.54 162.8 34.92 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.67 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.427 ' HB3' ' CG2' ' A' ' 16' ' ' THR . 14.0 t0 -158.83 172.05 18.94 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 62' ' ' TRP . 55.6 m-85 -94.62 157.01 16.16 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 73.6 m -104.76 172.82 6.59 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 123.289 0.368 . . . . 0.0 110.454 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -122.8 69.0 0.98 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.187 0.518 . . . . 0.0 110.305 -178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.739 HG21 ' CE1' ' A' ' 9' ' ' TYR . 2.3 p -102.05 132.39 21.62 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.665 176.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.42 ' HD2' HG23 ' A' ' 77' ' ' VAL . 11.0 Cg_endo -55.66 150.71 42.71 Favored 'Trans proline' 0 CA--C 1.512 -0.608 0 C-N-CA 124.25 3.3 . . . . 0.0 113.826 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -76.77 109.76 10.82 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.789 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.13 -38.26 57.01 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.694 178.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.59 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . . . -90.97 61.33 4.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.971 179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.054 178.789 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 76.7 p . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -94.94 -5.4 44.85 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . 0.445 ' O ' ' HA2' ' A' ' 11' ' ' GLY . . . 66.29 15.4 10.08 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.432 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.678 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 41.3 t0 -99.78 59.42 1.07 Allowed 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.086 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.599 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.6 OUTLIER -150.79 152.51 33.92 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.558 -179.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.766 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 12.3 ptt? -96.78 159.33 14.98 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.629 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 85.5 m-85 -114.23 100.63 8.5 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.475 177.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.36 -115.33 4.0 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.019 -175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -82.41 -19.84 38.27 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 124.411 0.712 . . . . 0.0 110.486 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.651 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.09 17.06 13.4 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 119.874 -1.155 . . . . 0.0 110.999 -174.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -66.91 -50.97 60.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -97.88 28.49 14.25 Favored Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 172.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.666 ' CE1' HG21 ' A' ' 77' ' ' VAL . 3.6 t80 -69.51 102.57 1.84 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 173.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -106.45 40.59 1.59 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.337 0.589 . . . . 0.0 109.772 -176.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.641 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -90.41 -154.45 30.05 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.941 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -151.24 23.59 0.73 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.858 0.361 . . . . 0.0 110.556 -172.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.974 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 20.2 mmt180 -68.9 135.99 51.91 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 21' ' ' PRO . 3.9 m -136.96 36.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-O 122.037 0.923 . . . . 0.0 109.573 -174.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 1.048 HG23 ' HA2' ' A' ' 19' ' ' GLY . 0.6 OUTLIER -151.65 133.41 14.88 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 113.908 -1.496 . . . . 0.0 107.235 -172.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 56.5 p -73.76 -170.6 0.9 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.091 -176.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.1 m -63.94 -21.66 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.302 0.573 . . . . 0.0 110.712 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.3 p -92.89 -10.79 35.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 122.115 0.96 . . . . 0.0 109.08 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 1.048 ' HA2' HG23 ' A' ' 15' ' ' THR . . . 82.98 11.92 80.53 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.214 -1.357 . . . . 0.0 112.23 -173.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.409 HG21 ' HB2' ' A' ' 67' ' ' ASN . 80.8 m -71.28 121.2 83.59 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 174.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 82.6 Cg_exo -51.03 134.76 43.53 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 C-N-CA 122.713 2.276 . . . . 0.0 113.353 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 86.1 m -75.53 141.76 42.93 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.541 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -72.94 165.95 23.97 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.231 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 12.4 m-20 -76.52 126.2 30.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 175.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.717 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 48.7 m95 -54.65 -29.4 52.29 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 175.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.63 -22.4 54.19 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.972 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.403 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -97.67 150.45 21.16 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -172.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.619 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 32.5 mm-40 -104.76 31.45 4.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 26.7 mt-10 -147.2 123.31 5.49 Favored Pre-proline 0 N--CA 1.425 -1.693 0 CA-C-N 113.705 -1.589 . . . . 0.0 114.163 -156.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.512 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 86.1 Cg_endo -86.44 27.03 11.9 Favored 'Cis proline' 0 C--N 1.346 0.438 0 C-N-CA 123.445 -1.481 . . . . 0.0 112.97 0.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.514 ' HB3' HD12 ' A' ' 71' ' ' LEU . 56.8 m80 -129.0 108.43 10.4 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.619 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 1.7 tmm_? -79.23 122.46 26.34 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -173.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.46 ' C ' ' H ' ' A' ' 35' ' ' ILE . 4.3 p80 -150.24 97.16 2.51 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.92 0.867 . . . . 0.0 110.821 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.27 35.46 0.22 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.56 0.695 . . . . 0.0 110.107 172.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.46 ' H ' ' C ' ' A' ' 33' ' ' HIS . 23.0 pt -143.11 142.5 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -175.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.599 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 42.9 m-85 50.56 51.02 17.72 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-O 122.124 0.964 . . . . 0.0 111.591 -175.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 26.5 p -99.58 175.94 2.18 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.025 169.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 25.5 Cg_exo -64.59 -21.21 65.79 Favored 'Trans proline' 0 N--CA 1.461 -0.382 0 C-N-CA 121.91 1.74 . . . . 0.0 111.877 172.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -100.33 -23.63 14.73 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.395 -171.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 35.4 p -90.32 -19.18 24.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.262 0.553 . . . . 0.0 109.646 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.599 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.2 m120 -136.16 62.76 46.9 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.888 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.66 9.08 1.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.168 1.912 . . . . 0.0 111.955 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -111.18 -12.33 14.14 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.476 -177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.76 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -104.49 8.2 35.51 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.135 0.493 . . . . 0.0 110.149 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.35 44.67 97.76 Favored Glycine 0 C--O 1.228 -0.253 0 CA-C-N 114.825 -1.079 . . . . 0.0 113.419 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.76 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.3 mp -80.17 96.47 6.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.224 0.535 . . . . 0.0 110.834 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.642 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.3 pt-20 -111.59 135.12 52.61 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.658 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.473 ' HD3' ' HA ' ' A' ' 48' ' ' LYS . 23.9 mmtp 56.06 -118.08 1.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.663 0.602 . . . . 0.0 111.998 175.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -130.82 14.01 5.32 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.922 0.392 . . . . 0.0 110.804 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.642 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 20.7 m-85 -66.06 133.13 50.11 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.623 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 73.8 m -54.93 149.78 11.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.848 0.356 . . . . 0.0 111.833 -175.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.452 ' CG ' HH11 ' A' ' 52' ' ' ARG . 0.1 OUTLIER -153.48 162.53 41.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.714 -175.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -125.69 80.99 65.83 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.268 171.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.735 ' HG3' HD21 ' A' ' 46' ' ' LEU . 15.1 Cg_exo -64.53 -21.09 66.15 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.676 2.25 . . . . 0.0 112.029 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -89.63 -30.74 17.92 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.979 0.895 . . . . 0.0 109.304 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.66 39.53 95.42 Favored Glycine 0 N--CA 1.433 -1.51 0 CA-C-N 113.945 -1.48 . . . . 0.0 110.054 -166.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -43.79 131.59 5.4 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 124.452 0.737 . . . . 0.0 109.587 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 t -70.82 3.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.274 0.559 . . . . 0.0 111.07 -174.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.27 -22.13 13.65 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 130.06 -175.59 19.1 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 119.761 -1.209 . . . . 0.0 111.78 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.766 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 97.8 Cg_endo -76.82 159.95 34.43 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.515 2.144 . . . . 0.0 111.708 -174.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.573 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.0 p-90 -148.88 -172.85 4.21 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.879 -172.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.717 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 29.8 p -168.73 -178.87 3.56 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.305 178.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -100.84 140.83 34.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 67' ' ' ASN . 1.3 p -99.84 148.64 24.22 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.36 -171.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 67.2 p -76.99 15.0 0.74 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.982 0.42 . . . . 0.0 110.968 172.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' A' ' 69' ' ' ARG . 24.0 t30 -100.84 119.69 57.64 Favored Pre-proline 0 C--O 1.233 0.2 0 C-N-CA 123.168 0.587 . . . . 0.0 111.057 -177.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.4 Cg_exo -69.47 6.7 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.307 2.671 . . . . 0.0 113.503 -178.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . 21.3 mmm180 -82.26 -49.35 10.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.025 0.441 . . . . 0.0 110.704 173.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HE2' HD22 ' A' ' 67' ' ' ASN . 0.0 OUTLIER -139.14 134.96 33.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.596 0.713 . . . . 0.0 111.186 -176.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 31' ' ' HIS . 40.3 tp -64.78 -39.92 94.39 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.605 -1.179 . . . . 0.0 111.541 -172.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -143.19 164.82 29.12 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.483 ' HB3' HG21 ' A' ' 16' ' ' THR . 44.5 t0 -162.0 172.28 16.22 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -92.81 156.21 17.14 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 96.2 m -104.66 170.01 8.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.236 0.541 . . . . 0.0 111.325 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -112.85 67.26 0.66 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.136 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.974 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 5.0 p -111.66 129.51 24.08 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.324 0.583 . . . . 0.0 110.994 174.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.43 161.76 33.46 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 123.941 3.094 . . . . 0.0 113.708 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.79 114.47 14.43 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.088 178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.599 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -74.77 -41.23 60.44 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.333 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.629 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -80.73 48.59 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.688 178.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.592 -0.718 . . . . 0.0 110.448 -179.622 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.982 0.42 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -88.2 -9.48 52.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.373 -176.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 66.28 21.08 11.05 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.511 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.426 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 26.3 t70 -90.35 59.4 4.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.981 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.514 ' HA ' ' CG2' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -152.24 158.69 43.18 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.7 178.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.741 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 9.4 ptt? -97.5 154.59 17.4 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.548 0.69 . . . . 0.0 112.65 -177.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.698 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 53.9 m-85 -110.29 105.8 14.96 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.29 -114.58 3.91 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.185 -1.007 . . . . 0.0 111.162 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -88.21 -16.07 34.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.98 -0.61 . . . . 0.0 109.832 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.744 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 107.56 11.22 25.58 Favored Glycine 0 N--CA 1.437 -1.279 0 C-N-CA 119.933 -1.127 . . . . 0.0 110.937 -173.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -63.16 -40.5 97.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.514 ' O ' ' HG2' ' A' ' 10' ' ' ARG . . . -108.16 22.33 27.45 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.201 173.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.744 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 4.2 t80 -66.46 109.98 2.95 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 172.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -119.01 39.21 3.6 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -178.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.472 ' HA3' ' HE1' ' A' ' 9' ' ' TYR . . . -91.33 -152.57 28.41 Favored Glycine 0 C--O 1.235 0.19 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.538 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HD3' ' HB2' ' A' ' -1' ' ' ASP . 0.0 OUTLIER -149.07 23.71 0.94 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 120.916 0.388 . . . . 0.0 110.899 -170.763 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.723 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.8 mmt180 -69.78 137.55 51.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 170.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -138.26 34.67 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.64 0.733 . . . . 0.0 111.063 -170.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.599 HG22 ' HA2' ' A' ' 19' ' ' GLY . 2.1 m -151.46 138.29 18.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -174.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.407 HG21 HG22 ' A' ' 65' ' ' THR . 68.3 p -74.88 -174.67 2.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.903 -173.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.9 m -68.06 -17.98 22.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.417 0.627 . . . . 0.0 110.728 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.5 p -92.75 -14.58 27.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.187 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.599 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 86.6 15.8 63.06 Favored Glycine 0 N--CA 1.435 -1.409 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.5 -174.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.884 HG21 ' HB2' ' A' ' 67' ' ' ASN . 89.7 m -77.11 122.5 86.39 Favored Pre-proline 0 N--CA 1.448 -0.555 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 168.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -51.72 125.05 15.83 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.309 2.006 . . . . 0.0 112.7 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.404 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 85.4 m -63.29 141.83 58.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.348 0.594 . . . . 0.0 110.652 173.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 25.2 tt0 -74.86 165.34 25.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.476 176.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 4.1 m-20 -76.07 124.57 27.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 175.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.673 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 40.7 m95 -54.87 -29.98 56.84 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.07 -17.8 58.47 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.198 -1.364 . . . . 0.0 113.314 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.26 151.78 22.27 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 119.093 0.86 . . . . 0.0 109.339 -173.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.713 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.0 mm-40 -103.18 32.46 3.74 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 49.1 mt-10 -143.62 118.01 6.11 Favored Pre-proline 0 N--CA 1.429 -1.512 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -156.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 70.4 Cg_endo -89.68 31.07 10.26 Favored 'Cis proline' 0 C--N 1.348 0.511 0 C-N-CA 123.52 -1.45 . . . . 0.0 113.316 1.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.611 ' HB3' HD12 ' A' ' 71' ' ' LEU . 61.9 m80 -130.77 110.76 11.57 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.713 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.1 OUTLIER -74.53 119.26 18.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.648 -176.52 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.479 ' HE1' ' HA ' ' A' ' 25' ' ' TRP . 4.2 p80 -151.86 99.23 2.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 122.17 0.986 . . . . 0.0 110.271 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.6 t -82.15 32.13 0.39 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.568 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' H ' ' C ' ' A' ' 33' ' ' HIS . 26.5 pt -141.26 151.8 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -177.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.568 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 39.1 m-85 51.04 47.11 25.46 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 122.04 0.924 . . . . 0.0 111.038 -173.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 28.0 p -99.42 171.16 5.93 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.027 171.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 39.7 Cg_exo -59.64 -21.33 62.18 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.132 1.888 . . . . 0.0 112.219 171.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -101.9 -19.85 15.1 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.533 -170.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.9 p -96.91 -18.02 19.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.134 0.492 . . . . 0.0 110.182 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.568 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 14.2 m120 -136.02 64.63 55.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.028 -177.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.89 18.07 0.66 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.633 2.222 . . . . 0.0 112.736 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -109.93 -23.54 11.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.411 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.697 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -102.13 7.11 41.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.353 0.597 . . . . 0.0 110.469 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.93 42.88 99.58 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.771 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.4 mp -74.95 110.39 9.21 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.535 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 4.3 pt-20 -128.6 149.22 50.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.801 172.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.978 ' HE2' ' HA ' ' A' ' 48' ' ' LYS . 5.0 mmpt? 49.67 -111.05 0.46 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.001 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -139.85 18.1 2.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.11 0.481 . . . . 0.0 110.236 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.535 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 33.4 m-85 -67.34 126.41 29.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.589 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 71.7 m -51.68 152.73 2.68 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.556 0.535 . . . . 0.0 111.689 -174.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 44.0 mmt-85 -154.37 170.69 20.75 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.348 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -133.3 77.11 67.12 Favored Pre-proline 0 C--N 1.319 -0.721 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.438 171.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.526 ' HD2' ' CE2' ' A' ' 62' ' ' TRP . 27.9 Cg_exo -61.06 -33.39 91.78 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.769 2.313 . . . . 0.0 112.427 178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -90.72 -16.04 29.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.491 0.663 . . . . 0.0 110.366 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.09 48.7 84.81 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.358 -175.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 59' ' ' GLY . 4.4 t0 -48.48 129.01 15.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 t -75.91 31.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 122.085 0.945 . . . . 0.0 110.319 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -125.18 -14.49 3.3 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 175.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.78 -179.51 16.2 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.741 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 95.2 Cg_endo -76.31 161.03 35.37 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.348 2.032 . . . . 0.0 111.713 -174.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.526 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 28.1 p-90 -145.46 -173.07 4.02 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.223 -173.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.673 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.3 p -167.98 -178.94 3.94 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' A' ' 72' ' ' TYR . 48.4 m-85 -100.24 145.29 28.25 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.447 ' HB ' HG21 ' A' ' 20' ' ' THR . 4.4 p -98.86 153.91 18.43 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.611 -171.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.416 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 31.0 p -85.77 26.58 0.95 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.334 0.587 . . . . 0.0 110.143 166.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.884 ' HB2' HG21 ' A' ' 20' ' ' THR . 59.3 t-20 -107.52 118.76 52.59 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.495 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.46 2.39 1.96 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.904 2.402 . . . . 0.0 113.392 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -83.77 -46.38 12.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.328 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.05 151.92 51.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.999 0.428 . . . . 0.0 110.558 -176.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 31' ' ' HIS . 41.7 tp -76.29 -43.18 42.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.386 -177.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.516 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 50.4 p90 -143.93 169.33 18.02 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.777 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -161.68 178.37 9.08 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -96.44 156.3 16.4 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 81.5 m -105.89 168.94 8.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.872 0.368 . . . . 0.0 110.888 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -116.89 70.5 0.77 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.263 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.723 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 4.2 p -110.86 127.06 27.53 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 121.304 0.574 . . . . 0.0 110.883 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.65 160.5 20.64 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 124.165 3.243 . . . . 0.0 113.761 -178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -75.56 112.71 12.18 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.216 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.485 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.1 OUTLIER -75.87 -43.37 45.92 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.364 176.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.698 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -83.33 61.16 6.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.031 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.949 178.641 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . 0.697 HD21 ' HD3' ' A' ' 12' ' ' LYS . 55.7 t30 -117.63 -8.31 10.94 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 67.92 15.63 9.55 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.335 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.448 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 20.6 t0 -90.27 61.37 5.06 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.645 -1.162 . . . . 0.0 108.791 175.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.462 ' HA ' HG22 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -156.4 151.55 26.43 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.906 -176.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.749 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 8.4 ptt? -97.4 158.19 15.6 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.755 ' HD1' ' HB2' ' A' ' 81' ' ' ALA . 79.0 m-85 -113.94 96.15 5.68 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.36 -111.83 3.34 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -173.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -79.47 -29.52 41.73 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 124.626 0.839 . . . . 0.0 110.889 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.613 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 109.8 19.77 8.03 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.982 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.792 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 95.1 mttt -66.4 -38.08 86.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.873 0.368 . . . . 0.0 110.299 175.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -105.8 19.47 38.48 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 173.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.731 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.3 t80 -64.38 99.41 0.29 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 174.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.3 46.35 0.92 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.027 0.441 . . . . 0.0 110.249 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.657 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -97.06 -158.97 31.27 Favored Glycine 0 CA--C 1.517 0.195 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.687 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.697 ' HD3' HD21 ' A' ' -3' ' ' ASN . 10.3 ptmm? -145.87 20.26 1.45 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.992 0.396 . . . . 0.0 110.802 -170.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.761 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 14.9 mmt180 -68.17 139.74 56.12 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 174.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.8 m -138.84 35.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 121.726 0.774 . . . . 0.0 110.677 -171.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.87 140.3 21.45 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.356 -176.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 75' ' ' CYS . 46.6 p -75.43 -174.81 2.56 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.106 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.8 m -72.85 -12.62 15.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.454 0.645 . . . . 0.0 110.115 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.1 p -92.57 -13.54 29.54 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.904 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.95 7.57 70.4 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.342 -176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.938 HG21 ' HB2' ' A' ' 67' ' ' ASN . 92.9 m -75.68 120.06 79.95 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -47.46 123.48 8.05 Favored 'Trans proline' 0 CA--C 1.514 -0.52 0 C-N-CA 122.809 2.339 . . . . 0.0 112.861 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.402 ' SG ' ' SG ' ' A' ' 51' ' ' CYS . 84.6 m -62.27 135.43 57.47 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.474 0.654 . . . . 0.0 110.488 173.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 29' ' ' GLU . 23.2 tt0 -68.26 164.8 19.82 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.225 174.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.48 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 15.0 m-20 -76.3 125.91 30.04 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 176.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.758 ' CE3' HD23 ' A' ' 46' ' ' LEU . 40.2 m95 -53.36 -31.71 45.79 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.12 -19.09 57.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.239 -1.346 . . . . 0.0 113.18 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.48 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -101.52 150.13 23.38 Favored 'General case' 0 C--O 1.21 -0.997 0 O-C-N 121.32 -0.863 . . . . 0.0 109.014 -173.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.765 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 28.9 mm-40 -103.24 33.64 3.22 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 30' ' ' PRO . 29.2 mt-10 -141.62 117.38 7.15 Favored Pre-proline 0 N--CA 1.435 -1.195 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -157.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 29' ' ' GLU . 19.6 Cg_endo -91.8 33.38 8.98 Favored 'Cis proline' 0 C--N 1.347 0.464 0 C-N-CA 123.635 -1.402 . . . . 0.0 112.974 0.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.562 ' HB3' HD12 ' A' ' 71' ' ' LEU . 55.1 m80 -130.37 107.46 9.27 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.765 ' HA ' ' HB3' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -74.22 118.48 17.23 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.451 0.643 . . . . 0.0 109.889 -178.086 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.467 ' HE1' ' HA ' ' A' ' 25' ' ' TRP . 4.4 p80 -147.65 99.15 3.07 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 122.002 0.906 . . . . 0.0 109.957 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -80.12 32.98 0.28 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.601 175.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.453 ' H ' ' C ' ' A' ' 33' ' ' HIS . 21.5 pt -141.91 147.85 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -176.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.501 ' HD2' ' HH ' ' A' ' 64' ' ' TYR . 38.3 m-85 53.12 45.55 28.46 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-O 122.01 0.91 . . . . 0.0 110.96 -174.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 18.1 p -99.11 172.46 4.68 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-N 114.378 -1.283 . . . . 0.0 108.586 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HG3' ' O ' ' A' ' 46' ' ' LEU . 28.6 Cg_exo -60.59 -20.45 64.73 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 121.855 1.703 . . . . 0.0 111.818 172.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -91.37 -35.7 14.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.089 -175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.8 p -85.91 -25.23 26.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.822 0.344 . . . . 0.0 110.447 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.5 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 13.3 m120 -132.8 65.21 73.77 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.015 0.436 . . . . 0.0 110.814 -178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -75.89 13.5 1.22 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.327 2.018 . . . . 0.0 112.13 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -103.56 -21.37 13.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.84 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -107.57 -0.83 21.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.54 -175.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.82 46.41 67.66 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.684 176.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.818 HD21 ' HG3' ' A' ' 54' ' ' PRO . 5.4 mp -76.52 67.2 2.65 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.776 0.322 . . . . 0.0 110.872 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' HG3' ' HD2' ' A' ' 50' ' ' TYR . 6.1 pt-20 -94.42 151.28 19.5 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.713 0.292 . . . . 0.0 110.762 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.8 mptp? 48.24 -110.32 0.35 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.442 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -140.18 17.84 2.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.965 0.412 . . . . 0.0 110.613 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.49 ' HD2' ' HG3' ' A' ' 47' ' ' GLU . 27.8 m-85 -66.75 126.57 29.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.649 178.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.495 ' O ' ' HD3' ' A' ' 52' ' ' ARG . 93.6 m -53.79 150.73 7.1 Favored 'General case' 0 CA--C 1.513 -0.453 0 O-C-N 123.468 0.48 . . . . 0.0 111.96 -173.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' A' ' 51' ' ' CYS . 41.9 mmt-85 -153.74 165.99 34.25 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.924 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -131.33 76.38 75.93 Favored Pre-proline 0 C--N 1.32 -0.699 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.002 172.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.818 ' HG3' HD21 ' A' ' 46' ' ' LEU . 34.9 Cg_exo -55.8 -35.7 94.04 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.844 2.362 . . . . 0.0 112.318 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.89 -12.36 25.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.91 -175.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.792 ' HA3' ' HE3' ' A' ' 7' ' ' LYS . . . 59.17 52.15 55.03 Favored Glycine 0 N--CA 1.439 -1.104 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.526 -174.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 59' ' ' GLY . 6.1 t70 -51.26 133.65 28.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 174.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 t -72.02 9.39 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.616 0.722 . . . . 0.0 110.568 -175.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 57' ' ' ASP . . . -107.04 -15.98 14.85 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.73 -177.48 17.04 Favored Glycine 0 N--CA 1.44 -1.091 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.295 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.749 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 73.5 Cg_endo -73.8 158.4 46.74 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.37 2.046 . . . . 0.0 110.984 -175.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.558 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 31.5 p-90 -144.13 -176.31 4.96 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.441 -172.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.575 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 31.4 p -167.92 179.64 4.6 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.472 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.501 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 49.5 m-85 -99.18 146.43 26.17 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 172.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.433 ' HB ' HG21 ' A' ' 20' ' ' THR . 3.9 p -99.0 150.78 21.62 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.474 -170.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.9 p -85.03 23.14 1.27 Allowed 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.008 166.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.938 ' HB2' HG21 ' A' ' 20' ' ' THR . 56.9 t-20 -99.65 117.79 63.09 Favored Pre-proline 0 N--CA 1.456 -0.135 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.098 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 15.1 Cg_exo -68.27 4.96 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.87 2.38 . . . . 0.0 113.632 -177.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -88.37 -38.84 14.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.755 0.312 . . . . 0.0 111.21 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.24 159.9 41.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.136 0.493 . . . . 0.0 111.38 -174.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.562 HD12 ' HB3' ' A' ' 31' ' ' HIS . 49.9 tp -81.37 -49.61 10.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.968 -175.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.567 ' HB2' ' O ' ' A' ' 63' ' ' CYS . 17.8 p90 -143.6 163.65 32.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.958 0.408 . . . . 0.0 110.701 -178.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -154.56 -175.7 5.54 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.103 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -93.79 158.79 15.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 16' ' ' THR . 86.9 m -105.94 169.94 8.19 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.278 0.561 . . . . 0.0 111.474 178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -115.27 72.31 0.79 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.096 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.761 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 3.5 p -113.46 128.54 25.57 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.373 0.606 . . . . 0.0 110.697 174.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 77' ' ' VAL . 17.6 Cg_endo -58.16 155.49 34.21 Favored 'Trans proline' 0 CA--C 1.513 -0.531 0 C-N-CA 123.941 3.094 . . . . 0.0 113.871 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.27 111.3 11.56 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.32 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.46 ' HB2' ' C ' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.26 -39.38 54.54 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.08 179.218 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.755 ' HB2' ' HD1' ' A' ' 3' ' ' PHE . . . -87.44 62.13 6.98 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.585 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.969 179.06 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.801 0.334 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -83.51 -5.58 59.2 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 73.87 10.96 4.59 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.706 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' ASP . . . . . 0.54 ' OD1' ' HG2' ' A' ' 13' ' ' ARG . 24.1 t0 -88.55 58.85 4.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.228 1.013 . . . . 0.0 109.576 178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.584 ' HB2' ' CA ' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -156.35 152.9 28.17 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.916 -179.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.556 ' SD ' ' HD3' ' A' ' 61' ' ' PRO . 6.0 ptt? -95.6 151.2 19.54 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -176.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.564 ' HD2' ' HB2' ' A' ' 81' ' ' ALA . 79.5 m-85 -109.26 96.27 6.18 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.88 -115.97 4.12 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -174.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -79.59 -21.92 44.38 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 124.684 0.873 . . . . 0.0 110.291 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 9' ' ' TYR . . . 106.71 15.68 16.22 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.95 -1.119 . . . . 0.0 111.166 -176.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -63.81 -34.56 78.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.065 0.46 . . . . 0.0 110.146 176.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -109.98 20.01 27.0 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 174.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.748 ' CE1' HG21 ' A' ' 77' ' ' VAL . 4.9 t80 -68.22 101.07 1.11 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.053 0.454 . . . . 0.0 110.185 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.63 49.3 0.81 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.404 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.604 ' HA3' ' CE1' ' A' ' 9' ' ' TYR . . . -96.75 -151.76 28.24 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.858 -176.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HE2' ' HB3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -150.73 22.78 0.79 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.928 0.394 . . . . 0.0 111.017 -174.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.864 ' HG3' ' HB ' ' A' ' 77' ' ' VAL . 16.8 mmt180 -68.35 137.58 54.72 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 170.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.4 m -140.06 30.86 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 121.804 0.811 . . . . 0.0 110.796 -171.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.722 HG22 ' HA2' ' A' ' 19' ' ' GLY . 7.3 m -151.45 134.81 16.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -174.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.425 HG21 HG22 ' A' ' 65' ' ' THR . 75.9 p -73.0 -176.92 2.23 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.122 0.487 . . . . 0.0 112.242 -170.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -67.23 -15.65 19.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.367 0.603 . . . . 0.0 110.806 177.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.0 p -93.09 -15.36 26.16 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.839 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.722 ' HA2' HG22 ' A' ' 15' ' ' THR . . . 85.35 15.53 66.31 Favored Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.352 -174.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.977 HG21 ' HB2' ' A' ' 67' ' ' ASN . 85.1 m -78.32 121.88 84.4 Favored Pre-proline 0 N--CA 1.446 -0.67 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 169.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -48.51 131.59 23.73 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.713 2.275 . . . . 0.0 113.216 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 80.9 m -71.0 137.13 48.8 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.586 173.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.401 ' HG2' ' N ' ' A' ' 24' ' ' ASP . 24.1 tt0 -71.1 166.09 22.16 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.153 174.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.568 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 10.0 m-20 -75.98 127.73 33.57 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.709 ' CH2' ' HA ' ' A' ' 63' ' ' CYS . 43.3 m95 -54.35 -31.47 54.54 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 172.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.04 -16.69 57.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.461 -1.245 . . . . 0.0 112.915 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.568 ' CB ' ' HB2' ' A' ' 24' ' ' ASP . . . -98.02 148.04 23.9 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 118.625 0.648 . . . . 0.0 109.616 -173.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 32' ' ' ARG . 31.4 mm-40 -106.58 14.86 26.52 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -176.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.502 ' HA ' ' N ' ' A' ' 31' ' ' HIS . 44.6 mt-10 -147.77 145.55 21.57 Favored Pre-proline 0 N--CA 1.431 -1.382 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.273 -174.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.93 20.46 5.76 Favored 'Cis proline' 0 CA--C 1.533 0.441 0 C-N-CA 123.458 -1.476 . . . . 0.0 113.334 1.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.502 ' N ' ' HA ' ' A' ' 29' ' ' GLU . 62.9 m80 -131.61 107.65 8.98 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.437 ' HD2' ' N ' ' A' ' 32' ' ' ARG . 3.4 mpt_? -74.93 115.34 14.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.434 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 4.5 p80 -147.23 98.09 2.96 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.088 0.946 . . . . 0.0 111.621 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.0 m -78.07 33.1 0.18 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.531 173.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 33' ' ' HIS . 28.9 pt -142.02 147.05 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.563 ' HA ' ' OD1' ' A' ' 41' ' ' ASN . 52.0 m-85 49.93 47.68 22.89 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.09 0.947 . . . . 0.0 111.276 -173.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 38' ' ' PRO . 30.9 p -100.05 174.57 2.92 Favored Pre-proline 0 C--N 1.315 -0.905 0 CA-C-N 114.428 -1.26 . . . . 0.0 108.869 170.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 37' ' ' THR . 20.9 Cg_exo -66.15 -16.26 51.43 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.868 1.712 . . . . 0.0 111.348 170.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -91.07 -34.33 15.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.371 -175.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 47.9 p -93.94 -20.4 20.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.551 -176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.563 ' OD1' ' HA ' ' A' ' 36' ' ' PHE . 15.3 m120 -133.35 65.05 71.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.202 -177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.9 25.75 0.5 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 122.487 2.125 . . . . 0.0 111.746 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -115.44 -13.35 11.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.555 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.667 ' HB3' HD11 ' A' ' 46' ' ' LEU . . . -116.1 4.38 13.66 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.53 -175.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.48 41.71 96.17 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.856 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 44' ' ' ALA . 5.5 mp -70.85 99.64 1.78 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.821 0.343 . . . . 0.0 110.287 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.575 ' HB3' ' HD2' ' A' ' 50' ' ' TYR . 28.4 tt0 -109.84 148.95 30.59 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.941 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.477 ' HG2' ' HG2' ' A' ' 47' ' ' GLU . 46.2 mmtm 46.84 -109.62 0.25 Allowed 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.543 1.152 . . . . 0.0 111.271 173.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -135.63 17.63 3.33 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.874 175.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.575 ' HD2' ' HB3' ' A' ' 47' ' ' GLU . 34.6 m-85 -66.12 128.68 37.06 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.097 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.616 ' HB2' ' HE2' ' A' ' 9' ' ' TYR . 70.8 m -53.62 148.99 8.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.243 0.544 . . . . 0.0 112.284 -174.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' HD2' ' O ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -154.7 157.47 38.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.89 -174.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -122.45 81.55 46.55 Favored Pre-proline 0 N--CA 1.446 -0.646 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.243 171.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.577 ' HD2' ' CE2' ' A' ' 62' ' ' TRP . 19.4 Cg_exo -63.25 -24.67 72.15 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.399 2.066 . . . . 0.0 112.397 178.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -88.75 -27.47 21.15 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.025 0.916 . . . . 0.0 109.575 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 63.29 39.6 98.03 Favored Glycine 0 N--CA 1.431 -1.682 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.925 -166.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -43.93 133.26 5.04 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.909 -0.646 . . . . 0.0 110.042 170.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 t -70.87 5.94 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.62 0.724 . . . . 0.0 110.878 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -99.83 -18.14 23.62 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.42 179.64 16.1 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.056 -1.069 . . . . 0.0 111.269 177.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.556 ' HD3' ' SD ' ' A' ' 2' ' ' MET . 60.5 Cg_endo -71.59 157.61 55.56 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.272 1.981 . . . . 0.0 111.49 -176.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.577 ' CE2' ' HD2' ' A' ' 54' ' ' PRO . 25.1 p-90 -146.68 -170.89 3.63 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.819 -170.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.709 ' HA ' ' CH2' ' A' ' 25' ' ' TRP . 30.6 p -168.36 -178.59 3.63 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.789 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.54 ' HH ' ' HD2' ' A' ' 36' ' ' PHE . 53.1 m-85 -100.53 144.43 29.53 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 171.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.453 ' OG1' ' HB3' ' A' ' 67' ' ' ASN . 3.6 p -101.82 150.7 22.9 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.38 -171.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.7 p -84.41 35.0 0.53 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.358 0.599 . . . . 0.0 109.791 167.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.977 ' HB2' HG21 ' A' ' 20' ' ' THR . 57.8 t-20 -115.63 123.77 30.88 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.269 -176.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 67' ' ' ASN . 14.2 Cg_exo -69.13 -1.3 7.71 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 122.787 2.325 . . . . 0.0 113.682 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -84.02 -38.01 21.43 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.778 0.323 . . . . 0.0 111.777 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -143.9 143.14 31.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.134 0.492 . . . . 0.0 110.116 -176.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.454 ' O ' ' HD1' ' A' ' 64' ' ' TYR . 52.5 tp -71.05 -38.03 72.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.645 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -143.55 160.9 39.79 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -156.17 176.03 13.21 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -94.68 156.59 16.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 77.5 m -106.2 166.13 10.74 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.964 0.411 . . . . 0.0 111.55 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -101.74 33.0 3.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.023 -172.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.864 ' HB ' ' HG3' ' A' ' 13' ' ' ARG . 4.6 p -81.85 127.22 73.13 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-O 121.519 0.675 . . . . 0.0 111.63 -177.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.66 161.61 27.78 Favored 'Trans proline' 0 CA--C 1.515 -0.466 0 C-N-CA 124.378 3.385 . . . . 0.0 113.78 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -75.33 114.05 13.42 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.605 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.584 ' CA ' ' HB2' ' A' ' 1' ' ' CYS . 0.5 OUTLIER -76.07 -40.23 53.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.632 179.116 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB2' ' HD2' ' A' ' 3' ' ' PHE . . . -79.91 51.07 1.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.655 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.844 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.831 179.76 . . . . . . . . 0 0 . 1 stop_ save_